evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
3	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:11242110	SUPPORT	MODEL_ORGANISM	mice heterozygous for the mutation had a high incidence of cardiac outflow tract anomalies, thus modeling one of the major abnormalities of the human syndrome	Tbx1 heterozygous mice recapitulate the cardiac phenotype of human 22q11.2DS.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Tbx1 heterozygous mice recapitulate the cardiac phenotype of human 22q11.2DS."", ""reference"": ""PMID:11242110"", ""snippet"": ""mice heterozygous for the mutation had a high incidence of cardiac outflow tract anomalies, thus modeling one of the major abnormalities of the human syndrome"", ""supports"": ""SUPPORT""}"
4	3	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:11242110	SUPPORT	MODEL_ORGANISM	Tbx1-/- mice displayed a wide range of developmental anomalies encompassing almost all of the common DGS/VCFS features, including hypoplasia of the thymus and parathyroid glands, cardiac outflow tract abnormalities, abnormal facial structures, abnormal vertebrae and cleft palate	Homozygous Tbx1 knockout recapitulates the full DiGeorge phenotype.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Homozygous Tbx1 knockout recapitulates the full DiGeorge phenotype."", ""reference"": ""PMID:11242110"", ""snippet"": ""Tbx1-/- mice displayed a wide range of developmental anomalies encompassing almost all of the common DGS/VCFS features, including hypoplasia of the thymus and parathyroid glands, cardiac outflow tract abnormalities, abnormal facial structures, abnormal vertebrae and cleft palate"", ""supports"": ""SUPPORT""}"
5	4	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus)	GeneReviews documents the characteristic cardiac malformations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews documents the characteristic cardiac malformations."", ""reference"": ""PMID:20301696"", ""snippet"": ""congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus)"", ""supports"": ""SUPPORT""}"
6	5	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	immune deficiency	Immune deficiency is a major clinical manifestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Immune deficiency is a major clinical manifestation."", ""reference"": ""PMID:20301696"", ""snippet"": ""immune deficiency"", ""supports"": ""SUPPORT""}"
19	27	2	ALK-Rearranged Non-Small Cell Lung Cancer	ALK_Rearranged_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:27637426	SUPPORT		An early result of this search was the discovery of NSCLC driven by activating rearrangements of the anaplastic lymphoma kinase (ALK) gene.	This abstract states that ALK rearrangements drive a subset of NSCLC, supporting the ALK gene rearrangement mechanism.	"{""explanation"": ""This abstract states that ALK rearrangements drive a subset of NSCLC, supporting the ALK gene rearrangement mechanism."", ""reference"": ""PMID:27637426"", ""snippet"": ""An early result of this search was the discovery of NSCLC driven by activating rearrangements of the anaplastic lymphoma kinase (ALK) gene."", ""supports"": ""SUPPORT""}"
21	45	3	Acute Promyelocytic Leukemia, PML-RARA	APL_PML_RARA.yaml	pathophysiology	0	evidence	0	PMID:41580016	SUPPORT		Dysfunction of the retinoic acid (RA) signaling pathway, which is mediated by the formation of the PML-RARA fusion gene, plays a central role in the pathogenesis of acute promyelocytic leukemia (APL).	This abstract directly links PML-RARA fusion to APL pathogenesis, supporting the fusion oncogene mechanism.	"{""explanation"": ""This abstract directly links PML-RARA fusion to APL pathogenesis, supporting the fusion oncogene mechanism."", ""reference"": ""PMID:41580016"", ""snippet"": ""Dysfunction of the retinoic acid (RA) signaling pathway, which is mediated by the formation of the PML-RARA fusion gene, plays a central role in the pathogenesis of acute promyelocytic leukemia (APL)."", ""supports"": ""SUPPORT""}"
49	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	evidence	0	PMID:34884963	SUPPORT		Transthyretin (TTR) amyloidogenesis involves the formation, aggregation, and deposition of amyloid fibrils from tetrameric TTR in different organs and tissues.	The abstract mentions that TTR amyloidogenesis involves the formation and aggregation of amyloid fibrils, which supports the statement that mutations in the TTR gene result in the production of unstable transthyretin proteins that misfold and aggregate into amyloid fibrils.	"{""explanation"": ""The abstract mentions that TTR amyloidogenesis involves the formation and aggregation of amyloid fibrils, which supports the statement that mutations in the TTR gene result in the production of unstable transthyretin proteins that misfold and aggregate into amyloid fibrils."", ""reference"": ""PMID:34884963"", ""snippet"": ""Transthyretin (TTR) amyloidogenesis involves the formation, aggregation, and deposition of amyloid fibrils from tetrameric TTR in different organs and tissues."", ""supports"": ""SUPPORT""}"
50	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	evidence	1	PMID:35830843	SUPPORT		Familial amyloid polyneuropathy is currently prevalent worldwide as the transthyretin (TTR) Val30Met mutation, and there are other types of mutations.	This reference supports the statement by mentioning that familial amyloid polyneuropathy is caused by mutations in the TTR gene, which is consistent with the production of unstable transthyretin proteins that misfold and aggregate.	"{""explanation"": ""This reference supports the statement by mentioning that familial amyloid polyneuropathy is caused by mutations in the TTR gene, which is consistent with the production of unstable transthyretin proteins that misfold and aggregate."", ""reference"": ""PMID:35830843"", ""snippet"": ""Familial amyloid polyneuropathy is currently prevalent worldwide as the transthyretin (TTR) Val30Met mutation, and there are other types of mutations."", ""supports"": ""SUPPORT""}"
51	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	evidence	2	PMID:38844302	SUPPORT		Hereditary transthyretin-related amyloidosis (hATTR) is the most common form of familial amyloidosis. It is an autosomal dominant disease caused by a pathogenic variant in the TTR gene.	This reference supports the statement by explaining that hereditary transthyretin-related amyloidosis is caused by pathogenic variants in the TTR gene.	"{""explanation"": ""This reference supports the statement by explaining that hereditary transthyretin-related amyloidosis is caused by pathogenic variants in the TTR gene."", ""reference"": ""PMID:38844302"", ""snippet"": ""Hereditary transthyretin-related amyloidosis (hATTR) is the most common form of familial amyloidosis. It is an autosomal dominant disease caused by a pathogenic variant in the TTR gene."", ""supports"": ""SUPPORT""}"
52	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	evidence	3	PMID:22471982	SUPPORT		hereditary transthyretin (TTR) amyloidosis which is a genetically transmitted disease that results from a mutation in the gene encoding the plasma TTR protein.	The abstract confirms that hereditary transthyretin amyloidosis results from mutations in the TTR gene, which aligns with the statement.	"{""explanation"": ""The abstract confirms that hereditary transthyretin amyloidosis results from mutations in the TTR gene, which aligns with the statement."", ""reference"": ""PMID:22471982"", ""snippet"": ""hereditary transthyretin (TTR) amyloidosis which is a genetically transmitted disease that results from a mutation in the gene encoding the plasma TTR protein."", ""supports"": ""SUPPORT""}"
53	73	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	0	evidence	4	PMID:29962408	SUPPORT		Hereditary transthyretin (TTR)-related amyloidosis is caused by mutations in the TTR gene. The mutations destabilize the tetramer and/or monomer of TTR, and thus the stabilization of TTR is a key strategy for the treatment of TTR-related amyloidosis.	This reference explicitly states that hereditary transthyretin-related amyloidosis is caused by mutations in the TTR gene that destabilize the protein, supporting the statement.	"{""explanation"": ""This reference explicitly states that hereditary transthyretin-related amyloidosis is caused by mutations in the TTR gene that destabilize the protein, supporting the statement."", ""reference"": ""PMID:29962408"", ""snippet"": ""Hereditary transthyretin (TTR)-related amyloidosis is caused by mutations in the TTR gene. The mutations destabilize the tetramer and/or monomer of TTR, and thus the stabilization of TTR is a key strategy for the treatment of TTR-related amyloidosis."", ""supports"": ""SUPPORT""}"
54	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:40649158	SUPPORT		Transthyretin-related (ATTR) amyloidosis is a progressive, multisystem disease caused by the extracellular deposition of misfolded transthyretin (TTR) monomers as insoluble amyloid fibrils. Clinical manifestations vary widely and may include cardiomyopathy (ATTR-CM), polyneuropathy (ATTR-PN), or mixed phenotypes.	This 2025 review explicitly states that misfolded TTR monomers cause both cardiomyopathy and polyneuropathy, establishing the causal link between amyloid deposition and organ dysfunction.	"{""explanation"": ""This 2025 review explicitly states that misfolded TTR monomers cause both cardiomyopathy and polyneuropathy, establishing the causal link between amyloid deposition and organ dysfunction."", ""reference"": ""PMID:40649158"", ""snippet"": ""Transthyretin-related (ATTR) amyloidosis is a progressive, multisystem disease caused by the extracellular deposition of misfolded transthyretin (TTR) monomers as insoluble amyloid fibrils. Clinical manifestations vary widely and may include cardiomyopathy (ATTR-CM), polyneuropathy (ATTR-PN), or mixed phenotypes."", ""supports"": ""SUPPORT""}"
55	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	evidence	0	PMID:31452023	PARTIAL		fibrillar deposits in a several organs including the heart, kidney, liver, and peripheral nerves cause organ dysfunction and associated morbidity and mortality.	The reference supports that amyloid fibrils deposit in the heart, kidney, and peripheral nerves, but does not mention the gastrointestinal tract.	"{""explanation"": ""The reference supports that amyloid fibrils deposit in the heart, kidney, and peripheral nerves, but does not mention the gastrointestinal tract."", ""reference"": ""PMID:31452023"", ""snippet"": ""fibrillar deposits in a several organs including the heart, kidney, liver, and peripheral nerves cause organ dysfunction and associated morbidity and mortality."", ""supports"": ""PARTIAL""}"
56	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	evidence	1	PMID:15126690	PARTIAL		It is possible that a common factor in the amyloidogenesis process exists among the different forms; this common factor can involve changes produced by mutations in the three-dimensional structure of TTR, rendering it prone to deposition as amyloid.	The reference supports that misfolded transthyretin proteins form amyloid fibrils but does not specify all the tissues mentioned in the statement.	"{""explanation"": ""The reference supports that misfolded transthyretin proteins form amyloid fibrils but does not specify all the tissues mentioned in the statement."", ""reference"": ""PMID:15126690"", ""snippet"": ""It is possible that a common factor in the amyloidogenesis process exists among the different forms; this common factor can involve changes produced by mutations in the three-dimensional structure of TTR, rendering it prone to deposition as amyloid."", ""supports"": ""PARTIAL""}"
57	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	evidence	2	PMID:34018852	PARTIAL		Age-related wild-type transthyretin amyloidosis (wtATTR) is characterized by systemic deposition of amyloidogenic fibrils of misfolded transthyretin (TTR) in the connective tissue of many organs. In the heart, this leads to cardiac dysfunction, which is a significant cause of age-related heart failure.	The reference supports that amyloid fibrils deposit in the heart and connective tissue, but does not mention the nerves, kidneys, or gastrointestinal tract.	"{""explanation"": ""The reference supports that amyloid fibrils deposit in the heart and connective tissue, but does not mention the nerves, kidneys, or gastrointestinal tract."", ""reference"": ""PMID:34018852"", ""snippet"": ""Age-related wild-type transthyretin amyloidosis (wtATTR) is characterized by systemic deposition of amyloidogenic fibrils of misfolded transthyretin (TTR) in the connective tissue of many organs. In the heart, this leads to cardiac dysfunction, which is a significant cause of age-related heart failure."", ""supports"": ""PARTIAL""}"
58	74	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	pathophysiology	1	evidence	3	PMID:34361762	PARTIAL		Studies of nerve biopsy or cardiac autopsy specimens from patients with ATTR and AL amyloidoses show atrophy of cells near amyloid fibril aggregates.	The reference supports that amyloid fibrils deposit in the nerves and heart but does not mention the kidneys or gastrointestinal tract.	"{""explanation"": ""The reference supports that amyloid fibrils deposit in the nerves and heart but does not mention the kidneys or gastrointestinal tract."", ""reference"": ""PMID:34361762"", ""snippet"": ""Studies of nerve biopsy or cardiac autopsy specimens from patients with ATTR and AL amyloidoses show atrophy of cells near amyloid fibril aggregates."", ""supports"": ""PARTIAL""}"
115	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	evidence	0	PMID:7829510	SUPPORT	HUMAN_CLINICAL	A transition of G2853 to A in exon 41 produced a substitution of Gly769 by Ser within the triple helical domain of the alpha 1(II) chain of type II collagen, interrupting the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple helical type II collagen molecules	Demonstrates that glycine substitutions in the Gly-X-Y repeat domain interrupt the formation of stable triple helical collagen molecules.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that glycine substitutions in the Gly-X-Y repeat domain interrupt the formation of stable triple helical collagen molecules."", ""reference"": ""PMID:7829510"", ""snippet"": ""A transition of G2853 to A in exon 41 produced a substitution of Gly769 by Ser within the triple helical domain of the alpha 1(II) chain of type II collagen, interrupting the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple helical type II collagen molecules"", ""supports"": ""SUPPORT""}"
116	103	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	0	evidence	1	PMID:10745044	SUPPORT	HUMAN_CLINICAL	Five patients were heterozygous for a nucleotide change that predicted a glycine substitution in the triple helical domain (G313S, G517V, G571A, G910C, G943S)	Documents multiple glycine substitution mutations in the COL2A1 triple helical domain causing lethal type II collagen disorders.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents multiple glycine substitution mutations in the COL2A1 triple helical domain causing lethal type II collagen disorders."", ""reference"": ""PMID:10745044"", ""snippet"": ""Five patients were heterozygous for a nucleotide change that predicted a glycine substitution in the triple helical domain (G313S, G517V, G571A, G910C, G943S)"", ""supports"": ""SUPPORT""}"
117	104	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	1	evidence	0	PMID:7829510	SUPPORT	HUMAN_CLINICAL	resulting in the complete absence of type II collagen in the cartilage, which had a gelatinous composition	Demonstrates that the COL2A1 mutation results in complete loss of type II collagen from cartilage, leading to abnormal gelatinous matrix composition.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that the COL2A1 mutation results in complete loss of type II collagen from cartilage, leading to abnormal gelatinous matrix composition."", ""reference"": ""PMID:7829510"", ""snippet"": ""resulting in the complete absence of type II collagen in the cartilage, which had a gelatinous composition"", ""supports"": ""SUPPORT""}"
118	104	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	1	evidence	1	PMID:7829510	SUPPORT	HUMAN_CLINICAL	Type I and III collagens were the major species found in cartilage tissue and synthesized by cultured chondrocytes along with cartilage type XI collagen	Shows that mutant type II collagen is replaced by type I and III collagens, which are unable to support normal hyaline cartilage structure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Shows that mutant type II collagen is replaced by type I and III collagens, which are unable to support normal hyaline cartilage structure."", ""reference"": ""PMID:7829510"", ""snippet"": ""Type I and III collagens were the major species found in cartilage tissue and synthesized by cultured chondrocytes along with cartilage type XI collagen"", ""supports"": ""SUPPORT""}"
119	104	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	1	evidence	2	PMID:10745044	SUPPORT	HUMAN_CLINICAL	Overmodified type II collagen and the presence of type I collagen was found in the cartilage matrix of all seven cases	Confirms that abnormal type II collagen processing and replacement by type I collagen is a consistent finding in lethal type II collagenopathies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that abnormal type II collagen processing and replacement by type I collagen is a consistent finding in lethal type II collagenopathies."", ""reference"": ""PMID:10745044"", ""snippet"": ""Overmodified type II collagen and the presence of type I collagen was found in the cartilage matrix of all seven cases"", ""supports"": ""SUPPORT""}"
120	105	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	pathophysiology	2	evidence	0	PMID:10745044	SUPPORT	HUMAN_CLINICAL	Study of the clinical, radiographic, and morphological features of the seven cases supports evidence for a phenotypic continuum between achondrogenesis II-hypochondrogenesis and lethal SEDC and suggests a relationship between the amount of type I collagen in the cartilage and the severity of the phenotype.	Documents the phenotypic continuum from ACG2 through hypochondrogenesis to lethal SEDC and establishes the correlation between type I collagen content and disease severity.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents the phenotypic continuum from ACG2 through hypochondrogenesis to lethal SEDC and establishes the correlation between type I collagen content and disease severity."", ""reference"": ""PMID:10745044"", ""snippet"": ""Study of the clinical, radiographic, and morphological features of the seven cases supports evidence for a phenotypic continuum between achondrogenesis II-hypochondrogenesis and lethal SEDC and suggests a relationship between the amount of type I collagen in the cartilage and the severity of the phenotype."", ""supports"": ""SUPPORT""}"
127	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	evidence	0	PMID:7913883	SUPPORT	HUMAN_CLINICAL	DNA studies revealed point mutations in the FGFR3 gene in ACH heterozygotes and homozygotes. The mutation on 15 of the 16 ACH-affected chromosomes was the same, a G-->A transition, at nucleotide 1138 of the cDNA.	This landmark 1994 Cell paper by Shiang et al. identified FGFR3 mutations as the cause of achondroplasia, establishing the molecular basis of the disease.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This landmark 1994 Cell paper by Shiang et al. identified FGFR3 mutations as the cause of achondroplasia, establishing the molecular basis of the disease."", ""reference"": ""PMID:7913883"", ""snippet"": ""DNA studies revealed point mutations in the FGFR3 gene in ACH heterozygotes and homozygotes. The mutation on 15 of the 16 ACH-affected chromosomes was the same, a G-->A transition, at nucleotide 1138 of the cDNA."", ""supports"": ""SUPPORT""}"
128	117	6	Achondroplasia	Achondroplasia.yaml	pathophysiology	0	evidence	1	PMID:7847369	SUPPORT	HUMAN_CLINICAL	All but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380. Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position.	This study of 154 unrelated achondroplasia patients confirmed the G380R mutation is essentially universal, with over 97% having the same recurrent mutation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study of 154 unrelated achondroplasia patients confirmed the G380R mutation is essentially universal, with over 97% having the same recurrent mutation."", ""reference"": ""PMID:7847369"", ""snippet"": ""All but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380. Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position."", ""supports"": ""SUPPORT""}"
138	139	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:31287245	SUPPORT		The optic‐trigeminal summation hypothesis postulates that, during light stimulation, the activated optic nerve pathways cross‐activate the trigeminal nerve pathways	Cross-activation between visual and trigeminal pathways is a leading hypothesis.	"{""explanation"": ""Cross-activation between visual and trigeminal pathways is a leading hypothesis."", ""reference"": ""PMID:31287245"", ""snippet"": ""The optic‐trigeminal summation hypothesis postulates that, during light stimulation, the activated optic nerve pathways cross‐activate the trigeminal nerve pathways"", ""supports"": ""SUPPORT""}"
139	140	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:31287245	SUPPORT		According to the parasympathetic generalization hypothesis, when a light stimulus excites a specific branch of the parasympathetic nervous system, it activates other branches, resulting in nasal secretion and a tickling sensation in the nasal mucosa	Parasympathetic generalization is one of the proposed mechanisms.	"{""explanation"": ""Parasympathetic generalization is one of the proposed mechanisms."", ""reference"": ""PMID:31287245"", ""snippet"": ""According to the parasympathetic generalization hypothesis, when a light stimulus excites a specific branch of the parasympathetic nervous system, it activates other branches, resulting in nasal secretion and a tickling sensation in the nasal mucosa"", ""supports"": ""SUPPORT""}"
140	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:20169159	SUPPORT		we found a generally enhanced excitability of the visual cortex (mainly in the cuneus) to visual stimuli in 'photic sneezers' compared with control subjects	EEG study demonstrating enhanced visual cortex activation in photic sneezers.	"{""explanation"": ""EEG study demonstrating enhanced visual cortex activation in photic sneezers."", ""reference"": ""PMID:20169159"", ""snippet"": ""we found a generally enhanced excitability of the visual cortex (mainly in the cuneus) to visual stimuli in 'photic sneezers' compared with control subjects"", ""supports"": ""SUPPORT""}"
141	141	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:20169159	SUPPORT		a stronger prickling sensation in the nose of photic sneezers was found to be associated with activation in the insula and stronger activation in the secondary somatosensory cortex	Somatosensory cortex co-activation during nasal prickling sensation.	"{""explanation"": ""Somatosensory cortex co-activation during nasal prickling sensation."", ""reference"": ""PMID:20169159"", ""snippet"": ""a stronger prickling sensation in the nose of photic sneezers was found to be associated with activation in the insula and stronger activation in the secondary somatosensory cortex"", ""supports"": ""SUPPORT""}"
142	142	7	Achoo Syndrome	Achoo_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:34133943	SUPPORT		neuromedin B (NMB) peptide is essential for signaling sneezing. Ablation of NMB-sensitive postsynaptic neurons in the sneeze-evoking region or deficiency in NMB receptor abolished the sneezing reflex.	NMB-NMBR signaling is the molecular pathway mediating sneeze signal transmission in the brainstem.	"{""explanation"": ""NMB-NMBR signaling is the molecular pathway mediating sneeze signal transmission in the brainstem."", ""reference"": ""PMID:34133943"", ""snippet"": ""neuromedin B (NMB) peptide is essential for signaling sneezing. Ablation of NMB-sensitive postsynaptic neurons in the sneeze-evoking region or deficiency in NMB receptor abolished the sneezing reflex."", ""supports"": ""SUPPORT""}"
169	170	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	0	evidence	0	PMID:32748305	SUPPORT		Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms	This review explicitly identifies hyperkeratinization of the pilosebaceous follicles as a key factor in acne pathogenesis.	"{""explanation"": ""This review explicitly identifies hyperkeratinization of the pilosebaceous follicles as a key factor in acne pathogenesis."", ""reference"": ""PMID:32748305"", ""snippet"": ""Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"", ""supports"": ""SUPPORT""}"
170	171	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	1	evidence	0	PMID:32748305	SUPPORT		Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms	Follicular hyperkeratinization is the initiating event that drives microcomedone formation in acne.	"{""explanation"": ""Follicular hyperkeratinization is the initiating event that drives microcomedone formation in acne."", ""reference"": ""PMID:32748305"", ""snippet"": ""Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"", ""supports"": ""SUPPORT""}"
171	172	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	2	evidence	0	PMID:32748305	SUPPORT		In acne, mTORC1 mediates sebaceous gland hyperproliferation, lipid synthesis, and hyperplasia of keratinocytes	This review links sebaceous gland hyperproliferation and lipid synthesis to acne pathogenesis.	"{""explanation"": ""This review links sebaceous gland hyperproliferation and lipid synthesis to acne pathogenesis."", ""reference"": ""PMID:32748305"", ""snippet"": ""In acne, mTORC1 mediates sebaceous gland hyperproliferation, lipid synthesis, and hyperplasia of keratinocytes"", ""supports"": ""SUPPORT""}"
172	173	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	3	evidence	0	PMID:20871834	SUPPORT		Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid	This review highlights altered sebum fatty acid composition as a pathophysiologic feature of acne.	"{""explanation"": ""This review highlights altered sebum fatty acid composition as a pathophysiologic feature of acne."", ""reference"": ""PMID:20871834"", ""snippet"": ""Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid"", ""supports"": ""SUPPORT""}"
173	174	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	4	evidence	0	PMID:24062871	SUPPORT		Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule.	This review describes C. acnes colonization and its role in lesion progression.	"{""explanation"": ""This review describes C. acnes colonization and its role in lesion progression."", ""reference"": ""PMID:24062871"", ""snippet"": ""Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule."", ""supports"": ""SUPPORT""}"
174	175	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	5	evidence	0	DOI:10.3389/fimmu.2023.1075834	SUPPORT		The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens.	This review explains inflammasome activation, a key mechanism implicated in acne inflammation.	"{""explanation"": ""This review explains inflammasome activation, a key mechanism implicated in acne inflammation."", ""reference"": ""DOI:10.3389/fimmu.2023.1075834"", ""snippet"": ""The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."", ""supports"": ""SUPPORT""}"
175	176	8	Acne Vulgaris	Acne_Vulgaris.yaml	pathophysiology	6	evidence	0	DOI:10.3389/fimmu.2023.1075834	SUPPORT		The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens.	Inflammasome activation supports downstream cytokine-mediated inflammation in acne lesions.	"{""explanation"": ""Inflammasome activation supports downstream cytokine-mediated inflammation in acne lesions."", ""reference"": ""DOI:10.3389/fimmu.2023.1075834"", ""snippet"": ""The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."", ""supports"": ""SUPPORT""}"
223	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:23772614	SUPPORT		The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI).	The literature supports that the depletion of CD4 T-cells is a critical mechanism in the pathogenesis of AIDS.	"{""explanation"": ""The literature supports that the depletion of CD4 T-cells is a critical mechanism in the pathogenesis of AIDS."", ""reference"": ""PMID:23772614"", ""snippet"": ""The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."", ""supports"": ""SUPPORT""}"
224	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:9730930	SUPPORT		HIV-1 infects mononuclear cells using the CD4+ molecule... ongoing cellular destruction, leading to the characteristic immunodeficiency of AIDS and its opportunistic infections and neoplasms.	The literature affirms that HIV infects and destroys CD4 T-cells, leading to immunodeficiency.	"{""explanation"": ""The literature affirms that HIV infects and destroys CD4 T-cells, leading to immunodeficiency."", ""reference"": ""PMID:9730930"", ""snippet"": ""HIV-1 infects mononuclear cells using the CD4+ molecule... ongoing cellular destruction, leading to the characteristic immunodeficiency of AIDS and its opportunistic infections and neoplasms."", ""supports"": ""SUPPORT""}"
225	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:9735117	SUPPORT		The entry of one HIV virion into a human being has the potential to cause death by the inexorable replication of the virus within the principal T lymphocyte, the CD4+ T cell.	This reference supports the assertion that HIV infects and leads to the destruction of CD4 T-cells, which are crucial for immune function.	"{""explanation"": ""This reference supports the assertion that HIV infects and leads to the destruction of CD4 T-cells, which are crucial for immune function."", ""reference"": ""PMID:9735117"", ""snippet"": ""The entry of one HIV virion into a human being has the potential to cause death by the inexorable replication of the virus within the principal T lymphocyte, the CD4+ T cell."", ""supports"": ""SUPPORT""}"
226	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:17691934	SUPPORT		The role of the Human Immunodeficiency Virus (HIV) in the pathogenesis of the Acquired Immune-Deficiency Syndrome (AIDS) is changed. Direct HIV-mediated killing of CD4(+) T cells is not the only mechanism leading to lymphocyte depletion.	While it indicates additional mechanisms, this literature still supports the role of direct HIV-mediated killing of CD4 T-cells.	"{""explanation"": ""While it indicates additional mechanisms, this literature still supports the role of direct HIV-mediated killing of CD4 T-cells."", ""reference"": ""PMID:17691934"", ""snippet"": ""The role of the Human Immunodeficiency Virus (HIV) in the pathogenesis of the Acquired Immune-Deficiency Syndrome (AIDS) is changed. Direct HIV-mediated killing of CD4(+) T cells is not the only mechanism leading to lymphocyte depletion."", ""supports"": ""SUPPORT""}"
227	218	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	0	evidence	4	PMID:38474196	SUPPORT		HIV is a major cause of death worldwide... HIV-positive individuals also demonstrate diminished glutathione (GSH) levels which allows for increased viral replication and...slowed the decline of CD4+ T cell counts in HIV-positive individuals.	This reference supports the statement by noting the decline of CD4 T-cell counts due to HIV infection but adds information on glutathione's role in such processes.	"{""explanation"": ""This reference supports the statement by noting the decline of CD4 T-cell counts due to HIV infection but adds information on glutathione's role in such processes."", ""reference"": ""PMID:38474196"", ""snippet"": ""HIV is a major cause of death worldwide... HIV-positive individuals also demonstrate diminished glutathione (GSH) levels which allows for increased viral replication and...slowed the decline of CD4+ T cell counts in HIV-positive individuals."", ""supports"": ""SUPPORT""}"
228	219	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:23772614	SUPPORT		The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI).	This reference directly supports the statement by highlighting the progressive loss of CD4 T-cells as a key mechanism leading to severe immunodeficiency in AIDS.	"{""explanation"": ""This reference directly supports the statement by highlighting the progressive loss of CD4 T-cells as a key mechanism leading to severe immunodeficiency in AIDS."", ""reference"": ""PMID:23772614"", ""snippet"": ""The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."", ""supports"": ""SUPPORT""}"
229	219	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:34481993	SUPPORT		The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses.	The literature confirms that AIDS is caused by HIV targeting CD4 T cells, leading to defective immune responses, which aligns with the statement.	"{""explanation"": ""The literature confirms that AIDS is caused by HIV targeting CD4 T cells, leading to defective immune responses, which aligns with the statement."", ""reference"": ""PMID:34481993"", ""snippet"": ""The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses."", ""supports"": ""SUPPORT""}"
230	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:1981824	SUPPORT		The inability of CD4+ T cells of HIV-1-infected patients to mount an effective immune response is widely believed to explain the increased susceptibility of these patients to opportunistic infections.	This references clearly indicates that the impaired immunity in Acquired Immunodeficiency Syndrome (AIDS) increases susceptibility to opportunistic infections, thus supporting the statement.	"{""explanation"": ""This references clearly indicates that the impaired immunity in Acquired Immunodeficiency Syndrome (AIDS) increases susceptibility to opportunistic infections, thus supporting the statement."", ""reference"": ""PMID:1981824"", ""snippet"": ""The inability of CD4+ T cells of HIV-1-infected patients to mount an effective immune response is widely believed to explain the increased susceptibility of these patients to opportunistic infections."", ""supports"": ""SUPPORT""}"
231	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:19584497	SUPPORT		Opportunistic parasitic infection can cause severe morbidity and mortality. Because many of these infections are treatable, an early and accurate diagnosis is important.	This study underscores the impact of opportunistic infections due to impaired immunity in AIDS patients.	"{""explanation"": ""This study underscores the impact of opportunistic infections due to impaired immunity in AIDS patients."", ""reference"": ""PMID:19584497"", ""snippet"": ""Opportunistic parasitic infection can cause severe morbidity and mortality. Because many of these infections are treatable, an early and accurate diagnosis is important."", ""supports"": ""SUPPORT""}"
232	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	2	PMID:11868686	SUPPORT		The acquired immune deficiency syndrome (AIDS) is the result of a human immunodeficiency virus (HIV) infection damaging the cell-mediated immune system. ... A wide range of opportunistic infections (Ols) and tumours develop; additionally, HIV directly damages some organs.	The reference clearly states that impaired immunity from AIDS leads to various opportunistic infections.	"{""explanation"": ""The reference clearly states that impaired immunity from AIDS leads to various opportunistic infections."", ""reference"": ""PMID:11868686"", ""snippet"": ""The acquired immune deficiency syndrome (AIDS) is the result of a human immunodeficiency virus (HIV) infection damaging the cell-mediated immune system. ... A wide range of opportunistic infections (Ols) and tumours develop; additionally, HIV directly damages some organs."", ""supports"": ""SUPPORT""}"
233	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	3	PMID:25093312	SUPPORT		Incidence as well as morbidity and mortality of opportunistic infections (OI) have declined remarkably since the availability of antiretroviral treatment (ART).	Acknowledging the relationship between impaired immunity from HIV and opportunistic infections.	"{""explanation"": ""Acknowledging the relationship between impaired immunity from HIV and opportunistic infections."", ""reference"": ""PMID:25093312"", ""snippet"": ""Incidence as well as morbidity and mortality of opportunistic infections (OI) have declined remarkably since the availability of antiretroviral treatment (ART)."", ""supports"": ""SUPPORT""}"
234	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	4	PMID:34481993	SUPPORT		The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses.	Clearly states how HIV causes defective immune responses, resulting in opportunistic infections.	"{""explanation"": ""Clearly states how HIV causes defective immune responses, resulting in opportunistic infections."", ""reference"": ""PMID:34481993"", ""snippet"": ""The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses."", ""supports"": ""SUPPORT""}"
235	220	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	2	evidence	5	PMID:2680057	SUPPORT		The number and severity of such infections have increased markedly with the emergence of the acquired immunodeficiency syndrome (AIDS) epidemic.	The reference confirms the link between AIDS-related immunosuppression and increased severity of opportunistic infections.	"{""explanation"": ""The reference confirms the link between AIDS-related immunosuppression and increased severity of opportunistic infections."", ""reference"": ""PMID:2680057"", ""snippet"": ""The number and severity of such infections have increased markedly with the emergence of the acquired immunodeficiency syndrome (AIDS) epidemic."", ""supports"": ""SUPPORT""}"
236	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:37317962	SUPPORT		These data demonstrate that MG harbor replication-competent HIV and serve as a persistent reservoir in the brain.	This study directly demonstrates that brain microglia harbor replication-competent HIV and serve as a persistent CNS reservoir.	"{""explanation"": ""This study directly demonstrates that brain microglia harbor replication-competent HIV and serve as a persistent CNS reservoir."", ""reference"": ""PMID:37317962"", ""snippet"": ""These data demonstrate that MG harbor replication-competent HIV and serve as a persistent reservoir in the brain."", ""supports"": ""SUPPORT""}"
237	221	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:25604237	SUPPORT		Recent work suggests that the stage for HIV neuropathogenesis may be set with initial viral entry into the CNS, followed by initiation of pathogenetic processes including neuroinflammation and neurotoxicity, and establishment of local, compartmentalized HIV replication that may reflect a tissue reservoir for HIV.	This review describes early CNS invasion by HIV and the establishment of compartmentalized CNS reservoirs with associated neuroinflammation.	"{""explanation"": ""This review describes early CNS invasion by HIV and the establishment of compartmentalized CNS reservoirs with associated neuroinflammation."", ""reference"": ""PMID:25604237"", ""snippet"": ""Recent work suggests that the stage for HIV neuropathogenesis may be set with initial viral entry into the CNS, followed by initiation of pathogenetic processes including neuroinflammation and neurotoxicity, and establishment of local, compartmentalized HIV replication that may reflect a tissue reservoir for HIV."", ""supports"": ""SUPPORT""}"
238	223	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:12525676	SUPPORT		In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors.	The statement is supported by the literature indicating that weakened immune surveillance in the context of HIV infection increases the risk of certain cancers, such as Kaposi's sarcoma and non-Hodgkin's lymphoma.	"{""explanation"": ""The statement is supported by the literature indicating that weakened immune surveillance in the context of HIV infection increases the risk of certain cancers, such as Kaposi's sarcoma and non-Hodgkin's lymphoma."", ""reference"": ""PMID:12525676"", ""snippet"": ""In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors."", ""supports"": ""SUPPORT""}"
239	223	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	5	evidence	1	PMID:33843468	SUPPORT		Kaposi Sarcoma (KS) is the most common AIDS-defining cancer, even as HIV-positive people live longer. Like other herpesviruses, human herpesvirus-8 (HHV-8) establishes a lifelong infection of the host that in association with HIV infection may develop at any time during the illness.	The literature supports the notion that weakened immune surveillance due to HIV infection increases the risk of Kaposi Sarcoma, an AIDS-related cancer.	"{""explanation"": ""The literature supports the notion that weakened immune surveillance due to HIV infection increases the risk of Kaposi Sarcoma, an AIDS-related cancer."", ""reference"": ""PMID:33843468"", ""snippet"": ""Kaposi Sarcoma (KS) is the most common AIDS-defining cancer, even as HIV-positive people live longer. Like other herpesviruses, human herpesvirus-8 (HHV-8) establishes a lifelong infection of the host that in association with HIV infection may develop at any time during the illness."", ""supports"": ""SUPPORT""}"
240	223	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	pathophysiology	5	evidence	2	PMID:23259425	SUPPORT		A markedly increased risk of cervical cancer is known in women immunosuppressed due to AIDS or therapy following organ transplantation.	The literature indicates that immunosuppression due to AIDS increases the risk of cervical cancer, thus supporting the statement.	"{""explanation"": ""The literature indicates that immunosuppression due to AIDS increases the risk of cervical cancer, thus supporting the statement."", ""reference"": ""PMID:23259425"", ""snippet"": ""A markedly increased risk of cervical cancer is known in women immunosuppressed due to AIDS or therapy following organ transplantation."", ""supports"": ""SUPPORT""}"
331	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	evidence	0	PMID:29631795	SUPPORT		Autoimmunity against the adrenal cortex is the leading cause of Addison's disease in industrialized countries... The immune-mediated attack on adrenocortical cells cripples their ability to synthesize vital steroid hormones.	The provided literature supports that the immune system mistakenly attacks the adrenal cortex, leading to reduced hormone production.	"{""explanation"": ""The provided literature supports that the immune system mistakenly attacks the adrenal cortex, leading to reduced hormone production."", ""reference"": ""PMID:29631795"", ""snippet"": ""Autoimmunity against the adrenal cortex is the leading cause of Addison's disease in industrialized countries... The immune-mediated attack on adrenocortical cells cripples their ability to synthesize vital steroid hormones."", ""supports"": ""SUPPORT""}"
332	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	evidence	1	PMID:1946105	SUPPORT		In most cases, autoimmune destruction of the adrenal cortex is the cause of Addison's disease.	This reference confirms that autoimmune destruction of the adrenal cortex leads to Addison's disease.	"{""explanation"": ""This reference confirms that autoimmune destruction of the adrenal cortex leads to Addison's disease."", ""reference"": ""PMID:1946105"", ""snippet"": ""In most cases, autoimmune destruction of the adrenal cortex is the cause of Addison's disease."", ""supports"": ""SUPPORT""}"
333	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	evidence	2	PMID:20357943	SUPPORT		Hypoadrenocorticism typically results from immune-mediated destruction of all adrenocortical layers, resulting in deficiencies of min-eralocorticoids (aldosterone) and glucocorticoids (cortisol).	The literature supports the statement that the immune system attacks the adrenal cortex, leading to reduced cortisol and aldosterone production.	"{""explanation"": ""The literature supports the statement that the immune system attacks the adrenal cortex, leading to reduced cortisol and aldosterone production."", ""reference"": ""PMID:20357943"", ""snippet"": ""Hypoadrenocorticism typically results from immune-mediated destruction of all adrenocortical layers, resulting in deficiencies of min-eralocorticoids (aldosterone) and glucocorticoids (cortisol)."", ""supports"": ""SUPPORT""}"
334	254	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	0	evidence	3	PMID:34996091	SUPPORT		The immune system mistakenly attacks one's own cells, as if they were foreign, which typically results in endocrine gland hypofunction and inadequate hormone production... conditions such as Addison disease are encountered less frequently.	This reference supports the idea that autoimmune processes lead to endocrine gland hypofunction, including Addison's disease.	"{""explanation"": ""This reference supports the idea that autoimmune processes lead to endocrine gland hypofunction, including Addison's disease."", ""reference"": ""PMID:34996091"", ""snippet"": ""The immune system mistakenly attacks one's own cells, as if they were foreign, which typically results in endocrine gland hypofunction and inadequate hormone production... conditions such as Addison disease are encountered less frequently."", ""supports"": ""SUPPORT""}"
335	255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	evidence	0	PMID:16828409	SUPPORT		Addison's disease, or primary adrenal insufficiency, results in glucocorticoid and mineralocorticoid deficiency... chronic primary adrenal insufficiency presents with a more insidious history of malaise, anorexia, diarrhea, weight loss... hypoglycemia characterize acute adrenal crisis.	The literature describes Addison's disease as resulting in glucocorticoid (cortisol) deficiency, which leads to symptoms such as hypoglycemia and weight loss.	"{""explanation"": ""The literature describes Addison's disease as resulting in glucocorticoid (cortisol) deficiency, which leads to symptoms such as hypoglycemia and weight loss."", ""reference"": ""PMID:16828409"", ""snippet"": ""Addison's disease, or primary adrenal insufficiency, results in glucocorticoid and mineralocorticoid deficiency... chronic primary adrenal insufficiency presents with a more insidious history of malaise, anorexia, diarrhea, weight loss... hypoglycemia characterize acute adrenal crisis."", ""supports"": ""SUPPORT""}"
336	255	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	1	evidence	1	PMID:30120786	SUPPORT		Adrenal insufficiency (AI) is a rare, life-threatening disorder characterized by insufficient production of corticosteroid hormones... Conventional treatment of both primary and secondary adrenal insufficiencies involves lifelong glucocorticoid replacement therapy.	The literature confirms that adrenal insufficiency, which includes Addison's disease, is characterized by insufficient cortisol production and requires glucocorticoid replacement therapy.	"{""explanation"": ""The literature confirms that adrenal insufficiency, which includes Addison's disease, is characterized by insufficient cortisol production and requires glucocorticoid replacement therapy."", ""reference"": ""PMID:30120786"", ""snippet"": ""Adrenal insufficiency (AI) is a rare, life-threatening disorder characterized by insufficient production of corticosteroid hormones... Conventional treatment of both primary and secondary adrenal insufficiencies involves lifelong glucocorticoid replacement therapy."", ""supports"": ""SUPPORT""}"
337	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	evidence	0	PMID:6091953	SUPPORT		On the other hand, impaired secretion, as in Addison's disease or in congenital deficiencies of other steroid-synthesizing enzymes, leads to hypotension, sodium loss with hypovolaemia, and hyperkalaemia.	The excerpt clearly supports the statement by mentioning the effects of impaired aldosterone secretion in Addison's disease, which includes sodium loss (hyponatremia), hypovolemia (dehydration), and hyperkalemia.	"{""explanation"": ""The excerpt clearly supports the statement by mentioning the effects of impaired aldosterone secretion in Addison's disease, which includes sodium loss (hyponatremia), hypovolemia (dehydration), and hyperkalemia."", ""reference"": ""PMID:6091953"", ""snippet"": ""On the other hand, impaired secretion, as in Addison's disease or in congenital deficiencies of other steroid-synthesizing enzymes, leads to hypotension, sodium loss with hypovolaemia, and hyperkalaemia."", ""supports"": ""SUPPORT""}"
338	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	evidence	1	PMID:28132947	SUPPORT		Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment involves normalisation of sodium concentration and corticosteroids replacement.	The literature states that Addison's disease involves the destruction of the adrenal cortex, leading to issues with sodium concentration, supporting the statement about insufficient aldosterone affecting sodium and potassium balance.	"{""explanation"": ""The literature states that Addison's disease involves the destruction of the adrenal cortex, leading to issues with sodium concentration, supporting the statement about insufficient aldosterone affecting sodium and potassium balance."", ""reference"": ""PMID:28132947"", ""snippet"": ""Addison's disease is characterized by the destruction of the adrenal cortex. Autoimmune adrenalitis is the main cause of adrenal insufficiency. Treatment involves normalisation of sodium concentration and corticosteroids replacement."", ""supports"": ""SUPPORT""}"
339	256	10	Addison's Disease	Addisons_Disease.yaml	pathophysiology	2	evidence	2	PMID:13851580	SUPPORT		Addison's disease.	The reference title directly mentions Addison's disease, supporting the context of the statement.	"{""explanation"": ""The reference title directly mentions Addison's disease, supporting the context of the statement."", ""reference"": ""PMID:13851580"", ""snippet"": ""Addison's disease."", ""supports"": ""SUPPORT""}"
392	290	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	0	evidence	0	PMID:15129647	SUPPORT		HTLV-1 causes 2 major diseases: adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-1-associated myelopathy.	Abstract states HTLV-1 causes ATLL, supporting the infectious etiology.	"{""explanation"": ""Abstract states HTLV-1 causes ATLL, supporting the infectious etiology."", ""reference"": ""PMID:15129647"", ""snippet"": ""HTLV-1 causes 2 major diseases: adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-1-associated myelopathy."", ""supports"": ""SUPPORT""}"
393	290	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	pathophysiology	0	evidence	1	PMID:15129647	SUPPORT		Tax is a 40-kDa phosphoprotein that is encoded by the pX region of the virus.	Abstract identifies Tax as a viral protein, supporting Tax oncoprotein expression.	"{""explanation"": ""Abstract identifies Tax as a viral protein, supporting Tax oncoprotein expression."", ""reference"": ""PMID:15129647"", ""snippet"": ""Tax is a 40-kDa phosphoprotein that is encoded by the pX region of the virus."", ""supports"": ""SUPPORT""}"
404	346	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	0	evidence	0	PMID:38731137	SUPPORT		Drusen comprise a yellowish white substance that accumulates typically under the retinal pigment epithelium (RPE), and their constituents are lipids, complement, amyloid, crystallin, and others.	This confirms that drusen are lipid and protein deposits under the RPE with characteristic composition including lipids, complement proteins, and other components.	"{""explanation"": ""This confirms that drusen are lipid and protein deposits under the RPE with characteristic composition including lipids, complement proteins, and other components."", ""reference"": ""PMID:38731137"", ""snippet"": ""Drusen comprise a yellowish white substance that accumulates typically under the retinal pigment epithelium (RPE), and their constituents are lipids, complement, amyloid, crystallin, and others."", ""supports"": ""SUPPORT""}"
405	347	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	1	evidence	0	PMID:38193957	SUPPORT		AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration and loss of central vision. The late stages of AMD are characterized by outer retinal atrophy, termed geographic atrophy, or neovascularization associated with subretinal and/or intraretinal exudation, termed exudative neovascular AMD.	This describes the progression from deposit accumulation to photoreceptor degeneration and atrophy, supporting the role of RPE dysfunction in geographic atrophy development.	"{""explanation"": ""This describes the progression from deposit accumulation to photoreceptor degeneration and atrophy, supporting the role of RPE dysfunction in geographic atrophy development."", ""reference"": ""PMID:38193957"", ""snippet"": ""AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration and loss of central vision. The late stages of AMD are characterized by outer retinal atrophy, termed geographic atrophy, or neovascularization associated with subretinal and/or intraretinal exudation, termed exudative neovascular AMD."", ""supports"": ""SUPPORT""}"
406	348	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	2	evidence	0	PMID:38690727	SUPPORT		Careful regulation of the complement system is critical for enabling complement proteins to titrate immune defense while also preventing collateral tissue damage from poorly controlled inflammation. In the eye, this balance between complement activity and inhibition is crucial, as a low level of basal complement activity is necessary to support ocular immune privilege, a prerequisite for maintaining vision.	This explains the importance of complement regulation in the eye and how dysregulation leads to inflammation and tissue damage, which is central to AMD pathogenesis.	"{""explanation"": ""This explains the importance of complement regulation in the eye and how dysregulation leads to inflammation and tissue damage, which is central to AMD pathogenesis."", ""reference"": ""PMID:38690727"", ""snippet"": ""Careful regulation of the complement system is critical for enabling complement proteins to titrate immune defense while also preventing collateral tissue damage from poorly controlled inflammation. In the eye, this balance between complement activity and inhibition is crucial, as a low level of basal complement activity is necessary to support ocular immune privilege, a prerequisite for maintaining vision."", ""supports"": ""SUPPORT""}"
407	348	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	2	evidence	1	PMID:38690727	SUPPORT		Complement dysregulation has been implicated in many ocular diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD).	Direct confirmation that complement dysregulation is implicated in AMD pathogenesis.	"{""explanation"": ""Direct confirmation that complement dysregulation is implicated in AMD pathogenesis."", ""reference"": ""PMID:38690727"", ""snippet"": ""Complement dysregulation has been implicated in many ocular diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD)."", ""supports"": ""SUPPORT""}"
408	349	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	pathophysiology	3	evidence	0	PMID:38193957	SUPPORT		In exudative neovascular AMD, 94.6% of patients receiving monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections experience less than a 15-letter visual acuity loss after 12 months compared with 62.2% receiving sham treatment.	The effectiveness of anti-VEGF therapy demonstrates that VEGF-driven angiogenesis is the key pathophysiological mechanism in neovascular AMD.	"{""explanation"": ""The effectiveness of anti-VEGF therapy demonstrates that VEGF-driven angiogenesis is the key pathophysiological mechanism in neovascular AMD."", ""reference"": ""PMID:38193957"", ""snippet"": ""In exudative neovascular AMD, 94.6% of patients receiving monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections experience less than a 15-letter visual acuity loss after 12 months compared with 62.2% receiving sham treatment."", ""supports"": ""SUPPORT""}"
419	366	14	Ainhum	Ainhum.yaml	pathophysiology	0	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	a groove or fissure of constricting tissue forms around the proximal end of the fifth toe.	The abstract describes the initiating constriction groove around the fifth toe.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract describes the initiating constriction groove around the fifth toe."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""a groove or fissure of constricting tissue forms around the proximal end of the fifth toe."", ""supports"": ""SUPPORT""}"
420	366	14	Ainhum	Ainhum.yaml	pathophysiology	0	evidence	1	PMID:12500788	SUPPORT	HUMAN_CLINICAL	Dactylolysis spontanea is an idiopathic condition affecting the fifth toe, and sometimes other toes	Radiological survey notes fifth toe predominance with possible involvement of other toes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Radiological survey notes fifth toe predominance with possible involvement of other toes."", ""reference"": ""PMID:12500788"", ""snippet"": ""Dactylolysis spontanea is an idiopathic condition affecting the fifth toe, and sometimes other toes"", ""supports"": ""SUPPORT""}"
421	366	14	Ainhum	Ainhum.yaml	pathophysiology	0	evidence	2	PMID:1539609	SUPPORT	HUMAN_CLINICAL	It usually affects the fifth toe bilaterally	Case report emphasizes typical bilateral fifth toe involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report emphasizes typical bilateral fifth toe involvement."", ""reference"": ""PMID:1539609"", ""snippet"": ""It usually affects the fifth toe bilaterally"", ""supports"": ""SUPPORT""}"
422	367	14	Ainhum	Ainhum.yaml	pathophysiology	1	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	Eventually, the groove extends to encircle the toe, the underlying structures are absorbed and the toe autoamputates.	The abstract notes progression from groove to encircling constriction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract notes progression from groove to encircling constriction."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""Eventually, the groove extends to encircle the toe, the underlying structures are absorbed and the toe autoamputates."", ""supports"": ""SUPPORT""}"
423	368	14	Ainhum	Ainhum.yaml	pathophysiology	2	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	the underlying structures are absorbed and the toe autoamputates.	The abstract explicitly links constriction to absorption of underlying structures.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract explicitly links constriction to absorption of underlying structures."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""the underlying structures are absorbed and the toe autoamputates."", ""supports"": ""SUPPORT""}"
424	369	14	Ainhum	Ainhum.yaml	pathophysiology	3	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	the toe autoamputates.	The abstract describes autoamputation as the end-stage outcome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract describes autoamputation as the end-stage outcome."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""the toe autoamputates."", ""supports"": ""SUPPORT""}"
444	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Despite its profound impact, the condition remains poorly understood beyond the established centrality of cortical area V5/MT in visual motion perception.	This systematic review highlights V5/MT as central to motion perception, supporting V5/MT dysfunction as a core mechanism.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This systematic review highlights V5/MT as central to motion perception, supporting V5/MT dysfunction as a core mechanism."", ""reference"": ""PMID:39996018"", ""snippet"": ""Despite its profound impact, the condition remains poorly understood beyond the established centrality of cortical area V5/MT in visual motion perception."", ""supports"": ""SUPPORT""}"
445	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	evidence	1	PMID:27193360	SUPPORT	HUMAN_CLINICAL	akinetopsia (cortical syndrome in which patient losses the ability to perceive visual motion)	This review defines akinetopsia as a cortical syndrome with loss of visual motion perception.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review defines akinetopsia as a cortical syndrome with loss of visual motion perception."", ""reference"": ""PMID:27193360"", ""snippet"": ""akinetopsia (cortical syndrome in which patient losses the ability to perceive visual motion)"", ""supports"": ""SUPPORT""}"
446	386	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	0	evidence	2	PMID:37938052	SUPPORT	HUMAN_CLINICAL	Our results revealed distinct characteristics for the various etiologies of this phenomenon in addition to a shared pathophysiologic pathway among them.	This systematic review supports a shared pathophysiologic pathway across akinetopsia etiologies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This systematic review supports a shared pathophysiologic pathway across akinetopsia etiologies."", ""reference"": ""PMID:37938052"", ""snippet"": ""Our results revealed distinct characteristics for the various etiologies of this phenomenon in addition to a shared pathophysiologic pathway among them."", ""supports"": ""SUPPORT""}"
447	387	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	1	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Pathophysiologically, in right-handed individuals, the left area V5/MT was found to be particularly susceptible to acute interference, as evidenced by the experimental studies.	This indicates left V5/MT vulnerability to acute interference in experimental cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This indicates left V5/MT vulnerability to acute interference in experimental cases."", ""reference"": ""PMID:39996018"", ""snippet"": ""Pathophysiologically, in right-handed individuals, the left area V5/MT was found to be particularly susceptible to acute interference, as evidenced by the experimental studies."", ""supports"": ""SUPPORT""}"
448	388	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	2	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	we found a greater prevalence of right-hemispheric afflictions in clinical cases, suggesting that the right area V5/MT plays a more dominant role in motion perception.	This supports right-hemisphere predominance for motion perception in clinical akinetopsia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports right-hemisphere predominance for motion perception in clinical akinetopsia."", ""reference"": ""PMID:39996018"", ""snippet"": ""we found a greater prevalence of right-hemispheric afflictions in clinical cases, suggesting that the right area V5/MT plays a more dominant role in motion perception."", ""supports"": ""SUPPORT""}"
449	389	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	3	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	the severity of the condition also depends on surviving components of the visual motion network as a whole, and-in line with the dynamic parallellism theory-the speed of moving objects.	This supports network redundancy and stimulus speed as modifiers of symptom severity.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports network redundancy and stimulus speed as modifiers of symptom severity."", ""reference"": ""PMID:39996018"", ""snippet"": ""the severity of the condition also depends on surviving components of the visual motion network as a whole, and-in line with the dynamic parallellism theory-the speed of moving objects."", ""supports"": ""SUPPORT""}"
450	390	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	4	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy.	This supports structural neurological disease as the dominant mechanism leading to motion network damage.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports structural neurological disease as the dominant mechanism leading to motion network damage."", ""reference"": ""PMID:39996018"", ""snippet"": ""Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy."", ""supports"": ""SUPPORT""}"
451	391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy.	This indicates that intoxications and paroxysmal disorders can underlie akinetopsia in some cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This indicates that intoxications and paroxysmal disorders can underlie akinetopsia in some cases."", ""reference"": ""PMID:39996018"", ""snippet"": ""Aetiologically, most cases were associated with structural neurological conditions such as stroke and neurodegenerative disease, and fewer with intoxications or paroxysmal neurological disorders such as epilepsy."", ""supports"": ""SUPPORT""}"
452	391	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	5	evidence	1	PMID:25667833	SUPPORT	HUMAN_CLINICAL	We describe a patient who showed akinetopsia recurrently as epileptic seizures.	This case report documents epileptic seizures presenting as recurrent akinetopsia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report documents epileptic seizures presenting as recurrent akinetopsia."", ""reference"": ""PMID:25667833"", ""snippet"": ""We describe a patient who showed akinetopsia recurrently as epileptic seizures."", ""supports"": ""SUPPORT""}"
453	392	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	6	evidence	0	PMID:25667833	SUPPORT	HUMAN_CLINICAL	We diagnosed his visual symptom as akinetopsia, which was aroused by hyperexcitability of the right temporal and parietal cortices, including area MT/V5.	This case report attributes akinetopsia to hyperexcitability in right temporal/parietal cortices including MT/V5.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report attributes akinetopsia to hyperexcitability in right temporal/parietal cortices including MT/V5."", ""reference"": ""PMID:25667833"", ""snippet"": ""We diagnosed his visual symptom as akinetopsia, which was aroused by hyperexcitability of the right temporal and parietal cortices, including area MT/V5."", ""supports"": ""SUPPORT""}"
454	393	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	7	evidence	0	PMID:40605075	SUPPORT	HUMAN_CLINICAL	Recent cases have demonstrated that it is not necessarily attributed only to vascular causes and neurodegenerative diseases but can also be induced through transcranial magnetic stimulation, and certain medications.	This review documents TMS- and medication-induced akinetopsia, supporting reversible circuit disruption mechanisms.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review documents TMS- and medication-induced akinetopsia, supporting reversible circuit disruption mechanisms."", ""reference"": ""PMID:40605075"", ""snippet"": ""Recent cases have demonstrated that it is not necessarily attributed only to vascular causes and neurodegenerative diseases but can also be induced through transcranial magnetic stimulation, and certain medications."", ""supports"": ""SUPPORT""}"
455	394	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	8	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity.	This links bilateral V5/MT lesions to downstream global and chronic akinetopsia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This links bilateral V5/MT lesions to downstream global and chronic akinetopsia."", ""reference"": ""PMID:39996018"", ""snippet"": ""Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity."", ""supports"": ""SUPPORT""}"
456	395	15	Akinetopsia	Akinetopsia.yaml	pathophysiology	9	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity.	This supports global and chronic akinetopsia as a frequent outcome of bilateral V5/MT lesions.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports global and chronic akinetopsia as a frequent outcome of bilateral V5/MT lesions."", ""reference"": ""PMID:39996018"", ""snippet"": ""Bilateral lesions to V5/MT most often coincided with global akinetopsia and chronicity."", ""supports"": ""SUPPORT""}"
464	402	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	0	evidence	0	PMID:39362713	SUPPORT		Alcohol metabolism, cellular stress, and gut-derived factors contribute to hepatocyte and immune cell injury leading to cytokine and chemokine production.	The review links alcohol metabolism and cellular stress to hepatocyte and immune cell injury with cytokine and chemokine production.	"{""explanation"": ""The review links alcohol metabolism and cellular stress to hepatocyte and immune cell injury with cytokine and chemokine production."", ""reference"": ""PMID:39362713"", ""snippet"": ""Alcohol metabolism, cellular stress, and gut-derived factors contribute to hepatocyte and immune cell injury leading to cytokine and chemokine production."", ""supports"": ""SUPPORT""}"
465	403	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	pathophysiology	1	evidence	0	PMID:37143126	SUPPORT		ethanol damages the intestinal barrier, resulting in the release of endotoxins and alterations in intestinal flora content and bile acid metabolism.	The review describes ethanol-induced barrier damage and endotoxin release as part of ALD pathogenesis.	"{""explanation"": ""The review describes ethanol-induced barrier damage and endotoxin release as part of ALD pathogenesis."", ""reference"": ""PMID:37143126"", ""snippet"": ""ethanol damages the intestinal barrier, resulting in the release of endotoxins and alterations in intestinal flora content and bile acid metabolism."", ""supports"": ""SUPPORT""}"
507	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	0	PMID:28320296	SUPPORT		These intra- or extracellular insoluble aggregates (fibers or plaques) are hallmarks of many neurodegenerative pathologies including Alzheimer's disease (AD)...	This reference supports the statement by confirming that amyloid plaques are a hallmark of Alzheimer's disease and discusses the formation and role of amyloid aggregates in AD.	"{""explanation"": ""This reference supports the statement by confirming that amyloid plaques are a hallmark of Alzheimer's disease and discusses the formation and role of amyloid aggregates in AD."", ""reference"": ""PMID:28320296"", ""snippet"": ""These intra- or extracellular insoluble aggregates (fibers or plaques) are hallmarks of many neurodegenerative pathologies including Alzheimer's disease (AD)..."", ""supports"": ""SUPPORT""}"
508	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	1	PMID:26322584	SUPPORT		Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-beta peptide.	This reference supports the statement by indicating that the accumulation of amyloid plaques, composed of amyloid-beta peptide, is a characteristic of Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by indicating that the accumulation of amyloid plaques, composed of amyloid-beta peptide, is a characteristic of Alzheimer's disease."", ""reference"": ""PMID:26322584"", ""snippet"": ""Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-beta peptide."", ""supports"": ""SUPPORT""}"
509	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	2	PMID:22351073	SUPPORT		Generation of amyloid peptide (Abeta) is at the beginning of a cascade that leads to Alzheimer's disease (AD)... soluble assembly states of Abeta peptides can cause cognitive problems by disrupting synaptic function...	This reference supports the statement by mentioning that amyloid-beta peptides lead to Alzheimer's disease and cause synaptic dysfunction.	"{""explanation"": ""This reference supports the statement by mentioning that amyloid-beta peptides lead to Alzheimer's disease and cause synaptic dysfunction."", ""reference"": ""PMID:22351073"", ""snippet"": ""Generation of amyloid peptide (Abeta) is at the beginning of a cascade that leads to Alzheimer's disease (AD)... soluble assembly states of Abeta peptides can cause cognitive problems by disrupting synaptic function..."", ""supports"": ""SUPPORT""}"
510	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	3	PMID:10911965	SUPPORT		Alzheimer's disease (AD) pathology is characterized by A beta peptide-containing plaques, neurofibrillary tangles consisting of hyperphosphorylated tau, extensive neuritic degeneration, and distinct neuron loss.	This reference supports the statement by describing Alzheimer's disease pathology, including amyloid-beta peptide-containing plaques.	"{""explanation"": ""This reference supports the statement by describing Alzheimer's disease pathology, including amyloid-beta peptide-containing plaques."", ""reference"": ""PMID:10911965"", ""snippet"": ""Alzheimer's disease (AD) pathology is characterized by A beta peptide-containing plaques, neurofibrillary tangles consisting of hyperphosphorylated tau, extensive neuritic degeneration, and distinct neuron loss."", ""supports"": ""SUPPORT""}"
511	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	4	PMID:10702374	SUPPORT		beta-amyloid (Abeta) is the main constituent of the amyloidogenic plaques which are a primary pathological hallmark of Alzheimer's disease...	This reference supports the statement by confirming that beta-amyloid is the main constituent of amyloid plaques, a hallmark of Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by confirming that beta-amyloid is the main constituent of amyloid plaques, a hallmark of Alzheimer's disease."", ""reference"": ""PMID:10702374"", ""snippet"": ""beta-amyloid (Abeta) is the main constituent of the amyloidogenic plaques which are a primary pathological hallmark of Alzheimer's disease..."", ""supports"": ""SUPPORT""}"
512	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	5	PMID:36555791	SUPPORT		Neuritic plaques are one of the major pathological hallmarks of Alzheimer's disease. They are formed by the aggregation of extracellular amyloid-beta protein (Abeta)...	This reference supports the statement by indicating that neuritic plaques, formed by the aggregation of amyloid-beta protein, are a hallmark of Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by indicating that neuritic plaques, formed by the aggregation of amyloid-beta protein, are a hallmark of Alzheimer's disease."", ""reference"": ""PMID:36555791"", ""snippet"": ""Neuritic plaques are one of the major pathological hallmarks of Alzheimer's disease. They are formed by the aggregation of extracellular amyloid-beta protein (Abeta)..."", ""supports"": ""SUPPORT""}"
513	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	6	PMID:25941885	SUPPORT		The 'amyloid cascade hypothesis' posits that an extracellular build-up of amyloid-beta oligomers (Abeta-os) and polymers (fibrils) subsequently inducing toxic hyperphosphorylated (p)-Tau oligomers (p-Tau-os) and neurofibrillary tangles starts the sporadic late-onset Alzheimer's disease (LOAD)...	This reference supports the statement by discussing the amyloid cascade hypothesis, which involves the build-up of amyloid-beta leading to Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by discussing the amyloid cascade hypothesis, which involves the build-up of amyloid-beta leading to Alzheimer's disease."", ""reference"": ""PMID:25941885"", ""snippet"": ""The 'amyloid cascade hypothesis' posits that an extracellular build-up of amyloid-beta oligomers (Abeta-os) and polymers (fibrils) subsequently inducing toxic hyperphosphorylated (p)-Tau oligomers (p-Tau-os) and neurofibrillary tangles starts the sporadic late-onset Alzheimer's disease (LOAD)..."", ""supports"": ""SUPPORT""}"
514	420	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	0	evidence	7	PMID:16611586	SUPPORT		The amyloidogenesis occurring in Alzheimer's disease represents a fundamental membrane-related pathology... the amyloid-beta peptide (Abeta), which accumulates extracellularly as plaques in the brains of Alzheimer's disease patients...	This reference supports the statement by describing the accumulation of amyloid-beta peptide as plaques in Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by describing the accumulation of amyloid-beta peptide as plaques in Alzheimer's disease."", ""reference"": ""PMID:16611586"", ""snippet"": ""The amyloidogenesis occurring in Alzheimer's disease represents a fundamental membrane-related pathology... the amyloid-beta peptide (Abeta), which accumulates extracellularly as plaques in the brains of Alzheimer's disease patients..."", ""supports"": ""SUPPORT""}"
515	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	0	PMID:21509508	SUPPORT		Extracellular accumulations of Abeta, hyperphosphorylation of tau and intracellular neurofibrillary tangle formation have been the hallmarks of Alzheimer's Disease (AD).	The article discusses the role of tau hyperphosphorylation and neurofibrillary tangle formation in Alzheimer's Disease, supporting the statement about these processes.	"{""explanation"": ""The article discusses the role of tau hyperphosphorylation and neurofibrillary tangle formation in Alzheimer's Disease, supporting the statement about these processes."", ""reference"": ""PMID:21509508"", ""snippet"": ""Extracellular accumulations of Abeta, hyperphosphorylation of tau and intracellular neurofibrillary tangle formation have been the hallmarks of Alzheimer's Disease (AD)."", ""supports"": ""SUPPORT""}"
516	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	1	PMID:36001963	SUPPORT		In Alzheimer's disease and other neurodegenerative tauopathies, tau is found hyperphosphorylated and aggregated in neurofibrillary tangles.	This article supports the statement by mentioning the hyperphosphorylation and aggregation of tau in neurofibrillary tangles in Alzheimer's Disease.	"{""explanation"": ""This article supports the statement by mentioning the hyperphosphorylation and aggregation of tau in neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:36001963"", ""snippet"": ""In Alzheimer's disease and other neurodegenerative tauopathies, tau is found hyperphosphorylated and aggregated in neurofibrillary tangles."", ""supports"": ""SUPPORT""}"
517	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	2	PMID:37266762	SUPPORT		Tau is a microtubule-associated binding protein in the nervous system that is known for its role in stabilizing microtubules throughout the nerve cell. It accumulates as beta-sheet-rich aggregates and neurofibrillary tangles, leading to an array of different pathologies.	The article confirms that hyperphosphorylated tau leads to the formation of neurofibrillary tangles and disrupts microtubule stabilization, supporting the statement.	"{""explanation"": ""The article confirms that hyperphosphorylated tau leads to the formation of neurofibrillary tangles and disrupts microtubule stabilization, supporting the statement."", ""reference"": ""PMID:37266762"", ""snippet"": ""Tau is a microtubule-associated binding protein in the nervous system that is known for its role in stabilizing microtubules throughout the nerve cell. It accumulates as beta-sheet-rich aggregates and neurofibrillary tangles, leading to an array of different pathologies."", ""supports"": ""SUPPORT""}"
518	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	3	PMID:19542604	SUPPORT		Tau protein is the principal component of the neurofibrillary tangles found in Alzheimer's disease (AD), where it is hyperphosphorylated on serine and threonine residues.	This article supports the statement by identifying hyperphosphorylated tau as the main component of neurofibrillary tangles in Alzheimer's Disease.	"{""explanation"": ""This article supports the statement by identifying hyperphosphorylated tau as the main component of neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:19542604"", ""snippet"": ""Tau protein is the principal component of the neurofibrillary tangles found in Alzheimer's disease (AD), where it is hyperphosphorylated on serine and threonine residues."", ""supports"": ""SUPPORT""}"
519	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	4	PMID:28100644	SUPPORT		These multicellular interactions are initiated by insoluble tangles of phosphorylated tau protein and plaques of amyloid peptides.	This article supports the statement by discussing how phosphorylated tau protein tangles initiate multicellular interactions in Alzheimer's Disease.	"{""explanation"": ""This article supports the statement by discussing how phosphorylated tau protein tangles initiate multicellular interactions in Alzheimer's Disease."", ""reference"": ""PMID:28100644"", ""snippet"": ""These multicellular interactions are initiated by insoluble tangles of phosphorylated tau protein and plaques of amyloid peptides."", ""supports"": ""SUPPORT""}"
520	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	5	PMID:2135393	SUPPORT		The most common of these conditions is Alzheimer's disease, in which microtubules are lost from neurites that fill up with filamentous structures. One component of the filamentous structures is the microtubule-associated protein (MAP), tau.	The article supports the statement by explaining how tau protein is involved in the formation of filamentous structures in Alzheimer's Disease, leading to microtubule destabilization.	"{""explanation"": ""The article supports the statement by explaining how tau protein is involved in the formation of filamentous structures in Alzheimer's Disease, leading to microtubule destabilization."", ""reference"": ""PMID:2135393"", ""snippet"": ""The most common of these conditions is Alzheimer's disease, in which microtubules are lost from neurites that fill up with filamentous structures. One component of the filamentous structures is the microtubule-associated protein (MAP), tau."", ""supports"": ""SUPPORT""}"
521	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	6	PMID:12859672	SUPPORT		Neurofibrillary tangles are composed of insoluble aggregates of the microtubule-associated protein tau. In Alzheimer's disease the accumulation of neurofibrillary tangles occurs in the absence of tau mutations.	This article supports the statement by describing the composition and formation of neurofibrillary tangles from tau protein in Alzheimer's Disease.	"{""explanation"": ""This article supports the statement by describing the composition and formation of neurofibrillary tangles from tau protein in Alzheimer's Disease."", ""reference"": ""PMID:12859672"", ""snippet"": ""Neurofibrillary tangles are composed of insoluble aggregates of the microtubule-associated protein tau. In Alzheimer's disease the accumulation of neurofibrillary tangles occurs in the absence of tau mutations."", ""supports"": ""SUPPORT""}"
522	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	7	PMID:31903881	SUPPORT		Hyperphosphorylation of tau protein leads to aggregation of tau into paired helical filaments like structures which are major constituents of neurofibrillary tangles, a hallmark of Alzheimer's disease.	The article supports the statement by linking tau hyperphosphorylation and aggregation to the formation of neurofibrillary tangles in Alzheimer's Disease.	"{""explanation"": ""The article supports the statement by linking tau hyperphosphorylation and aggregation to the formation of neurofibrillary tangles in Alzheimer's Disease."", ""reference"": ""PMID:31903881"", ""snippet"": ""Hyperphosphorylation of tau protein leads to aggregation of tau into paired helical filaments like structures which are major constituents of neurofibrillary tangles, a hallmark of Alzheimer's disease."", ""supports"": ""SUPPORT""}"
523	421	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	1	evidence	8	PMID:23948895	SUPPORT		Tauopathies are neurodegenerative diseases characterized behaviorally by dementia and neuropathologically by neurofibrillary tangles and neuronal loss.	The article supports the statement by describing tauopathies, including Alzheimer's Disease, as being characterized by neurofibrillary tangles and neuronal loss.	"{""explanation"": ""The article supports the statement by describing tauopathies, including Alzheimer's Disease, as being characterized by neurofibrillary tangles and neuronal loss."", ""reference"": ""PMID:23948895"", ""snippet"": ""Tauopathies are neurodegenerative diseases characterized behaviorally by dementia and neuropathologically by neurofibrillary tangles and neuronal loss."", ""supports"": ""SUPPORT""}"
524	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	evidence	0	PMID:27662312	SUPPORT		Compelling evidence suggests that soluble amyloid-beta (Abeta) and hyperphosphorylated tau serve as toxins in the dysfunction of synaptic plasticity and aberrant neurotransmitter (NT) release at synapses consequently causing a cognitive decline in Alzheimer's disease (AD).	The statement is supported by the reference which discusses the role of neurotransmitter release and synaptic plasticity in Alzheimer's Disease, leading to cognitive decline.	"{""explanation"": ""The statement is supported by the reference which discusses the role of neurotransmitter release and synaptic plasticity in Alzheimer's Disease, leading to cognitive decline."", ""reference"": ""PMID:27662312"", ""snippet"": ""Compelling evidence suggests that soluble amyloid-beta (Abeta) and hyperphosphorylated tau serve as toxins in the dysfunction of synaptic plasticity and aberrant neurotransmitter (NT) release at synapses consequently causing a cognitive decline in Alzheimer's disease (AD)."", ""supports"": ""SUPPORT""}"
525	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	evidence	1	PMID:27163751	PARTIAL		The important role of the hippocampus in age-related cognitive decline and in vulnerability to disease processes such as Alzheimer's disease has prompted this review, which will focus on the complexity of changes that characterize aging, and on the molecular connections that exist between normal aging and Alzheimer's disease.	The reference supports the cognitive decline aspect but does not elaborate on neurotransmitter signaling or synaptic plasticity in detail.	"{""explanation"": ""The reference supports the cognitive decline aspect but does not elaborate on neurotransmitter signaling or synaptic plasticity in detail."", ""reference"": ""PMID:27163751"", ""snippet"": ""The important role of the hippocampus in age-related cognitive decline and in vulnerability to disease processes such as Alzheimer's disease has prompted this review, which will focus on the complexity of changes that characterize aging, and on the molecular connections that exist between normal aging and Alzheimer's disease."", ""supports"": ""PARTIAL""}"
526	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	evidence	2	PMID:12973746	SUPPORT		Histological studies indicate loss of pyramidal neurones and their synapses in Alzheimer's disease (AD), this together with biochemical evidence suggests presynaptic (and postsynaptic) glutamatergic hypoactivity.	The reference supports the statement by discussing the loss of synapses and impaired glutamatergic neurotransmitter signaling in Alzheimer's Disease.	"{""explanation"": ""The reference supports the statement by discussing the loss of synapses and impaired glutamatergic neurotransmitter signaling in Alzheimer's Disease."", ""reference"": ""PMID:12973746"", ""snippet"": ""Histological studies indicate loss of pyramidal neurones and their synapses in Alzheimer's disease (AD), this together with biochemical evidence suggests presynaptic (and postsynaptic) glutamatergic hypoactivity."", ""supports"": ""SUPPORT""}"
527	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	evidence	3	PMID:33232936	SUPPORT		In the present study, we examined alterations in several GABA-specific targets in the APP/PS1 mouse model at different ages... Overall, our study provides evidence of altered GABAergic signaling in an amyloid model of AD at a time point consistent with AD-related deficits.	The reference supports the statement by providing evidence of altered GABAergic signaling and its role in Alzheimer's Disease.	"{""explanation"": ""The reference supports the statement by providing evidence of altered GABAergic signaling and its role in Alzheimer's Disease."", ""reference"": ""PMID:33232936"", ""snippet"": ""In the present study, we examined alterations in several GABA-specific targets in the APP/PS1 mouse model at different ages... Overall, our study provides evidence of altered GABAergic signaling in an amyloid model of AD at a time point consistent with AD-related deficits."", ""supports"": ""SUPPORT""}"
528	422	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	2	evidence	4	PMID:9024330	SUPPORT		The major component of the extraneuronal neuritic plaque is beta-amyloid (A beta), which may be neurotoxic. The major component of the intraneuronal neurofibrillary tangle is hyperphosphorylated tau protein.	The reference supports the statement by discussing neurotoxic components that contribute to synaptic dysfunction and cognitive decline in Alzheimer's Disease.	"{""explanation"": ""The reference supports the statement by discussing neurotoxic components that contribute to synaptic dysfunction and cognitive decline in Alzheimer's Disease."", ""reference"": ""PMID:9024330"", ""snippet"": ""The major component of the extraneuronal neuritic plaque is beta-amyloid (A beta), which may be neurotoxic. The major component of the intraneuronal neurofibrillary tangle is hyperphosphorylated tau protein."", ""supports"": ""SUPPORT""}"
529	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	0	PMID:28019679	SUPPORT		NOD-like receptor (NLR) family, pyrin domain containing 3 and 1 inflammasomes, present in myeloid cells and neurons, respectively, represent key components of the innate immune reaction observed in Alzheimer patient brains.	The reference supports the involvement of NLRP3 inflammasome activation in Alzheimer's disease, which is part of the immune activation process contributing to neuroinflammation.	"{""explanation"": ""The reference supports the involvement of NLRP3 inflammasome activation in Alzheimer's disease, which is part of the immune activation process contributing to neuroinflammation."", ""reference"": ""PMID:28019679"", ""snippet"": ""NOD-like receptor (NLR) family, pyrin domain containing 3 and 1 inflammasomes, present in myeloid cells and neurons, respectively, represent key components of the innate immune reaction observed in Alzheimer patient brains."", ""supports"": ""SUPPORT""}"
530	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	1	PMID:32061803	SUPPORT		The response of astrocytes to the presence of Abeta, as well astrocytic and microglial interaction and inflammatory cytokine release is also discussed, highlighting a cyclical behaviour of these cells in contributing to AD pathogenesis.	This reference supports the role of astrocytes and microglia in cytokine production and their interaction contributing to Alzheimer's disease pathology.	"{""explanation"": ""This reference supports the role of astrocytes and microglia in cytokine production and their interaction contributing to Alzheimer's disease pathology."", ""reference"": ""PMID:32061803"", ""snippet"": ""The response of astrocytes to the presence of Abeta, as well astrocytic and microglial interaction and inflammatory cytokine release is also discussed, highlighting a cyclical behaviour of these cells in contributing to AD pathogenesis."", ""supports"": ""SUPPORT""}"
531	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	2	PMID:35406803	SUPPORT		Once activated, microglial cells, which are brain-resident immune cells, exert several key actions, including phagocytosis, chemotaxis, and the release of pro- or anti-inflammatory mediators.	This reference supports the involvement of microglia in immune activation, cytokine production, and phagocytosis in Alzheimer's disease.	"{""explanation"": ""This reference supports the involvement of microglia in immune activation, cytokine production, and phagocytosis in Alzheimer's disease."", ""reference"": ""PMID:35406803"", ""snippet"": ""Once activated, microglial cells, which are brain-resident immune cells, exert several key actions, including phagocytosis, chemotaxis, and the release of pro- or anti-inflammatory mediators."", ""supports"": ""SUPPORT""}"
532	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	3	PMID:21546088	SUPPORT		In age related diseases, such as Alzheimer's disease (AD), accumulating amyloid proteins elicit complement activation and a local, chronic inflammatory response that leads to attraction and activation of glial cells that, under such activation conditions, can produce neurotoxic substances, including pro-inflammatory cytokines and oxygen radicals.	This reference supports the involvement of complement proteins, cytokines, and oxidative stress in Alzheimer's disease.	"{""explanation"": ""This reference supports the involvement of complement proteins, cytokines, and oxidative stress in Alzheimer's disease."", ""reference"": ""PMID:21546088"", ""snippet"": ""In age related diseases, such as Alzheimer's disease (AD), accumulating amyloid proteins elicit complement activation and a local, chronic inflammatory response that leads to attraction and activation of glial cells that, under such activation conditions, can produce neurotoxic substances, including pro-inflammatory cytokines and oxygen radicals."", ""supports"": ""SUPPORT""}"
533	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	4	PMID:33958577	SUPPORT		The apoptotic loss of dendritic spines would be aggravated by microglia activation through a recently described signaling system from complement abnormalities and proteins of the MHC, thus implicating the immune system in schizophrenia.	While primarily discussing schizophrenia, this reference supports the role of microglia activation and complement proteins in neuroinflammation, which is relevant to Alzheimer's disease.	"{""explanation"": ""While primarily discussing schizophrenia, this reference supports the role of microglia activation and complement proteins in neuroinflammation, which is relevant to Alzheimer's disease."", ""reference"": ""PMID:33958577"", ""snippet"": ""The apoptotic loss of dendritic spines would be aggravated by microglia activation through a recently described signaling system from complement abnormalities and proteins of the MHC, thus implicating the immune system in schizophrenia."", ""supports"": ""SUPPORT""}"
534	423	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	3	evidence	5	PMID:36357946	SUPPORT		Furthermore, exposure to chronic stress alters the phenotype of microglia, a population of innate immune cells that reside in the CNS parenchyma.	This reference supports the role of microglia as key players in immune activation and neuroinflammation.	"{""explanation"": ""This reference supports the role of microglia as key players in immune activation and neuroinflammation."", ""reference"": ""PMID:36357946"", ""snippet"": ""Furthermore, exposure to chronic stress alters the phenotype of microglia, a population of innate immune cells that reside in the CNS parenchyma."", ""supports"": ""SUPPORT""}"
535	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	evidence	0	PMID:34416493	SUPPORT		Emerging evidence suggests that accumulated oxidative stress may be one of the key mechanisms causing cognitive aging and neurodegenerative diseases such as Alzheimer's disease (AD).	The literature supports the role of oxidative stress, including the imbalance between ROS production and antioxidant defenses, in the development of Alzheimer's disease.	"{""explanation"": ""The literature supports the role of oxidative stress, including the imbalance between ROS production and antioxidant defenses, in the development of Alzheimer's disease."", ""reference"": ""PMID:34416493"", ""snippet"": ""Emerging evidence suggests that accumulated oxidative stress may be one of the key mechanisms causing cognitive aging and neurodegenerative diseases such as Alzheimer's disease (AD)."", ""supports"": ""SUPPORT""}"
536	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	evidence	1	PMID:27888001	SUPPORT		Depending on its level, HNE exerts harmful or protective effects associated with the induction of antioxidant defense mechanisms. These effects make HNE a key player in maintaining redox homeostasis, as well as producing imbalances in this system that participate in aging and the development of pathological conditions.	This reference supports the involvement of oxidative stress and the imbalance in ROS/RNS in the pathology of neurodegenerative diseases.	"{""explanation"": ""This reference supports the involvement of oxidative stress and the imbalance in ROS/RNS in the pathology of neurodegenerative diseases."", ""reference"": ""PMID:27888001"", ""snippet"": ""Depending on its level, HNE exerts harmful or protective effects associated with the induction of antioxidant defense mechanisms. These effects make HNE a key player in maintaining redox homeostasis, as well as producing imbalances in this system that participate in aging and the development of pathological conditions."", ""supports"": ""SUPPORT""}"
537	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	evidence	2	PMID:9024330	PARTIAL		Although the specific process that destroys neurons in patients with Alzheimer's disease (AD) remains obscure, biochemical studies of AD neurohistologic lesions and molecular attempts to map and clone genes in familial AD have contributed greatly to our knowledge of AD.	This reference discusses the uncertainty around the specific processes but acknowledges oxidative stress as a contributing factor.	"{""explanation"": ""This reference discusses the uncertainty around the specific processes but acknowledges oxidative stress as a contributing factor."", ""reference"": ""PMID:9024330"", ""snippet"": ""Although the specific process that destroys neurons in patients with Alzheimer's disease (AD) remains obscure, biochemical studies of AD neurohistologic lesions and molecular attempts to map and clone genes in familial AD have contributed greatly to our knowledge of AD."", ""supports"": ""PARTIAL""}"
538	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	evidence	3	PMID:25772897	PARTIAL		Key elements driving neurodegeneration include microglia activation, chronic oxidative injury, accumulation of mitochondrial damage in axons, and age-related iron accumulation in the human brain.	This reference supports the involvement of oxidative stress and mitochondrial damage in neurodegeneration but does not specifically focus on Alzheimer's disease.	"{""explanation"": ""This reference supports the involvement of oxidative stress and mitochondrial damage in neurodegeneration but does not specifically focus on Alzheimer's disease."", ""reference"": ""PMID:25772897"", ""snippet"": ""Key elements driving neurodegeneration include microglia activation, chronic oxidative injury, accumulation of mitochondrial damage in axons, and age-related iron accumulation in the human brain."", ""supports"": ""PARTIAL""}"
539	424	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	4	evidence	4	PMID:33164705	SUPPORT		Oxidative stress-induced neuronal apoptosis plays a pivotal role in pathogenesis of neurodegeneration.	This reference supports the role of oxidative stress in neurodegeneration, which is relevant to Alzheimer's disease.	"{""explanation"": ""This reference supports the role of oxidative stress in neurodegeneration, which is relevant to Alzheimer's disease."", ""reference"": ""PMID:33164705"", ""snippet"": ""Oxidative stress-induced neuronal apoptosis plays a pivotal role in pathogenesis of neurodegeneration."", ""supports"": ""SUPPORT""}"
540	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	evidence	0	PMID:28902142	SUPPORT		Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Abeta accumulation and neurovascular unit impairments during disease progression.	This reference supports the statement by indicating that blood-brain barrier (BBB) dysfunction contributes to Alzheimer's disease (AD) pathogenesis, including amyloid-beta (Abeta) accumulation and neurovascular impairments.	"{""explanation"": ""This reference supports the statement by indicating that blood-brain barrier (BBB) dysfunction contributes to Alzheimer's disease (AD) pathogenesis, including amyloid-beta (Abeta) accumulation and neurovascular impairments."", ""reference"": ""PMID:28902142"", ""snippet"": ""Thus, current evidence suggests that BBB dysfunction may causatively and consequently contribute to AD pathogenesis, forming a vicious cycle between brain Abeta accumulation and neurovascular unit impairments during disease progression."", ""supports"": ""SUPPORT""}"
541	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	evidence	1	PMID:16443487	SUPPORT		Understanding cerebral degeneration and accumulation of beta-amyloid has generated hopes for discovery of disease-modifying treatments. Progress is needed in understanding the mechanisms that link beta-amyloid accumulation and neuronal death.	This reference supports the statement by discussing the accumulation of beta-amyloid and its link to neuronal death in Alzheimer's disease, which is relevant to the described consequences of vascular dysfunction.	"{""explanation"": ""This reference supports the statement by discussing the accumulation of beta-amyloid and its link to neuronal death in Alzheimer's disease, which is relevant to the described consequences of vascular dysfunction."", ""reference"": ""PMID:16443487"", ""snippet"": ""Understanding cerebral degeneration and accumulation of beta-amyloid has generated hopes for discovery of disease-modifying treatments. Progress is needed in understanding the mechanisms that link beta-amyloid accumulation and neuronal death."", ""supports"": ""SUPPORT""}"
542	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	evidence	2	PMID:26898552	SUPPORT		There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-beta accumulation or brain atrophy.	This reference supports the statement by highlighting the role of cerebral blood flow changes in the early stages of Alzheimer's disease, which is consistent with the described vascular dysfunction.	"{""explanation"": ""This reference supports the statement by highlighting the role of cerebral blood flow changes in the early stages of Alzheimer's disease, which is consistent with the described vascular dysfunction."", ""reference"": ""PMID:26898552"", ""snippet"": ""There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-beta accumulation or brain atrophy."", ""supports"": ""SUPPORT""}"
543	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	evidence	3	PMID:36293539	SUPPORT		Aberrant remodeling of microvesselsis associated with blood-brain barrier breakdown, development of neuroinflammation, inadequate microcirculation in active brain regions, and leads to the dysfunction of the neurovascular unit and progressive neurological deficits.	This reference supports the statement by describing how microvascular remodeling and blood-brain barrier breakdown contribute to neurovascular unit dysfunction and neurological deficits, relevant to Alzheimer's disease.	"{""explanation"": ""This reference supports the statement by describing how microvascular remodeling and blood-brain barrier breakdown contribute to neurovascular unit dysfunction and neurological deficits, relevant to Alzheimer's disease."", ""reference"": ""PMID:36293539"", ""snippet"": ""Aberrant remodeling of microvesselsis associated with blood-brain barrier breakdown, development of neuroinflammation, inadequate microcirculation in active brain regions, and leads to the dysfunction of the neurovascular unit and progressive neurological deficits."", ""supports"": ""SUPPORT""}"
544	425	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	pathophysiology	5	evidence	4	PMID:35289012	SUPPORT		We consider how abnormalities of the constituent cells of the neurovascular unit - particularly of endothelial cells and pericytes - and impairment of the blood-brain barrier (BBB) impact on the pathogenesis of AD.	This reference supports the statement by discussing the role of endothelial cells and pericytes in blood-brain barrier impairment and Alzheimer's disease pathogenesis.	"{""explanation"": ""This reference supports the statement by discussing the role of endothelial cells and pericytes in blood-brain barrier impairment and Alzheimer's disease pathogenesis."", ""reference"": ""PMID:35289012"", ""snippet"": ""We consider how abnormalities of the constituent cells of the neurovascular unit - particularly of endothelial cells and pericytes - and impairment of the blood-brain barrier (BBB) impact on the pathogenesis of AD."", ""supports"": ""SUPPORT""}"
580	446	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	0	evidence	0	PMID:32682334	SUPPORT		"Anagen stage hair follicles (HFs) exhibit ""immune privilege (IP)"" from the level of the bulge downwards to the bulb. Both passive and active IP mechanisms protect HFs from physiologically undesired immune responses and limit immune surveillance. IP is relative, not absolute, and is primarily based on absent, or greatly reduced, intra-follicular antigen presentation via MHC class I and II molecules, along with prominent expression of ""no danger"" signals like CD200 and the creation of an immunoinhibitory signalling milieu generated by the secretory activities of HFs."	This review describes the mechanisms of hair follicle immune privilege including reduced MHC expression and immunosuppressive signaling, confirming the normal maintenance of immune privilege in anagen hair follicles.	"{""explanation"": ""This review describes the mechanisms of hair follicle immune privilege including reduced MHC expression and immunosuppressive signaling, confirming the normal maintenance of immune privilege in anagen hair follicles."", ""reference"": ""PMID:32682334"", ""snippet"": ""Anagen stage hair follicles (HFs) exhibit \""immune privilege (IP)\"" from the level of the bulge downwards to the bulb. Both passive and active IP mechanisms protect HFs from physiologically undesired immune responses and limit immune surveillance. IP is relative, not absolute, and is primarily based on absent, or greatly reduced, intra-follicular antigen presentation via MHC class I and II molecules, along with prominent expression of \""no danger\"" signals like CD200 and the creation of an immunoinhibitory signalling milieu generated by the secretory activities of HFs."", ""supports"": ""SUPPORT""}"
581	446	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	0	evidence	1	PMID:38673994	SUPPORT		Immune privilege collapse has been extensively investigated in AA pathogenesis, including the suppression of immunomodulatory factors (e.g., transforming growth factor-β (TGF-β), programmed death-ligand 1 (PDL1), interleukin-10 (IL-10), α-melanocyte-stimulating hormone (α-MSH), and macrophage migration inhibitory factor (MIF)) and enhanced expression of the major histocompatibility complex (MHC) throughout hair follicles.	This study documents the specific immunomodulatory factors that are suppressed during immune privilege collapse in AA, along with enhanced MHC expression that enables autoreactive T cell recognition.	"{""explanation"": ""This study documents the specific immunomodulatory factors that are suppressed during immune privilege collapse in AA, along with enhanced MHC expression that enables autoreactive T cell recognition."", ""reference"": ""PMID:38673994"", ""snippet"": ""Immune privilege collapse has been extensively investigated in AA pathogenesis, including the suppression of immunomodulatory factors (e.g., transforming growth factor-β (TGF-β), programmed death-ligand 1 (PDL1), interleukin-10 (IL-10), α-melanocyte-stimulating hormone (α-MSH), and macrophage migration inhibitory factor (MIF)) and enhanced expression of the major histocompatibility complex (MHC) throughout hair follicles."", ""supports"": ""SUPPORT""}"
582	447	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	1	evidence	0	PMID:32682334	SUPPORT		In AA, lesional HFs are rapidly infiltrated by NKG2D + T cells and natural killer (NK) cells, while perifollicular mast cells acquire a profoundly pro-inflammatory phenotype and interact with autoreactive CD8+ T cells. Using animal models, significant functional evidence has accumulated that demonstrates the dominance of the immune system in AA pathogenesis. Purified CD8+T-cell and NK cell populations alone, which secrete fγ, suffice to induce the AA phenotype, while CD4+T-cells aggravate it, and Tregs and iNKT cells may provide relative protection against AA development.	This demonstrates that CD8+ T cells alone are sufficient to induce alopecia areata in animal models, establishing their central role as disease drivers. The NKG2D+ phenotype and IFN-gamma production are key features.	"{""explanation"": ""This demonstrates that CD8+ T cells alone are sufficient to induce alopecia areata in animal models, establishing their central role as disease drivers. The NKG2D+ phenotype and IFN-gamma production are key features."", ""reference"": ""PMID:32682334"", ""snippet"": ""In AA, lesional HFs are rapidly infiltrated by NKG2D + T cells and natural killer (NK) cells, while perifollicular mast cells acquire a profoundly pro-inflammatory phenotype and interact with autoreactive CD8+ T cells. Using animal models, significant functional evidence has accumulated that demonstrates the dominance of the immune system in AA pathogenesis. Purified CD8+T-cell and NK cell populations alone, which secrete fγ, suffice to induce the AA phenotype, while CD4+T-cells aggravate it, and Tregs and iNKT cells may provide relative protection against AA development."", ""supports"": ""SUPPORT""}"
583	447	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	1	evidence	1	PMID:37365384	SUPPORT		Pathogenic activity of CD44s-hiCD49dlo CD8+ T cells was mediated by NKG2D-dependent innate-like cytotoxicity, which was further augmented by IL-15 stimulation and triggered disease onset.	This identifies the specific mechanism of CD8+ T cell cytotoxicity in AA through NKG2D-dependent pathways, and demonstrates that IL-15 stimulation enhances their pathogenic activity.	"{""explanation"": ""This identifies the specific mechanism of CD8+ T cell cytotoxicity in AA through NKG2D-dependent pathways, and demonstrates that IL-15 stimulation enhances their pathogenic activity."", ""reference"": ""PMID:37365384"", ""snippet"": ""Pathogenic activity of CD44s-hiCD49dlo CD8+ T cells was mediated by NKG2D-dependent innate-like cytotoxicity, which was further augmented by IL-15 stimulation and triggered disease onset."", ""supports"": ""SUPPORT""}"
584	448	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	2	evidence	0	PMID:38673994	SUPPORT		Both AA and vitiligo are autoimmune diseases that share commonalities in pathogenesis, including the involvement of plasmacytoid dendritic cells (and interferon-α (IFN- α) signaling pathways) and cytotoxic CD8+ T lymphocytes (and activated IFN-γ signaling pathways).	This establishes that IFN-gamma signaling pathways are activated in AA pathogenesis, providing the mechanistic basis for JAK-STAT pathway involvement since these cytokines signal through JAK-STAT.	"{""explanation"": ""This establishes that IFN-gamma signaling pathways are activated in AA pathogenesis, providing the mechanistic basis for JAK-STAT pathway involvement since these cytokines signal through JAK-STAT."", ""reference"": ""PMID:38673994"", ""snippet"": ""Both AA and vitiligo are autoimmune diseases that share commonalities in pathogenesis, including the involvement of plasmacytoid dendritic cells (and interferon-α (IFN- α) signaling pathways) and cytotoxic CD8+ T lymphocytes (and activated IFN-γ signaling pathways)."", ""supports"": ""SUPPORT""}"
585	448	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	2	evidence	1	PMID:37326792	SUPPORT		In two pivotal placebo-controlled phase 3 clinical trials in adults with severe alopecia areata, oral baricitinib once daily was associated with clinically meaningful scalp, eyebrow, and eyelash hair regrowth over 36 weeks.	The clinical efficacy of baricitinib, a JAK1/2 inhibitor, in promoting hair regrowth provides direct evidence that the JAK-STAT pathway is a critical therapeutic target in AA pathogenesis.	"{""explanation"": ""The clinical efficacy of baricitinib, a JAK1/2 inhibitor, in promoting hair regrowth provides direct evidence that the JAK-STAT pathway is a critical therapeutic target in AA pathogenesis."", ""reference"": ""PMID:37326792"", ""snippet"": ""In two pivotal placebo-controlled phase 3 clinical trials in adults with severe alopecia areata, oral baricitinib once daily was associated with clinically meaningful scalp, eyebrow, and eyelash hair regrowth over 36 weeks."", ""supports"": ""SUPPORT""}"
586	448	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	2	evidence	2	PMID:38338982	SUPPORT		Interferon-γ (IFNγ) treatment increased the secretion of CXCL12 from DFs through the signal transducer and activator of transcription 3 (STAT3) pathway, and αCXCL12 treatment protected the hair follicle from IFNγ in hair organ culture.	This demonstrates that IFN-gamma signals through STAT3 to drive pathogenic chemokine production, providing direct mechanistic evidence for JAK-STAT pathway activation in AA.	"{""explanation"": ""This demonstrates that IFN-gamma signals through STAT3 to drive pathogenic chemokine production, providing direct mechanistic evidence for JAK-STAT pathway activation in AA."", ""reference"": ""PMID:38338982"", ""snippet"": ""Interferon-γ (IFNγ) treatment increased the secretion of CXCL12 from DFs through the signal transducer and activator of transcription 3 (STAT3) pathway, and αCXCL12 treatment protected the hair follicle from IFNγ in hair organ culture."", ""supports"": ""SUPPORT""}"
587	449	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	3	evidence	0	PMID:38338982	SUPPORT		CXCL12 expression is increased in AA mice, while s.c. injection of αCXCL12 significantly inhibited hair loss in AA mice and reduced the number of CD8+, MHC-I+, and MHC-II+ cells in the skin. In addition, injection of αCXCL12 also prevented the onset of AA and reduced the number of CD8+ cells.	This demonstrates that CXCL12 drives CD8+ T cell recruitment to hair follicles, and blocking this chemokine can prevent disease onset and reduce immune cell infiltration in AA.	"{""explanation"": ""This demonstrates that CXCL12 drives CD8+ T cell recruitment to hair follicles, and blocking this chemokine can prevent disease onset and reduce immune cell infiltration in AA."", ""reference"": ""PMID:38338982"", ""snippet"": ""CXCL12 expression is increased in AA mice, while s.c. injection of αCXCL12 significantly inhibited hair loss in AA mice and reduced the number of CD8+, MHC-I+, and MHC-II+ cells in the skin. In addition, injection of αCXCL12 also prevented the onset of AA and reduced the number of CD8+ cells."", ""supports"": ""SUPPORT""}"
588	449	18	Alopecia Areata	Alopecia_Areata.yaml	pathophysiology	3	evidence	1	PMID:38673994	SUPPORT		Blood chemokine C-X-C motif ligand 9 (CXCL9) and CXCL10 are elevated in both diseases.	Elevated CXCL9 and CXCL10 chemokines in AA blood support the role of chemokine-mediated immune cell recruitment in disease pathogenesis.	"{""explanation"": ""Elevated CXCL9 and CXCL10 chemokines in AA blood support the role of chemokine-mediated immune cell recruitment in disease pathogenesis."", ""reference"": ""PMID:38673994"", ""snippet"": ""Blood chemokine C-X-C motif ligand 9 (CXCL9) and CXCL10 are elevated in both diseases."", ""supports"": ""SUPPORT""}"
594	460	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	0	evidence	0	PMID:22500781	SUPPORT		Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema.	This review confirms that emphysema is a common manifestation of alpha-1 antitrypsin deficiency.	"{""explanation"": ""This review confirms that emphysema is a common manifestation of alpha-1 antitrypsin deficiency."", ""reference"": ""PMID:22500781"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema."", ""supports"": ""SUPPORT""}"
595	461	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	1	evidence	0	PMID:22500781	SUPPORT		Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema.	Review confirms that AATD manifests with liver cirrhosis due to protein aggregation in hepatocytes.	"{""explanation"": ""Review confirms that AATD manifests with liver cirrhosis due to protein aggregation in hepatocytes."", ""reference"": ""PMID:22500781"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema."", ""supports"": ""SUPPORT""}"
596	463	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	pathophysiology	3	evidence	0	PMID:36896570	SUPPORT		Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic approaches in medicine in the past 5 years.	Confirms that pulmonary inflammation is a primary manifestation of AATD requiring advanced therapeutic interventions	"{""explanation"": ""Confirms that pulmonary inflammation is a primary manifestation of AATD requiring advanced therapeutic interventions"", ""reference"": ""PMID:36896570"", ""snippet"": ""Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic approaches in medicine in the past 5 years."", ""supports"": ""SUPPORT""}"
616	486	20	Alveolar Rhabdomyosarcoma	Alveolar_Rhabdomyosarcoma.yaml	pathophysiology	0	evidence	0	PMID:39686893	SUPPORT		According to literature data, the frequency of the PAX3::FOXO1 translocation is 70-90% and the PAX7::FOXO1 translocation 10-30%.	Supports the prevalence of PAX3/7-FOXO1 fusions in alveolar rhabdomyosarcoma.	"{""explanation"": ""Supports the prevalence of PAX3/7-FOXO1 fusions in alveolar rhabdomyosarcoma."", ""reference"": ""PMID:39686893"", ""snippet"": ""According to literature data, the frequency of the PAX3::FOXO1 translocation is 70-90% and the PAX7::FOXO1 translocation 10-30%."", ""supports"": ""SUPPORT""}"
622	500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	evidence	0	PMID:21456963	SUPPORT		Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.	Confirms that Aβ accumulation in the brain is a hallmark characteristic of Alzheimer's disease.	"{""explanation"": ""Confirms that Aβ accumulation in the brain is a hallmark characteristic of Alzheimer's disease."", ""reference"": ""PMID:21456963"", ""snippet"": ""Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."", ""supports"": ""SUPPORT""}"
623	500	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	0	evidence	1	PMID:21456963	SUPPORT		physiologic generation of the neurotoxic Aβ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous γ-secretase complex	Describes the sequential proteolytic processing of APP by secretases to generate Aβ peptides.	"{""explanation"": ""Describes the sequential proteolytic processing of APP by secretases to generate Aβ peptides."", ""reference"": ""PMID:21456963"", ""snippet"": ""physiologic generation of the neurotoxic Aβ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous γ-secretase complex"", ""supports"": ""SUPPORT""}"
624	501	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	1	evidence	0	PMID:37264120	SUPPORT		Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer's disease (AD), highlighting the role of PKs in neurodegeneration.	Confirms that tau hyperphosphorylation is a key pathological feature of Alzheimer's disease and involves protein kinases.	"{""explanation"": ""Confirms that tau hyperphosphorylation is a key pathological feature of Alzheimer's disease and involves protein kinases."", ""reference"": ""PMID:37264120"", ""snippet"": ""Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer's disease (AD), highlighting the role of PKs in neurodegeneration."", ""supports"": ""SUPPORT""}"
625	501	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	1	evidence	1	PMID:21456963	SUPPORT		Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.	Documents that hyperphosphorylated tau is a characteristic neuropathological hallmark of Alzheimer's disease.	"{""explanation"": ""Documents that hyperphosphorylated tau is a characteristic neuropathological hallmark of Alzheimer's disease."", ""reference"": ""PMID:21456963"", ""snippet"": ""Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau."", ""supports"": ""SUPPORT""}"
626	502	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	2	evidence	0	PMID:28059794	SUPPORT		The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss.	Confirms that synaptic loss correlates with cognitive impairment and precedes neuronal death in Alzheimer's disease.	"{""explanation"": ""Confirms that synaptic loss correlates with cognitive impairment and precedes neuronal death in Alzheimer's disease."", ""reference"": ""PMID:28059794"", ""snippet"": ""The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss."", ""supports"": ""SUPPORT""}"
627	502	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	2	evidence	1	PMID:28059794	SUPPORT		Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction.	Describes how oxidative stress affects synaptic activity and neurotransmission, contributing to cognitive dysfunction.	"{""explanation"": ""Describes how oxidative stress affects synaptic activity and neurotransmission, contributing to cognitive dysfunction."", ""reference"": ""PMID:28059794"", ""snippet"": ""Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction."", ""supports"": ""SUPPORT""}"
628	503	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	3	evidence	0	PMID:32048973	SUPPORT		An emerging concept is that microglia, the innate immune cells of the brain, are major players in AD pathogenesis. Microglia are longlived tissue-resident professional phagocytes that survey and rapidly respond to changes in their microenvironment. Subpopulations of microglia cluster around Aβ plaques and adopt a transcriptomic signature specifically linked to neurodegeneration.	Describes how microglia respond to Aβ plaques and play a major role in AD pathogenesis through neuroinflammation.	"{""explanation"": ""Describes how microglia respond to Aβ plaques and play a major role in AD pathogenesis through neuroinflammation."", ""reference"": ""PMID:32048973"", ""snippet"": ""An emerging concept is that microglia, the innate immune cells of the brain, are major players in AD pathogenesis. Microglia are longlived tissue-resident professional phagocytes that survey and rapidly respond to changes in their microenvironment. Subpopulations of microglia cluster around Aβ plaques and adopt a transcriptomic signature specifically linked to neurodegeneration."", ""supports"": ""SUPPORT""}"
629	503	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	3	evidence	1	PMID:32048973	SUPPORT		A plethora of molecules and pathways associated with microglia function and dysfunction has been identified as important players in mediating neurodegeneration.	Confirms the role of microglial dysfunction in mediating neurodegeneration in Alzheimer's disease.	"{""explanation"": ""Confirms the role of microglial dysfunction in mediating neurodegeneration in Alzheimer's disease."", ""reference"": ""PMID:32048973"", ""snippet"": ""A plethora of molecules and pathways associated with microglia function and dysfunction has been identified as important players in mediating neurodegeneration."", ""supports"": ""SUPPORT""}"
630	504	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	4	evidence	0	PMID:28059794	SUPPORT		Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-β (Aβ) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle.	Describes the vicious cycle of Aβ, tau, and oxidative stress that leads to neuronal damage and death.	"{""explanation"": ""Describes the vicious cycle of Aβ, tau, and oxidative stress that leads to neuronal damage and death."", ""reference"": ""PMID:28059794"", ""snippet"": ""Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-β (Aβ) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle."", ""supports"": ""SUPPORT""}"
631	504	21	Alzheimer's Disease	Alzheimers_Disease.yaml	pathophysiology	4	evidence	1	PMID:28059794	SUPPORT		Alzheimer's disease (AD) is a devastating neurodegenerative disorder without a cure. Most AD cases are sporadic where age represents the greatest risk factor.	Confirms Alzheimer's as a neurodegenerative disorder characterized by progressive neuronal loss.	"{""explanation"": ""Confirms Alzheimer's as a neurodegenerative disorder characterized by progressive neuronal loss."", ""reference"": ""PMID:28059794"", ""snippet"": ""Alzheimer's disease (AD) is a devastating neurodegenerative disorder without a cure. Most AD cases are sporadic where age represents the greatest risk factor."", ""supports"": ""SUPPORT""}"
648	531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	evidence	0	PMID:38521060	SUPPORT		Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) share many clinical, pathological, and genetic features	Single-cell analysis confirms motor neuron vulnerability in ALS and identifies vulnerable populations in cortical layer 5.	"{""explanation"": ""Single-cell analysis confirms motor neuron vulnerability in ALS and identifies vulnerable populations in cortical layer 5."", ""reference"": ""PMID:38521060"", ""snippet"": ""Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) share many clinical, pathological, and genetic features"", ""supports"": ""SUPPORT""}"
649	531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	evidence	1	PMID:38891021	SUPPORT		upper and lower motor neurons in the brain and spinal cord progressively degenerate during the course of the disease, leading to the loss of the voluntary movement of the arms and legs.	Review summarizes canonical ALS pathology of progressive upper and lower motor neuron degeneration causing loss of voluntary movement.	"{""explanation"": ""Review summarizes canonical ALS pathology of progressive upper and lower motor neuron degeneration causing loss of voluntary movement."", ""reference"": ""PMID:38891021"", ""snippet"": ""upper and lower motor neurons in the brain and spinal cord progressively degenerate during the course of the disease, leading to the loss of the voluntary movement of the arms and legs."", ""supports"": ""SUPPORT""}"
650	531	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	0	evidence	2	PMID:36116464	SUPPORT		Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease.	Lancet Seminar underscores ALS as a fatal neurodegenerative disorder affecting central nervous system motor pathways.	"{""explanation"": ""Lancet Seminar underscores ALS as a fatal neurodegenerative disorder affecting central nervous system motor pathways."", ""reference"": ""PMID:36116464"", ""snippet"": ""Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease."", ""supports"": ""SUPPORT""}"
651	532	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	1	evidence	0	PMID:16736722	SUPPORT		the most common tau negative ubiquitin positive amyotrophic lateral sclerosis (ALS) type inclusions	Review confirms ubiquitin-positive inclusions as a common pathological feature in ALS.	"{""explanation"": ""Review confirms ubiquitin-positive inclusions as a common pathological feature in ALS."", ""reference"": ""PMID:16736722"", ""snippet"": ""the most common tau negative ubiquitin positive amyotrophic lateral sclerosis (ALS) type inclusions"", ""supports"": ""SUPPORT""}"
652	533	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	2	evidence	0	PMID:21944778	SUPPORT		Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%). The repeat expansion leads to the loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, suggesting multiple disease mechanisms.	Original discovery paper establishing C9orf72 repeat expansion as a major cause of both FTD and ALS with dual mechanisms.	"{""explanation"": ""Original discovery paper establishing C9orf72 repeat expansion as a major cause of both FTD and ALS with dual mechanisms."", ""reference"": ""PMID:21944778"", ""snippet"": ""Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%). The repeat expansion leads to the loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, suggesting multiple disease mechanisms."", ""supports"": ""SUPPORT""}"
653	534	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	3	evidence	0	PMID:8302340	SUPPORT		Some research suggests that the excitatory amino acid neurotransmitter glutamate may be involved in the pathogenesis.	Trial of riluzole, an antiglutamate agent, supports role of glutamate excitotoxicity in ALS pathogenesis.	"{""explanation"": ""Trial of riluzole, an antiglutamate agent, supports role of glutamate excitotoxicity in ALS pathogenesis."", ""reference"": ""PMID:8302340"", ""snippet"": ""Some research suggests that the excitatory amino acid neurotransmitter glutamate may be involved in the pathogenesis."", ""supports"": ""SUPPORT""}"
654	534	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	3	evidence	1	PMID:40508048	SUPPORT		understanding of the key pathogenetic links of ALS, including glutamate-mediated excitotoxicity and oxidative stress, has significantly advanced.	Recent mechanistic review highlights glutamate-mediated excitotoxicity as a key pathogenic process and therapeutic target in ALS.	"{""explanation"": ""Recent mechanistic review highlights glutamate-mediated excitotoxicity as a key pathogenic process and therapeutic target in ALS."", ""reference"": ""PMID:40508048"", ""snippet"": ""understanding of the key pathogenetic links of ALS, including glutamate-mediated excitotoxicity and oxidative stress, has significantly advanced."", ""supports"": ""SUPPORT""}"
655	535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	evidence	0	PMID:8446170	SUPPORT		a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion	Discovery of SOD1 mutations in familial ALS implicates oxidative stress in disease pathogenesis.	"{""explanation"": ""Discovery of SOD1 mutations in familial ALS implicates oxidative stress in disease pathogenesis."", ""reference"": ""PMID:8446170"", ""snippet"": ""a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion"", ""supports"": ""SUPPORT""}"
656	535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	evidence	1	PMID:40508048	SUPPORT		This review considers the recent evidence on molecular mechanisms of these processes, as well as the therapeutic strategies aimed at their modulation. Special attention is paid to antiglutamatergic and antioxidant drugs as approaches to the ALS pathogenetic therapy.	Review emphasizes oxidative stress as a targetable pathogenic mechanism and discusses antioxidant therapeutic strategies in ALS.	"{""explanation"": ""Review emphasizes oxidative stress as a targetable pathogenic mechanism and discusses antioxidant therapeutic strategies in ALS."", ""reference"": ""PMID:40508048"", ""snippet"": ""This review considers the recent evidence on molecular mechanisms of these processes, as well as the therapeutic strategies aimed at their modulation. Special attention is paid to antiglutamatergic and antioxidant drugs as approaches to the ALS pathogenetic therapy."", ""supports"": ""SUPPORT""}"
657	535	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	4	evidence	2	PMID:35269543	SUPPORT		ALS has a multifaceted nature affected by many pathological mechanisms, including oxidative stress (also via protein aggregation), mitochondrial dysfunction, glutamate-induced excitotoxicity, apoptosis, neuroinflammation, axonal degeneration, skeletal muscle deterioration and viruses.	Therapeutic strategies review highlights oxidative stress among key pathological mechanisms contributing to ALS.	"{""explanation"": ""Therapeutic strategies review highlights oxidative stress among key pathological mechanisms contributing to ALS."", ""reference"": ""PMID:35269543"", ""snippet"": ""ALS has a multifaceted nature affected by many pathological mechanisms, including oxidative stress (also via protein aggregation), mitochondrial dysfunction, glutamate-induced excitotoxicity, apoptosis, neuroinflammation, axonal degeneration, skeletal muscle deterioration and viruses."", ""supports"": ""SUPPORT""}"
658	536	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	5	evidence	0	PMID:34440810	SUPPORT		In the archetypical neurodegenerative disorder amyotrophic lateral sclerosis (ALS), the recruitment of T-cells is well known	Review confirms immune cell involvement in ALS pathophysiology with T-cell recruitment to affected areas.	"{""explanation"": ""Review confirms immune cell involvement in ALS pathophysiology with T-cell recruitment to affected areas."", ""reference"": ""PMID:34440810"", ""snippet"": ""In the archetypical neurodegenerative disorder amyotrophic lateral sclerosis (ALS), the recruitment of T-cells is well known"", ""supports"": ""SUPPORT""}"
659	537	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	6	evidence	0	PMID:34874625	SUPPORT		Triggering receptor expressed on myeloid cell 2 (TREM2) is a surface receptor that, within the CNS, is exclusively expressed on microglia and plays crucial roles in microglial proliferation, migration, activation, metabolism, and phagocytosis.	Review summarizes how microglial TREM2 function shapes ALS progression and highlights its role in microglial activation.	"{""explanation"": ""Review summarizes how microglial TREM2 function shapes ALS progression and highlights its role in microglial activation."", ""reference"": ""PMID:34874625"", ""snippet"": ""Triggering receptor expressed on myeloid cell 2 (TREM2) is a surface receptor that, within the CNS, is exclusively expressed on microglia and plays crucial roles in microglial proliferation, migration, activation, metabolism, and phagocytosis."", ""supports"": ""SUPPORT""}"
660	538	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	7	evidence	0	PMID:22312314	SUPPORT		Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS).	Review confirms axonal transport defects as early pathogenic events in ALS.	"{""explanation"": ""Review confirms axonal transport defects as early pathogenic events in ALS."", ""reference"": ""PMID:22312314"", ""snippet"": ""Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS)."", ""supports"": ""SUPPORT""}"
661	539	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	8	evidence	0	PMID:28148298	SUPPORT		TBK1 also has a major role in autophagy and mitophagy, chiefly the phosphorylation of autophagy adaptors. Several other ALS genes are also involved in autophagy, including p62 and OPTN.	Review describes TBK1's role in autophagy and confirms multiple ALS genes function in autophagy pathways.	"{""explanation"": ""Review describes TBK1's role in autophagy and confirms multiple ALS genes function in autophagy pathways."", ""reference"": ""PMID:28148298"", ""snippet"": ""TBK1 also has a major role in autophagy and mitophagy, chiefly the phosphorylation of autophagy adaptors. Several other ALS genes are also involved in autophagy, including p62 and OPTN."", ""supports"": ""SUPPORT""}"
662	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	evidence	0	PMID:37024676	SUPPORT		Recent advances in sequencing technologies and collaborative efforts have led to substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS). This momentum has, in turn, fostered the development of putative molecular therapies.	Review links expanding ALS genetic discoveries to the development of targeted molecular therapies.	"{""explanation"": ""Review links expanding ALS genetic discoveries to the development of targeted molecular therapies."", ""reference"": ""PMID:37024676"", ""snippet"": ""Recent advances in sequencing technologies and collaborative efforts have led to substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS). This momentum has, in turn, fostered the development of putative molecular therapies."", ""supports"": ""SUPPORT""}"
663	540	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	pathophysiology	9	evidence	1	PMID:36543887	SUPPORT		Significant discoveries and advances have been made in ALS preclinical models, genetics, pathology, biomarkers, imaging and clinical readouts over the last 10-15 years.	Drug discovery review notes recent genetic and translational advances enabling targeted ALS therapies.	"{""explanation"": ""Drug discovery review notes recent genetic and translational advances enabling targeted ALS therapies."", ""reference"": ""PMID:36543887"", ""snippet"": ""Significant discoveries and advances have been made in ALS preclinical models, genetics, pathology, biomarkers, imaging and clinical readouts over the last 10-15 years."", ""supports"": ""SUPPORT""}"
685	562	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	0	evidence	0	PMID:33692806	SUPPORT		The unfolded protein response (UPR) theory postulates that unconventional HLA-B27 variants homodimerize instead of heterodimerize; the misfolded proteins accumulate in the intracellular compartment triggering endoplasmic reticulum stress and increasing IL-23 production.	Evidence supporting HLA-B27 misfolding mechanism that triggers ER stress and activates IL-23 production in ankylosing spondylitis.	"{""explanation"": ""Evidence supporting HLA-B27 misfolding mechanism that triggers ER stress and activates IL-23 production in ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""The unfolded protein response (UPR) theory postulates that unconventional HLA-B27 variants homodimerize instead of heterodimerize; the misfolded proteins accumulate in the intracellular compartment triggering endoplasmic reticulum stress and increasing IL-23 production."", ""supports"": ""SUPPORT""}"
686	563	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	1	evidence	0	PMID:33692806	SUPPORT		Well-established experimental data support the concept that IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as PsA, Psoriasis, Psoriatic Arthritis; AS, Ankylosing Spondylitis; IBD, Inflammatory Bowel Disease; RA, Rheumatoid Arthritis; SS, Sjogren Syndrome; MS, Multiple Sclerosis.	Review evidence confirming the central role of IL-23/IL-17 axis in ankylosing spondylitis pathogenesis and other autoimmune diseases.	"{""explanation"": ""Review evidence confirming the central role of IL-23/IL-17 axis in ankylosing spondylitis pathogenesis and other autoimmune diseases."", ""reference"": ""PMID:33692806"", ""snippet"": ""Well-established experimental data support the concept that IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as PsA, Psoriasis, Psoriatic Arthritis; AS, Ankylosing Spondylitis; IBD, Inflammatory Bowel Disease; RA, Rheumatoid Arthritis; SS, Sjogren Syndrome; MS, Multiple Sclerosis."", ""supports"": ""SUPPORT""}"
687	563	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	1	evidence	1	PMID:33692806	SUPPORT		The fundamental role played by the IL-23/IL-17 axis comes from several lines of evidence depicting a clear increase in IL-23 and IL-17 levels in the sera of AS patients (113). This observation is coupled with the increased number of Th17 cells in peripheral blood from AS patients (114).	Direct evidence of elevated IL-23 and IL-17 levels and increased Th17 cells in ankylosing spondylitis patients.	"{""explanation"": ""Direct evidence of elevated IL-23 and IL-17 levels and increased Th17 cells in ankylosing spondylitis patients."", ""reference"": ""PMID:33692806"", ""snippet"": ""The fundamental role played by the IL-23/IL-17 axis comes from several lines of evidence depicting a clear increase in IL-23 and IL-17 levels in the sera of AS patients (113). This observation is coupled with the increased number of Th17 cells in peripheral blood from AS patients (114)."", ""supports"": ""SUPPORT""}"
688	564	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	pathophysiology	2	evidence	0	PMID:33692806	SUPPORT		New bone formation, determined by chronic inflammation involving the spine, leads to vertebral ankylosis, severe chronic pain and disability as major consequences of disease progression.	Evidence linking chronic spinal inflammation to pathological new bone formation and ankylosis in ankylosing spondylitis.	"{""explanation"": ""Evidence linking chronic spinal inflammation to pathological new bone formation and ankylosis in ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""New bone formation, determined by chronic inflammation involving the spine, leads to vertebral ankylosis, severe chronic pain and disability as major consequences of disease progression."", ""supports"": ""SUPPORT""}"
721	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:29867951	SUPPORT		The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that bind the phospholipid-binding protein beta2 glycoprotein I (beta2GPI) or that directly recognize negatively charged membrane phospholipids.	This reference supports the statement by describing how the immune system produces antibodies that target phospholipid-associated proteins in cell membranes, a process involving the participation of both B cells and other immune cells.	"{""explanation"": ""This reference supports the statement by describing how the immune system produces antibodies that target phospholipid-associated proteins in cell membranes, a process involving the participation of both B cells and other immune cells."", ""reference"": ""PMID:29867951"", ""snippet"": ""The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that bind the phospholipid-binding protein beta2 glycoprotein I (beta2GPI) or that directly recognize negatively charged membrane phospholipids."", ""supports"": ""SUPPORT""}"
722	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:30864219	SUPPORT		Antiphospholipid antibodies (aPL) are pathogenic autoantibodies in antiphospholipid syndrome (APS). ... In PAPS and SLE/APS patients, Th2, Th17, and plasmablasts were increased while regulatory T, memory B, and regulatory B cells were decreased compared to healthy controls.	This reference supports the statement by noting the involvement of T and B cells in the production of antiphospholipid antibodies, which are pathogenic in APS.	"{""explanation"": ""This reference supports the statement by noting the involvement of T and B cells in the production of antiphospholipid antibodies, which are pathogenic in APS."", ""reference"": ""PMID:30864219"", ""snippet"": ""Antiphospholipid antibodies (aPL) are pathogenic autoantibodies in antiphospholipid syndrome (APS). ... In PAPS and SLE/APS patients, Th2, Th17, and plasmablasts were increased while regulatory T, memory B, and regulatory B cells were decreased compared to healthy controls."", ""supports"": ""SUPPORT""}"
723	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:33722752	SUPPORT		It is now widely accepted that antiphospholipid antibodies (aPL) have direct pathogenic effects and that B cells, notably through aPL production, play a key role in the development of antiphospholipid syndrome (APS).	This reference further strengthens the support by indicating B cells' key role in the production of antiphospholipid antibodies in APS.	"{""explanation"": ""This reference further strengthens the support by indicating B cells' key role in the production of antiphospholipid antibodies in APS."", ""reference"": ""PMID:33722752"", ""snippet"": ""It is now widely accepted that antiphospholipid antibodies (aPL) have direct pathogenic effects and that B cells, notably through aPL production, play a key role in the development of antiphospholipid syndrome (APS)."", ""supports"": ""SUPPORT""}"
724	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:8968222	SUPPORT		Antiphospholipid antibodies are a heterogeneous group of antibodies with varying specificities. ... There are numerous potential links between antiphospholipid antibodies and coagulation disorders, including interaction of antiphospholipid antibodies and a cofactor, beta 2-glycoprotein I.	This reference supports the involvement of immune-produced antiphospholipid antibodies in APS and their interaction with cell membrane proteins.	"{""explanation"": ""This reference supports the involvement of immune-produced antiphospholipid antibodies in APS and their interaction with cell membrane proteins."", ""reference"": ""PMID:8968222"", ""snippet"": ""Antiphospholipid antibodies are a heterogeneous group of antibodies with varying specificities. ... There are numerous potential links between antiphospholipid antibodies and coagulation disorders, including interaction of antiphospholipid antibodies and a cofactor, beta 2-glycoprotein I."", ""supports"": ""SUPPORT""}"
725	585	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	0	evidence	4	PMID:22055541	SUPPORT		Diverse experimental evidence exists implicating the activation of various different cell surface receptors and intracellular pathways by antiphospholipid antibodies (aPL).	This reference discusses the cellular mechanisms activated by antiphospholipid antibodies, supporting the role of B and T cells in APS.	"{""explanation"": ""This reference discusses the cellular mechanisms activated by antiphospholipid antibodies, supporting the role of B and T cells in APS."", ""reference"": ""PMID:22055541"", ""snippet"": ""Diverse experimental evidence exists implicating the activation of various different cell surface receptors and intracellular pathways by antiphospholipid antibodies (aPL)."", ""supports"": ""SUPPORT""}"
726	586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:22100379	SUPPORT		Antiphospholipids are a heterogeneous group of circulating autoantibodies associated with a risk of thrombosis and can paradoxically prolong in vitro the clotting times	This reference highlights the association of antiphospholipid antibodies with thrombosis risk, supporting the statement that they increase the risk of forming clots.	"{""explanation"": ""This reference highlights the association of antiphospholipid antibodies with thrombosis risk, supporting the statement that they increase the risk of forming clots."", ""reference"": ""PMID:22100379"", ""snippet"": ""Antiphospholipids are a heterogeneous group of circulating autoantibodies associated with a risk of thrombosis and can paradoxically prolong in vitro the clotting times"", ""supports"": ""SUPPORT""}"
727	586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:8968222	SUPPORT		It is clear that antiphospholipid antibodies are associated with an immune-mediated prothrombotic state.	This reference explains that antiphospholipid antibodies are linked to a prothrombotic state, indicating an increased risk of clots in both arteries and veins.	"{""explanation"": ""This reference explains that antiphospholipid antibodies are linked to a prothrombotic state, indicating an increased risk of clots in both arteries and veins."", ""reference"": ""PMID:8968222"", ""snippet"": ""It is clear that antiphospholipid antibodies are associated with an immune-mediated prothrombotic state."", ""supports"": ""SUPPORT""}"
728	586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:29867951	SUPPORT		The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that... may contribute to arterial or venous thrombosis.	This reference supports the statement by elaborating on the role of antibodies in arterial and venous thrombosis.	"{""explanation"": ""This reference supports the statement by elaborating on the role of antibodies in arterial and venous thrombosis."", ""reference"": ""PMID:29867951"", ""snippet"": ""The primary anti-phospholipid syndrome (APS) is characterized by the production of antibodies that... may contribute to arterial or venous thrombosis."", ""supports"": ""SUPPORT""}"
729	586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	evidence	3	PMID:12848964	SUPPORT		Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis, the pathogenic role of aPL in the development of thrombosis has not been fully elucidated.	Although it acknowledges the mechanisms are not fully understood, it confirms the strong association between antiphospholipid antibodies and thrombosis.	"{""explanation"": ""Although it acknowledges the mechanisms are not fully understood, it confirms the strong association between antiphospholipid antibodies and thrombosis."", ""reference"": ""PMID:12848964"", ""snippet"": ""Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis, the pathogenic role of aPL in the development of thrombosis has not been fully elucidated."", ""supports"": ""SUPPORT""}"
730	586	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	1	evidence	4	PMID:24321419	SUPPORT		Antiphospholipid syndrome (APS) is associated with the risk of both arterial and venous thrombosis.	This directly supports the statement by indicating that APS is associated with both arterial and venous thrombosis.	"{""explanation"": ""This directly supports the statement by indicating that APS is associated with both arterial and venous thrombosis."", ""reference"": ""PMID:24321419"", ""snippet"": ""Antiphospholipid syndrome (APS) is associated with the risk of both arterial and venous thrombosis."", ""supports"": ""SUPPORT""}"
731	587	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:29339317	SUPPORT		antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of recurrent arterial and/or venous thrombosis	The literature supports that APS is characterized by thrombosis, which aligns with blood clots obstructing normal blood flow.	"{""explanation"": ""The literature supports that APS is characterized by thrombosis, which aligns with blood clots obstructing normal blood flow."", ""reference"": ""PMID:29339317"", ""snippet"": ""antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of recurrent arterial and/or venous thrombosis"", ""supports"": ""SUPPORT""}"
732	587	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:33878780	SUPPORT		aPL induce excessive activation of the endothelium, monocytes, and platelets in consort with aberrations in hemostasis/clotting, fibrinolytic system, and complement activation.	The mechanism by which antiphospholipid antibodies induce thrombosis directly aligns with the provided statement.	"{""explanation"": ""The mechanism by which antiphospholipid antibodies induce thrombosis directly aligns with the provided statement."", ""reference"": ""PMID:33878780"", ""snippet"": ""aPL induce excessive activation of the endothelium, monocytes, and platelets in consort with aberrations in hemostasis/clotting, fibrinolytic system, and complement activation."", ""supports"": ""SUPPORT""}"
733	587	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	2	evidence	2	PMID:33341301	SUPPORT		Thrombotic Antiphospholipid Syndrome (APS) is a condition affecting young individuals in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL).	The thromboembolic events described are consistent with blood clots obstructing normal blood flow.	"{""explanation"": ""The thromboembolic events described are consistent with blood clots obstructing normal blood flow."", ""reference"": ""PMID:33341301"", ""snippet"": ""Thrombotic Antiphospholipid Syndrome (APS) is a condition affecting young individuals in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL)."", ""supports"": ""SUPPORT""}"
734	587	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	2	evidence	3	PMID:21047408	SUPPORT		APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus formation, pulmonary hypertension and dilated cardiomyopathy.	Various cardiovascular complications consistent with blood clots obstructing blood flow are described.	"{""explanation"": ""Various cardiovascular complications consistent with blood clots obstructing blood flow are described."", ""reference"": ""PMID:21047408"", ""snippet"": ""APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus formation, pulmonary hypertension and dilated cardiomyopathy."", ""supports"": ""SUPPORT""}"
735	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:22247356	SUPPORT		After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died... Neurologic damage is the most common cause of morbidity.	The study details the incidence of organ damage in patients with APS, supporting the statement that clots in vital organs can impair function and cause significant damage.	"{""explanation"": ""The study details the incidence of organ damage in patients with APS, supporting the statement that clots in vital organs can impair function and cause significant damage."", ""reference"": ""PMID:22247356"", ""snippet"": ""After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died... Neurologic damage is the most common cause of morbidity."", ""supports"": ""SUPPORT""}"
736	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:27198137	SUPPORT		The kidney is a major target organ in both primary and secondary antiphospholipid syndrome... APSN is a vascular nephropathy characterized by small vessel vaso-occlusive lesions.	This reference supports the statement by explaining APS-induced damage in the kidneys through vascular blockage.	"{""explanation"": ""This reference supports the statement by explaining APS-induced damage in the kidneys through vascular blockage."", ""reference"": ""PMID:27198137"", ""snippet"": ""The kidney is a major target organ in both primary and secondary antiphospholipid syndrome... APSN is a vascular nephropathy characterized by small vessel vaso-occlusive lesions."", ""supports"": ""SUPPORT""}"
737	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	evidence	2	PMID:24741580	SUPPORT		Typically, neurological manifestations of APS include thrombosis of cerebral vessels leading to stroke.	This reference provides evidence of brain damage caused by APS-induced clots, corroborating the statement.	"{""explanation"": ""This reference provides evidence of brain damage caused by APS-induced clots, corroborating the statement."", ""reference"": ""PMID:24741580"", ""snippet"": ""Typically, neurological manifestations of APS include thrombosis of cerebral vessels leading to stroke."", ""supports"": ""SUPPORT""}"
738	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	evidence	3	PMID:36575066	SUPPORT		Venous thromboembolism belongs to the most frequent clinical manifestation of this syndrome... we summarised basic pathophysiological mechanisms of venous thrombosis and lung embolism development.	This reference supports the statement by discussing lung damage caused by clots in patients with APS.	"{""explanation"": ""This reference supports the statement by discussing lung damage caused by clots in patients with APS."", ""reference"": ""PMID:36575066"", ""snippet"": ""Venous thromboembolism belongs to the most frequent clinical manifestation of this syndrome... we summarised basic pathophysiological mechanisms of venous thrombosis and lung embolism development."", ""supports"": ""SUPPORT""}"
739	588	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	3	evidence	4	PMID:8968222	SUPPORT		Patients with the highest titers of IgG antiphospholipid antibodies have a relatively high risk of recurrent thrombotic events, especially stroke, deep venous thrombosis, and spontaneous abortion.	The mention of recurrent thrombotic events leading to stroke helps substantiate the role of APS in causing significant organ damage, especially in the brain.	"{""explanation"": ""The mention of recurrent thrombotic events leading to stroke helps substantiate the role of APS in causing significant organ damage, especially in the brain."", ""reference"": ""PMID:8968222"", ""snippet"": ""Patients with the highest titers of IgG antiphospholipid antibodies have a relatively high risk of recurrent thrombotic events, especially stroke, deep venous thrombosis, and spontaneous abortion."", ""supports"": ""SUPPORT""}"
740	589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:19665761	SUPPORT		Women with antiphospholipid syndrome (APS) and antiphospholipid antibodies (aPL) are at high risk for recurrent spontaneous miscarriage and late pregnancy complications, such as preeclampsia and preterm labor.	The literature mentions APS causing recurrent miscarriage and late pregnancy complications including preeclampsia.	"{""explanation"": ""The literature mentions APS causing recurrent miscarriage and late pregnancy complications including preeclampsia."", ""reference"": ""PMID:19665761"", ""snippet"": ""Women with antiphospholipid syndrome (APS) and antiphospholipid antibodies (aPL) are at high risk for recurrent spontaneous miscarriage and late pregnancy complications, such as preeclampsia and preterm labor."", ""supports"": ""SUPPORT""}"
741	589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	evidence	1	PMID:20822807	SUPPORT		The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency.	The article explicitly states that APS causes pregnancy loss and preterm delivery related to severe pre-eclampsia or placental insufficiency.	"{""explanation"": ""The article explicitly states that APS causes pregnancy loss and preterm delivery related to severe pre-eclampsia or placental insufficiency."", ""reference"": ""PMID:20822807"", ""snippet"": ""The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency."", ""supports"": ""SUPPORT""}"
742	589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	evidence	2	PMID:19557318	SUPPORT		In pregnant women, antiphospholipid syndrome (APS) is associated with an increased risk of preeclampsia, fetal intrauterine growth restriction, and other complications related to uteroplacental insufficiency.	This reference directly supports the statement by associating APS with preeclampsia and placental blood flow issues leading to complications.	"{""explanation"": ""This reference directly supports the statement by associating APS with preeclampsia and placental blood flow issues leading to complications."", ""reference"": ""PMID:19557318"", ""snippet"": ""In pregnant women, antiphospholipid syndrome (APS) is associated with an increased risk of preeclampsia, fetal intrauterine growth restriction, and other complications related to uteroplacental insufficiency."", ""supports"": ""SUPPORT""}"
743	589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	evidence	3	PMID:17499708	SUPPORT		Antiphospholipid syndrome (APS) is frequently associated with complications during pregnancy... prematurity, intrauterine growth retardation, pregnancy-induced hypertensive disorders, and pulmonary hypertension can complicate pregnancy as well.	The reference lists various pregnancy complications associated with APS, such as prematurity and hypertensive disorders.	"{""explanation"": ""The reference lists various pregnancy complications associated with APS, such as prematurity and hypertensive disorders."", ""reference"": ""PMID:17499708"", ""snippet"": ""Antiphospholipid syndrome (APS) is frequently associated with complications during pregnancy... prematurity, intrauterine growth retardation, pregnancy-induced hypertensive disorders, and pulmonary hypertension can complicate pregnancy as well."", ""supports"": ""SUPPORT""}"
744	589	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	4	evidence	4	PMID:22784367	SUPPORT		In patients with the antiphospholipid syndrome (APS), the presence of a group of pathogenic autoantibodies called antiphospholipid antibodies causes arteriovenous thrombosis and pregnancy complications.	The literature points out that antiphospholipid antibodies cause pregnancy complications in APS, supporting the mechanisms described in the statement.	"{""explanation"": ""The literature points out that antiphospholipid antibodies cause pregnancy complications in APS, supporting the mechanisms described in the statement."", ""reference"": ""PMID:22784367"", ""snippet"": ""In patients with the antiphospholipid syndrome (APS), the presence of a group of pathogenic autoantibodies called antiphospholipid antibodies causes arteriovenous thrombosis and pregnancy complications."", ""supports"": ""SUPPORT""}"
745	590	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:38368768	SUPPORT		APS patients had a higher frequency of damage accrual. Microangiopathy and non-criteria manifestations were independent risk factors for damage accrual.	The study found that APS patients had a higher frequency of organ damage, supporting the statement that persistent clotting episodes can lead to long-term damage.	"{""explanation"": ""The study found that APS patients had a higher frequency of organ damage, supporting the statement that persistent clotting episodes can lead to long-term damage."", ""reference"": ""PMID:38368768"", ""snippet"": ""APS patients had a higher frequency of damage accrual. Microangiopathy and non-criteria manifestations were independent risk factors for damage accrual."", ""supports"": ""SUPPORT""}"
746	590	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	5	evidence	1	PMID:28572466	SUPPORT		A high proportion of patients experienced new thrombotic events and organ damage.	This study also confirms that patients with APS often experience organ damage due to thromboses, supporting the statement.	"{""explanation"": ""This study also confirms that patients with APS often experience organ damage due to thromboses, supporting the statement."", ""reference"": ""PMID:28572466"", ""snippet"": ""A high proportion of patients experienced new thrombotic events and organ damage."", ""supports"": ""SUPPORT""}"
747	590	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	pathophysiology	5	evidence	2	PMID:22247356	SUPPORT		After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died.	This study describes morbidity, organ damage, and mortality in APS patients, confirming the association between persistent clotting episodes and long-term organ damage.	"{""explanation"": ""This study describes morbidity, organ damage, and mortality in APS patients, confirming the association between persistent clotting episodes and long-term organ damage."", ""reference"": ""PMID:22247356"", ""snippet"": ""After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died."", ""supports"": ""SUPPORT""}"
782	606	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:7719344	SUPPORT	HUMAN_CLINICAL	We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied.	Original identification of S252W and P253R mutations in FGFR2 linker region in all 40 Apert syndrome cases, establishing causative role of these mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original identification of S252W and P253R mutations in FGFR2 linker region in all 40 Apert syndrome cases, establishing causative role of these mutations."", ""reference"": ""PMID:7719344"", ""snippet"": ""We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied."", ""supports"": ""SUPPORT""}"
783	607	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:19117954	SUPPORT	IN_VITRO	Both WT and MT FGFR2 increased early and late osteoblast gene expression and matrix mineralization.	Demonstrates that Apert S252W mutation enhances osteoblast differentiation and mineralization compared to wild-type FGFR2, explaining premature suture fusion.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Demonstrates that Apert S252W mutation enhances osteoblast differentiation and mineralization compared to wild-type FGFR2, explaining premature suture fusion."", ""reference"": ""PMID:19117954"", ""snippet"": ""Both WT and MT FGFR2 increased early and late osteoblast gene expression and matrix mineralization."", ""supports"": ""SUPPORT""}"
784	608	25	Apert Syndrome	Apert_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:19117954	SUPPORT	IN_VITRO	MT, but not WT, also increased protein kinase C (PKC) activity.	Shows mutant FGFR2 activates PKC pathway while wild-type does not, identifying a key mechanistic difference in Apert syndrome signaling.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Shows mutant FGFR2 activates PKC pathway while wild-type does not, identifying a key mechanistic difference in Apert syndrome signaling."", ""reference"": ""PMID:19117954"", ""snippet"": ""MT, but not WT, also increased protein kinase C (PKC) activity."", ""supports"": ""SUPPORT""}"
798	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	evidence	0	PMID:35837780	SUPPORT		Aromatase deficiency (AD) is a rare autosomal recessive genetic disease caused by loss-of-function mutations in aromatase gene (CYP19A1), leading to congenital estrogen deficiency syndrome.	The reference clearly states that mutations in the CYP19A1 gene result in deficient aromatase enzyme activity, which causes aromatase deficiency.	"{""explanation"": ""The reference clearly states that mutations in the CYP19A1 gene result in deficient aromatase enzyme activity, which causes aromatase deficiency."", ""reference"": ""PMID:35837780"", ""snippet"": ""Aromatase deficiency (AD) is a rare autosomal recessive genetic disease caused by loss-of-function mutations in aromatase gene (CYP19A1), leading to congenital estrogen deficiency syndrome."", ""supports"": ""SUPPORT""}"
799	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	evidence	1	PMID:14968547	SUPPORT		Aromatase, a key enzyme in estrogen synthesis, is tissue-specifically regulated in various tissues and plays an important role through endocrine and intracrine estrogen production in various physiological functions. Therefore, aromatase deficiency caused crucial impairments of physiological functions in the gonadal tissues as well as extra-gonadal tissues.	This reference details the crucial role of aromatase and how its deficiency, caused by lack of function due to gene mutations, leads to significant physiological impairments.	"{""explanation"": ""This reference details the crucial role of aromatase and how its deficiency, caused by lack of function due to gene mutations, leads to significant physiological impairments."", ""reference"": ""PMID:14968547"", ""snippet"": ""Aromatase, a key enzyme in estrogen synthesis, is tissue-specifically regulated in various tissues and plays an important role through endocrine and intracrine estrogen production in various physiological functions. Therefore, aromatase deficiency caused crucial impairments of physiological functions in the gonadal tissues as well as extra-gonadal tissues."", ""supports"": ""SUPPORT""}"
800	627	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	0	evidence	2	PMID:27032764	SUPPORT		Cytochrome P450 aromatase (CYP19A1), in human placenta metabolizes androgens to estrogens and uses reduced nicotinamide adenine dinucleotide phosphate through cytochrome P450 oxidoreductase (POR) for the energy requirements of its metabolic activities.	The reference indicates that CYP19A1 (cytochrome P450 aromatase) mutations can result in reduced activity of the enzyme, thereby supporting the mechanism of aromatase deficiency due to mutations in CYP19A1.	"{""explanation"": ""The reference indicates that CYP19A1 (cytochrome P450 aromatase) mutations can result in reduced activity of the enzyme, thereby supporting the mechanism of aromatase deficiency due to mutations in CYP19A1."", ""reference"": ""PMID:27032764"", ""snippet"": ""Cytochrome P450 aromatase (CYP19A1), in human placenta metabolizes androgens to estrogens and uses reduced nicotinamide adenine dinucleotide phosphate through cytochrome P450 oxidoreductase (POR) for the energy requirements of its metabolic activities."", ""supports"": ""SUPPORT""}"
801	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:24705274	SUPPORT		P450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors. Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency.	This paper directly establishes the causal chain from CYP19A1 mutations to loss of aromatase function to estrogen deficiency and androgen accumulation leading to virilization.	"{""explanation"": ""This paper directly establishes the causal chain from CYP19A1 mutations to loss of aromatase function to estrogen deficiency and androgen accumulation leading to virilization."", ""reference"": ""PMID:24705274"", ""snippet"": ""P450 aromatase (CYP19A1) is essential for the biosynthesis of estrogens from androgen precursors. Mutations in the coding region of CYP19A1 lead to autosomal recessive aromatase deficiency."", ""supports"": ""SUPPORT""}"
802	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	evidence	0	PMID:18448329	SUPPORT		Human congenital estrogen deficiency, due to an inactivating mutation of the aromatase gene, leads to the lack of the estrogen synthesis, with gonadotropins and circulating testosterone ranging from normal to elevated. The aromatese-deficient females show hyperandrogenism and virilization at birth with ambiguous genitalia. During childhood there are a dysfunction in the LHRH-LH/FSH axis and a progressive delay in bone age.	This supports the statement as it describes that aromatase deficiency leads to a lack of estrogen, which affects sexual development and bone maturation.	"{""explanation"": ""This supports the statement as it describes that aromatase deficiency leads to a lack of estrogen, which affects sexual development and bone maturation."", ""reference"": ""PMID:18448329"", ""snippet"": ""Human congenital estrogen deficiency, due to an inactivating mutation of the aromatase gene, leads to the lack of the estrogen synthesis, with gonadotropins and circulating testosterone ranging from normal to elevated. The aromatese-deficient females show hyperandrogenism and virilization at birth with ambiguous genitalia. During childhood there are a dysfunction in the LHRH-LH/FSH axis and a progressive delay in bone age."", ""supports"": ""SUPPORT""}"
803	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	evidence	1	PMID:18567553	SUPPORT		Findings from estrogen-resistant and aromatase-deficient men have provided important insights into the role of estrogen in the male skeleton during growth.	This also supports the statement by indicating that aromatase deficiency affects bone maturation.	"{""explanation"": ""This also supports the statement by indicating that aromatase deficiency affects bone maturation."", ""reference"": ""PMID:18567553"", ""snippet"": ""Findings from estrogen-resistant and aromatase-deficient men have provided important insights into the role of estrogen in the male skeleton during growth."", ""supports"": ""SUPPORT""}"
804	628	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	pathophysiology	1	evidence	2	PMID:21874760	SUPPORT		Several lines of clinical and experimental evidence now clearly indicate that aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals.	The lack of aromatase activity, and hence estrogen deficiency, affects bone maturation, confirming the consequence stated.	"{""explanation"": ""The lack of aromatase activity, and hence estrogen deficiency, affects bone maturation, confirming the consequence stated."", ""reference"": ""PMID:21874760"", ""snippet"": ""Several lines of clinical and experimental evidence now clearly indicate that aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals."", ""supports"": ""SUPPORT""}"
912	695	28	Asthma	Asthma.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:38395082	SUPPORT		Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness.	This review establishes the mechanistic link between airway hyperresponsiveness and bronchoconstriction in asthma, showing that AHR enables bronchoconstriction when triggered by various stimuli.	"{""explanation"": ""This review establishes the mechanistic link between airway hyperresponsiveness and bronchoconstriction in asthma, showing that AHR enables bronchoconstriction when triggered by various stimuli."", ""reference"": ""PMID:38395082"", ""snippet"": ""Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness."", ""supports"": ""SUPPORT""}"
913	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	0	PMID:18503727	SUPPORT		The pathogenesis of allergic airway inflammation is complex, involving multiple cell types such as T helper 2 cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and parenchymal cells of the lung.	This reference indicates the involvement of multiple cell types, including mast cells, eosinophils, and T lymphocytes in allergic airway inflammation, which supports the statement.	"{""explanation"": ""This reference indicates the involvement of multiple cell types, including mast cells, eosinophils, and T lymphocytes in allergic airway inflammation, which supports the statement."", ""reference"": ""PMID:18503727"", ""snippet"": ""The pathogenesis of allergic airway inflammation is complex, involving multiple cell types such as T helper 2 cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and parenchymal cells of the lung."", ""supports"": ""SUPPORT""}"
914	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	1	PMID:8324396	SUPPORT		The numbers of eosinophils and neutrophils are increased 4 h after challenge with allergen in the broncho-alveolar lavage fluid (BAL) of asthmatics who show an LPR.	This reference mentions eosinophils and neutrophils as part of the chronic inflammatory response in asthma, supporting the statement.	"{""explanation"": ""This reference mentions eosinophils and neutrophils as part of the chronic inflammatory response in asthma, supporting the statement."", ""reference"": ""PMID:8324396"", ""snippet"": ""The numbers of eosinophils and neutrophils are increased 4 h after challenge with allergen in the broncho-alveolar lavage fluid (BAL) of asthmatics who show an LPR."", ""supports"": ""SUPPORT""}"
915	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	2	PMID:9753516	SUPPORT		Accumulation of basophils and mast cells in airway tissues during allergic and allergic-type inflammatory responses, including asthma, is one of the hallmarks of these disease processes.	This reference highlights the involvement of basophils and mast cells in airway inflammation in asthma, supporting the statement.	"{""explanation"": ""This reference highlights the involvement of basophils and mast cells in airway inflammation in asthma, supporting the statement."", ""reference"": ""PMID:9753516"", ""snippet"": ""Accumulation of basophils and mast cells in airway tissues during allergic and allergic-type inflammatory responses, including asthma, is one of the hallmarks of these disease processes."", ""supports"": ""SUPPORT""}"
916	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	3	PMID:38395082	SUPPORT		Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness.	This reference supports the clinical manifestations of asthma as described in the statement.	"{""explanation"": ""This reference supports the clinical manifestations of asthma as described in the statement."", ""reference"": ""PMID:38395082"", ""snippet"": ""Airway hyperresponsiveness (AHR) is a key clinical feature of asthma. The presence of AHR in people with asthma provides the substrate for bronchoconstriction in response to numerous diverse stimuli, contributing to airflow limitation and symptoms including breathlessness, wheeze, and chest tightness."", ""supports"": ""SUPPORT""}"
917	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	4	PMID:23234454	PARTIAL		Pulmonary edema and pulmonary vascular congestion have been thought to be the primary causes of cardiac asthma but most patients have a poor response to diuretics... Evidence suggests that circulating inflammatory factors and tissue growth factors also lead to airway obstruction suggesting the possibility of developing novel therapies.	While this reference focuses on cardiac asthma, it acknowledges the involvement of inflammatory factors leading to airway obstruction, which partially supports the inflammatory aspect mentioned.	"{""explanation"": ""While this reference focuses on cardiac asthma, it acknowledges the involvement of inflammatory factors leading to airway obstruction, which partially supports the inflammatory aspect mentioned."", ""reference"": ""PMID:23234454"", ""snippet"": ""Pulmonary edema and pulmonary vascular congestion have been thought to be the primary causes of cardiac asthma but most patients have a poor response to diuretics... Evidence suggests that circulating inflammatory factors and tissue growth factors also lead to airway obstruction suggesting the possibility of developing novel therapies."", ""supports"": ""PARTIAL""}"
918	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	5	PMID:1571812	SUPPORT		Asthmatics can have a blood eosinophilia which in some studies correlates with the severity of the disease... The eosinophils that contribute to asthma will be those in the lung.	Specifically talks about the role of eosinophils in asthma, supporting the statement.	"{""explanation"": ""Specifically talks about the role of eosinophils in asthma, supporting the statement."", ""reference"": ""PMID:1571812"", ""snippet"": ""Asthmatics can have a blood eosinophilia which in some studies correlates with the severity of the disease... The eosinophils that contribute to asthma will be those in the lung."", ""supports"": ""SUPPORT""}"
919	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	6	PMID:28687463	SUPPORT		NAEB shares similar eosinophilic inflammation of airway and response to corticosteroids with asthma.	This supports the role of eosinophils in airway inflammation in asthma, consistent with the statement.	"{""explanation"": ""This supports the role of eosinophils in airway inflammation in asthma, consistent with the statement."", ""reference"": ""PMID:28687463"", ""snippet"": ""NAEB shares similar eosinophilic inflammation of airway and response to corticosteroids with asthma."", ""supports"": ""SUPPORT""}"
920	695	28	Asthma	Asthma.yaml	pathophysiology	0	evidence	7	PMID:6101920	NO_EVIDENCE		Exercise-induced asthma can appear as one of many forms of airway hyperreactivity or as a unique clinical entity.	Does not provide specific information about the role of the cell types mentioned in the statement.	"{""explanation"": ""Does not provide specific information about the role of the cell types mentioned in the statement."", ""reference"": ""PMID:6101920"", ""snippet"": ""Exercise-induced asthma can appear as one of many forms of airway hyperreactivity or as a unique clinical entity."", ""supports"": ""NO_EVIDENCE""}"
921	696	28	Asthma	Asthma.yaml	pathophysiology	1	evidence	0	PMID:24914235	SUPPORT		The other main cause of airway obstruction is contraction of airway smooth muscle.	The reference points out that contraction of airway smooth muscle is a main cause of airway obstruction, thus supporting the statement.	"{""explanation"": ""The reference points out that contraction of airway smooth muscle is a main cause of airway obstruction, thus supporting the statement."", ""reference"": ""PMID:24914235"", ""snippet"": ""The other main cause of airway obstruction is contraction of airway smooth muscle."", ""supports"": ""SUPPORT""}"
922	696	28	Asthma	Asthma.yaml	pathophysiology	1	evidence	1	PMID:22011234	SUPPORT		Breathing difficulties are caused by excessive narrowing of the pulmonary airways, which is instigated by shortening of the airway smooth muscle (ASM).	This reference explains that the narrowing of the airways, caused by the contraction of airway smooth muscle, leads to breathing difficulties, thus supporting the statement.	"{""explanation"": ""This reference explains that the narrowing of the airways, caused by the contraction of airway smooth muscle, leads to breathing difficulties, thus supporting the statement."", ""reference"": ""PMID:22011234"", ""snippet"": ""Breathing difficulties are caused by excessive narrowing of the pulmonary airways, which is instigated by shortening of the airway smooth muscle (ASM)."", ""supports"": ""SUPPORT""}"
923	696	28	Asthma	Asthma.yaml	pathophysiology	1	evidence	2	PMID:27603525	SUPPORT		In acute and chronic allergen driven animal models of asthma, statins reduce airway hyper-responsiveness, inflammation and remodeling.	The use of statins to reduce airway hyper-responsiveness implies the involvement of smooth muscle cells, supporting the statement.	"{""explanation"": ""The use of statins to reduce airway hyper-responsiveness implies the involvement of smooth muscle cells, supporting the statement."", ""reference"": ""PMID:27603525"", ""snippet"": ""In acute and chronic allergen driven animal models of asthma, statins reduce airway hyper-responsiveness, inflammation and remodeling."", ""supports"": ""SUPPORT""}"
924	696	28	Asthma	Asthma.yaml	pathophysiology	1	evidence	3	PMID:16543052	SUPPORT		ASM plays an important role in regulating bronchomotor tone, in perpetuating airway inflammation, and in remodeling of the airways.	This reference highlights multiple functions of airway smooth muscle in asthma, which supports the statement regarding the role of smooth muscle cells in bronchoconstriction.	"{""explanation"": ""This reference highlights multiple functions of airway smooth muscle in asthma, which supports the statement regarding the role of smooth muscle cells in bronchoconstriction."", ""reference"": ""PMID:16543052"", ""snippet"": ""ASM plays an important role in regulating bronchomotor tone, in perpetuating airway inflammation, and in remodeling of the airways."", ""supports"": ""SUPPORT""}"
925	696	28	Asthma	Asthma.yaml	pathophysiology	1	evidence	4	PMID:18669785	SUPPORT		Airway smooth muscle cells are known to be the main effector cells of airway narrowing.	This reference clearly identifies airway smooth muscle cells as key players in the narrowing of airways (bronchoconstriction), thus supporting the statement.	"{""explanation"": ""This reference clearly identifies airway smooth muscle cells as key players in the narrowing of airways (bronchoconstriction), thus supporting the statement."", ""reference"": ""PMID:18669785"", ""snippet"": ""Airway smooth muscle cells are known to be the main effector cells of airway narrowing."", ""supports"": ""SUPPORT""}"
926	697	28	Asthma	Asthma.yaml	pathophysiology	2	evidence	0	PMID:19689269	PARTIAL		Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway.	The reference confirms Goblet cell involvement in asthma and mucus production but does not mention Mucosal Epithelial Cell specifically.	"{""explanation"": ""The reference confirms Goblet cell involvement in asthma and mucus production but does not mention Mucosal Epithelial Cell specifically."", ""reference"": ""PMID:19689269"", ""snippet"": ""Goblet cells are major mucus-producing cells, and goblet cell hyperplasia (GCH) is one feature of airway remodeling, defined as structural changes occurring in the airway."", ""supports"": ""PARTIAL""}"
927	697	28	Asthma	Asthma.yaml	pathophysiology	2	evidence	1	PMID:24914235	PARTIAL		Airway epithelial cells, which are the first line of defense against inhaled pathogens and particles, initiate airway inflammation and produce mucus, an important contributor to airway obstruction.	The reference supports that Bronchial Epithelial Cells play a role in mucus production but does not discuss Mucosal Epithelial Cells specifically.	"{""explanation"": ""The reference supports that Bronchial Epithelial Cells play a role in mucus production but does not discuss Mucosal Epithelial Cells specifically."", ""reference"": ""PMID:24914235"", ""snippet"": ""Airway epithelial cells, which are the first line of defense against inhaled pathogens and particles, initiate airway inflammation and produce mucus, an important contributor to airway obstruction."", ""supports"": ""PARTIAL""}"
928	697	28	Asthma	Asthma.yaml	pathophysiology	2	evidence	2	PMID:37520564	PARTIAL		Basal cells... goblet cell hyperplasia and increased epithelial mesenchymal transition, which contribute to impaired mucociliary clearance and airway remodelling.	The reference confirms Goblet cell hyperplasia and the contribution of epithelial cells in asthma but does not detail Mucosal Epithelial Cells.	"{""explanation"": ""The reference confirms Goblet cell hyperplasia and the contribution of epithelial cells in asthma but does not detail Mucosal Epithelial Cells."", ""reference"": ""PMID:37520564"", ""snippet"": ""Basal cells... goblet cell hyperplasia and increased epithelial mesenchymal transition, which contribute to impaired mucociliary clearance and airway remodelling."", ""supports"": ""PARTIAL""}"
929	697	28	Asthma	Asthma.yaml	pathophysiology	2	evidence	3	PMID:23638644	PARTIAL		Goblet cell differentiation and mucus production are subject to extensive control. An emerging concept is that not all goblet cells are phenotypically identical suggesting that specific molecular pathways orchestrate mucin overproduction.	The reference supports Goblet cells' role in mucus production but lacks information on Mucosal Epithelial Cells.	"{""explanation"": ""The reference supports Goblet cells' role in mucus production but lacks information on Mucosal Epithelial Cells."", ""reference"": ""PMID:23638644"", ""snippet"": ""Goblet cell differentiation and mucus production are subject to extensive control. An emerging concept is that not all goblet cells are phenotypically identical suggesting that specific molecular pathways orchestrate mucin overproduction."", ""supports"": ""PARTIAL""}"
930	697	28	Asthma	Asthma.yaml	pathophysiology	2	evidence	4	PMID:16101538	PARTIAL		Bronchial epithelial cells (BEC) are known to play an integral role in the airway defense mechanism via mucociliary system as well as mechanical barriers.	The reference confirms the involvement of Bronchial Epithelial Cells but does not mention Mucosal Epithelial Cells.	"{""explanation"": ""The reference confirms the involvement of Bronchial Epithelial Cells but does not mention Mucosal Epithelial Cells."", ""reference"": ""PMID:16101538"", ""snippet"": ""Bronchial epithelial cells (BEC) are known to play an integral role in the airway defense mechanism via mucociliary system as well as mechanical barriers."", ""supports"": ""PARTIAL""}"
931	698	28	Asthma	Asthma.yaml	pathophysiology	3	evidence	0	PMID:20500603	SUPPORT		In asthma, it includes alterations of the epithelial cell layer with goblet cell hyperplasia, thickening of basement membranes, peri-bronchial and peri-bronchoalveolar fibrosis.	The reference acknowledges that airway remodeling in asthma involves changes to the epithelial cell layer, fibroblasts, and smooth muscle cells.	"{""explanation"": ""The reference acknowledges that airway remodeling in asthma involves changes to the epithelial cell layer, fibroblasts, and smooth muscle cells."", ""reference"": ""PMID:20500603"", ""snippet"": ""In asthma, it includes alterations of the epithelial cell layer with goblet cell hyperplasia, thickening of basement membranes, peri-bronchial and peri-bronchoalveolar fibrosis."", ""supports"": ""SUPPORT""}"
932	698	28	Asthma	Asthma.yaml	pathophysiology	3	evidence	1	PMID:10907591	SUPPORT		In the long-term, asthma may become moderately to fully irreversible. Severe, irreversible airflow obstruction may develop despite apparently appropriate therapy.	The reference supports the idea that long-standing inflammation can result in irreversible structural changes affecting lung function.	"{""explanation"": ""The reference supports the idea that long-standing inflammation can result in irreversible structural changes affecting lung function."", ""reference"": ""PMID:10907591"", ""snippet"": ""In the long-term, asthma may become moderately to fully irreversible. Severe, irreversible airflow obstruction may develop despite apparently appropriate therapy."", ""supports"": ""SUPPORT""}"
933	698	28	Asthma	Asthma.yaml	pathophysiology	3	evidence	2	PMID:15896192	SUPPORT		Structural changes reported in the airways of asthmatics include epithelial fragility, goblet cell hyperplasia, enlarged submucosal mucus glands, angiogenesis, increased matrix deposition in the airway wall, increased airway smooth muscle mass, wall thickening and abnormalities in elastin.	The reference details structural changes involving various cell types, including epithelial cells, smooth muscle cells, and other airway structures resulting from long-term inflammation in asthma.	"{""explanation"": ""The reference details structural changes involving various cell types, including epithelial cells, smooth muscle cells, and other airway structures resulting from long-term inflammation in asthma."", ""reference"": ""PMID:15896192"", ""snippet"": ""Structural changes reported in the airways of asthmatics include epithelial fragility, goblet cell hyperplasia, enlarged submucosal mucus glands, angiogenesis, increased matrix deposition in the airway wall, increased airway smooth muscle mass, wall thickening and abnormalities in elastin."", ""supports"": ""SUPPORT""}"
934	698	28	Asthma	Asthma.yaml	pathophysiology	3	evidence	3	PMID:12405265	SUPPORT		Asthma is a chronic inflammatory disorder of the airways interacting with altered structure and function of the formed elements including smooth muscle.	The reference confirms that chronic inflammation in asthma involves structural alterations involving smooth muscle cells and other components, supporting airway remodeling.	"{""explanation"": ""The reference confirms that chronic inflammation in asthma involves structural alterations involving smooth muscle cells and other components, supporting airway remodeling."", ""reference"": ""PMID:12405265"", ""snippet"": ""Asthma is a chronic inflammatory disorder of the airways interacting with altered structure and function of the formed elements including smooth muscle."", ""supports"": ""SUPPORT""}"
935	698	28	Asthma	Asthma.yaml	pathophysiology	3	evidence	4	PMID:24914235	SUPPORT		Two airway cell types are critical for asthma pathogenesis: epithelial cells and smooth muscle cells.	The reference highlights the importance of epithelial cells and smooth muscle cells in asthma pathogenesis, supporting the role of these cell types in airway remodeling.	"{""explanation"": ""The reference highlights the importance of epithelial cells and smooth muscle cells in asthma pathogenesis, supporting the role of these cell types in airway remodeling."", ""reference"": ""PMID:24914235"", ""snippet"": ""Two airway cell types are critical for asthma pathogenesis: epithelial cells and smooth muscle cells."", ""supports"": ""SUPPORT""}"
993	731	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	0	evidence	0	PMID:39146015	SUPPORT		NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden.	This demonstrates that electrical remodeling including altered action potential duration is a key pathophysiological mechanism in AF.	"{""explanation"": ""This demonstrates that electrical remodeling including altered action potential duration is a key pathophysiological mechanism in AF."", ""reference"": ""PMID:39146015"", ""snippet"": ""NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden."", ""supports"": ""SUPPORT""}"
994	731	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	0	evidence	1	PMID:38255832	SUPPORT		Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate.	Confirms AF affects atrial electrical function and is influenced by electrophysiological mechanisms.	"{""explanation"": ""Confirms AF affects atrial electrical function and is influenced by electrophysiological mechanisms."", ""reference"": ""PMID:38255832"", ""snippet"": ""Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate."", ""supports"": ""SUPPORT""}"
995	732	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	1	evidence	0	PMID:38255832	SUPPORT		it is influenced by a complex interplay of autoimmune, inflammatory, and electrophysiological mechanisms.	Inflammatory mechanisms contribute to structural remodeling including fibrosis that maintains AF substrate.	"{""explanation"": ""Inflammatory mechanisms contribute to structural remodeling including fibrosis that maintains AF substrate."", ""reference"": ""PMID:38255832"", ""snippet"": ""it is influenced by a complex interplay of autoimmune, inflammatory, and electrophysiological mechanisms."", ""supports"": ""SUPPORT""}"
996	734	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	pathophysiology	3	evidence	0	PMID:38255832	SUPPORT		Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate.	AF affects cardiac function including atrial contraction, which contributes to thromboembolism risk and impacts patient survival.	"{""explanation"": ""AF affects cardiac function including atrial contraction, which contributes to thromboembolism risk and impacts patient survival."", ""reference"": ""PMID:38255832"", ""snippet"": ""Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the patients' survival rate."", ""supports"": ""SUPPORT""}"
1005	751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:33887125	SUPPORT		The gut fermentation syndrome (GFS), also known as the endogenous alcohol fermentation syndrome or auto brewery syndrome, is a rare and underdiagnosed medical condition where consumed carbohydrates are converted to alcohol by the microbiota in the gastrointestinal or urinary tract.	Systematic review confirms that carbohydrates are fermented to alcohol by microbiota in the GI tract.	"{""explanation"": ""Systematic review confirms that carbohydrates are fermented to alcohol by microbiota in the GI tract."", ""reference"": ""PMID:33887125"", ""snippet"": ""The gut fermentation syndrome (GFS), also known as the endogenous alcohol fermentation syndrome or auto brewery syndrome, is a rare and underdiagnosed medical condition where consumed carbohydrates are converted to alcohol by the microbiota in the gastrointestinal or urinary tract."", ""supports"": ""SUPPORT""}"
1006	751	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:33887125	SUPPORT		The species that caused the GFS included Klebsiella pneumoniae, Candida albicans, C. glabrata, Saccharomyces cerevisiae, C. intermedia, C. parapsilosis, and C. kefyr.	Identifies the spectrum of fungal organisms responsible for gut fermentation syndrome.	"{""explanation"": ""Identifies the spectrum of fungal organisms responsible for gut fermentation syndrome."", ""reference"": ""PMID:33887125"", ""snippet"": ""The species that caused the GFS included Klebsiella pneumoniae, Candida albicans, C. glabrata, Saccharomyces cerevisiae, C. intermedia, C. parapsilosis, and C. kefyr."", ""supports"": ""SUPPORT""}"
1007	752	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:31543403	SUPPORT		high-alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) is associated with up to 60% of individuals with NAFLD in a Chinese cohort	Demonstrates that high-alcohol-producing Klebsiella strains can generate significant endogenous ethanol.	"{""explanation"": ""Demonstrates that high-alcohol-producing Klebsiella strains can generate significant endogenous ethanol."", ""reference"": ""PMID:31543403"", ""snippet"": ""high-alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) is associated with up to 60% of individuals with NAFLD in a Chinese cohort"", ""supports"": ""SUPPORT""}"
1008	752	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:37060744	SUPPORT		We isolated three species of HiAlc Klebsiella from ABS patients, which were able to induce ABS in mice.	Confirms that Klebsiella species isolated from ABS patients can cause the syndrome in animal models.	"{""explanation"": ""Confirms that Klebsiella species isolated from ABS patients can cause the syndrome in animal models."", ""reference"": ""PMID:37060744"", ""snippet"": ""We isolated three species of HiAlc Klebsiella from ABS patients, which were able to induce ABS in mice."", ""supports"": ""SUPPORT""}"
1009	753	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:34682761	SUPPORT		The pathophysiology of ABS is reportedly due to a fungal type dysbiosis of the gut that ferments some carbohydrates into ethanol	Describes the metabolic storm where gut dysbiosis leads to ethanol production that can overwhelm hepatic clearance.	"{""explanation"": ""Describes the metabolic storm where gut dysbiosis leads to ethanol production that can overwhelm hepatic clearance."", ""reference"": ""PMID:34682761"", ""snippet"": ""The pathophysiology of ABS is reportedly due to a fungal type dysbiosis of the gut that ferments some carbohydrates into ethanol"", ""supports"": ""SUPPORT""}"
1025	771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	evidence	0	PMID:38673882	SUPPORT		Warm-antibody AIHA (wAIHA) exhibits a pan-reactive IgG autoantibody recognizing a portion of band 3 (wherein the DAT may be positive with IgG, C3d or both). Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q.	This comprehensive 2024 review confirms that warm AIHA is mediated by IgG autoantibodies that recognize RBC antigens like band 3, consistent with the FcR-mediated phagocytosis mechanism.	"{""explanation"": ""This comprehensive 2024 review confirms that warm AIHA is mediated by IgG autoantibodies that recognize RBC antigens like band 3, consistent with the FcR-mediated phagocytosis mechanism."", ""reference"": ""PMID:38673882"", ""snippet"": ""Warm-antibody AIHA (wAIHA) exhibits a pan-reactive IgG autoantibody recognizing a portion of band 3 (wherein the DAT may be positive with IgG, C3d or both). Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q."", ""supports"": ""SUPPORT""}"
1026	771	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	0	evidence	1	PMID:29692344	SUPPORT		Tissue-resident macrophages in the spleen play a major role in the clearance of immunoglobulin G (IgG)-opsonized blood cells, as occurs in immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). Blood cells are phagocytosed via the Fc-γ receptors (FcγRs)	This study demonstrates that splenic red pulp macrophages express FcγRIIa and FcγRIIIa receptors and are responsible for phagocytosis of IgG-opsonized RBCs in AIHA, directly supporting the mechanism of extravascular hemolysis in warm AIHA.	"{""explanation"": ""This study demonstrates that splenic red pulp macrophages express FcγRIIa and FcγRIIIa receptors and are responsible for phagocytosis of IgG-opsonized RBCs in AIHA, directly supporting the mechanism of extravascular hemolysis in warm AIHA."", ""reference"": ""PMID:29692344"", ""snippet"": ""Tissue-resident macrophages in the spleen play a major role in the clearance of immunoglobulin G (IgG)-opsonized blood cells, as occurs in immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). Blood cells are phagocytosed via the Fc-γ receptors (FcγRs)"", ""supports"": ""SUPPORT""}"
1027	772	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	1	evidence	0	PMID:38673882	SUPPORT		Cold-antibody AIHA due to IgMs range from cold agglutinin syndrome (CAS) to cold agglutin disease (CAD). These are typically specific to the Ii blood group system, with the former (CAS) being polyclonal and the latter (CAD) being a more severe and monoclonal entity. The DAT in either case is positive only with C3d.	This comprehensive review confirms that cold AIHA is mediated by IgM autoantibodies that activate the complement cascade, resulting in C3d deposition on RBCs and complement-mediated hemolysis.	"{""explanation"": ""This comprehensive review confirms that cold AIHA is mediated by IgM autoantibodies that activate the complement cascade, resulting in C3d deposition on RBCs and complement-mediated hemolysis."", ""reference"": ""PMID:38673882"", ""snippet"": ""Cold-antibody AIHA due to IgMs range from cold agglutinin syndrome (CAS) to cold agglutin disease (CAD). These are typically specific to the Ii blood group system, with the former (CAS) being polyclonal and the latter (CAD) being a more severe and monoclonal entity. The DAT in either case is positive only with C3d."", ""supports"": ""SUPPORT""}"
1028	772	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	1	evidence	1	PMID:30559259	SUPPORT		Cold agglutinin disease is a difficult-to-treat autoimmune hemolytic anemia in which immunoglobulin M antibodies bind to erythrocytes and fix complement, resulting in predominantly extravascular hemolysis.	This first-in-human trial of C1s inhibition confirms the central role of classical complement pathway activation in cold agglutinin disease, where IgM binding triggers complement fixation leading to C3b opsonization and extravascular hemolysis.	"{""explanation"": ""This first-in-human trial of C1s inhibition confirms the central role of classical complement pathway activation in cold agglutinin disease, where IgM binding triggers complement fixation leading to C3b opsonization and extravascular hemolysis."", ""reference"": ""PMID:30559259"", ""snippet"": ""Cold agglutinin disease is a difficult-to-treat autoimmune hemolytic anemia in which immunoglobulin M antibodies bind to erythrocytes and fix complement, resulting in predominantly extravascular hemolysis."", ""supports"": ""SUPPORT""}"
1029	772	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	1	evidence	2	PMID:32176765	SUPPORT		Cold agglutinin disease (CAD) causes predominantly extravascular hemolysis and anemia via complement activation. Sutimlimab is a novel humanized monoclonal antibody directed against classical pathway complement factor C1s.	This clinical study demonstrates that blocking C1s (the serine protease in the C1 complex) effectively stops complement-mediated hemolysis in CAD, confirming that classical pathway activation via C1s is the key mechanism driving RBC destruction in cold agglutinin disease.	"{""explanation"": ""This clinical study demonstrates that blocking C1s (the serine protease in the C1 complex) effectively stops complement-mediated hemolysis in CAD, confirming that classical pathway activation via C1s is the key mechanism driving RBC destruction in cold agglutinin disease."", ""reference"": ""PMID:32176765"", ""snippet"": ""Cold agglutinin disease (CAD) causes predominantly extravascular hemolysis and anemia via complement activation. Sutimlimab is a novel humanized monoclonal antibody directed against classical pathway complement factor C1s."", ""supports"": ""SUPPORT""}"
1030	773	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	2	evidence	0	PMID:39371250	SUPPORT		Therapy is quite different, as steroids and rituximab are effective in the former, but have a lower response rate and duration in the latter.	This 2024 review confirms that B cell-targeting therapy (rituximab, anti-CD20) is effective in warm AIHA, supporting the role of dysregulated B cells in autoantibody production against RBCs.	"{""explanation"": ""This 2024 review confirms that B cell-targeting therapy (rituximab, anti-CD20) is effective in warm AIHA, supporting the role of dysregulated B cells in autoantibody production against RBCs."", ""reference"": ""PMID:39371250"", ""snippet"": ""Therapy is quite different, as steroids and rituximab are effective in the former, but have a lower response rate and duration in the latter."", ""supports"": ""SUPPORT""}"
1031	773	31	Autoimmune Hemolytic Anemia	Autoimmune_Hemolytic_Anemia.yaml	pathophysiology	2	evidence	1	PMID:38673882	SUPPORT		Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q.	The efficacy of anti-CD20 (rituximab) and anti-CD38 (daratumumab) therapies demonstrates that B cells and plasma cells are the cellular sources of pathogenic autoantibodies in AIHA, confirming the role of B cell dysregulation in disease pathogenesis.	"{""explanation"": ""The efficacy of anti-CD20 (rituximab) and anti-CD38 (daratumumab) therapies demonstrates that B cells and plasma cells are the cellular sources of pathogenic autoantibodies in AIHA, confirming the role of B cell dysregulation in disease pathogenesis."", ""reference"": ""PMID:38673882"", ""snippet"": ""Treatment involves glucocorticoids and steroid-sparing agents and may consider IVIG or monoclonal antibodies to CD20, CD38 or C1q."", ""supports"": ""SUPPORT""}"
1034	790	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	0	evidence	0	PMID:39817450	SUPPORT		SepSecS-specific CD4+ T cell clones were found in patients with AIH who were anti-SLA-positive and anti-SLA-negative, and, to a lesser extent, in patients with non-AIH liver diseases and in healthy individuals. SepSecS-specific T cell clones from patients with AIH produced IFN-γ, IL-4, and IL-10, targeted multiple SepSecS epitopes, and, in one patient, were clonally expanded in both blood and liver biopsy.	Demonstrates that autoreactive CD4+ T cells targeting the liver autoantigen SepSecS are present and clonally expanded in AIH patients, producing inflammatory cytokines and infiltrating liver tissue.	"{""explanation"": ""Demonstrates that autoreactive CD4+ T cells targeting the liver autoantigen SepSecS are present and clonally expanded in AIH patients, producing inflammatory cytokines and infiltrating liver tissue."", ""reference"": ""PMID:39817450"", ""snippet"": ""SepSecS-specific CD4+ T cell clones were found in patients with AIH who were anti-SLA-positive and anti-SLA-negative, and, to a lesser extent, in patients with non-AIH liver diseases and in healthy individuals. SepSecS-specific T cell clones from patients with AIH produced IFN-γ, IL-4, and IL-10, targeted multiple SepSecS epitopes, and, in one patient, were clonally expanded in both blood and liver biopsy."", ""supports"": ""SUPPORT""}"
1035	791	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	1	evidence	0	PMID:39817450	SUPPORT		The anti-SepSecS mAbs isolated were primarily IgG1, affinity-matured compared with their germline versions, and recognized at least 3 nonoverlapping epitopes.	Shows that anti-SLA/SepSecS autoantibodies in AIH undergo affinity maturation and class-switching to IgG1, indicating an adaptive B cell response with germinal center involvement.	"{""explanation"": ""Shows that anti-SLA/SepSecS autoantibodies in AIH undergo affinity maturation and class-switching to IgG1, indicating an adaptive B cell response with germinal center involvement."", ""reference"": ""PMID:39817450"", ""snippet"": ""The anti-SepSecS mAbs isolated were primarily IgG1, affinity-matured compared with their germline versions, and recognized at least 3 nonoverlapping epitopes."", ""supports"": ""SUPPORT""}"
1036	791	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	1	evidence	1	PMID:31226726	SUPPORT		Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells.	Highlights multiple mechanisms by which B cells and autoantibodies contribute to AIH pathogenesis beyond simple diagnostic markers.	"{""explanation"": ""Highlights multiple mechanisms by which B cells and autoantibodies contribute to AIH pathogenesis beyond simple diagnostic markers."", ""reference"": ""PMID:31226726"", ""snippet"": ""Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells."", ""supports"": ""SUPPORT""}"
1037	792	32	Autoimmune Hepatitis	Autoimmune_Hepatitis.yaml	pathophysiology	2	evidence	0	PMID:31226726	SUPPORT		Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells.	Indicates that B cells in AIH can actively inhibit regulatory T cells, contributing to the loss of immune tolerance and allowing autoreactive T cell expansion.	"{""explanation"": ""Indicates that B cells in AIH can actively inhibit regulatory T cells, contributing to the loss of immune tolerance and allowing autoreactive T cell expansion."", ""reference"": ""PMID:31226726"", ""snippet"": ""Autoreactive B cells can promote autoimmunity through antigen presentation to autoreactive T cells, production of autoantibodies, generation of cytokines promoting T cell activation and differentiation, and inhibition of regulatory T cells and B cells."", ""supports"": ""SUPPORT""}"
1071	809	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	0	evidence	0	PMID:22199394	SUPPORT		Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease.	Confirms PITX2 and FOXC1 as the primary genes involved in ARS pathogenesis.	"{""explanation"": ""Confirms PITX2 and FOXC1 as the primary genes involved in ARS pathogenesis."", ""reference"": ""PMID:22199394"", ""snippet"": ""Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease."", ""supports"": ""SUPPORT""}"
1072	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	evidence	0	PMID:19218601	SUPPORT		Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding and transcriptional activation despite normal nuclear localization.	The reference indicates that some mutations in PITX2 result in reduced DNA-binding and transcriptional activation, which aligns with the statement that mutations disrupt its function.	"{""explanation"": ""The reference indicates that some mutations in PITX2 result in reduced DNA-binding and transcriptional activation, which aligns with the statement that mutations disrupt its function."", ""reference"": ""PMID:19218601"", ""snippet"": ""Two homeobox mutations, R43W and R90C, resulted in severely reduced DNA-binding and transcriptional activation despite normal nuclear localization."", ""supports"": ""SUPPORT""}"
1073	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	evidence	1	PMID:15509533	SUPPORT		It has been reported that some mutations in PITX2 increase transactivation, whereas most mutations cause defects in DNA binding or transactivation.	This reference supports the statement that mutations in PITX2 can disrupt its function, and mentions that some mutations can increase transactivation activity.	"{""explanation"": ""This reference supports the statement that mutations in PITX2 can disrupt its function, and mentions that some mutations can increase transactivation activity."", ""reference"": ""PMID:15509533"", ""snippet"": ""It has been reported that some mutations in PITX2 increase transactivation, whereas most mutations cause defects in DNA binding or transactivation."", ""supports"": ""SUPPORT""}"
1074	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	evidence	2	PMID:12130547	SUPPORT		The five mutants appeared to be transcriptionally defective despite conserved DNA-binding in CV1 cells.	This reference supports the idea that PITX2 mutations can impair its ability to regulate gene expression.	"{""explanation"": ""This reference supports the idea that PITX2 mutations can impair its ability to regulate gene expression."", ""reference"": ""PMID:12130547"", ""snippet"": ""The five mutants appeared to be transcriptionally defective despite conserved DNA-binding in CV1 cells."", ""supports"": ""SUPPORT""}"
1075	810	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	1	evidence	3	PMID:21837767	SUPPORT		Mutation in either gene caused reduced transcriptional activation to different extents on the FOXO1 and PLOD1 promoters.	This reference supports the idea that PITX2 mutations can disrupt its function as a transcription factor.	"{""explanation"": ""This reference supports the idea that PITX2 mutations can disrupt its function as a transcription factor."", ""reference"": ""PMID:21837767"", ""snippet"": ""Mutation in either gene caused reduced transcriptional activation to different extents on the FOXO1 and PLOD1 promoters."", ""supports"": ""SUPPORT""}"
1076	811	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	2	evidence	0	PMID:36926528	SUPPORT		Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily characterized by ocular anterior segment anomalies but is also associated with craniofacial, dental, cardiac, and neurologic abnormalities.	The literature states that ARS is characterized by ocular anterior segment anomalies, supporting the statement that it involves improper development of the anterior segment of the eye.	"{""explanation"": ""The literature states that ARS is characterized by ocular anterior segment anomalies, supporting the statement that it involves improper development of the anterior segment of the eye."", ""reference"": ""PMID:36926528"", ""snippet"": ""Axenfeld-Rieger syndrome (ARS) is a rare congenital disease that is primarily characterized by ocular anterior segment anomalies but is also associated with craniofacial, dental, cardiac, and neurologic abnormalities."", ""supports"": ""SUPPORT""}"
1077	811	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	2	evidence	1	PMID:12015278	SUPPORT		Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma.	The reference confirms that malformations of the anterior segment of the eye are associated with conditions like glaucoma, supporting the statement about improper development and associated issues.	"{""explanation"": ""The reference confirms that malformations of the anterior segment of the eye are associated with conditions like glaucoma, supporting the statement about improper development and associated issues."", ""reference"": ""PMID:12015278"", ""snippet"": ""Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma."", ""supports"": ""SUPPORT""}"
1078	811	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	2	evidence	2	PMID:35327965	SUPPORT		Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies.	The literature describes Axenfeld and Rieger anomalies as part of anterior segment dysgenesis, which includes iris defects and abnormal angle structures, supporting the statement.	"{""explanation"": ""The literature describes Axenfeld and Rieger anomalies as part of anterior segment dysgenesis, which includes iris defects and abnormal angle structures, supporting the statement."", ""reference"": ""PMID:35327965"", ""snippet"": ""Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies."", ""supports"": ""SUPPORT""}"
1079	811	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	2	evidence	3	PMID:31560925	SUPPORT		Aniridia and Axenfeld-Rieger Syndrome are related, human ocular disorders that are typically inherited in an autosomal dominant manner. Both result from incorrect development of the eye and have, as their most serious consequences, elevated risk to develop the blinding condition glaucoma.	The literature confirms that Axenfeld-Rieger Syndrome results from incorrect development of the eye, specifically mentioning the anterior segment, supporting the statement.	"{""explanation"": ""The literature confirms that Axenfeld-Rieger Syndrome results from incorrect development of the eye, specifically mentioning the anterior segment, supporting the statement."", ""reference"": ""PMID:31560925"", ""snippet"": ""Aniridia and Axenfeld-Rieger Syndrome are related, human ocular disorders that are typically inherited in an autosomal dominant manner. Both result from incorrect development of the eye and have, as their most serious consequences, elevated risk to develop the blinding condition glaucoma."", ""supports"": ""SUPPORT""}"
1080	812	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	3	evidence	0	PMID:16302606	SUPPORT		Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations.	The literature describes Axenfeld-Rieger syndrome as involving multiple systems, including dental and craniofacial abnormalities, which supports the statement.	"{""explanation"": ""The literature describes Axenfeld-Rieger syndrome as involving multiple systems, including dental and craniofacial abnormalities, which supports the statement."", ""reference"": ""PMID:16302606"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations."", ""supports"": ""SUPPORT""}"
1081	812	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	3	evidence	1	PMID:36543336	SUPPORT		Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies.	The reference confirms that Axenfeld-Rieger syndrome is a multi-system disorder, which aligns with the statement that it involves multiple systems.	"{""explanation"": ""The reference confirms that Axenfeld-Rieger syndrome is a multi-system disorder, which aligns with the statement that it involves multiple systems."", ""reference"": ""PMID:36543336"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies."", ""supports"": ""SUPPORT""}"
1082	812	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	3	evidence	2	PMID:18599376	SUPPORT		We will consider successively syndromic forms of amelogenesis imperfecta or enamel defects, dentinogenesis imperfecta (i.e. osteogenesis imperfecta) and other dentine anomalies.	The literature mentions dental anomalies as significant features in various syndromes, including Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The literature mentions dental anomalies as significant features in various syndromes, including Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:18599376"", ""snippet"": ""We will consider successively syndromic forms of amelogenesis imperfecta or enamel defects, dentinogenesis imperfecta (i.e. osteogenesis imperfecta) and other dentine anomalies."", ""supports"": ""SUPPORT""}"
1083	813	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	4	evidence	0	PMID:35733478	SUPPORT		Treatment is predominantly the management of glaucoma and is mostly medical but can be surgical in refractory cases.	The reference discusses the management of glaucoma in Axenfeld-Rieger syndrome, indicating that loss of vision due to uncontrolled intraocular pressure is a concern.	"{""explanation"": ""The reference discusses the management of glaucoma in Axenfeld-Rieger syndrome, indicating that loss of vision due to uncontrolled intraocular pressure is a concern."", ""reference"": ""PMID:35733478"", ""snippet"": ""Treatment is predominantly the management of glaucoma and is mostly medical but can be surgical in refractory cases."", ""supports"": ""SUPPORT""}"
1084	813	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	4	evidence	1	PMID:33367186	SUPPORT		Glaucoma is the main cause of visual morbidity in patients with ARS.	The reference explicitly states that glaucoma is the main cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The reference explicitly states that glaucoma is the main cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:33367186"", ""snippet"": ""Glaucoma is the main cause of visual morbidity in patients with ARS."", ""supports"": ""SUPPORT""}"
1085	813	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	4	evidence	2	PMID:28549150	SUPPORT		Other early-onset glaucomas may arise secondary to developmental abnormalities, such as glaucomas that occur with aniridia or as part of Axenfeld-Rieger syndrome.	The reference mentions that glaucomas associated with Axenfeld-Rieger syndrome can lead to visual disability, supporting the statement.	"{""explanation"": ""The reference mentions that glaucomas associated with Axenfeld-Rieger syndrome can lead to visual disability, supporting the statement."", ""reference"": ""PMID:28549150"", ""snippet"": ""Other early-onset glaucomas may arise secondary to developmental abnormalities, such as glaucomas that occur with aniridia or as part of Axenfeld-Rieger syndrome."", ""supports"": ""SUPPORT""}"
1086	813	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	pathophysiology	4	evidence	3	PMID:5467709	SUPPORT		Glaucoma and Rieger's syndrome.	The title suggests a direct relationship between glaucoma and Axenfeld-Rieger syndrome, implying that vision loss due to glaucoma is a concern.	"{""explanation"": ""The title suggests a direct relationship between glaucoma and Axenfeld-Rieger syndrome, implying that vision loss due to glaucoma is a concern."", ""reference"": ""PMID:5467709"", ""snippet"": ""Glaucoma and Rieger's syndrome."", ""supports"": ""SUPPORT""}"
1135	853	35	BRAF V600E-Mutant Colorectal Cancer	BRAF_V600E_Mutant_Colorectal_Cancer.yaml	pathophysiology	0	evidence	0	PMID:30739887	SUPPORT		BRAF mutations confers a poor prognosis in Western CRC patients, particularly in metastatic CRC (mCRC) and its mutations occur in approximately 4-20% CRC, with the vast majority being the V600E hotspot mutation.	This abstract links BRAF mutations in CRC to the V600E hotspot and supports the relevance of V600E in colorectal cancer.	"{""explanation"": ""This abstract links BRAF mutations in CRC to the V600E hotspot and supports the relevance of V600E in colorectal cancer."", ""reference"": ""PMID:30739887"", ""snippet"": ""BRAF mutations confers a poor prognosis in Western CRC patients, particularly in metastatic CRC (mCRC) and its mutations occur in approximately 4-20% CRC, with the vast majority being the V600E hotspot mutation."", ""supports"": ""SUPPORT""}"
1138	871	36	BRAF V600E-Mutant Non-Small Cell Lung Cancer	BRAF_V600E_Mutant_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:41158045	SUPPORT		The incidence of BRAF mutations in non-small cell lung cancer (NSCLC) patients ranges from 1.5% to 5.5%, with BRAF V600 mutations accounting for approximately 30%-50% of all BRAF mutations, among which BRAF V600E represents the most prevalent mutation type.	Supports the presence and predominance of BRAF V600E among BRAF-mutant NSCLC.	"{""explanation"": ""Supports the presence and predominance of BRAF V600E among BRAF-mutant NSCLC."", ""reference"": ""PMID:41158045"", ""snippet"": ""The incidence of BRAF mutations in non-small cell lung cancer (NSCLC) patients ranges from 1.5% to 5.5%, with BRAF V600 mutations accounting for approximately 30%-50% of all BRAF mutations, among which BRAF V600E represents the most prevalent mutation type."", ""supports"": ""SUPPORT""}"
1140	887	37	BRAF V600 Mutant Melanoma	BRAF_V600_Mutant_Melanoma.yaml	pathophysiology	0	evidence	0	PMID:40023845	SUPPORT		Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively.	This abstract reports frequent hotspot BRAF mutations in cutaneous melanoma, supporting the relevance of BRAF-driven melanoma.	"{""explanation"": ""This abstract reports frequent hotspot BRAF mutations in cutaneous melanoma, supporting the relevance of BRAF-driven melanoma."", ""reference"": ""PMID:40023845"", ""snippet"": ""Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively."", ""supports"": ""SUPPORT""}"
1188	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	evidence	0	PMID:26804733	SUPPORT		Streptococcus pneumoniae (the pneumococcus) is the major cause of bacterial meningitis. The mechanisms by which pneumococci from the bloodstream penetrate the blood-brain barrier to reach the brain are not fully understood.	The reference discusses how Streptococcus pneumoniae can penetrate the blood-brain barrier from the bloodstream, which supports the statement about bacterial meningitis involving bacteria entering the bloodstream and crossing the blood-brain barrier.	"{""explanation"": ""The reference discusses how Streptococcus pneumoniae can penetrate the blood-brain barrier from the bloodstream, which supports the statement about bacterial meningitis involving bacteria entering the bloodstream and crossing the blood-brain barrier."", ""reference"": ""PMID:26804733"", ""snippet"": ""Streptococcus pneumoniae (the pneumococcus) is the major cause of bacterial meningitis. The mechanisms by which pneumococci from the bloodstream penetrate the blood-brain barrier to reach the brain are not fully understood."", ""supports"": ""SUPPORT""}"
1189	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	evidence	1	PMID:31805229	SUPPORT		Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules.	This reference explicitly states that microbial penetration of the blood-brain barrier is necessary for the development of bacterial meningitis, supporting the statement.	"{""explanation"": ""This reference explicitly states that microbial penetration of the blood-brain barrier is necessary for the development of bacterial meningitis, supporting the statement."", ""reference"": ""PMID:31805229"", ""snippet"": ""Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules."", ""supports"": ""SUPPORT""}"
1190	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	evidence	2	PMID:27367319	SUPPORT		If the infection is not controlled at the stage in which the bacterium is in the liver, for instance, due to a severe immunodepression, a secondary bacteraemia can be developed and L. monocytogenes reaches the preferred sites transgressing the blood-brain barrier or the placental barrier.	The reference mentions that Listeria monocytogenes can cross the blood-brain barrier after entering the bloodstream, which supports the statement about the process of bacterial invasion in meningitis.	"{""explanation"": ""The reference mentions that Listeria monocytogenes can cross the blood-brain barrier after entering the bloodstream, which supports the statement about the process of bacterial invasion in meningitis."", ""reference"": ""PMID:27367319"", ""snippet"": ""If the infection is not controlled at the stage in which the bacterium is in the liver, for instance, due to a severe immunodepression, a secondary bacteraemia can be developed and L. monocytogenes reaches the preferred sites transgressing the blood-brain barrier or the placental barrier."", ""supports"": ""SUPPORT""}"
1191	931	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	0	evidence	3	PMID:11008113	SUPPORT		Transcellular penetration, e.g., transcytosis across the BBB has been demonstrated for Escherichia coli K1, group B streptococcus, Listeria monocytogenes, Citrobacter freundii and Streptococcus pneumonia strains.	Highlights BBB transcytosis by common neonatal and adult meningitis pathogens, reinforcing the invasion step across brain microvascular endothelium.	"{""explanation"": ""Highlights BBB transcytosis by common neonatal and adult meningitis pathogens, reinforcing the invasion step across brain microvascular endothelium."", ""reference"": ""PMID:11008113"", ""snippet"": ""Transcellular penetration, e.g., transcytosis across the BBB has been demonstrated for Escherichia coli K1, group B streptococcus, Listeria monocytogenes, Citrobacter freundii and Streptococcus pneumonia strains."", ""supports"": ""SUPPORT""}"
1192	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	evidence	0	PMID:39116800	SUPPORT		Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs), Nucleotide oligomerization domain (NOD)-like receptor-mediated signaling, pneumolysin related signaling, NF-kappaB signaling and many other pathways that lead to pro-inflammatory cascade and subsequent cytokine release including interleukine (IL)-1beta, tumor necrosis factor(TNF)-alpha, IL-6, IL-8, chemokine (C-X-C motif) ligand 1 (CXCL1) along with other mediators, leading to neuroinflammation.	The reference describes how bacterial meningitis triggers several inflammatory pathways leading to the release of cytokines and chemokines, supporting the statement that bacterial components trigger a strong inflammatory response in the subarachnoid space.	"{""explanation"": ""The reference describes how bacterial meningitis triggers several inflammatory pathways leading to the release of cytokines and chemokines, supporting the statement that bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""reference"": ""PMID:39116800"", ""snippet"": ""Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs), Nucleotide oligomerization domain (NOD)-like receptor-mediated signaling, pneumolysin related signaling, NF-kappaB signaling and many other pathways that lead to pro-inflammatory cascade and subsequent cytokine release including interleukine (IL)-1beta, tumor necrosis factor(TNF)-alpha, IL-6, IL-8, chemokine (C-X-C motif) ligand 1 (CXCL1) along with other mediators, leading to neuroinflammation."", ""supports"": ""SUPPORT""}"
1193	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	evidence	1	PMID:37544134	SUPPORT		The inflammatory response in the subarachnoid space, modulated by different cytokines, plays a major role in the pathogenesis of acute central nervous system infections.	The reference explicitly states that cytokines modulate the inflammatory response in the subarachnoid space during bacterial meningitis, supporting the statement.	"{""explanation"": ""The reference explicitly states that cytokines modulate the inflammatory response in the subarachnoid space during bacterial meningitis, supporting the statement."", ""reference"": ""PMID:37544134"", ""snippet"": ""The inflammatory response in the subarachnoid space, modulated by different cytokines, plays a major role in the pathogenesis of acute central nervous system infections."", ""supports"": ""SUPPORT""}"
1194	932	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	1	evidence	2	PMID:24412248	SUPPORT		Complement factors C1q and MBL as well as common complement pathway factors C3a, iC3b, C5a, sC5b-9 and complement regulator CFH were all elevated in patients with bacterial meningitis as compared to the controls.	The reference mentions the elevation of complement factors, which are part of the immune response, supporting the idea that bacterial components trigger a strong inflammatory response in the subarachnoid space.	"{""explanation"": ""The reference mentions the elevation of complement factors, which are part of the immune response, supporting the idea that bacterial components trigger a strong inflammatory response in the subarachnoid space."", ""reference"": ""PMID:24412248"", ""snippet"": ""Complement factors C1q and MBL as well as common complement pathway factors C3a, iC3b, C5a, sC5b-9 and complement regulator CFH were all elevated in patients with bacterial meningitis as compared to the controls."", ""supports"": ""SUPPORT""}"
1195	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	evidence	0	PMID:2498090	SUPPORT		Their presence in the cerebrospinal fluid is associated with the induction of inflammation and with the development of brain edema and increased intracranial pressure.	The literature supports that inflammation in bacterial meningitis is associated with increased intracranial pressure.	"{""explanation"": ""The literature supports that inflammation in bacterial meningitis is associated with increased intracranial pressure."", ""reference"": ""PMID:2498090"", ""snippet"": ""Their presence in the cerebrospinal fluid is associated with the induction of inflammation and with the development of brain edema and increased intracranial pressure."", ""supports"": ""SUPPORT""}"
1196	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	evidence	1	PMID:24413408	SUPPORT		Fulminant bacterial meningitis is a rare host reaction to infection characterized by sudden onset, rapid deterioration, abrupt cerebral edema and refractory intracranial hypertension.	This supports the statement that bacterial meningitis can lead to increased intracranial pressure due to inflammation.	"{""explanation"": ""This supports the statement that bacterial meningitis can lead to increased intracranial pressure due to inflammation."", ""reference"": ""PMID:24413408"", ""snippet"": ""Fulminant bacterial meningitis is a rare host reaction to infection characterized by sudden onset, rapid deterioration, abrupt cerebral edema and refractory intracranial hypertension."", ""supports"": ""SUPPORT""}"
1197	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	evidence	2	PMID:31378869	SUPPORT		Acute bacterial meningitis may present with symptoms as nonspecific as headache and fever, but rapid progression to an altered level of consciousness is not unusual.	The literature mentions altered mental status as a downstream effect of bacterial meningitis, supporting the statement.	"{""explanation"": ""The literature mentions altered mental status as a downstream effect of bacterial meningitis, supporting the statement."", ""reference"": ""PMID:31378869"", ""snippet"": ""Acute bacterial meningitis may present with symptoms as nonspecific as headache and fever, but rapid progression to an altered level of consciousness is not unusual."", ""supports"": ""SUPPORT""}"
1198	933	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	2	evidence	3	PMID:8859061	SUPPORT		The clinical course of bacterial meningitis still is characterized by a high mortality and frequent neurological deficits in survivors.	The literature supports that bacterial meningitis can lead to neurological deficits, aligning with the downstream effects mentioned in the statement.	"{""explanation"": ""The literature supports that bacterial meningitis can lead to neurological deficits, aligning with the downstream effects mentioned in the statement."", ""reference"": ""PMID:8859061"", ""snippet"": ""The clinical course of bacterial meningitis still is characterized by a high mortality and frequent neurological deficits in survivors."", ""supports"": ""SUPPORT""}"
1199	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	evidence	0	PMID:39116800	SUPPORT		Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs).	Describes BBB-breaching bacteria activating TLR signaling during meningitis, matching the TLR-driven innate activation described in this node.	"{""explanation"": ""Describes BBB-breaching bacteria activating TLR signaling during meningitis, matching the TLR-driven innate activation described in this node."", ""reference"": ""PMID:39116800"", ""snippet"": ""Many in-vitro and in-vivo analyses have shown that after the disruption of the blood-brain barrier (BBB), these pathogens trigger several inflammatory pathways including Toll-Like Receptor (TLR) signaling in response to Pathogen-Associated Molecular Patterns (PAMPs)."", ""supports"": ""SUPPORT""}"
1200	934	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	3	evidence	1	PMID:16785556	SUPPORT		We show that both heat-inactivated whole GBS and a secreted proteinaceous factor from GBS (GBS-F) induce neuronal apoptosis via the activation of murine microglia through a TLR2-dependent and MyD88-dependent pathway in vitro.	Shows meningitis-causing GBS activating microglial TLR2/MyD88 signaling and causing neuronal injury, directly supporting TLR-driven innate activation in the CNS.	"{""explanation"": ""Shows meningitis-causing GBS activating microglial TLR2/MyD88 signaling and causing neuronal injury, directly supporting TLR-driven innate activation in the CNS."", ""reference"": ""PMID:16785556"", ""snippet"": ""We show that both heat-inactivated whole GBS and a secreted proteinaceous factor from GBS (GBS-F) induce neuronal apoptosis via the activation of murine microglia through a TLR2-dependent and MyD88-dependent pathway in vitro."", ""supports"": ""SUPPORT""}"
1201	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	evidence	0	PMID:39116800	SUPPORT		The activation of another protein complex, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome, also takes place resulting in the maturation and release of IL-1β and IL-18, hence potentiating neuroinflammation.	States that NLRP3 inflammasome activation in bacterial meningitis drives IL-1β/IL-18 maturation, consistent with inflammasome-driven pyroptotic inflammation.	"{""explanation"": ""States that NLRP3 inflammasome activation in bacterial meningitis drives IL-1β/IL-18 maturation, consistent with inflammasome-driven pyroptotic inflammation."", ""reference"": ""PMID:39116800"", ""snippet"": ""The activation of another protein complex, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome, also takes place resulting in the maturation and release of IL-1β and IL-18, hence potentiating neuroinflammation."", ""supports"": ""SUPPORT""}"
1202	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	evidence	1	PMID:37603152	SUPPORT		The animals in the meningitis group at 24 h showed increased levels of cytokines, NLRP3, and IBA-1 expression, and the use of the MCC950 significantly reduced those levels.	Experimental pneumococcal meningitis shows NLRP3 upregulation that is blunted by an NLRP3 inhibitor, supporting inflammasome-driven pathology.	"{""explanation"": ""Experimental pneumococcal meningitis shows NLRP3 upregulation that is blunted by an NLRP3 inhibitor, supporting inflammasome-driven pathology."", ""reference"": ""PMID:37603152"", ""snippet"": ""The animals in the meningitis group at 24 h showed increased levels of cytokines, NLRP3, and IBA-1 expression, and the use of the MCC950 significantly reduced those levels."", ""supports"": ""SUPPORT""}"
1203	935	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	4	evidence	2	PMID:37001294	SUPPORT		We found that the formation of the NEK7-NLRP3 complex significantly increased during S. pneumoniae infection and that anaplastic lymphoma kinase (ALK) and Jun N-terminal kinase (JNK) were phosphorylated rapidly.	Shows pneumococcal infection driving NEK7-NLRP3 inflammasome assembly through ALK/JNK signaling, supporting inflammasome activation in meningitis.	"{""explanation"": ""Shows pneumococcal infection driving NEK7-NLRP3 inflammasome assembly through ALK/JNK signaling, supporting inflammasome activation in meningitis."", ""reference"": ""PMID:37001294"", ""snippet"": ""We found that the formation of the NEK7-NLRP3 complex significantly increased during S. pneumoniae infection and that anaplastic lymphoma kinase (ALK) and Jun N-terminal kinase (JNK) were phosphorylated rapidly."", ""supports"": ""SUPPORT""}"
1204	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	evidence	0	PMID:31805229	SUPPORT		Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules.	Establishes BBB penetration as an early pathogenic step requiring host signaling changes that enable barrier breach, supporting BBB disruption in meningitis pathophysiology.	"{""explanation"": ""Establishes BBB penetration as an early pathogenic step requiring host signaling changes that enable barrier breach, supporting BBB disruption in meningitis pathophysiology."", ""reference"": ""PMID:31805229"", ""snippet"": ""Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules."", ""supports"": ""SUPPORT""}"
1205	936	39	Bacterial meningitis	Bacterial_meningitis.yaml	pathophysiology	5	evidence	1	PMID:36769171	SUPPORT		A defining feature of the pathogenesis of bacterial meningitis is the increase in BBB permeability.	States BBB permeability rise as central to meningitis pathogenesis, supporting the barrier-disruption node.	"{""explanation"": ""States BBB permeability rise as central to meningitis pathogenesis, supporting the barrier-disruption node."", ""reference"": ""PMID:36769171"", ""snippet"": ""A defining feature of the pathogenesis of bacterial meningitis is the increase in BBB permeability."", ""supports"": ""SUPPORT""}"
1317	976	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:26231314	SUPPORT		From the analysis of the mutational burden in patients to the functional characterization of the BBS proteins, this syndrome has become a model for both understanding oligogenic patterns of inheritance and the biology of a particular cellular organelle: the primary cilium.	This excerpt supports the assertion that BBS mechanisms are related to defects in primary cilia function caused by mutations in BBS genes, leading to a wide range of symptoms.	"{""explanation"": ""This excerpt supports the assertion that BBS mechanisms are related to defects in primary cilia function caused by mutations in BBS genes, leading to a wide range of symptoms."", ""reference"": ""PMID:26231314"", ""snippet"": ""From the analysis of the mutational burden in patients to the functional characterization of the BBS proteins, this syndrome has become a model for both understanding oligogenic patterns of inheritance and the biology of a particular cellular organelle: the primary cilium."", ""supports"": ""SUPPORT""}"
1318	976	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:29534263	SUPPORT		The photoreceptor connecting cilium plays a leading role in these ciliopathy-related retinal dystrophies. Dysfunctional photoreceptor cilia cause the most severe type of retinal dystrophy: Leber's congenital amaurosis (LCA). The most common syndromic ciliopathies with an ocular manifestation are Bardet-Biedl syndrome (BBS) and Usher syndrome.	This reference emphasizes the role of primary cilia dysfunction in BBS and its association with retinal dystrophies, supporting the statement.	"{""explanation"": ""This reference emphasizes the role of primary cilia dysfunction in BBS and its association with retinal dystrophies, supporting the statement."", ""reference"": ""PMID:29534263"", ""snippet"": ""The photoreceptor connecting cilium plays a leading role in these ciliopathy-related retinal dystrophies. Dysfunctional photoreceptor cilia cause the most severe type of retinal dystrophy: Leber's congenital amaurosis (LCA). The most common syndromic ciliopathies with an ocular manifestation are Bardet-Biedl syndrome (BBS) and Usher syndrome."", ""supports"": ""SUPPORT""}"
1319	976	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:33560420	SUPPORT		One ciliopathy, Bardet-Biedl syndrome (BBS; OMIM 209900), presents with diverse clinical features, many of which are attributed to defects in ciliary signaling during both embryonic development and postnatal life	This supports the statement by explaining that BBS symptoms are attributed to ciliary defects.	"{""explanation"": ""This supports the statement by explaining that BBS symptoms are attributed to ciliary defects."", ""reference"": ""PMID:33560420"", ""snippet"": ""One ciliopathy, Bardet-Biedl syndrome (BBS; OMIM 209900), presents with diverse clinical features, many of which are attributed to defects in ciliary signaling during both embryonic development and postnatal life"", ""supports"": ""SUPPORT""}"
1370	1011	41	Basal Cell Carcinoma	Basal_Cell_Carcinoma.yaml	pathophysiology	0	evidence	0	PMID:19082818	SUPPORT		Aberrant activation of sonic hedgehog signaling has been reported for sporadic and hereditary basal cell carcinoma caused by specific genetic mutations.	Supports aberrant Hedgehog signaling as a driver in basal cell carcinoma.	"{""explanation"": ""Supports aberrant Hedgehog signaling as a driver in basal cell carcinoma."", ""reference"": ""PMID:19082818"", ""snippet"": ""Aberrant activation of sonic hedgehog signaling has been reported for sporadic and hereditary basal cell carcinoma caused by specific genetic mutations."", ""supports"": ""SUPPORT""}"
1371	1029	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	0	evidence	0	PMID:38778397	SUPPORT		genetic factors (such as HLA-B51), dysregulated immune responses of both the innate and adaptive immune systems, infections (such as streptococcus), and environmental factors (such as GDP) are all involved in its development.	This review confirms that HLA-B51 is a key genetic factor in Behcet's disease pathogenesis, supporting the role of aberrant antigen presentation in disease development.	"{""explanation"": ""This review confirms that HLA-B51 is a key genetic factor in Behcet's disease pathogenesis, supporting the role of aberrant antigen presentation in disease development."", ""reference"": ""PMID:38778397"", ""snippet"": ""genetic factors (such as HLA-B51), dysregulated immune responses of both the innate and adaptive immune systems, infections (such as streptococcus), and environmental factors (such as GDP) are all involved in its development."", ""supports"": ""SUPPORT""}"
1372	1030	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	1	evidence	0	PMID:38778397	SUPPORT		Innate immunity, including hyperactivity of neutrophils and γδT cells and elevated NK1/NK2 ratios, has been shown to play an essential role in this disease.	This review highlights neutrophil hyperactivity as a key feature of innate immune dysregulation in Behcet's uveitis, supporting the role of neutrophil activation in pathogenesis.	"{""explanation"": ""This review highlights neutrophil hyperactivity as a key feature of innate immune dysregulation in Behcet's uveitis, supporting the role of neutrophil activation in pathogenesis."", ""reference"": ""PMID:38778397"", ""snippet"": ""Innate immunity, including hyperactivity of neutrophils and γδT cells and elevated NK1/NK2 ratios, has been shown to play an essential role in this disease."", ""supports"": ""SUPPORT""}"
1373	1030	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	1	evidence	1	PMID:37435539	SUPPORT		Skin histopathology demonstrates the overactivation of innate immunity, such as neutrophilic dermatitis/panniculitis, in patients with BD.	Histopathological evidence confirms neutrophil overactivation in Behcet's disease skin lesions, demonstrating the pathologic role of neutrophils in tissue inflammation.	"{""explanation"": ""Histopathological evidence confirms neutrophil overactivation in Behcet's disease skin lesions, demonstrating the pathologic role of neutrophils in tissue inflammation."", ""reference"": ""PMID:37435539"", ""snippet"": ""Skin histopathology demonstrates the overactivation of innate immunity, such as neutrophilic dermatitis/panniculitis, in patients with BD."", ""supports"": ""SUPPORT""}"
1374	1031	42	Behcet's Disease	Behcets_Disease.yaml	pathophysiology	2	evidence	0	PMID:38778397	SUPPORT		Adaptive immune system disturbance, including homeostatic perturbations, Th1, Th17 overaction, and Treg cell dysfunction, is thought to be involved in BU pathogenesis.	This review describes the imbalance between pro-inflammatory Th1/Th17 responses and regulatory T cell dysfunction as central to Behcet's uveitis pathogenesis, supporting the role of cytokine imbalance in disease progression.	"{""explanation"": ""This review describes the imbalance between pro-inflammatory Th1/Th17 responses and regulatory T cell dysfunction as central to Behcet's uveitis pathogenesis, supporting the role of cytokine imbalance in disease progression."", ""reference"": ""PMID:38778397"", ""snippet"": ""Adaptive immune system disturbance, including homeostatic perturbations, Th1, Th17 overaction, and Treg cell dysfunction, is thought to be involved in BU pathogenesis."", ""supports"": ""SUPPORT""}"
1384	1056	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	0	evidence	0	PMID:38654277	SUPPORT		Proliferative nodular formation represents a characteristic pathological feature of benign prostatic hyperplasia (BPH) and serves as the primary cause for prostate volume enlargement and consequent lower urinary tract symptoms (LUTS).	This evidence confirms that proliferative nodular formation in the transition zone is the primary pathological feature driving BPH symptoms.	"{""explanation"": ""This evidence confirms that proliferative nodular formation in the transition zone is the primary pathological feature driving BPH symptoms."", ""reference"": ""PMID:38654277"", ""snippet"": ""Proliferative nodular formation represents a characteristic pathological feature of benign prostatic hyperplasia (BPH) and serves as the primary cause for prostate volume enlargement and consequent lower urinary tract symptoms (LUTS)."", ""supports"": ""SUPPORT""}"
1385	1058	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	2	evidence	0	PMID:37827216	SUPPORT		Benign prostate hyperplasia (BPH) is caused by the nonmalignant enlargement of the transition zone of the prostate gland, leading to lower urinary tract symptoms.	This evidence supports that BPH-related enlargement causes lower urinary tract symptoms through bladder outlet obstruction and detrusor dysfunction.	"{""explanation"": ""This evidence supports that BPH-related enlargement causes lower urinary tract symptoms through bladder outlet obstruction and detrusor dysfunction."", ""reference"": ""PMID:37827216"", ""snippet"": ""Benign prostate hyperplasia (BPH) is caused by the nonmalignant enlargement of the transition zone of the prostate gland, leading to lower urinary tract symptoms."", ""supports"": ""SUPPORT""}"
1386	1060	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	4	evidence	0	PMID:38654277	SUPPORT		A distinct subgroup of basal epithelial (BE) cells, referred to as BE5, was identified to play a crucial role in driving this progression through the hypoxia-induced epithelial-mesenchymal transition (EMT) signaling pathway.	This evidence identifies BE5 cells as key drivers of BPH through hypoxia-induced EMT, establishing a molecular mechanism for nodular formation.	"{""explanation"": ""This evidence identifies BE5 cells as key drivers of BPH through hypoxia-induced EMT, establishing a molecular mechanism for nodular formation."", ""reference"": ""PMID:38654277"", ""snippet"": ""A distinct subgroup of basal epithelial (BE) cells, referred to as BE5, was identified to play a crucial role in driving this progression through the hypoxia-induced epithelial-mesenchymal transition (EMT) signaling pathway."", ""supports"": ""SUPPORT""}"
1387	1061	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	5	evidence	0	PMID:38711089	SUPPORT		The aberrant activation of transforming growth factor β (TGF-β)/Rho kinase 1 (ROCK1) increased the stemness of BPH tissue by recruiting mesenchymal stem cells (MSCs), indicating the important role of embryonic reawakening in BPH.	This evidence demonstrates that TGF-beta/ROCK1 activation drives prostatic stromal hyperplasia through MSC recruitment and differentiation.	"{""explanation"": ""This evidence demonstrates that TGF-beta/ROCK1 activation drives prostatic stromal hyperplasia through MSC recruitment and differentiation."", ""reference"": ""PMID:38711089"", ""snippet"": ""The aberrant activation of transforming growth factor β (TGF-β)/Rho kinase 1 (ROCK1) increased the stemness of BPH tissue by recruiting mesenchymal stem cells (MSCs), indicating the important role of embryonic reawakening in BPH."", ""supports"": ""SUPPORT""}"
1388	1061	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	5	evidence	1	PMID:39455522	SUPPORT		ROCK1 and ROCK2 were significantly up-regulated in BPH tissues, correlating with clinical parameters.	This evidence confirms upregulation of ROCK1/2 in human BPH tissues and their correlation with disease severity.	"{""explanation"": ""This evidence confirms upregulation of ROCK1/2 in human BPH tissues and their correlation with disease severity."", ""reference"": ""PMID:39455522"", ""snippet"": ""ROCK1 and ROCK2 were significantly up-regulated in BPH tissues, correlating with clinical parameters."", ""supports"": ""SUPPORT""}"
1389	1062	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	6	evidence	0	PMID:39455522	SUPPORT		ROCK downregulation inhibited the β-catenin signaling pathway (such as C-MYC, Snail and Survivin) and decreased β-catenin protein stability, while inhibiting TGF-β/Smad2/3 signaling.	This evidence shows ROCK signaling converges on beta-catenin pathway to drive BPH pathophysiology, providing a therapeutic target.	"{""explanation"": ""This evidence shows ROCK signaling converges on beta-catenin pathway to drive BPH pathophysiology, providing a therapeutic target."", ""reference"": ""PMID:39455522"", ""snippet"": ""ROCK downregulation inhibited the β-catenin signaling pathway (such as C-MYC, Snail and Survivin) and decreased β-catenin protein stability, while inhibiting TGF-β/Smad2/3 signaling."", ""supports"": ""SUPPORT""}"
1390	1063	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	7	evidence	0	PMID:37827216	SUPPORT		Pb-PRL mouse prostates exhibited increased vulnerability to oxidative stress due to reduction of antioxidant enzyme expression. One-month treatment of Pb-PRL mice with anethole trithione (ATT), a specific inhibitor of mitochondrial ROS production, reduced prostate weight and voiding frequency.	This evidence demonstrates that oxidative stress contributes to BPH progression and that antioxidant therapy can reduce prostate enlargement and symptoms.	"{""explanation"": ""This evidence demonstrates that oxidative stress contributes to BPH progression and that antioxidant therapy can reduce prostate enlargement and symptoms."", ""reference"": ""PMID:37827216"", ""snippet"": ""Pb-PRL mouse prostates exhibited increased vulnerability to oxidative stress due to reduction of antioxidant enzyme expression. One-month treatment of Pb-PRL mice with anethole trithione (ATT), a specific inhibitor of mitochondrial ROS production, reduced prostate weight and voiding frequency."", ""supports"": ""SUPPORT""}"
1391	1064	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	pathophysiology	8	evidence	0	PMID:38764065	SUPPORT		P. gingivalis infection promoted prostate cell proliferation, inhibited apoptosis, and upregulated the expression of inflammatory cytokines interleukin-6 (IL-6; 4.47-fold), interleukin-6 receptor-α (IL-6Rα; 5.74-fold) and glycoprotein 130 (gp130; 4.47-fold) in prostatic tissue.	This evidence links oral-prostate inflammation to BPH progression through IL-6/IL-6R/gp130-mediated Akt signaling, representing a novel pathophysiological axis.	"{""explanation"": ""This evidence links oral-prostate inflammation to BPH progression through IL-6/IL-6R/gp130-mediated Akt signaling, representing a novel pathophysiological axis."", ""reference"": ""PMID:38764065"", ""snippet"": ""P. gingivalis infection promoted prostate cell proliferation, inhibited apoptosis, and upregulated the expression of inflammatory cytokines interleukin-6 (IL-6; 4.47-fold), interleukin-6 receptor-α (IL-6Rα; 5.74-fold) and glycoprotein 130 (gp130; 4.47-fold) in prostatic tissue."", ""supports"": ""SUPPORT""}"
1397	1083	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	pathophysiology	0	evidence	0	PMID:32847582	SUPPORT		a rare lysosomal storage disorder named beta-mannosidosis whose clinical manifestation includes deafness and mental retardation	Confirms that beta-mannosidosis is a lysosomal storage disorder with neurological and auditory manifestations.	"{""explanation"": ""Confirms that beta-mannosidosis is a lysosomal storage disorder with neurological and auditory manifestations."", ""reference"": ""PMID:32847582"", ""snippet"": ""a rare lysosomal storage disorder named beta-mannosidosis whose clinical manifestation includes deafness and mental retardation"", ""supports"": ""SUPPORT""}"
1403	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	evidence	0	PMID:22363263	SUPPORT		Activation of the dopamine receptor 2 (D2R) has been shown to stimulate the inactivation of Akt by PP2A (Beaulieu et al., 2005; Beaulieu and Gainetdinov, 2011), therefore providing a mechanism through which GPCR activation can inhibit Akt in response to extracellular signals.	Dopamine D2 receptor signaling regulates the Akt/GSK3 pathway, providing a molecular link between monoaminergic neurotransmission and mood regulation in bipolar disorder.	"{""explanation"": ""Dopamine D2 receptor signaling regulates the Akt/GSK3 pathway, providing a molecular link between monoaminergic neurotransmission and mood regulation in bipolar disorder."", ""reference"": ""PMID:22363263"", ""snippet"": ""Activation of the dopamine receptor 2 (D2R) has been shown to stimulate the inactivation of Akt by PP2A (Beaulieu et al., 2005; Beaulieu and Gainetdinov, 2011), therefore providing a mechanism through which GPCR activation can inhibit Akt in response to extracellular signals."", ""supports"": ""SUPPORT""}"
1404	1103	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	0	evidence	1	PMID:22363263	SUPPORT		This mechanism of D2R signaling appears to play important roles in the regulation of locomotor behavior and sensory motor gating by dopamine (Beaulieu et al., 2004; Emamian et al., 2004). It could also contribute to the therapeutic and/or adverse effects of psychoactive drugs like amphetamines and antpsychotics that act on dopamine neurotransmission	The D2 receptor-mediated regulation of GSK3 activity through beta-arrestin signaling is implicated in behavioral regulation relevant to bipolar disorder and the mechanism of mood stabilizers and antipsychotics.	"{""explanation"": ""The D2 receptor-mediated regulation of GSK3 activity through beta-arrestin signaling is implicated in behavioral regulation relevant to bipolar disorder and the mechanism of mood stabilizers and antipsychotics."", ""reference"": ""PMID:22363263"", ""snippet"": ""This mechanism of D2R signaling appears to play important roles in the regulation of locomotor behavior and sensory motor gating by dopamine (Beaulieu et al., 2004; Emamian et al., 2004). It could also contribute to the therapeutic and/or adverse effects of psychoactive drugs like amphetamines and antpsychotics that act on dopamine neurotransmission"", ""supports"": ""SUPPORT""}"
1405	1104	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	1	evidence	0	PMID:30285728	SUPPORT		Psychiatric disorders (such as bipolar disorder, depression, and schizophrenia) affect the lives of millions of individuals worldwide.	This review discusses the molecular mechanisms underlying psychiatric disorders including bipolar disorder, with focus on the DISC1/GSK3 complex which regulates mitochondrial and cellular functions.	"{""explanation"": ""This review discusses the molecular mechanisms underlying psychiatric disorders including bipolar disorder, with focus on the DISC1/GSK3 complex which regulates mitochondrial and cellular functions."", ""reference"": ""PMID:30285728"", ""snippet"": ""Psychiatric disorders (such as bipolar disorder, depression, and schizophrenia) affect the lives of millions of individuals worldwide."", ""supports"": ""SUPPORT""}"
1406	1105	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	2	evidence	0	PMID:22363263	SUPPORT		For more than 60 years, the mood stabilizer lithium has been used alone or in combination for the treatment of bipolar disorder, schizophrenia, depression, and other mental illnesses.	This comprehensive review discusses lithium as the gold standard treatment for bipolar disorder, noting its mood-stabilizing effects through GSK3 inhibition which affects multiple cellular pathways including circadian regulation.	"{""explanation"": ""This comprehensive review discusses lithium as the gold standard treatment for bipolar disorder, noting its mood-stabilizing effects through GSK3 inhibition which affects multiple cellular pathways including circadian regulation."", ""reference"": ""PMID:22363263"", ""snippet"": ""For more than 60 years, the mood stabilizer lithium has been used alone or in combination for the treatment of bipolar disorder, schizophrenia, depression, and other mental illnesses."", ""supports"": ""SUPPORT""}"
1407	1106	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	3	evidence	0	PMID:30285728	SUPPORT		DISC1 binds directly to GSK3 and modulates many cellular functions by negatively inhibiting GSK3 activity.	GSK3 inhibition by DISC1 and mood stabilizers like lithium is a key mechanism in bipolar disorder treatment, affecting synaptic plasticity and neuronal survival pathways.	"{""explanation"": ""GSK3 inhibition by DISC1 and mood stabilizers like lithium is a key mechanism in bipolar disorder treatment, affecting synaptic plasticity and neuronal survival pathways."", ""reference"": ""PMID:30285728"", ""snippet"": ""DISC1 binds directly to GSK3 and modulates many cellular functions by negatively inhibiting GSK3 activity."", ""supports"": ""SUPPORT""}"
1408	1106	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	3	evidence	1	PMID:30285728	SUPPORT		In the present review, we will focus on the emerging roles of TRAX and its interacting proteins (including DISC1 and GSK3β) in psychiatric disorders and the potential implications for developing therapeutic interventions.	The TRAX/DISC1/GSK3β complex is implicated in psychiatric disorders including bipolar disorder and represents a therapeutic target for enhancing neuroplasticity.	"{""explanation"": ""The TRAX/DISC1/GSK3β complex is implicated in psychiatric disorders including bipolar disorder and represents a therapeutic target for enhancing neuroplasticity."", ""reference"": ""PMID:30285728"", ""snippet"": ""In the present review, we will focus on the emerging roles of TRAX and its interacting proteins (including DISC1 and GSK3β) in psychiatric disorders and the potential implications for developing therapeutic interventions."", ""supports"": ""SUPPORT""}"
1409	1107	46	Bipolar Disorder	Bipolar_Disorder.yaml	pathophysiology	4	evidence	0	PMID:33958577	SUPPORT		considering that schizophrenia is a multifactorial and highly polygenic disorder that shares many risk genes with other psychiatric illnesses including bipolar disorder, depression, intellectual disability and autism spectrum disorders, it is to be expected that these diseases may also share some of these same mechanisms	Microglial activation and inflammatory processes are shared pathophysiological mechanisms across psychiatric disorders including bipolar disorder, contributing to synaptic dysfunction.	"{""explanation"": ""Microglial activation and inflammatory processes are shared pathophysiological mechanisms across psychiatric disorders including bipolar disorder, contributing to synaptic dysfunction."", ""reference"": ""PMID:33958577"", ""snippet"": ""considering that schizophrenia is a multifactorial and highly polygenic disorder that shares many risk genes with other psychiatric illnesses including bipolar disorder, depression, intellectual disability and autism spectrum disorders, it is to be expected that these diseases may also share some of these same mechanisms"", ""supports"": ""SUPPORT""}"
1447	1145	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	0	evidence	0	DOI:10.3390/ijms24032884	SUPPORT	MODEL_ORGANISM	Bird-related hypersensitivity pneumonitis (BRHP) is an interstitial lung disease induced by avian proteins.	The review defines BRHP as an avian protein-induced interstitial lung disease.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The review defines BRHP as an avian protein-induced interstitial lung disease."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Bird-related hypersensitivity pneumonitis (BRHP) is an interstitial lung disease induced by avian proteins."", ""supports"": ""SUPPORT""}"
1448	1145	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	0	evidence	1	PMID:39958101	SUPPORT	HUMAN_CLINICAL	Bird fancier's lung (BFL) is a subtype of hypersensitivity pneumonitis (HP), an immune-mediated interstitial lung disease (ILD) resulting from the repeated inhalation of avian proteins found in bird droppings, feathers, and serum.	The case report links BFL to repeated inhalation of avian proteins as the causative trigger for interstitial lung disease.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report links BFL to repeated inhalation of avian proteins as the causative trigger for interstitial lung disease."", ""reference"": ""PMID:39958101"", ""snippet"": ""Bird fancier's lung (BFL) is a subtype of hypersensitivity pneumonitis (HP), an immune-mediated interstitial lung disease (ILD) resulting from the repeated inhalation of avian proteins found in bird droppings, feathers, and serum."", ""supports"": ""SUPPORT""}"
1449	1145	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	0	evidence	2	PMID:33318919	SUPPORT	HUMAN_CLINICAL	Bird Fancier's Lung is a type of hypersensitivity pneumonitis, an immunologically mediated lung disease due to repetitive exposure of air-borne avian antigen.	The report characterizes BFL as an immune-mediated interstitial lung disease driven by repetitive avian antigen exposure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The report characterizes BFL as an immune-mediated interstitial lung disease driven by repetitive avian antigen exposure."", ""reference"": ""PMID:33318919"", ""snippet"": ""Bird Fancier's Lung is a type of hypersensitivity pneumonitis, an immunologically mediated lung disease due to repetitive exposure of air-borne avian antigen."", ""supports"": ""SUPPORT""}"
1450	1146	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	1	evidence	0	DOI:10.3390/ijms24032884	SUPPORT	MODEL_ORGANISM	Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups.	The mouse model reports increased resident monocytes, interstitial macrophages, and type 2 dendritic cells after bird antigen exposure.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The mouse model reports increased resident monocytes, interstitial macrophages, and type 2 dendritic cells after bird antigen exposure."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups."", ""supports"": ""SUPPORT""}"
1451	1147	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	2	evidence	0	DOI:10.3390/ijms24032884	SUPPORT	MODEL_ORGANISM	Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups.	The same experiment reports reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The same experiment reports reduced inflammatory monocytes, alveolar macrophages, and tolerogenic dendritic cells."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups."", ""supports"": ""SUPPORT""}"
1452	1148	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	3	evidence	0	DOI:10.3390/ijms24032884	SUPPORT	MODEL_ORGANISM	In the first stages of BRHP, there is a mixed Th1/Th2 immune response, while during the progression of the disease, although there is a Th1 response, the cytokine levels seem to indicate a switch towards a Th2/Th17 mixed response.	The cytokine profile indicates a stage-dependent shift toward Th2/Th17 responses during disease progression.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The cytokine profile indicates a stage-dependent shift toward Th2/Th17 responses during disease progression."", ""reference"": ""DOI:10.3390/ijms24032884"", ""snippet"": ""In the first stages of BRHP, there is a mixed Th1/Th2 immune response, while during the progression of the disease, although there is a Th1 response, the cytokine levels seem to indicate a switch towards a Th2/Th17 mixed response."", ""supports"": ""SUPPORT""}"
1453	1149	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	4	evidence	0	PMID:33041192	SUPPORT	HUMAN_CLINICAL	The levels of sIgG/sIgA against the bird antigens of the three species were significantly higher in subjects with acute bird-related HP and chronic bird-related HP with acute episodes (recurrent type) than in the control subjects.	Elevated bird-specific IgG/IgA in affected patients supports a humoral immune response to avian antigens.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Elevated bird-specific IgG/IgA in affected patients supports a humoral immune response to avian antigens."", ""reference"": ""PMID:33041192"", ""snippet"": ""The levels of sIgG/sIgA against the bird antigens of the three species were significantly higher in subjects with acute bird-related HP and chronic bird-related HP with acute episodes (recurrent type) than in the control subjects."", ""supports"": ""SUPPORT""}"
1454	1150	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	5	evidence	0	PMID:33041192	SUPPORT	HUMAN_CLINICAL	We executed a clinical performance test by conducting a multi-institutional study to measure the levels of sIgG/sIgA against pigeon, parrot and budgerigar antigens by the ImmunoCAP® system in 29 acute and 46 chronic bird-related HP patients.	The study explicitly lists pigeon, parrot, and budgerigar antigens as the species used in standardized antibody testing for bird-related HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study explicitly lists pigeon, parrot, and budgerigar antigens as the species used in standardized antibody testing for bird-related HP."", ""reference"": ""PMID:33041192"", ""snippet"": ""We executed a clinical performance test by conducting a multi-institutional study to measure the levels of sIgG/sIgA against pigeon, parrot and budgerigar antigens by the ImmunoCAP® system in 29 acute and 46 chronic bird-related HP patients."", ""supports"": ""SUPPORT""}"
1455	1151	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	6	evidence	0	PMID:38924775	SUPPORT	HUMAN_CLINICAL	Compared with control samples, FHP has elevated classical monocytes (adjusted-P = 2.5 × 10-3) and is enriched in CCL3hi/CCL4hi and S100Ahi classical monocytes (adjusted-P < 2.2 × 10-16).	Single-cell profiling identifies enriched classical monocyte states in fibrotic HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Single-cell profiling identifies enriched classical monocyte states in fibrotic HP."", ""reference"": ""PMID:38924775"", ""snippet"": ""Compared with control samples, FHP has elevated classical monocytes (adjusted-P = 2.5 × 10-3) and is enriched in CCL3hi/CCL4hi and S100Ahi classical monocytes (adjusted-P < 2.2 × 10-16)."", ""supports"": ""SUPPORT""}"
1456	1152	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	7	evidence	0	PMID:38924775	SUPPORT	HUMAN_CLINICAL	Trajectory analyses demonstrate that S100Ahi classical monocytes differentiate into SPP1hi lung macrophages associated with fibrosis.	Trajectory analyses link classical monocytes to profibrotic macrophages in fibrotic HP.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Trajectory analyses link classical monocytes to profibrotic macrophages in fibrotic HP."", ""reference"": ""PMID:38924775"", ""snippet"": ""Trajectory analyses demonstrate that S100Ahi classical monocytes differentiate into SPP1hi lung macrophages associated with fibrosis."", ""supports"": ""SUPPORT""}"
1457	1153	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	8	evidence	0	PMID:38924775	SUPPORT	HUMAN_CLINICAL	Compared with both control subjects and IPF, cells from patients with FHP are significantly enriched in GZMhi cytotoxic T cells. These cells exhibit TF activities indicative of TGFβ and TNFα and NFκB pathways.	Cytotoxic T cell enrichment with profibrotic signaling programs supports a T cell-driven inflammatory mechanism.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cytotoxic T cell enrichment with profibrotic signaling programs supports a T cell-driven inflammatory mechanism."", ""reference"": ""PMID:38924775"", ""snippet"": ""Compared with both control subjects and IPF, cells from patients with FHP are significantly enriched in GZMhi cytotoxic T cells. These cells exhibit TF activities indicative of TGFβ and TNFα and NFκB pathways."", ""supports"": ""SUPPORT""}"
1458	1154	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	9	evidence	0	PMID:38218353	SUPPORT	MODEL_ORGANISM	we identified MMP14high macrophage subcluster with a predominant M2 phenotype that exhibited higher activity in promoting fibroblast-to myofibroblast transition (FMT).	The study identifies a macrophage subset driving fibroblast-to-myofibroblast transition, a key fibrotic remodeling process.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The study identifies a macrophage subset driving fibroblast-to-myofibroblast transition, a key fibrotic remodeling process."", ""reference"": ""PMID:38218353"", ""snippet"": ""we identified MMP14high macrophage subcluster with a predominant M2 phenotype that exhibited higher activity in promoting fibroblast-to myofibroblast transition (FMT)."", ""supports"": ""SUPPORT""}"
1459	1155	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	pathophysiology	10	evidence	0	PMID:38218353	SUPPORT	MODEL_ORGANISM	We demonstrated that suppressing toll-like receptor 2 (TLR2) and nuclear factor kappa-B (NF-κB) could attenuate MMP14 expression and exosome secretion in macrophages stimulation with SR-Ag.	The abstract links TLR2/NF-κB signaling to MMP14 regulation and exosome secretion in HP macrophages.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The abstract links TLR2/NF-κB signaling to MMP14 regulation and exosome secretion in HP macrophages."", ""reference"": ""PMID:38218353"", ""snippet"": ""We demonstrated that suppressing toll-like receptor 2 (TLR2) and nuclear factor kappa-B (NF-κB) could attenuate MMP14 expression and exosome secretion in macrophages stimulation with SR-Ag."", ""supports"": ""SUPPORT""}"
1481	1171	48	Botulism	Botulism.yaml	pathophysiology	0	evidence	0	PMID:31157190	SUPPORT		Botulism is rare neuroparalytic disease caused by botulinum toxin, one of the most toxic substances known.	The abstract identifies botulinum toxin as the cause of the neuroparalytic disease.	"{""explanation"": ""The abstract identifies botulinum toxin as the cause of the neuroparalytic disease."", ""reference"": ""PMID:31157190"", ""snippet"": ""Botulism is rare neuroparalytic disease caused by botulinum toxin, one of the most toxic substances known."", ""supports"": ""SUPPORT""}"
1482	1172	48	Botulism	Botulism.yaml	pathophysiology	1	evidence	0	PMID:8331029	SUPPORT	IN_VITRO	Clostridium botulinum type toxin A (BoTx) blocks stimulus-induced acetylcholine (ACh) release from presynaptic nerve terminals at peripheral neuromuscular junctions.	The abstract reports botulinum toxin inhibition of acetylcholine release at neuromuscular junctions.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""The abstract reports botulinum toxin inhibition of acetylcholine release at neuromuscular junctions."", ""reference"": ""PMID:8331029"", ""snippet"": ""Clostridium botulinum type toxin A (BoTx) blocks stimulus-induced acetylcholine (ACh) release from presynaptic nerve terminals at peripheral neuromuscular junctions."", ""supports"": ""SUPPORT""}"
1486	1176	49	Breast Fibroadenoma	Breast_Fibroadenoma.yaml	pathophysiology	0	evidence	0	PMID:11270760	SUPPORT		Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women.	The abstract describes fibroadenoma as a common benign breast lump.	"{""explanation"": ""The abstract describes fibroadenoma as a common benign breast lump."", ""reference"": ""PMID:11270760"", ""snippet"": ""Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women."", ""supports"": ""SUPPORT""}"
1492	1226	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	0	evidence	0	PMID:40893393	SUPPORT		Burkitt lymphoma (BL) is an aggressive B-cell malignancy characterized by rapid progression and MYC gene translocations.	This abstract directly identifies MYC translocations as a defining feature of Burkitt lymphoma.	"{""explanation"": ""This abstract directly identifies MYC translocations as a defining feature of Burkitt lymphoma."", ""reference"": ""PMID:40893393"", ""snippet"": ""Burkitt lymphoma (BL) is an aggressive B-cell malignancy characterized by rapid progression and MYC gene translocations."", ""supports"": ""SUPPORT""}"
1493	1226	51	Burkitt Lymphoma	Burkitt_Lymphoma.yaml	pathophysiology	0	evidence	1	PMID:1301171	SUPPORT		In about 80% of Burkitt's lymphoma cases, the tumour cell harbours a reciprocal chromosomal translocation which invariably transposes the coding exons 2 and 3 of c-myc from chromosome 8 to the immunoglobulin heavy chain locus on chromosome 14.	Abstract reports MYC translocation to immunoglobulin loci in most Burkitt lymphoma cases.	"{""explanation"": ""Abstract reports MYC translocation to immunoglobulin loci in most Burkitt lymphoma cases."", ""reference"": ""PMID:1301171"", ""snippet"": ""In about 80% of Burkitt's lymphoma cases, the tumour cell harbours a reciprocal chromosomal translocation which invariably transposes the coding exons 2 and 3 of c-myc from chromosome 8 to the immunoglobulin heavy chain locus on chromosome 14."", ""supports"": ""SUPPORT""}"
1495	1241	52	Buruli ulcer	Buruli_Ulcer.yaml	pathophysiology	0	evidence	0	PMID:30429139	SUPPORT		Mycobacterium ulcerans produces a mycolactone toxin that leads to subcutaneous tissue destruction and immunosuppression, resulting in deep ulcerations	The abstract links mycolactone to tissue destruction and ulceration.	"{""explanation"": ""The abstract links mycolactone to tissue destruction and ulceration."", ""reference"": ""PMID:30429139"", ""snippet"": ""Mycobacterium ulcerans produces a mycolactone toxin that leads to subcutaneous tissue destruction and immunosuppression, resulting in deep ulcerations"", ""supports"": ""SUPPORT""}"
1503	1246	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	0	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss. Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate.	Establishes PIGL mutations as the cause of CHIME syndrome and describes the gene's role in GPI anchor biosynthesis.	"{""explanation"": ""Establishes PIGL mutations as the cause of CHIME syndrome and describes the gene's role in GPI anchor biosynthesis."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss. Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate."", ""supports"": ""SUPPORT""}"
1504	1247	53	CHIME_syndrome	CHIME_syndrome.yaml	pathophysiology	1	evidence	0	PMID:22444671	SUPPORT		Furthermore, cell lines derived from these cases had significantly reduced levels of the two GPI anchor markers, CD59 and a GPI-binding toxin, aerolysin (FLAER), confirming the pathogenicity of the mutations.	Demonstrates functional consequences of PIGL mutations showing reduced GPI anchor markers in patient cells.	"{""explanation"": ""Demonstrates functional consequences of PIGL mutations showing reduced GPI anchor markers in patient cells."", ""reference"": ""PMID:22444671"", ""snippet"": ""Furthermore, cell lines derived from these cases had significantly reduced levels of the two GPI anchor markers, CD59 and a GPI-binding toxin, aerolysin (FLAER), confirming the pathogenicity of the mutations."", ""supports"": ""SUPPORT""}"
1517	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	evidence	0	PMID:23746550	SUPPORT		Our findings indicate that haploinsufficiency of CTCF affects genomic interaction of enhancers and their regulated gene promoters that drive developmental processes and cognition.	Original discovery paper establishing that CTCF haploinsufficiency disrupts enhancer-promoter interactions critical for development and cognition.	"{""explanation"": ""Original discovery paper establishing that CTCF haploinsufficiency disrupts enhancer-promoter interactions critical for development and cognition."", ""reference"": ""PMID:23746550"", ""snippet"": ""Our findings indicate that haploinsufficiency of CTCF affects genomic interaction of enhancers and their regulated gene promoters that drive developmental processes and cognition."", ""supports"": ""SUPPORT""}"
1518	1267	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	0	evidence	1	PMID:31239556	SUPPORT		Our extensive follow-up study does not indicate any clear correlation between nature and location of variants and clinical presentation. Furthermore, differentially expressed genes significantly overlapped between individuals with either missense or LGD variants	Large cohort study demonstrating that both missense and loss-of-function variants lead to similar functional consequences, supporting haploinsufficiency as the disease mechanism.	"{""explanation"": ""Large cohort study demonstrating that both missense and loss-of-function variants lead to similar functional consequences, supporting haploinsufficiency as the disease mechanism."", ""reference"": ""PMID:31239556"", ""snippet"": ""Our extensive follow-up study does not indicate any clear correlation between nature and location of variants and clinical presentation. Furthermore, differentially expressed genes significantly overlapped between individuals with either missense or LGD variants"", ""supports"": ""SUPPORT""}"
1519	1268	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	1	evidence	0	PMID:38951485	SUPPORT		it specifically hinders CTCF binding to peripheral motifs upstream to the core consensus site, causing alterations in local chromatin structure and gene expression, particularly at the clustered protocadherin locus	The R567W mutation causes specific chromatin structure alterations and dysregulation of protocadherin genes important for neuronal connectivity.	"{""explanation"": ""The R567W mutation causes specific chromatin structure alterations and dysregulation of protocadherin genes important for neuronal connectivity."", ""reference"": ""PMID:38951485"", ""snippet"": ""it specifically hinders CTCF binding to peripheral motifs upstream to the core consensus site, causing alterations in local chromatin structure and gene expression, particularly at the clustered protocadherin locus"", ""supports"": ""SUPPORT""}"
1520	1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	evidence	0	PMID:31239556	SUPPORT		RNA-sequencing in five individuals identified 3828 deregulated genes enriched for known NDD genes and biological processes such as transcriptional regulation	Transcriptome analysis shows broad dysregulation of genes including those implicated in neurodevelopmental disorders.	"{""explanation"": ""Transcriptome analysis shows broad dysregulation of genes including those implicated in neurodevelopmental disorders."", ""reference"": ""PMID:31239556"", ""snippet"": ""RNA-sequencing in five individuals identified 3828 deregulated genes enriched for known NDD genes and biological processes such as transcriptional regulation"", ""supports"": ""SUPPORT""}"
1521	1269	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	2	evidence	1	PMID:23746550	SUPPORT		Transcriptome analyses in all three individuals with point mutations revealed deregulation of genes involved in signal transduction and emphasized the role of CTCF in enhancer-driven expression of genes.	Initial transcriptome analysis showed CTCF mutations cause deregulation of signal transduction genes.	"{""explanation"": ""Initial transcriptome analysis showed CTCF mutations cause deregulation of signal transduction genes."", ""reference"": ""PMID:23746550"", ""snippet"": ""Transcriptome analyses in all three individuals with point mutations revealed deregulation of genes involved in signal transduction and emphasized the role of CTCF in enhancer-driven expression of genes."", ""supports"": ""SUPPORT""}"
1522	1270	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	pathophysiology	3	evidence	0	PMID:38951485	SUPPORT		This mutation induces premature stem-like cell exhaustion, accelerates the maturation of GABAergic neurons, and disrupts neurodevelopmental and synaptic pathways.	Mouse model and human organoid studies show the R567W mutation causes premature neural progenitor depletion and accelerated GABAergic neuron maturation.	"{""explanation"": ""Mouse model and human organoid studies show the R567W mutation causes premature neural progenitor depletion and accelerated GABAergic neuron maturation."", ""reference"": ""PMID:38951485"", ""snippet"": ""This mutation induces premature stem-like cell exhaustion, accelerates the maturation of GABAergic neurons, and disrupts neurodevelopmental and synaptic pathways."", ""supports"": ""SUPPORT""}"
1541	1299	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	1	evidence	0	PMID:21531865	SUPPORT		A missense mutation in MYH3 (a gene coding for the heavy chain of myosin), causing an F437I amino acid substitution, was identified that segregated with distal arthrogryposis in this family.	Demonstrates MYH3 mutations causing distal arthrogryposis with contractures, linking sarcomeric protein dysfunction to congenital joint contractures.	"{""explanation"": ""Demonstrates MYH3 mutations causing distal arthrogryposis with contractures, linking sarcomeric protein dysfunction to congenital joint contractures."", ""reference"": ""PMID:21531865"", ""snippet"": ""A missense mutation in MYH3 (a gene coding for the heavy chain of myosin), causing an F437I amino acid substitution, was identified that segregated with distal arthrogryposis in this family."", ""supports"": ""SUPPORT""}"
1542	1300	55	Camptodactyly	Camptodactyly.yaml	pathophysiology	2	evidence	0	PMID:29397575	SUPPORT		CACP is caused by mutations in the proteoglycan 4 (PRG4) gene, which encodes a lubricating glycoprotein present in the synovial fluid and at the surface of articular cartilage.	Documents PRG4 as the causative gene for CACP syndrome, encoding lubricin present in synovial fluid and cartilage surfaces.	"{""explanation"": ""Documents PRG4 as the causative gene for CACP syndrome, encoding lubricin present in synovial fluid and cartilage surfaces."", ""reference"": ""PMID:29397575"", ""snippet"": ""CACP is caused by mutations in the proteoglycan 4 (PRG4) gene, which encodes a lubricating glycoprotein present in the synovial fluid and at the surface of articular cartilage."", ""supports"": ""SUPPORT""}"
1551	1318	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:16439621	SUPPORT	HUMAN_CLINICAL	heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF	Landmark Science paper establishing that CFC syndrome is caused by de novo mutations in MAPK pathway genes, with BRAF as the predominant causative gene.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark Science paper establishing that CFC syndrome is caused by de novo mutations in MAPK pathway genes, with BRAF as the predominant causative gene."", ""reference"": ""PMID:16439621"", ""snippet"": ""heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF"", ""supports"": ""SUPPORT""}"
1555	1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	evidence	0	PMID:10684852	SUPPORT		tissue transglutaminase (tTG)-mediated deamidation of gliadin plays an important role in recognition of this food antigen by intestinal T cells	Demonstrates the critical role of tTG deamidation in converting gluten peptides into immunogenic epitopes recognized by T cells in celiac disease.	"{""explanation"": ""Demonstrates the critical role of tTG deamidation in converting gluten peptides into immunogenic epitopes recognized by T cells in celiac disease."", ""reference"": ""PMID:10684852"", ""snippet"": ""tissue transglutaminase (tTG)-mediated deamidation of gliadin plays an important role in recognition of this food antigen by intestinal T cells"", ""supports"": ""SUPPORT""}"
1556	1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	evidence	1	PMID:10684852	SUPPORT		the deamidated peptides displayed an increased affinity for DQ2, a molecule known to preferentially bind peptides containing negatively charged residues	Shows how tTG deamidation increases HLA-DQ2 binding affinity by introducing negatively charged glutamate residues, enhancing antigen presentation.	"{""explanation"": ""Shows how tTG deamidation increases HLA-DQ2 binding affinity by introducing negatively charged glutamate residues, enhancing antigen presentation."", ""reference"": ""PMID:10684852"", ""snippet"": ""the deamidated peptides displayed an increased affinity for DQ2, a molecule known to preferentially bind peptides containing negatively charged residues"", ""supports"": ""SUPPORT""}"
1557	1345	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	0	evidence	2	PMID:38914866	SUPPORT		Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates antigenic presentation and a strong anti-gluten T cell response.	Confirms TG2 deamidation as the pivotal mechanism enabling gluten peptide presentation and T cell activation in celiac disease pathogenesis.	"{""explanation"": ""Confirms TG2 deamidation as the pivotal mechanism enabling gluten peptide presentation and T cell activation in celiac disease pathogenesis."", ""reference"": ""PMID:38914866"", ""snippet"": ""Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates antigenic presentation and a strong anti-gluten T cell response."", ""supports"": ""SUPPORT""}"
1558	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	evidence	0	PMID:38914866	SUPPORT		Nearly half of the gluten-induced gene expression changes in CeD were associated with the epithelial interferon-γ response.	Demonstrates that IFN-gamma signaling drives a major portion of the transcriptional changes underlying epithelial damage in celiac disease.	"{""explanation"": ""Demonstrates that IFN-gamma signaling drives a major portion of the transcriptional changes underlying epithelial damage in celiac disease."", ""reference"": ""PMID:38914866"", ""snippet"": ""Nearly half of the gluten-induced gene expression changes in CeD were associated with the epithelial interferon-γ response."", ""supports"": ""SUPPORT""}"
1559	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	evidence	1	PMID:15357947	SUPPORT		under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells	Shows how IL-15 converts intraepithelial CD8+ T cells into cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating epithelial damage.	"{""explanation"": ""Shows how IL-15 converts intraepithelial CD8+ T cells into cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating epithelial damage."", ""reference"": ""PMID:15357947"", ""snippet"": ""under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells"", ""supports"": ""SUPPORT""}"
1560	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	evidence	2	PMID:24942692	SUPPORT		the upregulation of IL-15 expression in the intestinal mucosa has become a hallmark of the disease	Identifies IL-15 upregulation as a defining feature of celiac disease that drives intraepithelial lymphocyte expansion and epithelial injury.	"{""explanation"": ""Identifies IL-15 upregulation as a defining feature of celiac disease that drives intraepithelial lymphocyte expansion and epithelial injury."", ""reference"": ""PMID:24942692"", ""snippet"": ""the upregulation of IL-15 expression in the intestinal mucosa has become a hallmark of the disease"", ""supports"": ""SUPPORT""}"
1561	1346	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	1	evidence	3	PMID:38914866	SUPPORT		ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group.	Provides interventional evidence that blocking TG2-mediated T cell activation prevents the downstream epithelial damage, villous atrophy, and malabsorption.	"{""explanation"": ""Provides interventional evidence that blocking TG2-mediated T cell activation prevents the downstream epithelial damage, villous atrophy, and malabsorption."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}"
1562	1347	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	2	evidence	0	PMID:39273359	SUPPORT		"Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed ""gluten"", in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."	Describes the immune-mediated nature of celiac disease, which includes both cellular and humoral (antibody) responses to gluten antigens.	"{""explanation"": ""Describes the immune-mediated nature of celiac disease, which includes both cellular and humoral (antibody) responses to gluten antigens."", ""reference"": ""PMID:39273359"", ""snippet"": ""Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed \""gluten\"", in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."", ""supports"": ""SUPPORT""}"
1563	1348	57	Celiac Disease	Celiac_Disease.yaml	pathophysiology	3	evidence	0	PMID:38914866	SUPPORT		ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group.	Blocking TG2 prevents gluten-induced disruption of epithelial barrier integrity and differentiation programs, indicating barrier dysfunction is downstream of adaptive immune activation.	"{""explanation"": ""Blocking TG2 prevents gluten-induced disruption of epithelial barrier integrity and differentiation programs, indicating barrier dysfunction is downstream of adaptive immune activation."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}"
1570	1385	59	Chagas disease	Chagas_Disease.yaml	pathophysiology	0	evidence	0	PMID:18512345	SUPPORT		Metacyclic trypomastigotes promptly invade host cells (including gastric mucosa) and once free in the cytoplasm, differentiate into amastigotes that replicate by binary fission.	The abstract describes intracellular invasion and amastigote replication.	"{""explanation"": ""The abstract describes intracellular invasion and amastigote replication."", ""reference"": ""PMID:18512345"", ""snippet"": ""Metacyclic trypomastigotes promptly invade host cells (including gastric mucosa) and once free in the cytoplasm, differentiate into amastigotes that replicate by binary fission."", ""supports"": ""SUPPORT""}"
1669	1426	61	Cholera	Cholera.yaml	pathophysiology	3	evidence	0	PMID:8783505	SUPPORT		Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells... CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells.	The statement is supported by the information that cholera toxin (CT) from Vibrio cholerae activates the adenylate cyclase-cAMP system in intestinal epithelial cells.	"{""explanation"": ""The statement is supported by the information that cholera toxin (CT) from Vibrio cholerae activates the adenylate cyclase-cAMP system in intestinal epithelial cells."", ""reference"": ""PMID:8783505"", ""snippet"": ""Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells... CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells."", ""supports"": ""SUPPORT""}"
1670	1426	61	Cholera	Cholera.yaml	pathophysiology	3	evidence	1	PMID:30624615	SUPPORT		Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR).	The statement is supported as it describes CT inducing diarrhea through cAMP-mediated mechanisms.	"{""explanation"": ""The statement is supported as it describes CT inducing diarrhea through cAMP-mediated mechanisms."", ""reference"": ""PMID:30624615"", ""snippet"": ""Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."", ""supports"": ""SUPPORT""}"
1671	1426	61	Cholera	Cholera.yaml	pathophysiology	3	evidence	2	PMID:4364505	SUPPORT		Comparable results were also obtained when cholera toxin was used. The degree of enzyme stimulation was proportional to the concentration of enterotoxin.	This further confirms that cholera toxin stimulates adenylate cyclase activity in cells.	"{""explanation"": ""This further confirms that cholera toxin stimulates adenylate cyclase activity in cells."", ""reference"": ""PMID:4364505"", ""snippet"": ""Comparable results were also obtained when cholera toxin was used. The degree of enzyme stimulation was proportional to the concentration of enterotoxin."", ""supports"": ""SUPPORT""}"
1672	1426	61	Cholera	Cholera.yaml	pathophysiology	3	evidence	3	PMID:8817767	SUPPORT		V cholerae, the representative noninvasive pathogen, has fimbrial adhesins that mediate attachment and colonization... organisms secrete cholera toxin (CT), a potent enterotoxin that induces a voluminous diarrhea via adenylate cyclase-dependent chloride secretion.	This literature confirms that cholera toxin induces diarrhea by acting on the adenylate cyclase system in the intestinal epithelial cells, resulting in elevated cAMP levels.	"{""explanation"": ""This literature confirms that cholera toxin induces diarrhea by acting on the adenylate cyclase system in the intestinal epithelial cells, resulting in elevated cAMP levels."", ""reference"": ""PMID:8817767"", ""snippet"": ""V cholerae, the representative noninvasive pathogen, has fimbrial adhesins that mediate attachment and colonization... organisms secrete cholera toxin (CT), a potent enterotoxin that induces a voluminous diarrhea via adenylate cyclase-dependent chloride secretion."", ""supports"": ""SUPPORT""}"
1673	1427	61	Cholera	Cholera.yaml	pathophysiology	4	evidence	0	PMID:23651092	SUPPORT		Increased intracellular cAMP in human intestinal epithelial cells accounts for pathogenesis of profuse diarrhea and severe fluid loss in cholera	This reference directly supports the statement by confirming that elevated cAMP levels in intestinal epithelial cells lead to the secretion of fluid, resulting in profuse diarrhea, which aligns with the described pathophysiology.	"{""explanation"": ""This reference directly supports the statement by confirming that elevated cAMP levels in intestinal epithelial cells lead to the secretion of fluid, resulting in profuse diarrhea, which aligns with the described pathophysiology."", ""reference"": ""PMID:23651092"", ""snippet"": ""Increased intracellular cAMP in human intestinal epithelial cells accounts for pathogenesis of profuse diarrhea and severe fluid loss in cholera"", ""supports"": ""SUPPORT""}"
1674	1427	61	Cholera	Cholera.yaml	pathophysiology	4	evidence	1	PMID:30624615	SUPPORT		Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR).	This reference supports the statement by explaining that CT-induced diarrhea involves cAMP-mediated chloride secretion, leading to diarrhea.	"{""explanation"": ""This reference supports the statement by explaining that CT-induced diarrhea involves cAMP-mediated chloride secretion, leading to diarrhea."", ""reference"": ""PMID:30624615"", ""snippet"": ""Cholera toxin (CT)-induced diarrhea is mediated by cyclic adenosine monophosphate (cAMP)-mediated active Cl- secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)."", ""supports"": ""SUPPORT""}"
1675	1427	61	Cholera	Cholera.yaml	pathophysiology	4	evidence	2	PMID:80378	PARTIAL		Cholera toxin causes net secretion of fluid into the small intestine of weanling pigs, and secretory rates are dependent on the dose of the toxin placed in intestinal loops.	While this study supports that cholera toxin leads to fluid secretion, it notes that net fluid fluxes did not always correlate with total mucosal cAMP concentrations in pigs. Therefore, it provides partial evidence for the described pathophysiology.	"{""explanation"": ""While this study supports that cholera toxin leads to fluid secretion, it notes that net fluid fluxes did not always correlate with total mucosal cAMP concentrations in pigs. Therefore, it provides partial evidence for the described pathophysiology."", ""reference"": ""PMID:80378"", ""snippet"": ""Cholera toxin causes net secretion of fluid into the small intestine of weanling pigs, and secretory rates are dependent on the dose of the toxin placed in intestinal loops."", ""supports"": ""PARTIAL""}"
1676	1428	61	Cholera	Cholera.yaml	pathophysiology	5	evidence	0	PMID:14738797	SUPPORT		Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.	The statement describes the loss of large volumes of fluids and electrolytes through diarrhea, leading to severe dehydration and hypovolemic shock, which aligns with the literature.	"{""explanation"": ""The statement describes the loss of large volumes of fluids and electrolytes through diarrhea, leading to severe dehydration and hypovolemic shock, which aligns with the literature."", ""reference"": ""PMID:14738797"", ""snippet"": ""Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."", ""supports"": ""SUPPORT""}"
1677	1428	61	Cholera	Cholera.yaml	pathophysiology	5	evidence	1	PMID:15367740	SUPPORT		A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.	The literature describes large fluid losses and severe dehydration due to cholera, supporting the statement's explanation of pathophysiology.	"{""explanation"": ""The literature describes large fluid losses and severe dehydration due to cholera, supporting the statement's explanation of pathophysiology."", ""reference"": ""PMID:15367740"", ""snippet"": ""A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."", ""supports"": ""SUPPORT""}"
1678	1428	61	Cholera	Cholera.yaml	pathophysiology	5	evidence	2	PMID:28448489	SUPPORT		To take advantage of emerging opportunities to reduce morbidity and mortality from diarrheal disease, we need to better understand the determinants of life-threatening severe dehydration (SD) in resource-poor settings.	The text mentions severe dehydration as a key issue in the pathophysiology of cholera.	"{""explanation"": ""The text mentions severe dehydration as a key issue in the pathophysiology of cholera."", ""reference"": ""PMID:28448489"", ""snippet"": ""To take advantage of emerging opportunities to reduce morbidity and mortality from diarrheal disease, we need to better understand the determinants of life-threatening severe dehydration (SD) in resource-poor settings."", ""supports"": ""SUPPORT""}"
1679	1428	61	Cholera	Cholera.yaml	pathophysiology	5	evidence	3	PMID:34523840	SUPPORT		A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting... which is typical for cholera and can amount to 1000 cc/hour.	This literature supports the rapid loss of fluids through profuse watery diarrhea leading to severe dehydration, consistent with the pathophysiology described.	"{""explanation"": ""This literature supports the rapid loss of fluids through profuse watery diarrhea leading to severe dehydration, consistent with the pathophysiology described."", ""reference"": ""PMID:34523840"", ""snippet"": ""A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting... which is typical for cholera and can amount to 1000 cc/hour."", ""supports"": ""SUPPORT""}"
1680	1428	61	Cholera	Cholera.yaml	pathophysiology	5	evidence	4	PMID:38702080	SUPPORT		The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%).	This literature mentions severe dehydration and electrolyte imbalance as common complications, supporting the statement regarding the pathophysiology of cholera.	"{""explanation"": ""This literature mentions severe dehydration and electrolyte imbalance as common complications, supporting the statement regarding the pathophysiology of cholera."", ""reference"": ""PMID:38702080"", ""snippet"": ""The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%)."", ""supports"": ""SUPPORT""}"
1778	1473	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	0	evidence	0	PMID:37356965	SUPPORT		Autoimmune neuropathies are a heterogeneous group of rare and disabling diseases in which the immune system is thought to target antigens in the peripheral nervous system: they usually respond to immune therapies.	This pathology review confirms that CIDP involves immune-mediated targeting of peripheral nerve antigens, supporting the role of adaptive immunity including T cell responses in disease pathogenesis.	"{""explanation"": ""This pathology review confirms that CIDP involves immune-mediated targeting of peripheral nerve antigens, supporting the role of adaptive immunity including T cell responses in disease pathogenesis."", ""reference"": ""PMID:37356965"", ""snippet"": ""Autoimmune neuropathies are a heterogeneous group of rare and disabling diseases in which the immune system is thought to target antigens in the peripheral nervous system: they usually respond to immune therapies."", ""supports"": ""SUPPORT""}"
1779	1474	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	1	evidence	0	PMID:35378684	SUPPORT		The complement system appears to play a role in promoting macrophage-mediated demyelination.	This review establishes the role of complement activation in CIDP pathogenesis, linking complement to the amplification of macrophage-mediated nerve damage.	"{""explanation"": ""This review establishes the role of complement activation in CIDP pathogenesis, linking complement to the amplification of macrophage-mediated nerve damage."", ""reference"": ""PMID:35378684"", ""snippet"": ""The complement system appears to play a role in promoting macrophage-mediated demyelination."", ""supports"": ""SUPPORT""}"
1780	1474	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	1	evidence	1	PMID:36346134	SUPPORT		Besides IgG4, subclass IgG3 was detected and associated with complement binding and cytotoxic effects in vitro.	Experimental evidence showing that IgG3 subclass antibodies activate complement, demonstrating complement-mediated pathogenic mechanisms in autoantibody-positive CIDP.	"{""explanation"": ""Experimental evidence showing that IgG3 subclass antibodies activate complement, demonstrating complement-mediated pathogenic mechanisms in autoantibody-positive CIDP."", ""reference"": ""PMID:36346134"", ""snippet"": ""Besides IgG4, subclass IgG3 was detected and associated with complement binding and cytotoxic effects in vitro."", ""supports"": ""SUPPORT""}"
1781	1475	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	2	evidence	0	PMID:37356965	SUPPORT		In contrast, the mechanisms of demyelination of other dysimmune neuropathies induced by macrophages are unexplained, as no antibodies have been identified in such cases.	This pathology review acknowledges macrophage-induced demyelination as a distinct mechanism in CIDP, occurring even in cases without identified autoantibodies, supporting the role of innate immune responses independent of antibody-mediated damage.	"{""explanation"": ""This pathology review acknowledges macrophage-induced demyelination as a distinct mechanism in CIDP, occurring even in cases without identified autoantibodies, supporting the role of innate immune responses independent of antibody-mediated damage."", ""reference"": ""PMID:37356965"", ""snippet"": ""In contrast, the mechanisms of demyelination of other dysimmune neuropathies induced by macrophages are unexplained, as no antibodies have been identified in such cases."", ""supports"": ""SUPPORT""}"
1782	1475	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	pathophysiology	2	evidence	1	PMID:36645654	SUPPORT		The proposed mechanisms of action of IVIg that can mediate its therapeutic effects are reviewed. These include anti-idiotypic interactions, inhibition of neonatal Fc receptors (FcRn), anti-complement activity, upregulation of inhibitory FcγRIIB receptors, and downregulation of macrophage activation.	IVIg therapy works in part by downregulating macrophage activation, providing indirect evidence that macrophages play a central pathogenic role in CIDP that can be therapeutically targeted.	"{""explanation"": ""IVIg therapy works in part by downregulating macrophage activation, providing indirect evidence that macrophages play a central pathogenic role in CIDP that can be therapeutically targeted."", ""reference"": ""PMID:36645654"", ""snippet"": ""The proposed mechanisms of action of IVIg that can mediate its therapeutic effects are reviewed. These include anti-idiotypic interactions, inhibition of neonatal Fc receptors (FcRn), anti-complement activity, upregulation of inhibitory FcγRIIB receptors, and downregulation of macrophage activation."", ""supports"": ""SUPPORT""}"
1784	1499	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	0	evidence	0	PMID:38653563	SUPPORT		Patients diagnosed with AKI often undergo diverse clinical trajectories, such as early or late recovery, relapses, and even a potential transition from AKI to chronic kidney disease (CKD).	This describes how acute injury leads to progressive nephron loss and CKD transition, supporting the concept that initial damage triggers compensatory mechanisms that accelerate further injury.	"{""explanation"": ""This describes how acute injury leads to progressive nephron loss and CKD transition, supporting the concept that initial damage triggers compensatory mechanisms that accelerate further injury."", ""reference"": ""PMID:38653563"", ""snippet"": ""Patients diagnosed with AKI often undergo diverse clinical trajectories, such as early or late recovery, relapses, and even a potential transition from AKI to chronic kidney disease (CKD)."", ""supports"": ""SUPPORT""}"
1785	1499	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	0	evidence	1	PMID:38339031	SUPPORT		This article provides a thorough overview of the biomarkers, pathophysiology, and molecular pathways involved in the transition from acute kidney injury (AKI) and acute kidney disease (AKD) to chronic kidney disease (CKD).	The transition from AKI to CKD involves progressive nephron loss with maladaptive repair mechanisms that drive ongoing damage and fibrosis.	"{""explanation"": ""The transition from AKI to CKD involves progressive nephron loss with maladaptive repair mechanisms that drive ongoing damage and fibrosis."", ""reference"": ""PMID:38339031"", ""snippet"": ""This article provides a thorough overview of the biomarkers, pathophysiology, and molecular pathways involved in the transition from acute kidney injury (AKI) and acute kidney disease (AKD) to chronic kidney disease (CKD)."", ""supports"": ""SUPPORT""}"
1786	1500	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	1	evidence	0	PMID:38610646	SUPPORT		Chronic kidney disease (CKD) is a slowly progressive condition characterized by decreased kidney function, tubular injury, oxidative stress, and inflammation.	This describes the inflammatory and oxidative stress components that drive glomerulosclerosis alongside hemodynamic factors.	"{""explanation"": ""This describes the inflammatory and oxidative stress components that drive glomerulosclerosis alongside hemodynamic factors."", ""reference"": ""PMID:38610646"", ""snippet"": ""Chronic kidney disease (CKD) is a slowly progressive condition characterized by decreased kidney function, tubular injury, oxidative stress, and inflammation."", ""supports"": ""SUPPORT""}"
1787	1500	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	1	evidence	1	PMID:37857763	SUPPORT		Reactive oxygen species (ROS) are derivatives of oxygen molecules that are generated during aerobic metabolism and are involved in a variety of cellular functions that are governed by redox conditions.	ROS generation contributes to oxidative stress and metabolic factors that drive glomerular scarring and impaired filtration.	"{""explanation"": ""ROS generation contributes to oxidative stress and metabolic factors that drive glomerular scarring and impaired filtration."", ""reference"": ""PMID:37857763"", ""snippet"": ""Reactive oxygen species (ROS) are derivatives of oxygen molecules that are generated during aerobic metabolism and are involved in a variety of cellular functions that are governed by redox conditions."", ""supports"": ""SUPPORT""}"
1788	1501	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	2	evidence	0	PMID:38610646	SUPPORT		Transforming growth factor (TGF)-β is a central mediator in promoting transdifferentiation of polarized renal tubular epithelial cells into mesenchymal cells, resulting in irreversible kidney injury.	This supports the mechanism of fibrotic replacement where TGF-β drives transdifferentiation of tubular epithelial cells, leading to fibrosis and irreversible injury.	"{""explanation"": ""This supports the mechanism of fibrotic replacement where TGF-β drives transdifferentiation of tubular epithelial cells, leading to fibrosis and irreversible injury."", ""reference"": ""PMID:38610646"", ""snippet"": ""Transforming growth factor (TGF)-β is a central mediator in promoting transdifferentiation of polarized renal tubular epithelial cells into mesenchymal cells, resulting in irreversible kidney injury."", ""supports"": ""SUPPORT""}"
1789	1501	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	2	evidence	1	PMID:38339031	SUPPORT		Key signaling pathways, such as Wnt/β-catenin, TGF-β/SMAD, and Hippo/YAP/TAZ, promote fibrosis and impact renal function.	This confirms that TGF-β/SMAD and other pathways drive fibrotic processes that characterize the final common pathway of CKD progression.	"{""explanation"": ""This confirms that TGF-β/SMAD and other pathways drive fibrotic processes that characterize the final common pathway of CKD progression."", ""reference"": ""PMID:38339031"", ""snippet"": ""Key signaling pathways, such as Wnt/β-catenin, TGF-β/SMAD, and Hippo/YAP/TAZ, promote fibrosis and impact renal function."", ""supports"": ""SUPPORT""}"
1790	1502	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	3	evidence	0	PMID:38339031	SUPPORT		The renin-angiotensin-aldosterone system (RAAS) triggers a cascade leading to renal fibrosis, with aldosterone exacerbating the oxidative stress and cellular changes that promote fibrosis.	This directly supports the mechanism by which RAAS activation promotes fibrosis through aldosterone-mediated oxidative stress and cellular injury in CKD.	"{""explanation"": ""This directly supports the mechanism by which RAAS activation promotes fibrosis through aldosterone-mediated oxidative stress and cellular injury in CKD."", ""reference"": ""PMID:38339031"", ""snippet"": ""The renin-angiotensin-aldosterone system (RAAS) triggers a cascade leading to renal fibrosis, with aldosterone exacerbating the oxidative stress and cellular changes that promote fibrosis."", ""supports"": ""SUPPORT""}"
1791	1502	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	pathophysiology	3	evidence	1	PMID:38610646	SUPPORT		Current therapies such as renin-angiotensin blockers, mineralocorticoid receptor antagonists, and sodium/glucose cotransporter 2 inhibitors aim to delay progression.	The therapeutic efficacy of RAAS blockers confirms that RAAS activation is a key driver of CKD progression, supporting its role in promoting hypertension and fibrosis.	"{""explanation"": ""The therapeutic efficacy of RAAS blockers confirms that RAAS activation is a key driver of CKD progression, supporting its role in promoting hypertension and fibrosis."", ""reference"": ""PMID:38610646"", ""snippet"": ""Current therapies such as renin-angiotensin blockers, mineralocorticoid receptor antagonists, and sodium/glucose cotransporter 2 inhibitors aim to delay progression."", ""supports"": ""SUPPORT""}"
1800	1550	66	Chronic Myeloid Leukemia, BCR-ABL1 Positive	Chronic_Myeloid_Leukemia.yaml	pathophysiology	0	evidence	0	PMID:11287972	SUPPORT		BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML.	This landmark paper establishes that BCR-ABL is a constitutively activated tyrosine kinase that causes CML, directly supporting the pathophysiology description.	"{""explanation"": ""This landmark paper establishes that BCR-ABL is a constitutively activated tyrosine kinase that causes CML, directly supporting the pathophysiology description."", ""reference"": ""PMID:11287972"", ""snippet"": ""BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML."", ""supports"": ""SUPPORT""}"
1837	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:39046133	SUPPORT		Chronic exposure to smoking and noxious particles or gases induces inflammation and remodeling, leading to airway obstruction and SAD, eventually resulting in complete airway loss.	This 2024 review establishes that chronic inflammation and remodeling cause irreversible airflow limitation and progressive respiratory decline in COPD.	"{""explanation"": ""This 2024 review establishes that chronic inflammation and remodeling cause irreversible airflow limitation and progressive respiratory decline in COPD."", ""reference"": ""PMID:39046133"", ""snippet"": ""Chronic exposure to smoking and noxious particles or gases induces inflammation and remodeling, leading to airway obstruction and SAD, eventually resulting in complete airway loss."", ""supports"": ""SUPPORT""}"
1838	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	evidence	0	PMID:23204254	SUPPORT		CB is caused by overproduction and hypersecretion of mucus by goblet cells, which leads to worsening airflow obstruction by luminal obstruction of small airways, epithelial remodeling, and alteration of airway surface tension predisposing to collapse	This study describes how mucus build-up and epithelial remodeling lead to airflow obstruction in COPD.	"{""explanation"": ""This study describes how mucus build-up and epithelial remodeling lead to airflow obstruction in COPD."", ""reference"": ""PMID:23204254"", ""snippet"": ""CB is caused by overproduction and hypersecretion of mucus by goblet cells, which leads to worsening airflow obstruction by luminal obstruction of small airways, epithelial remodeling, and alteration of airway surface tension predisposing to collapse"", ""supports"": ""SUPPORT""}"
1839	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	evidence	1	PMID:36108172	PARTIAL		Phenotypic alterations in the lung epithelium have been widely implicated in chronic obstructive pulmonary disease (COPD) pathogenesis, but the precise mechanisms orchestrating this persistent inflammatory process remain unknown.	This study notes the involvement of epithelial cells in COPD but states that mechanisms remain unknown, partially supporting the role of epithelial cells in airflow obstruction.	"{""explanation"": ""This study notes the involvement of epithelial cells in COPD but states that mechanisms remain unknown, partially supporting the role of epithelial cells in airflow obstruction."", ""reference"": ""PMID:36108172"", ""snippet"": ""Phenotypic alterations in the lung epithelium have been widely implicated in chronic obstructive pulmonary disease (COPD) pathogenesis, but the precise mechanisms orchestrating this persistent inflammatory process remain unknown."", ""supports"": ""PARTIAL""}"
1840	1584	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	0	evidence	2	PMID:38625125	SUPPORT		Chronic exposure to environmental hazards causes airway epithelial dysfunction, primarily impaired physical barriers, immune dysfunction, and repair or regeneration. Impairment of airway epithelial function subsequently leads to exaggerated airway inflammation and remodeling, the main features of chronic obstructive pulmonary disease (COPD).	This study supports the statement by highlighting the role of epithelial dysfunction, inflammation, and remodeling in COPD pathophysiology.	"{""explanation"": ""This study supports the statement by highlighting the role of epithelial dysfunction, inflammation, and remodeling in COPD pathophysiology."", ""reference"": ""PMID:38625125"", ""snippet"": ""Chronic exposure to environmental hazards causes airway epithelial dysfunction, primarily impaired physical barriers, immune dysfunction, and repair or regeneration. Impairment of airway epithelial function subsequently leads to exaggerated airway inflammation and remodeling, the main features of chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1841	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	evidence	0	PMID:17305517	SUPPORT		Neutrophils and macrophages have been implicated in this process; they release proteolytic enzymes and generate oxidants, which cause tissue damage, as well as cytokines and chemokines, which can potentiate inflammation and trigger an immune response.	The literature describes the involvement of neutrophils, macrophages, and T-lymphocytes in the inflammatory process associated with COPD, supporting the notion of persistent irritation and chronic inflammation.	"{""explanation"": ""The literature describes the involvement of neutrophils, macrophages, and T-lymphocytes in the inflammatory process associated with COPD, supporting the notion of persistent irritation and chronic inflammation."", ""reference"": ""PMID:17305517"", ""snippet"": ""Neutrophils and macrophages have been implicated in this process; they release proteolytic enzymes and generate oxidants, which cause tissue damage, as well as cytokines and chemokines, which can potentiate inflammation and trigger an immune response."", ""supports"": ""SUPPORT""}"
1842	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	evidence	1	PMID:24507838	SUPPORT		This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation.	This article further substantiates the involvement of these cell types (neutrophils, macrophages, and T-lymphocytes) in the pathophysiology of COPD, linking them to chronic inflammation.	"{""explanation"": ""This article further substantiates the involvement of these cell types (neutrophils, macrophages, and T-lymphocytes) in the pathophysiology of COPD, linking them to chronic inflammation."", ""reference"": ""PMID:24507838"", ""snippet"": ""This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation."", ""supports"": ""SUPPORT""}"
1843	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	evidence	2	PMID:38035712	SUPPORT		In this study, we found that neutrophilic phenotype (NP, 58.0%) was the most common airway inflammation phenotype in patients with COPD, followed by mixed granulocytic phenotype (MGP, 32.6%).	The study indicates that neutrophils are predominant in COPD, supporting the statement about chronic inflammation.	"{""explanation"": ""The study indicates that neutrophils are predominant in COPD, supporting the statement about chronic inflammation."", ""reference"": ""PMID:38035712"", ""snippet"": ""In this study, we found that neutrophilic phenotype (NP, 58.0%) was the most common airway inflammation phenotype in patients with COPD, followed by mixed granulocytic phenotype (MGP, 32.6%)."", ""supports"": ""SUPPORT""}"
1844	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	evidence	3	PMID:38891820	SUPPORT		Recent multiomics-based evidence suggests that the plasticity of alveolar macrophages contributes to the onset and progression of COPD through the coordinated modulation of numerous transcription factors.	The article highlights the role of macrophages in the pathogenesis and progression of COPD, thus supporting the statement.	"{""explanation"": ""The article highlights the role of macrophages in the pathogenesis and progression of COPD, thus supporting the statement."", ""reference"": ""PMID:38891820"", ""snippet"": ""Recent multiomics-based evidence suggests that the plasticity of alveolar macrophages contributes to the onset and progression of COPD through the coordinated modulation of numerous transcription factors."", ""supports"": ""SUPPORT""}"
1845	1585	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	1	evidence	4	PMID:11993785	PARTIAL		The characteristic changes in the central airways include inflammatory cellular infiltration into the airway wall and mucous gland enlargement.	This reference provides a broader overview of the pathological changes in COPD, mentioning inflammatory cells but not specifically detailing the involvement of neutrophils, macrophages, and T-lymphocytes.	"{""explanation"": ""This reference provides a broader overview of the pathological changes in COPD, mentioning inflammatory cells but not specifically detailing the involvement of neutrophils, macrophages, and T-lymphocytes."", ""reference"": ""PMID:11993785"", ""snippet"": ""The characteristic changes in the central airways include inflammatory cellular infiltration into the airway wall and mucous gland enlargement."", ""supports"": ""PARTIAL""}"
1846	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	evidence	0	PMID:20500603	SUPPORT		Moreover, airway remodelling occurs not only in asthma but also in several pulmonary disorders such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and systemic sclerosis.	The statement aligns with the mentioned literature which notes airway remodeling as part of chronic obstructive pulmonary disease.	"{""explanation"": ""The statement aligns with the mentioned literature which notes airway remodeling as part of chronic obstructive pulmonary disease."", ""reference"": ""PMID:20500603"", ""snippet"": ""Moreover, airway remodelling occurs not only in asthma but also in several pulmonary disorders such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and systemic sclerosis."", ""supports"": ""SUPPORT""}"
1847	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	evidence	1	PMID:30257694	SUPPORT		Multiple dysfunctions of ASM contribute to modulating airway responses to stimuli, remodeling, and fibrosis, as well as influence the compliance of lungs.	The statement is supported as this literature highlights the role of airway smooth muscle cells in airway remodeling and fibrosis in COPD.	"{""explanation"": ""The statement is supported as this literature highlights the role of airway smooth muscle cells in airway remodeling and fibrosis in COPD."", ""reference"": ""PMID:30257694"", ""snippet"": ""Multiple dysfunctions of ASM contribute to modulating airway responses to stimuli, remodeling, and fibrosis, as well as influence the compliance of lungs."", ""supports"": ""SUPPORT""}"
1848	1586	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	2	evidence	2	PMID:15347849	SUPPORT		Increases in airway smooth muscle mass occur in large airways of severe asthmatics and in small airways of patients with COPD.	The literature supports the statement by confirming the involvement of smooth muscle cells and structural changes in the airways in COPD.	"{""explanation"": ""The literature supports the statement by confirming the involvement of smooth muscle cells and structural changes in the airways in COPD."", ""reference"": ""PMID:15347849"", ""snippet"": ""Increases in airway smooth muscle mass occur in large airways of severe asthmatics and in small airways of patients with COPD."", ""supports"": ""SUPPORT""}"
1849	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	evidence	0	PMID:11993785	PARTIAL		In the lung parenchyma, emphysema defined as alveolar destruction and airspace enlargement is present.	While the reference supports alveolar destruction as part of COPD's pathophysiology, it does not mention alveolar macrophages specifically.	"{""explanation"": ""While the reference supports alveolar destruction as part of COPD's pathophysiology, it does not mention alveolar macrophages specifically."", ""reference"": ""PMID:11993785"", ""snippet"": ""In the lung parenchyma, emphysema defined as alveolar destruction and airspace enlargement is present."", ""supports"": ""PARTIAL""}"
1850	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	evidence	1	PMID:29433833	PARTIAL		In inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD), despite their increased numbers, macrophages demonstrate significantly reduced phagocytic capacity of bacteria and apoptotic cells.	The macrophages' role in the pathophysiology of COPD is discussed, focusing on their reduced phagocytic capacity rather than direct alveolar destruction.	"{""explanation"": ""The macrophages' role in the pathophysiology of COPD is discussed, focusing on their reduced phagocytic capacity rather than direct alveolar destruction."", ""reference"": ""PMID:29433833"", ""snippet"": ""In inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD), despite their increased numbers, macrophages demonstrate significantly reduced phagocytic capacity of bacteria and apoptotic cells."", ""supports"": ""PARTIAL""}"
1851	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	evidence	2	PMID:32493486	PARTIAL		External insults like smoke and pollution can disturb surfactant homeostasis and result in either surfactant insufficiency or accumulation. But disruption of surfactant homeostasis is also observed in many chronic adult diseases, including chronic obstructive pulmonary disease (COPD).	The role of alveolar macrophages (responsible for the degradation of surfactant) in the development of COPD is mentioned, but no direct link to alveolar destruction.	"{""explanation"": ""The role of alveolar macrophages (responsible for the degradation of surfactant) in the development of COPD is mentioned, but no direct link to alveolar destruction."", ""reference"": ""PMID:32493486"", ""snippet"": ""External insults like smoke and pollution can disturb surfactant homeostasis and result in either surfactant insufficiency or accumulation. But disruption of surfactant homeostasis is also observed in many chronic adult diseases, including chronic obstructive pulmonary disease (COPD)."", ""supports"": ""PARTIAL""}"
1852	1587	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	pathophysiology	3	evidence	3	PMID:24707174	PARTIAL		There are eight types of EMPs which are defined by the presence of different endothelial markers on the cell membrane: vascular endothelial-cadherin; platelet endothelial cell adhesion molecule; melanoma cell adhesion molecule; E-selectin; CD51; CD105; von Willebrand factor; and CD143 EMPs.	The reference discusses endothelial injury and microparticles in COPD, which may indirectly relate to alveolar destruction, but does not directly address it or the role of alveolar macrophages.	"{""explanation"": ""The reference discusses endothelial injury and microparticles in COPD, which may indirectly relate to alveolar destruction, but does not directly address it or the role of alveolar macrophages."", ""reference"": ""PMID:24707174"", ""snippet"": ""There are eight types of EMPs which are defined by the presence of different endothelial markers on the cell membrane: vascular endothelial-cadherin; platelet endothelial cell adhesion molecule; melanoma cell adhesion molecule; E-selectin; CD51; CD105; von Willebrand factor; and CD143 EMPs."", ""supports"": ""PARTIAL""}"
1917	1628	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	0	evidence	0	PMID:23622130	SUPPORT		Pancreatic ductal adenocarcinoma is a devastating disease, and patient outcomes have not improved in decades.	"This paper discusses pancreatic stellate cells and their role in pancreatic pathology. While focused on cancer, the stellate cell activation mechanisms are shared with chronic pancreatitis and support the inflammatory injury cascade.
"	"{""explanation"": ""This paper discusses pancreatic stellate cells and their role in pancreatic pathology. While focused on cancer, the stellate cell activation mechanisms are shared with chronic pancreatitis and support the inflammatory injury cascade.\n"", ""reference"": ""PMID:23622130"", ""snippet"": ""Pancreatic ductal adenocarcinoma is a devastating disease, and patient outcomes have not improved in decades."", ""supports"": ""SUPPORT""}"
1918	1629	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	1	evidence	0	PMID:23622130	SUPPORT		There is compelling in vitro and in vivo evidence for the influence of pancreatic stellate cells on pancreatic cancer development; several recent preclinical studies have reported encouraging results with approaches designed to target pancreatic stellate cells and the stroma.	"Pancreatic stellate cells are the key drivers of fibrosis in chronic pancreatitis. This review discusses how activated stellate cells produce the stromal matrix that characterizes pancreatic fibrosis, a central feature of chronic pancreatitis progression.
"	"{""explanation"": ""Pancreatic stellate cells are the key drivers of fibrosis in chronic pancreatitis. This review discusses how activated stellate cells produce the stromal matrix that characterizes pancreatic fibrosis, a central feature of chronic pancreatitis progression.\n"", ""reference"": ""PMID:23622130"", ""snippet"": ""There is compelling in vitro and in vivo evidence for the influence of pancreatic stellate cells on pancreatic cancer development; several recent preclinical studies have reported encouraging results with approaches designed to target pancreatic stellate cells and the stroma."", ""supports"": ""SUPPORT""}"
1919	1630	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	2	evidence	0	PMID:30074926	SUPPORT		Exocrine pancreatic insufficiency was diagnosed in 84.6% (77/91) of patients based on symptoms of bloating, steatorrhea, or weight loss.	High prevalence of exocrine pancreatic insufficiency (84.6%) in chronic pancreatitis patients, manifesting as bloating, steatorrhea, or weight loss.	"{""explanation"": ""High prevalence of exocrine pancreatic insufficiency (84.6%) in chronic pancreatitis patients, manifesting as bloating, steatorrhea, or weight loss."", ""reference"": ""PMID:30074926"", ""snippet"": ""Exocrine pancreatic insufficiency was diagnosed in 84.6% (77/91) of patients based on symptoms of bloating, steatorrhea, or weight loss."", ""supports"": ""SUPPORT""}"
1920	1630	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	2	evidence	1	PMID:30074926	SUPPORT		There is a high prevalence of fat-soluble vitamin deficiencies, osteopathy, and malnutrition in CP patients, which is underestimated due to a lack of effective diagnosis and suboptimal therapies for EPI.	EPI leads to significant complications including vitamin deficiencies (35-62% prevalence) and osteopathy (68.9% with osteopenia/osteoporosis).	"{""explanation"": ""EPI leads to significant complications including vitamin deficiencies (35-62% prevalence) and osteopathy (68.9% with osteopenia/osteoporosis)."", ""reference"": ""PMID:30074926"", ""snippet"": ""There is a high prevalence of fat-soluble vitamin deficiencies, osteopathy, and malnutrition in CP patients, which is underestimated due to a lack of effective diagnosis and suboptimal therapies for EPI."", ""supports"": ""SUPPORT""}"
1921	1631	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	pathophysiology	3	evidence	0	PMID:28404095	SUPPORT		The most commonly identified causes of type 3c diabetes are chronic pancreatitis, pancreatic ductal adenocarcinoma, haemochromatosis, cystic fibrosis, and previous pancreatic surgery.	Chronic pancreatitis is the leading cause of type 3c diabetes, confirming that endocrine insufficiency develops as a consequence of pancreatic damage.	"{""explanation"": ""Chronic pancreatitis is the leading cause of type 3c diabetes, confirming that endocrine insufficiency develops as a consequence of pancreatic damage."", ""reference"": ""PMID:28404095"", ""snippet"": ""The most commonly identified causes of type 3c diabetes are chronic pancreatitis, pancreatic ductal adenocarcinoma, haemochromatosis, cystic fibrosis, and previous pancreatic surgery."", ""supports"": ""SUPPORT""}"
1938	1652	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	0	evidence	0	PMID:37085424	SUPPORT		These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1	This comprehensive review confirms VHL as the primary genomic biomarker and driver mutation in ccRCC.	"{""explanation"": ""This comprehensive review confirms VHL as the primary genomic biomarker and driver mutation in ccRCC."", ""reference"": ""PMID:37085424"", ""snippet"": ""These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1"", ""supports"": ""SUPPORT""}"
1939	1656	69	Clear Cell Renal Cell Carcinoma	Clear_Cell_Renal_Cell_Carcinoma.yaml	pathophysiology	4	evidence	0	PMID:37085424	SUPPORT		These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1	This review confirms PBRM1, SETD2, and BAP1 as recurrent genomic biomarkers in ccRCC contributing to epigenetic dysregulation.	"{""explanation"": ""This review confirms PBRM1, SETD2, and BAP1 as recurrent genomic biomarkers in ccRCC contributing to epigenetic dysregulation."", ""reference"": ""PMID:37085424"", ""snippet"": ""These include somatic gene mutations such as VHL, PBRM1, SETD2, and BAP1"", ""supports"": ""SUPPORT""}"
1941	1672	70	Clear Cell Sarcoma	Clear_Cell_Sarcoma.yaml	pathophysiology	0	evidence	0	PMID:9793401	SUPPORT		reciprocal translocation between the long arms of chromosomes 12 and 22	Supports the characteristic t(12;22) translocation in clear cell sarcoma.	"{""explanation"": ""Supports the characteristic t(12;22) translocation in clear cell sarcoma."", ""reference"": ""PMID:9793401"", ""snippet"": ""reciprocal translocation between the long arms of chromosomes 12 and 22"", ""supports"": ""SUPPORT""}"
1948	1690	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	0	evidence	0	PMID:28613708	SUPPORT		The most significant risk factor for C difficile infection is broad-spectrum antibiotics. Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection.	StatPearls notes antibiotic-driven dysbiosis allows C. difficile overgrowth in the colon.	"{""explanation"": ""StatPearls notes antibiotic-driven dysbiosis allows C. difficile overgrowth in the colon."", ""reference"": ""PMID:28613708"", ""snippet"": ""The most significant risk factor for C difficile infection is broad-spectrum antibiotics. Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."", ""supports"": ""SUPPORT""}"
1949	1691	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	1	evidence	0	PMID:26185088	SUPPORT		A general feature of a normal, healthy gut microbiota can generate conditions in the gut that disfavor colonization of enteric pathogens. This is termed colonization-resistance (CR). Upon disturbance of the microbiota, CR can be transiently disrupted, and pathogens can gain the opportunity to grow to high levels.	Review describes colonization resistance as a key protective function lost during antibiotic-induced dysbiosis.	"{""explanation"": ""Review describes colonization resistance as a key protective function lost during antibiotic-induced dysbiosis."", ""reference"": ""PMID:26185088"", ""snippet"": ""A general feature of a normal, healthy gut microbiota can generate conditions in the gut that disfavor colonization of enteric pathogens. This is termed colonization-resistance (CR). Upon disturbance of the microbiota, CR can be transiently disrupted, and pathogens can gain the opportunity to grow to high levels."", ""supports"": ""SUPPORT""}"
1950	1691	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	1	evidence	1	PMID:40366862	SUPPORT		The gut microbiota in the Control group showed higher Chao1 index (p < 0.05)... Collinsella_aerofaciens, Collinsella_sp_4_8_47FAA, Collinsella_tanakaei and Collinsella_sp_CAG_166 were enriched in Control.	Metagenomic study confirms CDI patients have reduced diversity and depletion of protective Collinsella species compared to healthy controls.	"{""explanation"": ""Metagenomic study confirms CDI patients have reduced diversity and depletion of protective Collinsella species compared to healthy controls."", ""reference"": ""PMID:40366862"", ""snippet"": ""The gut microbiota in the Control group showed higher Chao1 index (p < 0.05)... Collinsella_aerofaciens, Collinsella_sp_4_8_47FAA, Collinsella_tanakaei and Collinsella_sp_CAG_166 were enriched in Control."", ""supports"": ""SUPPORT""}"
1951	1692	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	2	evidence	0	PMID:32179626	SUPPORT		Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production.	Study shows bile acid conversion by bai operon-carrying bacteria is key to C. difficile inhibition.	"{""explanation"": ""Study shows bile acid conversion by bai operon-carrying bacteria is key to C. difficile inhibition."", ""reference"": ""PMID:32179626"", ""snippet"": ""Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production."", ""supports"": ""SUPPORT""}"
1952	1692	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	2	evidence	1	PMID:28066726	SUPPORT		Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid composition by reconstituting 7α-dehydroxylation. These changes had only minor effects on the composition of the native Oligo-MM12, but significantly decreased early large intestinal C. difficile colonization and pathogenesis.	Gnotobiotic mouse study demonstrates C. scindens provides colonization resistance through bile acid metabolism.	"{""explanation"": ""Gnotobiotic mouse study demonstrates C. scindens provides colonization resistance through bile acid metabolism."", ""reference"": ""PMID:28066726"", ""snippet"": ""Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid composition by reconstituting 7α-dehydroxylation. These changes had only minor effects on the composition of the native Oligo-MM12, but significantly decreased early large intestinal C. difficile colonization and pathogenesis."", ""supports"": ""SUPPORT""}"
1953	1693	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	3	evidence	0	PMID:28613708	SUPPORT		Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection.	Antibiotic-disrupted environment permits C. difficile overgrowth from spore to vegetative form.	"{""explanation"": ""Antibiotic-disrupted environment permits C. difficile overgrowth from spore to vegetative form."", ""reference"": ""PMID:28613708"", ""snippet"": ""Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."", ""supports"": ""SUPPORT""}"
1954	1694	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	4	evidence	0	PMID:15831824	SUPPORT		Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine.	Comprehensive review details the molecular mechanism of toxin action on Rho GTPases.	"{""explanation"": ""Comprehensive review details the molecular mechanism of toxin action on Rho GTPases."", ""reference"": ""PMID:15831824"", ""snippet"": ""Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine."", ""supports"": ""SUPPORT""}"
1955	1694	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	4	evidence	1	PMID:34837014	SUPPORT		The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea.	Review confirms toxins as major virulence factors causing disease pathology.	"{""explanation"": ""Review confirms toxins as major virulence factors causing disease pathology."", ""reference"": ""PMID:34837014"", ""snippet"": ""The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea."", ""supports"": ""SUPPORT""}"
1956	1695	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	5	evidence	0	PMID:15831824	SUPPORT		By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell.	Review describes the cellular consequences of toxin-mediated GTPase inactivation.	"{""explanation"": ""Review describes the cellular consequences of toxin-mediated GTPase inactivation."", ""reference"": ""PMID:15831824"", ""snippet"": ""By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell."", ""supports"": ""SUPPORT""}"
1957	1696	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	6	evidence	0	PMID:15831824	SUPPORT		Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells.	Review details toxin-induced inflammatory cascade including neutrophil recruitment.	"{""explanation"": ""Review details toxin-induced inflammatory cascade including neutrophil recruitment."", ""reference"": ""PMID:15831824"", ""snippet"": ""Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells."", ""supports"": ""SUPPORT""}"
1958	1697	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	pathophysiology	7	evidence	0	PMID:34837014	SUPPORT		These toxins promote inflammation, tissue damage and diarrhoea.	Toxin activity drives the pseudomembrane-associated inflammation and diarrheal fluid loss that characterize severe CDI.	"{""explanation"": ""Toxin activity drives the pseudomembrane-associated inflammation and diarrheal fluid loss that characterize severe CDI."", ""reference"": ""PMID:34837014"", ""snippet"": ""These toxins promote inflammation, tissue damage and diarrhoea."", ""supports"": ""SUPPORT""}"
1987	1722	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	0	evidence	0	DOI:10.1093/ecco-jcc/jjab123	SUPPORT		MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations	Systematic review documents that collagenous enteropathy and related conditions involve mucosal immune activation with T cell-mediated responses	"{""explanation"": ""Systematic review documents that collagenous enteropathy and related conditions involve mucosal immune activation with T cell-mediated responses"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations"", ""supports"": ""SUPPORT""}"
1988	1723	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	1	evidence	0	PMID:37070112	SUPPORT		The histological features are fundamentally characterized by the deposition of collagen beneath the basement membrane of gut mucosa	Collagen deposition alters mucosal architecture and epithelial integrity in collagenous sprue	"{""explanation"": ""Collagen deposition alters mucosal architecture and epithelial integrity in collagenous sprue"", ""reference"": ""PMID:37070112"", ""snippet"": ""The histological features are fundamentally characterized by the deposition of collagen beneath the basement membrane of gut mucosa"", ""supports"": ""SUPPORT""}"
1989	1724	72	Collagenous Sprue	Collagenous_Sprue.yaml	pathophysiology	2	evidence	0	PMID:37554741	SUPPORT		collagenous colitis, characterized by sub-epithelial trichrome-positive deposits having the ultrastructural features of collagen	Literature describes diagnostic subepithelial collagen deposition characteristic of collagenous diseases including sprue	"{""explanation"": ""Literature describes diagnostic subepithelial collagen deposition characteristic of collagenous diseases including sprue"", ""reference"": ""PMID:37554741"", ""snippet"": ""collagenous colitis, characterized by sub-epithelial trichrome-positive deposits having the ultrastructural features of collagen"", ""supports"": ""SUPPORT""}"
2004	1739	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	pathophysiology	0	evidence	0	PMID:8055224	SUPPORT		Molecular studies support the clinical impression that adenocarcinoma of the large intestine develops in stages. At the center of the pathological continuum between normal mucosa and invasive carcinoma is the premalignant lesion, the adenomatous polyp.	The abstract describes stage-wise progression through adenomatous polyps.	"{""explanation"": ""The abstract describes stage-wise progression through adenomatous polyps."", ""reference"": ""PMID:8055224"", ""snippet"": ""Molecular studies support the clinical impression that adenocarcinoma of the large intestine develops in stages. At the center of the pathological continuum between normal mucosa and invasive carcinoma is the premalignant lesion, the adenomatous polyp."", ""supports"": ""SUPPORT""}"
2005	1740	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	pathophysiology	1	evidence	0	PMID:19092804	SUPPORT	MODEL_ORGANISM	Intestinal cancer is initiated by Wnt-pathway-activating mutations in genes such as adenomatous polyposis coli (APC).	The abstract identifies APC loss and Wnt pathway activation as initiating events in intestinal cancer.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""The abstract identifies APC loss and Wnt pathway activation as initiating events in intestinal cancer."", ""reference"": ""PMID:19092804"", ""snippet"": ""Intestinal cancer is initiated by Wnt-pathway-activating mutations in genes such as adenomatous polyposis coli (APC)."", ""supports"": ""SUPPORT""}"
2013	1753	74	Acute Myeloid Leukemia, Core Binding Factor	Core_Binding_Factor_AML.yaml	pathophysiology	0	evidence	0	PMID:41152985	SUPPORT		core-binding factor acute myeloid leukemia patients, defined by the presence of a RUNX1::RUNX1T1 or CBFB::MYH11 fusion gene.	This abstract defines CBF-AML by RUNX1::RUNX1T1 or CBFB::MYH11 fusions, supporting the core-binding factor disruption described.	"{""explanation"": ""This abstract defines CBF-AML by RUNX1::RUNX1T1 or CBFB::MYH11 fusions, supporting the core-binding factor disruption described."", ""reference"": ""PMID:41152985"", ""snippet"": ""core-binding factor acute myeloid leukemia patients, defined by the presence of a RUNX1::RUNX1T1 or CBFB::MYH11 fusion gene."", ""supports"": ""SUPPORT""}"
2019	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	evidence	0	PMID:39518492	SUPPORT		We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation.	This review directly supports the role of lipid accumulation and inflammation in driving plaque formation in coronary artery disease.	"{""explanation"": ""This review directly supports the role of lipid accumulation and inflammation in driving plaque formation in coronary artery disease."", ""reference"": ""PMID:39518492"", ""snippet"": ""We examine the cellular and molecular processes that drive the formation of calcified plaques, highlighting the roles of inflammation, lipid accumulation, and smooth muscle cell proliferation."", ""supports"": ""SUPPORT""}"
2020	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	evidence	1	PMID:38639096	SUPPORT		Advanced stages of atherosclerosis progression and symptomatic carotid plaques were largely characterized by 3 smooth muscle cells (SMCs), and 3 macrophage subtype clusters with extracellular matrix organization/osteogenic (SMC), and M1-type proinflammatory/Trem2-high lipid-associated (macrophage) phenotypes.	Single-cell analysis confirms the presence of lipid-associated macrophages and smooth muscle cells in advanced atherosclerotic plaques, supporting foam cell formation and plaque progression.	"{""explanation"": ""Single-cell analysis confirms the presence of lipid-associated macrophages and smooth muscle cells in advanced atherosclerotic plaques, supporting foam cell formation and plaque progression."", ""reference"": ""PMID:38639096"", ""snippet"": ""Advanced stages of atherosclerosis progression and symptomatic carotid plaques were largely characterized by 3 smooth muscle cells (SMCs), and 3 macrophage subtype clusters with extracellular matrix organization/osteogenic (SMC), and M1-type proinflammatory/Trem2-high lipid-associated (macrophage) phenotypes."", ""supports"": ""SUPPORT""}"
2021	1779	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	0	evidence	2	PMID:40594772	SUPPORT		Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability.	This study identifies specific macrophage populations with pro-inflammatory phenotypes that contribute to atherosclerotic plaque formation and progression.	"{""explanation"": ""This study identifies specific macrophage populations with pro-inflammatory phenotypes that contribute to atherosclerotic plaque formation and progression."", ""reference"": ""PMID:40594772"", ""snippet"": ""Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability."", ""supports"": ""SUPPORT""}"
2022	1780	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	1	evidence	0	PMID:40594772	SUPPORT		CD36 + positive ECs exhibited significant senescence phenotypes following disturbed flow stimulation.	This study demonstrates that endothelial cells undergo senescence under disturbed flow conditions, a key mechanism in endothelial dysfunction during atherosclerosis.	"{""explanation"": ""This study demonstrates that endothelial cells undergo senescence under disturbed flow conditions, a key mechanism in endothelial dysfunction during atherosclerosis."", ""reference"": ""PMID:40594772"", ""snippet"": ""CD36 + positive ECs exhibited significant senescence phenotypes following disturbed flow stimulation."", ""supports"": ""SUPPORT""}"
2023	1780	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	1	evidence	1	PMID:40594772	SUPPORT		Atherosclerosis tends to occur in regions of disturbed blood flow. This study explored how disturbed flow aggravates atherosclerosis using single-cell RNA-seq (scRNA-seq) datasets from mouse carotid arteries under disturbed flow and human carotid artery plaques.	Disturbed flow-induced endothelial dysfunction is a primary mechanism for atherosclerosis initiation in specific arterial regions.	"{""explanation"": ""Disturbed flow-induced endothelial dysfunction is a primary mechanism for atherosclerosis initiation in specific arterial regions."", ""reference"": ""PMID:40594772"", ""snippet"": ""Atherosclerosis tends to occur in regions of disturbed blood flow. This study explored how disturbed flow aggravates atherosclerosis using single-cell RNA-seq (scRNA-seq) datasets from mouse carotid arteries under disturbed flow and human carotid artery plaques."", ""supports"": ""SUPPORT""}"
2024	1781	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	2	evidence	0	PMID:40594772	SUPPORT		Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability.	Pro-inflammatory macrophages contribute to plaque instability, which predisposes to rupture and thrombotic complications.	"{""explanation"": ""Pro-inflammatory macrophages contribute to plaque instability, which predisposes to rupture and thrombotic complications."", ""reference"": ""PMID:40594772"", ""snippet"": ""Notable increases in VEGFA+ macrophages were discovered in the disturbed flow stimulation group, displaying a pronounced M1 pro-inflammatory phenotype associated with the severity of atherosclerosis and plaque stability."", ""supports"": ""SUPPORT""}"
2025	1781	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	pathophysiology	2	evidence	1	PMID:38639096	SUPPORT		By identifying and integrating the most gene-rich single-cell subclusters of atherosclerosis to date with a coronary artery disease framework of GRNs, GRN39 was identified and independently validated as being critical for the transformation of contractile SMCs into an osteogenic phenotype promoting advanced, symptomatic atherosclerosis.	Smooth muscle cell transformation into osteogenic phenotypes contributes to plaque vulnerability and symptomatic disease, increasing risk of rupture and thrombotic events.	"{""explanation"": ""Smooth muscle cell transformation into osteogenic phenotypes contributes to plaque vulnerability and symptomatic disease, increasing risk of rupture and thrombotic events."", ""reference"": ""PMID:38639096"", ""snippet"": ""By identifying and integrating the most gene-rich single-cell subclusters of atherosclerosis to date with a coronary artery disease framework of GRNs, GRN39 was identified and independently validated as being critical for the transformation of contractile SMCs into an osteogenic phenotype promoting advanced, symptomatic atherosclerosis."", ""supports"": ""SUPPORT""}"
2028	1793	76	Costello Syndrome	Costello_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:38415356	SUPPORT	IN_VITRO	CS-associated gain-of-function HRASG12 mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia.	iPSC-derived atrial cardiomyocyte model demonstrates that HRAS mutations cause transcriptional reprogramming toward pacemaker-nodal phenotype with increased automaticity, providing mechanistic basis for arrhythmias.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""iPSC-derived atrial cardiomyocyte model demonstrates that HRAS mutations cause transcriptional reprogramming toward pacemaker-nodal phenotype with increased automaticity, providing mechanistic basis for arrhythmias."", ""reference"": ""PMID:38415356"", ""snippet"": ""CS-associated gain-of-function HRASG12 mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia."", ""supports"": ""SUPPORT""}"
2074	1825	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	0	evidence	0	PMID:32242028	SUPPORT		Several factors have been implicated in the cause of Crohn's disease, including a dysregulated immune system, an altered microbiota, genetic susceptibility and environmental factors, but the cause of the disease remains unknown.	The statement is supported as one of the major factors causing Crohn's Disease is the dysregulated immune system attacking the gastrointestinal tract.	"{""explanation"": ""The statement is supported as one of the major factors causing Crohn's Disease is the dysregulated immune system attacking the gastrointestinal tract."", ""reference"": ""PMID:32242028"", ""snippet"": ""Several factors have been implicated in the cause of Crohn's disease, including a dysregulated immune system, an altered microbiota, genetic susceptibility and environmental factors, but the cause of the disease remains unknown."", ""supports"": ""SUPPORT""}"
2075	1825	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	0	evidence	1	PMID:36720220	SUPPORT		Crohn's disease (CD) is a chronic gastrointestinal disease that is increasing in prevalence worldwide. CD is multifactorial, involving the complex interplay of genetic, immune, and environmental factors... we mapped markers of disease-associated myofibroblast activation and identified CHMP1A, TBX3, and RNF168 as regulators of fibrotic complications.	This study supports the mechanism involving the immune system leading to inflammation and chronic disease in the gastrointestinal tract.	"{""explanation"": ""This study supports the mechanism involving the immune system leading to inflammation and chronic disease in the gastrointestinal tract."", ""reference"": ""PMID:36720220"", ""snippet"": ""Crohn's disease (CD) is a chronic gastrointestinal disease that is increasing in prevalence worldwide. CD is multifactorial, involving the complex interplay of genetic, immune, and environmental factors... we mapped markers of disease-associated myofibroblast activation and identified CHMP1A, TBX3, and RNF168 as regulators of fibrotic complications."", ""supports"": ""SUPPORT""}"
2076	1825	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	0	evidence	2	PMID:21543977	SUPPORT		The lymphatic system is re-emerging as a critical player in inflammatory and immune processes... Recent studies reporting lymphangitis, lymphangiogenesis, bacterial infiltration and lymph node infection, immune cell trafficking, and fat-wrapping in Crohn's disease suggest altered lymph drainage and lymphatic pumping, implicating the lymphatic system as a likely player in inflammatory disorders and IBDs.	The literature acknowledges the immune system's involvement in Crohn's Disease through various mechanisms, including lymphatic system dysfunction.	"{""explanation"": ""The literature acknowledges the immune system's involvement in Crohn's Disease through various mechanisms, including lymphatic system dysfunction."", ""reference"": ""PMID:21543977"", ""snippet"": ""The lymphatic system is re-emerging as a critical player in inflammatory and immune processes... Recent studies reporting lymphangitis, lymphangiogenesis, bacterial infiltration and lymph node infection, immune cell trafficking, and fat-wrapping in Crohn's disease suggest altered lymph drainage and lymphatic pumping, implicating the lymphatic system as a likely player in inflammatory disorders and IBDs."", ""supports"": ""SUPPORT""}"
2077	1826	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	1	evidence	0	PMID:34313550	SUPPORT		Crohn's disease (CD) is a major form of inflammatory bowel disease characterized by transmural inflammation along the alimentary tract. Changes in the microbial composition and reduction in species diversity are recognized as pivotal hallmarks in disease dynamics, challenging the gut barrier function and shaping a pathological immune response in genetically influenced subjects.	This study details changes in microbial composition and reduction in species diversity as key factors in the dynamics of Crohn's Disease, thereby supporting the statement.	"{""explanation"": ""This study details changes in microbial composition and reduction in species diversity as key factors in the dynamics of Crohn's Disease, thereby supporting the statement."", ""reference"": ""PMID:34313550"", ""snippet"": ""Crohn's disease (CD) is a major form of inflammatory bowel disease characterized by transmural inflammation along the alimentary tract. Changes in the microbial composition and reduction in species diversity are recognized as pivotal hallmarks in disease dynamics, challenging the gut barrier function and shaping a pathological immune response in genetically influenced subjects."", ""supports"": ""SUPPORT""}"
2078	1826	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	1	evidence	1	PMID:18810765	SUPPORT		This ileal and colonic defect in innate defence mediated by a deficiency of the protective alpha- and beta-defensins may enable the luminal microbes to invade the mucosa and trigger the inflammation.	This study indicates that defects in innate defense mechanisms allow microbial invasion, which triggers inflammation, supporting the involvement of microbiota alterations in Crohn's Disease.	"{""explanation"": ""This study indicates that defects in innate defense mechanisms allow microbial invasion, which triggers inflammation, supporting the involvement of microbiota alterations in Crohn's Disease."", ""reference"": ""PMID:18810765"", ""snippet"": ""This ileal and colonic defect in innate defence mediated by a deficiency of the protective alpha- and beta-defensins may enable the luminal microbes to invade the mucosa and trigger the inflammation."", ""supports"": ""SUPPORT""}"
2079	1826	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	1	evidence	2	PMID:23971750	SUPPORT		Inflammatory bowel disease includes ulcerative colitis and Crohn's disease, which are both inflammatory disorders of the gastrointestinal tract. Both types of inflammatory bowel disease have a complex etiology, resulting from a genetically determined susceptibility interacting with environmental factors, including the diet and gut microbiota.	This article mentions the role of gut microbiota as an environmental factor in the etiology of Crohn's Disease, supporting the contribution of microbiome imbalance to disease mechanisms.	"{""explanation"": ""This article mentions the role of gut microbiota as an environmental factor in the etiology of Crohn's Disease, supporting the contribution of microbiome imbalance to disease mechanisms."", ""reference"": ""PMID:23971750"", ""snippet"": ""Inflammatory bowel disease includes ulcerative colitis and Crohn's disease, which are both inflammatory disorders of the gastrointestinal tract. Both types of inflammatory bowel disease have a complex etiology, resulting from a genetically determined susceptibility interacting with environmental factors, including the diet and gut microbiota."", ""supports"": ""SUPPORT""}"
2080	1827	77	Crohn Disease	Crohn_Disease.yaml	pathophysiology	2	evidence	0	PMID:18849966	SUPPORT		ATG16L1- and ATG5-deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway	This study demonstrates that autophagy proteins ATG16L1 and ATG5 are essential for Paneth cell function and that defects cause granule abnormalities linked to Crohn's disease.	"{""explanation"": ""This study demonstrates that autophagy proteins ATG16L1 and ATG5 are essential for Paneth cell function and that defects cause granule abnormalities linked to Crohn's disease."", ""reference"": ""PMID:18849966"", ""snippet"": ""ATG16L1- and ATG5-deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway"", ""supports"": ""SUPPORT""}"
2144	1869	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	0	evidence	0	PMID:33163187	SUPPORT		CCS is typically characterized by gastrointestinal symptoms, such as diarrhea and skin changes (e.g. alopecia, pigmentation, and nail atrophy). Endoscopic features include diffuse polyps throughout the entire gastrointestinal tract, except for the esophagus.	Describes the characteristic clinical presentation and gastrointestinal involvement in Cronkhite-Canada syndrome	"{""explanation"": ""Describes the characteristic clinical presentation and gastrointestinal involvement in Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""CCS is typically characterized by gastrointestinal symptoms, such as diarrhea and skin changes (e.g. alopecia, pigmentation, and nail atrophy). Endoscopic features include diffuse polyps throughout the entire gastrointestinal tract, except for the esophagus."", ""supports"": ""SUPPORT""}"
2145	1869	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	0	evidence	1	PMID:39470508	SUPPORT		CCS is characterized by an extremely rare, nonfamilial hamartomatous polyposis syndrome, in which polyps are distributed in the stomach and colon (90%), small intestine(80%), and rectum (67%), while sparing the esophagus.	Comprehensive case series quantifies the distribution and frequency of polyp involvement across different GI segments	"{""explanation"": ""Comprehensive case series quantifies the distribution and frequency of polyp involvement across different GI segments"", ""reference"": ""PMID:39470508"", ""snippet"": ""CCS is characterized by an extremely rare, nonfamilial hamartomatous polyposis syndrome, in which polyps are distributed in the stomach and colon (90%), small intestine(80%), and rectum (67%), while sparing the esophagus."", ""supports"": ""SUPPORT""}"
2146	1870	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	1	evidence	0	PMID:33163187	SUPPORT		IgG4-positive plasma-cell infiltration was also found in CCS polyps	Establishes IgG4-positive plasma cell infiltration as a key pathogenic feature of Cronkhite-Canada syndrome	"{""explanation"": ""Establishes IgG4-positive plasma cell infiltration as a key pathogenic feature of Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""IgG4-positive plasma-cell infiltration was also found in CCS polyps"", ""supports"": ""SUPPORT""}"
2147	1870	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	1	evidence	1	PMID:39470508	SUPPORT		In this case, from the lower esophageal sphincter to the rectum, there is an increasing trend of eosinophil and mast cell infiltration. These lesions can cause a positive IgG result.	Demonstrates the progressive eosinophil and mast cell infiltration along the GI tract with IgG involvement in CCS pathology	"{""explanation"": ""Demonstrates the progressive eosinophil and mast cell infiltration along the GI tract with IgG involvement in CCS pathology"", ""reference"": ""PMID:39470508"", ""snippet"": ""In this case, from the lower esophageal sphincter to the rectum, there is an increasing trend of eosinophil and mast cell infiltration. These lesions can cause a positive IgG result."", ""supports"": ""SUPPORT""}"
2148	1871	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	2	evidence	0	PMID:33163187	SUPPORT		The prognosis of CCS is poor, with a 5-year mortality rate of 55%	Indicates the severe clinical consequences of CCS including complications from protein-losing enteropathy	"{""explanation"": ""Indicates the severe clinical consequences of CCS including complications from protein-losing enteropathy"", ""reference"": ""PMID:33163187"", ""snippet"": ""The prognosis of CCS is poor, with a 5-year mortality rate of 55%"", ""supports"": ""SUPPORT""}"
2149	1871	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	2	evidence	1	PMID:39470508	SUPPORT		The primary distinct features of this syndrome include ectodermal abnormalities and diffuse gastrointestinal polyp changes accompanied by protein loss.	Establishes protein loss as a primary pathogenic feature accompanying the GI polyp changes in CCS	"{""explanation"": ""Establishes protein loss as a primary pathogenic feature accompanying the GI polyp changes in CCS"", ""reference"": ""PMID:39470508"", ""snippet"": ""The primary distinct features of this syndrome include ectodermal abnormalities and diffuse gastrointestinal polyp changes accompanied by protein loss."", ""supports"": ""SUPPORT""}"
2150	1872	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	3	evidence	0	PMID:33163187	SUPPORT		54% of patients with CCS had Hp infection and some studies noted that CCS was alleviated after Hp eradication	Documents the association between H. pylori infection and CCS with therapeutic improvement after eradication	"{""explanation"": ""Documents the association between H. pylori infection and CCS with therapeutic improvement after eradication"", ""reference"": ""PMID:33163187"", ""snippet"": ""54% of patients with CCS had Hp infection and some studies noted that CCS was alleviated after Hp eradication"", ""supports"": ""SUPPORT""}"
2151	1872	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	pathophysiology	3	evidence	1	PMID:39470508	SUPPORT		Pathological analysis indicates that the extent and severity of lesions in the middle and lower gastrointestinal tract are more substantial than in the upper tract.	Recent case demonstrates the gradual pattern of GI tract involvement that may reflect H. pylori-associated inflammation patterns	"{""explanation"": ""Recent case demonstrates the gradual pattern of GI tract involvement that may reflect H. pylori-associated inflammation patterns"", ""reference"": ""PMID:39470508"", ""snippet"": ""Pathological analysis indicates that the extent and severity of lesions in the middle and lower gastrointestinal tract are more substantial than in the upper tract."", ""supports"": ""SUPPORT""}"
2178	1884	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	we have identified 10 different mutations in the FGFR2 extracellular immunoglobulin III (IgIII) domain in 50% (16/32) of our Crouzon syndrome patients	Confirms that FGFR2 mutations in the Ig-III domain are found in a substantial proportion of Crouzon syndrome patients, supporting the pathophysiology centered on FGFR2 dysfunction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that FGFR2 mutations in the Ig-III domain are found in a substantial proportion of Crouzon syndrome patients, supporting the pathophysiology centered on FGFR2 dysfunction."", ""reference"": ""PMID:7493034"", ""snippet"": ""we have identified 10 different mutations in the FGFR2 extracellular immunoglobulin III (IgIII) domain in 50% (16/32) of our Crouzon syndrome patients"", ""supports"": ""SUPPORT""}"
2184	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	evidence	0	PMID:10696568	SUPPORT	HUMAN_CLINICAL	Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active.	"This evidence supports the gain-of-function mechanism where FGFR3 mutations cause constitutive receptor activation leading to the disease phenotype.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This evidence supports the gain-of-function mechanism where FGFR3 mutations cause constitutive receptor activation leading to the disease phenotype.\n"", ""reference"": ""PMID:10696568"", ""snippet"": ""Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active."", ""supports"": ""SUPPORT""}"
2185	1895	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	pathophysiology	0	evidence	1	PMID:7493034	SUPPORT	HUMAN_CLINICAL	The association of non-dwarfing and even non-skeletal conditions with FGFR3 mutations reveals the potential for a wide range of FGFR pleiotropic effects as well as locus heterogeneity in Crouzon syndrome.	"Demonstrates that FGFR3 mutations can affect multiple tissue types including both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that FGFR3 mutations can affect multiple tissue types including both skeletal (craniosynostosis) and cutaneous (acanthosis nigricans) tissues.\n"", ""reference"": ""PMID:7493034"", ""snippet"": ""The association of non-dwarfing and even non-skeletal conditions with FGFR3 mutations reveals the potential for a wide range of FGFR pleiotropic effects as well as locus heterogeneity in Crouzon syndrome."", ""supports"": ""SUPPORT""}"
2188	1904	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome is defined as a prolonged increase in plasma cortisol levels that is not due to a physiological etiology.	This review confirms the fundamental pathophysiology of Cushing's syndrome as prolonged cortisol excess.	"{""explanation"": ""This review confirms the fundamental pathophysiology of Cushing's syndrome as prolonged cortisol excess."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is defined as a prolonged increase in plasma cortisol levels that is not due to a physiological etiology."", ""supports"": ""SUPPORT""}"
2189	1905	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:37432427	SUPPORT		Cushing disease, in which corticotropin excess is produced by a benign pituitary tumor, occurs in approximately 60% to 70% of patients with Cushing syndrome due to endogenous cortisol production.	This confirms that ACTH-secreting pituitary tumors are the most common cause of endogenous Cushing's, representing HPA axis dysregulation.	"{""explanation"": ""This confirms that ACTH-secreting pituitary tumors are the most common cause of endogenous Cushing's, representing HPA axis dysregulation."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing disease, in which corticotropin excess is produced by a benign pituitary tumor, occurs in approximately 60% to 70% of patients with Cushing syndrome due to endogenous cortisol production."", ""supports"": ""SUPPORT""}"
2190	1906	81	Cushing's Syndrome	Cushings_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.	This confirms the metabolic consequences including hyperglycemia, protein catabolism, and weight gain.	"{""explanation"": ""This confirms the metabolic consequences including hyperglycemia, protein catabolism, and weight gain."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."", ""supports"": ""SUPPORT""}"
2202	1919	82	Cystic echinococcosis	Cystic_Echinococcosis.yaml	pathophysiology	0	evidence	0	PMID:27047771	SUPPORT		Upon infection with CE, cyst formation mainly occurs in the liver (70%).	The abstract reports predominant liver cyst formation.	"{""explanation"": ""The abstract reports predominant liver cyst formation."", ""reference"": ""PMID:27047771"", ""snippet"": ""Upon infection with CE, cyst formation mainly occurs in the liver (70%)."", ""supports"": ""SUPPORT""}"
2207	1934	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	pathophysiology	0	evidence	0	PMID:9922375	SUPPORT		The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique member of the ABC transporter family that forms a novel Cl- channel. It is located predominantly in the apical membrane of epithelia where it mediates transepithelial salt and liquid movement. Dysfunction of CFTR causes the genetic disease cystic fibrosis.	Comprehensive review establishes CFTR as chloride channel whose dysfunction causes cystic fibrosis.	"{""explanation"": ""Comprehensive review establishes CFTR as chloride channel whose dysfunction causes cystic fibrosis."", ""reference"": ""PMID:9922375"", ""snippet"": ""The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique member of the ABC transporter family that forms a novel Cl- channel. It is located predominantly in the apical membrane of epithelia where it mediates transepithelial salt and liquid movement. Dysfunction of CFTR causes the genetic disease cystic fibrosis."", ""supports"": ""SUPPORT""}"
2222	1954	84	Danon disease	Danon_disease.yaml	pathophysiology	0	evidence	0	DOI:10.1111/nan.12587	SUPPORT		The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes.	Confirms that LAMP-2 deficiency disrupts autophagy through impaired lysosome-autophagosome fusion.	"{""explanation"": ""Confirms that LAMP-2 deficiency disrupts autophagy through impaired lysosome-autophagosome fusion."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes."", ""supports"": ""SUPPORT""}"
2223	1955	84	Danon disease	Danon_disease.yaml	pathophysiology	1	evidence	0	DOI:10.1038/cddis.2016.475	SUPPORT	MODEL_ORGANISM	DD is characterized by mutations in the lysosome-associated membrane protein 2 (LAMP2) gene. The DD mouse model suggests that inefficient lysosome biogenesis/maturation and impairment of autophagosome-lysosome fusion contribute to the pathogenesis of muscle wasting.	Demonstrates that LAMP2 mutations cause impaired autophagosome-lysosome fusion and lysosome biogenesis defects.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that LAMP2 mutations cause impaired autophagosome-lysosome fusion and lysosome biogenesis defects."", ""reference"": ""DOI:10.1038/cddis.2016.475"", ""snippet"": ""DD is characterized by mutations in the lysosome-associated membrane protein 2 (LAMP2) gene. The DD mouse model suggests that inefficient lysosome biogenesis/maturation and impairment of autophagosome-lysosome fusion contribute to the pathogenesis of muscle wasting."", ""supports"": ""SUPPORT""}"
2224	1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	evidence	0	DOI:10.3390/biom14101272	SUPPORT		Pathologically, the disease is characterized by the appearance of unique autophagic vacuoles with sarcolemmal features (AVSFs).	Confirms AVSFs as a pathological hallmark of Danon disease.	"{""explanation"": ""Confirms AVSFs as a pathological hallmark of Danon disease."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""Pathologically, the disease is characterized by the appearance of unique autophagic vacuoles with sarcolemmal features (AVSFs)."", ""supports"": ""SUPPORT""}"
2225	1956	84	Danon disease	Danon_disease.yaml	pathophysiology	2	evidence	1	DOI:10.1038/cddis.2016.475	SUPPORT		Among them, Danon Disease (DD) and glycogen storage disease type II (GSDII) are due to primary lysosomal protein defects.	Establishes Danon disease as a lysosomal storage disorder with autophagic vacuolar myopathy.	"{""explanation"": ""Establishes Danon disease as a lysosomal storage disorder with autophagic vacuolar myopathy."", ""reference"": ""DOI:10.1038/cddis.2016.475"", ""snippet"": ""Among them, Danon Disease (DD) and glycogen storage disease type II (GSDII) are due to primary lysosomal protein defects."", ""supports"": ""SUPPORT""}"
2226	1957	84	Danon disease	Danon_disease.yaml	pathophysiology	3	evidence	0	DOI:10.3390/biom14101272	SUPPORT		This disease is one of the autophagy-related muscle diseases.	Confirms Danon disease as an autophagy-related disorder affecting muscle.	"{""explanation"": ""Confirms Danon disease as an autophagy-related disorder affecting muscle."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""This disease is one of the autophagy-related muscle diseases."", ""supports"": ""SUPPORT""}"
2227	1958	84	Danon disease	Danon_disease.yaml	pathophysiology	4	evidence	0	DOI:10.3390/biom14101272	SUPPORT		This disease is one of the autophagy-related muscle diseases.	Confirms the role of autophagy dysfunction in muscle disease pathogenesis.	"{""explanation"": ""Confirms the role of autophagy dysfunction in muscle disease pathogenesis."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""This disease is one of the autophagy-related muscle diseases."", ""supports"": ""SUPPORT""}"
2244	1969	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	0	evidence	0	PMID:29222591	SUPPORT		Both are characterized morphologically by widespread cortical and subcortical α-synuclein/Lewy body plus β-amyloid and tau pathologies.	This confirms that alpha-synuclein aggregation forming Lewy bodies is the central pathological feature of DLB, distributed throughout cortical and subcortical regions.	"{""explanation"": ""This confirms that alpha-synuclein aggregation forming Lewy bodies is the central pathological feature of DLB, distributed throughout cortical and subcortical regions."", ""reference"": ""PMID:29222591"", ""snippet"": ""Both are characterized morphologically by widespread cortical and subcortical α-synuclein/Lewy body plus β-amyloid and tau pathologies."", ""supports"": ""SUPPORT""}"
2245	1970	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	1	evidence	0	PMID:39107446	SUPPORT		Autophagy is a lysosome-based degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and aggregate-prone proteins. Their postmitotic nature and extremely polarized morphologies make neurons particularly vulnerable to disruptions caused by autophagy-lysosomal defects, especially as the brain ages.	This establishes that autophagy-lysosome dysfunction is a fundamental mechanism in neurodegenerative diseases including Parkinson disease and related Lewy body disorders.	"{""explanation"": ""This establishes that autophagy-lysosome dysfunction is a fundamental mechanism in neurodegenerative diseases including Parkinson disease and related Lewy body disorders."", ""reference"": ""PMID:39107446"", ""snippet"": ""Autophagy is a lysosome-based degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and aggregate-prone proteins. Their postmitotic nature and extremely polarized morphologies make neurons particularly vulnerable to disruptions caused by autophagy-lysosomal defects, especially as the brain ages."", ""supports"": ""SUPPORT""}"
2246	1970	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	1	evidence	1	PMID:40598239	SUPPORT		In particular, we highlight antibody-based therapies to attenuate protein aggregation, compounds that enhance the generation of cellular energy and autophagy-enhancing agents as particular areas of promise.	This confirms that autophagy dysfunction is a key therapeutic target in DLB, with autophagy-enhancing agents being developed as potential disease-modifying therapies.	"{""explanation"": ""This confirms that autophagy dysfunction is a key therapeutic target in DLB, with autophagy-enhancing agents being developed as potential disease-modifying therapies."", ""reference"": ""PMID:40598239"", ""snippet"": ""In particular, we highlight antibody-based therapies to attenuate protein aggregation, compounds that enhance the generation of cellular energy and autophagy-enhancing agents as particular areas of promise."", ""supports"": ""SUPPORT""}"
2247	1971	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	pathophysiology	2	evidence	0	PMID:29222591	SUPPORT		Intravitam PET and post-mortem studies revealed more pronounced cortical atrophy, elevated cortical and limbic Lewy pathologies.	This demonstrates that the alpha-synuclein pathology leads to cortical atrophy through neuronal loss, particularly pronounced in cortical and limbic regions.	"{""explanation"": ""This demonstrates that the alpha-synuclein pathology leads to cortical atrophy through neuronal loss, particularly pronounced in cortical and limbic regions."", ""reference"": ""PMID:29222591"", ""snippet"": ""Intravitam PET and post-mortem studies revealed more pronounced cortical atrophy, elevated cortical and limbic Lewy pathologies."", ""supports"": ""SUPPORT""}"
2256	1979	86	Dengue	Dengue.yaml	pathophysiology	0	evidence	0	PMID:32265181	SUPPORT		Plasma leakages is the main pathophysiological hallmark that distinguishes DHF from DF. Severe plasma leakage can result in hypovolemic shock.	The review highlights plasma leakage and shock in severe dengue.	"{""explanation"": ""The review highlights plasma leakage and shock in severe dengue."", ""reference"": ""PMID:32265181"", ""snippet"": ""Plasma leakages is the main pathophysiological hallmark that distinguishes DHF from DF. Severe plasma leakage can result in hypovolemic shock."", ""supports"": ""SUPPORT""}"
2262	1990	87	Dermatofibrosarcoma Protuberans	Dermatofibrosarcoma_Protuberans.yaml	pathophysiology	0	evidence	0	PMID:17397592	SUPPORT		The demonstration of the oncogenic power of the translocation COL1A1-PDGFB in DFSP has allowed the successful introduction of drug therapy with antagonists of the PDGFB receptor for metastatic or locally advanced cases.	Supports the COL1A1-PDGFB translocation as a driver in DFSP.	"{""explanation"": ""Supports the COL1A1-PDGFB translocation as a driver in DFSP."", ""reference"": ""PMID:17397592"", ""snippet"": ""The demonstration of the oncogenic power of the translocation COL1A1-PDGFB in DFSP has allowed the successful introduction of drug therapy with antagonists of the PDGFB receptor for metastatic or locally advanced cases."", ""supports"": ""SUPPORT""}"
2263	2004	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	0	evidence	0	PMID:38143369	SUPPORT		Deposition of complement around capillaries and/or the sarcolemma was observed in muscle biopsy specimens from patients with DM, ASS, and IMNM, suggesting the pathomechanism of complement-dependent muscle and endothelial cell injury.	This evidence demonstrates that complement deposition is a characteristic pathological feature of dermatomyositis, contributing to muscle and endothelial cell injury through complement-dependent mechanisms.	"{""explanation"": ""This evidence demonstrates that complement deposition is a characteristic pathological feature of dermatomyositis, contributing to muscle and endothelial cell injury through complement-dependent mechanisms."", ""reference"": ""PMID:38143369"", ""snippet"": ""Deposition of complement around capillaries and/or the sarcolemma was observed in muscle biopsy specimens from patients with DM, ASS, and IMNM, suggesting the pathomechanism of complement-dependent muscle and endothelial cell injury."", ""supports"": ""SUPPORT""}"
2264	2004	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	0	evidence	1	PMID:38143369	SUPPORT		Juvenile DM is characterized by the loss of capillaries, perivascular inflammation, and small-vessel angiopathies, which may be related to microinfarction and perifascicular atrophy.	This evidence links the microangiopathy to the characteristic perifascicular atrophy observed in dermatomyositis, supporting the ischemic mechanism of muscle damage.	"{""explanation"": ""This evidence links the microangiopathy to the characteristic perifascicular atrophy observed in dermatomyositis, supporting the ischemic mechanism of muscle damage."", ""reference"": ""PMID:38143369"", ""snippet"": ""Juvenile DM is characterized by the loss of capillaries, perivascular inflammation, and small-vessel angiopathies, which may be related to microinfarction and perifascicular atrophy."", ""supports"": ""SUPPORT""}"
2265	2005	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	1	evidence	0	PMID:38143369	SUPPORT		The pathological observation of myxovirus resistance protein A (MxA), which suggests a type 1 interferon (IFN1) signature in DM, supports the diagnosis and further understanding of the pathomechanism of IIM.	MxA expression is a hallmark of type I interferon activation in dermatomyositis, providing diagnostic and pathomechanistic insights.	"{""explanation"": ""MxA expression is a hallmark of type I interferon activation in dermatomyositis, providing diagnostic and pathomechanistic insights."", ""reference"": ""PMID:38143369"", ""snippet"": ""The pathological observation of myxovirus resistance protein A (MxA), which suggests a type 1 interferon (IFN1) signature in DM, supports the diagnosis and further understanding of the pathomechanism of IIM."", ""supports"": ""SUPPORT""}"
2266	2005	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	1	evidence	1	PMID:39334579	SUPPORT		Histopathological studies have revealed critical roles of type I interferons and vasculopathy in the development of JDM.	This evidence confirms that type I interferon signaling is a central pathogenic mechanism in dermatomyositis, including juvenile forms.	"{""explanation"": ""This evidence confirms that type I interferon signaling is a central pathogenic mechanism in dermatomyositis, including juvenile forms."", ""reference"": ""PMID:39334579"", ""snippet"": ""Histopathological studies have revealed critical roles of type I interferons and vasculopathy in the development of JDM."", ""supports"": ""SUPPORT""}"
2267	2006	88	Dermatomyositis	Dermatomyositis.yaml	pathophysiology	2	evidence	0	PMID:39334579	SUPPORT		Each MSA or MAA is associated with distinct clinical features and outcomes, although there are several differences in the prevalence of MSA/MAA and autoantibody-phenotype relationships between age and ethnic groups.	This evidence confirms that myositis-specific autoantibodies (MSAs) define distinct clinical phenotypes in dermatomyositis, supporting the concept of autoantibody-driven disease subtypes.	"{""explanation"": ""This evidence confirms that myositis-specific autoantibodies (MSAs) define distinct clinical phenotypes in dermatomyositis, supporting the concept of autoantibody-driven disease subtypes."", ""reference"": ""PMID:39334579"", ""snippet"": ""Each MSA or MAA is associated with distinct clinical features and outcomes, although there are several differences in the prevalence of MSA/MAA and autoantibody-phenotype relationships between age and ethnic groups."", ""supports"": ""SUPPORT""}"
2276	2023	89	Desmoplastic Small Round Cell Tumor	Desmoplastic_Small_Round_Cell_Tumor.yaml	pathophysiology	0	evidence	0	PMID:20066421	SUPPORT		Using microdissection techniques, EWS-WT1-gene fusion transcripts were detected in the cystic (single-cell-layered), the papillary and the solid tumor proliferations (exon 7 of EWS on chromosome 22 with exon 8 of WT1 on chromosome 11).	Supports the presence of EWS-WT1 fusion transcripts in DSRCT.	"{""explanation"": ""Supports the presence of EWS-WT1 fusion transcripts in DSRCT."", ""reference"": ""PMID:20066421"", ""snippet"": ""Using microdissection techniques, EWS-WT1-gene fusion transcripts were detected in the cystic (single-cell-layered), the papillary and the solid tumor proliferations (exon 7 of EWS on chromosome 22 with exon 8 of WT1 on chromosome 11)."", ""supports"": ""SUPPORT""}"
2281	2044	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	pathophysiology	0	evidence	0	PMID:35243119	SUPPORT		Dieulafoy's lesion is an abnormally large, tortuous, submucosal vessel that erodes the overlying mucosa, without primary ulceration or erosion.	Review defines Dieulafoy lesion as a caliber-persistent submucosal artery that breaches mucosa without ulceration, causing bleeding.	"{""explanation"": ""Review defines Dieulafoy lesion as a caliber-persistent submucosal artery that breaches mucosa without ulceration, causing bleeding."", ""reference"": ""PMID:35243119"", ""snippet"": ""Dieulafoy's lesion is an abnormally large, tortuous, submucosal vessel that erodes the overlying mucosa, without primary ulceration or erosion."", ""supports"": ""SUPPORT""}"
2282	2044	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	pathophysiology	0	evidence	1	PMID:37425531	SUPPORT		A duodenal Dieulafoy lesion is characterized by the presence of a larger-caliber artery that protrudes through the GI mucosa and can lead to massive hemorrhage.	Case review reiterates the defining pathology of a large-caliber artery protruding through mucosa leading to hemorrhage.	"{""explanation"": ""Case review reiterates the defining pathology of a large-caliber artery protruding through mucosa leading to hemorrhage."", ""reference"": ""PMID:37425531"", ""snippet"": ""A duodenal Dieulafoy lesion is characterized by the presence of a larger-caliber artery that protrudes through the GI mucosa and can lead to massive hemorrhage."", ""supports"": ""SUPPORT""}"
2283	2045	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	pathophysiology	1	evidence	0	PMID:37065413	SUPPORT		A Dieulafoy lesion is an aberrant vessel that does not reduce in caliber when it extends from the submucosa to the mucosa. Damage to this artery can result in severe, intermittent arterial bleeding from tiny, difficult-to-visualize vessel stumps.	Case review highlights the persistent caliber artery and intermittent, severe arterial bleeding typical of Dieulafoy lesions.	"{""explanation"": ""Case review highlights the persistent caliber artery and intermittent, severe arterial bleeding typical of Dieulafoy lesions."", ""reference"": ""PMID:37065413"", ""snippet"": ""A Dieulafoy lesion is an aberrant vessel that does not reduce in caliber when it extends from the submucosa to the mucosa. Damage to this artery can result in severe, intermittent arterial bleeding from tiny, difficult-to-visualize vessel stumps."", ""supports"": ""SUPPORT""}"
2295	2079	92	Dorsalgia	Dorsalgia.yaml	pathophysiology	0	evidence	0	PMID:35110524	SUPPORT		Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes.	The GWAS links dorsalgia-related loci to cartilage, bone, neurologic, and inflammatory pathways.	"{""explanation"": ""The GWAS links dorsalgia-related loci to cartilage, bone, neurologic, and inflammatory pathways."", ""reference"": ""PMID:35110524"", ""snippet"": ""Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes."", ""supports"": ""SUPPORT""}"
2298	2092	93	Down_syndrome	Down_syndrome.yaml	pathophysiology	0	evidence	0	PMID:32029743	SUPPORT		Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of clinical features commonly known as Down syndrome (DS).	Establishes that trisomy 21 (extra chromosome 21) causes Down syndrome.	"{""explanation"": ""Establishes that trisomy 21 (extra chromosome 21) causes Down syndrome."", ""reference"": ""PMID:32029743"", ""snippet"": ""Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of clinical features commonly known as Down syndrome (DS)."", ""supports"": ""SUPPORT""}"
2307	2111	94	Dracunculiasis	Dracunculiasis.yaml	pathophysiology	0	evidence	0	PMID:27162746	SUPPORT		The transmitting vectors are Cyclops copepods (water fleas), which are tiny free-swimming crustaceans usually found abundantly in freshwater ponds.	The abstract identifies Cyclops copepods as transmitting vectors.	"{""explanation"": ""The abstract identifies Cyclops copepods as transmitting vectors."", ""reference"": ""PMID:27162746"", ""snippet"": ""The transmitting vectors are Cyclops copepods (water fleas), which are tiny free-swimming crustaceans usually found abundantly in freshwater ponds."", ""supports"": ""SUPPORT""}"
2310	2125	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	0	evidence	0	PMID:21463282	SUPPORT		Loss-of-function in Na(v) 1.1 channels results in severely impaired sodium current and action potential firing in hippocampal γ-aminobutyric acid (GABA)ergic interneurons without detectable changes in excitatory pyramidal neurons.		"{""reference"": ""PMID:21463282"", ""snippet"": ""Loss-of-function in Na(v) 1.1 channels results in severely impaired sodium current and action potential firing in hippocampal γ-aminobutyric acid (GABA)ergic interneurons without detectable changes in excitatory pyramidal neurons."", ""supports"": ""SUPPORT""}"
2311	2126	95	Dravet_syndrome	Dravet_syndrome.yaml	pathophysiology	1	evidence	0	PMID:21463282	SUPPORT		The resulting imbalance between excitation and inhibition likely contributes to hyperexcitability and seizures.		"{""reference"": ""PMID:21463282"", ""snippet"": ""The resulting imbalance between excitation and inhibition likely contributes to hyperexcitability and seizures."", ""supports"": ""SUPPORT""}"
2314	2153	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	0	evidence	0	PMID:37435300	SUPPORT		The identification of the dystrophin gene as central to DMD pathogenesis has led to the understanding of the muscle membrane and the proteins involved in membrane stability as the focal point of the disease.	Review confirms dystrophin gene mutations cause membrane instability as the central pathogenic mechanism.	"{""explanation"": ""Review confirms dystrophin gene mutations cause membrane instability as the central pathogenic mechanism."", ""reference"": ""PMID:37435300"", ""snippet"": ""The identification of the dystrophin gene as central to DMD pathogenesis has led to the understanding of the muscle membrane and the proteins involved in membrane stability as the focal point of the disease."", ""supports"": ""SUPPORT""}"
2315	2154	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	pathophysiology	1	evidence	0	PMID:37435300	SUPPORT		Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy.	Review confirms progressive muscle wasting is a defining feature of DMD.	"{""explanation"": ""Review confirms progressive muscle wasting is a defining feature of DMD."", ""reference"": ""PMID:37435300"", ""snippet"": ""Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy."", ""supports"": ""SUPPORT""}"
2331	2194	98	EGFR-Mutant Non-Small Cell Lung Cancer	EGFR_Mutant_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:15118073	SUPPORT		A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib.	This abstract links EGFR mutations in NSCLC with sensitivity to EGFR TKIs, supporting the role of activating EGFR mutations.	"{""explanation"": ""This abstract links EGFR mutations in NSCLC with sensitivity to EGFR TKIs, supporting the role of activating EGFR mutations."", ""reference"": ""PMID:15118073"", ""snippet"": ""A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib."", ""supports"": ""SUPPORT""}"
2335	2215	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	pathophysiology	0	evidence	0	PMID:41549581	SUPPORT		At the heart of this subtype is the estrogen signaling pathway, especially the estrogen receptor alpha (ERα), which plays a major role in the development, growth, and response to these cancers.	This abstract links ER+ breast cancer to estrogen receptor alpha-driven signaling, supporting the core mechanism described.	"{""explanation"": ""This abstract links ER+ breast cancer to estrogen receptor alpha-driven signaling, supporting the core mechanism described."", ""reference"": ""PMID:41549581"", ""snippet"": ""At the heart of this subtype is the estrogen signaling pathway, especially the estrogen receptor alpha (ERα), which plays a major role in the development, growth, and response to these cancers."", ""supports"": ""SUPPORT""}"
2452	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:7086195	SUPPORT		Several abnormalities in collagen biosynthesis have been described in patients with Ehlers-Danlos syndrome. Examples of collagen structural mutations as well as post-translational enzymatic defects have been detected.	This reference confirms that mutations affecting collagen synthesis and enzymes responsible for collagen modification are associated with Ehlers-Danlos Syndrome.	"{""explanation"": ""This reference confirms that mutations affecting collagen synthesis and enzymes responsible for collagen modification are associated with Ehlers-Danlos Syndrome."", ""reference"": ""PMID:7086195"", ""snippet"": ""Several abnormalities in collagen biosynthesis have been described in patients with Ehlers-Danlos syndrome. Examples of collagen structural mutations as well as post-translational enzymatic defects have been detected."", ""supports"": ""SUPPORT""}"
2453	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:37187299	SUPPORT		Vascular Ehlers-Danlos Syndrome (vEDS) is a rare autosomal dominant disease caused by mutations in the COL3A1 gene.	This reference identifies specific gene mutations (e.g., COL3A1) responsible for defective collagen synthesis leading to Ehlers-Danlos Syndrome.	"{""explanation"": ""This reference identifies specific gene mutations (e.g., COL3A1) responsible for defective collagen synthesis leading to Ehlers-Danlos Syndrome."", ""reference"": ""PMID:37187299"", ""snippet"": ""Vascular Ehlers-Danlos Syndrome (vEDS) is a rare autosomal dominant disease caused by mutations in the COL3A1 gene."", ""supports"": ""SUPPORT""}"
2454	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:2010058	SUPPORT		Recently, several mutations in three other collagen genes (COL2A1, COL3A1, and COL4A5) have been found in probands with genetic diseases involving tissues rich in these collagens.	The reference supports the statement by elaborating on how mutations in various collagen genes lead to defects tied to diseases including Ehlers-Danlos Syndrome.	"{""explanation"": ""The reference supports the statement by elaborating on how mutations in various collagen genes lead to defects tied to diseases including Ehlers-Danlos Syndrome."", ""reference"": ""PMID:2010058"", ""snippet"": ""Recently, several mutations in three other collagen genes (COL2A1, COL3A1, and COL4A5) have been found in probands with genetic diseases involving tissues rich in these collagens."", ""supports"": ""SUPPORT""}"
2455	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:30246406	SUPPORT		Human EDS may be caused by variants in several different genes including COL5A1, which encodes the collagen type V alpha 1 chain.	This reference describes how mutations in the COL5A1 gene can result in defective collagen synthesis, aligned with the nature of Ehlers-Danlos Syndrome.	"{""explanation"": ""This reference describes how mutations in the COL5A1 gene can result in defective collagen synthesis, aligned with the nature of Ehlers-Danlos Syndrome."", ""reference"": ""PMID:30246406"", ""snippet"": ""Human EDS may be caused by variants in several different genes including COL5A1, which encodes the collagen type V alpha 1 chain."", ""supports"": ""SUPPORT""}"
2456	2290	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	0	evidence	4	PMID:30668708	SUPPORT		Bi-allelic loss-of-function mutations in the adipocyte enhancer-binding protein 1 (AEBP1) gene were reported in three families with an autosomal recessive EDS-like condition.	The reference confirms that mutations in genes involved in collagen biosynthesis or assembly can lead to EDS-like conditions.	"{""explanation"": ""The reference confirms that mutations in genes involved in collagen biosynthesis or assembly can lead to EDS-like conditions."", ""reference"": ""PMID:30668708"", ""snippet"": ""Bi-allelic loss-of-function mutations in the adipocyte enhancer-binding protein 1 (AEBP1) gene were reported in three families with an autosomal recessive EDS-like condition."", ""supports"": ""SUPPORT""}"
2457	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:358109	SUPPORT		The cardinal features are cutaneous hyperextensibility, joint hypermobility, bleeding diathesis, and tissue fragility, and these features lead to a large variety of additional manifestations.	The provided snippet mentions tissue fragility as a cardinal feature of Ehlers-Danlos Syndrome (EDS), which is consistent with the statement that abnormal collagen leads to weakened connective tissues.	"{""explanation"": ""The provided snippet mentions tissue fragility as a cardinal feature of Ehlers-Danlos Syndrome (EDS), which is consistent with the statement that abnormal collagen leads to weakened connective tissues."", ""reference"": ""PMID:358109"", ""snippet"": ""The cardinal features are cutaneous hyperextensibility, joint hypermobility, bleeding diathesis, and tissue fragility, and these features lead to a large variety of additional manifestations."", ""supports"": ""SUPPORT""}"
2458	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:36960056	SUPPORT		pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex.	This reference explains that pEDS is related to these genetic mutations which interfere with the collagen matrix, fitting the description of abnormal collagen leading to connective tissue fragility.	"{""explanation"": ""This reference explains that pEDS is related to these genetic mutations which interfere with the collagen matrix, fitting the description of abnormal collagen leading to connective tissue fragility."", ""reference"": ""PMID:36960056"", ""snippet"": ""pEDS is caused by heterozygous missense mutations in C1R and C1S genes of the classical complement C1 complex."", ""supports"": ""SUPPORT""}"
2459	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:1448	SUPPORT		Any defect in the normal mechanisms responsible for the synthesis and secretion of collagen molecules or the deposition of these molecules into extracellular fibers could result in abnormal fibrillogenesis; such defects could result in a connective tissue disease.	This reference discusses how defects in collagen mechanisms can lead to connective tissue diseases, supporting the statement about abnormal collagen leading to connective tissue fragility.	"{""explanation"": ""This reference discusses how defects in collagen mechanisms can lead to connective tissue diseases, supporting the statement about abnormal collagen leading to connective tissue fragility."", ""reference"": ""PMID:1448"", ""snippet"": ""Any defect in the normal mechanisms responsible for the synthesis and secretion of collagen molecules or the deposition of these molecules into extracellular fibers could result in abnormal fibrillogenesis; such defects could result in a connective tissue disease."", ""supports"": ""SUPPORT""}"
2460	2291	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	1	evidence	3	PMID:31329366	SUPPORT		Collagen, which forms the framework of vessel walls, is altered in many patients with Ehlers-Danlos syndrome (EDS) leading to weakening of the vessel wall or the supporting tissues.	This reference directly supports the statement by mentioning how altered collagen in EDS patients leads to weakening of vessel walls and supporting tissues.	"{""explanation"": ""This reference directly supports the statement by mentioning how altered collagen in EDS patients leads to weakening of vessel walls and supporting tissues."", ""reference"": ""PMID:31329366"", ""snippet"": ""Collagen, which forms the framework of vessel walls, is altered in many patients with Ehlers-Danlos syndrome (EDS) leading to weakening of the vessel wall or the supporting tissues."", ""supports"": ""SUPPORT""}"
2461	2292	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:24443025	PARTIAL		The Ehlers-Danlos Syndromes comprise a heterogeneous group of diseases, which are characterized by fragility of the soft connective tissues and widespread manifestations in skin, ligaments and joints, blood vessels and internal organs... The clinical spectrum varies from mild skin and joint hyperlaxity to severe physical disability and life-threatening vascular complications.	The excerpt confirms tissue fragility and various manifestations affecting skin, joints, and internal organs, but does not explicitly mention every detail cited in the statement such as joint dislocations, organ ruptures, or poor wound healing.	"{""explanation"": ""The excerpt confirms tissue fragility and various manifestations affecting skin, joints, and internal organs, but does not explicitly mention every detail cited in the statement such as joint dislocations, organ ruptures, or poor wound healing."", ""reference"": ""PMID:24443025"", ""snippet"": ""The Ehlers-Danlos Syndromes comprise a heterogeneous group of diseases, which are characterized by fragility of the soft connective tissues and widespread manifestations in skin, ligaments and joints, blood vessels and internal organs... The clinical spectrum varies from mild skin and joint hyperlaxity to severe physical disability and life-threatening vascular complications."", ""supports"": ""PARTIAL""}"
2462	2292	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:29982180	PARTIAL		Arterial fragility is an important feature of the disease... Arterial fragility is an important characteristic of kyphoscoliotic EDS. It manifests as spontaneous arterial rupture, dissections and dissecting aneurysms.	The excerpt supports the statement by highlighting arterial fragility and spontaneous ruptures, contributing to tissue injury and dysfunction. However, it does not explicitly mention joint dislocations or poor wound healing.	"{""explanation"": ""The excerpt supports the statement by highlighting arterial fragility and spontaneous ruptures, contributing to tissue injury and dysfunction. However, it does not explicitly mention joint dislocations or poor wound healing."", ""reference"": ""PMID:29982180"", ""snippet"": ""Arterial fragility is an important feature of the disease... Arterial fragility is an important characteristic of kyphoscoliotic EDS. It manifests as spontaneous arterial rupture, dissections and dissecting aneurysms."", ""supports"": ""PARTIAL""}"
2463	2292	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	pathophysiology	2	evidence	2	PMID:19592142	PARTIAL		Easy bruising and bleeding are prominent features of some heritable disorders of connective tissue (HDCT), resulting from fragility of capillaries and the perivascular connective tissue... In the vascular subtype of EDS, caused by defects in type III collagen, fragility of vessel walls can lead to life-threatening bleeding and premature death.	The text discusses tissue fragility leading to bruising and bleeding, supporting aspects of tissue injury and dysfunction. However, it does not explicitly address joint dislocations or organ ruptures.	"{""explanation"": ""The text discusses tissue fragility leading to bruising and bleeding, supporting aspects of tissue injury and dysfunction. However, it does not explicitly address joint dislocations or organ ruptures."", ""reference"": ""PMID:19592142"", ""snippet"": ""Easy bruising and bleeding are prominent features of some heritable disorders of connective tissue (HDCT), resulting from fragility of capillaries and the perivascular connective tissue... In the vascular subtype of EDS, caused by defects in type III collagen, fragility of vessel walls can lead to life-threatening bleeding and premature death."", ""supports"": ""PARTIAL""}"
2524	2319	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	0	evidence	0	PMID:9042913	SUPPORT		The mutation causes the substitution of the most 5' cysteine residue by a serine within a highly conserved sequence of the pro(alpha)1(V) C-propeptide domain and causes reduction of collagen V by preventing incorporation of the mutant pro(alpha)1(V) chains in the collagen V trimers.	This reference describes how mutations in COL5A1 lead to defective synthesis and assembly of collagen type V, supporting the given statement.	"{""explanation"": ""This reference describes how mutations in COL5A1 lead to defective synthesis and assembly of collagen type V, supporting the given statement."", ""reference"": ""PMID:9042913"", ""snippet"": ""The mutation causes the substitution of the most 5' cysteine residue by a serine within a highly conserved sequence of the pro(alpha)1(V) C-propeptide domain and causes reduction of collagen V by preventing incorporation of the mutant pro(alpha)1(V) chains in the collagen V trimers."", ""supports"": ""SUPPORT""}"
2525	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	evidence	0	PMID:20847697	SUPPORT		In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen.	The literature indicates that mutations in the COL5A1 gene lead to abnormalities in collagen type V, resulting in weakened connective tissues.	"{""explanation"": ""The literature indicates that mutations in the COL5A1 gene lead to abnormalities in collagen type V, resulting in weakened connective tissues."", ""reference"": ""PMID:20847697"", ""snippet"": ""In the majority of patients with molecularly characterized classic Ehlers-Danlos syndrome, the disease is caused by a mutation leading to a nonfunctional COL5A1 allele and resulting in haploinsufficiency of type V collagen."", ""supports"": ""SUPPORT""}"
2526	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	evidence	1	PMID:15095409	SUPPORT		EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts. ... a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and OI cells.	This study demonstrates that reduced type V collagen results in weaker connective tissue due to a significant decrease in collagen fibril assembly.	"{""explanation"": ""This study demonstrates that reduced type V collagen results in weaker connective tissue due to a significant decrease in collagen fibril assembly."", ""reference"": ""PMID:15095409"", ""snippet"": ""EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts. ... a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and OI cells."", ""supports"": ""SUPPORT""}"
2527	2320	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	1	evidence	2	PMID:12836217	SUPPORT		The classical form of the syndrome, which will be principally discussed in this review, can be due to mutations on collagen V, a fibrillar collagen present in small amounts in affected tissues.	The literature describes the role of collagen V and its mutations in causing connective tissue fragility, therefore supporting the statement.	"{""explanation"": ""The literature describes the role of collagen V and its mutations in causing connective tissue fragility, therefore supporting the statement."", ""reference"": ""PMID:12836217"", ""snippet"": ""The classical form of the syndrome, which will be principally discussed in this review, can be due to mutations on collagen V, a fibrillar collagen present in small amounts in affected tissues."", ""supports"": ""SUPPORT""}"
2528	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	evidence	0	PMID:19370768	SUPPORT		Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing.	The provided literature directly supports the claim that Ehlers-Danlos Syndrome, particularly related to COL5A1, results in fragile tissues leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing.	"{""explanation"": ""The provided literature directly supports the claim that Ehlers-Danlos Syndrome, particularly related to COL5A1, results in fragile tissues leading to manifestations like joint dislocations, skin hyperextensibility, and poor wound healing."", ""reference"": ""PMID:19370768"", ""snippet"": ""Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing."", ""supports"": ""SUPPORT""}"
2529	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	evidence	1	PMID:19592142	SUPPORT		The bleeding tendency is most prominent in the Ehlers-Danlos syndrome (EDS), a heterogeneous group of HDCT sharing clinical manifestations of fragility in skin, ligaments, blood vessels and internal organs.	The literature mentions fragility in tissues due to EDS, consistent with fragile tissues leading to manifestations such as joint dislocations and skin hyperextensibility.	"{""explanation"": ""The literature mentions fragility in tissues due to EDS, consistent with fragile tissues leading to manifestations such as joint dislocations and skin hyperextensibility."", ""reference"": ""PMID:19592142"", ""snippet"": ""The bleeding tendency is most prominent in the Ehlers-Danlos syndrome (EDS), a heterogeneous group of HDCT sharing clinical manifestations of fragility in skin, ligaments, blood vessels and internal organs."", ""supports"": ""SUPPORT""}"
2530	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	evidence	2	PMID:20697718	SUPPORT		Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility.	The literature supports the claim, highlighting tissue fragility, joint hypermobility, and skin hyperextensibility as key characteristics.	"{""explanation"": ""The literature supports the claim, highlighting tissue fragility, joint hypermobility, and skin hyperextensibility as key characteristics."", ""reference"": ""PMID:20697718"", ""snippet"": ""Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility."", ""supports"": ""SUPPORT""}"
2531	2321	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	pathophysiology	2	evidence	3	PMID:19055167	SUPPORT		Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, 'cigarette-paper' scarring over bony prominences.	This reference supports the claim, describing characteristics that align with tissue fragility and symptoms such as joint dislocations, skin hyperextensibility, and poor wound healing.	"{""explanation"": ""This reference supports the claim, describing characteristics that align with tissue fragility and symptoms such as joint dislocations, skin hyperextensibility, and poor wound healing."", ""reference"": ""PMID:19055167"", ""snippet"": ""Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, 'cigarette-paper' scarring over bony prominences."", ""supports"": ""SUPPORT""}"
2569	2348	103	Embryonal Rhabdomyosarcoma	Embryonal_Rhabdomyosarcoma.yaml	pathophysiology	0	evidence	0	PMID:10095436	SUPPORT		Allelic losses of 11p15.5 are characteristic of embryonal RMS (eRMS), whereas an increase in the expression of the Igf2 gene located on 11p15.5 has regularly been observed in eRMS and alveolar RMS (aRMS).	Supports 11p15.5 loss of heterozygosity as characteristic of embryonal rhabdomyosarcoma.	"{""explanation"": ""Supports 11p15.5 loss of heterozygosity as characteristic of embryonal rhabdomyosarcoma."", ""reference"": ""PMID:10095436"", ""snippet"": ""Allelic losses of 11p15.5 are characteristic of embryonal RMS (eRMS), whereas an increase in the expression of the Igf2 gene located on 11p15.5 has regularly been observed in eRMS and alveolar RMS (aRMS)."", ""supports"": ""SUPPORT""}"
2570	2368	104	Endometriosis	Endometriosis.yaml	pathophysiology	0	evidence	0	PMID:16166933	SUPPORT		Endometriosis is classically described as the presence of both endometrial glandular and stromal cells outside the uterine cavity, mainly in the pelvis.	Defines endometriosis as ectopic presence of endometrial glandular and stromal cells outside the uterus	"{""explanation"": ""Defines endometriosis as ectopic presence of endometrial glandular and stromal cells outside the uterus"", ""reference"": ""PMID:16166933"", ""snippet"": ""Endometriosis is classically described as the presence of both endometrial glandular and stromal cells outside the uterine cavity, mainly in the pelvis."", ""supports"": ""SUPPORT""}"
2571	2369	104	Endometriosis	Endometriosis.yaml	pathophysiology	1	evidence	0	PMID:16166933	SUPPORT		Although multiple theories have been put forth to explain the pathophysiology and pathogenesis of endometriosis, the retrograde menstruation theory of Sampson is the most widely accepted. However, since retrograde menstruation occurs in most of the reproductive age women, it is clear that there must be other factors which may contribute to the implantation of endometrial cells and their subsequent development into endometriotic disease.	Retrograde menstruation is the most widely accepted theory but insufficient alone to explain disease development	"{""explanation"": ""Retrograde menstruation is the most widely accepted theory but insufficient alone to explain disease development"", ""reference"": ""PMID:16166933"", ""snippet"": ""Although multiple theories have been put forth to explain the pathophysiology and pathogenesis of endometriosis, the retrograde menstruation theory of Sampson is the most widely accepted. However, since retrograde menstruation occurs in most of the reproductive age women, it is clear that there must be other factors which may contribute to the implantation of endometrial cells and their subsequent development into endometriotic disease."", ""supports"": ""SUPPORT""}"
2572	2370	104	Endometriosis	Endometriosis.yaml	pathophysiology	2	evidence	0	PMID:16166933	SUPPORT		Increased levels of several cytokines and growth factors which are secreted by either immune and endometrial cells seem to promote implantation and growth of ectopic endometrium by inducing proliferation and angiogenesis.	Elevated cytokines and growth factors in the inflammatory milieu support lesion implantation and growth	"{""explanation"": ""Elevated cytokines and growth factors in the inflammatory milieu support lesion implantation and growth"", ""reference"": ""PMID:16166933"", ""snippet"": ""Increased levels of several cytokines and growth factors which are secreted by either immune and endometrial cells seem to promote implantation and growth of ectopic endometrium by inducing proliferation and angiogenesis."", ""supports"": ""SUPPORT""}"
2573	2371	104	Endometriosis	Endometriosis.yaml	pathophysiology	3	evidence	0	PMID:10731122	SUPPORT		Estrogen is the most important known factor that stimulates the growth of endometriosis. Estrogen delivery to endometriotic implants was classically viewed to be only via the circulating blood in an endocrine fashion. We recently uncovered an autocrine positive feedback mechanism, which favored the continuous production of estrogen and prostaglandin (PG)E2 in the endometriotic stromal cells.	Estrogen drives endometriosis growth through both systemic delivery and local autocrine production	"{""explanation"": ""Estrogen drives endometriosis growth through both systemic delivery and local autocrine production"", ""reference"": ""PMID:10731122"", ""snippet"": ""Estrogen is the most important known factor that stimulates the growth of endometriosis. Estrogen delivery to endometriotic implants was classically viewed to be only via the circulating blood in an endocrine fashion. We recently uncovered an autocrine positive feedback mechanism, which favored the continuous production of estrogen and prostaglandin (PG)E2 in the endometriotic stromal cells."", ""supports"": ""SUPPORT""}"
2574	2371	104	Endometriosis	Endometriosis.yaml	pathophysiology	3	evidence	1	PMID:10731122	SUPPORT		The enzyme, aromatase, is aberrantly expressed in endometriotic stromal cells and catalyzes the conversion of C19 steroids to estrogens, which then stimulate cyclooxygenase-2 to increase the levels of PGE2. PGE2, in turn, is a potent inducer of aromatase activity in endometriotic stromal cells. Aromatase is not expressed in the eutopic endometrium.	Aromatase expression in endometriotic stromal cells creates a positive feedback loop with PGE2 for local estrogen production	"{""explanation"": ""Aromatase expression in endometriotic stromal cells creates a positive feedback loop with PGE2 for local estrogen production"", ""reference"": ""PMID:10731122"", ""snippet"": ""The enzyme, aromatase, is aberrantly expressed in endometriotic stromal cells and catalyzes the conversion of C19 steroids to estrogens, which then stimulate cyclooxygenase-2 to increase the levels of PGE2. PGE2, in turn, is a potent inducer of aromatase activity in endometriotic stromal cells. Aromatase is not expressed in the eutopic endometrium."", ""supports"": ""SUPPORT""}"
2575	2371	104	Endometriosis	Endometriosis.yaml	pathophysiology	3	evidence	2	PMID:10731122	SUPPORT		In addition, we find that endometriotic tissue is deficient in 17beta-hydroxysteroid dehydrogenase type 2, which is normally expressed in eutopic endometrial glandular cells and inactivates estradiol-17beta to estrone. This deficiency is another aberration that favors higher levels of estradiol-17beta in endometriotic tissues in comparison with the eutopic endometrium.	Deficiency of 17beta-HSD type 2 prevents estradiol inactivation, contributing to local estrogen dominance	"{""explanation"": ""Deficiency of 17beta-HSD type 2 prevents estradiol inactivation, contributing to local estrogen dominance"", ""reference"": ""PMID:10731122"", ""snippet"": ""In addition, we find that endometriotic tissue is deficient in 17beta-hydroxysteroid dehydrogenase type 2, which is normally expressed in eutopic endometrial glandular cells and inactivates estradiol-17beta to estrone. This deficiency is another aberration that favors higher levels of estradiol-17beta in endometriotic tissues in comparison with the eutopic endometrium."", ""supports"": ""SUPPORT""}"
2576	2372	104	Endometriosis	Endometriosis.yaml	pathophysiology	4	evidence	0	PMID:16166933	SUPPORT		Increased number and activation of peritoneal macrophages, decreased T cell and natural killer (NK) cell cytotoxicities are the alterations in cellular immunity and result in inadequate removal of ectopic endometrial cells from the peritoneal cavity.	Immune cell dysfunction leads to impaired clearance of ectopic endometrial cells	"{""explanation"": ""Immune cell dysfunction leads to impaired clearance of ectopic endometrial cells"", ""reference"": ""PMID:16166933"", ""snippet"": ""Increased number and activation of peritoneal macrophages, decreased T cell and natural killer (NK) cell cytotoxicities are the alterations in cellular immunity and result in inadequate removal of ectopic endometrial cells from the peritoneal cavity."", ""supports"": ""SUPPORT""}"
2577	2372	104	Endometriosis	Endometriosis.yaml	pathophysiology	4	evidence	1	PMID:28971893	SUPPORT		The dysfunction of NK cells in women with endometriosis (EMS) contributes to the immune escape of menstrual endometrial fragments refluxed into the peritoneal cavity.	NK cell dysfunction is a key mechanism enabling immune escape of refluxed endometrial fragments	"{""explanation"": ""NK cell dysfunction is a key mechanism enabling immune escape of refluxed endometrial fragments"", ""reference"": ""PMID:28971893"", ""snippet"": ""The dysfunction of NK cells in women with endometriosis (EMS) contributes to the immune escape of menstrual endometrial fragments refluxed into the peritoneal cavity."", ""supports"": ""SUPPORT""}"
2578	2372	104	Endometriosis	Endometriosis.yaml	pathophysiology	4	evidence	2	PMID:28971893	SUPPORT		After incubation with ESCs and macrophages, the expression of CD16, NKG2D, perforin and IFN-γ, viability and cytotoxicity of NK cells were significantly downregulated. The secretion of interleukin (IL)-1β, IL-10 and transforming growth factor (TGF)-β in the co-culture system of ESCs and macrophages was increased.	Interaction between endometrial stromal cells and macrophages suppresses NK cell cytotoxicity through IL-10 and TGF-beta	"{""explanation"": ""Interaction between endometrial stromal cells and macrophages suppresses NK cell cytotoxicity through IL-10 and TGF-beta"", ""reference"": ""PMID:28971893"", ""snippet"": ""After incubation with ESCs and macrophages, the expression of CD16, NKG2D, perforin and IFN-γ, viability and cytotoxicity of NK cells were significantly downregulated. The secretion of interleukin (IL)-1β, IL-10 and transforming growth factor (TGF)-β in the co-culture system of ESCs and macrophages was increased."", ""supports"": ""SUPPORT""}"
2579	2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	evidence	0	PMID:26408396	SUPPORT		Endometriosis is associated with local angiogenic and hypoxic mechanisms. Indeed, peritoneal fluid of women with endometriosis generates a specific microenvironment to support the growth and development of ectopic endometrial tissues.	Angiogenic and hypoxic mechanisms create a supportive microenvironment for ectopic lesion growth	"{""explanation"": ""Angiogenic and hypoxic mechanisms create a supportive microenvironment for ectopic lesion growth"", ""reference"": ""PMID:26408396"", ""snippet"": ""Endometriosis is associated with local angiogenic and hypoxic mechanisms. Indeed, peritoneal fluid of women with endometriosis generates a specific microenvironment to support the growth and development of ectopic endometrial tissues."", ""supports"": ""SUPPORT""}"
2580	2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	evidence	1	PMID:26408396	SUPPORT		Ovarian endometrioma expresses high levels of HIF-1/2α, PAR-1/4, and VEGF-A, while DIE did not show significantly different gene expression compared to endometrium from unaffected women. A positive correlation between the expression of HIF-1/2α and VEGF-A mRNA was observed in OMA.	Ovarian endometriomas specifically show elevated hypoxia-inducible factors and VEGF with correlated expression	"{""explanation"": ""Ovarian endometriomas specifically show elevated hypoxia-inducible factors and VEGF with correlated expression"", ""reference"": ""PMID:26408396"", ""snippet"": ""Ovarian endometrioma expresses high levels of HIF-1/2α, PAR-1/4, and VEGF-A, while DIE did not show significantly different gene expression compared to endometrium from unaffected women. A positive correlation between the expression of HIF-1/2α and VEGF-A mRNA was observed in OMA."", ""supports"": ""SUPPORT""}"
2581	2373	104	Endometriosis	Endometriosis.yaml	pathophysiology	5	evidence	2	PMID:30074218	SUPPORT		The results showed that serum concentrations of MMIF, HIF-1α, and VEGF were significantly higher in EM patients than in controls (P<0.05). The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05).	HIF-1alpha and VEGF expression correlates with disease stage and dysmenorrhea severity	"{""explanation"": ""HIF-1alpha and VEGF expression correlates with disease stage and dysmenorrhea severity"", ""reference"": ""PMID:30074218"", ""snippet"": ""The results showed that serum concentrations of MMIF, HIF-1α, and VEGF were significantly higher in EM patients than in controls (P<0.05). The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05)."", ""supports"": ""SUPPORT""}"
2586	2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	evidence	0	PMID:39056027	SUPPORT		Patients with temporal lobe epilepsy showed a significantly larger exponent, corresponding to inhibition-directed E/I balance, in bilateral frontal and temporal regions.	Demonstrates measurable excitation/inhibition imbalance in epilepsy patients using EEG aperiodic exponent as a proxy for E/I balance.	"{""explanation"": ""Demonstrates measurable excitation/inhibition imbalance in epilepsy patients using EEG aperiodic exponent as a proxy for E/I balance."", ""reference"": ""PMID:39056027"", ""snippet"": ""Patients with temporal lobe epilepsy showed a significantly larger exponent, corresponding to inhibition-directed E/I balance, in bilateral frontal and temporal regions."", ""supports"": ""SUPPORT""}"
2587	2405	105	Epilepsy	Epilepsy.yaml	pathophysiology	0	evidence	1	PMID:39056027	SUPPORT		Limited to patients with temporal lobe epilepsy, we detected a significant correlation between the exponent and the cortical expression of GABRA1, GRIN2A, GABRD, GABRG2, KCNA2 and PDYN genes.	Links E/I imbalance to expression of key genes encoding GABA receptors, glutamate receptors, and ion channels, supporting the molecular basis of hyperexcitability.	"{""explanation"": ""Links E/I imbalance to expression of key genes encoding GABA receptors, glutamate receptors, and ion channels, supporting the molecular basis of hyperexcitability."", ""reference"": ""PMID:39056027"", ""snippet"": ""Limited to patients with temporal lobe epilepsy, we detected a significant correlation between the exponent and the cortical expression of GABRA1, GRIN2A, GABRD, GABRG2, KCNA2 and PDYN genes."", ""supports"": ""SUPPORT""}"
2588	2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	evidence	0	PMID:35422069	SUPPORT		claudin-5 protein levels are significantly diminished in surgically resected brain tissue from patients with treatment-resistant epilepsy. Concomitantly, dynamic contrast-enhanced MRI in these patients showed widespread BBB disruption.	Demonstrates that BBB dysfunction occurs in human epilepsy patients and is characterized by loss of tight junction proteins.	"{""explanation"": ""Demonstrates that BBB dysfunction occurs in human epilepsy patients and is characterized by loss of tight junction proteins."", ""reference"": ""PMID:35422069"", ""snippet"": ""claudin-5 protein levels are significantly diminished in surgically resected brain tissue from patients with treatment-resistant epilepsy. Concomitantly, dynamic contrast-enhanced MRI in these patients showed widespread BBB disruption."", ""supports"": ""SUPPORT""}"
2589	2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	evidence	1	PMID:35422069	SUPPORT		inducible knockdown of claudin-5 in mice leads to spontaneous recurrent seizures, severe neuroinflammation, and mortality.	Establishes causal role of BBB dysfunction in seizure generation, showing that disruption of endothelial tight junctions is sufficient to trigger spontaneous seizures.	"{""explanation"": ""Establishes causal role of BBB dysfunction in seizure generation, showing that disruption of endothelial tight junctions is sufficient to trigger spontaneous seizures."", ""reference"": ""PMID:35422069"", ""snippet"": ""inducible knockdown of claudin-5 in mice leads to spontaneous recurrent seizures, severe neuroinflammation, and mortality."", ""supports"": ""SUPPORT""}"
2590	2406	105	Epilepsy	Epilepsy.yaml	pathophysiology	1	evidence	2	PMID:35422069	SUPPORT		RepSox, a regulator of claudin-5 expression, can prevent seizure activity in experimental epilepsy.	Provides proof-of-concept that stabilizing the BBB through claudin-5 upregulation can prevent seizures, supporting BBB as a therapeutic target.	"{""explanation"": ""Provides proof-of-concept that stabilizing the BBB through claudin-5 upregulation can prevent seizures, supporting BBB as a therapeutic target."", ""reference"": ""PMID:35422069"", ""snippet"": ""RepSox, a regulator of claudin-5 expression, can prevent seizure activity in experimental epilepsy."", ""supports"": ""SUPPORT""}"
2591	2410	105	Epilepsy	Epilepsy.yaml	pathophysiology	5	evidence	0	PMID:31174205	SUPPORT		Treatment with the mTORC1 inhibitor rapamycin starting after 3 weeks of age significantly prolonged the survival of Depdc5cc+ mice and partially rescued the behavioral hyperactivity.	Demonstrates that mTORC1 pathway hyperactivation caused by DEPDC5 loss drives epilepsy pathogenesis and that mTOR inhibition can rescue the phenotype.	"{""explanation"": ""Demonstrates that mTORC1 pathway hyperactivation caused by DEPDC5 loss drives epilepsy pathogenesis and that mTOR inhibition can rescue the phenotype."", ""reference"": ""PMID:31174205"", ""snippet"": ""Treatment with the mTORC1 inhibitor rapamycin starting after 3 weeks of age significantly prolonged the survival of Depdc5cc+ mice and partially rescued the behavioral hyperactivity."", ""supports"": ""SUPPORT""}"
2592	2410	105	Epilepsy	Epilepsy.yaml	pathophysiology	5	evidence	1	PMID:31174205	SUPPORT		Rapamycin decreased the enlarged brain size of Depdc5cc+ mice with corresponding decrease in neuronal soma size.	Shows that mTOR hyperactivation causes abnormal neuronal growth contributing to epileptogenesis, which can be reversed by mTOR inhibition.	"{""explanation"": ""Shows that mTOR hyperactivation causes abnormal neuronal growth contributing to epileptogenesis, which can be reversed by mTOR inhibition."", ""reference"": ""PMID:31174205"", ""snippet"": ""Rapamycin decreased the enlarged brain size of Depdc5cc+ mice with corresponding decrease in neuronal soma size."", ""supports"": ""SUPPORT""}"
2593	2411	105	Epilepsy	Epilepsy.yaml	pathophysiology	6	evidence	0	PMID:38710875	SUPPORT		We uncovered multiple signatures of cellular senescence in these pathological cells, including p53/p16 expression, SASP expression and senescence-associated β-galactosidase activity.	Identifies cellular senescence as a novel mechanism in mTOR-related focal cortical dysplasia, linking dysmorphic neurons to epileptogenesis.	"{""explanation"": ""Identifies cellular senescence as a novel mechanism in mTOR-related focal cortical dysplasia, linking dysmorphic neurons to epileptogenesis."", ""reference"": ""PMID:38710875"", ""snippet"": ""We uncovered multiple signatures of cellular senescence in these pathological cells, including p53/p16 expression, SASP expression and senescence-associated β-galactosidase activity."", ""supports"": ""SUPPORT""}"
2594	2411	105	Epilepsy	Epilepsy.yaml	pathophysiology	6	evidence	1	PMID:38710875	SUPPORT		administration of senolytic drugs (dasatinib/quercetin) decreases the load of senescent cells and reduces seizure frequency in an MtorS2215F FCDII preclinical mouse model	Provides proof-of-concept for targeting senescent dysmorphic neurons as a disease-modifying therapeutic strategy in mTOR-related epilepsy.	"{""explanation"": ""Provides proof-of-concept for targeting senescent dysmorphic neurons as a disease-modifying therapeutic strategy in mTOR-related epilepsy."", ""reference"": ""PMID:38710875"", ""snippet"": ""administration of senolytic drugs (dasatinib/quercetin) decreases the load of senescent cells and reduces seizure frequency in an MtorS2215F FCDII preclinical mouse model"", ""supports"": ""SUPPORT""}"
2602	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	evidence	0	PMID:37080965	SUPPORT		The alterations in signaling pathways in these cells are the key molecular mechanisms underlying vascular dysfunction and hypertension development.	This supports the central role of vascular dysfunction in hypertension pathophysiology.	"{""explanation"": ""This supports the central role of vascular dysfunction in hypertension pathophysiology."", ""reference"": ""PMID:37080965"", ""snippet"": ""The alterations in signaling pathways in these cells are the key molecular mechanisms underlying vascular dysfunction and hypertension development."", ""supports"": ""SUPPORT""}"
2603	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	evidence	1	PMID:38172242	SUPPORT		Effector mediators impair nitric oxide bioavailability, leading to endothelial dysfunction and increased vascular contractility.	This describes the mechanism by which endothelial dysfunction increases vascular resistance.	"{""explanation"": ""This describes the mechanism by which endothelial dysfunction increases vascular resistance."", ""reference"": ""PMID:38172242"", ""snippet"": ""Effector mediators impair nitric oxide bioavailability, leading to endothelial dysfunction and increased vascular contractility."", ""supports"": ""SUPPORT""}"
2604	2431	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	0	evidence	2	PMID:36703963	SUPPORT		Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling.	This confirms the role of vascular remodeling in increasing resistance.	"{""explanation"": ""This confirms the role of vascular remodeling in increasing resistance."", ""reference"": ""PMID:36703963"", ""snippet"": ""Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling."", ""supports"": ""SUPPORT""}"
2605	2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	evidence	0	PMID:39765782	SUPPORT		Activation of intrarenal angiotensin II receptors contributes to sodium retention and high BP.	This directly supports RAAS activation causing sodium retention and elevated blood pressure.	"{""explanation"": ""This directly supports RAAS activation causing sodium retention and elevated blood pressure."", ""reference"": ""PMID:39765782"", ""snippet"": ""Activation of intrarenal angiotensin II receptors contributes to sodium retention and high BP."", ""supports"": ""SUPPORT""}"
2606	2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	evidence	1	PMID:39765782	SUPPORT		Oxidative stress, inflammation, and activation of the renin-angiotensin-aldosterone system (RAAS) play critical roles in causing kidney injury in HTN.	This confirms RAAS activation as a critical mechanism in hypertension.	"{""explanation"": ""This confirms RAAS activation as a critical mechanism in hypertension."", ""reference"": ""PMID:39765782"", ""snippet"": ""Oxidative stress, inflammation, and activation of the renin-angiotensin-aldosterone system (RAAS) play critical roles in causing kidney injury in HTN."", ""supports"": ""SUPPORT""}"
2607	2432	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	1	evidence	2	PMID:37080965	SUPPORT		In this manuscript, we will comprehensively review the signaling pathways involved in vascular function regulation and hypertension progression, including calcium pathway, NO-NOsGC-cGMP pathway, various vascular remodeling pathways and some important upstream pathways such as renin-angiotensin-aldosterone system, oxidative stress-related signaling pathway, immunity/inflammation pathway, etc.	This confirms RAAS as a key upstream pathway driving hypertension.	"{""explanation"": ""This confirms RAAS as a key upstream pathway driving hypertension."", ""reference"": ""PMID:37080965"", ""snippet"": ""In this manuscript, we will comprehensively review the signaling pathways involved in vascular function regulation and hypertension progression, including calcium pathway, NO-NOsGC-cGMP pathway, various vascular remodeling pathways and some important upstream pathways such as renin-angiotensin-aldosterone system, oxidative stress-related signaling pathway, immunity/inflammation pathway, etc."", ""supports"": ""SUPPORT""}"
2608	2433	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	2	evidence	0	PMID:38172242	SUPPORT		Neoantigens, the NLRP3 inflammasome and increased sympathetic outflow, as well as cytokines (including IL-6, IL-7, IL-15, IL-18 and IL-21) and a high-salt environment, can contribute to immune activation in hypertension.	This confirms increased sympathetic outflow as a contributor to hypertension pathogenesis.	"{""explanation"": ""This confirms increased sympathetic outflow as a contributor to hypertension pathogenesis."", ""reference"": ""PMID:38172242"", ""snippet"": ""Neoantigens, the NLRP3 inflammasome and increased sympathetic outflow, as well as cytokines (including IL-6, IL-7, IL-15, IL-18 and IL-21) and a high-salt environment, can contribute to immune activation in hypertension."", ""supports"": ""SUPPORT""}"
2609	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	evidence	0	PMID:38172242	SUPPORT		T cells, monocytes, macrophages, dendritic cells, B cells and natural killer cells are all implicated in hypertension.	This establishes the broad involvement of immune cells in hypertension.	"{""explanation"": ""This establishes the broad involvement of immune cells in hypertension."", ""reference"": ""PMID:38172242"", ""snippet"": ""T cells, monocytes, macrophages, dendritic cells, B cells and natural killer cells are all implicated in hypertension."", ""supports"": ""SUPPORT""}"
2610	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	evidence	1	PMID:38172242	SUPPORT		The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia.	This describes how immune cell infiltration leads to target organ damage in hypertension.	"{""explanation"": ""This describes how immune cell infiltration leads to target organ damage in hypertension."", ""reference"": ""PMID:38172242"", ""snippet"": ""The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia."", ""supports"": ""SUPPORT""}"
2611	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	evidence	2	PMID:36703963	SUPPORT		Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension.	This confirms the role of chronic inflammation in hypertension pathogenesis.	"{""explanation"": ""This confirms the role of chronic inflammation in hypertension pathogenesis."", ""reference"": ""PMID:36703963"", ""snippet"": ""Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension."", ""supports"": ""SUPPORT""}"
2612	2434	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	3	evidence	3	PMID:38164753	SUPPORT		Elevated sodium activates antigen-presenting cells to release proinflammatory cytokines including IL (interleukin) 6, tumor necrosis factor-α, IL-1β, and accumulate isolevuglandin-protein adducts. In turn, these activate T cells release prohypertensive cytokines including IL-17A.	This describes the salt-sensitive immune activation pathway driving hypertension.	"{""explanation"": ""This describes the salt-sensitive immune activation pathway driving hypertension."", ""reference"": ""PMID:38164753"", ""snippet"": ""Elevated sodium activates antigen-presenting cells to release proinflammatory cytokines including IL (interleukin) 6, tumor necrosis factor-α, IL-1β, and accumulate isolevuglandin-protein adducts. In turn, these activate T cells release prohypertensive cytokines including IL-17A."", ""supports"": ""SUPPORT""}"
2613	2435	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	4	evidence	0	PMID:39765782	SUPPORT		Overproduction of reactive oxygen species (ROS) plays a crucial role in the development and progression of HTN, impacting renal function and BP regulation.	This establishes the central role of ROS in hypertension development.	"{""explanation"": ""This establishes the central role of ROS in hypertension development."", ""reference"": ""PMID:39765782"", ""snippet"": ""Overproduction of reactive oxygen species (ROS) plays a crucial role in the development and progression of HTN, impacting renal function and BP regulation."", ""supports"": ""SUPPORT""}"
2614	2435	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	4	evidence	1	PMID:39765782	SUPPORT		Targeting specific NADPH oxidase (NOX) isoforms to inhibit ROS production and enhance antioxidant mechanisms may improve renal structure and function while lowering blood pressure.	This confirms NOX enzymes as key sources of pathogenic ROS in hypertension.	"{""explanation"": ""This confirms NOX enzymes as key sources of pathogenic ROS in hypertension."", ""reference"": ""PMID:39765782"", ""snippet"": ""Targeting specific NADPH oxidase (NOX) isoforms to inhibit ROS production and enhance antioxidant mechanisms may improve renal structure and function while lowering blood pressure."", ""supports"": ""SUPPORT""}"
2615	2435	106	Essential Hypertension	Essential_Hypertension.yaml	pathophysiology	4	evidence	2	PMID:36703963	SUPPORT		In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction.	This describes how immune activation leads to oxidative stress and endothelial dysfunction.	"{""explanation"": ""This describes how immune activation leads to oxidative stress and endothelial dysfunction."", ""reference"": ""PMID:36703963"", ""snippet"": ""In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction."", ""supports"": ""SUPPORT""}"
2628	2452	107	Essential Thrombocythemia	Essential_Thrombocythemia.yaml	pathophysiology	0	evidence	0	PMID:41577837	SUPPORT		Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative neoplasms (MPNs), often associated with mutations in JAK2, CALR, and MPL.	This abstract links ET to JAK2/CALR/MPL mutations, supporting the JAK-STAT activation described.	"{""explanation"": ""This abstract links ET to JAK2/CALR/MPL mutations, supporting the JAK-STAT activation described."", ""reference"": ""PMID:41577837"", ""snippet"": ""Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative neoplasms (MPNs), often associated with mutations in JAK2, CALR, and MPL."", ""supports"": ""SUPPORT""}"
2630	2470	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	0	evidence	0	PMID:33741715	SUPPORT		Ewing sarcomas are driven by EWS-ETS fusions, most commonly EWS-FLI1, which promotes widespread metabolic reprogramming, including activation of serine biosynthesis.	This study demonstrates that EWS-FLI1 is the driver fusion oncogene in Ewing sarcoma that activates transcriptional programs including metabolic reprogramming.	"{""explanation"": ""This study demonstrates that EWS-FLI1 is the driver fusion oncogene in Ewing sarcoma that activates transcriptional programs including metabolic reprogramming."", ""reference"": ""PMID:33741715"", ""snippet"": ""Ewing sarcomas are driven by EWS-ETS fusions, most commonly EWS-FLI1, which promotes widespread metabolic reprogramming, including activation of serine biosynthesis."", ""supports"": ""SUPPORT""}"
2631	2471	108	Ewing Sarcoma	Ewing_Sarcoma.yaml	pathophysiology	1	evidence	0	PMID:33741715	SUPPORT		We identified and validated an EWS-FLI1 binding site at the ATF4 promoter, indicating that the fusion can directly activate ATF4 transcription.	This study demonstrates that EWS-FLI1 functions as an aberrant transcription factor that directly binds promoter regions to activate target genes.	"{""explanation"": ""This study demonstrates that EWS-FLI1 functions as an aberrant transcription factor that directly binds promoter regions to activate target genes."", ""reference"": ""PMID:33741715"", ""snippet"": ""We identified and validated an EWS-FLI1 binding site at the ATF4 promoter, indicating that the fusion can directly activate ATF4 transcription."", ""supports"": ""SUPPORT""}"
2634	2489	109	FGFR-Altered Cholangiocarcinoma	FGFR_Altered_Cholangiocarcinoma.yaml	pathophysiology	0	evidence	0	PMID:36535760	SUPPORT		Gene fusions are among the most frequent alterations, involving FGFR2 in 10-15% of iCCAs in particular, and NTRK genes at a lower frequency (<1%).	Supports FGFR2 fusions as frequent alterations in intrahepatic cholangiocarcinoma.	"{""explanation"": ""Supports FGFR2 fusions as frequent alterations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:36535760"", ""snippet"": ""Gene fusions are among the most frequent alterations, involving FGFR2 in 10-15% of iCCAs in particular, and NTRK genes at a lower frequency (<1%)."", ""supports"": ""SUPPORT""}"
2667	2554	112	Acute Myeloid Leukemia, FLT3-Mutated	FLT3_Mutant_AML.yaml	pathophysiology	0	evidence	0	PMID:41228209	SUPPORT		In acute myeloid leukemia (AML), FLT3 mutations-most commonly internal tandem duplications (FLT3-ITD) and tyrosine kinase domain (FLT3-TKD) substitutions-are among the most frequent genetic alterations, driving constitutive activation of proliferative and antiapoptotic pathways and conferring adverse prognosis.	This abstract describes FLT3-ITD/TKD mutations driving constitutive activation in AML, matching the mechanism described.	"{""explanation"": ""This abstract describes FLT3-ITD/TKD mutations driving constitutive activation in AML, matching the mechanism described."", ""reference"": ""PMID:41228209"", ""snippet"": ""In acute myeloid leukemia (AML), FLT3 mutations-most commonly internal tandem duplications (FLT3-ITD) and tyrosine kinase domain (FLT3-TKD) substitutions-are among the most frequent genetic alterations, driving constitutive activation of proliferative and antiapoptotic pathways and conferring adverse prognosis."", ""supports"": ""SUPPORT""}"
2678	2576	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	0	evidence	0	PMID:31939530	SUPPORT		Mutations in the GLA gene lead to the progressive accumulation of globotriaosylceramide (Gb3). Gb3 accumulates in lysosomes of different types of cells of the heart, kidneys, skin, eyes, central nervous system, and gastrointestinal system	Confirms that GLA mutations cause Gb3 accumulation in lysosomes across multiple organ systems	"{""explanation"": ""Confirms that GLA mutations cause Gb3 accumulation in lysosomes across multiple organ systems"", ""reference"": ""PMID:31939530"", ""snippet"": ""Mutations in the GLA gene lead to the progressive accumulation of globotriaosylceramide (Gb3). Gb3 accumulates in lysosomes of different types of cells of the heart, kidneys, skin, eyes, central nervous system, and gastrointestinal system"", ""supports"": ""SUPPORT""}"
2679	2577	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	1	evidence	0	PMID:39978321	SUPPORT		Missense variants in the coding sequence of the GLA gene would generate the misfolding of the altered protein alpha-galactosidase A. Emergence of misfolded proteins may generate stress of the endoplasmic reticulum, leading to induction of the unfolded protein response (UPR)	Describes the mechanism by which GLA variants cause ER stress and UPR activation independent of lipid accumulation	"{""explanation"": ""Describes the mechanism by which GLA variants cause ER stress and UPR activation independent of lipid accumulation"", ""reference"": ""PMID:39978321"", ""snippet"": ""Missense variants in the coding sequence of the GLA gene would generate the misfolding of the altered protein alpha-galactosidase A. Emergence of misfolded proteins may generate stress of the endoplasmic reticulum, leading to induction of the unfolded protein response (UPR)"", ""supports"": ""SUPPORT""}"
2680	2578	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	2	evidence	0	PMID:29530533	SUPPORT		Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the GLA gene leading to deficient α-galactosidase A activity, glycosphingolipid accumulation, and life-threatening complications	Establishes the molecular basis linking GLA deficiency to progressive glycosphingolipid accumulation and organ damage	"{""explanation"": ""Establishes the molecular basis linking GLA deficiency to progressive glycosphingolipid accumulation and organ damage"", ""reference"": ""PMID:29530533"", ""snippet"": ""Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the GLA gene leading to deficient α-galactosidase A activity, glycosphingolipid accumulation, and life-threatening complications"", ""supports"": ""SUPPORT""}"
2681	2579	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	3	evidence	0	PMID:37014703	SUPPORT		Genetic and pharmacological inhibition of SNCA improved lysosomal structure and function in Fabry podocytes, exceeding the benefits of ERT	Shows that α-synuclein accumulation impairs lysosomal function and autophagy in Fabry podocytes, and that SNCA is a key driver of injury beyond Gb3 accumulation	"{""explanation"": ""Shows that α-synuclein accumulation impairs lysosomal function and autophagy in Fabry podocytes, and that SNCA is a key driver of injury beyond Gb3 accumulation"", ""reference"": ""PMID:37014703"", ""snippet"": ""Genetic and pharmacological inhibition of SNCA improved lysosomal structure and function in Fabry podocytes, exceeding the benefits of ERT"", ""supports"": ""SUPPORT""}"
2682	2580	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	4	evidence	0	PMID:38304433	SUPPORT		we demonstrate strong activation of the complement system in 17 classical male FD patients with either missense or nonsense mutations before and after ERT as evidenced by high C3a and C5a serum levels	Demonstrates that complement system is strongly activated in Fabry disease patients, supporting the role of innate immune activation in pathogenesis	"{""explanation"": ""Demonstrates that complement system is strongly activated in Fabry disease patients, supporting the role of innate immune activation in pathogenesis"", ""reference"": ""PMID:38304433"", ""snippet"": ""we demonstrate strong activation of the complement system in 17 classical male FD patients with either missense or nonsense mutations before and after ERT as evidenced by high C3a and C5a serum levels"", ""supports"": ""SUPPORT""}"
2683	2580	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	4	evidence	1	PMID:38932991	SUPPORT		Inflammation is emerging as an important aspect of the pathogenesis of Fabry disease. This is thought to be predominantly mediated by the innate immune response, with growing evidence pointing towards the potential involvement of adaptive immune mechanisms	Confirms inflammation as a key pathogenic mechanism in Fabry disease, with emphasis on innate immune response	"{""explanation"": ""Confirms inflammation as a key pathogenic mechanism in Fabry disease, with emphasis on innate immune response"", ""reference"": ""PMID:38932991"", ""snippet"": ""Inflammation is emerging as an important aspect of the pathogenesis of Fabry disease. This is thought to be predominantly mediated by the innate immune response, with growing evidence pointing towards the potential involvement of adaptive immune mechanisms"", ""supports"": ""SUPPORT""}"
2684	2581	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	5	evidence	0	PMID:31939530	SUPPORT		Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency	Documents progressive vascular and organ involvement resulting from lysosomal substrate accumulation	"{""explanation"": ""Documents progressive vascular and organ involvement resulting from lysosomal substrate accumulation"", ""reference"": ""PMID:31939530"", ""snippet"": ""Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency"", ""supports"": ""SUPPORT""}"
2685	2582	113	Fabry disease	Fabry_Disease.yaml	pathophysiology	6	evidence	0	PMID:38304433	SUPPORT		we found increased IL-6, IL-10 and TGF-ß1 serum levels in FD patients	Shows elevated TGF-β1 in Fabry disease patients, confirming profibrotic signaling as a mechanism of organ damage	"{""explanation"": ""Shows elevated TGF-β1 in Fabry disease patients, confirming profibrotic signaling as a mechanism of organ damage"", ""reference"": ""PMID:38304433"", ""snippet"": ""we found increased IL-6, IL-10 and TGF-ß1 serum levels in FD patients"", ""supports"": ""SUPPORT""}"
2698	2599	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	pathophysiology	0	evidence	0	PMID:28668823	SUPPORT		In agreement with Knudson's 'two-hit' theory, the inactivation of the residual APC gene in FAP is a critical step in the development of both colorectal cancer and desmoids.	Confirms that FAP follows the two-hit mechanism for both colorectal cancer and desmoid tumor development.	"{""explanation"": ""Confirms that FAP follows the two-hit mechanism for both colorectal cancer and desmoid tumor development."", ""reference"": ""PMID:28668823"", ""snippet"": ""In agreement with Knudson's 'two-hit' theory, the inactivation of the residual APC gene in FAP is a critical step in the development of both colorectal cancer and desmoids."", ""supports"": ""SUPPORT""}"
2719	2624	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	0	evidence	0	PMID:28154935	SUPPORT		Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. These gain of function mutations lead to an increased activation of the inflammasome pyrin with a subsequent disproportional proinflammatory reaction.	Mutations in the MEFV gene result in increased activation of pyrin, causing excessive inflammation.	"{""explanation"": ""Mutations in the MEFV gene result in increased activation of pyrin, causing excessive inflammation."", ""reference"": ""PMID:28154935"", ""snippet"": ""Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. These gain of function mutations lead to an increased activation of the inflammasome pyrin with a subsequent disproportional proinflammatory reaction."", ""supports"": ""SUPPORT""}"
2720	2624	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	0	evidence	1	PMID:25307949	SUPPORT		Mutations in the MEFV gene are associated with the human autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and induce inflammatory caspase-1 activation in monocytic cells.	This article discusses the role of pyrin in inducing inflammatory responses, supporting the effect of MEFV gene mutations in causing excessive inflammation.	"{""explanation"": ""This article discusses the role of pyrin in inducing inflammatory responses, supporting the effect of MEFV gene mutations in causing excessive inflammation."", ""reference"": ""PMID:25307949"", ""snippet"": ""Mutations in the MEFV gene are associated with the human autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and induce inflammatory caspase-1 activation in monocytic cells."", ""supports"": ""SUPPORT""}"
2721	2624	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	0	evidence	2	PMID:36889987	SUPPORT		MEFV gene mutation spectrum in patients with familial mediterranean fever	The mutation spectrum in the MEFV gene is related to the pathogenesis involving pyrin and inflammation, supporting the given statement.	"{""explanation"": ""The mutation spectrum in the MEFV gene is related to the pathogenesis involving pyrin and inflammation, supporting the given statement."", ""reference"": ""PMID:36889987"", ""snippet"": ""MEFV gene mutation spectrum in patients with familial mediterranean fever"", ""supports"": ""SUPPORT""}"
2722	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	downstream[0].evidence	0	PMID:30938266	SUPPORT		mutations in the MEFV gene encoding pyrin, which result in inflammasome activation and the uncontrolled production of IL-1β	This 2018 review explains that MEFV gene mutations cause pyrin dysfunction leading to inappropriate inflammasome activation and uncontrolled IL-1β production, which drives the characteristic recurrent fever episodes and inflammatory attacks.	"{""explanation"": ""This 2018 review explains that MEFV gene mutations cause pyrin dysfunction leading to inappropriate inflammasome activation and uncontrolled IL-1β production, which drives the characteristic recurrent fever episodes and inflammatory attacks."", ""reference"": ""PMID:30938266"", ""snippet"": ""mutations in the MEFV gene encoding pyrin, which result in inflammasome activation and the uncontrolled production of IL-1β"", ""supports"": ""SUPPORT""}"
2723	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	evidence	0	PMID:16344627	SUPPORT		The spectrum of reported genetic mutations and susceptible ethnicities for the hereditary periodic fever subset of the autoinflammatory diseases has continued to expand. At the same time, the pathogeneses of many of these diseases are now understood to involve different aspects of a common pathway, largely affecting inflammatory cascades related to IL-1 or tumor necrosis factor-alpha.	This reference supports the involvement of IL-1 and inflammatory pathways in autoinflammatory diseases, including Familial Mediterranean Fever (FMF).	"{""explanation"": ""This reference supports the involvement of IL-1 and inflammatory pathways in autoinflammatory diseases, including Familial Mediterranean Fever (FMF)."", ""reference"": ""PMID:16344627"", ""snippet"": ""The spectrum of reported genetic mutations and susceptible ethnicities for the hereditary periodic fever subset of the autoinflammatory diseases has continued to expand. At the same time, the pathogeneses of many of these diseases are now understood to involve different aspects of a common pathway, largely affecting inflammatory cascades related to IL-1 or tumor necrosis factor-alpha."", ""supports"": ""SUPPORT""}"
2724	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	evidence	1	PMID:29148036	SUPPORT		Pyrin, encoded by the MEFV gene, is an intracellular pattern recognition receptor that assembles inflammasome complexes in response to pathogen infections. Mutations in the MEFV gene have been linked to autoinflammatory diseases such as familial Mediterranean fever (FMF) or pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND).	This reference describes the role of pyrin in inflammasome activation and its link to FMF, supporting the statement about dysregulated inflammatory responses and recurrent inflammatory episodes.	"{""explanation"": ""This reference describes the role of pyrin in inflammasome activation and its link to FMF, supporting the statement about dysregulated inflammatory responses and recurrent inflammatory episodes."", ""reference"": ""PMID:29148036"", ""snippet"": ""Pyrin, encoded by the MEFV gene, is an intracellular pattern recognition receptor that assembles inflammasome complexes in response to pathogen infections. Mutations in the MEFV gene have been linked to autoinflammatory diseases such as familial Mediterranean fever (FMF) or pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND)."", ""supports"": ""SUPPORT""}"
2725	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	evidence	2	PMID:33026080	SUPPORT		FMF is an autoinflammatory disease characterized by recurrent attacks and increased IL-1 synthesis owing to activation of the pyrin inflammasome	This reference directly mentions recurrent attacks and increased IL-1 synthesis due to pyrin inflammasome activation, supporting the mechanisms described in the statement.	"{""explanation"": ""This reference directly mentions recurrent attacks and increased IL-1 synthesis due to pyrin inflammasome activation, supporting the mechanisms described in the statement."", ""reference"": ""PMID:33026080"", ""snippet"": ""FMF is an autoinflammatory disease characterized by recurrent attacks and increased IL-1 synthesis owing to activation of the pyrin inflammasome"", ""supports"": ""SUPPORT""}"
2726	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	evidence	3	PMID:32601469	SUPPORT		Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage.	This reference supports the genetic basis of FMF involving mutations in MEFV, which leads to the dysregulated inflammatory response observed in FMF.	"{""explanation"": ""This reference supports the genetic basis of FMF involving mutations in MEFV, which leads to the dysregulated inflammatory response observed in FMF."", ""reference"": ""PMID:32601469"", ""snippet"": ""Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by homozygous or compound heterozygous gain-of-function mutations in MEFV, which encodes pyrin, an inflammasome protein. Heterozygous carrier frequencies for multiple MEFV mutations are high in several Mediterranean populations, suggesting that they confer selective advantage."", ""supports"": ""SUPPORT""}"
2727	2626	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	pathophysiology	2	evidence	4	PMID:29051974	SUPPORT		Familial Mediterranean fever (FMF) is an autoinflammatory disease manifested by inflammatory attacks of peritonitis, pleuritis, pericarditis accompanied by fever and arthritis. Mutations of MEFV gene results in pyrin dysfunction, which causes uncontrolled interleukin-1 beta production and triggers the inflammatory attacks.	This reference supports the mechanism described in the statement, emphasizing pyrin dysfunction and the uncontrolled production of interleukin-1 beta.	"{""explanation"": ""This reference supports the mechanism described in the statement, emphasizing pyrin dysfunction and the uncontrolled production of interleukin-1 beta."", ""reference"": ""PMID:29051974"", ""snippet"": ""Familial Mediterranean fever (FMF) is an autoinflammatory disease manifested by inflammatory attacks of peritonitis, pleuritis, pericarditis accompanied by fever and arthritis. Mutations of MEFV gene results in pyrin dysfunction, which causes uncontrolled interleukin-1 beta production and triggers the inflammatory attacks."", ""supports"": ""SUPPORT""}"
2822	2703	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	0	evidence	0	PMID:35596788	SUPPORT	HUMAN_CLINICAL	At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway. This pathway coordinates multiple processes and proteins to facilitate the repair of DNA adducts including interstrand crosslinks (ICLs)		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:35596788"", ""snippet"": ""At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway. This pathway coordinates multiple processes and proteins to facilitate the repair of DNA adducts including interstrand crosslinks (ICLs)"", ""supports"": ""SUPPORT""}"
2823	2704	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	1	evidence	0	PMID:38424108	SUPPORT	MODEL_ORGANISM	we identify increased protein synthesis rates in the fetal hematopoietic stem cell pool at the onset of hematopoietic failure in Fanconi Anemia, a prototypical DNA repair disorder that manifests with bone marrow failure.	Demonstrates that bone marrow failure is a defining manifestation of Fanconi anemia, with origins in fetal HSC dysfunction.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that bone marrow failure is a defining manifestation of Fanconi anemia, with origins in fetal HSC dysfunction."", ""reference"": ""PMID:38424108"", ""snippet"": ""we identify increased protein synthesis rates in the fetal hematopoietic stem cell pool at the onset of hematopoietic failure in Fanconi Anemia, a prototypical DNA repair disorder that manifests with bone marrow failure."", ""supports"": ""SUPPORT""}"
2824	2705	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	2	evidence	0	PMID:35596788	SUPPORT	HUMAN_CLINICAL	ICLs can interfere with DNA transactions, including replication and transcription. If not properly removed and repaired, ICLs cause DNA breaks and lead to genomic instability, a hallmark of cancer.		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:35596788"", ""snippet"": ""ICLs can interfere with DNA transactions, including replication and transcription. If not properly removed and repaired, ICLs cause DNA breaks and lead to genomic instability, a hallmark of cancer."", ""supports"": ""SUPPORT""}"
2825	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	evidence	0	PMID:38424108	SUPPORT	MODEL_ORGANISM	proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers.	Demonstrates that inflammatory signaling drives HSC pool deficits in FA, and that dampening inflammation rescues HSC numbers.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates that inflammatory signaling drives HSC pool deficits in FA, and that dampening inflammation rescues HSC numbers."", ""reference"": ""PMID:38424108"", ""snippet"": ""proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers."", ""supports"": ""SUPPORT""}"
2826	2706	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	3	evidence	1	PMID:24037726	SUPPORT	HUMAN_CLINICAL	the FA proteins might counteract aldehyde-induced genotoxicity in hematopoietic stem cells	Establishes that aldehydes cause genotoxicity in HSCs and FA proteins normally protect against this damage.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes that aldehydes cause genotoxicity in HSCs and FA proteins normally protect against this damage."", ""reference"": ""PMID:24037726"", ""snippet"": ""the FA proteins might counteract aldehyde-induced genotoxicity in hematopoietic stem cells"", ""supports"": ""SUPPORT""}"
2827	2707	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	4	evidence	0	PMID:25237197	SUPPORT	OTHER	Establishing the interaction network involving the FA proteins and their associated partners has revealed an intersection of FA with several DNA repair pathways, including homologous recombination, DNA mismatch repair, nucleotide excision repair, and translesion DNA synthesis.	Demonstrates that the FA pathway intersects with translesion DNA synthesis, establishing the mechanistic link.	"{""evidence_source"": ""OTHER"", ""explanation"": ""Demonstrates that the FA pathway intersects with translesion DNA synthesis, establishing the mechanistic link."", ""reference"": ""PMID:25237197"", ""snippet"": ""Establishing the interaction network involving the FA proteins and their associated partners has revealed an intersection of FA with several DNA repair pathways, including homologous recombination, DNA mismatch repair, nucleotide excision repair, and translesion DNA synthesis."", ""supports"": ""SUPPORT""}"
2828	2708	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	5	evidence	0	PMID:25237197	SUPPORT	OTHER	the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology.	The overlap of FA genes with breast cancer genes (BRCA1, BRCA2, PALB2) establishes the connection between FA and homologous recombination repair.	"{""evidence_source"": ""OTHER"", ""explanation"": ""The overlap of FA genes with breast cancer genes (BRCA1, BRCA2, PALB2) establishes the connection between FA and homologous recombination repair."", ""reference"": ""PMID:25237197"", ""snippet"": ""the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology."", ""supports"": ""SUPPORT""}"
2829	2709	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	6	evidence	0	PMID:24037726	SUPPORT	HUMAN_CLINICAL	We examined 64 Japanese FA patients, and found that the ALDH2 variant is associated with accelerated progression of BMF	Human clinical data showing that impaired aldehyde detoxification (ALDH2 variant) accelerates bone marrow failure in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Human clinical data showing that impaired aldehyde detoxification (ALDH2 variant) accelerates bone marrow failure in FA patients."", ""reference"": ""PMID:24037726"", ""snippet"": ""We examined 64 Japanese FA patients, and found that the ALDH2 variant is associated with accelerated progression of BMF"", ""supports"": ""SUPPORT""}"
2830	2709	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	6	evidence	1	PMID:25237197	SUPPORT	OTHER	recent studies have shown a major involvement of the FA pathway in the tolerance of reactive aldehydes.	Establishes that the FA pathway is required for tolerance of aldehyde-induced DNA damage.	"{""evidence_source"": ""OTHER"", ""explanation"": ""Establishes that the FA pathway is required for tolerance of aldehyde-induced DNA damage."", ""reference"": ""PMID:25237197"", ""snippet"": ""recent studies have shown a major involvement of the FA pathway in the tolerance of reactive aldehydes."", ""supports"": ""SUPPORT""}"
2831	2710	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	7	evidence	0	PMID:35596788	SUPPORT	HUMAN_CLINICAL	At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway.	Core complex genes form the upstream signaling arm of the FA pathway.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Core complex genes form the upstream signaling arm of the FA pathway."", ""reference"": ""PMID:35596788"", ""snippet"": ""At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway."", ""supports"": ""SUPPORT""}"
2832	2711	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	8	evidence	0	PMID:32106311	SUPPORT	HUMAN_CLINICAL	This reflects the indispensable role of FANCB protein in the enzymatic activation of FANCD2 monoubiquitination, an essential step in the repair of DNA interstrand crosslinks.	FANCD2 monoubiquitination is the essential central step in ICL repair.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCD2 monoubiquitination is the essential central step in ICL repair."", ""reference"": ""PMID:32106311"", ""snippet"": ""This reflects the indispensable role of FANCB protein in the enzymatic activation of FANCD2 monoubiquitination, an essential step in the repair of DNA interstrand crosslinks."", ""supports"": ""SUPPORT""}"
2833	2712	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	9	evidence	0	PMID:25237197	SUPPORT	OTHER	the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology.	Downstream FA genes overlap with breast cancer susceptibility genes.	"{""evidence_source"": ""OTHER"", ""explanation"": ""Downstream FA genes overlap with breast cancer susceptibility genes."", ""reference"": ""PMID:25237197"", ""snippet"": ""the fact that 5 FA genes are in fact familial breast cancer genes and FA gene mutations are found frequently in sporadic cancers suggest wider applicability in hematopoiesis and oncology."", ""supports"": ""SUPPORT""}"
2834	2713	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	10	evidence	0	PMID:38424108	SUPPORT	MODEL_ORGANISM	proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers.	Inflammatory signaling in the BM microenvironment drives HSC loss in FA.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Inflammatory signaling in the BM microenvironment drives HSC loss in FA."", ""reference"": ""PMID:38424108"", ""snippet"": ""proteostasis deregulation itself is driven by excess sterile inflammatory activity in hematopoietic and stromal cells within the fetal liver, and dampened Type I interferon signaling similarly restores fetal Fancd2-/- long-term hematopoietic stem cells to wild type-equivalent numbers."", ""supports"": ""SUPPORT""}"
2835	2714	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	11	evidence	0	PMID:26369989	SUPPORT	HUMAN_CLINICAL	The incidence of central nervous system (CNS) abnormalities in FA is higher than previously reported, with a midline predominance that points to impact in the early stages of CNS development.	Midline predominance of anomalies supports developmental progenitor loss during embryogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Midline predominance of anomalies supports developmental progenitor loss during embryogenesis."", ""reference"": ""PMID:26369989"", ""snippet"": ""The incidence of central nervous system (CNS) abnormalities in FA is higher than previously reported, with a midline predominance that points to impact in the early stages of CNS development."", ""supports"": ""SUPPORT""}"
2836	2715	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	12	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors	30% malignancy rate reflects ongoing clonal evolution in FA HSCs.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""30% malignancy rate reflects ongoing clonal evolution in FA HSCs."", ""reference"": ""PMID:31558676"", ""snippet"": ""30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors"", ""supports"": ""SUPPORT""}"
2837	2716	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	13	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.	Confirms epithelial tissue susceptibility to malignancy in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms epithelial tissue susceptibility to malignancy in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA."", ""supports"": ""SUPPORT""}"
2838	2717	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	14	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females	HPV vaccination recommendation implies HPV is a significant co-factor for epithelial cancer in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""HPV vaccination recommendation implies HPV is a significant co-factor for epithelial cancer in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females"", ""supports"": ""SUPPORT""}"
2839	2718	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	15	evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	Endocrine abnormalities were present in 73%, including short stature and/or GH deficiency (51%), hypothyroidism (37%), midline brain abnormalities (17%)	Giri et al. documents 73% endocrine abnormality prevalence.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. documents 73% endocrine abnormality prevalence."", ""reference"": ""PMID:17426088"", ""snippet"": ""Endocrine abnormalities were present in 73%, including short stature and/or GH deficiency (51%), hypothyroidism (37%), midline brain abnormalities (17%)"", ""supports"": ""SUPPORT""}"
2840	2718	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	15	evidence	1	PMID:26369989	SUPPORT	HUMAN_CLINICAL	Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)	Small pituitary in 68% provides anatomical basis for endocrine dysfunction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Small pituitary in 68% provides anatomical basis for endocrine dysfunction."", ""reference"": ""PMID:26369989"", ""snippet"": ""Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)"", ""supports"": ""SUPPORT""}"
2841	2719	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	16	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies.	75% of FA patients have physical abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""75% of FA patients have physical abnormalities."", ""reference"": ""PMID:20301575"", ""snippet"": ""Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies."", ""supports"": ""SUPPORT""}"
2842	2720	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	17	evidence	0	PMID:26369989	SUPPORT	HUMAN_CLINICAL	Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)	90% brain MRI abnormality rate with midline predominance.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""90% brain MRI abnormality rate with midline predominance."", ""reference"": ""PMID:26369989"", ""snippet"": ""Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)"", ""supports"": ""SUPPORT""}"
2843	2720	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	17	evidence	1	PMID:26369989	SUPPORT	HUMAN_CLINICAL	Posterior fossa abnormalities were seen in six cases (30%, p = 0.01) including Chiari I malformation (n = 3), Dandy-Walker variant (n = 2) and cerebellar atrophy (n = 2).	Posterior fossa and corpus callosum anomalies reflect early CNS developmental impact.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Posterior fossa and corpus callosum anomalies reflect early CNS developmental impact."", ""reference"": ""PMID:26369989"", ""snippet"": ""Posterior fossa abnormalities were seen in six cases (30%, p = 0.01) including Chiari I malformation (n = 3), Dandy-Walker variant (n = 2) and cerebellar atrophy (n = 2)."", ""supports"": ""SUPPORT""}"
2844	2721	116	Fanconi_Anemia	Fanconi_Anemia.yaml	pathophysiology	18	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%).	Café-au-lait spots are the most common congenital anomaly in the Israeli FA cohort.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Café-au-lait spots are the most common congenital anomaly in the Israeli FA cohort."", ""reference"": ""PMID:31558676"", ""snippet"": ""More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%)."", ""supports"": ""SUPPORT""}"
3000	2824	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:20463014	SUPPORT		mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients	The study demonstrates that the R206H mutation causes BMP signal activation in muscle tissue, leading to ectopic bone formation.	"{""explanation"": ""The study demonstrates that the R206H mutation causes BMP signal activation in muscle tissue, leading to ectopic bone formation."", ""reference"": ""PMID:20463014"", ""snippet"": ""mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients"", ""supports"": ""SUPPORT""}"
3001	2824	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	0	evidence	0	PMID:17572636	SUPPORT		Protein modeling predicts that substitution with histidine, and only histidine, creates a pH-sensitive switch within the activation domain of the receptor that leads to ligand-independent activation of ACVR1 in fibrodysplasia ossificans progressiva.	This study explains the unique molecular mechanism of the R206H mutation creating pH-dependent receptor dysregulation.	"{""explanation"": ""This study explains the unique molecular mechanism of the R206H mutation creating pH-dependent receptor dysregulation."", ""reference"": ""PMID:17572636"", ""snippet"": ""Protein modeling predicts that substitution with histidine, and only histidine, creates a pH-sensitive switch within the activation domain of the receptor that leads to ligand-independent activation of ACVR1 in fibrodysplasia ossificans progressiva."", ""supports"": ""SUPPORT""}"
3002	2825	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	1	evidence	0	PMID:20463014	SUPPORT		The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling	Loss of FKBP1A binding is a key mechanism allowing leaky BMP signaling.	"{""explanation"": ""Loss of FKBP1A binding is a key mechanism allowing leaky BMP signaling."", ""reference"": ""PMID:20463014"", ""snippet"": ""The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling"", ""supports"": ""SUPPORT""}"
3003	2826	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	2	evidence	0	PMID:26896819	SUPPORT		Most FOP patients carry an activating mutation in a bone morphogenetic protein (BMP) type I receptor gene, ACVR1(R206H), that promotes ectopic chondrogenesis and osteogenesis and, in turn, HO	Confirms that the ACVR1 R206H mutation promotes ectopic chondrogenesis and osteogenesis through aberrant BMP signaling.	"{""explanation"": ""Confirms that the ACVR1 R206H mutation promotes ectopic chondrogenesis and osteogenesis through aberrant BMP signaling."", ""reference"": ""PMID:26896819"", ""snippet"": ""Most FOP patients carry an activating mutation in a bone morphogenetic protein (BMP) type I receptor gene, ACVR1(R206H), that promotes ectopic chondrogenesis and osteogenesis and, in turn, HO"", ""supports"": ""SUPPORT""}"
3004	2827	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	3	evidence	0	PMID:26896819	SUPPORT		Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans	Establishes FOP as the most severe form of heterotopic ossification.	"{""explanation"": ""Establishes FOP as the most severe form of heterotopic ossification."", ""reference"": ""PMID:26896819"", ""snippet"": ""Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans"", ""supports"": ""SUPPORT""}"
3005	2828	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	pathophysiology	4	evidence	0	PMID:26896819	SUPPORT		Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans	FOP is characterized by progressive HO following inflammatory flare-ups triggered by trauma or other stimuli.	"{""explanation"": ""FOP is characterized by progressive HO following inflammatory flare-ups triggered by trauma or other stimuli."", ""reference"": ""PMID:26896819"", ""snippet"": ""Fibrodysplasia ossificans progressiva (FOP), a rare and as yet untreatable genetic disorder of progressive extraskeletal ossification, is the most disabling form of heterotopic ossification (HO) in humans"", ""supports"": ""SUPPORT""}"
3020	2856	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	0	evidence	0	PMID:7526868	SUPPORT		CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001)	Elevated substance P in cerebrospinal fluid directly supports central sensitization mechanism with increased excitatory nociceptive signaling.	"{""explanation"": ""Elevated substance P in cerebrospinal fluid directly supports central sensitization mechanism with increased excitatory nociceptive signaling."", ""reference"": ""PMID:7526868"", ""snippet"": ""CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001)"", ""supports"": ""SUPPORT""}"
3021	2856	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	0	evidence	1	PMID:21684692	SUPPORT		Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the conversion of glutamate to GABA and decreased expression or activity of this enzyme could result in an imbalance of excitatory and inhibitory neurotransmission in the ascending and descending pain pathways.	Proposes mechanism for excitatory/inhibitory imbalance underlying central sensitization via altered GAD activity affecting glutamate-GABA balance.	"{""explanation"": ""Proposes mechanism for excitatory/inhibitory imbalance underlying central sensitization via altered GAD activity affecting glutamate-GABA balance."", ""reference"": ""PMID:21684692"", ""snippet"": ""Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the conversion of glutamate to GABA and decreased expression or activity of this enzyme could result in an imbalance of excitatory and inhibitory neurotransmission in the ascending and descending pain pathways."", ""supports"": ""SUPPORT""}"
3022	2856	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	0	evidence	2	PMID:33494476	SUPPORT		Fibromyalgia is the most common of the central sensitivity syndromes affecting 2-5% of the adult population in the United States. This pain amplification syndrome has enormous societal impact	Establishes fibromyalgia as a prototypical central sensitivity syndrome with augmented pain processing.	"{""explanation"": ""Establishes fibromyalgia as a prototypical central sensitivity syndrome with augmented pain processing."", ""reference"": ""PMID:33494476"", ""snippet"": ""Fibromyalgia is the most common of the central sensitivity syndromes affecting 2-5% of the adult population in the United States. This pain amplification syndrome has enormous societal impact"", ""supports"": ""SUPPORT""}"
3023	2857	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	1	evidence	0	PMID:21684692	SUPPORT		A number of neurotransmitters in the ascending and descending pain pathways have been implicated in FM including glutamate and GABA.	Identifies neurotransmitter dysfunction in descending pain pathways as a key mechanism in fibromyalgia pathophysiology.	"{""explanation"": ""Identifies neurotransmitter dysfunction in descending pain pathways as a key mechanism in fibromyalgia pathophysiology."", ""reference"": ""PMID:21684692"", ""snippet"": ""A number of neurotransmitters in the ascending and descending pain pathways have been implicated in FM including glutamate and GABA."", ""supports"": ""SUPPORT""}"
3024	2857	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	1	evidence	1	PMID:21684692	SUPPORT		GAD65 knockout mice have been shown to exhibit supraspinal hyperalgesia.	Animal model evidence supporting the role of impaired inhibitory neurotransmission in pain amplification.	"{""explanation"": ""Animal model evidence supporting the role of impaired inhibitory neurotransmission in pain amplification."", ""reference"": ""PMID:21684692"", ""snippet"": ""GAD65 knockout mice have been shown to exhibit supraspinal hyperalgesia."", ""supports"": ""SUPPORT""}"
3025	2858	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	2	evidence	0	PMID:22126705	SUPPORT		We report elevated cerebrospinal fluid and serum concentrations of interleukin-8, but not interleukin-1beta, in FM patients. This profile is in accordance with FM symptoms being mediated by sympathetic activity rather than dependent on prostaglandin associated mechanisms and supports the hypothesis of glia cell activation in response to pain mechanisms.	Direct evidence of central inflammation in fibromyalgia via elevated CSF IL-8 levels, supporting glial cell activation hypothesis.	"{""explanation"": ""Direct evidence of central inflammation in fibromyalgia via elevated CSF IL-8 levels, supporting glial cell activation hypothesis."", ""reference"": ""PMID:22126705"", ""snippet"": ""We report elevated cerebrospinal fluid and serum concentrations of interleukin-8, but not interleukin-1beta, in FM patients. This profile is in accordance with FM symptoms being mediated by sympathetic activity rather than dependent on prostaglandin associated mechanisms and supports the hypothesis of glia cell activation in response to pain mechanisms."", ""supports"": ""SUPPORT""}"
3026	2858	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	2	evidence	1	PMID:22126705	SUPPORT		Activation of glia cells resulting in intrathecal elevation of cytokines and chemokines has been hypothesized in chronic pain syndromes such as fibromyalgia.	Establishes theoretical framework linking glial activation to intrathecal cytokine elevation in fibromyalgia pathophysiology.	"{""explanation"": ""Establishes theoretical framework linking glial activation to intrathecal cytokine elevation in fibromyalgia pathophysiology."", ""reference"": ""PMID:22126705"", ""snippet"": ""Activation of glia cells resulting in intrathecal elevation of cytokines and chemokines has been hypothesized in chronic pain syndromes such as fibromyalgia."", ""supports"": ""SUPPORT""}"
3027	2858	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	2	evidence	2	PMID:29684996	SUPPORT		Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM.	Identifies mast cell-mediated inflammation as a contributor to low-grade chronic neuroinflammation in fibromyalgia.	"{""explanation"": ""Identifies mast cell-mediated inflammation as a contributor to low-grade chronic neuroinflammation in fibromyalgia."", ""reference"": ""PMID:29684996"", ""snippet"": ""Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM."", ""supports"": ""SUPPORT""}"
3028	2859	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	3	evidence	0	PMID:7980669	SUPPORT		Patients with FM had low 24-hour urinary free cortisol, but normal peak and elevated trough plasma cortisol levels, compared with normal subjects.	Documents specific HPA axis abnormalities including low urinary cortisol and elevated trough levels supporting HPA dysregulation mechanism.	"{""explanation"": ""Documents specific HPA axis abnormalities including low urinary cortisol and elevated trough levels supporting HPA dysregulation mechanism."", ""reference"": ""PMID:7980669"", ""snippet"": ""Patients with FM had low 24-hour urinary free cortisol, but normal peak and elevated trough plasma cortisol levels, compared with normal subjects."", ""supports"": ""SUPPORT""}"
3029	2859	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	3	evidence	1	PMID:15157948	SUPPORT		There was a significant delay in the rate of decline from acrophase to nadir for cortisol levels in patients with FMS (P <.01).	Demonstrates altered circadian cortisol rhythm with delayed decline indicating loss of HPA axis resiliency.	"{""explanation"": ""Demonstrates altered circadian cortisol rhythm with delayed decline indicating loss of HPA axis resiliency."", ""reference"": ""PMID:15157948"", ""snippet"": ""There was a significant delay in the rate of decline from acrophase to nadir for cortisol levels in patients with FMS (P <.01)."", ""supports"": ""SUPPORT""}"
3030	2859	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	3	evidence	2	PMID:7980669	SUPPORT		These data support the view that HPA axis function is perturbed in patients with FM.	Concludes that HPA axis perturbations are a characteristic feature of fibromyalgia pathophysiology.	"{""explanation"": ""Concludes that HPA axis perturbations are a characteristic feature of fibromyalgia pathophysiology."", ""reference"": ""PMID:7980669"", ""snippet"": ""These data support the view that HPA axis function is perturbed in patients with FM."", ""supports"": ""SUPPORT""}"
3031	2860	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	4	evidence	0	PMID:39062116	SUPPORT		These include central sensitization, associated with an increase in the release of both excitatory and inhibitory neurotransmitters; peripheral sensitization, involving alterations in peripheral nociceptor signaling; and inflammatory and immune mechanisms that develop concurrently with the aforementioned processes.	Establishes peripheral sensitization involving nociceptor signaling as one of three key pathophysiological processes in fibromyalgia.	"{""explanation"": ""Establishes peripheral sensitization involving nociceptor signaling as one of three key pathophysiological processes in fibromyalgia."", ""reference"": ""PMID:39062116"", ""snippet"": ""These include central sensitization, associated with an increase in the release of both excitatory and inhibitory neurotransmitters; peripheral sensitization, involving alterations in peripheral nociceptor signaling; and inflammatory and immune mechanisms that develop concurrently with the aforementioned processes."", ""supports"": ""SUPPORT""}"
3032	2861	118	Fibromyalgia	Fibromyalgia.yaml	pathophysiology	5	evidence	0	PMID:21905019	SUPPORT		Evidence of association in the replication cohort was observed for TAAR1, RGS4, CNR1, and GRIA4.	Large-scale genetic study identifies TAAR1, RGS4, CNR1, and GRIA4 as genes with evidence of association with fibromyalgia in replication cohort.	"{""explanation"": ""Large-scale genetic study identifies TAAR1, RGS4, CNR1, and GRIA4 as genes with evidence of association with fibromyalgia in replication cohort."", ""reference"": ""PMID:21905019"", ""snippet"": ""Evidence of association in the replication cohort was observed for TAAR1, RGS4, CNR1, and GRIA4."", ""supports"": ""SUPPORT""}"
3051	2894	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:24346713	SUPPORT		Most FXS cases occur due to the expansion of the CGG trinucleotide repeats in the 5' un-translated region of FMR1, which leads to hypermethylation and in turn silences the expression of FMRP	Review confirms CGG repeat expansion leads to FMRP silencing in Fragile X syndrome.	"{""explanation"": ""Review confirms CGG repeat expansion leads to FMRP silencing in Fragile X syndrome."", ""reference"": ""PMID:24346713"", ""snippet"": ""Most FXS cases occur due to the expansion of the CGG trinucleotide repeats in the 5' un-translated region of FMR1, which leads to hypermethylation and in turn silences the expression of FMRP"", ""supports"": ""SUPPORT""}"
3052	2895	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:24346713	SUPPORT		In the absence of FMRP, the basal protein translation is enhanced and not responsive to neuronal stimulation. The altered protein translation may contribute to functional abnormalities in certain aspects of synaptic plasticity	Review confirms FMRP absence leads to altered synaptic protein synthesis and plasticity.	"{""explanation"": ""Review confirms FMRP absence leads to altered synaptic protein synthesis and plasticity."", ""reference"": ""PMID:24346713"", ""snippet"": ""In the absence of FMRP, the basal protein translation is enhanced and not responsive to neuronal stimulation. The altered protein translation may contribute to functional abnormalities in certain aspects of synaptic plasticity"", ""supports"": ""SUPPORT""}"
3053	2895	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:22483044	SUPPORT		FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5.	Review confirms FMRP normally inhibits synaptic protein translation.	"{""explanation"": ""Review confirms FMRP normally inhibits synaptic protein translation."", ""reference"": ""PMID:22483044"", ""snippet"": ""FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5."", ""supports"": ""SUPPORT""}"
3066	2912	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	0	evidence	0	PMID:19664364	SUPPORT		TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major steps in the pathogenesis of FTLD due to TDP-43 proteinopathy (FTLD-TDP).	This confirms that TDP-43 aggregation and mislocalization are central to the pathogenesis of FTLD-TDP, a major subtype of frontotemporal dementia.	"{""explanation"": ""This confirms that TDP-43 aggregation and mislocalization are central to the pathogenesis of FTLD-TDP, a major subtype of frontotemporal dementia."", ""reference"": ""PMID:19664364"", ""snippet"": ""TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major steps in the pathogenesis of FTLD due to TDP-43 proteinopathy (FTLD-TDP)."", ""supports"": ""SUPPORT""}"
3067	2914	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	2	evidence	0	PMID:26473392	SUPPORT		MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy.	This demonstrates the genotype-specific patterns of brain atrophy and their relationship to clinical phenotypes in frontotemporal dementia.	"{""explanation"": ""This demonstrates the genotype-specific patterns of brain atrophy and their relationship to clinical phenotypes in frontotemporal dementia."", ""reference"": ""PMID:26473392"", ""snippet"": ""MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy."", ""supports"": ""SUPPORT""}"
3068	2915	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	pathophysiology	3	evidence	0	PMID:30711676	SUPPORT		We observed that biological changes and intracortical facilitation transmission abnormalities significantly antecede the emergence of clinical symptoms of at least 3 decades.	This shows that neurobiological changes underlying neuronal dysfunction begin decades before clinical symptoms in genetic FTD.	"{""explanation"": ""This shows that neurobiological changes underlying neuronal dysfunction begin decades before clinical symptoms in genetic FTD."", ""reference"": ""PMID:30711676"", ""snippet"": ""We observed that biological changes and intracortical facilitation transmission abnormalities significantly antecede the emergence of clinical symptoms of at least 3 decades."", ""supports"": ""SUPPORT""}"
3074	2956	123	Gastric Cancer H. pylori Associated	Gastric_Cancer_H_pylori_Associated.yaml	pathophysiology	2	evidence	0	PMID:26668499	SUPPORT		This cascade is a dynamic process that includes lesions, such as atrophic gastritis, intestinal metaplasia and dysplasia.	Abstract describes the gastric precancerous cascade with atrophic gastritis, intestinal metaplasia, and dysplasia.	"{""explanation"": ""Abstract describes the gastric precancerous cascade with atrophic gastritis, intestinal metaplasia, and dysplasia."", ""reference"": ""PMID:26668499"", ""snippet"": ""This cascade is a dynamic process that includes lesions, such as atrophic gastritis, intestinal metaplasia and dysplasia."", ""supports"": ""SUPPORT""}"
3075	2970	124	Gastric Ulcer	Gastric_Ulcer.yaml	pathophysiology	0	evidence	0	PMID:28242110	SUPPORT		Peptic ulcers not associated with H pylori infection or the use of non-steroidal anti-inflammatory drugs are now also imposing substantial diagnostic and therapeutic challenges.	The review notes H. pylori infection and NSAID use as key etiologic contexts for peptic ulcers.	"{""explanation"": ""The review notes H. pylori infection and NSAID use as key etiologic contexts for peptic ulcers."", ""reference"": ""PMID:28242110"", ""snippet"": ""Peptic ulcers not associated with H pylori infection or the use of non-steroidal anti-inflammatory drugs are now also imposing substantial diagnostic and therapeutic challenges."", ""supports"": ""SUPPORT""}"
3076	2981	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	0	evidence	0	PMID:38177402	SUPPORT		GERD starts in the stomach, where the refluxate material is produced. Following the trajectory of reflux, the failure of the antireflux barrier, primarily the lower oesophageal sphincter and the crural diaphragm, enables the refluxate to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal symptoms.	This review describes the failure of the antireflux barrier, particularly the lower esophageal sphincter, as a core mechanism allowing refluxate to enter the esophagus and cause symptoms.	"{""explanation"": ""This review describes the failure of the antireflux barrier, particularly the lower esophageal sphincter, as a core mechanism allowing refluxate to enter the esophagus and cause symptoms."", ""reference"": ""PMID:38177402"", ""snippet"": ""GERD starts in the stomach, where the refluxate material is produced. Following the trajectory of reflux, the failure of the antireflux barrier, primarily the lower oesophageal sphincter and the crural diaphragm, enables the refluxate to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal symptoms."", ""supports"": ""SUPPORT""}"
3077	2981	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	0	evidence	1	PMID:38177402	SUPPORT		Alterations of the oesophageal mucosal integrity, such as macroscopic oesophagitis or microscopic changes, determine the perception of symptoms.	The review explains how LES dysfunction leads to mucosal damage that determines symptom perception in GERD.	"{""explanation"": ""The review explains how LES dysfunction leads to mucosal damage that determines symptom perception in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Alterations of the oesophageal mucosal integrity, such as macroscopic oesophagitis or microscopic changes, determine the perception of symptoms."", ""supports"": ""SUPPORT""}"
3078	2982	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	1	evidence	0	PMID:38177402	SUPPORT		Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage.	This highlights the importance of clearance mechanisms in preventing mucosal damage from refluxate exposure in GERD.	"{""explanation"": ""This highlights the importance of clearance mechanisms in preventing mucosal damage from refluxate exposure in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."", ""supports"": ""SUPPORT""}"
3079	2982	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	1	evidence	1	PMID:38177402	SUPPORT		It is now recognized that different GERD phenotypes have different degrees of reflux, severity of mucosal integrity damage and type, and severity of symptoms.	This review recognizes that mucosal integrity damage varies across GERD phenotypes and contributes to symptom severity.	"{""explanation"": ""This review recognizes that mucosal integrity damage varies across GERD phenotypes and contributes to symptom severity."", ""reference"": ""PMID:38177402"", ""snippet"": ""It is now recognized that different GERD phenotypes have different degrees of reflux, severity of mucosal integrity damage and type, and severity of symptoms."", ""supports"": ""SUPPORT""}"
3080	2983	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	2	evidence	0	PMID:38177402	SUPPORT		Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage.	This directly supports the role of impaired clearance mechanisms in prolonging refluxate exposure and increasing mucosal damage in GERD.	"{""explanation"": ""This directly supports the role of impaired clearance mechanisms in prolonging refluxate exposure and increasing mucosal damage in GERD."", ""reference"": ""PMID:38177402"", ""snippet"": ""Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."", ""supports"": ""SUPPORT""}"
3081	2984	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	3	evidence	0	PMID:38177402	SUPPORT		The intensity of the symptoms is affected by peripheral and central neural and psychological mechanisms.	This describes how neural mechanisms, including visceral hypersensitivity, affect symptom intensity in GERD patients even with varying degrees of acid exposure.	"{""explanation"": ""This describes how neural mechanisms, including visceral hypersensitivity, affect symptom intensity in GERD patients even with varying degrees of acid exposure."", ""reference"": ""PMID:38177402"", ""snippet"": ""The intensity of the symptoms is affected by peripheral and central neural and psychological mechanisms."", ""supports"": ""SUPPORT""}"
3082	2985	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	4	evidence	0	PMID:38449873	SUPPORT		The IVW method's findings suggested protective roles against GERD for the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus Anaerostipes (P = 0.049), and Phylum Tenericutes (P = 0.024) emerged as potential GERD risk factors.	This Mendelian randomization study establishes causal relationships between specific gut microbiota taxa and GERD risk, identifying both protective and risk-associated bacterial groups.	"{""explanation"": ""This Mendelian randomization study establishes causal relationships between specific gut microbiota taxa and GERD risk, identifying both protective and risk-associated bacterial groups."", ""reference"": ""PMID:38449873"", ""snippet"": ""The IVW method's findings suggested protective roles against GERD for the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus Anaerostipes (P = 0.049), and Phylum Tenericutes (P = 0.024) emerged as potential GERD risk factors."", ""supports"": ""SUPPORT""}"
3083	2985	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	4	evidence	1	PMID:38449873	SUPPORT		For the first time, the MR analysis indicates a genetic link between gut microbiota abundance changes and GERD risk. This not only substantiates the potential of intestinal microecological therapy for GERD, but also establishes a basis for advanced research into the role of intestinal microbiota in the etiology of GERD.	This confirms a genetic basis for the gut microbiome's causal role in GERD development and supports microbiome-targeted therapeutic approaches.	"{""explanation"": ""This confirms a genetic basis for the gut microbiome's causal role in GERD development and supports microbiome-targeted therapeutic approaches."", ""reference"": ""PMID:38449873"", ""snippet"": ""For the first time, the MR analysis indicates a genetic link between gut microbiota abundance changes and GERD risk. This not only substantiates the potential of intestinal microecological therapy for GERD, but also establishes a basis for advanced research into the role of intestinal microbiota in the etiology of GERD."", ""supports"": ""SUPPORT""}"
3084	2986	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	5	evidence	0	PMID:17932229	SUPPORT		In SCE, Cldn-18 was the most highly expressed at the mRNA level and this finding is paralleled by marked elevation in protein expression on immunoblots. In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable at the protein level.	This demonstrates that Barrett's esophagus exhibits a dramatic shift in tight junction protein composition, with claudin-18 becoming the dominant protein in metaplastic epithelium.	"{""explanation"": ""This demonstrates that Barrett's esophagus exhibits a dramatic shift in tight junction protein composition, with claudin-18 becoming the dominant protein in metaplastic epithelium."", ""reference"": ""PMID:17932229"", ""snippet"": ""In SCE, Cldn-18 was the most highly expressed at the mRNA level and this finding is paralleled by marked elevation in protein expression on immunoblots. In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable at the protein level."", ""supports"": ""SUPPORT""}"
3085	2986	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	5	evidence	1	PMID:17932229	SUPPORT		We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich TJ in SCE contributes to the greater acid resistance of BE.	This establishes that the claudin-18-rich tight junctions in Barrett's esophagus provide enhanced acid resistance compared to normal squamous epithelium.	"{""explanation"": ""This establishes that the claudin-18-rich tight junctions in Barrett's esophagus provide enhanced acid resistance compared to normal squamous epithelium."", ""reference"": ""PMID:17932229"", ""snippet"": ""We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich TJ in SCE contributes to the greater acid resistance of BE."", ""supports"": ""SUPPORT""}"
3086	2986	125	Gastroesophageal Reflux Disease	Gastroesophageal_Reflux_Disease.yaml	pathophysiology	5	evidence	2	PMID:17932229	SUPPORT		Barrett's esophagus (BE) is a specialized columnar epithelium (SCE) that develops as replacement for damaged squamous epithelium (SqE) in subjects with reflux disease, and as such it is apparently more acid resistant than SqE.	This describes Barrett's esophagus as a metaplastic adaptation that develops in response to chronic reflux-induced damage and provides greater acid resistance.	"{""explanation"": ""This describes Barrett's esophagus as a metaplastic adaptation that develops in response to chronic reflux-induced damage and provides greater acid resistance."", ""reference"": ""PMID:17932229"", ""snippet"": ""Barrett's esophagus (BE) is a specialized columnar epithelium (SCE) that develops as replacement for damaged squamous epithelium (SqE) in subjects with reflux disease, and as such it is apparently more acid resistant than SqE."", ""supports"": ""SUPPORT""}"
3088	3006	126	Gastrointestinal Stromal Tumor	Gastrointestinal_Stromal_Tumor.yaml	pathophysiology	0	evidence	0	PMID:12181401	SUPPORT		Constitutive activation of KIT receptor tyrosine kinase is critical in the pathogenesis of gastrointestinal stromal tumors.	This landmark NEJM study established that constitutive KIT activation is the critical driver of GIST pathogenesis.	"{""explanation"": ""This landmark NEJM study established that constitutive KIT activation is the critical driver of GIST pathogenesis."", ""reference"": ""PMID:12181401"", ""snippet"": ""Constitutive activation of KIT receptor tyrosine kinase is critical in the pathogenesis of gastrointestinal stromal tumors."", ""supports"": ""SUPPORT""}"
3091	3026	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	0	evidence	0	PMID:28218669	SUPPORT		It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages.	Review confirms glucocerebrosidase deficiency causes glucosylceramide accumulation in macrophages.	"{""explanation"": ""Review confirms glucocerebrosidase deficiency causes glucosylceramide accumulation in macrophages."", ""reference"": ""PMID:28218669"", ""snippet"": ""It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages."", ""supports"": ""SUPPORT""}"
3092	3027	127	Gaucher Disease	Gaucher_Disease.yaml	pathophysiology	1	evidence	0	PMID:28218669	SUPPORT		The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.	Review confirms Gaucher cell infiltration causes the major clinical manifestations.	"{""explanation"": ""Review confirms Gaucher cell infiltration causes the major clinical manifestations."", ""reference"": ""PMID:28218669"", ""snippet"": ""The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells."", ""supports"": ""SUPPORT""}"
3101	3049	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	0	evidence	0	PMID:38865810	SUPPORT		Evidence indicates that anxiety disorders arise from an imbalance in the functioning of brain circuits that govern the modulation of emotional responses to possibly threatening stimuli. The circuits under consideration in this context include the amygdala's bottom-up activity, which signifies the existence of stimuli that may be seen as dangerous. Moreover, these circuits encompass top-down regulatory processes that originate in the prefrontal cortex, facilitating the communication of the emotional significance associated with the inputs.	This evidence supports the model of amygdala hyperactivity in anxiety and the role of prefrontal cortex in regulating amygdala responses to threat stimuli.	"{""explanation"": ""This evidence supports the model of amygdala hyperactivity in anxiety and the role of prefrontal cortex in regulating amygdala responses to threat stimuli."", ""reference"": ""PMID:38865810"", ""snippet"": ""Evidence indicates that anxiety disorders arise from an imbalance in the functioning of brain circuits that govern the modulation of emotional responses to possibly threatening stimuli. The circuits under consideration in this context include the amygdala's bottom-up activity, which signifies the existence of stimuli that may be seen as dangerous. Moreover, these circuits encompass top-down regulatory processes that originate in the prefrontal cortex, facilitating the communication of the emotional significance associated with the inputs."", ""supports"": ""SUPPORT""}"
3102	3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	evidence	0	PMID:38865810	SUPPORT		A decrease in GABAergic activity is present in both anxiety disorders and severe depression. Research on cerebral functional imaging in depressive individuals has shown reduced levels of GABA within the cortical regions. Additionally, animal studies demonstrated that a reduction in the expression of GABAA/B receptors results in a behavioral pattern resembling anxiety.	This evidence demonstrates reduced GABAergic activity in anxiety disorders through both imaging studies and animal models showing that decreased GABA receptor expression leads to anxiety-like behavior.	"{""explanation"": ""This evidence demonstrates reduced GABAergic activity in anxiety disorders through both imaging studies and animal models showing that decreased GABA receptor expression leads to anxiety-like behavior."", ""reference"": ""PMID:38865810"", ""snippet"": ""A decrease in GABAergic activity is present in both anxiety disorders and severe depression. Research on cerebral functional imaging in depressive individuals has shown reduced levels of GABA within the cortical regions. Additionally, animal studies demonstrated that a reduction in the expression of GABAA/B receptors results in a behavioral pattern resembling anxiety."", ""supports"": ""SUPPORT""}"
3103	3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	evidence	1	PMID:38865810	SUPPORT		The amygdala consists of inhibitory networks composed of GABAergic interneurons, responsible for modulating anxiety responses in both normal and pathological conditions. The GABAA receptor has allosteric sites (e.g., α/γ, γ/β, and α/β) which enable regulation of neuronal inhibition in the amygdala. These sites serve as molecular targets for anxiolytic medications such as benzodiazepine and barbiturates.	This supports the mechanism of GABAergic dysfunction in the amygdala and explains how benzodiazepines work by targeting GABAA receptor allosteric sites to enhance inhibition.	"{""explanation"": ""This supports the mechanism of GABAergic dysfunction in the amygdala and explains how benzodiazepines work by targeting GABAA receptor allosteric sites to enhance inhibition."", ""reference"": ""PMID:38865810"", ""snippet"": ""The amygdala consists of inhibitory networks composed of GABAergic interneurons, responsible for modulating anxiety responses in both normal and pathological conditions. The GABAA receptor has allosteric sites (e.g., α/γ, γ/β, and α/β) which enable regulation of neuronal inhibition in the amygdala. These sites serve as molecular targets for anxiolytic medications such as benzodiazepine and barbiturates."", ""supports"": ""SUPPORT""}"
3104	3050	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	1	evidence	2	PMID:39294497	SUPPORT		We leveraged information from more than 1.2 million participants, including 97,383 cases, to investigate the genetics of anxiety disorders across five continental groups. Through ancestry-specific and cross-ancestry genome-wide association studies, we identified 51 anxiety-associated loci, 39 of which were novel.	Large-scale GWAS provides genetic evidence for biological mechanisms underlying anxiety disorders, with identified loci enriched for GABAergic signaling pathways.	"{""explanation"": ""Large-scale GWAS provides genetic evidence for biological mechanisms underlying anxiety disorders, with identified loci enriched for GABAergic signaling pathways."", ""reference"": ""PMID:39294497"", ""snippet"": ""We leveraged information from more than 1.2 million participants, including 97,383 cases, to investigate the genetics of anxiety disorders across five continental groups. Through ancestry-specific and cross-ancestry genome-wide association studies, we identified 51 anxiety-associated loci, 39 of which were novel."", ""supports"": ""SUPPORT""}"
3105	3051	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	2	evidence	0	PMID:24936175	SUPPORT		Decreased serotonergic activity has been implicated in anxiety and major depression, and antidepressants directly or indirectly increase the long-term activity of the serotonin system. A key component of serotonin circuitry is the 5-HT1A autoreceptor, which functions as the major somatodendritic autoreceptor to negatively regulate the 'gain' of the serotonin system.	This evidence establishes the role of decreased serotonergic activity in anxiety and explains how antidepressants work by increasing serotonin system activity.	"{""explanation"": ""This evidence establishes the role of decreased serotonergic activity in anxiety and explains how antidepressants work by increasing serotonin system activity."", ""reference"": ""PMID:24936175"", ""snippet"": ""Decreased serotonergic activity has been implicated in anxiety and major depression, and antidepressants directly or indirectly increase the long-term activity of the serotonin system. A key component of serotonin circuitry is the 5-HT1A autoreceptor, which functions as the major somatodendritic autoreceptor to negatively regulate the 'gain' of the serotonin system."", ""supports"": ""SUPPORT""}"
3106	3051	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	2	evidence	1	PMID:24936175	SUPPORT		In addition, 5-HT1A heteroreceptors are abundantly expressed post-synaptically in the prefrontal cortex (PFC), amygdala, and hippocampus to mediate serotonin actions on fear, anxiety, stress, and cognition.	This supports the specific role of serotonin signaling in prefrontal-limbic circuits that regulate anxiety and fear responses.	"{""explanation"": ""This supports the specific role of serotonin signaling in prefrontal-limbic circuits that regulate anxiety and fear responses."", ""reference"": ""PMID:24936175"", ""snippet"": ""In addition, 5-HT1A heteroreceptors are abundantly expressed post-synaptically in the prefrontal cortex (PFC), amygdala, and hippocampus to mediate serotonin actions on fear, anxiety, stress, and cognition."", ""supports"": ""SUPPORT""}"
3107	3052	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	3	evidence	0	PMID:20808146	SUPPORT		Generalized anxiety disorder (GAD) is a common disorder in older adults, which has been linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this age group.	This evidence directly links GAD to HPA axis hyperactivity, particularly in older adults.	"{""explanation"": ""This evidence directly links GAD to HPA axis hyperactivity, particularly in older adults."", ""reference"": ""PMID:20808146"", ""snippet"": ""Generalized anxiety disorder (GAD) is a common disorder in older adults, which has been linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this age group."", ""supports"": ""SUPPORT""}"
3108	3052	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	3	evidence	1	PMID:20808146	SUPPORT		Compared with placebo-treated patients, SSRI-treated patients had a significantly greater reduction in both peak and total cortisol. This reduction in cortisol was limited to patients with elevated (above the median) baseline cortisol, in whom SSRI-treated patients showed substantially greater reduction in cortisol than did placebo-treated patients. Reductions in cortisol were associated with improvements in anxiety.	This demonstrates that HPA axis hyperactivity with elevated cortisol is present in GAD patients and that successful treatment reduces cortisol levels in parallel with anxiety symptom reduction.	"{""explanation"": ""This demonstrates that HPA axis hyperactivity with elevated cortisol is present in GAD patients and that successful treatment reduces cortisol levels in parallel with anxiety symptom reduction."", ""reference"": ""PMID:20808146"", ""snippet"": ""Compared with placebo-treated patients, SSRI-treated patients had a significantly greater reduction in both peak and total cortisol. This reduction in cortisol was limited to patients with elevated (above the median) baseline cortisol, in whom SSRI-treated patients showed substantially greater reduction in cortisol than did placebo-treated patients. Reductions in cortisol were associated with improvements in anxiety."", ""supports"": ""SUPPORT""}"
3109	3054	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	5	evidence	0	PMID:38204917	SUPPORT		The 8-OHdG values of the GAD group were determined to be statistically significantly higher than those of the control group (p=0.028).	This demonstrates elevated oxidative DNA damage in GAD patients as measured by 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of oxidative stress.	"{""explanation"": ""This demonstrates elevated oxidative DNA damage in GAD patients as measured by 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of oxidative stress."", ""reference"": ""PMID:38204917"", ""snippet"": ""The 8-OHdG values of the GAD group were determined to be statistically significantly higher than those of the control group (p=0.028)."", ""supports"": ""SUPPORT""}"
3110	3054	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	5	evidence	1	PMID:38204917	SUPPORT		The results of this study showed that there could be DNA damage because of oxidative stress in GAD patients.	This concludes that oxidative stress contributes to the pathophysiology of GAD through DNA damage mechanisms.	"{""explanation"": ""This concludes that oxidative stress contributes to the pathophysiology of GAD through DNA damage mechanisms."", ""reference"": ""PMID:38204917"", ""snippet"": ""The results of this study showed that there could be DNA damage because of oxidative stress in GAD patients."", ""supports"": ""SUPPORT""}"
3111	3055	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	6	evidence	0	PMID:37542162	SUPPORT		Applying an enrichment-based sequencing approach covering nearly 28 million autosomal CpG sites, we conducted a methylome-wide association study (MWAS) of lifetime ANX in 1132 participants (618 cases/514 controls) from the Netherlands Study of Depression and Anxiety. Using epigenomic deconvolution, we performed MWAS for the main cell types in blood: granulocytes, T-cells, B-cells and monocytes. Cell-type specific analyses identified 280 and 82 methylome-wide significant associations (q-value < 0.1) in monocytes and granulocytes, respectively.	This large-scale epigenome-wide study identifies hundreds of significant DNA methylation sites associated with anxiety disorders, supporting the role of epigenetic mechanisms in GAD pathophysiology.	"{""explanation"": ""This large-scale epigenome-wide study identifies hundreds of significant DNA methylation sites associated with anxiety disorders, supporting the role of epigenetic mechanisms in GAD pathophysiology."", ""reference"": ""PMID:37542162"", ""snippet"": ""Applying an enrichment-based sequencing approach covering nearly 28 million autosomal CpG sites, we conducted a methylome-wide association study (MWAS) of lifetime ANX in 1132 participants (618 cases/514 controls) from the Netherlands Study of Depression and Anxiety. Using epigenomic deconvolution, we performed MWAS for the main cell types in blood: granulocytes, T-cells, B-cells and monocytes. Cell-type specific analyses identified 280 and 82 methylome-wide significant associations (q-value < 0.1) in monocytes and granulocytes, respectively."", ""supports"": ""SUPPORT""}"
3112	3055	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	pathophysiology	6	evidence	1	PMID:37542162	SUPPORT		In monocytes, two specific sites in the FZR1 gene showed significant replication after Bonferroni correction with an additional 15 nominally replicated sites in monocytes and 4 in T-cells. FZR1 regulates neurogenesis in the hippocampus, and its knockout leads to impairments in associative fear memory and long-term potentiation in mice.	This identifies FZR1 as a key gene with replicable methylation changes in anxiety, linking epigenetic alterations to hippocampal neurogenesis and fear memory mechanisms.	"{""explanation"": ""This identifies FZR1 as a key gene with replicable methylation changes in anxiety, linking epigenetic alterations to hippocampal neurogenesis and fear memory mechanisms."", ""reference"": ""PMID:37542162"", ""snippet"": ""In monocytes, two specific sites in the FZR1 gene showed significant replication after Bonferroni correction with an additional 15 nominally replicated sites in monocytes and 4 in T-cells. FZR1 regulates neurogenesis in the hippocampus, and its knockout leads to impairments in associative fear memory and long-term potentiation in mice."", ""supports"": ""SUPPORT""}"
3114	3075	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	0	evidence	0	PMID:35629030	SUPPORT		Once activated, dendritic cells recruit CD4 T cells and induce their activation, proliferation and polarization into Th1 and Th17, which produce interferon-gamma (IFN-γ) and interleukin-17 (IL-17), respectively.	This evidence confirms that dendritic cells are key initiators of the immune response in GCA, recruiting and activating CD4 T cells in the vessel wall.	"{""explanation"": ""This evidence confirms that dendritic cells are key initiators of the immune response in GCA, recruiting and activating CD4 T cells in the vessel wall."", ""reference"": ""PMID:35629030"", ""snippet"": ""Once activated, dendritic cells recruit CD4 T cells and induce their activation, proliferation and polarization into Th1 and Th17, which produce interferon-gamma (IFN-γ) and interleukin-17 (IL-17), respectively."", ""supports"": ""SUPPORT""}"
3115	3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	evidence	0	PMID:35629030	SUPPORT		IFN-γ triggers the production of chemokines by vascular smooth muscle cells, which leads to the recruitment of additional CD4 and CD8 T cells and also monocytes that differentiate into macrophages.	This demonstrates the role of IFN-gamma from Th1 cells in recruiting additional immune cells and promoting macrophage differentiation in the vessel wall.	"{""explanation"": ""This demonstrates the role of IFN-gamma from Th1 cells in recruiting additional immune cells and promoting macrophage differentiation in the vessel wall."", ""reference"": ""PMID:35629030"", ""snippet"": ""IFN-γ triggers the production of chemokines by vascular smooth muscle cells, which leads to the recruitment of additional CD4 and CD8 T cells and also monocytes that differentiate into macrophages."", ""supports"": ""SUPPORT""}"
3116	3076	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	1	evidence	1	PMID:36656970	SUPPORT		Loss of self-tolerance in the adaptive immune system is linked to aberrant signaling in the NOTCH pathway, leading to expansion of NOTCH1+CD4+ T cells and the functional decline of NOTCH4+ T regulatory cells (Checkpoint 1).	This evidence describes the checkpoint mechanism by which CD4+ T cells become dysregulated through NOTCH signaling, enabling their pathogenic infiltration into the arterial wall.	"{""explanation"": ""This evidence describes the checkpoint mechanism by which CD4+ T cells become dysregulated through NOTCH signaling, enabling their pathogenic infiltration into the arterial wall."", ""reference"": ""PMID:36656970"", ""snippet"": ""Loss of self-tolerance in the adaptive immune system is linked to aberrant signaling in the NOTCH pathway, leading to expansion of NOTCH1+CD4+ T cells and the functional decline of NOTCH4+ T regulatory cells (Checkpoint 1)."", ""supports"": ""SUPPORT""}"
3117	3077	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	2	evidence	0	PMID:36656970	SUPPORT		Due to the failure of the immuno-inhibitory PD-1 (programmed cell death protein 1)/PD-L1 (programmed cell death ligand 1) pathway, wall-infiltrating immune cells arrive in a permissive tissues microenvironment, where multiple T cell effector lineages thrive, shift toward high glycolytic activity, and support the development of tissue-damaging macrophages, including multinucleated giant cells (Checkpoint 3).	This describes the immune checkpoint failure that allows multinucleated giant cells to form in the vessel wall through unchecked macrophage activation.	"{""explanation"": ""This describes the immune checkpoint failure that allows multinucleated giant cells to form in the vessel wall through unchecked macrophage activation."", ""reference"": ""PMID:36656970"", ""snippet"": ""Due to the failure of the immuno-inhibitory PD-1 (programmed cell death protein 1)/PD-L1 (programmed cell death ligand 1) pathway, wall-infiltrating immune cells arrive in a permissive tissues microenvironment, where multiple T cell effector lineages thrive, shift toward high glycolytic activity, and support the development of tissue-damaging macrophages, including multinucleated giant cells (Checkpoint 3)."", ""supports"": ""SUPPORT""}"
3118	3077	129	Giant Cell Arteritis	Giant_Cell_Arteritis.yaml	pathophysiology	2	evidence	1	PMID:35629030	SUPPORT		Under the influence of different mediators, mainly endothelin-1 and PDGF, vascular smooth muscle cells migrate to the intima, proliferate and change their phenotype to become myofibroblasts that further proliferate and produce extracellular matrix proteins, increasing the vascular stenosis.	This evidence explains the mechanism of intimal hyperplasia whereby smooth muscle cells proliferate and produce extracellular matrix, leading to stenosis.	"{""explanation"": ""This evidence explains the mechanism of intimal hyperplasia whereby smooth muscle cells proliferate and produce extracellular matrix, leading to stenosis."", ""reference"": ""PMID:35629030"", ""snippet"": ""Under the influence of different mediators, mainly endothelin-1 and PDGF, vascular smooth muscle cells migrate to the intima, proliferate and change their phenotype to become myofibroblasts that further proliferate and produce extracellular matrix proteins, increasing the vascular stenosis."", ""supports"": ""SUPPORT""}"
3127	3101	130	Glaucoma	Glaucoma.yaml	pathophysiology	0	evidence	0	PMID:26497784	SUPPORT		Elevated intraocular pressure and aging, the main risk factors for glaucoma, accelerate RGC apoptosis.	Identifies elevated IOP as a main risk factor that accelerates retinal ganglion cell apoptosis in glaucoma.	"{""explanation"": ""Identifies elevated IOP as a main risk factor that accelerates retinal ganglion cell apoptosis in glaucoma."", ""reference"": ""PMID:26497784"", ""snippet"": ""Elevated intraocular pressure and aging, the main risk factors for glaucoma, accelerate RGC apoptosis."", ""supports"": ""SUPPORT""}"
3128	3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	evidence	0	PMID:26497784	SUPPORT		Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide.	Establishes that RGC apoptosis is the direct cause of visual field loss in glaucoma, confirming the central role of programmed cell death in disease pathogenesis.	"{""explanation"": ""Establishes that RGC apoptosis is the direct cause of visual field loss in glaucoma, confirming the central role of programmed cell death in disease pathogenesis."", ""reference"": ""PMID:26497784"", ""snippet"": ""Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide."", ""supports"": ""SUPPORT""}"
3129	3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	evidence	1	PMID:26302410	SUPPORT		A glaucoma-associated mutant of optineurin, E50K, impairs autophagy as well as vesicle trafficking, leading to death of retinal cells by apoptosis.	Links OPTN mutations to RGC apoptosis through impaired autophagy, providing a molecular mechanism for how genetic variants cause retinal ganglion cell death.	"{""explanation"": ""Links OPTN mutations to RGC apoptosis through impaired autophagy, providing a molecular mechanism for how genetic variants cause retinal ganglion cell death."", ""reference"": ""PMID:26302410"", ""snippet"": ""A glaucoma-associated mutant of optineurin, E50K, impairs autophagy as well as vesicle trafficking, leading to death of retinal cells by apoptosis."", ""supports"": ""SUPPORT""}"
3130	3102	130	Glaucoma	Glaucoma.yaml	pathophysiology	1	evidence	2	PMID:37542647	SUPPORT		Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation.	Confirms that RGC death is a hallmark of glaucoma neurodegeneration and highlights the role of neuroinflammation in the degenerative process.	"{""explanation"": ""Confirms that RGC death is a hallmark of glaucoma neurodegeneration and highlights the role of neuroinflammation in the degenerative process."", ""reference"": ""PMID:37542647"", ""snippet"": ""Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation."", ""supports"": ""SUPPORT""}"
3131	3104	130	Glaucoma	Glaucoma.yaml	pathophysiology	3	evidence	0	PMID:10617907	SUPPORT		Myocilin gene is expressed clearly in the trabecular meshwork cells of both glaucomatous and nonglaucomatous eyes.	Confirms myocilin expression in trabecular meshwork cells, linking MYOC to the trabecular meshwork dysfunction in glaucoma.	"{""explanation"": ""Confirms myocilin expression in trabecular meshwork cells, linking MYOC to the trabecular meshwork dysfunction in glaucoma."", ""reference"": ""PMID:10617907"", ""snippet"": ""Myocilin gene is expressed clearly in the trabecular meshwork cells of both glaucomatous and nonglaucomatous eyes."", ""supports"": ""SUPPORT""}"
3132	3104	130	Glaucoma	Glaucoma.yaml	pathophysiology	3	evidence	1	PMID:37217093	SUPPORT		The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration.	Describes how mutant myocilin causes trabecular meshwork cell death through intracellular aggregation, directly linking MYOC mutations to trabecular dysfunction and elevated IOP.	"{""explanation"": ""Describes how mutant myocilin causes trabecular meshwork cell death through intracellular aggregation, directly linking MYOC mutations to trabecular dysfunction and elevated IOP."", ""reference"": ""PMID:37217093"", ""snippet"": ""The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration."", ""supports"": ""SUPPORT""}"
3161	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	0	PMID:27040960	SUPPORT		G6PD deficiency, one of the commonest inherited enzyme abnormalities in humans, arises through one of many possible mutations, most of which reduce the stability of the enzyme and its level as red cells age.	The snippet confirms that mutations in the G6PD gene lead to reduced enzyme activity.	"{""explanation"": ""The snippet confirms that mutations in the G6PD gene lead to reduced enzyme activity."", ""reference"": ""PMID:27040960"", ""snippet"": ""G6PD deficiency, one of the commonest inherited enzyme abnormalities in humans, arises through one of many possible mutations, most of which reduce the stability of the enzyme and its level as red cells age."", ""supports"": ""SUPPORT""}"
3162	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	1	PMID:1580603	SUPPORT		Most of the studies have been performed in glucose-6-phosphate dehydrogenase deficiency, where a large number of point mutations have been identified.	The excerpt indicates that mutations are identified in G6PD deficiency, implying a link to decreased enzyme activity.	"{""explanation"": ""The excerpt indicates that mutations are identified in G6PD deficiency, implying a link to decreased enzyme activity."", ""reference"": ""PMID:1580603"", ""snippet"": ""Most of the studies have been performed in glucose-6-phosphate dehydrogenase deficiency, where a large number of point mutations have been identified."", ""supports"": ""SUPPORT""}"
3163	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	2	PMID:30279493	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) deficiency, one of the most common human genetic enzymopathies, is caused by over 160 different point mutations.	The snippet clearly states that G6PD deficiency is caused by numerous point mutations.	"{""explanation"": ""The snippet clearly states that G6PD deficiency is caused by numerous point mutations."", ""reference"": ""PMID:30279493"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency, one of the most common human genetic enzymopathies, is caused by over 160 different point mutations."", ""supports"": ""SUPPORT""}"
3164	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	3	PMID:33051526	SUPPORT		The results showed that the overall prevalence of G6PD deficiency in China was 2.10% at the national level. The top six common mutations were c.1388 G>A, c.1376 G>T, c.95 A>G, c.392 G>T, c.871 G>A and c.1024 C>T, accounting for more than 90% of G6PD deficient alleles.	This identifies specific mutations that lead to G6PD deficiency and thus, decreased enzyme activity.	"{""explanation"": ""This identifies specific mutations that lead to G6PD deficiency and thus, decreased enzyme activity."", ""reference"": ""PMID:33051526"", ""snippet"": ""The results showed that the overall prevalence of G6PD deficiency in China was 2.10% at the national level. The top six common mutations were c.1388 G>A, c.1376 G>T, c.95 A>G, c.392 G>T, c.871 G>A and c.1024 C>T, accounting for more than 90% of G6PD deficient alleles."", ""supports"": ""SUPPORT""}"
3165	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	4	PMID:23275194	SUPPORT		G6PD gene mutations cause deficiency of the enzyme and a large spectrum of diseases.	Specifically notes that G6PD gene mutations lead to enzyme deficiency.	"{""explanation"": ""Specifically notes that G6PD gene mutations lead to enzyme deficiency."", ""reference"": ""PMID:23275194"", ""snippet"": ""G6PD gene mutations cause deficiency of the enzyme and a large spectrum of diseases."", ""supports"": ""SUPPORT""}"
3166	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	5	PMID:34138756	SUPPORT		Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the single most common enzymopathy, present in approximately 400 million humans (approximately 5%).	This reference discusses the prevalence of G6PD deficiency, indirectly supporting the statement by establishing the link between mutations and enzyme deficiency.	"{""explanation"": ""This reference discusses the prevalence of G6PD deficiency, indirectly supporting the statement by establishing the link between mutations and enzyme deficiency."", ""reference"": ""PMID:34138756"", ""snippet"": ""Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the single most common enzymopathy, present in approximately 400 million humans (approximately 5%)."", ""supports"": ""SUPPORT""}"
3167	3155	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	0	evidence	6	PMID:30161219	SUPPORT		As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes	While the primary focus is on PAH, this underscores that decreased G6PD activity results from genetic mutations.	"{""explanation"": ""While the primary focus is on PAH, this underscores that decreased G6PD activity results from genetic mutations."", ""reference"": ""PMID:30161219"", ""snippet"": ""As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes"", ""supports"": ""SUPPORT""}"
3168	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	evidence	0	PMID:7602782	SUPPORT		Glucose 6-phosphate dehydrogenase (G6PD) plays a key role in the generation of NADPH which is essential for maintaining glutathione in the reduce state, and in the production of ribose 5-phosphate for the synthesis of nucleotides	This reference states that G6PD is crucial for generating NADPH, which is essential for maintaining cellular redox balance.	"{""explanation"": ""This reference states that G6PD is crucial for generating NADPH, which is essential for maintaining cellular redox balance."", ""reference"": ""PMID:7602782"", ""snippet"": ""Glucose 6-phosphate dehydrogenase (G6PD) plays a key role in the generation of NADPH which is essential for maintaining glutathione in the reduce state, and in the production of ribose 5-phosphate for the synthesis of nucleotides"", ""supports"": ""SUPPORT""}"
3169	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	evidence	1	PMID:31500396	SUPPORT		The generation of reducing equivalent NADPH via glucose-6-phosphate dehydrogenase (G6PD) is critical for the maintenance of redox homeostasis and reductive biosynthesis in cells.	This reference confirms that adequate G6PD activity is critical for maintaining redox homeostasis by generating NADPH.	"{""explanation"": ""This reference confirms that adequate G6PD activity is critical for maintaining redox homeostasis by generating NADPH."", ""reference"": ""PMID:31500396"", ""snippet"": ""The generation of reducing equivalent NADPH via glucose-6-phosphate dehydrogenase (G6PD) is critical for the maintenance of redox homeostasis and reductive biosynthesis in cells."", ""supports"": ""SUPPORT""}"
3170	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	evidence	2	PMID:35880537	SUPPORT		However, ROS are regulated by a key enzyme called G6PD via the production of reduced nicotinamide adenine dinucleotide phosphate (NADPH), which controls the generation and removal of ROS in a tissue-specific manner.	This reference indicates that G6PD plays a crucial role in regulating ROS via NADPH production, thus confirming the role of G6PD in maintaining redox balance.	"{""explanation"": ""This reference indicates that G6PD plays a crucial role in regulating ROS via NADPH production, thus confirming the role of G6PD in maintaining redox balance."", ""reference"": ""PMID:35880537"", ""snippet"": ""However, ROS are regulated by a key enzyme called G6PD via the production of reduced nicotinamide adenine dinucleotide phosphate (NADPH), which controls the generation and removal of ROS in a tissue-specific manner."", ""supports"": ""SUPPORT""}"
3171	3156	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	1	evidence	3	PMID:20484601	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) is an important site of metabolic control in the pentose phosphate pathway (PPP), providing reducing power (NADPH) and pentose phosphates.	This reference states that G6PD controls metabolic processes in the pentose phosphate pathway, providing NADPH necessary for redox balance.	"{""explanation"": ""This reference states that G6PD controls metabolic processes in the pentose phosphate pathway, providing NADPH necessary for redox balance."", ""reference"": ""PMID:20484601"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) is an important site of metabolic control in the pentose phosphate pathway (PPP), providing reducing power (NADPH) and pentose phosphates."", ""supports"": ""SUPPORT""}"
3172	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	evidence	0	PMID:17623517	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is indispensable to maintenance of the cytosolic pool of NADPH and thus the cellular redox balance.	The literature confirms that G6PD deficiency disrupts NADPH levels, impairing the cell's ability to handle oxidative stress, which is consistent with the statement.	"{""explanation"": ""The literature confirms that G6PD deficiency disrupts NADPH levels, impairing the cell's ability to handle oxidative stress, which is consistent with the statement."", ""reference"": ""PMID:17623517"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is indispensable to maintenance of the cytosolic pool of NADPH and thus the cellular redox balance."", ""supports"": ""SUPPORT""}"
3173	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	evidence	1	PMID:31961822	SUPPORT		Fresh G6PD-deficient RBCs demonstrated defects in the oxidative phase of the pentose phosphate pathway. During refrigerated storage, G6PD-deficient RBCs demonstrated increased glycolysis, impaired glutathione homeostasis, and increased purine oxidation, as compared with G6PD-normal RBCs.	The study describes how G6PD deficiency leads to impaired management of oxidative stress in red blood cells due to defects in glutathione homeostasis, supporting the statement.	"{""explanation"": ""The study describes how G6PD deficiency leads to impaired management of oxidative stress in red blood cells due to defects in glutathione homeostasis, supporting the statement."", ""reference"": ""PMID:31961822"", ""snippet"": ""Fresh G6PD-deficient RBCs demonstrated defects in the oxidative phase of the pentose phosphate pathway. During refrigerated storage, G6PD-deficient RBCs demonstrated increased glycolysis, impaired glutathione homeostasis, and increased purine oxidation, as compared with G6PD-normal RBCs."", ""supports"": ""SUPPORT""}"
3174	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	evidence	2	PMID:19769422	SUPPORT		Numerous drugs, infections, and metabolic conditions have been shown to cause acute hemolysis of red blood cells in the G6PD-deficient patient... The most effective management strategy is to prevent hemolysis by avoiding oxidative stressors.	This reference supports the idea that decreased NADPH levels in G6PD deficiency impair the ability of red blood cells to handle oxidative stress, leading to hemolysis.	"{""explanation"": ""This reference supports the idea that decreased NADPH levels in G6PD deficiency impair the ability of red blood cells to handle oxidative stress, leading to hemolysis."", ""reference"": ""PMID:19769422"", ""snippet"": ""Numerous drugs, infections, and metabolic conditions have been shown to cause acute hemolysis of red blood cells in the G6PD-deficient patient... The most effective management strategy is to prevent hemolysis by avoiding oxidative stressors."", ""supports"": ""SUPPORT""}"
3175	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	evidence	3	PMID:31235029	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an erythrocyte enzyme defect that amplifies the susceptibility of erythrocytes to oxidative stress... Consequently, erythrocyte destruction and hemolysis occur.	This article confirms that G6PD deficiency amplifies susceptibility to oxidative stress in erythrocytes, leading to hemolysis.	"{""explanation"": ""This article confirms that G6PD deficiency amplifies susceptibility to oxidative stress in erythrocytes, leading to hemolysis."", ""reference"": ""PMID:31235029"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an erythrocyte enzyme defect that amplifies the susceptibility of erythrocytes to oxidative stress... Consequently, erythrocyte destruction and hemolysis occur."", ""supports"": ""SUPPORT""}"
3176	3157	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	2	evidence	4	PMID:11763298	SUPPORT		G6PD generates nicotinamide adenine dinucleotide phosphate (NADPH), a co-factor in the synthesis of nitric oxide... Currently, there are 200 million people worldwide with red cell x-linked chromosome defects who... are at greater risk of developing hypertension or diabetes mellitus than those racial groups without the defect.	Although this study mainly discusses other health outcomes, it acknowledges the role of G6PD in generating NADPH, thus supporting the connection to oxidative stress and hemolysis due to deficiency.	"{""explanation"": ""Although this study mainly discusses other health outcomes, it acknowledges the role of G6PD in generating NADPH, thus supporting the connection to oxidative stress and hemolysis due to deficiency."", ""reference"": ""PMID:11763298"", ""snippet"": ""G6PD generates nicotinamide adenine dinucleotide phosphate (NADPH), a co-factor in the synthesis of nitric oxide... Currently, there are 200 million people worldwide with red cell x-linked chromosome defects who... are at greater risk of developing hypertension or diabetes mellitus than those racial groups without the defect."", ""supports"": ""SUPPORT""}"
3177	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	downstream[0].evidence	0	PMID:34389161	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) maintains redox balance in a variety of cell types and is essential for erythrocyte resistance to oxidative stress. G6PD deficiency, caused by mutations in the G6PD gene, is present in ~400 million people worldwide, and can cause acute hemolytic anemia.	This paper directly establishes that G6PD enzyme deficiency leads to reduced oxidative stress resistance in erythrocytes, resulting in acute hemolytic anemia.	"{""explanation"": ""This paper directly establishes that G6PD enzyme deficiency leads to reduced oxidative stress resistance in erythrocytes, resulting in acute hemolytic anemia."", ""reference"": ""PMID:34389161"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) maintains redox balance in a variety of cell types and is essential for erythrocyte resistance to oxidative stress. G6PD deficiency, caused by mutations in the G6PD gene, is present in ~400 million people worldwide, and can cause acute hemolytic anemia."", ""supports"": ""SUPPORT""}"
3178	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	evidence	0	PMID:31609781	SUPPORT		The G6PD enzyme is critical to protecting erythrocytes against oxidative stress, and deficiency may lead to hemolysis in the presence of certain environmental factors such as infection and some medications and foods.	This reference clearly states that G6PD deficiency can lead to hemolysis when exposed to oxidative stressors like infections, certain medications, and foods.	"{""explanation"": ""This reference clearly states that G6PD deficiency can lead to hemolysis when exposed to oxidative stressors like infections, certain medications, and foods."", ""reference"": ""PMID:31609781"", ""snippet"": ""The G6PD enzyme is critical to protecting erythrocytes against oxidative stress, and deficiency may lead to hemolysis in the presence of certain environmental factors such as infection and some medications and foods."", ""supports"": ""SUPPORT""}"
3179	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	evidence	1	PMID:32600868	SUPPORT		Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia.	The abstract supports the statement by mentioning that G6PD deficiency can trigger acute hemolytic anemia when exposed to specific oxidative stressors.	"{""explanation"": ""The abstract supports the statement by mentioning that G6PD deficiency can trigger acute hemolytic anemia when exposed to specific oxidative stressors."", ""reference"": ""PMID:32600868"", ""snippet"": ""Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia."", ""supports"": ""SUPPORT""}"
3180	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	evidence	2	PMID:31235029	SUPPORT		The possible mechanism of oxidative stress-mediated destruction of erythrocytes in G6PD deficient individuals induced by periodontal infection is highlighted.	This reference discusses the mechanism of oxidative stress-mediated hemolysis in individuals with G6PD deficiency, supporting the statement.	"{""explanation"": ""This reference discusses the mechanism of oxidative stress-mediated hemolysis in individuals with G6PD deficiency, supporting the statement."", ""reference"": ""PMID:31235029"", ""snippet"": ""The possible mechanism of oxidative stress-mediated destruction of erythrocytes in G6PD deficient individuals induced by periodontal infection is highlighted."", ""supports"": ""SUPPORT""}"
3181	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	evidence	3	PMID:33313989	SUPPORT		Ingestion of fava beans, as well as infection and certain drugs, are the most typical causes of acute hemolysis in people with G6PD deficiency.	The reference explicitly mentions that certain foods (like fava beans), infections, and drugs can cause acute hemolysis in G6PD-deficient individuals.	"{""explanation"": ""The reference explicitly mentions that certain foods (like fava beans), infections, and drugs can cause acute hemolysis in G6PD-deficient individuals."", ""reference"": ""PMID:33313989"", ""snippet"": ""Ingestion of fava beans, as well as infection and certain drugs, are the most typical causes of acute hemolysis in people with G6PD deficiency."", ""supports"": ""SUPPORT""}"
3182	3158	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	pathophysiology	3	evidence	4	PMID:30380124	SUPPORT		Although the resulting hemolysis is most often associated with drug exposure, it has also been reported after consumption of certain foods.	The reference confirms that hemolysis in G6PD deficiency can be triggered by certain foods and medications.	"{""explanation"": ""The reference confirms that hemolysis in G6PD deficiency can be triggered by certain foods and medications."", ""reference"": ""PMID:30380124"", ""snippet"": ""Although the resulting hemolysis is most often associated with drug exposure, it has also been reported after consumption of certain foods."", ""supports"": ""SUPPORT""}"
3229	3181	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:19032739	SUPPORT		NBCCS is caused by mutations in the PTCH1 gene and is transmitted as an autosomal dominant trait with complete penetrance and variable expressivity.	Establishes PTCH1 as the causative gene for NBCCS with autosomal dominant inheritance.	"{""explanation"": ""Establishes PTCH1 as the causative gene for NBCCS with autosomal dominant inheritance."", ""reference"": ""PMID:19032739"", ""snippet"": ""NBCCS is caused by mutations in the PTCH1 gene and is transmitted as an autosomal dominant trait with complete penetrance and variable expressivity."", ""supports"": ""SUPPORT""}"
3230	3181	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:28596197	SUPPORT		Heterozygous germline variants in PTCH1 and SUFU encoding components of the Sonic hedgehog pathway explain the majority of cases.	Confirms PTCH1 germline variants as the primary genetic cause of Gorlin syndrome.	"{""explanation"": ""Confirms PTCH1 germline variants as the primary genetic cause of Gorlin syndrome."", ""reference"": ""PMID:28596197"", ""snippet"": ""Heterozygous germline variants in PTCH1 and SUFU encoding components of the Sonic hedgehog pathway explain the majority of cases."", ""supports"": ""SUPPORT""}"
3231	3182	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:25403219	SUPPORT		We found a < 2% risk in PTCH1 mutation-positive individuals, with a risk up to 20× higher in SUFU mutation-positive individuals.	Demonstrates that SUFU mutations confer dramatically higher medulloblastoma risk than PTCH1 mutations.	"{""explanation"": ""Demonstrates that SUFU mutations confer dramatically higher medulloblastoma risk than PTCH1 mutations."", ""reference"": ""PMID:25403219"", ""snippet"": ""We found a < 2% risk in PTCH1 mutation-positive individuals, with a risk up to 20× higher in SUFU mutation-positive individuals."", ""supports"": ""SUPPORT""}"
3232	3182	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:29186568	SUPPORT		Germline SUFU mutations strongly predispose to medulloblastoma in the first years of life, with worse prognosis than usually observed for SHH medulloblastoma.	Confirms high medulloblastoma risk and poor prognosis in SUFU mutation carriers.	"{""explanation"": ""Confirms high medulloblastoma risk and poor prognosis in SUFU mutation carriers."", ""reference"": ""PMID:29186568"", ""snippet"": ""Germline SUFU mutations strongly predispose to medulloblastoma in the first years of life, with worse prognosis than usually observed for SHH medulloblastoma."", ""supports"": ""SUPPORT""}"
3243	3214	134	Gout	Gout.yaml	pathophysiology	0	evidence	0	PMID:38972919	SUPPORT		Crystallization of monosodium urate monohydrate (MSU) leads to painful gouty arthritis.	Establishes that hyperuricemia-driven MSU crystallization is the fundamental pathological process in gout.	"{""explanation"": ""Establishes that hyperuricemia-driven MSU crystallization is the fundamental pathological process in gout."", ""reference"": ""PMID:38972919"", ""snippet"": ""Crystallization of monosodium urate monohydrate (MSU) leads to painful gouty arthritis."", ""supports"": ""SUPPORT""}"
3244	3215	134	Gout	Gout.yaml	pathophysiology	1	evidence	0	PMID:38972919	SUPPORT		inflammatory MSU crystals form after a non-inflammatory amorphous precursor (AMSU) that nucleates heterogeneously on collagen fibrils from damaged articular cartilage of gout patients	Describes the non-classical crystallization pathway where MSU forms via an amorphous precursor on damaged cartilage collagen, explaining the anatomical specificity of crystal deposition.	"{""explanation"": ""Describes the non-classical crystallization pathway where MSU forms via an amorphous precursor on damaged cartilage collagen, explaining the anatomical specificity of crystal deposition."", ""reference"": ""PMID:38972919"", ""snippet"": ""inflammatory MSU crystals form after a non-inflammatory amorphous precursor (AMSU) that nucleates heterogeneously on collagen fibrils from damaged articular cartilage of gout patients"", ""supports"": ""SUPPORT""}"
3245	3215	134	Gout	Gout.yaml	pathophysiology	1	evidence	1	PMID:38972919	SUPPORT		This non-classical crystallization route imprints a nanogranular structure to biogenic acicular MSU crystals, which have smaller unit cell volume, lower microstrain, and higher crystallinity than synthetic MSU.	Characterizes the unique structural properties of pathological MSU crystals that form in vivo at low supersaturation over extended time periods.	"{""explanation"": ""Characterizes the unique structural properties of pathological MSU crystals that form in vivo at low supersaturation over extended time periods."", ""reference"": ""PMID:38972919"", ""snippet"": ""This non-classical crystallization route imprints a nanogranular structure to biogenic acicular MSU crystals, which have smaller unit cell volume, lower microstrain, and higher crystallinity than synthetic MSU."", ""supports"": ""SUPPORT""}"
3246	3216	134	Gout	Gout.yaml	pathophysiology	2	evidence	0	PMID:39386881	SUPPORT		Gout represents an autoinflammatory disorder instigated by monosodium urate crystals. Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages. Macrophages assume a pivotal role in the initiation of acute gouty inflammation and subsequent inflammatory cascades.	Establishes the central role of macrophages in initiating and propagating the acute inflammatory response to MSU crystals in gout.	"{""explanation"": ""Establishes the central role of macrophages in initiating and propagating the acute inflammatory response to MSU crystals in gout."", ""reference"": ""PMID:39386881"", ""snippet"": ""Gout represents an autoinflammatory disorder instigated by monosodium urate crystals. Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages. Macrophages assume a pivotal role in the initiation of acute gouty inflammation and subsequent inflammatory cascades."", ""supports"": ""SUPPORT""}"
3247	3216	134	Gout	Gout.yaml	pathophysiology	2	evidence	1	PMID:39386881	SUPPORT		Macrophages, characterized by different subtypes, exhibit distinct functionalities that either contribute to the progression or regression of gout.	Demonstrates that macrophages have complex, context-dependent roles in both promoting and resolving gouty inflammation depending on their polarization state.	"{""explanation"": ""Demonstrates that macrophages have complex, context-dependent roles in both promoting and resolving gouty inflammation depending on their polarization state."", ""reference"": ""PMID:39386881"", ""snippet"": ""Macrophages, characterized by different subtypes, exhibit distinct functionalities that either contribute to the progression or regression of gout."", ""supports"": ""SUPPORT""}"
3248	3216	134	Gout	Gout.yaml	pathophysiology	2	evidence	2	PMID:39426967	SUPPORT		At 48 weeks ULT, serum urate normalized in all gout patients, and flares declined in association with significantly altered proteins (p < 0.05) in clustering and proteome networks in sera and peripheral blood mononuclear cells.	Shows that effective urate-lowering therapy modulates immune cell proteomes, including those relevant to inflammasome activation, correlating with reduced flare burden.	"{""explanation"": ""Shows that effective urate-lowering therapy modulates immune cell proteomes, including those relevant to inflammasome activation, correlating with reduced flare burden."", ""reference"": ""PMID:39426967"", ""snippet"": ""At 48 weeks ULT, serum urate normalized in all gout patients, and flares declined in association with significantly altered proteins (p < 0.05) in clustering and proteome networks in sera and peripheral blood mononuclear cells."", ""supports"": ""SUPPORT""}"
3249	3217	134	Gout	Gout.yaml	pathophysiology	3	evidence	0	PMID:39386881	SUPPORT		Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages.	Confirms that neutrophil recruitment is a primary feature of the acute gouty inflammatory response.	"{""explanation"": ""Confirms that neutrophil recruitment is a primary feature of the acute gouty inflammatory response."", ""reference"": ""PMID:39386881"", ""snippet"": ""Its primary manifestation involves the recruitment of diverse immune cell populations, including neutrophils and macrophages."", ""supports"": ""SUPPORT""}"
3250	3217	134	Gout	Gout.yaml	pathophysiology	3	evidence	1	PMID:39426967	SUPPORT		In both cohorts, a treatment-emergent serum interactome included key gouty inflammation mediators (C5, IL-1B, CXCL8, IL6).	Identifies IL-1B and CXCL8 as key mediators in the serum interactome associated with gouty inflammation, supporting their role in neutrophil recruitment and activation.	"{""explanation"": ""Identifies IL-1B and CXCL8 as key mediators in the serum interactome associated with gouty inflammation, supporting their role in neutrophil recruitment and activation."", ""reference"": ""PMID:39426967"", ""snippet"": ""In both cohorts, a treatment-emergent serum interactome included key gouty inflammation mediators (C5, IL-1B, CXCL8, IL6)."", ""supports"": ""SUPPORT""}"
3251	3218	134	Gout	Gout.yaml	pathophysiology	4	evidence	0	PMID:39426967	SUPPORT		Sera demonstrated altered complement activation and regulatory gene ontology biologic processes.	Demonstrates that complement activation pathways are altered in gout and modulated by effective urate-lowering therapy.	"{""explanation"": ""Demonstrates that complement activation pathways are altered in gout and modulated by effective urate-lowering therapy."", ""reference"": ""PMID:39426967"", ""snippet"": ""Sera demonstrated altered complement activation and regulatory gene ontology biologic processes."", ""supports"": ""SUPPORT""}"
3252	3218	134	Gout	Gout.yaml	pathophysiology	4	evidence	1	PMID:39426967	SUPPORT		Reduced gout flares are linked with a XOI treatment-emergent serum protein interactome that includes inflammation regulators, associated with altered complement activation and regulatory biologic processes.	Shows that reduction in gout flares correlates with changes in complement activation pathways, establishing complement as a key therapeutic target and biomarker.	"{""explanation"": ""Shows that reduction in gout flares correlates with changes in complement activation pathways, establishing complement as a key therapeutic target and biomarker."", ""reference"": ""PMID:39426967"", ""snippet"": ""Reduced gout flares are linked with a XOI treatment-emergent serum protein interactome that includes inflammation regulators, associated with altered complement activation and regulatory biologic processes."", ""supports"": ""SUPPORT""}"
3253	3218	134	Gout	Gout.yaml	pathophysiology	4	evidence	2	PMID:39426967	SUPPORT		Last, febuxostat treatment decreased complement activation biologic process proteins in cultured BMDMs.	Provides mechanistic evidence that xanthine oxidase inhibitors directly modulate complement activation in macrophages beyond their urate-lowering effects.	"{""explanation"": ""Provides mechanistic evidence that xanthine oxidase inhibitors directly modulate complement activation in macrophages beyond their urate-lowering effects."", ""reference"": ""PMID:39426967"", ""snippet"": ""Last, febuxostat treatment decreased complement activation biologic process proteins in cultured BMDMs."", ""supports"": ""SUPPORT""}"
3254	3219	134	Gout	Gout.yaml	pathophysiology	5	evidence	0	PMID:38910565	SUPPORT		Neutrophil extracellular traps (NETs) are formed by neutrophils in response to pathogen attack. During gout, NETs induced by MSU crystals exacerbate inflammation, and aggregated NETs (aggNETs) promote the resolution of gout-associated inflammation by encapsulating MSU crystals, degrading cytokines and chemokines, and blocking the recruitment and activation of neutrophils.	Describes the dual role of NETs in gout - initially amplifying inflammation but then promoting resolution through aggregation and sequestration mechanisms.	"{""explanation"": ""Describes the dual role of NETs in gout - initially amplifying inflammation but then promoting resolution through aggregation and sequestration mechanisms."", ""reference"": ""PMID:38910565"", ""snippet"": ""Neutrophil extracellular traps (NETs) are formed by neutrophils in response to pathogen attack. During gout, NETs induced by MSU crystals exacerbate inflammation, and aggregated NETs (aggNETs) promote the resolution of gout-associated inflammation by encapsulating MSU crystals, degrading cytokines and chemokines, and blocking the recruitment and activation of neutrophils."", ""supports"": ""SUPPORT""}"
3255	3219	134	Gout	Gout.yaml	pathophysiology	5	evidence	1	PMID:38910565	SUPPORT		With disease progression, NETs participate in the formation of tophi.	Establishes the role of NETs in chronic gout pathology, specifically in the formation of tophi (urate crystal deposits).	"{""explanation"": ""Establishes the role of NETs in chronic gout pathology, specifically in the formation of tophi (urate crystal deposits)."", ""reference"": ""PMID:38910565"", ""snippet"": ""With disease progression, NETs participate in the formation of tophi."", ""supports"": ""SUPPORT""}"
3256	3219	134	Gout	Gout.yaml	pathophysiology	5	evidence	2	PMID:38910565	SUPPORT		Therefore, aggNETs are a possible mechanism of spontaneous gout regression.	Identifies aggregated NETs as a key mechanism underlying the self-limited nature of acute gout flares and spontaneous resolution.	"{""explanation"": ""Identifies aggregated NETs as a key mechanism underlying the self-limited nature of acute gout flares and spontaneous resolution."", ""reference"": ""PMID:38910565"", ""snippet"": ""Therefore, aggNETs are a possible mechanism of spontaneous gout regression."", ""supports"": ""SUPPORT""}"
3269	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	evidence	0	PMID:27939641	SUPPORT		Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-β-driven differentiation of smooth muscle cells.	Guo et al. 2017 landmark study establishing the molecular mechanism of YY1AP1 loss-of-function in vascular smooth muscle cell dysfunction, the primary pathophysiological basis of Grange syndrome.	"{""explanation"": ""Guo et al. 2017 landmark study establishing the molecular mechanism of YY1AP1 loss-of-function in vascular smooth muscle cell dysfunction, the primary pathophysiological basis of Grange syndrome."", ""reference"": ""PMID:27939641"", ""snippet"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-β-driven differentiation of smooth muscle cells."", ""supports"": ""SUPPORT""}"
3270	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	evidence	1	PMID:33971976	SUPPORT		This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities.	Raggio et al. 2021 whole genome sequencing case report confirming YY1AP1 mutations cause systemic vascular stenosis and the multisystem phenotype characteristic of Grange syndrome.	"{""explanation"": ""Raggio et al. 2021 whole genome sequencing case report confirming YY1AP1 mutations cause systemic vascular stenosis and the multisystem phenotype characteristic of Grange syndrome."", ""reference"": ""PMID:33971976"", ""snippet"": ""This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3271	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	evidence	2	PMID:37323195	SUPPORT		Grange syndrome (OMIM 602531) is characterized by a constellation of symptoms of hypertension, stenosis, or occlusion of different arteries (including the cerebral, renal, abdominal, and coronary vessels) with a variable occurrence of brachysyndactyly, bone fragility, and congenital heart defects.	Karakaya et al. 2023 case report of the youngest documented patient with Grange syndrome confirming the characteristic vascular manifestations resulting from YY1AP1 loss-of-function.	"{""explanation"": ""Karakaya et al. 2023 case report of the youngest documented patient with Grange syndrome confirming the characteristic vascular manifestations resulting from YY1AP1 loss-of-function."", ""reference"": ""PMID:37323195"", ""snippet"": ""Grange syndrome (OMIM 602531) is characterized by a constellation of symptoms of hypertension, stenosis, or occlusion of different arteries (including the cerebral, renal, abdominal, and coronary vessels) with a variable occurrence of brachysyndactyly, bone fragility, and congenital heart defects."", ""supports"": ""SUPPORT""}"
3272	3232	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	0	evidence	3	PMID:22987684	SUPPORT		We report on the case of an 18-year-old female presenting with subarachnoid hemorrhage due to the rupture of a basilar artery aneurysm, and with distinctive systemic features including extensive vasculopathy, facial dysmorphisms and brachysyndactyly, consistent with the diagnosis of Grange syndrome.	Volonghi et al. 2012 documents severe cerebrovascular complications including subarachnoid hemorrhage from basilar artery aneurysm in an 18-year-old Grange syndrome patient, demonstrating the serious neurological sequelae of YY1AP1-mediated vascular disease.	"{""explanation"": ""Volonghi et al. 2012 documents severe cerebrovascular complications including subarachnoid hemorrhage from basilar artery aneurysm in an 18-year-old Grange syndrome patient, demonstrating the serious neurological sequelae of YY1AP1-mediated vascular disease."", ""reference"": ""PMID:22987684"", ""snippet"": ""We report on the case of an 18-year-old female presenting with subarachnoid hemorrhage due to the rupture of a basilar artery aneurysm, and with distinctive systemic features including extensive vasculopathy, facial dysmorphisms and brachysyndactyly, consistent with the diagnosis of Grange syndrome."", ""supports"": ""SUPPORT""}"
3273	3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	evidence	0	PMID:27939641	SUPPORT		Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-β-driven differentiation of smooth muscle cells.	Guo et al. 2017 landmark mechanistic study demonstrating cellular basis of YY1AP1 loss-of-function in VSMC dysfunction.	"{""explanation"": ""Guo et al. 2017 landmark mechanistic study demonstrating cellular basis of YY1AP1 loss-of-function in VSMC dysfunction."", ""reference"": ""PMID:27939641"", ""snippet"": ""Loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-β-driven differentiation of smooth muscle cells."", ""supports"": ""SUPPORT""}"
3274	3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	evidence	1	PMID:33971976	SUPPORT		This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities.	Raggio et al. 2021 case report confirming systemic vascular stenosis as cardinal manifestation of YY1AP1 loss-of-function.	"{""explanation"": ""Raggio et al. 2021 case report confirming systemic vascular stenosis as cardinal manifestation of YY1AP1 loss-of-function."", ""reference"": ""PMID:33971976"", ""snippet"": ""This gene is related to Grange syndrome, a recessive rare disease, whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3275	3233	135	Grange syndrome	Grange_syndrome.yaml	pathophysiology	1	evidence	2	PMID:31270375	SUPPORT		Renovascular hypertension (RVH) is one of the major causes of secondary hypertension in children... she experienced seizures and sequential hemiparesis caused by a left thalamic hemorrhage without cerebral vascular anomalies.	Saida et al. 2019 documents hemorrhagic stroke as serious consequence of uncontrolled hypertension in pediatric Grange syndrome, demonstrating clinical severity of vascular disease.	"{""explanation"": ""Saida et al. 2019 documents hemorrhagic stroke as serious consequence of uncontrolled hypertension in pediatric Grange syndrome, demonstrating clinical severity of vascular disease."", ""reference"": ""PMID:31270375"", ""snippet"": ""Renovascular hypertension (RVH) is one of the major causes of secondary hypertension in children... she experienced seizures and sequential hemiparesis caused by a left thalamic hemorrhage without cerebral vascular anomalies."", ""supports"": ""SUPPORT""}"
3295	3252	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	0	evidence	0	PMID:37781373	SUPPORT		The pathogenesis of AAV includes ANCA-mediated neutrophil activation, subsequent release of inflammatory cytokines and reactive oxygen species (ROS), and formation of neutrophil extracellular traps (NETs).	This review confirms that ANCA-mediated neutrophil activation is a central pathogenic mechanism in AAV, leading to ROS release and vascular injury.	"{""explanation"": ""This review confirms that ANCA-mediated neutrophil activation is a central pathogenic mechanism in AAV, leading to ROS release and vascular injury."", ""reference"": ""PMID:37781373"", ""snippet"": ""The pathogenesis of AAV includes ANCA-mediated neutrophil activation, subsequent release of inflammatory cytokines and reactive oxygen species (ROS), and formation of neutrophil extracellular traps (NETs)."", ""supports"": ""SUPPORT""}"
3296	3252	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	0	evidence	1	PMID:38791316	SUPPORT		Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury.	This review describes neutrophil activation as a key mechanism in pulmonary manifestations of GPA, involving ANCA-triggered neutrophil responses.	"{""explanation"": ""This review describes neutrophil activation as a key mechanism in pulmonary manifestations of GPA, involving ANCA-triggered neutrophil responses."", ""reference"": ""PMID:38791316"", ""snippet"": ""Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury."", ""supports"": ""SUPPORT""}"
3297	3253	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	1	evidence	0	PMID:38791316	SUPPORT		This review explored the underlying pathogenesis of pulmonary involvement in vasculitis, encompassing various forms such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and anti-GBM disease.	This review discusses the granulomatous inflammation characteristic of GPA, particularly in the respiratory tract.	"{""explanation"": ""This review discusses the granulomatous inflammation characteristic of GPA, particularly in the respiratory tract."", ""reference"": ""PMID:38791316"", ""snippet"": ""This review explored the underlying pathogenesis of pulmonary involvement in vasculitis, encompassing various forms such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and anti-GBM disease."", ""supports"": ""SUPPORT""}"
3298	3253	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	1	evidence	1	PMID:35479831	SUPPORT		The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear nose and throat, respiratory tract, kidneys, skin and nervous system. They include granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA).	This review describes GPA as a distinct entity with granulomatous features affecting multiple organ systems including the respiratory tract.	"{""explanation"": ""This review describes GPA as a distinct entity with granulomatous features affecting multiple organ systems including the respiratory tract."", ""reference"": ""PMID:35479831"", ""snippet"": ""The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear nose and throat, respiratory tract, kidneys, skin and nervous system. They include granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA)."", ""supports"": ""SUPPORT""}"
3299	3254	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	2	evidence	0	PMID:38791316	SUPPORT		Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury.	This review confirms the role of the complement system in amplifying ANCA-mediated vascular injury in GPA.	"{""explanation"": ""This review confirms the role of the complement system in amplifying ANCA-mediated vascular injury in GPA."", ""reference"": ""PMID:38791316"", ""snippet"": ""Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury."", ""supports"": ""SUPPORT""}"
3300	3254	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	pathophysiology	2	evidence	1	PMID:37781373	SUPPORT		Mechanistically, cytokines or complement factors activate and prime neutrophils for ANCA-binding; thus, C5a receptor blocker has garnered attention as potential replacement for glucocorticoids in clinical settings.	This review describes how complement factors, particularly C5a, prime neutrophils for ANCA-mediated activation, validating the complement pathway as a therapeutic target.	"{""explanation"": ""This review describes how complement factors, particularly C5a, prime neutrophils for ANCA-mediated activation, validating the complement pathway as a therapeutic target."", ""reference"": ""PMID:37781373"", ""snippet"": ""Mechanistically, cytokines or complement factors activate and prime neutrophils for ANCA-binding; thus, C5a receptor blocker has garnered attention as potential replacement for glucocorticoids in clinical settings."", ""supports"": ""SUPPORT""}"
3336	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	evidence	0	PMID:37047805	PARTIAL		The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR), chronically stimulating it and leading to high levels of thyroid hormones in the body.	The literature confirms the role of B cells in producing autoantibodies that stimulate the thyroid, but it does not explicitly mention thyroid-stimulating immunoglobulins (TSIs).	"{""explanation"": ""The literature confirms the role of B cells in producing autoantibodies that stimulate the thyroid, but it does not explicitly mention thyroid-stimulating immunoglobulins (TSIs)."", ""reference"": ""PMID:37047805"", ""snippet"": ""The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR), chronically stimulating it and leading to high levels of thyroid hormones in the body."", ""supports"": ""PARTIAL""}"
3337	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	evidence	1	PMID:1356056	PARTIAL		In the former, there is overactivity of the thyroid due to the action of a thyroid-stimulating antibody (TSAb).	The literature confirms that thyroid-stimulating antibodies (TSAb) cause overactivity of the thyroid, but it does not explicitly mention T cells or the term 'thyroid-stimulating immunoglobulins (TSIs)'.	"{""explanation"": ""The literature confirms that thyroid-stimulating antibodies (TSAb) cause overactivity of the thyroid, but it does not explicitly mention T cells or the term 'thyroid-stimulating immunoglobulins (TSIs)'."", ""reference"": ""PMID:1356056"", ""snippet"": ""In the former, there is overactivity of the thyroid due to the action of a thyroid-stimulating antibody (TSAb)."", ""supports"": ""PARTIAL""}"
3338	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	evidence	2	PMID:6129186	PARTIAL		The presence of thyroid-stimulating immunoglobulins in patients with Graves' disease is well established.	The literature confirms the presence of thyroid-stimulating immunoglobulins (TSIs) in Graves' disease but does not explicitly mention the involvement of T cells.	"{""explanation"": ""The literature confirms the presence of thyroid-stimulating immunoglobulins (TSIs) in Graves' disease but does not explicitly mention the involvement of T cells."", ""reference"": ""PMID:6129186"", ""snippet"": ""The presence of thyroid-stimulating immunoglobulins in patients with Graves' disease is well established."", ""supports"": ""PARTIAL""}"
3339	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	evidence	3	PMID:9534029	SUPPORT		Graves' disease, one of the autoimmune thyroid diseases, is caused by the production of IgG autoantibodies directed against the thyrotropin receptor. These antibodies bind to and activate the receptor, causing the autonomous production of thyroid hormones.	The literature confirms that IgG autoantibodies (which include TSIs) activate the thyrotropin receptor, leading to overactive thyroid function.	"{""explanation"": ""The literature confirms that IgG autoantibodies (which include TSIs) activate the thyrotropin receptor, leading to overactive thyroid function."", ""reference"": ""PMID:9534029"", ""snippet"": ""Graves' disease, one of the autoimmune thyroid diseases, is caused by the production of IgG autoantibodies directed against the thyrotropin receptor. These antibodies bind to and activate the receptor, causing the autonomous production of thyroid hormones."", ""supports"": ""SUPPORT""}"
3340	3277	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	0	evidence	4	PMID:14654350	SUPPORT		In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone.	The literature confirms that thyroid-stimulating autoantibodies mimic TSH action, leading to an overactive thyroid.	"{""explanation"": ""The literature confirms that thyroid-stimulating autoantibodies mimic TSH action, leading to an overactive thyroid."", ""reference"": ""PMID:14654350"", ""snippet"": ""In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone."", ""supports"": ""SUPPORT""}"
3341	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	evidence	0	PMID:14654350	SUPPORT		In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone.	The reference supports the statement that excessive stimulation of the thyroid gland in Graves' Disease results in increased production of thyroid hormones (T4 and T3), leading to hyperthyroidism.	"{""explanation"": ""The reference supports the statement that excessive stimulation of the thyroid gland in Graves' Disease results in increased production of thyroid hormones (T4 and T3), leading to hyperthyroidism."", ""reference"": ""PMID:14654350"", ""snippet"": ""In Graves' disease, thyroid-stimulating autoantibodies can mimic TSH action and stimulate thyroid cells. This leads to hyperthyroidism and abnormal overproduction of thyroid hormone."", ""supports"": ""SUPPORT""}"
3342	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	evidence	1	PMID:17380820	SUPPORT		Common causes are Graves' disease, toxic multinodular goitre and toxic solitary nodule. Excess thyroid hormones in the circulation are also found in thyroiditis (hormone leakage) and excess exogenous thyroxine intake.	The reference supports the statement by listing Graves' disease as a common cause of hyperthyroidism due to the increased production of thyroid hormones.	"{""explanation"": ""The reference supports the statement by listing Graves' disease as a common cause of hyperthyroidism due to the increased production of thyroid hormones."", ""reference"": ""PMID:17380820"", ""snippet"": ""Common causes are Graves' disease, toxic multinodular goitre and toxic solitary nodule. Excess thyroid hormones in the circulation are also found in thyroiditis (hormone leakage) and excess exogenous thyroxine intake."", ""supports"": ""SUPPORT""}"
3343	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	evidence	2	PMID:9292944	SUPPORT		BCGF production by T cells from the thyroid or peripheral blood of Graves' patients, in the absence or presence of PHA, was significantly greater than that by peripheral T cells from healthy controls.	The reference supports the statement by indicating the role of immune cells in the thyroid gland's overactivity in Graves' disease, contributing to the excessive production of thyroid hormones.	"{""explanation"": ""The reference supports the statement by indicating the role of immune cells in the thyroid gland's overactivity in Graves' disease, contributing to the excessive production of thyroid hormones."", ""reference"": ""PMID:9292944"", ""snippet"": ""BCGF production by T cells from the thyroid or peripheral blood of Graves' patients, in the absence or presence of PHA, was significantly greater than that by peripheral T cells from healthy controls."", ""supports"": ""SUPPORT""}"
3344	3278	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	1	evidence	3	PMID:24126481	SUPPORT		Graves disease is an autoimmune disorder characterized by goitre, hyperthyroidism and, in 25% of patients, Graves ophthalmopathy. The hyperthyroidism is caused by thyroid hypertrophy and stimulation of function, resulting from interaction of anti-TSH-receptor antibodies (TRAb) with the TSH receptor on thyroid follicular cells.	The reference supports the statement by describing how Graves' disease leads to hyperthyroidism through excessive stimulation of the thyroid gland, resulting in increased production of thyroid hormones.	"{""explanation"": ""The reference supports the statement by describing how Graves' disease leads to hyperthyroidism through excessive stimulation of the thyroid gland, resulting in increased production of thyroid hormones."", ""reference"": ""PMID:24126481"", ""snippet"": ""Graves disease is an autoimmune disorder characterized by goitre, hyperthyroidism and, in 25% of patients, Graves ophthalmopathy. The hyperthyroidism is caused by thyroid hypertrophy and stimulation of function, resulting from interaction of anti-TSH-receptor antibodies (TRAb) with the TSH receptor on thyroid follicular cells."", ""supports"": ""SUPPORT""}"
3345	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	evidence	0	PMID:37047805	SUPPORT		The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR)... T cell populations are markedly distinct, including increased levels of Th17 and follicular helper T cells (Tfh), while Treg cells appear to be impaired.	This reference supports the involvement of both B cells and T cells in the dysregulated immune response leading to autoimmune attacks on the thyroid gland in Graves' disease.	"{""explanation"": ""This reference supports the involvement of both B cells and T cells in the dysregulated immune response leading to autoimmune attacks on the thyroid gland in Graves' disease."", ""reference"": ""PMID:37047805"", ""snippet"": ""The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR)... T cell populations are markedly distinct, including increased levels of Th17 and follicular helper T cells (Tfh), while Treg cells appear to be impaired."", ""supports"": ""SUPPORT""}"
3346	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	evidence	1	PMID:37515444	SUPPORT		The incidence of autoimmune thyroid diseases, such as subacute thyroiditis, Graves' disease, and Hashimoto's thyroiditis, increases in individuals with COVID-19 infection. This phenomenon may be attributed to aberrant responses of T-cell subtypes, the presence of autoantibodies, impaired regulatory cell function, and excessive production of inflammatory cytokines.	This reference supports the involvement of T cells and B cells (through autoantibodies) in the immune dysregulation associated with Graves' disease.	"{""explanation"": ""This reference supports the involvement of T cells and B cells (through autoantibodies) in the immune dysregulation associated with Graves' disease."", ""reference"": ""PMID:37515444"", ""snippet"": ""The incidence of autoimmune thyroid diseases, such as subacute thyroiditis, Graves' disease, and Hashimoto's thyroiditis, increases in individuals with COVID-19 infection. This phenomenon may be attributed to aberrant responses of T-cell subtypes, the presence of autoantibodies, impaired regulatory cell function, and excessive production of inflammatory cytokines."", ""supports"": ""SUPPORT""}"
3347	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	evidence	2	PMID:21850926	SUPPORT		The autoimmunity to the thyroid gland mainly consists of Hashimato thyroiditis and Grave's disease... The thyroid stimulating hormone receptor, thyroglobuline, enzymes of thyroid hormones synthesis are targeted by autoantibodies and cell- mediated reactions.	This reference supports the role of B cells (through autoantibodies) and T cells in the autoimmune attack on the thyroid gland in Graves' disease.	"{""explanation"": ""This reference supports the role of B cells (through autoantibodies) and T cells in the autoimmune attack on the thyroid gland in Graves' disease."", ""reference"": ""PMID:21850926"", ""snippet"": ""The autoimmunity to the thyroid gland mainly consists of Hashimato thyroiditis and Grave's disease... The thyroid stimulating hormone receptor, thyroglobuline, enzymes of thyroid hormones synthesis are targeted by autoantibodies and cell- mediated reactions."", ""supports"": ""SUPPORT""}"
3348	3279	137	Graves' Disease	Graves_Disease.yaml	pathophysiology	2	evidence	3	PMID:24802957	SUPPORT		Dendritic cells (DCs), considered as one of the crucial immune regulatory populations, are implicated in the immune pathology of various disorders... including Hashimoto's thyroiditis and Graves' disease.	This reference supports the involvement of immune cells in the pathology of Graves' disease, indicating immune system dysregulation.	"{""explanation"": ""This reference supports the involvement of immune cells in the pathology of Graves' disease, indicating immune system dysregulation."", ""reference"": ""PMID:24802957"", ""snippet"": ""Dendritic cells (DCs), considered as one of the crucial immune regulatory populations, are implicated in the immune pathology of various disorders... including Hashimoto's thyroiditis and Graves' disease."", ""supports"": ""SUPPORT""}"
3391	3309	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:24000328	SUPPORT		Molecular mimicry between sialylated lipooligosaccharide structures on the cell envelope of these bacteria and ganglioside epitopes on the human nerves that generates cross-reactive immune response results in autoimmune-driven nerve damage.	Demonstrates the molecular mimicry mechanism where C. jejuni lipooligosaccharides resemble nerve gangliosides, leading to cross-reactive antibodies that attack peripheral nerves.	"{""explanation"": ""Demonstrates the molecular mimicry mechanism where C. jejuni lipooligosaccharides resemble nerve gangliosides, leading to cross-reactive antibodies that attack peripheral nerves."", ""reference"": ""PMID:24000328"", ""snippet"": ""Molecular mimicry between sialylated lipooligosaccharide structures on the cell envelope of these bacteria and ganglioside epitopes on the human nerves that generates cross-reactive immune response results in autoimmune-driven nerve damage."", ""supports"": ""SUPPORT""}"
3392	3309	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:37108447	SUPPORT		The presence of specific anti-glycoconjugate antibodies indicates an underlying process of molecular mimicry and sometimes assists in the classification of these disorders.	Confirms that anti-ganglioside antibodies in GBS result from molecular mimicry and help classify disease subtypes.	"{""explanation"": ""Confirms that anti-ganglioside antibodies in GBS result from molecular mimicry and help classify disease subtypes."", ""reference"": ""PMID:37108447"", ""snippet"": ""The presence of specific anti-glycoconjugate antibodies indicates an underlying process of molecular mimicry and sometimes assists in the classification of these disorders."", ""supports"": ""SUPPORT""}"
3393	3310	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:10355667	SUPPORT		These data indicate that anti-ganglioside antibodies can diffuse into a desheathed nerve, bind to nodes of Ranvier and fix complement in vitro without resulting in any overt physiological deterioration of the nerve over 4-6 h.	Demonstrates that anti-ganglioside antibodies bind nodes of Ranvier and activate complement cascade, establishing the complement-mediated mechanism of nerve damage.	"{""explanation"": ""Demonstrates that anti-ganglioside antibodies bind nodes of Ranvier and activate complement cascade, establishing the complement-mediated mechanism of nerve damage."", ""reference"": ""PMID:10355667"", ""snippet"": ""These data indicate that anti-ganglioside antibodies can diffuse into a desheathed nerve, bind to nodes of Ranvier and fix complement in vitro without resulting in any overt physiological deterioration of the nerve over 4-6 h."", ""supports"": ""SUPPORT""}"
3394	3310	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:8619548	SUPPORT		Many fibers had a rim of the complement activation marker C3d and the terminal complement complex neoantigen C5b-9 along the outer surface of the Schwann cells.	Immunocytochemistry evidence showing C3d and C5b-9 membrane attack complex deposition on Schwann cell surfaces in AIDP, confirming complement-mediated pathology.	"{""explanation"": ""Immunocytochemistry evidence showing C3d and C5b-9 membrane attack complex deposition on Schwann cell surfaces in AIDP, confirming complement-mediated pathology."", ""reference"": ""PMID:8619548"", ""snippet"": ""Many fibers had a rim of the complement activation marker C3d and the terminal complement complex neoantigen C5b-9 along the outer surface of the Schwann cells."", ""supports"": ""SUPPORT""}"
3395	3311	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:37108447	SUPPORT		The immunological mechanisms, which include macrophage infiltration, inflammation and proliferation of Schwann cells, result in variable degrees of demyelination and axonal degeneration.	Describes macrophage infiltration as a key immunological mechanism leading to demyelination and axonal degeneration in immune-mediated neuropathies including GBS.	"{""explanation"": ""Describes macrophage infiltration as a key immunological mechanism leading to demyelination and axonal degeneration in immune-mediated neuropathies including GBS."", ""reference"": ""PMID:37108447"", ""snippet"": ""The immunological mechanisms, which include macrophage infiltration, inflammation and proliferation of Schwann cells, result in variable degrees of demyelination and axonal degeneration."", ""supports"": ""SUPPORT""}"
3396	3311	138	Guillain-Barre Syndrome	Guillain_Barre_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:8619548	SUPPORT		Vesicular degeneration was seen before the invasion of macrophages into the myelin, and was the predominant change in the subject with symptoms for 3 days.	Shows the temporal sequence of pathology in AIDP, with macrophage invasion into myelin following initial complement-mediated damage.	"{""explanation"": ""Shows the temporal sequence of pathology in AIDP, with macrophage invasion into myelin following initial complement-mediated damage."", ""reference"": ""PMID:8619548"", ""snippet"": ""Vesicular degeneration was seen before the invasion of macrophages into the myelin, and was the predominant change in the subject with symptoms for 3 days."", ""supports"": ""SUPPORT""}"
3398	3331	139	Diffuse Midline Glioma, H3 K27-Altered	H3_K27_Altered_Diffuse_Midline_Glioma.yaml	pathophysiology	0	evidence	0	PMID:41528563	SUPPORT		H3 K27-altered diffuse midline glioma (DMG) is a molecularly defined, highly aggressive tumor entity since the 2016 revision of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS).	This abstract defines H3 K27-altered DMG as a molecularly defined aggressive entity, supporting the disease context for this mutation-driven tumor.	"{""explanation"": ""This abstract defines H3 K27-altered DMG as a molecularly defined aggressive entity, supporting the disease context for this mutation-driven tumor."", ""reference"": ""PMID:41528563"", ""snippet"": ""H3 K27-altered diffuse midline glioma (DMG) is a molecularly defined, highly aggressive tumor entity since the 2016 revision of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS)."", ""supports"": ""SUPPORT""}"
3401	3347	140	HER2-Positive Breast Cancer	HER2_Positive_Breast_Cancer.yaml	pathophysiology	0	evidence	0	PMID:40303293	SUPPORT		HER2-positive breast cancer, which accounts for approximately 15-20% of all breast cancers, is characterized by its aggressive recurrence, metastasis and reduced survival.	This abstract identifies HER2-positive breast cancer as a distinct, aggressive subtype, supporting the disease definition used here.	"{""explanation"": ""This abstract identifies HER2-positive breast cancer as a distinct, aggressive subtype, supporting the disease definition used here."", ""reference"": ""PMID:40303293"", ""snippet"": ""HER2-positive breast cancer, which accounts for approximately 15-20% of all breast cancers, is characterized by its aggressive recurrence, metastasis and reduced survival."", ""supports"": ""SUPPORT""}"
3403	3366	141	HER2-Positive Colorectal Cancer	HER2_Positive_Colorectal_Cancer.yaml	pathophysiology	0	evidence	0	PMID:41361014	SUPPORT		Among 5545 patients, 144 (3.1%) had ERBB2 amp+ mCRC.	This abstract quantifies ERBB2-amplified metastatic colorectal cancer, supporting the existence of this molecular subgroup.	"{""explanation"": ""This abstract quantifies ERBB2-amplified metastatic colorectal cancer, supporting the existence of this molecular subgroup."", ""reference"": ""PMID:41361014"", ""snippet"": ""Among 5545 patients, 144 (3.1%) had ERBB2 amp+ mCRC."", ""supports"": ""SUPPORT""}"
3405	3386	142	HER2-Positive Gastric Cancer	HER2_Positive_Gastric_Cancer.yaml	pathophysiology	0	evidence	0	PMID:41355925	SUPPORT		Human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) represents a distinct molecular cancer subtype that is often associated with a poor prognosis.	This abstract identifies HER2-positive gastric cancer as a distinct molecular subtype, supporting the disease definition.	"{""explanation"": ""This abstract identifies HER2-positive gastric cancer as a distinct molecular subtype, supporting the disease definition."", ""reference"": ""PMID:41355925"", ""snippet"": ""Human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) represents a distinct molecular cancer subtype that is often associated with a poor prognosis."", ""supports"": ""SUPPORT""}"
3408	3403	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:30940925	SUPPORT		Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA).	The foundational paper establishing that biallelic P4HTM mutations cause HIDEA syndrome.	"{""explanation"": ""The foundational paper establishing that biallelic P4HTM mutations cause HIDEA syndrome."", ""reference"": ""PMID:30940925"", ""snippet"": ""Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA)."", ""supports"": ""SUPPORT""}"
3409	3405	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:30940925	SUPPORT		Hypoventilation, obstructive and central sleep apnea, and dysautonomia were identified as novel features associated with the phenotype.	The foundational HIDEA paper identified hypoventilation and central sleep apnea as core features.	"{""explanation"": ""The foundational HIDEA paper identified hypoventilation and central sleep apnea as core features."", ""reference"": ""PMID:30940925"", ""snippet"": ""Hypoventilation, obstructive and central sleep apnea, and dysautonomia were identified as novel features associated with the phenotype."", ""supports"": ""SUPPORT""}"
3410	3406	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:30940925	SUPPORT		The muscle biopsy of patient 1 showed low activity of mitochondrial respiratory chain complex III. In addition, the muscle biopsy of patient 2 was suggestive of a mitochondrial, neurometabolic disease.	Evidence from muscle biopsies showing mitochondrial respiratory chain deficiency in some HIDEA patients.	"{""explanation"": ""Evidence from muscle biopsies showing mitochondrial respiratory chain deficiency in some HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""The muscle biopsy of patient 1 showed low activity of mitochondrial respiratory chain complex III. In addition, the muscle biopsy of patient 2 was suggestive of a mitochondrial, neurometabolic disease."", ""supports"": ""SUPPORT""}"
3423	3439	144	HPV-Negative Head and Neck Cancer	HPV_Negative_Head_and_Neck_Cancer.yaml	pathophysiology	0	evidence	0	PMID:25631445	SUPPORT		Smoking-related HNSCCs demonstrate near universal loss-of-function TP53 mutations and CDKN2A inactivation	TCGA HNSCC abstract reports near-universal TP53 loss and CDKN2A inactivation in smoking-related tumors.	"{""explanation"": ""TCGA HNSCC abstract reports near-universal TP53 loss and CDKN2A inactivation in smoking-related tumors."", ""reference"": ""PMID:25631445"", ""snippet"": ""Smoking-related HNSCCs demonstrate near universal loss-of-function TP53 mutations and CDKN2A inactivation"", ""supports"": ""SUPPORT""}"
3426	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	evidence	0	PMID:39003267	SUPPORT		We identify damaged antigen-presenting TFCs with upregulated CD74 and MIF expression in thyroid samples from AITD patients.	Spatial transcriptomics demonstrates that thyroid follicular cells actively participate in autoimmune destruction by presenting antigens via CD74/MIF upregulation.	"{""explanation"": ""Spatial transcriptomics demonstrates that thyroid follicular cells actively participate in autoimmune destruction by presenting antigens via CD74/MIF upregulation."", ""reference"": ""PMID:39003267"", ""snippet"": ""We identify damaged antigen-presenting TFCs with upregulated CD74 and MIF expression in thyroid samples from AITD patients."", ""supports"": ""SUPPORT""}"
3427	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	evidence	1	PMID:38731922	SUPPORT		Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid.	Confirms the characteristic antibody profile and lymphocytic infiltration pattern in Hashimoto's thyroiditis.	"{""explanation"": ""Confirms the characteristic antibody profile and lymphocytic infiltration pattern in Hashimoto's thyroiditis."", ""reference"": ""PMID:38731922"", ""snippet"": ""Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid."", ""supports"": ""SUPPORT""}"
3428	3488	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	0	evidence	2	PMID:40535343	SUPPORT		Through this review, we aim to establish mechanistic connections between ICI pharmacodynamics and thyroid tissue immunopathology.	ICI-induced thyroiditis provides a mechanistic model that mirrors the autoimmune destruction seen in spontaneous Hashimoto's thyroiditis.	"{""explanation"": ""ICI-induced thyroiditis provides a mechanistic model that mirrors the autoimmune destruction seen in spontaneous Hashimoto's thyroiditis."", ""reference"": ""PMID:40535343"", ""snippet"": ""Through this review, we aim to establish mechanistic connections between ICI pharmacodynamics and thyroid tissue immunopathology."", ""supports"": ""SUPPORT""}"
3429	3489	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	1	evidence	0	PMID:38731922	SUPPORT		Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid.	Lymphocytic infiltration is a defining histological feature of Hashimoto's thyroiditis.	"{""explanation"": ""Lymphocytic infiltration is a defining histological feature of Hashimoto's thyroiditis."", ""reference"": ""PMID:38731922"", ""snippet"": ""Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid."", ""supports"": ""SUPPORT""}"
3430	3489	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	1	evidence	1	PMID:39003267	SUPPORT		Here, we use spatial transcriptomics to explore the molecular architecture, heterogeneity and location of different cells present in the thyroid tissue, including thyroid follicular cells (TFCs), stromal cells such as fibroblasts, endothelial cells, and thyroid infiltrating lymphocytes.	Spatial analysis confirms the presence and organization of infiltrating lymphocytes in the thyroid microenvironment.	"{""explanation"": ""Spatial analysis confirms the presence and organization of infiltrating lymphocytes in the thyroid microenvironment."", ""reference"": ""PMID:39003267"", ""snippet"": ""Here, we use spatial transcriptomics to explore the molecular architecture, heterogeneity and location of different cells present in the thyroid tissue, including thyroid follicular cells (TFCs), stromal cells such as fibroblasts, endothelial cells, and thyroid infiltrating lymphocytes."", ""supports"": ""SUPPORT""}"
3431	3490	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	2	evidence	0	PMID:38731922	SUPPORT		Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism.	Progressive thyroid destruction in Hashimoto's thyroiditis results in hypothyroidism through loss of hormone-producing cells.	"{""explanation"": ""Progressive thyroid destruction in Hashimoto's thyroiditis results in hypothyroidism through loss of hormone-producing cells."", ""reference"": ""PMID:38731922"", ""snippet"": ""Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism."", ""supports"": ""SUPPORT""}"
3432	3490	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	pathophysiology	2	evidence	1	PMID:40535343	SUPPORT		Elucidating the pathophysiological mechanisms underlying ICI-induced thyroiditis represents a critical step toward developing evidence-based diagnostic protocols and targeted therapeutic interventions for cancer patients undergoing immunotherapy.	Mechanistic understanding of immune-mediated thyroid destruction links to hormone deficiency in both ICI-induced and spontaneous thyroiditis.	"{""explanation"": ""Mechanistic understanding of immune-mediated thyroid destruction links to hormone deficiency in both ICI-induced and spontaneous thyroiditis."", ""reference"": ""PMID:40535343"", ""snippet"": ""Elucidating the pathophysiological mechanisms underlying ICI-induced thyroiditis represents a critical step toward developing evidence-based diagnostic protocols and targeted therapeutic interventions for cancer patients undergoing immunotherapy."", ""supports"": ""SUPPORT""}"
3437	3512	147	Heart Failure	Heart_Failure.yaml	pathophysiology	0	evidence	0	PMID:33432192	SUPPORT		Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart failure worldwide, is increasing in prevalence, confers substantial morbidity and mortality, and has very few effective treatments.	This review discusses the prevalence and severity of HFpEF, a form characterized by diastolic dysfunction rather than systolic dysfunction, demonstrating the importance of both contractile mechanisms in heart failure.	"{""explanation"": ""This review discusses the prevalence and severity of HFpEF, a form characterized by diastolic dysfunction rather than systolic dysfunction, demonstrating the importance of both contractile mechanisms in heart failure."", ""reference"": ""PMID:33432192"", ""snippet"": ""Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart failure worldwide, is increasing in prevalence, confers substantial morbidity and mortality, and has very few effective treatments."", ""supports"": ""SUPPORT""}"
3438	3512	147	Heart Failure	Heart_Failure.yaml	pathophysiology	0	evidence	1	PMID:40892534	SUPPORT		Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF.	This demonstrates how structural changes lead to diastolic dysfunction and impaired cardiac output, supporting the mechanism of contractile dysfunction in heart failure.	"{""explanation"": ""This demonstrates how structural changes lead to diastolic dysfunction and impaired cardiac output, supporting the mechanism of contractile dysfunction in heart failure."", ""reference"": ""PMID:40892534"", ""snippet"": ""Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF."", ""supports"": ""SUPPORT""}"
3439	3513	147	Heart Failure	Heart_Failure.yaml	pathophysiology	1	evidence	0	PMID:37895150	SUPPORT		In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous system (SNS), the renin-angiotensin-aldosterone system (RAAS) and the arginine vasopressin (AVP) system, are activated to various degrees producing often-observed tachycardia and concomitant increased systemic vascular resistance.	This directly confirms the activation of neurohormonal systems (RAAS and SNS) in heart failure patients, supporting the compensatory mechanism described.	"{""explanation"": ""This directly confirms the activation of neurohormonal systems (RAAS and SNS) in heart failure patients, supporting the compensatory mechanism described."", ""reference"": ""PMID:37895150"", ""snippet"": ""In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous system (SNS), the renin-angiotensin-aldosterone system (RAAS) and the arginine vasopressin (AVP) system, are activated to various degrees producing often-observed tachycardia and concomitant increased systemic vascular resistance."", ""supports"": ""SUPPORT""}"
3440	3513	147	Heart Failure	Heart_Failure.yaml	pathophysiology	1	evidence	1	PMID:37895150	SUPPORT		Furthermore, sustained neurohormonal activation plays a key role in the progression of HF and may be responsible for the pathogenetic mechanisms leading to the perpetuation of the pathophysiology and worsening of the HF signs and symptoms.	This supports the concept that while initially compensatory, sustained neurohormonal activation leads to maladaptive effects and disease progression.	"{""explanation"": ""This supports the concept that while initially compensatory, sustained neurohormonal activation leads to maladaptive effects and disease progression."", ""reference"": ""PMID:37895150"", ""snippet"": ""Furthermore, sustained neurohormonal activation plays a key role in the progression of HF and may be responsible for the pathogenetic mechanisms leading to the perpetuation of the pathophysiology and worsening of the HF signs and symptoms."", ""supports"": ""SUPPORT""}"
3441	3513	147	Heart Failure	Heart_Failure.yaml	pathophysiology	1	evidence	2	PMID:33432192	SUPPORT		This multiorgan involvement makes HFpEF difficult to model in experimental animals because the condition is not simply cardiac hypertrophy and hypertension with abnormal myocardial relaxation.	This highlights the complexity of neurohormonal effects extending beyond the heart to multiple organ systems in heart failure pathophysiology.	"{""explanation"": ""This highlights the complexity of neurohormonal effects extending beyond the heart to multiple organ systems in heart failure pathophysiology."", ""reference"": ""PMID:33432192"", ""snippet"": ""This multiorgan involvement makes HFpEF difficult to model in experimental animals because the condition is not simply cardiac hypertrophy and hypertension with abnormal myocardial relaxation."", ""supports"": ""SUPPORT""}"
3442	3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	evidence	0	PMID:40892534	SUPPORT		Comorbidities such as hypertension, obesity, or diabetes are present in many HFpEF patients and are hypothesized to contribute to adverse cardiac remodelling and myocardial fibrosis through a variety of haemodynamic and metabolic impairments, with nearly half of all HFpEF patients exhibiting left ventricular (LV) hypertrophy or concentric remodelling.	This demonstrates the prevalence and mechanisms of ventricular remodeling including hypertrophy and fibrosis in heart failure patients, particularly in HFpEF.	"{""explanation"": ""This demonstrates the prevalence and mechanisms of ventricular remodeling including hypertrophy and fibrosis in heart failure patients, particularly in HFpEF."", ""reference"": ""PMID:40892534"", ""snippet"": ""Comorbidities such as hypertension, obesity, or diabetes are present in many HFpEF patients and are hypothesized to contribute to adverse cardiac remodelling and myocardial fibrosis through a variety of haemodynamic and metabolic impairments, with nearly half of all HFpEF patients exhibiting left ventricular (LV) hypertrophy or concentric remodelling."", ""supports"": ""SUPPORT""}"
3443	3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	evidence	1	PMID:38636927	SUPPORT		Heart failure is usually accompanied by activation of the sympathetic nerve, and excessive activation of the sympathetic nerve promotes cardiac remodeling and cardiac dysfunction. In the isoproterenol (ISO)-induced animal model, it is often accompanied by myocardial hypertrophy, fibrosis, and inflammation.	This confirms that cardiac remodeling, including hypertrophy and fibrosis, is a key pathophysiological mechanism promoted by sympathetic activation in heart failure.	"{""explanation"": ""This confirms that cardiac remodeling, including hypertrophy and fibrosis, is a key pathophysiological mechanism promoted by sympathetic activation in heart failure."", ""reference"": ""PMID:38636927"", ""snippet"": ""Heart failure is usually accompanied by activation of the sympathetic nerve, and excessive activation of the sympathetic nerve promotes cardiac remodeling and cardiac dysfunction. In the isoproterenol (ISO)-induced animal model, it is often accompanied by myocardial hypertrophy, fibrosis, and inflammation."", ""supports"": ""SUPPORT""}"
3444	3514	147	Heart Failure	Heart_Failure.yaml	pathophysiology	2	evidence	2	PMID:38636927	SUPPORT		Lilrb4a alleviates cardiac dysfunction and ISO-induced arrhythmogenic remodeling associated with cardiac fibrosis and inflammation through the regulation of NF-κB signaling and MAPK signaling activation.	This identifies specific signaling pathways (NF-κB and MAPK) involved in cardiac remodeling and fibrosis, demonstrating the molecular mechanisms underlying structural changes.	"{""explanation"": ""This identifies specific signaling pathways (NF-κB and MAPK) involved in cardiac remodeling and fibrosis, demonstrating the molecular mechanisms underlying structural changes."", ""reference"": ""PMID:38636927"", ""snippet"": ""Lilrb4a alleviates cardiac dysfunction and ISO-induced arrhythmogenic remodeling associated with cardiac fibrosis and inflammation through the regulation of NF-κB signaling and MAPK signaling activation."", ""supports"": ""SUPPORT""}"
3445	3515	147	Heart Failure	Heart_Failure.yaml	pathophysiology	3	evidence	0	PMID:36769308	SUPPORT		The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration.	This demonstrates the bidirectional relationship between heart and kidney dysfunction that leads to fluid retention in heart failure through cardiorenal mechanisms.	"{""explanation"": ""This demonstrates the bidirectional relationship between heart and kidney dysfunction that leads to fluid retention in heart failure through cardiorenal mechanisms."", ""reference"": ""PMID:36769308"", ""snippet"": ""The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration."", ""supports"": ""SUPPORT""}"
3446	3515	147	Heart Failure	Heart_Failure.yaml	pathophysiology	3	evidence	1	PMID:36769308	SUPPORT		As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary.	This emphasizes the critical role of renal dysfunction in heart failure pathophysiology and outcomes, supporting the mechanism of fluid retention through impaired kidney function.	"{""explanation"": ""This emphasizes the critical role of renal dysfunction in heart failure pathophysiology and outcomes, supporting the mechanism of fluid retention through impaired kidney function."", ""reference"": ""PMID:36769308"", ""snippet"": ""As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary."", ""supports"": ""SUPPORT""}"
3454	3533	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	0	evidence	0	PMID:23985001	SUPPORT		Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y homozygous individuals.	Impaired HFE signaling results in low hepcidin in C282Y homozygotes.	"{""explanation"": ""Impaired HFE signaling results in low hepcidin in C282Y homozygotes."", ""reference"": ""PMID:23985001"", ""snippet"": ""Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y homozygous individuals."", ""supports"": ""SUPPORT""}"
3455	3534	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	1	evidence	0	PMID:23985001	SUPPORT		Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron	Low hepcidin permits unregulated ferroportin-mediated iron export from the gut.	"{""explanation"": ""Low hepcidin permits unregulated ferroportin-mediated iron export from the gut."", ""reference"": ""PMID:23985001"", ""snippet"": ""Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron"", ""supports"": ""SUPPORT""}"
3456	3535	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	2	evidence	0	PMID:37763705	SUPPORT		The key organ that is affected by iron overload is the liver, suffering from fibrosis, cirrhosis or hepatocellular carcinoma	Liver iron overload drives fibrotic injury and malignant risk.	"{""explanation"": ""Liver iron overload drives fibrotic injury and malignant risk."", ""reference"": ""PMID:37763705"", ""snippet"": ""The key organ that is affected by iron overload is the liver, suffering from fibrosis, cirrhosis or hepatocellular carcinoma"", ""supports"": ""SUPPORT""}"
3457	3536	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	3	evidence	0	PMID:35449524	SUPPORT		Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes	Early severe iron overload includes cardiomyopathy, consistent with cardiac iron toxicity.	"{""explanation"": ""Early severe iron overload includes cardiomyopathy, consistent with cardiac iron toxicity."", ""reference"": ""PMID:35449524"", ""snippet"": ""Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes"", ""supports"": ""SUPPORT""}"
3458	3537	148	Hemochromatosis	Hemochromatosis.yaml	pathophysiology	4	evidence	0	PMID:38886778	SUPPORT		Magnetic resonance imaging showed iron deposition in the liver, spleen, and pancreas, along with cirrhosis and splenomegaly.	Imaging confirms pancreatic iron deposition contributing to endocrine dysfunction.	"{""explanation"": ""Imaging confirms pancreatic iron deposition contributing to endocrine dysfunction."", ""reference"": ""PMID:38886778"", ""snippet"": ""Magnetic resonance imaging showed iron deposition in the liver, spleen, and pancreas, along with cirrhosis and splenomegaly."", ""supports"": ""SUPPORT""}"
3476	3556	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	0	evidence	0	PMID:3096583	SUPPORT		FVIII acts as a cofactor in the factor Xa-generating enzyme complex of the intrinsic coagulation cascade.	Review establishes the molecular role of Factor VIII as a cofactor in the intrinsic pathway.	"{""explanation"": ""Review establishes the molecular role of Factor VIII as a cofactor in the intrinsic pathway."", ""reference"": ""PMID:3096583"", ""snippet"": ""FVIII acts as a cofactor in the factor Xa-generating enzyme complex of the intrinsic coagulation cascade."", ""supports"": ""SUPPORT""}"
3477	3556	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	0	evidence	1	PMID:34197690	SUPPORT		Hemophilia A and B are rare X-linked inherited bleeding disorders caused by complete or partial deficiency in or the absence of coagulation factors VIII and IX.	Clinical review confirms Factor VIII deficiency as the cause of hemophilia A.	"{""explanation"": ""Clinical review confirms Factor VIII deficiency as the cause of hemophilia A."", ""reference"": ""PMID:34197690"", ""snippet"": ""Hemophilia A and B are rare X-linked inherited bleeding disorders caused by complete or partial deficiency in or the absence of coagulation factors VIII and IX."", ""supports"": ""SUPPORT""}"
3478	3557	149	Hemophilia A	Hemophilia_A.yaml	pathophysiology	1	evidence	0	PMID:11806995	SUPPORT		pharmacologic concentrations of factor VIIa cannot restore normal thrombin generation in hemophilia A and hemophilia B blood in vitro.	Study demonstrates that thrombin generation is fundamentally impaired in hemophilia A blood even with bypass therapy attempts.	"{""explanation"": ""Study demonstrates that thrombin generation is fundamentally impaired in hemophilia A blood even with bypass therapy attempts."", ""reference"": ""PMID:11806995"", ""snippet"": ""pharmacologic concentrations of factor VIIa cannot restore normal thrombin generation in hemophilia A and hemophilia B blood in vitro."", ""supports"": ""SUPPORT""}"
3489	3568	150	Hemophilia B	Hemophilia_B.yaml	pathophysiology	0	evidence	0	PMID:23430394	SUPPORT		Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX).	The abstract identifies factor IX deficiency as the cause of hemophilia B.	"{""explanation"": ""The abstract identifies factor IX deficiency as the cause of hemophilia B."", ""reference"": ""PMID:23430394"", ""snippet"": ""Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX)."", ""supports"": ""SUPPORT""}"
3549	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:34071064	SUPPORT		Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies.	This reference directly establishes that the immune response to HBV causes chronic liver inflammation.	"{""explanation"": ""This reference directly establishes that the immune response to HBV causes chronic liver inflammation."", ""reference"": ""PMID:34071064"", ""snippet"": ""Although innate and adaptive immune cells play crucial roles in controlling hepatitis B virus (HBV) infection, they are also accountable for inflammation and subsequently cause liver pathologies."", ""supports"": ""SUPPORT""}"
3550	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	evidence	0	PMID:33573130	SUPPORT		Human hepatitis B virus (HBV) can cause chronic, lifelong infection of the liver that may lead to persistent or episodic immune-mediated inflammation against virus-infected hepatocytes.	This reference confirms that HBV infects hepatocytes and leads to chronic inflammation.	"{""explanation"": ""This reference confirms that HBV infects hepatocytes and leads to chronic inflammation."", ""reference"": ""PMID:33573130"", ""snippet"": ""Human hepatitis B virus (HBV) can cause chronic, lifelong infection of the liver that may lead to persistent or episodic immune-mediated inflammation against virus-infected hepatocytes."", ""supports"": ""SUPPORT""}"
3551	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	evidence	1	PMID:32866519	SUPPORT		'Hepatitis B virus (HBV) specifically infects hepatocytes and causes severe liver diseases.	This reference confirms that HBV specifically infects hepatocytes.	"{""explanation"": ""This reference confirms that HBV specifically infects hepatocytes."", ""reference"": ""PMID:32866519"", ""snippet"": ""'Hepatitis B virus (HBV) specifically infects hepatocytes and causes severe liver diseases."", ""supports"": ""SUPPORT""}"
3552	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	evidence	2	PMID:30518652	SUPPORT		Distinct populations of hepatocytes infected with hepatitis B virus (HBV) or only harboring HBV DNA integrations coexist within an HBV chronically infected liver.	This reference confirms that HBV integrates into the host genome within hepatocytes and persists.	"{""explanation"": ""This reference confirms that HBV integrates into the host genome within hepatocytes and persists."", ""reference"": ""PMID:30518652"", ""snippet"": ""Distinct populations of hepatocytes infected with hepatitis B virus (HBV) or only harboring HBV DNA integrations coexist within an HBV chronically infected liver."", ""supports"": ""SUPPORT""}"
3553	3588	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	0	evidence	3	PMID:32151000	SUPPORT		HBV is a major cause of cirrhosis and hepatocellular carcinoma.	This reference supports the statement by indicating that HBV infection leads to chronic conditions such as cirrhosis, which is a form of chronic inflammation.	"{""explanation"": ""This reference supports the statement by indicating that HBV infection leads to chronic conditions such as cirrhosis, which is a form of chronic inflammation."", ""reference"": ""PMID:32151000"", ""snippet"": ""HBV is a major cause of cirrhosis and hepatocellular carcinoma."", ""supports"": ""SUPPORT""}"
3554	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	downstream[0].evidence	0	PMID:37041599	SUPPORT		During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The activation of hepatic stellate cells (HSCs) is a central event in the occurrence and progression of liver fibrosis.	This reference establishes the mechanistic link between chronic HBV, hepatic stellate cell activation, and fibrosis development.	"{""explanation"": ""This reference establishes the mechanistic link between chronic HBV, hepatic stellate cell activation, and fibrosis development."", ""reference"": ""PMID:37041599"", ""snippet"": ""During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The activation of hepatic stellate cells (HSCs) is a central event in the occurrence and progression of liver fibrosis."", ""supports"": ""SUPPORT""}"
3555	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	downstream[1].evidence	0	PMID:22375524	SUPPORT		Hepatitis B virus (HBV) infection currently accounts for approximately 600,000 deaths per year resulting from progression of liver fibrosis to cirrhosis and hepatocellular carcinoma.	This reference establishes that HBV causes progression from fibrosis to cirrhosis.	"{""explanation"": ""This reference establishes that HBV causes progression from fibrosis to cirrhosis."", ""reference"": ""PMID:22375524"", ""snippet"": ""Hepatitis B virus (HBV) infection currently accounts for approximately 600,000 deaths per year resulting from progression of liver fibrosis to cirrhosis and hepatocellular carcinoma."", ""supports"": ""SUPPORT""}"
3556	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	evidence	0	PMID:8571172	SUPPORT		The immune response to HBV-encoded antigens is responsible both for viral clearance and for disease pathogenesis during this infection.	This reference supports that the immune response against HBV-infected hepatocytes contributes to liver damage, which aligns with the statement.	"{""explanation"": ""This reference supports that the immune response against HBV-infected hepatocytes contributes to liver damage, which aligns with the statement."", ""reference"": ""PMID:8571172"", ""snippet"": ""The immune response to HBV-encoded antigens is responsible both for viral clearance and for disease pathogenesis during this infection."", ""supports"": ""SUPPORT""}"
3557	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	evidence	1	PMID:34543610	SUPPORT		Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as... hepatitis B or C infection.	This reference supports the link between chronic HBV infection and cirrhosis, which is a downstream effect of persistent immune response and liver damage.	"{""explanation"": ""This reference supports the link between chronic HBV infection and cirrhosis, which is a downstream effect of persistent immune response and liver damage."", ""reference"": ""PMID:34543610"", ""snippet"": ""Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as... hepatitis B or C infection."", ""supports"": ""SUPPORT""}"
3558	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	evidence	2	PMID:32147592	SUPPORT		Progression of liver fibrosis still occurs in some patients with chronic hepatitis B virus (HBV) infection despite antiviral therapy.	This reference supports that chronic HBV infection leads to liver fibrosis, which is a downstream effect of immune response and liver damage.	"{""explanation"": ""This reference supports that chronic HBV infection leads to liver fibrosis, which is a downstream effect of immune response and liver damage."", ""reference"": ""PMID:32147592"", ""snippet"": ""Progression of liver fibrosis still occurs in some patients with chronic hepatitis B virus (HBV) infection despite antiviral therapy."", ""supports"": ""SUPPORT""}"
3559	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	evidence	3	PMID:37041599	SUPPORT		During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage.	This reference supports the statement that HBV-induced liver damage leads to fibrosis, which is a downstream effect of chronic inflammation.	"{""explanation"": ""This reference supports the statement that HBV-induced liver damage leads to fibrosis, which is a downstream effect of chronic inflammation."", ""reference"": ""PMID:37041599"", ""snippet"": ""During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage."", ""supports"": ""SUPPORT""}"
3560	3590	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	2	evidence	4	PMID:31367154	SUPPORT		Hepatitis B virus (HBV) infection is one the leading risk factors for chronic hepatitis, liver fibrosis, cirrhosis and hepatocellular cancer (HCC).	This reference supports the link between chronic HBV infection and liver fibrosis/cirrhosis, which are downstream effects of immune response and liver damage.	"{""explanation"": ""This reference supports the link between chronic HBV infection and liver fibrosis/cirrhosis, which are downstream effects of immune response and liver damage."", ""reference"": ""PMID:31367154"", ""snippet"": ""Hepatitis B virus (HBV) infection is one the leading risk factors for chronic hepatitis, liver fibrosis, cirrhosis and hepatocellular cancer (HCC)."", ""supports"": ""SUPPORT""}"
3561	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	evidence	0	PMID:16461223	PARTIAL		The immune system plays an important role in determining the outcome of hepatitis B virus (HBV) infection... Multispecific antiviral CD4 and CD8 responses with a type 1 cytokine production can be observed in patients who recover from acute HBV infection.	The reference supports the role of T cells in immune clearance but does not mention B cells.	"{""explanation"": ""The reference supports the role of T cells in immune clearance but does not mention B cells."", ""reference"": ""PMID:16461223"", ""snippet"": ""The immune system plays an important role in determining the outcome of hepatitis B virus (HBV) infection... Multispecific antiviral CD4 and CD8 responses with a type 1 cytokine production can be observed in patients who recover from acute HBV infection."", ""supports"": ""PARTIAL""}"
3562	3591	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	3	evidence	1	PMID:36936922	PARTIAL		The clearance of HBV with virus-specific CD8 T cells is critical for a functional cure.	The reference supports the role of T cells in immune clearance but does not mention B cells.	"{""explanation"": ""The reference supports the role of T cells in immune clearance but does not mention B cells."", ""reference"": ""PMID:36936922"", ""snippet"": ""The clearance of HBV with virus-specific CD8 T cells is critical for a functional cure."", ""supports"": ""PARTIAL""}"
3563	3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	downstream[0].evidence	0	PMID:26691189	SUPPORT		Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC.	This reference establishes the progression from fibrosis to cirrhosis in chronic liver disease.	"{""explanation"": ""This reference establishes the progression from fibrosis to cirrhosis in chronic liver disease."", ""reference"": ""PMID:26691189"", ""snippet"": ""Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC."", ""supports"": ""SUPPORT""}"
3564	3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	evidence	0	PMID:17613356	SUPPORT		Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins.	The statement is supported as liver fibrosis involves the replacement of healthy liver cells with fibrotic tissue due to chronic inflammation.	"{""explanation"": ""The statement is supported as liver fibrosis involves the replacement of healthy liver cells with fibrotic tissue due to chronic inflammation."", ""reference"": ""PMID:17613356"", ""snippet"": ""Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins."", ""supports"": ""SUPPORT""}"
3565	3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	evidence	1	PMID:33528280	SUPPORT		Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection.	The statement is supported as chronic inflammation promotes liver fibrosis through specific inflammatory pathways.	"{""explanation"": ""The statement is supported as chronic inflammation promotes liver fibrosis through specific inflammatory pathways."", ""reference"": ""PMID:33528280"", ""snippet"": ""Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection."", ""supports"": ""SUPPORT""}"
3566	3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	evidence	2	PMID:26691189	SUPPORT		Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC.	The statement is supported as chronic inflammation leads to liver fibrosis and cirrhosis.	"{""explanation"": ""The statement is supported as chronic inflammation leads to liver fibrosis and cirrhosis."", ""reference"": ""PMID:26691189"", ""snippet"": ""Chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC."", ""supports"": ""SUPPORT""}"
3567	3592	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	4	evidence	3	PMID:31769518	SUPPORT		Recurrent hepatitis activity during chronic hepatitis B virus infection results in fibrosis and even hepatocellular carcinoma.	The statement is supported as recurrent inflammation in chronic HBV infection results in liver fibrosis.	"{""explanation"": ""The statement is supported as recurrent inflammation in chronic HBV infection results in liver fibrosis."", ""reference"": ""PMID:31769518"", ""snippet"": ""Recurrent hepatitis activity during chronic hepatitis B virus infection results in fibrosis and even hepatocellular carcinoma."", ""supports"": ""SUPPORT""}"
3568	3593	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	5	evidence	0	PMID:17981234	SUPPORT		Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals.	This reference supports the statement by indicating that chronic hepatitis B can lead to cirrhosis, which is associated with extensive fibrosis and scarring that impair liver function.	"{""explanation"": ""This reference supports the statement by indicating that chronic hepatitis B can lead to cirrhosis, which is associated with extensive fibrosis and scarring that impair liver function."", ""reference"": ""PMID:17981234"", ""snippet"": ""Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals."", ""supports"": ""SUPPORT""}"
3569	3593	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	5	evidence	1	PMID:19577114	SUPPORT		Cirrhosis is defined histologically as an advanced form of progressive hepatic fibrosis with distortion of the hepatic architecture and regenerative nodule formation.	This reference supports the statement by describing cirrhosis as an advanced form of hepatic fibrosis that distorts liver architecture, thereby impairing liver function.	"{""explanation"": ""This reference supports the statement by describing cirrhosis as an advanced form of hepatic fibrosis that distorts liver architecture, thereby impairing liver function."", ""reference"": ""PMID:19577114"", ""snippet"": ""Cirrhosis is defined histologically as an advanced form of progressive hepatic fibrosis with distortion of the hepatic architecture and regenerative nodule formation."", ""supports"": ""SUPPORT""}"
3570	3593	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	5	evidence	2	PMID:17613356	PARTIAL		Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins.	While this reference discusses liver fibrosis resulting from chronic liver damage, it does not explicitly connect it to cirrhosis or the impairment of liver function.	"{""explanation"": ""While this reference discusses liver fibrosis resulting from chronic liver damage, it does not explicitly connect it to cirrhosis or the impairment of liver function."", ""reference"": ""PMID:17613356"", ""snippet"": ""Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins."", ""supports"": ""PARTIAL""}"
3571	3593	151	Hepatitis B	Hepatitis_B.yaml	pathophysiology	5	evidence	3	PMID:24373083	SUPPORT		Long-lasting HBV-DNA suppression is considered to be the best surrogate end-point of antiviral therapy in patients with hepatitis B virus (HBV) related chronic hepatitis or cirrhosis, and it is a prerequisite to prevent liver-related complications and improve survival.	This reference supports the statement by mentioning cirrhosis in the context of chronic hepatitis B and its associated liver-related complications.	"{""explanation"": ""This reference supports the statement by mentioning cirrhosis in the context of chronic hepatitis B and its associated liver-related complications."", ""reference"": ""PMID:24373083"", ""snippet"": ""Long-lasting HBV-DNA suppression is considered to be the best surrogate end-point of antiviral therapy in patients with hepatitis B virus (HBV) related chronic hepatitis or cirrhosis, and it is a prerequisite to prevent liver-related complications and improve survival."", ""supports"": ""SUPPORT""}"
3647	3630	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	1	evidence	0	PMID:26569658	SUPPORT		patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis	Study specifically targets HCV patients with decompensated cirrhosis, confirming progression of chronic inflammation to advanced liver damage.	"{""explanation"": ""Study specifically targets HCV patients with decompensated cirrhosis, confirming progression of chronic inflammation to advanced liver damage."", ""reference"": ""PMID:26569658"", ""snippet"": ""patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis"", ""supports"": ""SUPPORT""}"
3648	3631	152	Hepatitis C	Hepatitis_C.yaml	pathophysiology	2	evidence	0	PMID:16127453	SUPPORT		'Knockdown' of IPS-1 by small interfering RNA blocked interferon induction by virus infection	Study demonstrates that viruses can interfere with interferon signaling through IPS-1/MAVS pathway, a mechanism also employed by HCV.	"{""explanation"": ""Study demonstrates that viruses can interfere with interferon signaling through IPS-1/MAVS pathway, a mechanism also employed by HCV."", ""reference"": ""PMID:16127453"", ""snippet"": ""'Knockdown' of IPS-1 by small interfering RNA blocked interferon induction by virus infection"", ""supports"": ""SUPPORT""}"
3656	3655	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	0	evidence	0	PMID:41567639	SUPPORT		HCC typically arises in patients with chronic liver disease, including hepatitis, cirrhosis, and non-alcoholic fatty liver diseases.	This abstract states that HCC commonly arises in chronic liver disease and cirrhosis, supporting the mechanism described.	"{""explanation"": ""This abstract states that HCC commonly arises in chronic liver disease and cirrhosis, supporting the mechanism described."", ""reference"": ""PMID:41567639"", ""snippet"": ""HCC typically arises in patients with chronic liver disease, including hepatitis, cirrhosis, and non-alcoholic fatty liver diseases."", ""supports"": ""SUPPORT""}"
3657	3661	153	Hepatocellular Carcinoma	Hepatocellular_Carcinoma.yaml	pathophysiology	6	evidence	0	PMID:19637355	SUPPORT		Hepatocellular carcinoma (HCC) is a highly vascular tumor, and angiogenesis is believed to play a considerable role in its development and progression.	Abstract notes HCC is highly vascular and angiogenesis plays a major role, supporting this mechanism.	"{""explanation"": ""Abstract notes HCC is highly vascular and angiogenesis plays a major role, supporting this mechanism."", ""reference"": ""PMID:19637355"", ""snippet"": ""Hepatocellular carcinoma (HCC) is a highly vascular tumor, and angiogenesis is believed to play a considerable role in its development and progression."", ""supports"": ""SUPPORT""}"
3660	3684	154	Hereditary Breast and Ovarian Cancer Syndrome	Hereditary_Breast_and_Ovarian_Cancer_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:22193408	SUPPORT		BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination. The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes.	Review distinguishes BRCA1 and BRCA2 roles in DNA damage response and homologous recombination repair.	"{""explanation"": ""Review distinguishes BRCA1 and BRCA2 roles in DNA damage response and homologous recombination repair."", ""reference"": ""PMID:22193408"", ""snippet"": ""BRCA1 is a pleiotropic DDR protein that functions in both checkpoint activation and DNA repair, whereas BRCA2 is a mediator of the core mechanism of homologous recombination. The links between the two proteins are not well understood, but they must exist to explain the marked similarity of human cancer susceptibility that arises with germline mutations in these genes."", ""supports"": ""SUPPORT""}"
3666	3701	155	Hereditary von Willebrand Disease	Hereditary_von_Willebrand_Disease.yaml	pathophysiology	0	evidence	0	PMID:21289515	SUPPORT		von Willebrand disease is a common inherited bleeding disorder characterized by excessive mucocutaneous bleeding.	The abstract characterizes von Willebrand disease as an inherited bleeding disorder.	"{""explanation"": ""The abstract characterizes von Willebrand disease as an inherited bleeding disorder."", ""reference"": ""PMID:21289515"", ""snippet"": ""von Willebrand disease is a common inherited bleeding disorder characterized by excessive mucocutaneous bleeding."", ""supports"": ""SUPPORT""}"
3707	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	evidence	0	PMID:33202966	SUPPORT		Hirschsprung's disease is a neurocristopathy, caused by defective migration, proliferation, differentiation and survival of neural crest cells, leading to gut aganglionosis.	The article describes Hirschsprung's disease as being caused by defective migration of neural crest cells during embryonic development, which results in aganglionosis (absence of ganglion cells) in the bowel.	"{""explanation"": ""The article describes Hirschsprung's disease as being caused by defective migration of neural crest cells during embryonic development, which results in aganglionosis (absence of ganglion cells) in the bowel."", ""reference"": ""PMID:33202966"", ""snippet"": ""Hirschsprung's disease is a neurocristopathy, caused by defective migration, proliferation, differentiation and survival of neural crest cells, leading to gut aganglionosis."", ""supports"": ""SUPPORT""}"
3708	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	evidence	1	PMID:36417785	SUPPORT		Derived from neural crest cells (NCCs), this little brain controls muscle contraction, motility, and bowel activities in response to stimuli. Failure of developing enteric ganglia at the distal bowel results in intestinal obstruction and Hirschsprung disease (HSCR).	The literature explains that Hirschsprung disease results from the failure of developing enteric ganglia, which are derived from neural crest cells, supporting the notion of defective migration leading to absent ganglion cells.	"{""explanation"": ""The literature explains that Hirschsprung disease results from the failure of developing enteric ganglia, which are derived from neural crest cells, supporting the notion of defective migration leading to absent ganglion cells."", ""reference"": ""PMID:36417785"", ""snippet"": ""Derived from neural crest cells (NCCs), this little brain controls muscle contraction, motility, and bowel activities in response to stimuli. Failure of developing enteric ganglia at the distal bowel results in intestinal obstruction and Hirschsprung disease (HSCR)."", ""supports"": ""SUPPORT""}"
3709	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	evidence	2	PMID:23342068	SUPPORT		Hirschsprung disease (HSCR) is a congenital malformation of the hindgut resulting from a disruption of neural crest cell migration during embryonic development.	This publication clearly states that disruption of neural crest cell migration during embryonic development leads to Hirschsprung disease.	"{""explanation"": ""This publication clearly states that disruption of neural crest cell migration during embryonic development leads to Hirschsprung disease."", ""reference"": ""PMID:23342068"", ""snippet"": ""Hirschsprung disease (HSCR) is a congenital malformation of the hindgut resulting from a disruption of neural crest cell migration during embryonic development."", ""supports"": ""SUPPORT""}"
3710	3723	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	0	evidence	3	PMID:8660047	SUPPORT		Current evidence on the pathogenesis of Hirschprung's disease, then, favours the 'abnormal microenvironment' hypothesis wherein the developing and migrating normal neural crest cells confront a segmentally abnormal and hostile microenvironment in the colon.	This reference supports the idea that Hirschsprung's disease involves issues with neural crest cell migration, although it adds the perspective of an abnormal microenvironment in the colon.	"{""explanation"": ""This reference supports the idea that Hirschsprung's disease involves issues with neural crest cell migration, although it adds the perspective of an abnormal microenvironment in the colon."", ""reference"": ""PMID:8660047"", ""snippet"": ""Current evidence on the pathogenesis of Hirschprung's disease, then, favours the 'abnormal microenvironment' hypothesis wherein the developing and migrating normal neural crest cells confront a segmentally abnormal and hostile microenvironment in the colon."", ""supports"": ""SUPPORT""}"
3711	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	evidence	0	PMID:20610192	SUPPORT		simon.kenny@liv.ac.uk Hirschsprung's disease (HSCR) is characterized by absence of the enteric nervous system in a variable portion of the distal gut	The absence of ganglion cells (aganglionosis) leads to disruption in enteric nervous system function and subsequent bowel motility issues.	"{""explanation"": ""The absence of ganglion cells (aganglionosis) leads to disruption in enteric nervous system function and subsequent bowel motility issues."", ""reference"": ""PMID:20610192"", ""snippet"": ""simon.kenny@liv.ac.uk Hirschsprung's disease (HSCR) is characterized by absence of the enteric nervous system in a variable portion of the distal gut"", ""supports"": ""SUPPORT""}"
3712	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	evidence	1	PMID:27426273	SUPPORT		Abnormal development or disturbed functioning of the enteric nervous system (ENS), the intrinsic innervation of the gastrointestinal tract, is associated with the development of neuropathic gastrointestinal motility disorders.	The lack of ganglion cells disrupts ENS function, leading to motility problems.	"{""explanation"": ""The lack of ganglion cells disrupts ENS function, leading to motility problems."", ""reference"": ""PMID:27426273"", ""snippet"": ""Abnormal development or disturbed functioning of the enteric nervous system (ENS), the intrinsic innervation of the gastrointestinal tract, is associated with the development of neuropathic gastrointestinal motility disorders."", ""supports"": ""SUPPORT""}"
3713	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	evidence	2	PMID:23917331	SUPPORT		The pathogenesis of HD is defined as a functional intestinal obstruction resulting from a defect in the intrinsic innervation of the distal bowel.	A defect in the ENS due to the lack of ganglion cells causes motility issues.	"{""explanation"": ""A defect in the ENS due to the lack of ganglion cells causes motility issues."", ""reference"": ""PMID:23917331"", ""snippet"": ""The pathogenesis of HD is defined as a functional intestinal obstruction resulting from a defect in the intrinsic innervation of the distal bowel."", ""supports"": ""SUPPORT""}"
3714	3724	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	pathophysiology	1	evidence	3	PMID:19782302	SUPPORT		Symptoms of abdominal discomfort are frequently encountered in the daily practice of pediatricians and pediatric surgeons. Normal peristalsis depends on the interaction between muscles, nerve cells, and tendinous connective tissue of muscularis propria. Malfunction of any of these components results in a motility disorder. Aganglionosis, typically of the left distal colon, is the cause of Hirschsprung disease.	Aganglionosis (lack of ganglion cells) leads to motility issues due to disrupted ENS function.	"{""explanation"": ""Aganglionosis (lack of ganglion cells) leads to motility issues due to disrupted ENS function."", ""reference"": ""PMID:19782302"", ""snippet"": ""Symptoms of abdominal discomfort are frequently encountered in the daily practice of pediatricians and pediatric surgeons. Normal peristalsis depends on the interaction between muscles, nerve cells, and tendinous connective tissue of muscularis propria. Malfunction of any of these components results in a motility disorder. Aganglionosis, typically of the left distal colon, is the cause of Hirschsprung disease."", ""supports"": ""SUPPORT""}"
3748	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	evidence	0	PMID:38344303	SUPPORT		Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network	Direct evidence that TBX5 maintains atrial cardiomyocyte identity through a dosage-sensitive chromatin-based mechanism	"{""explanation"": ""Direct evidence that TBX5 maintains atrial cardiomyocyte identity through a dosage-sensitive chromatin-based mechanism"", ""reference"": ""PMID:38344303"", ""snippet"": ""Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network"", ""supports"": ""SUPPORT""}"
3749	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	evidence	1	PMID:39829922	SUPPORT		Genome organization, including compartments, topologically associated domains, and chromatin loops, are sensitive to reduced TBX5 dosage in a human model of CHD	Demonstrates that TBX5 dosage affects 3D chromatin architecture, directly supporting the haploinsufficiency mechanism in HOS	"{""explanation"": ""Demonstrates that TBX5 dosage affects 3D chromatin architecture, directly supporting the haploinsufficiency mechanism in HOS"", ""reference"": ""PMID:39829922"", ""snippet"": ""Genome organization, including compartments, topologically associated domains, and chromatin loops, are sensitive to reduced TBX5 dosage in a human model of CHD"", ""supports"": ""SUPPORT""}"
3750	3741	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	0	evidence	2	PMID:36936432	SUPPORT		Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS	Confirms that TBX5 sequence alterations cause HOS with novel pathogenic mechanisms including 3'-UTR variants	"{""explanation"": ""Confirms that TBX5 sequence alterations cause HOS with novel pathogenic mechanisms including 3'-UTR variants"", ""reference"": ""PMID:36936432"", ""snippet"": ""Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS"", ""supports"": ""SUPPORT""}"
3751	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	evidence	0	PMID:38189150	SUPPORT		FOG2 bound a subset of GATA4 and TBX5 co-bound genomic locations... FOG2 repressed TBX5-dependent transcription from a subset of co-bound enhancers	Demonstrates the functional interaction between TBX5, GATA4, and FOG2 at atrial enhancers	"{""explanation"": ""Demonstrates the functional interaction between TBX5, GATA4, and FOG2 at atrial enhancers"", ""reference"": ""PMID:38189150"", ""snippet"": ""FOG2 bound a subset of GATA4 and TBX5 co-bound genomic locations... FOG2 repressed TBX5-dependent transcription from a subset of co-bound enhancers"", ""supports"": ""SUPPORT""}"
3752	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	evidence	1	PMID:38189150	SUPPORT		Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency	Genetic evidence that FOG2/ZFPM2 modulates TBX5-dependent conduction defects, supporting a direct functional interaction	"{""explanation"": ""Genetic evidence that FOG2/ZFPM2 modulates TBX5-dependent conduction defects, supporting a direct functional interaction"", ""reference"": ""PMID:38189150"", ""snippet"": ""Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency"", ""supports"": ""SUPPORT""}"
3753	3742	157	Holt-Oram syndrome	Holt_Oram.yaml	pathophysiology	1	evidence	2	PMID:39677667	SUPPORT		TBX5 recruits CHD4, a chromatin remodeling ATPase, to 33,170 genomic regions... CHD4 is essential for maintaining aCM gene expression, aCM identity, and atrial rhythm homeostasis	Shows that CHD4 is directly recruited by TBX5 and is critical for maintaining atrial cardiomyocyte identity	"{""explanation"": ""Shows that CHD4 is directly recruited by TBX5 and is critical for maintaining atrial cardiomyocyte identity"", ""reference"": ""PMID:39677667"", ""snippet"": ""TBX5 recruits CHD4, a chromatin remodeling ATPase, to 33,170 genomic regions... CHD4 is essential for maintaining aCM gene expression, aCM identity, and atrial rhythm homeostasis"", ""supports"": ""SUPPORT""}"
3769	3755	158	Human African trypanosomiasis	Human_African_Trypanosomiasis.yaml	pathophysiology	0	evidence	0	PMID:23829907	SUPPORT		central nervous system infection after trypanosomal traversal of the blood-brain barrier	The abstract links BBB traversal to CNS infection.	"{""explanation"": ""The abstract links BBB traversal to CNS infection."", ""reference"": ""PMID:23829907"", ""snippet"": ""central nervous system infection after trypanosomal traversal of the blood-brain barrier"", ""supports"": ""SUPPORT""}"
3824	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	evidence	0	PMID:7620118	SUPPORT		Early in 1993, an unstable, expanded trinucleotide repeat in a novel gene of unknown function was identified on HD chromosomes. This discovery unleased a flurry of experimentation that has established the expanded CAG repeat the almost universal cause of the characteristic neurologic symptoms and pathology of this neurodegenerative disorder of midlife onset.	The reference confirms that an expanded CAG repeat in the HTT gene is the cause of Huntington's Disease.	"{""explanation"": ""The reference confirms that an expanded CAG repeat in the HTT gene is the cause of Huntington's Disease."", ""reference"": ""PMID:7620118"", ""snippet"": ""Early in 1993, an unstable, expanded trinucleotide repeat in a novel gene of unknown function was identified on HD chromosomes. This discovery unleased a flurry of experimentation that has established the expanded CAG repeat the almost universal cause of the characteristic neurologic symptoms and pathology of this neurodegenerative disorder of midlife onset."", ""supports"": ""SUPPORT""}"
3825	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	evidence	1	PMID:35395060	SUPPORT		Huntington's disease (HD) is caused by an expansion of the CAG trinucleotide repeat domain in the huntingtin gene that results in expression of a mutant huntingtin protein (mHTT) containing an expanded polyglutamine tract in the amino terminus.	The literature clearly states that HD is caused by an expanded CAG repeat in the HTT gene, leading to a mutant huntingtin protein with an abnormal polyglutamine tract.	"{""explanation"": ""The literature clearly states that HD is caused by an expanded CAG repeat in the HTT gene, leading to a mutant huntingtin protein with an abnormal polyglutamine tract."", ""reference"": ""PMID:35395060"", ""snippet"": ""Huntington's disease (HD) is caused by an expansion of the CAG trinucleotide repeat domain in the huntingtin gene that results in expression of a mutant huntingtin protein (mHTT) containing an expanded polyglutamine tract in the amino terminus."", ""supports"": ""SUPPORT""}"
3826	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	evidence	2	PMID:27529325	SUPPORT		Huntington's disease (HD) belongs to the group of inherited polyglutamine (PolyQ) diseases caused by an expanded CAG repeat in the coding region of the Huntingtin (HTT) gene that results in an elongated polyQ stretch.	This reference supports the statement by specifying that HD is caused by an expanded CAG repeat in the HTT gene, leading to an elongated polyglutamine stretch.	"{""explanation"": ""This reference supports the statement by specifying that HD is caused by an expanded CAG repeat in the HTT gene, leading to an elongated polyglutamine stretch."", ""reference"": ""PMID:27529325"", ""snippet"": ""Huntington's disease (HD) belongs to the group of inherited polyglutamine (PolyQ) diseases caused by an expanded CAG repeat in the coding region of the Huntingtin (HTT) gene that results in an elongated polyQ stretch."", ""supports"": ""SUPPORT""}"
3827	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	evidence	3	PMID:33579866	SUPPORT		Huntington's disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene.	The reference supports the statement, confirming that HD is caused by an expanded CAG repeat in the HTT gene.	"{""explanation"": ""The reference supports the statement, confirming that HD is caused by an expanded CAG repeat in the HTT gene."", ""reference"": ""PMID:33579866"", ""snippet"": ""Huntington's disease (HD) (OMIM 143100) is caused by an expanded CAG repeat tract in the HTT gene."", ""supports"": ""SUPPORT""}"
3828	3782	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	0	evidence	4	PMID:31398342	SUPPORT		Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops.	This reference supports the statement by discussing the role of uninterrupted CAG repeats in the HTT gene in the development of HD.	"{""explanation"": ""This reference supports the statement by discussing the role of uninterrupted CAG repeats in the HTT gene in the development of HD."", ""reference"": ""PMID:31398342"", ""snippet"": ""Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops."", ""supports"": ""SUPPORT""}"
3829	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	evidence	0	PMID:35319359	SUPPORT		Pathogenesis of HD involves cleavage of the huntingtin protein followed by the neuronal accumulation of its aggregated form.	The literature supports that the pathogenesis of Huntington's Disease involves the accumulation of aggregated mutant huntingtin protein, leading to neuronal dysfunction and death.	"{""explanation"": ""The literature supports that the pathogenesis of Huntington's Disease involves the accumulation of aggregated mutant huntingtin protein, leading to neuronal dysfunction and death."", ""reference"": ""PMID:35319359"", ""snippet"": ""Pathogenesis of HD involves cleavage of the huntingtin protein followed by the neuronal accumulation of its aggregated form."", ""supports"": ""SUPPORT""}"
3830	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	evidence	1	PMID:12657365	SUPPORT		The initial and primary target of degeneration in HD is the striatal medium spiny GABAergic neuron, and by end stages of the disease up to 95% of these neurons are lost.	This reference supports the statement by highlighting the primary degeneration of neurons in the striatum due to Huntington's Disease.	"{""explanation"": ""This reference supports the statement by highlighting the primary degeneration of neurons in the striatum due to Huntington's Disease."", ""reference"": ""PMID:12657365"", ""snippet"": ""The initial and primary target of degeneration in HD is the striatal medium spiny GABAergic neuron, and by end stages of the disease up to 95% of these neurons are lost."", ""supports"": ""SUPPORT""}"
3831	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	evidence	2	PMID:31813995	SUPPORT		Mutant HTT (mHTT) toxicity is caused by its aggregation/oligomerization. The striatum is the most vulnerable region, although all brain regions undergo neuronal degeneration in the disease.	This literature supports the statement by confirming that mutant huntingtin protein aggregation leads to neurotoxicity, particularly in the striatum.	"{""explanation"": ""This literature supports the statement by confirming that mutant huntingtin protein aggregation leads to neurotoxicity, particularly in the striatum."", ""reference"": ""PMID:31813995"", ""snippet"": ""Mutant HTT (mHTT) toxicity is caused by its aggregation/oligomerization. The striatum is the most vulnerable region, although all brain regions undergo neuronal degeneration in the disease."", ""supports"": ""SUPPORT""}"
3832	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	evidence	3	PMID:23423362	SUPPORT		Evaluation of postmortem HD tissue indicates that the most prominent cell loss occurs in cerebral cortex and striatum, forebrain regions in which cortical pyramidal neurons (CPNs) and striatal medium spiny neurons (MSNs) are the most affected.	This reference supports the statement by indicating significant neuronal loss in the striatum and cerebral cortex in Huntington's Disease.	"{""explanation"": ""This reference supports the statement by indicating significant neuronal loss in the striatum and cerebral cortex in Huntington's Disease."", ""reference"": ""PMID:23423362"", ""snippet"": ""Evaluation of postmortem HD tissue indicates that the most prominent cell loss occurs in cerebral cortex and striatum, forebrain regions in which cortical pyramidal neurons (CPNs) and striatal medium spiny neurons (MSNs) are the most affected."", ""supports"": ""SUPPORT""}"
3833	3783	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	1	evidence	4	PMID:24048953	SUPPORT		Huntington's disease is caused by the expansion of a polyglutamine repeat (>37 glutamines) in the disease protein huntingtin, which results in preferential neuronal loss in distinct brain regions.	The literature supports the statement by confirming that mutant huntingtin protein causes neuronal loss in specific brain regions, including the striatum and cerebral cortex.	"{""explanation"": ""The literature supports the statement by confirming that mutant huntingtin protein causes neuronal loss in specific brain regions, including the striatum and cerebral cortex."", ""reference"": ""PMID:24048953"", ""snippet"": ""Huntington's disease is caused by the expansion of a polyglutamine repeat (>37 glutamines) in the disease protein huntingtin, which results in preferential neuronal loss in distinct brain regions."", ""supports"": ""SUPPORT""}"
3834	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	evidence	0	PMID:38776957	SUPPORT		We have identified transcriptional upregulation of genes encoding N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors in medium spiny neurons, the cell type preferentially lost early in HD.	The study identifies upregulation of glutamate receptors in medium spiny neurons, supporting the idea of excitotoxicity due to overactivation of these receptors leading to neuronal damage.	"{""explanation"": ""The study identifies upregulation of glutamate receptors in medium spiny neurons, supporting the idea of excitotoxicity due to overactivation of these receptors leading to neuronal damage."", ""reference"": ""PMID:38776957"", ""snippet"": ""We have identified transcriptional upregulation of genes encoding N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors in medium spiny neurons, the cell type preferentially lost early in HD."", ""supports"": ""SUPPORT""}"
3835	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	evidence	1	PMID:1464368	SUPPORT		Excitotoxicity refers to neuronal cell death caused by activation of excitatory amino acid receptors. A substantial body of evidence has implicated excitotoxicity as a mechanism of cell death in both acute and chronic neurologic diseases.	This reference explains the concept of excitotoxicity and supports the idea that overactivation of glutamate receptors can lead to neuronal damage.	"{""explanation"": ""This reference explains the concept of excitotoxicity and supports the idea that overactivation of glutamate receptors can lead to neuronal damage."", ""reference"": ""PMID:1464368"", ""snippet"": ""Excitotoxicity refers to neuronal cell death caused by activation of excitatory amino acid receptors. A substantial body of evidence has implicated excitotoxicity as a mechanism of cell death in both acute and chronic neurologic diseases."", ""supports"": ""SUPPORT""}"
3836	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	evidence	2	PMID:7590394	SUPPORT		Our results indicated that elevated glutamate concentrations (15 mM, 1.5 mM, and 150 microM glutamate in perfusing solutions) would significantly increased both the concentrations of 2,3 and 2,5 DHBA.	The study provides direct evidence that elevated glutamate levels increase the formation of hydroxyl radicals, implying oxidative stress induced by excitotoxicity, which supports the statement.	"{""explanation"": ""The study provides direct evidence that elevated glutamate levels increase the formation of hydroxyl radicals, implying oxidative stress induced by excitotoxicity, which supports the statement."", ""reference"": ""PMID:7590394"", ""snippet"": ""Our results indicated that elevated glutamate concentrations (15 mM, 1.5 mM, and 150 microM glutamate in perfusing solutions) would significantly increased both the concentrations of 2,3 and 2,5 DHBA."", ""supports"": ""SUPPORT""}"
3837	3784	159	Huntington's Disease	Huntingtons_Disease.yaml	pathophysiology	2	evidence	3	PMID:19805493	SUPPORT		Induction of striatal excitotoxicity in CB(2) receptor-deficient mice by quinolinic acid administration exacerbated brain oedema, microglial activation, proinflammatory-mediator state and medium-sized spiny neuron degeneration.	This study shows that excitotoxicity induced in the striatum leads to medium spiny neuron degeneration, supporting the idea of excitotoxicity causing neuronal damage in Huntington's Disease.	"{""explanation"": ""This study shows that excitotoxicity induced in the striatum leads to medium spiny neuron degeneration, supporting the idea of excitotoxicity causing neuronal damage in Huntington's Disease."", ""reference"": ""PMID:19805493"", ""snippet"": ""Induction of striatal excitotoxicity in CB(2) receptor-deficient mice by quinolinic acid administration exacerbated brain oedema, microglial activation, proinflammatory-mediator state and medium-sized spiny neuron degeneration."", ""supports"": ""SUPPORT""}"
3891	3811	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	0	evidence	0	PMID:38428029	SUPPORT		Pathologic cardiac hypertrophy is a common consequence of many cardiovascular diseases, including aortic stenosis (AS). AS is known to increase the pressure load of the left ventricle, causing a compensative response of the cardiac muscle, which progressively will lead to dilation and heart failure.	This reference discusses the pressure load on the left ventricle due to aortic stenosis, leading to cardiac remodeling and dysfunction, supporting the described mechanism of hypertensive heart disease.	"{""explanation"": ""This reference discusses the pressure load on the left ventricle due to aortic stenosis, leading to cardiac remodeling and dysfunction, supporting the described mechanism of hypertensive heart disease."", ""reference"": ""PMID:38428029"", ""snippet"": ""Pathologic cardiac hypertrophy is a common consequence of many cardiovascular diseases, including aortic stenosis (AS). AS is known to increase the pressure load of the left ventricle, causing a compensative response of the cardiac muscle, which progressively will lead to dilation and heart failure."", ""supports"": ""SUPPORT""}"
3892	3811	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	0	evidence	1	PMID:7496052	SUPPORT		Hypertension is associated with the remodeling of left ventricular geometry and abnormalities of function that may precede geometric changes. Rather than a specific disease, 'hypertensive heart failure' is a spectrum of disorders that result from left ventricular geometric changes and comorbid conditions.	The reference explains the remodeling of the left ventricle due to hypertension and the functional abnormalities that occur, supporting the described mechanism of hypertensive heart disease.	"{""explanation"": ""The reference explains the remodeling of the left ventricle due to hypertension and the functional abnormalities that occur, supporting the described mechanism of hypertensive heart disease."", ""reference"": ""PMID:7496052"", ""snippet"": ""Hypertension is associated with the remodeling of left ventricular geometry and abnormalities of function that may precede geometric changes. Rather than a specific disease, 'hypertensive heart failure' is a spectrum of disorders that result from left ventricular geometric changes and comorbid conditions."", ""supports"": ""SUPPORT""}"
3893	3811	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	0	evidence	2	PMID:19427497	SUPPORT		LVDD as an early measure of myocardial end-organ damage is commonly associated with hypertension and may well precede development of LVH in hypertension.	This reference discusses the association between hypertension and left ventricular dysfunction, an early indicator of cardiac remodeling and dysfunction, supporting the described mechanism.	"{""explanation"": ""This reference discusses the association between hypertension and left ventricular dysfunction, an early indicator of cardiac remodeling and dysfunction, supporting the described mechanism."", ""reference"": ""PMID:19427497"", ""snippet"": ""LVDD as an early measure of myocardial end-organ damage is commonly associated with hypertension and may well precede development of LVH in hypertension."", ""supports"": ""SUPPORT""}"
3894	3811	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	0	evidence	3	PMID:28082430	SUPPORT		SHR had lower ejection fraction compared with WKY at all ages, but there was no difference in cardiac output at any age. At 21 month the SHR had significantly elevated stroke work (51 +/- 3 mL.mmHg SHR vs. 24 +/- 2 mL.mmHg WKY; n = 8, 4; P < 0.001) and cardiac minute work (14.2 +/- 1.2 L.mmHg/min SHR vs. 6.2 +/- 0.8 L.mmHg/min WKY; n = 8, 4; P < 0.001) compared to control, in addition to significantly larger left ventricular mass to body mass ratio (3.61 +/- 0.15 mg/g SHR vs. 2.11 +/- 0.008 mg/g WKY; n = 8, 6; P < 0.001).	This study in spontaneously hypertensive rats shows increased cardiac work and hypertrophy, which aligns with the described mechanism of increased cardiac workload leading to dysfunction.	"{""explanation"": ""This study in spontaneously hypertensive rats shows increased cardiac work and hypertrophy, which aligns with the described mechanism of increased cardiac workload leading to dysfunction."", ""reference"": ""PMID:28082430"", ""snippet"": ""SHR had lower ejection fraction compared with WKY at all ages, but there was no difference in cardiac output at any age. At 21 month the SHR had significantly elevated stroke work (51 +/- 3 mL.mmHg SHR vs. 24 +/- 2 mL.mmHg WKY; n = 8, 4; P < 0.001) and cardiac minute work (14.2 +/- 1.2 L.mmHg/min SHR vs. 6.2 +/- 0.8 L.mmHg/min WKY; n = 8, 4; P < 0.001) compared to control, in addition to significantly larger left ventricular mass to body mass ratio (3.61 +/- 0.15 mg/g SHR vs. 2.11 +/- 0.008 mg/g WKY; n = 8, 6; P < 0.001)."", ""supports"": ""SUPPORT""}"
3895	3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	evidence	0	PMID:11062603	SUPPORT		Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature.	The paper discusses how hypertension causes left ventricular hypertrophy and affects multiple myocardial compartments.	"{""explanation"": ""The paper discusses how hypertension causes left ventricular hypertrophy and affects multiple myocardial compartments."", ""reference"": ""PMID:11062603"", ""snippet"": ""Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature."", ""supports"": ""SUPPORT""}"
3896	3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	evidence	1	PMID:36933415	SUPPORT		We computed both eccentric and concentric hypertrophy effects and tracked changes in the ventricle shape and wall thickness.	The study confirms that changes in wall thickness and ventricular shape due to hypertrophy reflect an adaptation to increased workload.	"{""explanation"": ""The study confirms that changes in wall thickness and ventricular shape due to hypertrophy reflect an adaptation to increased workload."", ""reference"": ""PMID:36933415"", ""snippet"": ""We computed both eccentric and concentric hypertrophy effects and tracked changes in the ventricle shape and wall thickness."", ""supports"": ""SUPPORT""}"
3897	3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	evidence	2	PMID:10652906	SUPPORT		Left ventricular hypertrophy (LVH) is pathognomonic of HHD.	Left ventricular hypertrophy is directly associated with hypertensive heart disease and involves thickening of the heart muscle.	"{""explanation"": ""Left ventricular hypertrophy is directly associated with hypertensive heart disease and involves thickening of the heart muscle."", ""reference"": ""PMID:10652906"", ""snippet"": ""Left ventricular hypertrophy (LVH) is pathognomonic of HHD."", ""supports"": ""SUPPORT""}"
3898	3812	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	1	evidence	3	PMID:37827810	SUPPORT		In case of hypertrophy, an increased influence of the dilating transmural fibre component might counteract systolic wall thickening, thereby counteract cardiac output.	The reference discusses the influence of hypertrophy on wall thickening and heart function.	"{""explanation"": ""The reference discusses the influence of hypertrophy on wall thickening and heart function."", ""reference"": ""PMID:37827810"", ""snippet"": ""In case of hypertrophy, an increased influence of the dilating transmural fibre component might counteract systolic wall thickening, thereby counteract cardiac output."", ""supports"": ""SUPPORT""}"
3899	3813	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	2	evidence	0	PMID:37739329	SUPPORT		Hypertension represents a major contributor to the development of coronary artery disease. The pathophysiological mechanisms underlying the link between hypertension and CAD are complex and include overactivation of neurohormones, accelerated development of the atherosclerotic plaque, endothelial dysfunction, altered intramyocardial coronary circulation...	This reference outlines how hypertension can lead to coronary artery disease by affecting atherosclerotic plaque development, endothelial dysfunction, and coronary circulation, which are consistent with the statement.	"{""explanation"": ""This reference outlines how hypertension can lead to coronary artery disease by affecting atherosclerotic plaque development, endothelial dysfunction, and coronary circulation, which are consistent with the statement."", ""reference"": ""PMID:37739329"", ""snippet"": ""Hypertension represents a major contributor to the development of coronary artery disease. The pathophysiological mechanisms underlying the link between hypertension and CAD are complex and include overactivation of neurohormones, accelerated development of the atherosclerotic plaque, endothelial dysfunction, altered intramyocardial coronary circulation..."", ""supports"": ""SUPPORT""}"
3900	3813	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	2	evidence	1	PMID:11062603	SUPPORT		Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature. Ventricular hypertrophy significantly increases the risk for cardiovascular morbidity and mortality in hypertensive disease. Impairments in coronary circulation and ventricular fibrosis, which are an essential part of hypertensive disease...	The report discusses the negative impact of hypertension on coronary circulation and the involvement of coronary vasculature impairments due to hypertensive disease, supporting the statement.	"{""explanation"": ""The report discusses the negative impact of hypertension on coronary circulation and the involvement of coronary vasculature impairments due to hypertensive disease, supporting the statement."", ""reference"": ""PMID:11062603"", ""snippet"": ""Sustained increase in arterial pressure causes left ventricular hypertrophy and adversely affects all myocardial compartments: myocytes, interstitium, and coronary vasculature. Ventricular hypertrophy significantly increases the risk for cardiovascular morbidity and mortality in hypertensive disease. Impairments in coronary circulation and ventricular fibrosis, which are an essential part of hypertensive disease..."", ""supports"": ""SUPPORT""}"
3901	3813	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	2	evidence	2	PMID:33143256	SUPPORT		Ischemic heart disease still represents a large burden on individuals and health care resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow-limiting obstruction in large-medium sized coronary arteries. However, clinical, angiographic and autoptic findings suggest a multifaceted pathophysiology for ischemic heart disease and just some cases are caused by severe or complicated atherosclerotic plaques.	This reference explains that ischemic heart disease, which can result from severe atherosclerotic plaques, aligns with the statement that hypertension-induced atherosclerosis can reduce coronary blood flow, contributing to myocardial ischemia.	"{""explanation"": ""This reference explains that ischemic heart disease, which can result from severe atherosclerotic plaques, aligns with the statement that hypertension-induced atherosclerosis can reduce coronary blood flow, contributing to myocardial ischemia."", ""reference"": ""PMID:33143256"", ""snippet"": ""Ischemic heart disease still represents a large burden on individuals and health care resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow-limiting obstruction in large-medium sized coronary arteries. However, clinical, angiographic and autoptic findings suggest a multifaceted pathophysiology for ischemic heart disease and just some cases are caused by severe or complicated atherosclerotic plaques."", ""supports"": ""SUPPORT""}"
3902	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	evidence	0	PMID:37999643	SUPPORT		In response to increased peripheral resistance in hypertension, intensified mechanical stretch in the myocardium induces cardiomyocyte hypertrophy and fibroblast activation to withstand increased pressure overload. This changes the structure and function of the heart, leading to pathological cardiac remodeling and eventual progression to heart failure.	The activation of fibroblasts in response to hypertension and their role in cardiac remodeling aligns with the statement that chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart.	"{""explanation"": ""The activation of fibroblasts in response to hypertension and their role in cardiac remodeling aligns with the statement that chronic pressure overload stimulates fibroblasts to deposit excess collagen in the heart."", ""reference"": ""PMID:37999643"", ""snippet"": ""In response to increased peripheral resistance in hypertension, intensified mechanical stretch in the myocardium induces cardiomyocyte hypertrophy and fibroblast activation to withstand increased pressure overload. This changes the structure and function of the heart, leading to pathological cardiac remodeling and eventual progression to heart failure."", ""supports"": ""SUPPORT""}"
3903	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	evidence	1	PMID:33568808	SUPPORT		Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion results from alterations in the regulation of fibrillary collagen turnover by fibroblasts, facilitating the excessive deposition of type I and type III collagen fibres within the myocardial interstitium and around intramyocardial vessels.	This reference details how fibroblasts facilitate excessive collagen deposition in the myocardium, which supports the statement regarding cardiac fibrosis due to chronic pressure overload.	"{""explanation"": ""This reference details how fibroblasts facilitate excessive collagen deposition in the myocardium, which supports the statement regarding cardiac fibrosis due to chronic pressure overload."", ""reference"": ""PMID:33568808"", ""snippet"": ""Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion results from alterations in the regulation of fibrillary collagen turnover by fibroblasts, facilitating the excessive deposition of type I and type III collagen fibres within the myocardial interstitium and around intramyocardial vessels."", ""supports"": ""SUPPORT""}"
3904	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	evidence	2	PMID:2532916	SUPPORT		In left ventricular pressure overload a reactive interstitial fibrosis, having distinctive biochemical and structural features, is seen. This reactive fibrosis occurs in the absence of myocyte necrosis, is progressive in nature, and initially is an adaptive response that preserves the force generating capacity, or active (systolic) stiffness, of the hypertrophied myocardium.	The description of reactive interstitial fibrosis in response to pressure overload supports the statement about fibroblasts depositing excess collagen in the heart under chronic pressure overload conditions, leading to fibrosis and stiffening.	"{""explanation"": ""The description of reactive interstitial fibrosis in response to pressure overload supports the statement about fibroblasts depositing excess collagen in the heart under chronic pressure overload conditions, leading to fibrosis and stiffening."", ""reference"": ""PMID:2532916"", ""snippet"": ""In left ventricular pressure overload a reactive interstitial fibrosis, having distinctive biochemical and structural features, is seen. This reactive fibrosis occurs in the absence of myocyte necrosis, is progressive in nature, and initially is an adaptive response that preserves the force generating capacity, or active (systolic) stiffness, of the hypertrophied myocardium."", ""supports"": ""SUPPORT""}"
3905	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	evidence	3	PMID:10829097	SUPPORT		Mechanisms underlying risk associated with hypertensive heart disease (HHD) and left ventricular hypertrophy (LVH) are discussed in this report and provide a rationale for understanding this very common and important cause of death from hypertension and its complications. Emphasized are impaired coronary hemodynamics, endothelial dysfunction, and ventricular fibrosis from increased collagen deposition intramurally and perivascularly.	The mention of ventricular fibrosis due to increased collagen deposition supports the statement that chronic pressure overload results in fibroblasts depositing excess collagen, leading to cardiac fibrosis.	"{""explanation"": ""The mention of ventricular fibrosis due to increased collagen deposition supports the statement that chronic pressure overload results in fibroblasts depositing excess collagen, leading to cardiac fibrosis."", ""reference"": ""PMID:10829097"", ""snippet"": ""Mechanisms underlying risk associated with hypertensive heart disease (HHD) and left ventricular hypertrophy (LVH) are discussed in this report and provide a rationale for understanding this very common and important cause of death from hypertension and its complications. Emphasized are impaired coronary hemodynamics, endothelial dysfunction, and ventricular fibrosis from increased collagen deposition intramurally and perivascularly."", ""supports"": ""SUPPORT""}"
3906	3814	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	pathophysiology	3	evidence	4	PMID:33570899	SUPPORT		The differentiation of TH17 cells reflected the cardiac hypertrophy and remodeling response to hypertension-induced pressure overload, and it might be a potential inflammatory marker to predict the prognosis of hypertensive patients.	Although this snippet primarily focuses on TH17 cells, it indicates that remodeling due to hypertension includes elements of fibroblast activation and fibrosis.	"{""explanation"": ""Although this snippet primarily focuses on TH17 cells, it indicates that remodeling due to hypertension includes elements of fibroblast activation and fibrosis."", ""reference"": ""PMID:33570899"", ""snippet"": ""The differentiation of TH17 cells reflected the cardiac hypertrophy and remodeling response to hypertension-induced pressure overload, and it might be a potential inflammatory marker to predict the prognosis of hypertensive patients."", ""supports"": ""SUPPORT""}"
4003	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	evidence	0	PMID:16416046	SUPPORT		Hypertrophic Cardiomyopathy (HCM) is a relatively common primary cardiac disorder defined as the presence of a hypertrophied left ventricle... to date, 270 independent mutations in nine sarcomeric protein genes have been linked to Familial Hypertrophic Cardiomyopathy (FHC)...	The reference discusses how mutations in sarcomeric protein genes are linked to hypertrophic cardiomyopathy, which leads to heart muscle thickening.	"{""explanation"": ""The reference discusses how mutations in sarcomeric protein genes are linked to hypertrophic cardiomyopathy, which leads to heart muscle thickening."", ""reference"": ""PMID:16416046"", ""snippet"": ""Hypertrophic Cardiomyopathy (HCM) is a relatively common primary cardiac disorder defined as the presence of a hypertrophied left ventricle... to date, 270 independent mutations in nine sarcomeric protein genes have been linked to Familial Hypertrophic Cardiomyopathy (FHC)..."", ""supports"": ""SUPPORT""}"
4004	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	evidence	1	PMID:36797478	SUPPORT		The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by variants in cardiac sarcomeric genes and leads to abnormal heart muscle thickening.	This reference directly states that HCM is caused by variants in sarcomeric genes resulting in heart muscle thickening.	"{""explanation"": ""This reference directly states that HCM is caused by variants in sarcomeric genes resulting in heart muscle thickening."", ""reference"": ""PMID:36797478"", ""snippet"": ""The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by variants in cardiac sarcomeric genes and leads to abnormal heart muscle thickening."", ""supports"": ""SUPPORT""}"
4005	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	evidence	2	PMID:28645928	SUPPORT		For example, increased myosin heavy chain (MHC) binding and ATP utilization lead to the hypercontractile sarcomere in HCM...	This reference explains how specific mutations in sarcomeric proteins lead to hypercontractility, a feature of muscle thickening in HCM.	"{""explanation"": ""This reference explains how specific mutations in sarcomeric proteins lead to hypercontractility, a feature of muscle thickening in HCM."", ""reference"": ""PMID:28645928"", ""snippet"": ""For example, increased myosin heavy chain (MHC) binding and ATP utilization lead to the hypercontractile sarcomere in HCM..."", ""supports"": ""SUPPORT""}"
4006	3858	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	0	evidence	3	PMID:37060436	SUPPORT		Recent advances in our mechanistic understanding of sarcomere pathophysiology include high-resolution molecular models of sarcomere components and the identification of the myosin super-relaxed state.	This reference details how understanding sarcomere function and its pathophysiology relates to mutations leading to cardiomyopathy, thereby supporting the statement about genetic mutations affecting sarcomere proteins.	"{""explanation"": ""This reference details how understanding sarcomere function and its pathophysiology relates to mutations leading to cardiomyopathy, thereby supporting the statement about genetic mutations affecting sarcomere proteins."", ""reference"": ""PMID:37060436"", ""snippet"": ""Recent advances in our mechanistic understanding of sarcomere pathophysiology include high-resolution molecular models of sarcomere components and the identification of the myosin super-relaxed state."", ""supports"": ""SUPPORT""}"
4007	3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	evidence	0	PMID:33447843	SUPPORT		Myocardial disarray is defined as disorganized cardiomyocyte spatial distribution, with loss of physiological fibre alignment and orientation.	The paper discusses how myocardial disarray is a typical feature of hypertrophic cardiomyopathy (HCM), implying its role in myocardial dysfunction.	"{""explanation"": ""The paper discusses how myocardial disarray is a typical feature of hypertrophic cardiomyopathy (HCM), implying its role in myocardial dysfunction."", ""reference"": ""PMID:33447843"", ""snippet"": ""Myocardial disarray is defined as disorganized cardiomyocyte spatial distribution, with loss of physiological fibre alignment and orientation."", ""supports"": ""SUPPORT""}"
4008	3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	evidence	1	PMID:7665141	SUPPORT		Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray).	This indicates that myocyte disarray is a feature of the disease, contributing to the thickening and impaired function of the myocardium.	"{""explanation"": ""This indicates that myocyte disarray is a feature of the disease, contributing to the thickening and impaired function of the myocardium."", ""reference"": ""PMID:7665141"", ""snippet"": ""Genes on five loci on separate chromosomes are responsible for a familial disease in which all or part of the ventricular muscle undergoes thickening with a histological picture of irregular hypertrophy and disorganized arrangement of myocytes (disarray)."", ""supports"": ""SUPPORT""}"
4009	3859	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	1	evidence	2	PMID:11040002	SUPPORT		Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002).	The correlation between hypertrophy, fibrosis, and disarray supports the statement that myocyte disarray contributes to myocardial dysfunction.	"{""explanation"": ""The correlation between hypertrophy, fibrosis, and disarray supports the statement that myocyte disarray contributes to myocardial dysfunction."", ""reference"": ""PMID:11040002"", ""snippet"": ""Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002)."", ""supports"": ""SUPPORT""}"
4010	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	evidence	0	PMID:1414892	SUPPORT		It appears that increased collagen production is mainly responsible for the functional consequences of structural remodelling	The increased collagen production discussed here is consistent with the contribution of interstitial cells to myocardial stiffness.	"{""explanation"": ""The increased collagen production discussed here is consistent with the contribution of interstitial cells to myocardial stiffness."", ""reference"": ""PMID:1414892"", ""snippet"": ""It appears that increased collagen production is mainly responsible for the functional consequences of structural remodelling"", ""supports"": ""SUPPORT""}"
4011	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	evidence	1	PMID:25573453	SUPPORT		Tissue from cats with pre-clinical HCM also had a higher number of neutrophils and a greater collagen content than the myocardium of normal cats.	This study shows increased collagen deposition, contributing to myocardial stiffness, aligning with the statement.	"{""explanation"": ""This study shows increased collagen deposition, contributing to myocardial stiffness, aligning with the statement."", ""reference"": ""PMID:25573453"", ""snippet"": ""Tissue from cats with pre-clinical HCM also had a higher number of neutrophils and a greater collagen content than the myocardium of normal cats."", ""supports"": ""SUPPORT""}"
4012	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	evidence	2	PMID:29522370	SUPPORT		We conclude that myocardial macrophages play an important role in the time-dependent increases in SPARC that enhance postsynthetic collagen processing, insoluble collagen content, and myocardial stiffness and contribute to the development of fibrosis.	The role of interstitial cells like macrophages in increasing collagen content supports the statement.	"{""explanation"": ""The role of interstitial cells like macrophages in increasing collagen content supports the statement."", ""reference"": ""PMID:29522370"", ""snippet"": ""We conclude that myocardial macrophages play an important role in the time-dependent increases in SPARC that enhance postsynthetic collagen processing, insoluble collagen content, and myocardial stiffness and contribute to the development of fibrosis."", ""supports"": ""SUPPORT""}"
4013	3860	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	pathophysiology	2	evidence	3	PMID:12510171	SUPPORT		The myocardial collagen matrix consists of a network of fibrillar collagen which is intimately connected to the myocyte.	The mention of the collagen matrix supports the idea of increased collagen deposition by interstitial cells contributing to myocardial stiffness.	"{""explanation"": ""The mention of the collagen matrix supports the idea of increased collagen deposition by interstitial cells contributing to myocardial stiffness."", ""reference"": ""PMID:12510171"", ""snippet"": ""The myocardial collagen matrix consists of a network of fibrillar collagen which is intimately connected to the myocyte."", ""supports"": ""SUPPORT""}"
4062	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	evidence	0	PMID:2572591	SUPPORT	HUMAN_CLINICAL	The substitution disrupts the invariant Gly-X-Y structural motif necessary for perfect triple helix formation and leads to extensive overmodification, intracellular retention, and reduced secretion of type II collagen.	Demonstrates that glycine substitutions in COL2A1 disrupt collagen triple helix formation, causing intracellular retention and reduced secretion.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that glycine substitutions in COL2A1 disrupt collagen triple helix formation, causing intracellular retention and reduced secretion."", ""reference"": ""PMID:2572591"", ""snippet"": ""The substitution disrupts the invariant Gly-X-Y structural motif necessary for perfect triple helix formation and leads to extensive overmodification, intracellular retention, and reduced secretion of type II collagen."", ""supports"": ""SUPPORT""}"
4063	3885	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	0	evidence	1	PMID:8175802	SUPPORT	HUMAN_CLINICAL	Microscopic examination of cartilage showed that the mutation altered the organization of the growth plate. Also, articular chondrocytes contained large cisternae of rough endoplasmic reticulum. The density of the extracellular matrix was reduced, and the intensity of the staining with an antibody to type II collagen was diminished.	Confirms that COL2A1 mutations cause ER retention of misfolded collagen and reduced extracellular matrix density in hypochondrogenesis patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that COL2A1 mutations cause ER retention of misfolded collagen and reduced extracellular matrix density in hypochondrogenesis patients."", ""reference"": ""PMID:8175802"", ""snippet"": ""Microscopic examination of cartilage showed that the mutation altered the organization of the growth plate. Also, articular chondrocytes contained large cisternae of rough endoplasmic reticulum. The density of the extracellular matrix was reduced, and the intensity of the staining with an antibody to type II collagen was diminished."", ""supports"": ""SUPPORT""}"
4064	3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	evidence	0	PMID:25187577	SUPPORT	IN_VITRO	The COL2pathy-iChon cells showed suppressed expression of COL2A1 and significant apoptosis. A distended endoplasmic reticulum (ER) was detected, thus suggesting the adaptation of gene expression and cell death caused by excess ER stress.	Demonstrates that type II collagenopathy chondrocytes exhibit ER stress and apoptosis due to misfolded collagen accumulation.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Demonstrates that type II collagenopathy chondrocytes exhibit ER stress and apoptosis due to misfolded collagen accumulation."", ""reference"": ""PMID:25187577"", ""snippet"": ""The COL2pathy-iChon cells showed suppressed expression of COL2A1 and significant apoptosis. A distended endoplasmic reticulum (ER) was detected, thus suggesting the adaptation of gene expression and cell death caused by excess ER stress."", ""supports"": ""SUPPORT""}"
4065	3886	162	Hypochondrogenesis	Hypochondrogenesis.yaml	pathophysiology	1	evidence	1	PMID:3717210	SUPPORT	HUMAN_CLINICAL	Chondro-osseous histology and ultrastructure was similar in all cases regardless of severity and was characterized by hypervascularity and hypercellularity of the cartilage with multiple small, round dilated cysternae of rough endoplasmic reticulum.	Confirms dilated ER cisternae in chondrocytes from hypochondrogenesis/achondrogenesis II patients, indicating ER stress from collagen misfolding.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms dilated ER cisternae in chondrocytes from hypochondrogenesis/achondrogenesis II patients, indicating ER stress from collagen misfolding."", ""reference"": ""PMID:3717210"", ""snippet"": ""Chondro-osseous histology and ultrastructure was similar in all cases regardless of severity and was characterized by hypervascularity and hypercellularity of the cartilage with multiple small, round dilated cysternae of rough endoplasmic reticulum."", ""supports"": ""SUPPORT""}"
4069	3911	164	Acute Myeloid Leukemia, IDH-Mutated	IDH_Mutant_AML.yaml	pathophysiology	0	evidence	0	PMID:37526143	SUPPORT		Mutations in isocitrate dehydrogenase (IDH) 1 and -2 increase the capacity of cancer cells to produce a normally scarce metabolite, D-2-hydroxyglutarate (2-HG), by several orders of magnitude.	This abstract links IDH1/2 mutations to increased 2-HG production, supporting the neomorphic IDH activity described.	"{""explanation"": ""This abstract links IDH1/2 mutations to increased 2-HG production, supporting the neomorphic IDH activity described."", ""reference"": ""PMID:37526143"", ""snippet"": ""Mutations in isocitrate dehydrogenase (IDH) 1 and -2 increase the capacity of cancer cells to produce a normally scarce metabolite, D-2-hydroxyglutarate (2-HG), by several orders of magnitude."", ""supports"": ""SUPPORT""}"
4071	3936	165	IDH-Mutant Astrocytoma	IDH_Mutant_Astrocytoma.yaml	pathophysiology	0	evidence	0	PMID:40916936	SUPPORT		This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH.	This abstract directly states that mutant IDH produces 2-HG, supporting the neomorphic IDH activity described.	"{""explanation"": ""This abstract directly states that mutant IDH produces 2-HG, supporting the neomorphic IDH activity described."", ""reference"": ""PMID:40916936"", ""snippet"": ""This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH."", ""supports"": ""SUPPORT""}"
4075	3955	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	0	evidence	0	PMID:25536104	SUPPORT		Commonly occurring GAs in intrahepatic CCA were TP53 (35%), KRAS (24%), ARID1A (20%), IDH1 (18%), MCL1 (16%) and PBRM1 (11%).	Supports the presence of IDH1 mutations in intrahepatic cholangiocarcinoma.	"{""explanation"": ""Supports the presence of IDH1 mutations in intrahepatic cholangiocarcinoma."", ""reference"": ""PMID:25536104"", ""snippet"": ""Commonly occurring GAs in intrahepatic CCA were TP53 (35%), KRAS (24%), ARID1A (20%), IDH1 (18%), MCL1 (16%) and PBRM1 (11%)."", ""supports"": ""SUPPORT""}"
4076	3956	166	IDH-Mutant Cholangiocarcinoma	IDH_Mutant_Cholangiocarcinoma.yaml	pathophysiology	1	evidence	0	PMID:24569570	SUPPORT		These mutations result in elevated levels of an oncometabolite, 2-hydroxyglutarate, which is associated with higher DNA CpG methylation and altered histone methylation that accompany a block in cellular differentiation.	Abstract links IDH mutations to elevated 2-hydroxyglutarate and epigenetic effects.	"{""explanation"": ""Abstract links IDH mutations to elevated 2-hydroxyglutarate and epigenetic effects."", ""reference"": ""PMID:24569570"", ""snippet"": ""These mutations result in elevated levels of an oncometabolite, 2-hydroxyglutarate, which is associated with higher DNA CpG methylation and altered histone methylation that accompany a block in cellular differentiation."", ""supports"": ""SUPPORT""}"
4078	3980	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	0	evidence	0	PMID:40916936	SUPPORT		This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH.	This abstract explicitly links mutant IDH to 2-HG production, supporting the neomorphic IDH mechanism.	"{""explanation"": ""This abstract explicitly links mutant IDH to 2-HG production, supporting the neomorphic IDH mechanism."", ""reference"": ""PMID:40916936"", ""snippet"": ""This unique immune microenvironment is shaped by 2-hydroxyglutarate (2-HG), an oncometabolite produced by mutant IDH."", ""supports"": ""SUPPORT""}"
4079	3981	167	IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma	IDH_Mutant_Oligodendroglioma.yaml	pathophysiology	1	evidence	0	PMID:37743332	SUPPORT		Oligodendrogliomas were clearly defined as tumors with IDH mutations and 1p/19q codeletion by the World Health Organization(WHO)in 2016.	Abstract defines oligodendrogliomas by IDH mutation and 1p/19q codeletion.	"{""explanation"": ""Abstract defines oligodendrogliomas by IDH mutation and 1p/19q codeletion."", ""reference"": ""PMID:37743332"", ""snippet"": ""Oligodendrogliomas were clearly defined as tumors with IDH mutations and 1p/19q codeletion by the World Health Organization(WHO)in 2016."", ""supports"": ""SUPPORT""}"
4080	3999	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	0	evidence	0	PMID:39124764	SUPPORT		The pathogenesis of IgAN is considered a multifactorial process involving the formation of immune complexes wherein aberrantly O-glycosylated IgA1 is recognized as an autoantigen.	This 2024 review confirms that aberrantly O-glycosylated IgA1 is central to IgAN pathogenesis and serves as the autoantigen triggering immune complex formation.	"{""explanation"": ""This 2024 review confirms that aberrantly O-glycosylated IgA1 is central to IgAN pathogenesis and serves as the autoantigen triggering immune complex formation."", ""reference"": ""PMID:39124764"", ""snippet"": ""The pathogenesis of IgAN is considered a multifactorial process involving the formation of immune complexes wherein aberrantly O-glycosylated IgA1 is recognized as an autoantigen."", ""supports"": ""SUPPORT""}"
4081	3999	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	0	evidence	1	PMID:22904352	SUPPORT		Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed.	This landmark study establishes that galactose-deficient IgA1 with exposed N-acetylgalactosamine residues is the characteristic molecular abnormality in IgAN.	"{""explanation"": ""This landmark study establishes that galactose-deficient IgA1 with exposed N-acetylgalactosamine residues is the characteristic molecular abnormality in IgAN."", ""reference"": ""PMID:22904352"", ""snippet"": ""Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed."", ""supports"": ""SUPPORT""}"
4082	4000	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	1	evidence	0	PMID:22904352	SUPPORT		Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression.	This study demonstrates that autoantibodies targeting galactose-deficient IgA1 are pathogenic in IgAN and correlate with disease progression.	"{""explanation"": ""This study demonstrates that autoantibodies targeting galactose-deficient IgA1 are pathogenic in IgAN and correlate with disease progression."", ""reference"": ""PMID:22904352"", ""snippet"": ""Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression."", ""supports"": ""SUPPORT""}"
4083	4000	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	1	evidence	1	PMID:38427309	SUPPORT		The O-glycosylation status of IgA1 plays a crucial role in disease pathophysiology. The level of poorly-O-galactosylated IgA1, or galactose-deficient IgA1 (Gd-IgA1), has also been identified as a potential biomarker in IgAN.	This 2024 systematic review confirms that Gd-IgA1 is central to IgAN pathophysiology and serves as the target for autoantibody formation.	"{""explanation"": ""This 2024 systematic review confirms that Gd-IgA1 is central to IgAN pathophysiology and serves as the target for autoantibody formation."", ""reference"": ""PMID:38427309"", ""snippet"": ""The O-glycosylation status of IgA1 plays a crucial role in disease pathophysiology. The level of poorly-O-galactosylated IgA1, or galactose-deficient IgA1 (Gd-IgA1), has also been identified as a potential biomarker in IgAN."", ""supports"": ""SUPPORT""}"
4084	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	evidence	0	PMID:38182298	SUPPORT		Mesangial complement C3 deposits, reflecting alternative and possibly lectin pathway activation, are characteristic in biopsies of patients with IgA nephropathy (IgAN).	This 2024 study confirms that mesangial C3 deposition is a hallmark of IgAN, indicating complement activation triggered by immune complex deposition in the mesangium.	"{""explanation"": ""This 2024 study confirms that mesangial C3 deposition is a hallmark of IgAN, indicating complement activation triggered by immune complex deposition in the mesangium."", ""reference"": ""PMID:38182298"", ""snippet"": ""Mesangial complement C3 deposits, reflecting alternative and possibly lectin pathway activation, are characteristic in biopsies of patients with IgA nephropathy (IgAN)."", ""supports"": ""SUPPORT""}"
4085	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	evidence	1	PMID:38053977	SUPPORT		The alternative complement pathway is the major complement cascade activator in IgAN, and glomerular C3 deposition has been shown to correlate with disease progression.	This comprehensive 2023 review establishes that alternative complement pathway activation in the mesangium drives IgAN progression.	"{""explanation"": ""This comprehensive 2023 review establishes that alternative complement pathway activation in the mesangium drives IgAN progression."", ""reference"": ""PMID:38053977"", ""snippet"": ""The alternative complement pathway is the major complement cascade activator in IgAN, and glomerular C3 deposition has been shown to correlate with disease progression."", ""supports"": ""SUPPORT""}"
4086	4001	168	IgA Nephropathy	IgA_Nephropathy.yaml	pathophysiology	2	evidence	2	PMID:35781866	SUPPORT		Patients with positive glomerular C3 deposition presented with more severe clinical and histopathological characteristics and a higher score on the Oxford scoring system. With the increasing intensity of C3 deposition, IgAN patients were more likely to present with high level of microscopic hematuria, fibrous crescents, interstitial inflammatory cell infiltration, and a higher score on segmental sclerosis lesions.	This study demonstrates that C3 deposition intensity in the mesangium correlates with disease severity and progression, supporting the role of complement-mediated mesangial injury in IgAN pathophysiology.	"{""explanation"": ""This study demonstrates that C3 deposition intensity in the mesangium correlates with disease severity and progression, supporting the role of complement-mediated mesangial injury in IgAN pathophysiology."", ""reference"": ""PMID:35781866"", ""snippet"": ""Patients with positive glomerular C3 deposition presented with more severe clinical and histopathological characteristics and a higher score on the Oxford scoring system. With the increasing intensity of C3 deposition, IgAN patients were more likely to present with high level of microscopic hematuria, fibrous crescents, interstitial inflammatory cell infiltration, and a higher score on segmental sclerosis lesions."", ""supports"": ""SUPPORT""}"
4087	4014	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	0	evidence	0	PMID:38396839	SUPPORT		A better understanding of the underlying pathology has facilitated the development of a number of new targeted therapies (Bruton's tyrosine kinase inhibitors, neonatal Fc receptors, strategies targeting B and plasma cells, strategies targeting T cells, complement inhibitors, and newer TPO-RAs for improving megakaryopoiesis), which seem to be highly effective and well tolerated and result in a significant improvement in patients' quality of life.	This review confirms that autoantibody-mediated platelet destruction is central to ITP pathogenesis, with therapeutic strategies targeting Fc receptors and B cells showing efficacy.	"{""explanation"": ""This review confirms that autoantibody-mediated platelet destruction is central to ITP pathogenesis, with therapeutic strategies targeting Fc receptors and B cells showing efficacy."", ""reference"": ""PMID:38396839"", ""snippet"": ""A better understanding of the underlying pathology has facilitated the development of a number of new targeted therapies (Bruton's tyrosine kinase inhibitors, neonatal Fc receptors, strategies targeting B and plasma cells, strategies targeting T cells, complement inhibitors, and newer TPO-RAs for improving megakaryopoiesis), which seem to be highly effective and well tolerated and result in a significant improvement in patients' quality of life."", ""supports"": ""SUPPORT""}"
4088	4015	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	1	evidence	0	PMID:38525349	SUPPORT		In vitro studies using ITP sera or monoclonal antibodies against platelet and megakaryocyte surface glycoproteins have shown an impairment of many steps of megakaryopoiesis and thrombopoiesis, such as megakaryocyte differentiation and maturation, migration from the osteoblastic to the vascular niche, adhesion to extracellular matrix proteins, and proplatelet formation, resulting in impaired and ectopic platelet production in the bone marrow and diminished platelet release in the bloodstream.	This study demonstrates that ITP autoantibodies directly impair multiple steps of megakaryocyte maturation and platelet production, contributing to thrombocytopenia beyond peripheral destruction.	"{""explanation"": ""This study demonstrates that ITP autoantibodies directly impair multiple steps of megakaryocyte maturation and platelet production, contributing to thrombocytopenia beyond peripheral destruction."", ""reference"": ""PMID:38525349"", ""snippet"": ""In vitro studies using ITP sera or monoclonal antibodies against platelet and megakaryocyte surface glycoproteins have shown an impairment of many steps of megakaryopoiesis and thrombopoiesis, such as megakaryocyte differentiation and maturation, migration from the osteoblastic to the vascular niche, adhesion to extracellular matrix proteins, and proplatelet formation, resulting in impaired and ectopic platelet production in the bone marrow and diminished platelet release in the bloodstream."", ""supports"": ""SUPPORT""}"
4089	4015	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	1	evidence	1	PMID:38525349	SUPPORT		Moreover, cytotoxic T cells may target bone marrow megakaryocytes, resulting in megakaryocyte destruction.	Evidence that cellular immunity, specifically cytotoxic T cells, can directly attack megakaryocytes in the bone marrow, providing a T cell-mediated mechanism for impaired platelet production.	"{""explanation"": ""Evidence that cellular immunity, specifically cytotoxic T cells, can directly attack megakaryocytes in the bone marrow, providing a T cell-mediated mechanism for impaired platelet production."", ""reference"": ""PMID:38525349"", ""snippet"": ""Moreover, cytotoxic T cells may target bone marrow megakaryocytes, resulting in megakaryocyte destruction."", ""supports"": ""SUPPORT""}"
4090	4016	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	2	evidence	0	PMID:37062251	SUPPORT		Studies have shown that an imbalance between T helper 17 (Th17) and Regulatory T (Treg) cells differentiated from CD4+T-cells is a key factor influencing the development and pathogenesis of immune thrombocytopenia. Th17 cells promote the development of chronic inflammatory disorders and induce autoimmune diseases, whereas Treg cells regulate immune homeostasis and prevent autoimmune diseases.	This review establishes that Th17/Treg imbalance is a key pathogenic factor in ITP, with Th17 cells promoting autoimmunity and Treg dysfunction leading to loss of tolerance.	"{""explanation"": ""This review establishes that Th17/Treg imbalance is a key pathogenic factor in ITP, with Th17 cells promoting autoimmunity and Treg dysfunction leading to loss of tolerance."", ""reference"": ""PMID:37062251"", ""snippet"": ""Studies have shown that an imbalance between T helper 17 (Th17) and Regulatory T (Treg) cells differentiated from CD4+T-cells is a key factor influencing the development and pathogenesis of immune thrombocytopenia. Th17 cells promote the development of chronic inflammatory disorders and induce autoimmune diseases, whereas Treg cells regulate immune homeostasis and prevent autoimmune diseases."", ""supports"": ""SUPPORT""}"
4091	4017	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	3	evidence	0	PMID:32515487	SUPPORT		Statistical analyses showed that acute ITP patients had higher plasma levels of sC5b-9 and C1q than CR or PR patients (median = sC5b-9: 200 versus 98 mg/dl, P-value < 0·001) (median C1q = 2·11 versus 1·00 mg/dl, P-value < 0·001). CR and PR ITP patients had sC5b-9 and C1q plasma levels comparable to those observed in healthy volunteers.	This study demonstrates that complement activation markers (sC5b-9 and C1q) are significantly elevated in acute ITP patients compared to patients in remission, and that sC5b-9 levels inversely correlate with platelet count, supporting complement's role in ITP pathogenesis.	"{""explanation"": ""This study demonstrates that complement activation markers (sC5b-9 and C1q) are significantly elevated in acute ITP patients compared to patients in remission, and that sC5b-9 levels inversely correlate with platelet count, supporting complement's role in ITP pathogenesis."", ""reference"": ""PMID:32515487"", ""snippet"": ""Statistical analyses showed that acute ITP patients had higher plasma levels of sC5b-9 and C1q than CR or PR patients (median = sC5b-9: 200 versus 98 mg/dl, P-value < 0·001) (median C1q = 2·11 versus 1·00 mg/dl, P-value < 0·001). CR and PR ITP patients had sC5b-9 and C1q plasma levels comparable to those observed in healthy volunteers."", ""supports"": ""SUPPORT""}"
4092	4017	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	pathophysiology	3	evidence	1	PMID:32515487	SUPPORT		The pathogenesis involves antibody production, cytokine release, T cell impairment, complement activation and clearance of platelets.	This research explicitly identifies complement activation as one of the key pathogenic mechanisms in ITP alongside antibodies and T cell dysfunction.	"{""explanation"": ""This research explicitly identifies complement activation as one of the key pathogenic mechanisms in ITP alongside antibodies and T cell dysfunction."", ""reference"": ""PMID:32515487"", ""snippet"": ""The pathogenesis involves antibody production, cytokine release, T cell impairment, complement activation and clearance of platelets."", ""supports"": ""SUPPORT""}"
4094	4027	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	0	evidence	0	PMID:36675263	SUPPORT		Infectious diseases, which are caused by pathogens such as bacteria, viruses, fungi, and parasites, pose a serious threat to humans, animals, and plants	The abstract defines infectious diseases as caused by pathogenic microorganisms.	"{""explanation"": ""The abstract defines infectious diseases as caused by pathogenic microorganisms."", ""reference"": ""PMID:36675263"", ""snippet"": ""Infectious diseases, which are caused by pathogens such as bacteria, viruses, fungi, and parasites, pose a serious threat to humans, animals, and plants"", ""supports"": ""SUPPORT""}"
4095	4028	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	1	evidence	0	PMID:10884944	SUPPORT		On exposure to a pathogen, a host may resist infection, become subclinically infected, or progress through several stages from mild to severe infection. Chronic sequelae may or may not occur. Host factors, particularly host genes, influence many of these stages.	The abstract describes staged progression and host genetic influence on infectious disease outcomes.	"{""explanation"": ""The abstract describes staged progression and host genetic influence on infectious disease outcomes."", ""reference"": ""PMID:10884944"", ""snippet"": ""On exposure to a pathogen, a host may resist infection, become subclinically infected, or progress through several stages from mild to severe infection. Chronic sequelae may or may not occur. Host factors, particularly host genes, influence many of these stages."", ""supports"": ""SUPPORT""}"
4096	4029	170	Infectious Disease	Infectious_Disease.yaml	pathophysiology	2	evidence	0	PMID:17280841	SUPPORT		Innate immunity relies on signalling by Toll-like receptors (TLRs) to alert the immune system of the presence of invading bacteria. TLR activation leads to the release of cytokines that allow for effective innate and adaptive immune responses.	The abstract links TLR signaling to cytokine release in bacterial infections.	"{""explanation"": ""The abstract links TLR signaling to cytokine release in bacterial infections."", ""reference"": ""PMID:17280841"", ""snippet"": ""Innate immunity relies on signalling by Toll-like receptors (TLRs) to alert the immune system of the presence of invading bacteria. TLR activation leads to the release of cytokines that allow for effective innate and adaptive immune responses."", ""supports"": ""SUPPORT""}"
4099	4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:18252749	SUPPORT		A significant 3.5-fold increase in median numbers of TRPV1-immunoreactive fibres was found in biopsies from IBS patients compared with controls (p<0.0001).	TRPV1-expressing sensory nerve fibers are significantly increased in IBS, providing a molecular basis for visceral hypersensitivity.	"{""explanation"": ""TRPV1-expressing sensory nerve fibers are significantly increased in IBS, providing a molecular basis for visceral hypersensitivity."", ""reference"": ""PMID:18252749"", ""snippet"": ""A significant 3.5-fold increase in median numbers of TRPV1-immunoreactive fibres was found in biopsies from IBS patients compared with controls (p<0.0001)."", ""supports"": ""SUPPORT""}"
4100	4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:18252749	SUPPORT		In multivariate regression analysis, only TRPV1-immuno-reactive fibres (p = 0.005) and mast cells (p = 0.008) were significantly related to the abdominal pain score.	TRPV1 nerve fiber density directly correlates with abdominal pain severity in IBS patients.	"{""explanation"": ""TRPV1 nerve fiber density directly correlates with abdominal pain severity in IBS patients."", ""reference"": ""PMID:18252749"", ""snippet"": ""In multivariate regression analysis, only TRPV1-immuno-reactive fibres (p = 0.005) and mast cells (p = 0.008) were significantly related to the abdominal pain score."", ""supports"": ""SUPPORT""}"
4101	4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:17241857	SUPPORT		Mediators from IBS patients, but not controls, markedly enhanced the firing of mesenteric nerves (14.7 +/- 3.2 imp/sec vs 2.8 +/- 1.5 imp/sec; P < .05) and stimulated mobilization of Ca(2+) in dorsal root ganglia neurons (29% +/- 4% vs 11% +/- 4%; P < .05).	Mucosal mediators from IBS patients directly excite visceral sensory neurons, demonstrating a mechanism for visceral hypersensitivity.	"{""explanation"": ""Mucosal mediators from IBS patients directly excite visceral sensory neurons, demonstrating a mechanism for visceral hypersensitivity."", ""reference"": ""PMID:17241857"", ""snippet"": ""Mediators from IBS patients, but not controls, markedly enhanced the firing of mesenteric nerves (14.7 +/- 3.2 imp/sec vs 2.8 +/- 1.5 imp/sec; P < .05) and stimulated mobilization of Ca(2+) in dorsal root ganglia neurons (29% +/- 4% vs 11% +/- 4%; P < .05)."", ""supports"": ""SUPPORT""}"
4102	4043	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:17241857	SUPPORT		On average, 64% of dorsal root ganglia responsive to mediators were capsaicin-sensitive, known to mediate nociception.	The majority of sensory neurons activated by IBS mucosal mediators are nociceptive, explaining the pain phenotype.	"{""explanation"": ""The majority of sensory neurons activated by IBS mucosal mediators are nociceptive, explaining the pain phenotype."", ""reference"": ""PMID:17241857"", ""snippet"": ""On average, 64% of dorsal root ganglia responsive to mediators were capsaicin-sensitive, known to mediate nociception."", ""supports"": ""SUPPORT""}"
4103	4044	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:15100164	SUPPORT		5-HT release from enterochromaffin (EC) cells initiates peristaltic, secretory, vasodilatory, vagal and nociceptive reflexes.	Serotonin from enterochromaffin cells is a key regulator of intestinal motility and peristaltic reflexes.	"{""explanation"": ""Serotonin from enterochromaffin cells is a key regulator of intestinal motility and peristaltic reflexes."", ""reference"": ""PMID:15100164"", ""snippet"": ""5-HT release from enterochromaffin (EC) cells initiates peristaltic, secretory, vasodilatory, vagal and nociceptive reflexes."", ""supports"": ""SUPPORT""}"
4104	4044	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:15100164	SUPPORT		5-HT directly and indirectly affects intestinal motor and secretory function and abnormalities may lead to either constipation or diarrhea.	Dysregulated serotonin signaling can account for both IBS-D and IBS-C subtypes through effects on motility.	"{""explanation"": ""Dysregulated serotonin signaling can account for both IBS-D and IBS-C subtypes through effects on motility."", ""reference"": ""PMID:15100164"", ""snippet"": ""5-HT directly and indirectly affects intestinal motor and secretory function and abnormalities may lead to either constipation or diarrhea."", ""supports"": ""SUPPORT""}"
4105	4045	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:37048642	SUPPORT		Although the pathophysiology of IBS has not been fully elucidated, it involves dysregulation of communication between the brain and gut (brain-gut axis) which is associated with alterations in intestinal motility, gut permeability, visceral hypersensitivity and gut microbiota composition.	The gut-brain axis is a central organizing principle in IBS pathophysiology, integrating multiple dysfunctional mechanisms.	"{""explanation"": ""The gut-brain axis is a central organizing principle in IBS pathophysiology, integrating multiple dysfunctional mechanisms."", ""reference"": ""PMID:37048642"", ""snippet"": ""Although the pathophysiology of IBS has not been fully elucidated, it involves dysregulation of communication between the brain and gut (brain-gut axis) which is associated with alterations in intestinal motility, gut permeability, visceral hypersensitivity and gut microbiota composition."", ""supports"": ""SUPPORT""}"
4106	4045	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:15100164	SUPPORT		Ongoing, bidirectional brain-gut interactions involving 5-HT pathways occur that significantly influence the effector systems.	Serotonin pathways mediate bidirectional brain-gut communication in IBS.	"{""explanation"": ""Serotonin pathways mediate bidirectional brain-gut communication in IBS."", ""reference"": ""PMID:15100164"", ""snippet"": ""Ongoing, bidirectional brain-gut interactions involving 5-HT pathways occur that significantly influence the effector systems."", ""supports"": ""SUPPORT""}"
4107	4046	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:17593135	SUPPORT		While a subgroup of patients with IBS appears to have evidence of increased intestinal permeability, improvements in the methods and validation are key to further research in this field in order to better understand intestinal barrier functions in IBS.	A subset of IBS patients demonstrate measurable increases in intestinal permeability, though the exact prevalence varies by methodology.	"{""explanation"": ""A subset of IBS patients demonstrate measurable increases in intestinal permeability, though the exact prevalence varies by methodology."", ""reference"": ""PMID:17593135"", ""snippet"": ""While a subgroup of patients with IBS appears to have evidence of increased intestinal permeability, improvements in the methods and validation are key to further research in this field in order to better understand intestinal barrier functions in IBS."", ""supports"": ""SUPPORT""}"
4108	4046	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:19595511	SUPPORT		Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio.	Nearly 40% of IBS-D patients show objective evidence of barrier dysfunction using validated permeability testing.	"{""explanation"": ""Nearly 40% of IBS-D patients show objective evidence of barrier dysfunction using validated permeability testing."", ""reference"": ""PMID:19595511"", ""snippet"": ""Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio."", ""supports"": ""SUPPORT""}"
4109	4046	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	3	evidence	2	PMID:19595511	SUPPORT		A subset of D-IBS patients had increased intestinal membrane permeability that was associated with an increased FBDSI score and increased hypersensitivity to visceral and thermal nociceptive pain stimuli.	Barrier dysfunction in IBS-D correlates with more severe symptoms and heightened visceral sensitivity, linking permeability to clinical phenotype.	"{""explanation"": ""Barrier dysfunction in IBS-D correlates with more severe symptoms and heightened visceral sensitivity, linking permeability to clinical phenotype."", ""reference"": ""PMID:19595511"", ""snippet"": ""A subset of D-IBS patients had increased intestinal membrane permeability that was associated with an increased FBDSI score and increased hypersensitivity to visceral and thermal nociceptive pain stimuli."", ""supports"": ""SUPPORT""}"
4110	4047	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:17241857	SUPPORT		IBS-dependent nerve firing and Ca(2+) mobilization were correlated with the area of the colonic lamina propria occupied by mast cells (r = 0.74; P < .01, and r = 0.78; P < .01, respectively).	Mast cell density directly correlates with sensory neuron activation in IBS, establishing a quantitative relationship.	"{""explanation"": ""Mast cell density directly correlates with sensory neuron activation in IBS, establishing a quantitative relationship."", ""reference"": ""PMID:17241857"", ""snippet"": ""IBS-dependent nerve firing and Ca(2+) mobilization were correlated with the area of the colonic lamina propria occupied by mast cells (r = 0.74; P < .01, and r = 0.78; P < .01, respectively)."", ""supports"": ""SUPPORT""}"
4111	4047	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	4	evidence	1	PMID:17241857	SUPPORT		Mucosal mast cell mediators from IBS patients excite rat nociceptive visceral sensory nerves. These results provide new insights into the mechanism underlying visceral hypersensitivity in IBS.	Mast cell mediators from IBS patients directly activate nociceptive neurons, providing a mechanistic link to pain.	"{""explanation"": ""Mast cell mediators from IBS patients directly activate nociceptive neurons, providing a mechanistic link to pain."", ""reference"": ""PMID:17241857"", ""snippet"": ""Mucosal mast cell mediators from IBS patients excite rat nociceptive visceral sensory nerves. These results provide new insights into the mechanism underlying visceral hypersensitivity in IBS."", ""supports"": ""SUPPORT""}"
4112	4047	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	4	evidence	2	PMID:18252749	SUPPORT		Substance P-immunoreactive fibres (p = 0.01), total nerve fibres (PGP9.5) (p = 0.002), mast cells (c-kit) (p = 0.02) and lymphocytes (CD3) (p = 0.03) were also significantly increased in the IBS group.	Both mast cells and immune cells are increased in IBS mucosa, indicating low-grade immune activation.	"{""explanation"": ""Both mast cells and immune cells are increased in IBS mucosa, indicating low-grade immune activation."", ""reference"": ""PMID:18252749"", ""snippet"": ""Substance P-immunoreactive fibres (p = 0.01), total nerve fibres (PGP9.5) (p = 0.002), mast cells (c-kit) (p = 0.02) and lymphocytes (CD3) (p = 0.03) were also significantly increased in the IBS group."", ""supports"": ""SUPPORT""}"
4113	4048	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:37048642	SUPPORT		It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduced quality of life, decreased work productivity and increased healthcare utilization and costs.	IBS is a common disorder with substantial public health impact, emphasizing the importance of understanding pathophysiological mechanisms including microbiome alterations.	"{""explanation"": ""IBS is a common disorder with substantial public health impact, emphasizing the importance of understanding pathophysiological mechanisms including microbiome alterations."", ""reference"": ""PMID:37048642"", ""snippet"": ""It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduced quality of life, decreased work productivity and increased healthcare utilization and costs."", ""supports"": ""SUPPORT""}"
4123	4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:7874170	SUPPORT	HUMAN_CLINICAL	We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described.	Landmark paper identifying FGFR2 mutations as the cause of Jackson-Weiss syndrome in the original Amish kindred.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark paper identifying FGFR2 mutations as the cause of Jackson-Weiss syndrome in the original Amish kindred."", ""reference"": ""PMID:7874170"", ""snippet"": ""We now report an FGFR2 mutation in the conserved region of the immunoglobulin IIIc domain in the Jackson-Weiss syndrome family in which the syndrome was originally described."", ""supports"": ""SUPPORT""}"
4124	4066	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:9385368	SUPPORT	HUMAN_CLINICAL	Both nucleotide changes predict a serine for cysteine-342 substitution in the second half of the third immunoglobulin-like domain.	Identifies specific FGFR2 mutations in JWS patients affecting the immunoglobulin-like domain critical for receptor function.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Identifies specific FGFR2 mutations in JWS patients affecting the immunoglobulin-like domain critical for receptor function."", ""reference"": ""PMID:9385368"", ""snippet"": ""Both nucleotide changes predict a serine for cysteine-342 substitution in the second half of the third immunoglobulin-like domain."", ""supports"": ""SUPPORT""}"
4151	4089	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:30082241	SUPPORT		Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity. Drug-resistant epilepsy is common, but the prognostic factors and clinical course leading to drug resistance have not been well characterized.	The abstract discusses drug resistance without specifying a particular genetic basis, but it does imply complexity by mentioning the variability in response to treatments and presence of multiple seizure types.	"{""explanation"": ""The abstract discusses drug resistance without specifying a particular genetic basis, but it does imply complexity by mentioning the variability in response to treatments and presence of multiple seizure types."", ""reference"": ""PMID:30082241"", ""snippet"": ""Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity. Drug-resistant epilepsy is common, but the prognostic factors and clinical course leading to drug resistance have not been well characterized."", ""supports"": ""SUPPORT""}"
4152	4090	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:21729035	PARTIAL		We observed two neurophysiologic findings in JS: (1) focal interictal EDs from posterior head region; and (2) predominant focal posterior ictal EDs preceding generalized EDs.	While the study supports an increased excitability of neurons in response to visual stimuli (such as photic stimulation), it does not specifically identify excitatory glutamatergic neurons as the key cell type involved.	"{""explanation"": ""While the study supports an increased excitability of neurons in response to visual stimuli (such as photic stimulation), it does not specifically identify excitatory glutamatergic neurons as the key cell type involved."", ""reference"": ""PMID:21729035"", ""snippet"": ""We observed two neurophysiologic findings in JS: (1) focal interictal EDs from posterior head region; and (2) predominant focal posterior ictal EDs preceding generalized EDs."", ""supports"": ""PARTIAL""}"
4153	4090	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:31444362	NO_EVIDENCE		The transition from a preictal state to a generalized seizure leads to an abrupt increase in neural activity and connectivity, which is accompanied by a strong alteration in glia-neuron interactions and a massive increase in extracellular glutamate.	This study discusses neural activity and connectivity alterations and increased extracellular glutamate during seizures but does not specifically associate these findings with Jeavons Syndrome.	"{""explanation"": ""This study discusses neural activity and connectivity alterations and increased extracellular glutamate during seizures but does not specifically associate these findings with Jeavons Syndrome."", ""reference"": ""PMID:31444362"", ""snippet"": ""The transition from a preictal state to a generalized seizure leads to an abrupt increase in neural activity and connectivity, which is accompanied by a strong alteration in glia-neuron interactions and a massive increase in extracellular glutamate."", ""supports"": ""NO_EVIDENCE""}"
4154	4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:21729035	PARTIAL		JS has been proposed as idiopathic generalized epilepsy (IGE) because of normal posterior dominant background activity and paroxysmal generalized ictal epileptiform discharges (EDs). However, we noticed subtle occipital EDs preceding EM and interictal posterior EDs using digital video-EEG... Further clinical observations of seizures induced by eye closure, photic stimulation, and hyperventilation along with EEG paroxysms would raise the possibility of the occipital cortex initiating generalized epilepsy network involving the brainstem, and thalamocortical and transcortical pathways in JS.	The literature indicates involvement of the occipital cortex and mentions generalized epilepsy networks, which may include the thalamus. However, it does not explicitly support the claim that disruptions in the visual cortex and thalamus are the predominant mechanisms in Jeavons Syndrome.	"{""explanation"": ""The literature indicates involvement of the occipital cortex and mentions generalized epilepsy networks, which may include the thalamus. However, it does not explicitly support the claim that disruptions in the visual cortex and thalamus are the predominant mechanisms in Jeavons Syndrome."", ""reference"": ""PMID:21729035"", ""snippet"": ""JS has been proposed as idiopathic generalized epilepsy (IGE) because of normal posterior dominant background activity and paroxysmal generalized ictal epileptiform discharges (EDs). However, we noticed subtle occipital EDs preceding EM and interictal posterior EDs using digital video-EEG... Further clinical observations of seizures induced by eye closure, photic stimulation, and hyperventilation along with EEG paroxysms would raise the possibility of the occipital cortex initiating generalized epilepsy network involving the brainstem, and thalamocortical and transcortical pathways in JS."", ""supports"": ""PARTIAL""}"
4155	4091	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:29880477	NO_EVIDENCE		Largely accepted in the literature is the role the interconnections between the thalamus and cortex play in generalized epilepsy. However, thalamocortical involvement is less understood in focal epilepsy in terms of the effect of seizures on thalamocortical circuitry in the developing brain and subsequent cognitive outcome.	This study discusses the role of thalamocortical connections in generalized and focal epilepsy but does not provide specific information on Jeavons Syndrome or its mechanisms.	"{""explanation"": ""This study discusses the role of thalamocortical connections in generalized and focal epilepsy but does not provide specific information on Jeavons Syndrome or its mechanisms."", ""reference"": ""PMID:29880477"", ""snippet"": ""Largely accepted in the literature is the role the interconnections between the thalamus and cortex play in generalized epilepsy. However, thalamocortical involvement is less understood in focal epilepsy in terms of the effect of seizures on thalamocortical circuitry in the developing brain and subsequent cognitive outcome."", ""supports"": ""NO_EVIDENCE""}"
4186	4114	174	KIT Mutant Melanoma	KIT_Mutant_Melanoma.yaml	pathophysiology	0	evidence	0	PMID:41042158	SUPPORT		Mutation of c-KIT has been observed in acral, mucosal, and chronically sun-damaged melanoma subtypes marking it as a key therapeutic target for melanoma.	This abstract documents c-KIT mutations in melanoma subtypes associated with KIT-mutant disease.	"{""explanation"": ""This abstract documents c-KIT mutations in melanoma subtypes associated with KIT-mutant disease."", ""reference"": ""PMID:41042158"", ""snippet"": ""Mutation of c-KIT has been observed in acral, mucosal, and chronically sun-damaged melanoma subtypes marking it as a key therapeutic target for melanoma."", ""supports"": ""SUPPORT""}"
4189	4133	175	KRAS G12C-Mutant Non-Small Cell Lung Cancer	KRAS_G12C_Mutant_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:33618059	SUPPORT		The KRAS glycine-to-cysteine mutation (G12C) composes approximately 44% of KRAS mutations in non-small cell lung cancer, with mutant KRasG12C present in approximately 13% of all patients with lung adenocarcinoma.	This abstract explicitly describes the KRAS G12C substitution and its frequency in NSCLC, supporting the oncogenic mutation context.	"{""explanation"": ""This abstract explicitly describes the KRAS G12C substitution and its frequency in NSCLC, supporting the oncogenic mutation context."", ""reference"": ""PMID:33618059"", ""snippet"": ""The KRAS glycine-to-cysteine mutation (G12C) composes approximately 44% of KRAS mutations in non-small cell lung cancer, with mutant KRasG12C present in approximately 13% of all patients with lung adenocarcinoma."", ""supports"": ""SUPPORT""}"
4194	4154	176	Kaposi Sarcoma	Kaposi_Sarcoma.yaml	pathophysiology	0	evidence	0	PMID:7489408	SUPPORT		KSHV/HHV-8 is present in the flat endothelial cells lining vascular spaces of KS lesions as well as in typical KS spindle cells.	Abstract reports HHV-8 presence in endothelial and spindle cells in KS lesions.	"{""explanation"": ""Abstract reports HHV-8 presence in endothelial and spindle cells in KS lesions."", ""reference"": ""PMID:7489408"", ""snippet"": ""KSHV/HHV-8 is present in the flat endothelial cells lining vascular spaces of KS lesions as well as in typical KS spindle cells."", ""supports"": ""SUPPORT""}"
4210	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:21447126	SUPPORT		Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate.	This reference directly establishes the mechanistic link between coronary arteritis and aneurysm formation through structural damage.	"{""explanation"": ""This reference directly establishes the mechanistic link between coronary arteritis and aneurysm formation through structural damage."", ""reference"": ""PMID:21447126"", ""snippet"": ""Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate."", ""supports"": ""SUPPORT""}"
4211	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	0	PMID:23188196	SUPPORT		Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries.	The literature confirms that Kawasaki disease involves widespread inflammation of medium-sized arteries, including coronary arteries.	"{""explanation"": ""The literature confirms that Kawasaki disease involves widespread inflammation of medium-sized arteries, including coronary arteries."", ""reference"": ""PMID:23188196"", ""snippet"": ""Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries."", ""supports"": ""SUPPORT""}"
4212	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	1	PMID:31599798	SUPPORT		Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA).	The literature supports that Kawasaki disease leads to vascular inflammation and aneurysm formation.	"{""explanation"": ""The literature supports that Kawasaki disease leads to vascular inflammation and aneurysm formation."", ""reference"": ""PMID:31599798"", ""snippet"": ""Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA)."", ""supports"": ""SUPPORT""}"
4213	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	2	PMID:27090101	SUPPORT		Coronary angiography showed multiple aneurysms which suggested sequelae of misdiagnosed Kawasaki disease.	The case report indicates that Kawasaki disease can lead to aneurysm formation as a result of vascular inflammation.	"{""explanation"": ""The case report indicates that Kawasaki disease can lead to aneurysm formation as a result of vascular inflammation."", ""reference"": ""PMID:27090101"", ""snippet"": ""Coronary angiography showed multiple aneurysms which suggested sequelae of misdiagnosed Kawasaki disease."", ""supports"": ""SUPPORT""}"
4214	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	3	PMID:36102118	SUPPORT		Long-term physiological dysfunction in coronary/systemic vasculature may persist in individuals with Kawasaki disease even in the absence of coronary artery abnormalities.	The literature suggests long-term vascular dysfunction due to Kawasaki disease, supporting the idea of widespread vascular inflammation.	"{""explanation"": ""The literature suggests long-term vascular dysfunction due to Kawasaki disease, supporting the idea of widespread vascular inflammation."", ""reference"": ""PMID:36102118"", ""snippet"": ""Long-term physiological dysfunction in coronary/systemic vasculature may persist in individuals with Kawasaki disease even in the absence of coronary artery abnormalities."", ""supports"": ""SUPPORT""}"
4215	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	4	PMID:35420684	SUPPORT		Kawasaki disease, an acute febrile illness, can cause vasculitis in the coronary arteries.	The literature confirms that Kawasaki disease causes inflammation in coronary arteries, leading to complications such as aneurysms.	"{""explanation"": ""The literature confirms that Kawasaki disease causes inflammation in coronary arteries, leading to complications such as aneurysms."", ""reference"": ""PMID:35420684"", ""snippet"": ""Kawasaki disease, an acute febrile illness, can cause vasculitis in the coronary arteries."", ""supports"": ""SUPPORT""}"
4216	4196	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	0	evidence	5	PMID:16990356	SUPPORT		Kawasaki disease is an acute inflammatory syndrome that takes the form of systemic vasculitis, and predominantly affects children. Important complications of this disease are coronary artery dilation and aneurysm formation.	The literature supports the statement that Kawasaki disease involves widespread vascular inflammation and aneurysm formation.	"{""explanation"": ""The literature supports the statement that Kawasaki disease involves widespread vascular inflammation and aneurysm formation."", ""reference"": ""PMID:16990356"", ""snippet"": ""Kawasaki disease is an acute inflammatory syndrome that takes the form of systemic vasculitis, and predominantly affects children. Important complications of this disease are coronary artery dilation and aneurysm formation."", ""supports"": ""SUPPORT""}"
4217	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	evidence	0	PMID:34890998	SUPPORT		Increasing evidence shows that the pathogenesis of Kawasaki disease (KD) is caused by abnormal and unbalanced innate and adaptive immune responses.	The literature supports the statement that Kawasaki Disease is characterized by immune response dysregulation leading to vessel wall damage and inflammation.	"{""explanation"": ""The literature supports the statement that Kawasaki Disease is characterized by immune response dysregulation leading to vessel wall damage and inflammation."", ""reference"": ""PMID:34890998"", ""snippet"": ""Increasing evidence shows that the pathogenesis of Kawasaki disease (KD) is caused by abnormal and unbalanced innate and adaptive immune responses."", ""supports"": ""SUPPORT""}"
4218	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	evidence	1	PMID:30183655	SUPPORT		Kawasaki disease (KD) is a vasculitis that is part of systemic vasculitis syndrome. It affects medium-sized vessels and is characterized by hypercytokinemia.	This reference supports that KD involves immune dysregulation leading to vessel wall damage.	"{""explanation"": ""This reference supports that KD involves immune dysregulation leading to vessel wall damage."", ""reference"": ""PMID:30183655"", ""snippet"": ""Kawasaki disease (KD) is a vasculitis that is part of systemic vasculitis syndrome. It affects medium-sized vessels and is characterized by hypercytokinemia."", ""supports"": ""SUPPORT""}"
4219	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	evidence	2	PMID:30619331	SUPPORT		Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue.	This supports the notion of an abnormal immune response leading to vessel wall damage in KD.	"{""explanation"": ""This supports the notion of an abnormal immune response leading to vessel wall damage in KD."", ""reference"": ""PMID:30619331"", ""snippet"": ""Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue."", ""supports"": ""SUPPORT""}"
4220	4197	177	Kawasaki Disease	Kawasaki_Disease.yaml	pathophysiology	1	evidence	3	PMID:39117827	SUPPORT		Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis, extremity changes, and cervical lymphadenopathy.	This reference supports the statement by describing KD as a hyperinflammatory syndrome, which involves immune dysregulation.	"{""explanation"": ""This reference supports the statement by describing KD as a hyperinflammatory syndrome, which involves immune dysregulation."", ""reference"": ""PMID:39117827"", ""snippet"": ""Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis, extremity changes, and cervical lymphadenopathy."", ""supports"": ""SUPPORT""}"
4283	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:10369869	SUPPORT		"Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.
"	Demonstrates that GJB2 mutations lead to impaired epidermal differentiation.	"{""explanation"": ""Demonstrates that GJB2 mutations lead to impaired epidermal differentiation."", ""reference"": ""PMID:10369869"", ""snippet"": ""Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.\n"", ""supports"": ""SUPPORT""}"
4284	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	downstream[1].evidence	0	PMID:10369869	SUPPORT		"Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).
"	Establishes the causal link between GJB2 mutations and hearing loss.	"{""explanation"": ""Establishes the causal link between GJB2 mutations and hearing loss."", ""reference"": ""PMID:10369869"", ""snippet"": ""Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).\n"", ""supports"": ""SUPPORT""}"
4285	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	evidence	0	PMID:10369869	SUPPORT		"This mutation occurs at a highly conserved residue in the first extracellular domain of the Cx26 molecule, and may exert its effects by interfering with assembly into connexons, docking with adjacent cells or gating properties of the gap junction.
"	Describes the molecular mechanism of GJB2 D66H mutation disrupting gap junction function.	"{""explanation"": ""Describes the molecular mechanism of GJB2 D66H mutation disrupting gap junction function."", ""reference"": ""PMID:10369869"", ""snippet"": ""This mutation occurs at a highly conserved residue in the first extracellular domain of the Cx26 molecule, and may exert its effects by interfering with assembly into connexons, docking with adjacent cells or gating properties of the gap junction.\n"", ""supports"": ""SUPPORT""}"
4286	4223	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	0	evidence	1	PMID:14681042	SUPPORT	MODEL_ORGANISM	"Expression of the transgene resulted in a loss of Cx26 and Cx30 at intercellular junctions of epidermal keratinocytes and accumulation of these connexins in the cytoplasm.
"	Transgenic mouse model demonstrates that D66H mutation causes loss of connexins at cell junctions.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mouse model demonstrates that D66H mutation causes loss of connexins at cell junctions."", ""reference"": ""PMID:14681042"", ""snippet"": ""Expression of the transgene resulted in a loss of Cx26 and Cx30 at intercellular junctions of epidermal keratinocytes and accumulation of these connexins in the cytoplasm.\n"", ""supports"": ""SUPPORT""}"
4287	4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:10369869	SUPPORT		"VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation
"	Links the keratoderma phenotype to digital constriction and autoamputation.	"{""explanation"": ""Links the keratoderma phenotype to digital constriction and autoamputation."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}"
4288	4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	evidence	0	PMID:10369869	SUPPORT		"Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.
"	Establishes that GJB2 mutations affect both epidermal and cochlear function.	"{""explanation"": ""Establishes that GJB2 mutations affect both epidermal and cochlear function."", ""reference"": ""PMID:10369869"", ""snippet"": ""Our results provide evidence that a specific mutation in Cx26 can impair epidermal differentiation, as well as inner ear function.\n"", ""supports"": ""SUPPORT""}"
4289	4224	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	1	evidence	1	PMID:14681042	SUPPORT	MODEL_ORGANISM	"Following birth, the transgenic mice developed keratoderma similar to that of human carriers of Cx26 (D66H).
"	Transgenic mice expressing mutant Cx26 develop keratoderma like human patients.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mice expressing mutant Cx26 develop keratoderma like human patients."", ""reference"": ""PMID:14681042"", ""snippet"": ""Following birth, the transgenic mice developed keratoderma similar to that of human carriers of Cx26 (D66H).\n"", ""supports"": ""SUPPORT""}"
4290	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	downstream[0].evidence	0	PMID:12072018	SUPPORT		"the accumulation of mutant loricrin in the nucleus appears to interfere with the later stages of epidermal differentiation, thereby explaining the clinical manifestations of ichthyosis, keratoderma and pseudoainhum.
"	Establishes the mechanistic link between loricrin nuclear accumulation and pseudoainhum.	"{""explanation"": ""Establishes the mechanistic link between loricrin nuclear accumulation and pseudoainhum."", ""reference"": ""PMID:12072018"", ""snippet"": ""the accumulation of mutant loricrin in the nucleus appears to interfere with the later stages of epidermal differentiation, thereby explaining the clinical manifestations of ichthyosis, keratoderma and pseudoainhum.\n"", ""supports"": ""SUPPORT""}"
4291	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	evidence	0	PMID:11121146	SUPPORT		"Mutant loricrin, as a dominant negative disrupter, is not likely to affect cornified cell envelope crosslinking directly, but seems to interfere with nuclear/nucleolar functions of differentiating keratinocytes.
"	Describes the mechanism by which mutant loricrin causes disease through nuclear interference.	"{""explanation"": ""Describes the mechanism by which mutant loricrin causes disease through nuclear interference."", ""reference"": ""PMID:11121146"", ""snippet"": ""Mutant loricrin, as a dominant negative disrupter, is not likely to affect cornified cell envelope crosslinking directly, but seems to interfere with nuclear/nucleolar functions of differentiating keratinocytes.\n"", ""supports"": ""SUPPORT""}"
4292	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	evidence	1	PMID:9326398	SUPPORT		"a G insertion producing a frameshift after codon 231 and an abnormal C-terminal peptide lacking residues necessary for cross-linking.
"	Identifies the specific mutation and its effect on loricrin protein structure.	"{""explanation"": ""Identifies the specific mutation and its effect on loricrin protein structure."", ""reference"": ""PMID:9326398"", ""snippet"": ""a G insertion producing a frameshift after codon 231 and an abnormal C-terminal peptide lacking residues necessary for cross-linking.\n"", ""supports"": ""SUPPORT""}"
4293	4225	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	2	evidence	2	PMID:11038186	SUPPORT	MODEL_ORGANISM	"Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope.
"	Transgenic mouse studies confirm nuclear mislocalization of mutant loricrin.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mouse studies confirm nuclear mislocalization of mutant loricrin."", ""reference"": ""PMID:11038186"", ""snippet"": ""Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope.\n"", ""supports"": ""SUPPORT""}"
4294	4226	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	3	evidence	0	PMID:10369869	SUPPORT		"VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation
"	Describes the progression from constricting bands to autoamputation.	"{""explanation"": ""Describes the progression from constricting bands to autoamputation."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}"
4295	4227	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	4	evidence	0	PMID:10369869	SUPPORT		"Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).
"	Establishes the role of GJB2 in both skin and hearing phenotypes.	"{""explanation"": ""Establishes the role of GJB2 in both skin and hearing phenotypes."", ""reference"": ""PMID:10369869"", ""snippet"": ""Mutations in the connexin26 (Cx26) gene (GJB2) at 13q11-q13 are a major cause of autosomal recessive hearing loss (DFNB1), but have also been reported in autosomal dominant deafness (DFNA3).\n"", ""supports"": ""SUPPORT""}"
4296	4227	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	pathophysiology	4	evidence	1	PMID:9326398	SUPPORT		"In our second family (VK2), affected members had sensorineural deafness but not ichthyosis.
"	Confirms that deafness segregates with connexin mutations, not loricrin mutations.	"{""explanation"": ""Confirms that deafness segregates with connexin mutations, not loricrin mutations."", ""reference"": ""PMID:9326398"", ""snippet"": ""In our second family (VK2), affected members had sensorineural deafness but not ichthyosis.\n"", ""supports"": ""SUPPORT""}"
4331	4252	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:17062147	SUPPORT		The term Klinefelter syndrome (KS) describes a group of chromosomal disorder in which there is at least one extra X chromosome to a normal male karyotype, 46,XY. XXY aneuploidy is the most common disorder of sex chromosomes in humans, with prevalence of one in 500 males.	The extra X chromosome results in the 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues.	"{""explanation"": ""The extra X chromosome results in the 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues."", ""reference"": ""PMID:17062147"", ""snippet"": ""The term Klinefelter syndrome (KS) describes a group of chromosomal disorder in which there is at least one extra X chromosome to a normal male karyotype, 46,XY. XXY aneuploidy is the most common disorder of sex chromosomes in humans, with prevalence of one in 500 males."", ""supports"": ""SUPPORT""}"
4332	4252	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:32484281	SUPPORT		Since the first description of Klinefelter syndrome (KS) was published in 1942...large inter-individual variability in the phenotypic presentation has been demonstrated... Evidence from the existing literature of KS indicates that not just one single genetic mechanism can explain the phenotype and the variable expressivity.	This indicates that the presence of an extra X chromosome (47,XXY karyotype) leads to a variety of physical, developmental, and reproductive issues.	"{""explanation"": ""This indicates that the presence of an extra X chromosome (47,XXY karyotype) leads to a variety of physical, developmental, and reproductive issues."", ""reference"": ""PMID:32484281"", ""snippet"": ""Since the first description of Klinefelter syndrome (KS) was published in 1942...large inter-individual variability in the phenotypic presentation has been demonstrated... Evidence from the existing literature of KS indicates that not just one single genetic mechanism can explain the phenotype and the variable expressivity."", ""supports"": ""SUPPORT""}"
4333	4252	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:25899809	SUPPORT		Klinefelter syndrome is the most common sex-chromosome disorder in humans, affecting one in 660 men. The key findings in Klinefelter syndrome are small testes, hypergonadotropic hypogonadism and cognitive impairment.	These physical and developmental issues are a result of the 47,XXY karyotype.	"{""explanation"": ""These physical and developmental issues are a result of the 47,XXY karyotype."", ""reference"": ""PMID:25899809"", ""snippet"": ""Klinefelter syndrome is the most common sex-chromosome disorder in humans, affecting one in 660 men. The key findings in Klinefelter syndrome are small testes, hypergonadotropic hypogonadism and cognitive impairment."", ""supports"": ""SUPPORT""}"
4367	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	evidence	0	PMID:8723084	SUPPORT	HUMAN_CLINICAL	"Pathologic findings included a disorganized physeal growth plate, soft crumbly cartilage with a ""Swiss-cheese"" appearance, and diastase resistant intracytoplasmic inclusions in the resting chondrocytes. Transmission electronmicroscopy showed dilated cisternae of rough endoplasmic reticulum with finely granular material of accumulated protein. Scanning electronmicroscopy documented striking fragmentation and disintegration of collagen fibrils resulting in a web-like pattern and large open cyst-like spaces, and deficiency and disorganization of the collagen fibrils."	This study documents the characteristic Swiss-cheese cartilage appearance and demonstrates collagen fibril disorganization and fragmentation in Kniest dysplasia, supporting the pathophysiology description.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents the characteristic Swiss-cheese cartilage appearance and demonstrates collagen fibril disorganization and fragmentation in Kniest dysplasia, supporting the pathophysiology description."", ""reference"": ""PMID:8723084"", ""snippet"": ""Pathologic findings included a disorganized physeal growth plate, soft crumbly cartilage with a \""Swiss-cheese\"" appearance, and diastase resistant intracytoplasmic inclusions in the resting chondrocytes. Transmission electronmicroscopy showed dilated cisternae of rough endoplasmic reticulum with finely granular material of accumulated protein. Scanning electronmicroscopy documented striking fragmentation and disintegration of collagen fibrils resulting in a web-like pattern and large open cyst-like spaces, and deficiency and disorganization of the collagen fibrils."", ""supports"": ""SUPPORT""}"
4368	4278	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	pathophysiology	0	evidence	1	PMID:3276736	SUPPORT	HUMAN_CLINICAL	In each case collagen fibril organization appeared abnormal by electron microscopy compared with age-matched normal cartilages: fibrils were much thinner, of irregular shape and did not exhibit the characteristic banding pattern. This was associated with the absence (compared with normal cartilage) of the C-propeptide of type II collagen (chondrocalcin) from the extracellular matrix of epiphyseal cartilages.	This study demonstrates abnormal collagen fibril organization in Kniest dysplasia cartilage, with thinner fibrils lacking normal banding pattern and absence of C-propeptide from extracellular matrix.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study demonstrates abnormal collagen fibril organization in Kniest dysplasia cartilage, with thinner fibrils lacking normal banding pattern and absence of C-propeptide from extracellular matrix."", ""reference"": ""PMID:3276736"", ""snippet"": ""In each case collagen fibril organization appeared abnormal by electron microscopy compared with age-matched normal cartilages: fibrils were much thinner, of irregular shape and did not exhibit the characteristic banding pattern. This was associated with the absence (compared with normal cartilage) of the C-propeptide of type II collagen (chondrocalcin) from the extracellular matrix of epiphyseal cartilages."", ""supports"": ""SUPPORT""}"
4386	4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:35912848	SUPPORT		Celiac disease (CD) and IPH diagnosis was made concurrently in 46 patients, whereas in 21 patients, the diagnosis of LHS was delayed for 2.5y (3 months-11 years).	Literature review documents the coexistence of celiac disease and pulmonary hemosiderosis in Lane-Hamilton syndrome	"{""explanation"": ""Literature review documents the coexistence of celiac disease and pulmonary hemosiderosis in Lane-Hamilton syndrome"", ""reference"": ""PMID:35912848"", ""snippet"": ""Celiac disease (CD) and IPH diagnosis was made concurrently in 46 patients, whereas in 21 patients, the diagnosis of LHS was delayed for 2.5y (3 months-11 years)."", ""supports"": ""SUPPORT""}"
4387	4304	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:35088581	SUPPORT		Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology. Several hypothetical mechanisms have been proposed to unify the coexistence of these two entities, also referred to as Lane-Hamilton syndrome (LHS).	Scoping review documents the association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients	"{""explanation"": ""Scoping review documents the association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients"", ""reference"": ""PMID:35088581"", ""snippet"": ""Nearly one-third of pediatric patients with IPH test positive for Celiac disease (CD) serology. Several hypothetical mechanisms have been proposed to unify the coexistence of these two entities, also referred to as Lane-Hamilton syndrome (LHS)."", ""supports"": ""SUPPORT""}"
4388	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:37416498	SUPPORT		The co-existence of idiopathic hemosiderosis and celiac disease is Lane-Hamilton Syndrome. This is a rare condition with only a few dozen cases reported to date.	Review article describes Lane-Hamilton syndrome as the coexistence of pulmonary hemosiderosis and celiac disease	"{""explanation"": ""Review article describes Lane-Hamilton syndrome as the coexistence of pulmonary hemosiderosis and celiac disease"", ""reference"": ""PMID:37416498"", ""snippet"": ""The co-existence of idiopathic hemosiderosis and celiac disease is Lane-Hamilton Syndrome. This is a rare condition with only a few dozen cases reported to date."", ""supports"": ""SUPPORT""}"
4389	4305	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:34708697	SUPPORT		The association of pulmonary hemosiderosis with celiac disease (Lane-Hamilton syndrome) is extremely rare.	Clinical analysis documents Lane-Hamilton syndrome as an association between pulmonary hemosiderosis and celiac disease	"{""explanation"": ""Clinical analysis documents Lane-Hamilton syndrome as an association between pulmonary hemosiderosis and celiac disease"", ""reference"": ""PMID:34708697"", ""snippet"": ""The association of pulmonary hemosiderosis with celiac disease (Lane-Hamilton syndrome) is extremely rare."", ""supports"": ""SUPPORT""}"
4390	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:36241572	SUPPORT		Lane-Hamilton syndrome: A rare cause of recurrent alveolar hemorrhage in an adult	Case report identifies Lane-Hamilton syndrome as a cause of recurrent alveolar hemorrhage in adult patients	"{""explanation"": ""Case report identifies Lane-Hamilton syndrome as a cause of recurrent alveolar hemorrhage in adult patients"", ""reference"": ""PMID:36241572"", ""snippet"": ""Lane-Hamilton syndrome: A rare cause of recurrent alveolar hemorrhage in an adult"", ""supports"": ""SUPPORT""}"
4391	4306	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:35754673	SUPPORT		HRCT of the chest and duodenal biopsy helped in concluding the diagnosis	Case report documents diagnostic findings in alveolar hemorrhage including HRCT imaging and biopsy results	"{""explanation"": ""Case report documents diagnostic findings in alveolar hemorrhage including HRCT imaging and biopsy results"", ""reference"": ""PMID:35754673"", ""snippet"": ""HRCT of the chest and duodenal biopsy helped in concluding the diagnosis"", ""supports"": ""SUPPORT""}"
4392	4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:36324124	SUPPORT			Review of updates in idiopathic pulmonary hemosiderosis in 2022 discusses chronic sequelae of recurrent hemorrhage and oxidative injury	"{""explanation"": ""Review of updates in idiopathic pulmonary hemosiderosis in 2022 discusses chronic sequelae of recurrent hemorrhage and oxidative injury"", ""reference"": ""PMID:36324124"", ""supports"": ""SUPPORT""}"
4393	4307	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:34401285	PARTIAL			Case report of Lane-Hamilton syndrome with concurrent idiopathic membranous nephropathy suggests systemic immune-mediated complications	"{""explanation"": ""Case report of Lane-Hamilton syndrome with concurrent idiopathic membranous nephropathy suggests systemic immune-mediated complications"", ""reference"": ""PMID:34401285"", ""supports"": ""PARTIAL""}"
4424	4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	evidence	0	DOI:10.1186/s40792-023-01650-7	SUPPORT	HUMAN_CLINICAL	LTEC occurs because of foregut maldevelopment	Case report links LTEC to foregut maldevelopment, supporting failed partitioning.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report links LTEC to foregut maldevelopment, supporting failed partitioning."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""LTEC occurs because of foregut maldevelopment"", ""supports"": ""SUPPORT""}"
4425	4336	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	0	evidence	1	PMID:38380453	SUPPORT	HUMAN_CLINICAL	failure of separation of the trachea and the oesophagus during fetal development	Case report reiterates fetal failure of trachea-esophagus separation in LTEC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report reiterates fetal failure of trachea-esophagus separation in LTEC."", ""reference"": ""PMID:38380453"", ""snippet"": ""failure of separation of the trachea and the oesophagus during fetal development"", ""supports"": ""SUPPORT""}"
4426	4337	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	1	evidence	0	PMID:37230380	SUPPORT	MODEL_ORGANISM	Disruption of BMP4 signaling is associated with laryngeal birth defects in a mouse model.	Mouse model demonstrates association of disrupted BMP4 signaling with laryngeal cleft.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mouse model demonstrates association of disrupted BMP4 signaling with laryngeal cleft."", ""reference"": ""PMID:37230380"", ""snippet"": ""Disruption of BMP4 signaling is associated with laryngeal birth defects in a mouse model."", ""supports"": ""SUPPORT""}"
4427	4338	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	2	evidence	0	DOI:10.1186/s40792-023-01650-7	SUPPORT	HUMAN_CLINICAL	Laryngotracheoesophageal cleft (LTEC) is a rare disease in which the larynx and trachea communicate posteriorly to the esophagus.	Case report defines LTEC as a posterior larynx/trachea communication with the esophagus.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report defines LTEC as a posterior larynx/trachea communication with the esophagus."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""Laryngotracheoesophageal cleft (LTEC) is a rare disease in which the larynx and trachea communicate posteriorly to the esophagus."", ""supports"": ""SUPPORT""}"
4428	4339	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	3	evidence	0	DOI:10.1186/s40792-023-01650-7	SUPPORT	HUMAN_CLINICAL	LTEC occurs because of foregut maldevelopment	Case report links LTEC to foregut maldevelopment.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report links LTEC to foregut maldevelopment."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""LTEC occurs because of foregut maldevelopment"", ""supports"": ""SUPPORT""}"
4429	4340	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	pathophysiology	4	evidence	0	DOI:10.1038/s41598-024-53098-w	SUPPORT	COMPUTATIONAL	the genes associated with esophageal malformations show their highest cell-type specific expression in lateral plate mesoderm cells and at the developmental stage of E8.75–E9.0 days.	Single-cell atlas analysis highlights lateral plate mesoderm enrichment of esophageal malformation genes.	"{""evidence_source"": ""COMPUTATIONAL"", ""explanation"": ""Single-cell atlas analysis highlights lateral plate mesoderm enrichment of esophageal malformation genes."", ""reference"": ""DOI:10.1038/s41598-024-53098-w"", ""snippet"": ""the genes associated with esophageal malformations show their highest cell-type specific expression in lateral plate mesoderm cells and at the developmental stage of E8.75–E9.0 days."", ""supports"": ""SUPPORT""}"
4469	4366	183	Leishmaniasis	Leishmaniasis.yaml	pathophysiology	0	evidence	0	PMID:33968798	SUPPORT		Inside vertebrate host macrophages, the parasites can differentiate into the amastigote form and multiply	The abstract describes amastigote differentiation and replication in macrophages.	"{""explanation"": ""The abstract describes amastigote differentiation and replication in macrophages."", ""reference"": ""PMID:33968798"", ""snippet"": ""Inside vertebrate host macrophages, the parasites can differentiate into the amastigote form and multiply"", ""supports"": ""SUPPORT""}"
4474	4371	184	Leprosy	Leprosy.yaml	pathophysiology	0	evidence	0	PMID:28763601	SUPPORT		The pathogen primarily affects the skin and peripheral nervous system.	The abstract states primary involvement of skin and peripheral nerves.	"{""explanation"": ""The abstract states primary involvement of skin and peripheral nerves."", ""reference"": ""PMID:28763601"", ""snippet"": ""The pathogen primarily affects the skin and peripheral nervous system."", ""supports"": ""SUPPORT""}"
4475	4372	184	Leprosy	Leprosy.yaml	pathophysiology	1	evidence	0	PMID:11791665	SUPPORT		The bacteria have affinity to the peripheral nerves and are likely to cause neuropathy.	The abstract notes affinity for peripheral nerves and neuropathy.	"{""explanation"": ""The abstract notes affinity for peripheral nerves and neuropathy."", ""reference"": ""PMID:11791665"", ""snippet"": ""The bacteria have affinity to the peripheral nerves and are likely to cause neuropathy."", ""supports"": ""SUPPORT""}"
4485	4398	186	Lichen Simplex Chronicus	Lichen_Simplex_Chronicus.yaml	pathophysiology	0	evidence	0	PMID:40855389	SUPPORT		The hallmark itch-scratch cycle contributes not only to visible skin changes but also to substantial sleep disruption, emotional distress, and functional impairment.	The review identifies the itch-scratch cycle as a central driver of chronic disease manifestations.	"{""explanation"": ""The review identifies the itch-scratch cycle as a central driver of chronic disease manifestations."", ""reference"": ""PMID:40855389"", ""snippet"": ""The hallmark itch-scratch cycle contributes not only to visible skin changes but also to substantial sleep disruption, emotional distress, and functional impairment."", ""supports"": ""SUPPORT""}"
4487	4417	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	0	evidence	0	PMID:39063116	SUPPORT		Chronic liver injury leads to liver inflammation and fibrosis (LF) as critical determinants of long-term outcomes such as cirrhosis, liver cancer, and mortality.	This review establishes that chronic liver injury is the initiating event leading to inflammation and fibrosis in cirrhosis development.	"{""explanation"": ""This review establishes that chronic liver injury is the initiating event leading to inflammation and fibrosis in cirrhosis development."", ""reference"": ""PMID:39063116"", ""snippet"": ""Chronic liver injury leads to liver inflammation and fibrosis (LF) as critical determinants of long-term outcomes such as cirrhosis, liver cancer, and mortality."", ""supports"": ""SUPPORT""}"
4488	4418	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	1	evidence	0	PMID:39063116	SUPPORT		LF is a wound-healing process characterized by excessive deposition of extracellular matrix (ECM) proteins due to the activation of hepatic stellate cells (HSCs). In the healthy liver, quiescent HSCs metabolize and store retinoids. Upon fibrogenic activation, quiescent HSCs transdifferentiate into myofibroblasts; lose their vitamin A; upregulate α-smooth muscle actin; and produce proinflammatory soluble mediators, collagens, and inhibitors of ECM degradation. Activated HSCs are the main effector cells during hepatic fibrogenesis.	This review definitively establishes HSC activation and transdifferentiation into myofibroblasts as the central mechanism of liver fibrosis and cirrhosis.	"{""explanation"": ""This review definitively establishes HSC activation and transdifferentiation into myofibroblasts as the central mechanism of liver fibrosis and cirrhosis."", ""reference"": ""PMID:39063116"", ""snippet"": ""LF is a wound-healing process characterized by excessive deposition of extracellular matrix (ECM) proteins due to the activation of hepatic stellate cells (HSCs). In the healthy liver, quiescent HSCs metabolize and store retinoids. Upon fibrogenic activation, quiescent HSCs transdifferentiate into myofibroblasts; lose their vitamin A; upregulate α-smooth muscle actin; and produce proinflammatory soluble mediators, collagens, and inhibitors of ECM degradation. Activated HSCs are the main effector cells during hepatic fibrogenesis."", ""supports"": ""SUPPORT""}"
4489	4418	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	1	evidence	1	PMID:39063116	SUPPORT		The accumulation and activation of profibrogenic macrophages in response to hepatocyte death play a critical role in the initiation of HSC activation and survival.	Macrophages play a key role in initiating and maintaining HSC activation, linking hepatocyte injury to stellate cell-mediated fibrosis.	"{""explanation"": ""Macrophages play a key role in initiating and maintaining HSC activation, linking hepatocyte injury to stellate cell-mediated fibrosis."", ""reference"": ""PMID:39063116"", ""snippet"": ""The accumulation and activation of profibrogenic macrophages in response to hepatocyte death play a critical role in the initiation of HSC activation and survival."", ""supports"": ""SUPPORT""}"
4490	4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	evidence	0	PMID:38642564	SUPPORT		Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome.	This comprehensive review establishes portal hypertension as the primary complication of cirrhosis, caused by increased intrahepatic vascular resistance and leading to major clinical complications.	"{""explanation"": ""This comprehensive review establishes portal hypertension as the primary complication of cirrhosis, caused by increased intrahepatic vascular resistance and leading to major clinical complications."", ""reference"": ""PMID:38642564"", ""snippet"": ""Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome."", ""supports"": ""SUPPORT""}"
4491	4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	evidence	1	PMID:38642564	SUPPORT		Existing knowledge indicates that the profibrogenic phenotype acquired by sinusoidal cells is the initial factor leading to increased hepatic vascular tone and fibrosis, which cause increased vascular resistance and portal hypertension.	This identifies the cellular mechanism by which sinusoidal cell dysfunction increases vascular resistance and drives portal hypertension development.	"{""explanation"": ""This identifies the cellular mechanism by which sinusoidal cell dysfunction increases vascular resistance and drives portal hypertension development."", ""reference"": ""PMID:38642564"", ""snippet"": ""Existing knowledge indicates that the profibrogenic phenotype acquired by sinusoidal cells is the initial factor leading to increased hepatic vascular tone and fibrosis, which cause increased vascular resistance and portal hypertension."", ""supports"": ""SUPPORT""}"
4492	4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	evidence	2	PMID:38534382	SUPPORT		Liver cirrhosis leads to portal hypertension (PH) with capillarization of liver sinusoidal endothelial cells (LSECs), although drug treatment options for PH are currently limited.	This study demonstrates that LSEC capillarization is a key pathological mechanism contributing to portal hypertension in cirrhosis.	"{""explanation"": ""This study demonstrates that LSEC capillarization is a key pathological mechanism contributing to portal hypertension in cirrhosis."", ""reference"": ""PMID:38534382"", ""snippet"": ""Liver cirrhosis leads to portal hypertension (PH) with capillarization of liver sinusoidal endothelial cells (LSECs), although drug treatment options for PH are currently limited."", ""supports"": ""SUPPORT""}"
4493	4419	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	2	evidence	3	PMID:38534382	SUPPORT		Tofogliflozin prevented PH with attenuated intrahepatic vasoconstriction, sinusoidal capillarization, and remodeling independent of glycemic status in CCl4-treated rats.	This experimental study demonstrates that preventing LSEC capillarization reduces portal hypertension, confirming the causal role of sinusoidal remodeling in PH development.	"{""explanation"": ""This experimental study demonstrates that preventing LSEC capillarization reduces portal hypertension, confirming the causal role of sinusoidal remodeling in PH development."", ""reference"": ""PMID:38534382"", ""snippet"": ""Tofogliflozin prevented PH with attenuated intrahepatic vasoconstriction, sinusoidal capillarization, and remodeling independent of glycemic status in CCl4-treated rats."", ""supports"": ""SUPPORT""}"
4494	4420	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	pathophysiology	3	evidence	0	PMID:39063116	SUPPORT		Recent data demonstrated that LF can revert even at advanced stages of cirrhosis if the underlying cause is eliminated, which inhibits the inflammatory and profibrogenic cells.	While addressing fibrosis reversibility, this demonstrates that loss of functional hepatocyte mass drives cirrhosis complications, and restoration depends on eliminating ongoing injury.	"{""explanation"": ""While addressing fibrosis reversibility, this demonstrates that loss of functional hepatocyte mass drives cirrhosis complications, and restoration depends on eliminating ongoing injury."", ""reference"": ""PMID:39063116"", ""snippet"": ""Recent data demonstrated that LF can revert even at advanced stages of cirrhosis if the underlying cause is eliminated, which inhibits the inflammatory and profibrogenic cells."", ""supports"": ""SUPPORT""}"
4507	4445	188	Long COVID	Long_COVID.yaml	pathophysiology	0	evidence	0	PMID:37140960	SUPPORT		Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear.	Links Long COVID to persistence of SARS-CoV-2 RNA or antigen in tissues and resulting immune responses.	"{""explanation"": ""Links Long COVID to persistence of SARS-CoV-2 RNA or antigen in tissues and resulting immune responses."", ""reference"": ""PMID:37140960"", ""snippet"": ""Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear."", ""supports"": ""SUPPORT""}"
4508	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	evidence	0	PMID:38212464	SUPPORT		LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets.	Demonstrates persistent systemic inflammation and altered immune signaling in Long COVID.	"{""explanation"": ""Demonstrates persistent systemic inflammation and altered immune signaling in Long COVID."", ""reference"": ""PMID:38212464"", ""snippet"": ""LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets."", ""supports"": ""SUPPORT""}"
4509	4446	188	Long COVID	Long_COVID.yaml	pathophysiology	1	evidence	1	PMID:37748514	SUPPORT		Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID.	Immune profiling shows broad myeloid/lymphocyte shifts and heightened humoral responses in Long COVID.	"{""explanation"": ""Immune profiling shows broad myeloid/lymphocyte shifts and heightened humoral responses in Long COVID."", ""reference"": ""PMID:37748514"", ""snippet"": ""Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID."", ""supports"": ""SUPPORT""}"
4510	4447	188	Long COVID	Long_COVID.yaml	pathophysiology	2	evidence	0	PMID:38212464	SUPPORT		LC individuals displayed increased frequencies of CD4+ T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8+ T cells	Documents tissue-trafficking CD4+ cells and exhausted virus-specific CD8+ cells in Long COVID.	"{""explanation"": ""Documents tissue-trafficking CD4+ cells and exhausted virus-specific CD8+ cells in Long COVID."", ""reference"": ""PMID:38212464"", ""snippet"": ""LC individuals displayed increased frequencies of CD4+ T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8+ T cells"", ""supports"": ""SUPPORT""}"
4511	4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	evidence	0	PMID:35195253	SUPPORT		The result, as is strongly manifested in platelet-poor plasma (PPP) of individuals with Long COVID, is extensive fibrin amyloid microclots that can persist, can entrap other proteins, and that may lead to the production of various autoantibodies.	Documents the presence and persistence of amyloid fibrin microclots in Long COVID patients.	"{""explanation"": ""Documents the presence and persistence of amyloid fibrin microclots in Long COVID patients."", ""reference"": ""PMID:35195253"", ""snippet"": ""The result, as is strongly manifested in platelet-poor plasma (PPP) of individuals with Long COVID, is extensive fibrin amyloid microclots that can persist, can entrap other proteins, and that may lead to the production of various autoantibodies."", ""supports"": ""SUPPORT""}"
4512	4448	188	Long COVID	Long_COVID.yaml	pathophysiology	3	evidence	1	PMID:35195253	SUPPORT		the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms	Explains how microclots may cause Long COVID symptoms through impaired oxygen delivery.	"{""explanation"": ""Explains how microclots may cause Long COVID symptoms through impaired oxygen delivery."", ""reference"": ""PMID:35195253"", ""snippet"": ""the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms"", ""supports"": ""SUPPORT""}"
4513	4449	188	Long COVID	Long_COVID.yaml	pathophysiology	4	evidence	0	PMID:37848036	SUPPORT		Viral infection and type I interferon-driven inflammation reduce serotonin through three mechanisms: diminished intestinal absorption of the serotonin precursor tryptophan; platelet hyperactivation and thrombocytopenia, which impacts serotonin storage; and enhanced MAO-mediated serotonin turnover.	Describes the three mechanistic drivers of serotonin loss in Long COVID.	"{""explanation"": ""Describes the three mechanistic drivers of serotonin loss in Long COVID."", ""reference"": ""PMID:37848036"", ""snippet"": ""Viral infection and type I interferon-driven inflammation reduce serotonin through three mechanisms: diminished intestinal absorption of the serotonin precursor tryptophan; platelet hyperactivation and thrombocytopenia, which impacts serotonin storage; and enhanced MAO-mediated serotonin turnover."", ""supports"": ""SUPPORT""}"
4514	4450	188	Long COVID	Long_COVID.yaml	pathophysiology	5	evidence	0	PMID:37848036	SUPPORT		Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and thereby impairs hippocampal responses and memory.	Connects serotonin loss to vagal signaling deficits and hippocampal dysfunction.	"{""explanation"": ""Connects serotonin loss to vagal signaling deficits and hippocampal dysfunction."", ""reference"": ""PMID:37848036"", ""snippet"": ""Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and thereby impairs hippocampal responses and memory."", ""supports"": ""SUPPORT""}"
4515	4451	188	Long COVID	Long_COVID.yaml	pathophysiology	6	evidence	0	PMID:33243837	SUPPORT		We posit that this condition may be related to a virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes.	Proposes autonomic nervous system disruption as a key mechanism in Long COVID.	"{""explanation"": ""Proposes autonomic nervous system disruption as a key mechanism in Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""We posit that this condition may be related to a virus- or immune-mediated disruption of the autonomic nervous system resulting in orthostatic intolerance syndromes."", ""supports"": ""SUPPORT""}"
4516	4451	188	Long COVID	Long_COVID.yaml	pathophysiology	6	evidence	1	PMID:33243837	SUPPORT		'Post-acute COVID' (known colloquially as 'long COVID') is emerging as a prevalent syndrome. It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)	Documents the prevalence of autonomic symptoms in Long COVID.	"{""explanation"": ""Documents the prevalence of autonomic symptoms in Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""'Post-acute COVID' (known colloquially as 'long COVID') is emerging as a prevalent syndrome. It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}"
4517	4452	188	Long COVID	Long_COVID.yaml	pathophysiology	7	evidence	0	PMID:38668888	SUPPORT		Emerging evidence has pointed to mitochondrial dysfunction as a potential underpinning mechanism contributing to the persistence and diversity of long COVID symptoms.	Links mitochondrial dysfunction and reduced energy production to persistent Long COVID symptoms.	"{""explanation"": ""Links mitochondrial dysfunction and reduced energy production to persistent Long COVID symptoms."", ""reference"": ""PMID:38668888"", ""snippet"": ""Emerging evidence has pointed to mitochondrial dysfunction as a potential underpinning mechanism contributing to the persistence and diversity of long COVID symptoms."", ""supports"": ""SUPPORT""}"
4518	4453	188	Long COVID	Long_COVID.yaml	pathophysiology	8	evidence	0	PMID:38668888	SUPPORT		This review aims to synthesize current findings related to mitochondrial dysfunction in long COVID, exploring its implications for cellular energy deficits, oxidative stress, immune dysregulation, metabolic disturbances, and endothelial dysfunction.	Describes oxidative stress and metabolic disturbances resulting from mitochondrial dysfunction in Long COVID.	"{""explanation"": ""Describes oxidative stress and metabolic disturbances resulting from mitochondrial dysfunction in Long COVID."", ""reference"": ""PMID:38668888"", ""snippet"": ""This review aims to synthesize current findings related to mitochondrial dysfunction in long COVID, exploring its implications for cellular energy deficits, oxidative stress, immune dysregulation, metabolic disturbances, and endothelial dysfunction."", ""supports"": ""SUPPORT""}"
4519	4454	188	Long COVID	Long_COVID.yaml	pathophysiology	9	evidence	0	PMID:37529714	SUPPORT		Previous studies have suggested that mast cell activation (MCA) may play a role in the pathophysiology of long-COVID, including in the mechanisms of its cardiovascular manifestations.	Implicates mast cell activation in Long COVID pathophysiology.	"{""explanation"": ""Implicates mast cell activation in Long COVID pathophysiology."", ""reference"": ""PMID:37529714"", ""snippet"": ""Previous studies have suggested that mast cell activation (MCA) may play a role in the pathophysiology of long-COVID, including in the mechanisms of its cardiovascular manifestations."", ""supports"": ""SUPPORT""}"
4520	4454	188	Long COVID	Long_COVID.yaml	pathophysiology	9	evidence	1	PMID:37529714	SUPPORT		Long-COVID symptoms disappeared completely in 29% of treated patients. There was a significant improvement in each of the considered symptoms (improved or disappeared) in all treated patients	Treatment response to antihistamines supports the role of mast cell activation in Long COVID.	"{""explanation"": ""Treatment response to antihistamines supports the role of mast cell activation in Long COVID."", ""reference"": ""PMID:37529714"", ""snippet"": ""Long-COVID symptoms disappeared completely in 29% of treated patients. There was a significant improvement in each of the considered symptoms (improved or disappeared) in all treated patients"", ""supports"": ""SUPPORT""}"
4521	4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	evidence	0	PMID:36846556	SUPPORT		Activation of microglia in response to an immune system challenge can lead to a significant impact on cognitive processes, such as learning, memory and emotional regulation.	Documents microglial activation and its impact on cognitive processes in Long COVID.	"{""explanation"": ""Documents microglial activation and its impact on cognitive processes in Long COVID."", ""reference"": ""PMID:36846556"", ""snippet"": ""Activation of microglia in response to an immune system challenge can lead to a significant impact on cognitive processes, such as learning, memory and emotional regulation."", ""supports"": ""SUPPORT""}"
4522	4455	188	Long COVID	Long_COVID.yaml	pathophysiology	10	evidence	1	PMID:36846556	SUPPORT		Inflammatory cytokines have been found to play a significant role in reductions in LTP and LTD, a reduction in neurogenesis, and in dendritic sprouting.	Explains how inflammatory cytokines impair neural function in Long COVID brain fog.	"{""explanation"": ""Explains how inflammatory cytokines impair neural function in Long COVID brain fog."", ""reference"": ""PMID:36846556"", ""snippet"": ""Inflammatory cytokines have been found to play a significant role in reductions in LTP and LTD, a reduction in neurogenesis, and in dendritic sprouting."", ""supports"": ""SUPPORT""}"
4573	4494	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	0	evidence	0	PMID:33383265	SUPPORT		Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth.	Establishes the odontogenic dental source leading to floor-of-mouth infection.	"{""explanation"": ""Establishes the odontogenic dental source leading to floor-of-mouth infection."", ""reference"": ""PMID:33383265"", ""snippet"": ""Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth."", ""supports"": ""SUPPORT""}"
4574	4495	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	1	evidence	0	PMID:33383265	SUPPORT		Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth.	Highlights rapid polymicrobial cellulitis centered on the mouth floor and submandibular spaces.	"{""explanation"": ""Highlights rapid polymicrobial cellulitis centered on the mouth floor and submandibular spaces."", ""reference"": ""PMID:33383265"", ""snippet"": ""Ludwig's angina is a rapidly spreading infection that involves the floor of the mouth."", ""supports"": ""SUPPORT""}"
4575	4496	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	2	evidence	0	PMID:35784784	SUPPORT		Ludwig's angina is a cellulitis that affects the submandibular, sublingual, and submental regions, fast-spreading along the fascial plane.	Describes rapid fascial-plane spread across submandibular and sublingual spaces.	"{""explanation"": ""Describes rapid fascial-plane spread across submandibular and sublingual spaces."", ""reference"": ""PMID:35784784"", ""snippet"": ""Ludwig's angina is a cellulitis that affects the submandibular, sublingual, and submental regions, fast-spreading along the fascial plane."", ""supports"": ""SUPPORT""}"
4576	4497	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	3	evidence	0	PMID:35784784	SUPPORT		Ludwig's angina with mediastinitis complication was established by a computed tomography (CT) scan.	CT-documented mediastinitis demonstrates downward extension along fascial planes.	"{""explanation"": ""CT-documented mediastinitis demonstrates downward extension along fascial planes."", ""reference"": ""PMID:35784784"", ""snippet"": ""Ludwig's angina with mediastinitis complication was established by a computed tomography (CT) scan."", ""supports"": ""SUPPORT""}"
4577	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	downstream[0].evidence	0	PMID:38445409	SUPPORT		trismus and elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor.	Links mouth-floor elevation to airway obstruction and stridor.	"{""explanation"": ""Links mouth-floor elevation to airway obstruction and stridor."", ""reference"": ""PMID:38445409"", ""snippet"": ""trismus and elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}"
4578	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	downstream[0].evidence	1	PMID:33904596	SUPPORT		which suggested that the cause of death was asphyxiation due to airway obstruction.	Fatal case underscores how submandibular edema can fully occlude the airway in Ludwig's angina.	"{""explanation"": ""Fatal case underscores how submandibular edema can fully occlude the airway in Ludwig's angina."", ""reference"": ""PMID:33904596"", ""snippet"": ""which suggested that the cause of death was asphyxiation due to airway obstruction."", ""supports"": ""SUPPORT""}"
4579	4498	189	Ludwig's Angina	Ludwigs_Angina.yaml	pathophysiology	4	evidence	0	PMID:38445409	SUPPORT		elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor.	Documents airway compromise from submandibular and sublingual edema.	"{""explanation"": ""Documents airway compromise from submandibular and sublingual edema."", ""reference"": ""PMID:38445409"", ""snippet"": ""elevation of the floor of the mouth that caused an obstruction of the airway and resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}"
4593	4512	190	Lung Carcinoma	Lung_Carcinoma.yaml	pathophysiology	0	evidence	0	PMID:22932130	SUPPORT		The discovery of activating mutations in the epidermal growth factor receptor and anaplastic lymphoma kinase positivity has made personalized treatment for NSCLC more feasible.	The abstract links EGFR mutations and ALK positivity with NSCLC.	"{""explanation"": ""The abstract links EGFR mutations and ALK positivity with NSCLC."", ""reference"": ""PMID:22932130"", ""snippet"": ""The discovery of activating mutations in the epidermal growth factor receptor and anaplastic lymphoma kinase positivity has made personalized treatment for NSCLC more feasible."", ""supports"": ""SUPPORT""}"
4594	4513	190	Lung Carcinoma	Lung_Carcinoma.yaml	pathophysiology	1	evidence	0	PMID:26542886	SUPPORT		Vascular endothelial growth factor A (VEGFA) is one of the main mediators of angiogenesis in non-small cell lung cancer (NSCLC).	The abstract identifies VEGFA as a key mediator of angiogenesis in NSCLC.	"{""explanation"": ""The abstract identifies VEGFA as a key mediator of angiogenesis in NSCLC."", ""reference"": ""PMID:26542886"", ""snippet"": ""Vascular endothelial growth factor A (VEGFA) is one of the main mediators of angiogenesis in non-small cell lung cancer (NSCLC)."", ""supports"": ""SUPPORT""}"
4612	4543	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	0	evidence	0	PMID:33669940	SUPPORT		The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease.	Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites.	"{""explanation"": ""Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites."", ""reference"": ""PMID:33669940"", ""snippet"": ""The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease."", ""supports"": ""SUPPORT""}"
4613	4544	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	1	evidence	0	PMID:34786243	SUPPORT		long-term exposure of the host's immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo.	Case review links persistent Borrelia exposure to downstream autoimmune disease.	"{""explanation"": ""Case review links persistent Borrelia exposure to downstream autoimmune disease."", ""reference"": ""PMID:34786243"", ""snippet"": ""long-term exposure of the host's immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo."", ""supports"": ""SUPPORT""}"
4614	4545	191	Lyme Disease	Lyme_Disease.yaml	pathophysiology	2	evidence	0	PMID:37407232	SUPPORT		Aspiration of the left knee joint revealed a white cell count of 21.0×109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis.	Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage.	"{""explanation"": ""Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage."", ""reference"": ""PMID:37407232"", ""snippet"": ""Aspiration of the left knee joint revealed a white cell count of 21.0×109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis."", ""supports"": ""SUPPORT""}"
4631	4561	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	0	evidence	0	PMID:21413271	SUPPORT		The adults of the lymphatic filariae inhabit lymph vessels, where blockage and host reaction can result in lymphatic inflammation and dysfunction, and eventually in lymphedema and fibrosis.	Adult worms in lymphatic vessels cause blockage, inflammation, dysfunction, and fibrosis.	"{""explanation"": ""Adult worms in lymphatic vessels cause blockage, inflammation, dysfunction, and fibrosis."", ""reference"": ""PMID:21413271"", ""snippet"": ""The adults of the lymphatic filariae inhabit lymph vessels, where blockage and host reaction can result in lymphatic inflammation and dysfunction, and eventually in lymphedema and fibrosis."", ""supports"": ""SUPPORT""}"
4632	4562	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	pathophysiology	1	evidence	0	PMID:39739969	SUPPORT		The adult parasites impact the integrity of lymphatic vessels and damage valves, leading to a remodeling of the lymphatic system and lymphatic dilation.	The abstract describes parasite-driven valve damage and lymphatic remodeling.	"{""explanation"": ""The abstract describes parasite-driven valve damage and lymphatic remodeling."", ""reference"": ""PMID:39739969"", ""snippet"": ""The adult parasites impact the integrity of lymphatic vessels and damage valves, leading to a remodeling of the lymphatic system and lymphatic dilation."", ""supports"": ""SUPPORT""}"
4640	4571	193	Lymphoma	Lymphoma.yaml	pathophysiology	0	evidence	0	PMID:12764636	SUPPORT		Lymphoma is a spectrum of malignant neoplasms of the lymphoid system.	The abstract defines lymphoma as malignant neoplasms of the lymphoid system.	"{""explanation"": ""The abstract defines lymphoma as malignant neoplasms of the lymphoid system."", ""reference"": ""PMID:12764636"", ""snippet"": ""Lymphoma is a spectrum of malignant neoplasms of the lymphoid system."", ""supports"": ""SUPPORT""}"
4641	4572	193	Lymphoma	Lymphoma.yaml	pathophysiology	1	evidence	0	PMID:15618006	SUPPORT		HRS cells in nearly all cases of HL derive from B cells, and only rarely from T cells.	The abstract states that Hodgkin/Reed-Sternberg cells are derived from B cells.	"{""explanation"": ""The abstract states that Hodgkin/Reed-Sternberg cells are derived from B cells."", ""reference"": ""PMID:15618006"", ""snippet"": ""HRS cells in nearly all cases of HL derive from B cells, and only rarely from T cells."", ""supports"": ""SUPPORT""}"
4692	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:25701956	SUPPORT		Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers.	This directly supports the mechanistic edge from mismatch repair deficiency to microsatellite instability.	"{""explanation"": ""This directly supports the mechanistic edge from mismatch repair deficiency to microsatellite instability."", ""reference"": ""PMID:25701956"", ""snippet"": ""Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers."", ""supports"": ""SUPPORT""}"
4693	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:19466295	SUPPORT		Lynch syndrome represents 1-7% of all cases of colorectal cancer and is an autosomal-dominant inherited cancer predisposition syndrome caused by germline mutations in deoxyribonucleic acid (DNA) mismatch repair genes.	This reference confirms that Lynch Syndrome involves mutations in mismatch repair genes.	"{""explanation"": ""This reference confirms that Lynch Syndrome involves mutations in mismatch repair genes."", ""reference"": ""PMID:19466295"", ""snippet"": ""Lynch syndrome represents 1-7% of all cases of colorectal cancer and is an autosomal-dominant inherited cancer predisposition syndrome caused by germline mutations in deoxyribonucleic acid (DNA) mismatch repair genes."", ""supports"": ""SUPPORT""}"
4694	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:29233924	SUPPORT		Many mutations first arise as DNA replication errors. These errors subsequently evade correction by cellular DNA repair, for example, by the well-known DNA mismatch repair (MMR) mechanism.	This supports the notion that DNA mismatch repair is crucial in correcting DNA replication errors, and its deficiency leads to the accumulation of these errors.	"{""explanation"": ""This supports the notion that DNA mismatch repair is crucial in correcting DNA replication errors, and its deficiency leads to the accumulation of these errors."", ""reference"": ""PMID:29233924"", ""snippet"": ""Many mutations first arise as DNA replication errors. These errors subsequently evade correction by cellular DNA repair, for example, by the well-known DNA mismatch repair (MMR) mechanism."", ""supports"": ""SUPPORT""}"
4695	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:34919656	SUPPORT		Lynch syndrome (LS, OMIM #120435) is caused by an inherited heterozygous defect in any of the four core DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1 or PMS2...	Clear evidence linking inherited defects in mismatch repair genes to Lynch Syndrome.	"{""explanation"": ""Clear evidence linking inherited defects in mismatch repair genes to Lynch Syndrome."", ""reference"": ""PMID:34919656"", ""snippet"": ""Lynch syndrome (LS, OMIM #120435) is caused by an inherited heterozygous defect in any of the four core DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1 or PMS2..."", ""supports"": ""SUPPORT""}"
4696	4597	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:24443998	SUPPORT		Inherited defects in the DNA mismatch repair (MMR) system, MLH1, MSH2, MSH6, and PMS2 genes, underlie Lynch syndrome, one of the most prevalent cancer syndromes in man.	Validates that Lynch Syndrome is underpinned by mutations in specific mismatch repair genes.	"{""explanation"": ""Validates that Lynch Syndrome is underpinned by mutations in specific mismatch repair genes."", ""reference"": ""PMID:24443998"", ""snippet"": ""Inherited defects in the DNA mismatch repair (MMR) system, MLH1, MSH2, MSH6, and PMS2 genes, underlie Lynch syndrome, one of the most prevalent cancer syndromes in man."", ""supports"": ""SUPPORT""}"
4697	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:38466935	SUPPORT		Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome.	This supports MSI-associated frameshift mutagenesis as a driver of rapid tumorigenesis.	"{""explanation"": ""This supports MSI-associated frameshift mutagenesis as a driver of rapid tumorigenesis."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome."", ""supports"": ""SUPPORT""}"
4698	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	downstream[1].evidence	0	PMID:34630437	SUPPORT		We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens.	This directly supports the causal edge from MSI-associated frameshift mutations to neoantigen generation.	"{""explanation"": ""This directly supports the causal edge from MSI-associated frameshift mutations to neoantigen generation."", ""reference"": ""PMID:34630437"", ""snippet"": ""We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens."", ""supports"": ""SUPPORT""}"
4699	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:25701956	SUPPORT		Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers.	The snippet confirms that defective mismatch repair causes microsatellite instability, supporting the statement.	"{""explanation"": ""The snippet confirms that defective mismatch repair causes microsatellite instability, supporting the statement."", ""reference"": ""PMID:25701956"", ""snippet"": ""Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers."", ""supports"": ""SUPPORT""}"
4700	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:35315099	SUPPORT		LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance.	The statement is supported by the evidence that Lynch Syndrome leads to microsatellite instability due to defective mismatch repair.	"{""explanation"": ""The statement is supported by the evidence that Lynch Syndrome leads to microsatellite instability due to defective mismatch repair."", ""reference"": ""PMID:35315099"", ""snippet"": ""LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance."", ""supports"": ""SUPPORT""}"
4701	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:31273487	SUPPORT		Lynch syndrome is a state of mismatch repair deficiency due to a monoallelic abnormality of any mismatch repair genes. The phenotype indicating the mismatch repair deficiency can be frequently shown as a microsatellite instability in tumors.	This reference supports the statement by linking mismatch repair deficiency and microsatellite instability in Lynch Syndrome.	"{""explanation"": ""This reference supports the statement by linking mismatch repair deficiency and microsatellite instability in Lynch Syndrome."", ""reference"": ""PMID:31273487"", ""snippet"": ""Lynch syndrome is a state of mismatch repair deficiency due to a monoallelic abnormality of any mismatch repair genes. The phenotype indicating the mismatch repair deficiency can be frequently shown as a microsatellite instability in tumors."", ""supports"": ""SUPPORT""}"
4702	4598	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	1	evidence	3	PMID:38466935	SUPPORT		Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome.	The snippet supports the statement by describing how defective mismatch repair in Lynch syndrome leads to microsatellite instability.	"{""explanation"": ""The snippet supports the statement by describing how defective mismatch repair in Lynch syndrome leads to microsatellite instability."", ""reference"": ""PMID:38466935"", ""snippet"": ""Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, which lead to high microsatellite instability and frameshift mutations at coding mononucleotide repeats in the genome."", ""supports"": ""SUPPORT""}"
4703	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:37478804	SUPPORT		Lynch Syndrome (LS) is one of the most common hereditary cancer syndromes, and is caused by mutations in one of the four DNA mismatch repair (MMR) genes, namely MLH1, MSH2, MSH6 and PMS2.	This further supports the fact that accumulation of mutations in key genes (MMR genes) in Lynch Syndrome contributes to an increased risk of developing certain cancers.	"{""explanation"": ""This further supports the fact that accumulation of mutations in key genes (MMR genes) in Lynch Syndrome contributes to an increased risk of developing certain cancers."", ""reference"": ""PMID:37478804"", ""snippet"": ""Lynch Syndrome (LS) is one of the most common hereditary cancer syndromes, and is caused by mutations in one of the four DNA mismatch repair (MMR) genes, namely MLH1, MSH2, MSH6 and PMS2."", ""supports"": ""SUPPORT""}"
4704	4599	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:23604856	SUPPORT		Lynch Syndrome, or hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant cancer predisposition syndrome caused by inactivating mutations in DNA mismatch repair genes.	This supports the idea that the mechanism of Lynch Syndrome involves the accumulation of mutations in key genes leading to cancer.	"{""explanation"": ""This supports the idea that the mechanism of Lynch Syndrome involves the accumulation of mutations in key genes leading to cancer."", ""reference"": ""PMID:23604856"", ""snippet"": ""Lynch Syndrome, or hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant cancer predisposition syndrome caused by inactivating mutations in DNA mismatch repair genes."", ""supports"": ""SUPPORT""}"
4705	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	downstream[0].evidence	0	PMID:37625240	SUPPORT		PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC.	This supports the causal link between immunogenic dMMR/MSI biology and checkpoint blockade sensitivity.	"{""explanation"": ""This supports the causal link between immunogenic dMMR/MSI biology and checkpoint blockade sensitivity."", ""reference"": ""PMID:37625240"", ""snippet"": ""PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC."", ""supports"": ""SUPPORT""}"
4706	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:34630437	SUPPORT		We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens.	This directly supports neoantigen generation from recurrent frameshift events in mismatch repair-deficient, MSI-high tumors seen in Lynch syndrome.	"{""explanation"": ""This directly supports neoantigen generation from recurrent frameshift events in mismatch repair-deficient, MSI-high tumors seen in Lynch syndrome."", ""reference"": ""PMID:34630437"", ""snippet"": ""We and others have characterized a subset of MSI-H associated highly recurrent frameshift mutations that yield shared immunogenic neoantigens."", ""supports"": ""SUPPORT""}"
4707	4600	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:35315099	SUPPORT		LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance.	This supports the immunogenic tumor microenvironment and immune activation component of this mechanism.	"{""explanation"": ""This supports the immunogenic tumor microenvironment and immune activation component of this mechanism."", ""reference"": ""PMID:35315099"", ""snippet"": ""LS tumours are characterised by unique pathogenesis, ultimately resulting in hypermutation, microsatellite instability and high immunogenicity that has significant implications for cancer risk, clinical presentation, treatment and surveillance."", ""supports"": ""SUPPORT""}"
4708	4601	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:37625240	SUPPORT		PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC.	This human clinical observation supports mechanistic sensitivity of dMMR/MSI Lynch tumors to immune checkpoint blockade.	"{""explanation"": ""This human clinical observation supports mechanistic sensitivity of dMMR/MSI Lynch tumors to immune checkpoint blockade."", ""reference"": ""PMID:37625240"", ""snippet"": ""PD-1 inhibitors are highly effective for dMMR and MSI-H LS CRCs, but not for pMMR or MSS LS CRCs or mucinous/signet-ring cell CRC."", ""supports"": ""SUPPORT""}"
4709	4601	194	Lynch Syndrome	Lynch_Syndrome.yaml	pathophysiology	4	evidence	1	PMID:37845474	PARTIAL		Metastatic and localized mismatch repair-deficient (dMMR) tumors are exquisitely sensitive to immune checkpoint blockade (ICB).	This supports high treatment sensitivity in dMMR states while also indicating that surveillance remains necessary.	"{""explanation"": ""This supports high treatment sensitivity in dMMR states while also indicating that surveillance remains necessary."", ""reference"": ""PMID:37845474"", ""snippet"": ""Metastatic and localized mismatch repair-deficient (dMMR) tumors are exquisitely sensitive to immune checkpoint blockade (ICB)."", ""supports"": ""PARTIAL""}"
4756	4633	196	MET Exon 14 Skipping Non-Small Cell Lung Cancer	MET_Exon_14_Skipping_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:26729443	SUPPORT		MET exon 14 mutations were identified in 28 of 933 nonsquamous NSCLCs (3.0%) and were not seen in other cancer types in this study.	This abstract documents MET exon 14 mutations in NSCLC, supporting the presence of exon 14 alterations in this subtype.	"{""explanation"": ""This abstract documents MET exon 14 mutations in NSCLC, supporting the presence of exon 14 alterations in this subtype."", ""reference"": ""PMID:26729443"", ""snippet"": ""MET exon 14 mutations were identified in 28 of 933 nonsquamous NSCLCs (3.0%) and were not seen in other cancer types in this study."", ""supports"": ""SUPPORT""}"
4760	4657	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	0	evidence	0	PMID:41113075	SUPPORT		High microsatellite instability (MSI-H) colorectal cancer (CRC), caused by deficient mismatch repair, accounts for about 15% of all CRC cases and is more common in right-sided tumors.	This abstract explicitly links MSI-H CRC to deficient mismatch repair, supporting the core disease mechanism described.	"{""explanation"": ""This abstract explicitly links MSI-H CRC to deficient mismatch repair, supporting the core disease mechanism described."", ""reference"": ""PMID:41113075"", ""snippet"": ""High microsatellite instability (MSI-H) colorectal cancer (CRC), caused by deficient mismatch repair, accounts for about 15% of all CRC cases and is more common in right-sided tumors."", ""supports"": ""SUPPORT""}"
4761	4658	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	1	evidence	0	PMID:36115290	SUPPORT		Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency	Abstract links MSI CRC to MMR deficiency, supporting the MSI mechanism.	"{""explanation"": ""Abstract links MSI CRC to MMR deficiency, supporting the MSI mechanism."", ""reference"": ""PMID:36115290"", ""snippet"": ""Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency"", ""supports"": ""SUPPORT""}"
4762	4659	197	MSI-High Colorectal Cancer	MSI_High_Colorectal_Cancer.yaml	pathophysiology	2	evidence	0	PMID:36115290	SUPPORT		The pathogenic alterations of MMR genes lead to the accumulation of frequent somatic mutational events	Abstract notes frequent somatic mutational events from MMR alterations, consistent with hypermutation.	"{""explanation"": ""Abstract notes frequent somatic mutational events from MMR alterations, consistent with hypermutation."", ""reference"": ""PMID:36115290"", ""snippet"": ""The pathogenic alterations of MMR genes lead to the accumulation of frequent somatic mutational events"", ""supports"": ""SUPPORT""}"
4770	4681	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	0	evidence	0	PMID:39860407	SUPPORT		Cancer immunotherapy through the use of PD-1/PD-L1 inhibitors have shown significant promise in endometrial carcinoma (EC), particularly in tumors with microsatellite instability (MSI) or mismatch repair deficiency (dMMR), present in approximately 30% of cases.	Supports the frequency of MSI/dMMR in endometrial carcinoma.	"{""explanation"": ""Supports the frequency of MSI/dMMR in endometrial carcinoma."", ""reference"": ""PMID:39860407"", ""snippet"": ""Cancer immunotherapy through the use of PD-1/PD-L1 inhibitors have shown significant promise in endometrial carcinoma (EC), particularly in tumors with microsatellite instability (MSI) or mismatch repair deficiency (dMMR), present in approximately 30% of cases."", ""supports"": ""SUPPORT""}"
4771	4682	198	MSI-High Endometrial Cancer	MSI_High_Endometrial_Cancer.yaml	pathophysiology	1	evidence	0	PMID:19620942	SUPPORT		Microsatellite instability (MSI) is the hallmark of a molecular pathway to carcinogenesis due to sporadic or inherited abnormalities of DNA mismatch repair genes.	Abstract links MSI to mismatch repair abnormalities, supporting this mechanism.	"{""explanation"": ""Abstract links MSI to mismatch repair abnormalities, supporting this mechanism."", ""reference"": ""PMID:19620942"", ""snippet"": ""Microsatellite instability (MSI) is the hallmark of a molecular pathway to carcinogenesis due to sporadic or inherited abnormalities of DNA mismatch repair genes."", ""supports"": ""SUPPORT""}"
4780	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	evidence	0	PMID:38331979	SUPPORT		The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis	This review confirms the neurotransmitter hypothesis as a foundational theory of MDD pathogenesis, though it notes that multiple hypotheses are needed to fully explain the disorder.	"{""explanation"": ""This review confirms the neurotransmitter hypothesis as a foundational theory of MDD pathogenesis, though it notes that multiple hypotheses are needed to fully explain the disorder."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}"
4781	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	evidence	1	PMID:39150594	SUPPORT		MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates.	This highlights the clinical reality of monoamine-based treatments, confirming their use while acknowledging their limitations in achieving remission.	"{""explanation"": ""This highlights the clinical reality of monoamine-based treatments, confirming their use while acknowledging their limitations in achieving remission."", ""reference"": ""PMID:39150594"", ""snippet"": ""MDD is especially burdensome as approved monoamine antidepressant treatments have weeks-long delays before clinical benefit and low remission rates."", ""supports"": ""SUPPORT""}"
4782	4707	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	0	evidence	2	PMID:38474387	SUPPORT		neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.	This demonstrates how inflammatory mechanisms contribute to decreased serotonin synthesis, supporting the monoamine deficiency theory while connecting it to broader pathophysiological processes.	"{""explanation"": ""This demonstrates how inflammatory mechanisms contribute to decreased serotonin synthesis, supporting the monoamine deficiency theory while connecting it to broader pathophysiological processes."", ""reference"": ""PMID:38474387"", ""snippet"": ""neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}"
4783	4708	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	1	evidence	0	PMID:38331979	SUPPORT		The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis	This review identifies the HPA axis hypothesis as one of the widely accepted core pathophysiological mechanisms in MDD.	"{""explanation"": ""This review identifies the HPA axis hypothesis as one of the widely accepted core pathophysiological mechanisms in MDD."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}"
4784	4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	evidence	0	PMID:38331979	SUPPORT		The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis	This comprehensive review identifies the neuroplasticity hypothesis as one of the core accepted mechanisms in MDD pathogenesis.	"{""explanation"": ""This comprehensive review identifies the neuroplasticity hypothesis as one of the core accepted mechanisms in MDD pathogenesis."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}"
4785	4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	evidence	1	PMID:39150594	SUPPORT		This narrative review provides a high-level overview of glutamate signaling in synaptogenesis and neural plasticity and the implications of glutamate dysregulation in depression.	This demonstrates the link between glutamate signaling, synaptogenesis, and neural plasticity deficits in depression, supporting the neuroplasticity deficit mechanism.	"{""explanation"": ""This demonstrates the link between glutamate signaling, synaptogenesis, and neural plasticity deficits in depression, supporting the neuroplasticity deficit mechanism."", ""reference"": ""PMID:39150594"", ""snippet"": ""This narrative review provides a high-level overview of glutamate signaling in synaptogenesis and neural plasticity and the implications of glutamate dysregulation in depression."", ""supports"": ""SUPPORT""}"
4786	4709	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	2	evidence	2	PMID:38474387	SUPPORT		neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.	This shows how inflammatory processes lead to impairments in neuroplasticity-related mechanisms, connecting inflammation to neuroplasticity deficits in MDD.	"{""explanation"": ""This shows how inflammatory processes lead to impairments in neuroplasticity-related mechanisms, connecting inflammation to neuroplasticity deficits in MDD."", ""reference"": ""PMID:38474387"", ""snippet"": ""neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}"
4787	4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	evidence	0	PMID:38331979	SUPPORT		The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis	This review identifies the cytokine hypothesis as one of the widely accepted theories of MDD pathogenesis, supporting the role of inflammatory mechanisms.	"{""explanation"": ""This review identifies the cytokine hypothesis as one of the widely accepted theories of MDD pathogenesis, supporting the role of inflammatory mechanisms."", ""reference"": ""PMID:38331979"", ""snippet"": ""The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis"", ""supports"": ""SUPPORT""}"
4788	4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	evidence	1	PMID:38474387	SUPPORT		The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation	This provides direct evidence for elevated pro-inflammatory cytokines in MDD and their role in eliciting neuroinflammatory processes.	"{""explanation"": ""This provides direct evidence for elevated pro-inflammatory cytokines in MDD and their role in eliciting neuroinflammatory processes."", ""reference"": ""PMID:38474387"", ""snippet"": ""The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation"", ""supports"": ""SUPPORT""}"
4789	4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	evidence	2	PMID:38474387	SUPPORT		mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity.	This demonstrates how neuroinflammation contributes to both monoamine depletion (decreased serotonin) and neuroplasticity deficits, confirming the description's mechanistic links.	"{""explanation"": ""This demonstrates how neuroinflammation contributes to both monoamine depletion (decreased serotonin) and neuroplasticity deficits, confirming the description's mechanistic links."", ""reference"": ""PMID:38474387"", ""snippet"": ""mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity."", ""supports"": ""SUPPORT""}"
4790	4710	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	3	evidence	3	PMID:20015486	SUPPORT		This meta-analysis reports significantly higher concentrations of the proinflammatory cytokines TNF-alpha and IL-6 in depressed subjects compared with control subjects.	Meta-analysis evidence shows elevated proinflammatory cytokines in major depression, supporting neuroinflammatory mechanisms.	"{""explanation"": ""Meta-analysis evidence shows elevated proinflammatory cytokines in major depression, supporting neuroinflammatory mechanisms."", ""reference"": ""PMID:20015486"", ""snippet"": ""This meta-analysis reports significantly higher concentrations of the proinflammatory cytokines TNF-alpha and IL-6 in depressed subjects compared with control subjects."", ""supports"": ""SUPPORT""}"
4791	4711	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	4	evidence	0	PMID:38256041	SUPPORT		The link between mitochondria and major depressive disorder (MDD) is increasingly evident, underscored both by mitochondria's involvement in many mechanisms identified in depression and the high prevalence of MDD in individuals with mitochondrial disorders.	This establishes the connection between mitochondrial dysfunction and MDD, noting both mechanistic involvement and epidemiological evidence.	"{""explanation"": ""This establishes the connection between mitochondrial dysfunction and MDD, noting both mechanistic involvement and epidemiological evidence."", ""reference"": ""PMID:38256041"", ""snippet"": ""The link between mitochondria and major depressive disorder (MDD) is increasingly evident, underscored both by mitochondria's involvement in many mechanisms identified in depression and the high prevalence of MDD in individuals with mitochondrial disorders."", ""supports"": ""SUPPORT""}"
4792	4711	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	4	evidence	1	PMID:38256041	SUPPORT		Similarities were observed between the Mito patient and a broader MDD cohort, including decreased respiration and mitochondrial function.	This provides direct evidence from patient-derived cells showing decreased mitochondrial respiration and function in MDD patients.	"{""explanation"": ""This provides direct evidence from patient-derived cells showing decreased mitochondrial respiration and function in MDD patients."", ""reference"": ""PMID:38256041"", ""snippet"": ""Similarities were observed between the Mito patient and a broader MDD cohort, including decreased respiration and mitochondrial function."", ""supports"": ""SUPPORT""}"
4793	4711	199	Major Depressive Disorder	Major_Depressive_Disorder.yaml	pathophysiology	4	evidence	2	PMID:38256041	SUPPORT		the Non-R patient's data offered a new perspective on MDD, suggesting a detrimental imbalance in mitochondrial and cellular processes, rather than simply reduced functions.	This suggests that mitochondrial dysfunction in MDD may involve complex imbalances beyond simple reduction, including altered respiratory rates and calcium homeostasis.	"{""explanation"": ""This suggests that mitochondrial dysfunction in MDD may involve complex imbalances beyond simple reduction, including altered respiratory rates and calcium homeostasis."", ""reference"": ""PMID:38256041"", ""snippet"": ""the Non-R patient's data offered a new perspective on MDD, suggesting a detrimental imbalance in mitochondrial and cellular processes, rather than simply reduced functions."", ""supports"": ""SUPPORT""}"
4800	4737	200	Malignant Mesothelioma	Malignant_Mesothelioma.yaml	pathophysiology	1	evidence	0	PMID:25889843	SUPPORT		pleural MMs have been genetically characterized by the loss of BAP1 (40-60%)	Abstract reports frequent BAP1 loss in pleural mesothelioma.	"{""explanation"": ""Abstract reports frequent BAP1 loss in pleural mesothelioma."", ""reference"": ""PMID:25889843"", ""snippet"": ""pleural MMs have been genetically characterized by the loss of BAP1 (40-60%)"", ""supports"": ""SUPPORT""}"
4801	4749	201	Malnutrition-Related Diabetes Mellitus	Malnutrition-related_Diabetes_Mellitus.yaml	pathophysiology	0	evidence	0	PMID:40049652	SUPPORT		Studies have shown that insulin deficiency due to pancreatic β-cell impairment is likely to contribute to the development of undernutrition-associated diabetes.	The review links undernutrition-associated diabetes to beta-cell impairment and insulin deficiency.	"{""explanation"": ""The review links undernutrition-associated diabetes to beta-cell impairment and insulin deficiency."", ""reference"": ""PMID:40049652"", ""snippet"": ""Studies have shown that insulin deficiency due to pancreatic β-cell impairment is likely to contribute to the development of undernutrition-associated diabetes."", ""supports"": ""SUPPORT""}"
4804	4760	202	Mantle Cell Lymphoma	Mantle_Cell_Lymphoma.yaml	pathophysiology	0	evidence	0	PMID:41369864	SUPPORT		Mantle cell lymphoma (MCL) is a mature B cell neoplasm characterized by the CCND1::IgH t(11;14) translocation.	This abstract statement identifies the CCND1::IgH translocation as a hallmark of MCL.	"{""explanation"": ""This abstract statement identifies the CCND1::IgH translocation as a hallmark of MCL."", ""reference"": ""PMID:41369864"", ""snippet"": ""Mantle cell lymphoma (MCL) is a mature B cell neoplasm characterized by the CCND1::IgH t(11;14) translocation."", ""supports"": ""SUPPORT""}"
4823	4796	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	0	evidence	0	PMID:35672312	SUPPORT		Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated.	This study confirms MSUD causes BCAA accumulation due to enzyme deficiency.	"{""explanation"": ""This study confirms MSUD causes BCAA accumulation due to enzyme deficiency."", ""reference"": ""PMID:35672312"", ""snippet"": ""Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated."", ""supports"": ""SUPPORT""}"
4824	4796	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	0	evidence	1	PMID:27373929	SUPPORT		Maple Syrup Urine Disease (MSUD) is an inherited disorder caused by the dysfunction in the branched chain keto-acid dehydrogenase (BCKDH) enzyme.	Confirms BCKDH enzyme dysfunction is the core defect in MSUD.	"{""explanation"": ""Confirms BCKDH enzyme dysfunction is the core defect in MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""Maple Syrup Urine Disease (MSUD) is an inherited disorder caused by the dysfunction in the branched chain keto-acid dehydrogenase (BCKDH) enzyme."", ""supports"": ""SUPPORT""}"
4825	4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	evidence	0	PMID:23478409	SUPPORT		Using quantitative proton magnetic resonance spectroscopy, we found lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, which correlated with specific neuropsychiatric outcomes.	Demonstrates neurochemical abnormalities in MSUD patients correlating with clinical manifestations.	"{""explanation"": ""Demonstrates neurochemical abnormalities in MSUD patients correlating with clinical manifestations."", ""reference"": ""PMID:23478409"", ""snippet"": ""Using quantitative proton magnetic resonance spectroscopy, we found lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, which correlated with specific neuropsychiatric outcomes."", ""supports"": ""SUPPORT""}"
4826	4797	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	1	evidence	1	PMID:27373929	SUPPORT		KIC is an inhibitor of mitochondrial function at disease relevant concentrations.	Confirms KIC directly inhibits mitochondrial function.	"{""explanation"": ""Confirms KIC directly inhibits mitochondrial function."", ""reference"": ""PMID:27373929"", ""snippet"": ""KIC is an inhibitor of mitochondrial function at disease relevant concentrations."", ""supports"": ""SUPPORT""}"
4827	4798	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	pathophysiology	2	evidence	0	PMID:27373929	SUPPORT		iMSUD mice displayed a significant reduction in muscle fiber size, suggesting muscle atrophy.	Animal model demonstrates skeletal muscle atrophy in MSUD.	"{""explanation"": ""Animal model demonstrates skeletal muscle atrophy in MSUD."", ""reference"": ""PMID:27373929"", ""snippet"": ""iMSUD mice displayed a significant reduction in muscle fiber size, suggesting muscle atrophy."", ""supports"": ""SUPPORT""}"
4877	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:8180508	SUPPORT	HUMAN_CLINICAL	The gene encoding for fibrillin, the FBN1 gene on chromosome 15, has been identified as the defective gene causing the Marfan syndrome. Fibrillin is the large glycoprotein with a repetitive domain structure and is a major protein component of microfibrils, a fibrillar system closely associated with elastin in connective tissue.	The statement is supported by the identification of the FBN1 gene as the cause of Marfan syndrome and its role in the structure of connective tissue.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of the FBN1 gene as the cause of Marfan syndrome and its role in the structure of connective tissue."", ""reference"": ""PMID:8180508"", ""snippet"": ""The gene encoding for fibrillin, the FBN1 gene on chromosome 15, has been identified as the defective gene causing the Marfan syndrome. Fibrillin is the large glycoprotein with a repetitive domain structure and is a major protein component of microfibrils, a fibrillar system closely associated with elastin in connective tissue."", ""supports"": ""SUPPORT""}"
4878	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:39096853	SUPPORT	HUMAN_CLINICAL	Marfan syndrome (MFS) is a hereditary condition caused by mutations in the FBN1 gene. Genetic mutations in the FBN1 locus impact the function of the encoded protein, Fibrillin 1, a structural molecule forming microfibrils found in the connective tissue.	The statement is supported by the description of FBN1 mutations affecting the function of fibrillin-1, which is crucial for connective tissue structure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the description of FBN1 mutations affecting the function of fibrillin-1, which is crucial for connective tissue structure."", ""reference"": ""PMID:39096853"", ""snippet"": ""Marfan syndrome (MFS) is a hereditary condition caused by mutations in the FBN1 gene. Genetic mutations in the FBN1 locus impact the function of the encoded protein, Fibrillin 1, a structural molecule forming microfibrils found in the connective tissue."", ""supports"": ""SUPPORT""}"
4879	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:17657824	SUPPORT	HUMAN_CLINICAL	Mutations in the FBN1 gene have been characterised in patients affected by Marfan syndrome and Marfan-related disorders.	The statement is supported by the identification of FBN1 mutations in Marfan syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of FBN1 mutations in Marfan syndrome patients."", ""reference"": ""PMID:17657824"", ""snippet"": ""Mutations in the FBN1 gene have been characterised in patients affected by Marfan syndrome and Marfan-related disorders."", ""supports"": ""SUPPORT""}"
4880	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:12938084	SUPPORT	HUMAN_CLINICAL	Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were first described in the heritable connective disorder, Marfan syndrome (MFS).	The statement is supported by the role of fibrillin as a major component of microfibrils and the impact of FBN1 mutations on connective tissue.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the role of fibrillin as a major component of microfibrils and the impact of FBN1 mutations on connective tissue."", ""reference"": ""PMID:12938084"", ""snippet"": ""Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were first described in the heritable connective disorder, Marfan syndrome (MFS)."", ""supports"": ""SUPPORT""}"
4881	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	4	PMID:24555249	SUPPORT	HUMAN_CLINICAL	Marfan syndrome is a genetic disorder of the connective tissue caused by mutations in FBN1 gene.	The statement is supported by the description of Marfan syndrome as a genetic disorder caused by FBN1 mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the description of Marfan syndrome as a genetic disorder caused by FBN1 mutations."", ""reference"": ""PMID:24555249"", ""snippet"": ""Marfan syndrome is a genetic disorder of the connective tissue caused by mutations in FBN1 gene."", ""supports"": ""SUPPORT""}"
4882	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	5	PMID:36004597	SUPPORT	HUMAN_CLINICAL	Marfan syndrome is an orphan disease that is caused by a mutation in the FBN1 gene located on chromosome 15 (15q21.1) and is usually inherited in an autosomal dominant manner.	The statement is supported by the identification of FBN1 mutations as the cause of Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of FBN1 mutations as the cause of Marfan syndrome."", ""reference"": ""PMID:36004597"", ""snippet"": ""Marfan syndrome is an orphan disease that is caused by a mutation in the FBN1 gene located on chromosome 15 (15q21.1) and is usually inherited in an autosomal dominant manner."", ""supports"": ""SUPPORT""}"
4883	4835	204	Marfan Syndrome	Marfan_Syndrome.yaml	pathophysiology	0	evidence	6	PMID:25729264	SUPPORT	HUMAN_CLINICAL	A C596G mutation in FBN1 was identified in a Chinese family with MFS. Our results expand the spectrum of FBN1 mutations and contribute to the understanding of the role of FBN1 in the pathogenesis of Marfan syndrome.	The statement is supported by the identification of specific FBN1 mutations in Marfan syndrome patients and their impact on connective tissue.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The statement is supported by the identification of specific FBN1 mutations in Marfan syndrome patients and their impact on connective tissue."", ""reference"": ""PMID:25729264"", ""snippet"": ""A C596G mutation in FBN1 was identified in a Chinese family with MFS. Our results expand the spectrum of FBN1 mutations and contribute to the understanding of the role of FBN1 in the pathogenesis of Marfan syndrome."", ""supports"": ""SUPPORT""}"
4932	4857	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	pathophysiology	0	evidence	0	PMID:8506491	SUPPORT		Meckel's diverticula are the result of incomplete degeneration of the vitelline duct.	This explains the embryological origin of Meckel diverticulum.	"{""explanation"": ""This explains the embryological origin of Meckel diverticulum."", ""reference"": ""PMID:8506491"", ""snippet"": ""Meckel's diverticula are the result of incomplete degeneration of the vitelline duct."", ""supports"": ""SUPPORT""}"
4933	4857	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	pathophysiology	0	evidence	1	PMID:15026601	SUPPORT		It results from improper closure and absorption of the omphalomesenteric duct.	This describes the embryological mechanism as failure of omphalomesenteric duct closure.	"{""explanation"": ""This describes the embryological mechanism as failure of omphalomesenteric duct closure."", ""reference"": ""PMID:15026601"", ""snippet"": ""It results from improper closure and absorption of the omphalomesenteric duct."", ""supports"": ""SUPPORT""}"
4996	4903	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:19211713	SUPPORT	MODEL_ORGANISM	the underlying mutated gene, TMEM67, encodes transmembrane protein 67, also called meckelin (OMIM 609884), which is an integral protein of the renal epithelial cell and membrane of the primary cilium.	TMEM67/meckelin is an integral primary cilium membrane protein implicated in MKS3.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""TMEM67/meckelin is an integral primary cilium membrane protein implicated in MKS3."", ""reference"": ""PMID:19211713"", ""snippet"": ""the underlying mutated gene, TMEM67, encodes transmembrane protein 67, also called meckelin (OMIM 609884), which is an integral protein of the renal epithelial cell and membrane of the primary cilium."", ""supports"": ""SUPPORT""}"
4997	4904	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	The gene mutated in type 1 MKS encodes a protein associated with the base of the cilium in vertebrates and nematodes.	MKS1 encodes a protein associated with the ciliary base, supporting ciliary base dysfunction in MKS.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""MKS1 encodes a protein associated with the ciliary base, supporting ciliary base dysfunction in MKS."", ""reference"": ""PMID:19776033"", ""snippet"": ""The gene mutated in type 1 MKS encodes a protein associated with the base of the cilium in vertebrates and nematodes."", ""supports"": ""SUPPORT""}"
4998	4905	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues.	Basal body localization is preserved while ciliogenesis fails in Mks1-deficient tissues.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Basal body localization is preserved while ciliogenesis fails in Mks1-deficient tissues."", ""reference"": ""PMID:19776033"", ""snippet"": ""loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues."", ""supports"": ""SUPPORT""}"
4999	4906	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues.	Mks1 loss leads to defective cilia formation across tissues in vivo.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Mks1 loss leads to defective cilia formation across tissues in vivo."", ""reference"": ""PMID:19776033"", ""snippet"": ""loss of Mks1 in vivo does not interfere with apical localization of epithelial basal bodies but rather leads to defective cilia formation in most, but not all, tissues."", ""supports"": ""SUPPORT""}"
5000	4907	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:18513680	SUPPORT	IN_VITRO	Immunofluorescence staining of patient's fibroblast cells demonstrates that the cells lack cilia, providing evidence for the critical role of CC2D2A in cilia formation.	Patient fibroblasts lacking cilia link CC2D2A to cilia formation.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Patient fibroblasts lacking cilia link CC2D2A to cilia formation."", ""reference"": ""PMID:18513680"", ""snippet"": ""Immunofluorescence staining of patient's fibroblast cells demonstrates that the cells lack cilia, providing evidence for the critical role of CC2D2A in cilia formation."", ""supports"": ""SUPPORT""}"
5001	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:41165761	SUPPORT	IN_VITRO	the B9 complex interacted with and anchored TMEM67 to the TZ membrane.	Disruption of the B9-TMEM67 transition zone interaction underlies downstream axonemal defects.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Disruption of the B9-TMEM67 transition zone interaction underlies downstream axonemal defects."", ""reference"": ""PMID:41165761"", ""snippet"": ""the B9 complex interacted with and anchored TMEM67 to the TZ membrane."", ""supports"": ""SUPPORT""}"
5002	4908	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	5	evidence	1	PMID:41165761	SUPPORT	IN_VITRO	Disruption of the B9-TMEM67 complex reduced posttranslational modifications of axonemal microtubules due to deregulation of tubulin-modifying enzymes within cilia.	B9 complex disruption impairs axonemal microtubule posttranslational modifications.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""B9 complex disruption impairs axonemal microtubule posttranslational modifications."", ""reference"": ""PMID:41165761"", ""snippet"": ""Disruption of the B9-TMEM67 complex reduced posttranslational modifications of axonemal microtubules due to deregulation of tubulin-modifying enzymes within cilia."", ""supports"": ""SUPPORT""}"
5003	4909	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	6	evidence	0	PMID:41165761	SUPPORT	IN_VITRO	B9 proteins localized to centrioles prior to ciliogenesis, where they facilitated the initiation of ciliogenesis.	B9 proteins are required for initiating ciliogenesis.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""B9 proteins are required for initiating ciliogenesis."", ""reference"": ""PMID:41165761"", ""snippet"": ""B9 proteins localized to centrioles prior to ciliogenesis, where they facilitated the initiation of ciliogenesis."", ""supports"": ""SUPPORT""}"
5004	4910	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	7	evidence	0	PMID:40436881	SUPPORT	IN_VITRO	Cleavage of the Meckel-Gruber syndrome protein TMEM67 by ADAMTS9 uncouples Wnt signaling and ciliogenesis.	TMEM67 cleavage separates Wnt signaling from ciliogenesis in MKS.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""TMEM67 cleavage separates Wnt signaling from ciliogenesis in MKS."", ""reference"": ""PMID:40436881"", ""snippet"": ""Cleavage of the Meckel-Gruber syndrome protein TMEM67 by ADAMTS9 uncouples Wnt signaling and ciliogenesis."", ""supports"": ""SUPPORT""}"
5005	4911	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	8	evidence	0	PMID:40841990	SUPPORT	IN_VITRO	Our study reveals severe functional consequences, including TMEM17 destabilization and mislocalization, anomalies in cilium composition and function, and abrogation of Sonic Hedgehog signaling.	TMEM17 variants disrupt ciliary function and abrogate SHH signaling.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""TMEM17 variants disrupt ciliary function and abrogate SHH signaling."", ""reference"": ""PMID:40841990"", ""snippet"": ""Our study reveals severe functional consequences, including TMEM17 destabilization and mislocalization, anomalies in cilium composition and function, and abrogation of Sonic Hedgehog signaling."", ""supports"": ""SUPPORT""}"
5006	4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects	Neural tube patterning defects in Mks1 mutants reflect altered Hedgehog signaling.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Neural tube patterning defects in Mks1 mutants reflect altered Hedgehog signaling."", ""reference"": ""PMID:19776033"", ""snippet"": ""Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects"", ""supports"": ""SUPPORT""}"
5007	4912	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	9	evidence	1	PMID:34981460	SUPPORT	IN_VITRO	HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells.	In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings."", ""reference"": ""PMID:34981460"", ""snippet"": ""HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells."", ""supports"": ""SUPPORT""}"
5008	4913	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	10	evidence	0	PMID:19776033	SUPPORT	MODEL_ORGANISM	Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects	Limb patterning defects in Mks1 mutants reflect altered Hedgehog signaling.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Limb patterning defects in Mks1 mutants reflect altered Hedgehog signaling."", ""reference"": ""PMID:19776033"", ""snippet"": ""Analysis of patterning in the neural tube and the limb demonstrates altered Hedgehog (Hh) pathway signaling underlies some MKS defects"", ""supports"": ""SUPPORT""}"
5009	4913	206	Meckel Syndrome	Meckel_Syndrome.yaml	pathophysiology	10	evidence	1	PMID:34981460	SUPPORT	IN_VITRO	HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells.	In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""In vitro experiments from MKS cases link SHH signaling changes to MKS-associated genetic findings."", ""reference"": ""PMID:34981460"", ""snippet"": ""HEK293T transfected with over-expression wildtype/mutated ZNF77 plasmid showed that SHH was increased in wildtype ZNF77 cells, while SHH and CC2D2A were increased in mutated ZNF77 cells."", ""supports"": ""SUPPORT""}"
5037	4951	208	Medulloblastoma, SHH-Activated	Medulloblastoma_SHH_Activated.yaml	pathophysiology	0	evidence	0	PMID:35489737	SUPPORT		SHH tumors contain mutations and alterations in GLI1, GLI2, SUFU, and PTCH1 genes, which constitutively activate the SHH pathway.	This abstract explicitly states that SHH tumors have GLI1/GLI2/SUFU/PTCH1 alterations that constitutively activate SHH signaling.	"{""explanation"": ""This abstract explicitly states that SHH tumors have GLI1/GLI2/SUFU/PTCH1 alterations that constitutively activate SHH signaling."", ""reference"": ""PMID:35489737"", ""snippet"": ""SHH tumors contain mutations and alterations in GLI1, GLI2, SUFU, and PTCH1 genes, which constitutively activate the SHH pathway."", ""supports"": ""SUPPORT""}"
5039	4971	209	Medulloblastoma, WNT-Activated	Medulloblastoma_WNT_Activated.yaml	pathophysiology	0	evidence	0	PMID:40967259	SUPPORT		nearly all cases harbor either somatic CTNNB1 mutations or germline APC mutations.	This abstract sentence supports that WNT-activated medulloblastomas are driven by CTNNB1 or APC mutations.	"{""explanation"": ""This abstract sentence supports that WNT-activated medulloblastomas are driven by CTNNB1 or APC mutations."", ""reference"": ""PMID:40967259"", ""snippet"": ""nearly all cases harbor either somatic CTNNB1 mutations or germline APC mutations."", ""supports"": ""SUPPORT""}"
5058	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	downstream[1].evidence	0	PMID:24129063	SUPPORT		Large-giant CMNs displayed NRAS mutations in 94.7% of cases (18/19). ... The results showed that NRAS mutation was the sole recurrent somatic event found in such melanocytic proliferations.	This study establishes NRAS mutations as the predominant genetic driver in large congenital melanocytic nevi, occurring in nearly 95% of cases, supporting the role of NRAS in the pathogenesis of lesions with malignant potential.	"{""explanation"": ""This study establishes NRAS mutations as the predominant genetic driver in large congenital melanocytic nevi, occurring in nearly 95% of cases, supporting the role of NRAS in the pathogenesis of lesions with malignant potential."", ""reference"": ""PMID:24129063"", ""snippet"": ""Large-giant CMNs displayed NRAS mutations in 94.7% of cases (18/19). ... The results showed that NRAS mutation was the sole recurrent somatic event found in such melanocytic proliferations."", ""supports"": ""SUPPORT""}"
5059	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	evidence	0	PMID:16750612	SUPPORT		The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi. This finding indicates that activation of the mitogen-activated protein kinase pathway may be a critical initiating step of melanocytic neoplasia.	This study supports the role of BRAF mutations in the pathophysiology of melanoma in melanocytic nevi, including congenital cases.	"{""explanation"": ""This study supports the role of BRAF mutations in the pathophysiology of melanoma in melanocytic nevi, including congenital cases."", ""reference"": ""PMID:16750612"", ""snippet"": ""The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi. This finding indicates that activation of the mitogen-activated protein kinase pathway may be a critical initiating step of melanocytic neoplasia."", ""supports"": ""SUPPORT""}"
5060	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	evidence	1	PMID:28110826	PARTIAL		Congenital melanocytic nevus syndrome (CMNS) is the result of an abnormal proliferation of melanocytes in the skin and central nervous system caused by progenitor-cell mutations during embryonic development. Mutations in the NRAS gene have been detected in many of these cells.	This reference covers NRAS mutations in congenital melanocytic nevus syndrome but does not mention BRAF mutations.	"{""explanation"": ""This reference covers NRAS mutations in congenital melanocytic nevus syndrome but does not mention BRAF mutations."", ""reference"": ""PMID:28110826"", ""snippet"": ""Congenital melanocytic nevus syndrome (CMNS) is the result of an abnormal proliferation of melanocytes in the skin and central nervous system caused by progenitor-cell mutations during embryonic development. Mutations in the NRAS gene have been detected in many of these cells."", ""supports"": ""PARTIAL""}"
5061	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	evidence	2	PMID:32100974	SUPPORT		Melanomas developing on pre-existing congenital or acquired nevi are usually of the superficial spreading subtype and harbor the BRAFV600E mutation.	This study supports the presence of BRAF mutations in melanomas associated with congenital melanocytic nevi.	"{""explanation"": ""This study supports the presence of BRAF mutations in melanomas associated with congenital melanocytic nevi."", ""reference"": ""PMID:32100974"", ""snippet"": ""Melanomas developing on pre-existing congenital or acquired nevi are usually of the superficial spreading subtype and harbor the BRAFV600E mutation."", ""supports"": ""SUPPORT""}"
5062	4995	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	0	evidence	3	PMID:31111470	SUPPORT		NRAS mosaicism was found in 68%, BRAF in 7% and double wild-type in 25% of cases of CMN. NRAS was the commonest mutation in all sizes of CMN.	This comprehensive review provides evidence of both NRAS and BRAF mutations in congenital melanocytic nevi, which supports their role in the development of melanoma.	"{""explanation"": ""This comprehensive review provides evidence of both NRAS and BRAF mutations in congenital melanocytic nevi, which supports their role in the development of melanoma."", ""reference"": ""PMID:31111470"", ""snippet"": ""NRAS mosaicism was found in 68%, BRAF in 7% and double wild-type in 25% of cases of CMN. NRAS was the commonest mutation in all sizes of CMN."", ""supports"": ""SUPPORT""}"
5063	4996	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	1	evidence	0	PMID:25268584	PARTIAL		the three CNMs contained an activating NRAS Q61 mutation and no TERT-p mutations.	While the study does not explicitly link UV radiation to melanoma in congenital melanocytic nevus (CNM), it differentiates the mutational spectrum of CNMs from other types of melanoma, suggesting a distinct pathogenesis. Thus, the connection between UV radiation and CNM-related melanoma remains implicit and not clearly defined.	"{""explanation"": ""While the study does not explicitly link UV radiation to melanoma in congenital melanocytic nevus (CNM), it differentiates the mutational spectrum of CNMs from other types of melanoma, suggesting a distinct pathogenesis. Thus, the connection between UV radiation and CNM-related melanoma remains implicit and not clearly defined."", ""reference"": ""PMID:25268584"", ""snippet"": ""the three CNMs contained an activating NRAS Q61 mutation and no TERT-p mutations."", ""supports"": ""PARTIAL""}"
5064	4996	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	pathophysiology	1	evidence	1	PMID:33759772	NO_EVIDENCE		validated the role of ultraviolet-induced DNA mutations in melanoma formation	This reference confirms the role of UV-induced DNA mutations in melanoma formation but does not specifically address melanoma developing from congenital melanocytic nevi.	"{""explanation"": ""This reference confirms the role of UV-induced DNA mutations in melanoma formation but does not specifically address melanoma developing from congenital melanocytic nevi."", ""reference"": ""PMID:33759772"", ""snippet"": ""validated the role of ultraviolet-induced DNA mutations in melanoma formation"", ""supports"": ""NO_EVIDENCE""}"
5132	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	evidence	0	PMID:39135018	SUPPORT		Melkersson-Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder characterized by recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue.	Establishes the clinical phenotype and neuromucocutaneous involvement characteristic of MRS	"{""explanation"": ""Establishes the clinical phenotype and neuromucocutaneous involvement characteristic of MRS"", ""reference"": ""PMID:39135018"", ""snippet"": ""Melkersson-Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder characterized by recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue."", ""supports"": ""SUPPORT""}"
5133	5029	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	0	evidence	1	PMID:30627963	SUPPORT		Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli.	Provides context for the granulomatous nature of orofacial pathology including MRS	"{""explanation"": ""Provides context for the granulomatous nature of orofacial pathology including MRS"", ""reference"": ""PMID:30627963"", ""snippet"": ""Granulomatous lesions of the orofacial region are a heterogeneous group of disorders characterized by a granulomatous reaction to a variety of stimuli."", ""supports"": ""SUPPORT""}"
5134	5030	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	1	evidence	0	PMID:32782477	SUPPORT		IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines.	Identifies the IL-12/23 and IFN-γ cytokine pathways implicated in orofacial granulomatous inflammation	"{""explanation"": ""Identifies the IL-12/23 and IFN-γ cytokine pathways implicated in orofacial granulomatous inflammation"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}"
5135	5031	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	pathophysiology	2	evidence	0	PMID:32782477	SUPPORT		IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines.	Supports the lymphatic dysfunction mechanism through inflammatory cytokine effects on endothelial function	"{""explanation"": ""Supports the lymphatic dysfunction mechanism through inflammatory cytokine effects on endothelial function"", ""reference"": ""PMID:32782477"", ""snippet"": ""IL-12 and IL-23 are linked to the production of IFN-γ, a pivotal mediator of inflammation in peripheral tissues, including orofacial mucosa, by promoting multiple proinflammatory cytokines."", ""supports"": ""SUPPORT""}"
5148	5041	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	0	evidence	0	PMID:27083887	SUPPORT		Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Menière's disease.	This review confirms endolymphatic hydrops as the pathologic correlate of Meniere's disease.	"{""explanation"": ""This review confirms endolymphatic hydrops as the pathologic correlate of Meniere's disease."", ""reference"": ""PMID:27083887"", ""snippet"": ""Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Menière's disease."", ""supports"": ""SUPPORT""}"
5149	5042	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	1	evidence	0	PMID:29436285	SUPPORT		on ELS epithelium. AQP2 expression density was significantly elevated in MD	Immunohistochemical study identifies AQP2 upregulation as a key molecular abnormality in MD endolymphatic sac	"{""explanation"": ""Immunohistochemical study identifies AQP2 upregulation as a key molecular abnormality in MD endolymphatic sac"", ""reference"": ""PMID:29436285"", ""snippet"": ""on ELS epithelium. AQP2 expression density was significantly elevated in MD"", ""supports"": ""SUPPORT""}"
5150	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	evidence	0	PMID:35280304	SUPPORT		Up-regulated expression of interferon-γ, interleukin-6 and tumor necrosis factor-α in the endolymphatic sac.	Study documents elevated pro-inflammatory cytokines (IFN-γ, IL-6, TNF-α) in MD endolymphatic sac tissue	"{""explanation"": ""Study documents elevated pro-inflammatory cytokines (IFN-γ, IL-6, TNF-α) in MD endolymphatic sac tissue"", ""reference"": ""PMID:35280304"", ""snippet"": ""Up-regulated expression of interferon-γ, interleukin-6 and tumor necrosis factor-α in the endolymphatic sac."", ""supports"": ""SUPPORT""}"
5151	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	evidence	1	PMID:29326686	SUPPORT		Carriers of the risk genotype may develop an NF-κB-mediated inflammatory response in MD.	Demonstrates TWEAK-FN14-NF-κB pathway activation as key inflammatory mechanism in MD	"{""explanation"": ""Demonstrates TWEAK-FN14-NF-κB pathway activation as key inflammatory mechanism in MD"", ""reference"": ""PMID:29326686"", ""snippet"": ""Carriers of the risk genotype may develop an NF-κB-mediated inflammatory response in MD."", ""supports"": ""SUPPORT""}"
5152	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	evidence	2	PMID:22053211	SUPPORT		MD displays an elevated prevalence of systemic AD such as RA, SLE and AS.	Large case-control study establishes association between MD and systemic autoimmune disease	"{""explanation"": ""Large case-control study establishes association between MD and systemic autoimmune disease"", ""reference"": ""PMID:22053211"", ""snippet"": ""MD displays an elevated prevalence of systemic AD such as RA, SLE and AS."", ""supports"": ""SUPPORT""}"
5153	5043	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	2	evidence	3	PMID:21208440	SUPPORT		Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease.	Case-control study identifies Fcγ receptor polymorphisms and immune complex dysregulation in MD	"{""explanation"": ""Case-control study identifies Fcγ receptor polymorphisms and immune complex dysregulation in MD"", ""reference"": ""PMID:21208440"", ""snippet"": ""Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease."", ""supports"": ""SUPPORT""}"
5154	5044	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	3	evidence	0	PMID:28325925	SUPPORT		Meniere's disease specimens revealed differential ultrastructural pathological changes in the cellular elements of the microvasculature.	Ultrastructural study documents pathological BLB changes including endothelial and pericyte damage in MD	"{""explanation"": ""Ultrastructural study documents pathological BLB changes including endothelial and pericyte damage in MD"", ""reference"": ""PMID:28325925"", ""snippet"": ""Meniere's disease specimens revealed differential ultrastructural pathological changes in the cellular elements of the microvasculature."", ""supports"": ""SUPPORT""}"
5155	5044	212	Meniere's Disease	Menieres_Disease.yaml	pathophysiology	3	evidence	1	PMID:30233382	SUPPORT		We proposed that oxidative stress mediated the damage to the vestibular endorgan and the BLB in MD.	Documents oxidative stress as key pathogenic mechanism in MD blood-labyrinth barrier dysfunction	"{""explanation"": ""Documents oxidative stress as key pathogenic mechanism in MD blood-labyrinth barrier dysfunction"", ""reference"": ""PMID:30233382"", ""snippet"": ""We proposed that oxidative stress mediated the damage to the vestibular endorgan and the BLB in MD."", ""supports"": ""SUPPORT""}"
5194	5096	214	Migraine	Migraine.yaml	pathophysiology	0	evidence	0	PMID:37495957	SUPPORT		Cortical spreading depolarization (CSD), the neurophysiological correlate of the migraine aura, can activate trigeminal pain pathways, but the neurobiological mechanisms and behavioural consequences remain unclear.	Establishes CSD as the neurophysiological basis of migraine aura and its role in activating trigeminal pain pathways.	"{""explanation"": ""Establishes CSD as the neurophysiological basis of migraine aura and its role in activating trigeminal pain pathways."", ""reference"": ""PMID:37495957"", ""snippet"": ""Cortical spreading depolarization (CSD), the neurophysiological correlate of the migraine aura, can activate trigeminal pain pathways, but the neurobiological mechanisms and behavioural consequences remain unclear."", ""supports"": ""SUPPORT""}"
5195	5096	214	Migraine	Migraine.yaml	pathophysiology	0	evidence	1	PMID:37495957	SUPPORT		In both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min.	Demonstrates that CSDs directly induce headache-related behaviors in animal models, supporting CSD's role in headache initiation.	"{""explanation"": ""Demonstrates that CSDs directly induce headache-related behaviors in animal models, supporting CSD's role in headache initiation."", ""reference"": ""PMID:37495957"", ""snippet"": ""In both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min."", ""supports"": ""SUPPORT""}"
5196	5096	214	Migraine	Migraine.yaml	pathophysiology	0	evidence	2	PMID:37495957	SUPPORT		Blocking Panx1 channels by TAT-Panx308 inhibited CSD-induced headache related behaviour and HMGB1 release.	Shows that pannexin-1 channels mediate CSD-induced neuroinflammatory signaling and headache behaviors, identifying a key mechanism linking CSD to pain.	"{""explanation"": ""Shows that pannexin-1 channels mediate CSD-induced neuroinflammatory signaling and headache behaviors, identifying a key mechanism linking CSD to pain."", ""reference"": ""PMID:37495957"", ""snippet"": ""Blocking Panx1 channels by TAT-Panx308 inhibited CSD-induced headache related behaviour and HMGB1 release."", ""supports"": ""SUPPORT""}"
5197	5096	214	Migraine	Migraine.yaml	pathophysiology	0	evidence	3	PMID:39080518	SUPPORT		Neuronal pannexin-1 channels act as stress sensors, initiating the inflammatory signaling by inflammasome formation and high-mobility group box-1 release in response to transient perturbations such as cortical spreading depolarization (CSD)	Explains the molecular mechanism by which CSD triggers neuroinflammation through pannexin-1 channels and HMGB1 release.	"{""explanation"": ""Explains the molecular mechanism by which CSD triggers neuroinflammation through pannexin-1 channels and HMGB1 release."", ""reference"": ""PMID:39080518"", ""snippet"": ""Neuronal pannexin-1 channels act as stress sensors, initiating the inflammatory signaling by inflammasome formation and high-mobility group box-1 release in response to transient perturbations such as cortical spreading depolarization (CSD)"", ""supports"": ""SUPPORT""}"
5198	5097	214	Migraine	Migraine.yaml	pathophysiology	1	evidence	0	PMID:37487740	SUPPORT		CSD is also thought to drive the headache phase in migraine by promoting the activation and mechanical sensitization of trigeminal primary afferent nociceptive neurons that innervate the cranial meninges.	Confirms that CSD drives trigeminovascular activation leading to headache phase in migraine.	"{""explanation"": ""Confirms that CSD drives trigeminovascular activation leading to headache phase in migraine."", ""reference"": ""PMID:37487740"", ""snippet"": ""CSD is also thought to drive the headache phase in migraine by promoting the activation and mechanical sensitization of trigeminal primary afferent nociceptive neurons that innervate the cranial meninges."", ""supports"": ""SUPPORT""}"
5199	5097	214	Migraine	Migraine.yaml	pathophysiology	1	evidence	1	PMID:39080518	SUPPORT		Studies in rodents have demonstrated that sterile meningeal inflammation can stimulate and sensitize meningeal nociceptors, culminating in headaches.	Shows that meningeal inflammation activates and sensitizes trigeminal nociceptors, producing headache.	"{""explanation"": ""Shows that meningeal inflammation activates and sensitizes trigeminal nociceptors, producing headache."", ""reference"": ""PMID:39080518"", ""snippet"": ""Studies in rodents have demonstrated that sterile meningeal inflammation can stimulate and sensitize meningeal nociceptors, culminating in headaches."", ""supports"": ""SUPPORT""}"
5200	5097	214	Migraine	Migraine.yaml	pathophysiology	1	evidence	2	PMID:39080518	SUPPORT		The parenchymal neuroinflammatory signaling involving neurons, astrocytes, and microglia, which eventually extends to the meninges, can link non-homeostatic perturbations in the insensate brain to pain-sensitive meninges.	Describes the pathway by which brain parenchymal inflammation extends to activate pain-sensitive meningeal structures and trigeminal afferents.	"{""explanation"": ""Describes the pathway by which brain parenchymal inflammation extends to activate pain-sensitive meningeal structures and trigeminal afferents."", ""reference"": ""PMID:39080518"", ""snippet"": ""The parenchymal neuroinflammatory signaling involving neurons, astrocytes, and microglia, which eventually extends to the meninges, can link non-homeostatic perturbations in the insensate brain to pain-sensitive meninges."", ""supports"": ""SUPPORT""}"
5201	5098	214	Migraine	Migraine.yaml	pathophysiology	2	evidence	0	PMID:37487740	SUPPORT		Broad-spectrum P2X receptor inhibition, selective blockade of the P2X7 receptor, and its related Pannexin 1 channel suppressed CSD-evoked afferent mechanical sensitization but did not affect the accompanying afferent activation response.	Demonstrates that P2X7 and Pannexin 1 signaling specifically mediate mechanical sensitization (allodynia) of meningeal afferents, a key component of central sensitization.	"{""explanation"": ""Demonstrates that P2X7 and Pannexin 1 signaling specifically mediate mechanical sensitization (allodynia) of meningeal afferents, a key component of central sensitization."", ""reference"": ""PMID:37487740"", ""snippet"": ""Broad-spectrum P2X receptor inhibition, selective blockade of the P2X7 receptor, and its related Pannexin 1 channel suppressed CSD-evoked afferent mechanical sensitization but did not affect the accompanying afferent activation response."", ""supports"": ""SUPPORT""}"
5202	5098	214	Migraine	Migraine.yaml	pathophysiology	2	evidence	1	PMID:37487740	SUPPORT		We propose that meningeal P2X7 and Pannexin 1 signaling, potentially in meningeal macrophages or neutrophils, mediates the mechanical sensitization of meningeal afferents, which contributes to migraine pain by exacerbating the headache during normally innocuous physical activities.	Explains how sensitization leads to allodynia where normally innocuous stimuli become painful during migraine attacks.	"{""explanation"": ""Explains how sensitization leads to allodynia where normally innocuous stimuli become painful during migraine attacks."", ""reference"": ""PMID:37487740"", ""snippet"": ""We propose that meningeal P2X7 and Pannexin 1 signaling, potentially in meningeal macrophages or neutrophils, mediates the mechanical sensitization of meningeal afferents, which contributes to migraine pain by exacerbating the headache during normally innocuous physical activities."", ""supports"": ""SUPPORT""}"
5203	5099	214	Migraine	Migraine.yaml	pathophysiology	3	evidence	0	PMID:39080518	SUPPORT		The efficacy of relatively blood-brain barrier-impermeable anti-calcitonin gene-related peptide antibodies and triptans in treating migraine attacks, both with and without aura, supports the concept of migraine pain originating in meninges.	Clinical efficacy of CGRP-targeting therapies validates the central role of the CGRP pathway in migraine pathophysiology.	"{""explanation"": ""Clinical efficacy of CGRP-targeting therapies validates the central role of the CGRP pathway in migraine pathophysiology."", ""reference"": ""PMID:39080518"", ""snippet"": ""The efficacy of relatively blood-brain barrier-impermeable anti-calcitonin gene-related peptide antibodies and triptans in treating migraine attacks, both with and without aura, supports the concept of migraine pain originating in meninges."", ""supports"": ""SUPPORT""}"
5204	5099	214	Migraine	Migraine.yaml	pathophysiology	3	evidence	1	PMID:37569648	SUPPORT		However, the progresses in unravelling the migraine pathophysiology allowed identifying novel putative targets as calcitonin gene-related peptide (CGRP).	Identifies CGRP as a key validated target in migraine treatment based on understanding of disease pathophysiology.	"{""explanation"": ""Identifies CGRP as a key validated target in migraine treatment based on understanding of disease pathophysiology."", ""reference"": ""PMID:37569648"", ""snippet"": ""However, the progresses in unravelling the migraine pathophysiology allowed identifying novel putative targets as calcitonin gene-related peptide (CGRP)."", ""supports"": ""SUPPORT""}"
5205	5099	214	Migraine	Migraine.yaml	pathophysiology	3	evidence	2	PMID:37569648	SUPPORT		Nevertheless, despite the revolution brought by CGRP monoclonal antibodies and gepants, a significant percentage of patients still remains burdened by an unsatisfactory response, suggesting that other pathways may play a critical role	Notes that while CGRP pathway is important, treatment resistance in some patients indicates involvement of additional pathways beyond CGRP.	"{""explanation"": ""Notes that while CGRP pathway is important, treatment resistance in some patients indicates involvement of additional pathways beyond CGRP."", ""reference"": ""PMID:37569648"", ""snippet"": ""Nevertheless, despite the revolution brought by CGRP monoclonal antibodies and gepants, a significant percentage of patients still remains burdened by an unsatisfactory response, suggesting that other pathways may play a critical role"", ""supports"": ""SUPPORT""}"
5227	5118	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	0	evidence	0	PMID:31440254	SUPPORT		Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE).	This epigenome-wide study confirms anti-U1-RNP antibodies as the defining serological feature of MCTD, with pervasive hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) supporting the central role of this autoimmune response in disease pathogenesis.	"{""explanation"": ""This epigenome-wide study confirms anti-U1-RNP antibodies as the defining serological feature of MCTD, with pervasive hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) supporting the central role of this autoimmune response in disease pathogenesis."", ""reference"": ""PMID:31440254"", ""snippet"": ""Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE)."", ""supports"": ""SUPPORT""}"
5228	5119	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	1	evidence	0	PMID:38479808	SUPPORT		Among the MCTD patients, patients with the SLE immunophenotype had higher proportions of Th1 cells	Machine learning-based immunophenotyping revealed that MCTD patients with SLE-like features show significantly elevated Th1 cells (2.85% vs 1.33%, P=0.027) and plasmablasts, with enhanced interferon-alpha and interferon-gamma responses in central memory CD8+ T cells, demonstrating the central role of T cell-driven inflammation in disease heterogeneity.	"{""explanation"": ""Machine learning-based immunophenotyping revealed that MCTD patients with SLE-like features show significantly elevated Th1 cells (2.85% vs 1.33%, P=0.027) and plasmablasts, with enhanced interferon-alpha and interferon-gamma responses in central memory CD8+ T cells, demonstrating the central role of T cell-driven inflammation in disease heterogeneity."", ""reference"": ""PMID:38479808"", ""snippet"": ""Among the MCTD patients, patients with the SLE immunophenotype had higher proportions of Th1 cells"", ""supports"": ""SUPPORT""}"
5229	5120	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	2	evidence	0	PMID:16084319	SUPPORT		It is the cutaneous symptom of a systemic vasculopathy that is characterized by intimal fibrosis and blood vessel obliteration that frequently leads to visceral involvement, particularly pulmonary hypertension.	Raynaud phenomenon in MCTD reflects an underlying systemic vasculopathy with intimal fibrosis and vascular obliteration, providing the mechanistic link between endothelial dysfunction and pulmonary arterial hypertension development.	"{""explanation"": ""Raynaud phenomenon in MCTD reflects an underlying systemic vasculopathy with intimal fibrosis and vascular obliteration, providing the mechanistic link between endothelial dysfunction and pulmonary arterial hypertension development."", ""reference"": ""PMID:16084319"", ""snippet"": ""It is the cutaneous symptom of a systemic vasculopathy that is characterized by intimal fibrosis and blood vessel obliteration that frequently leads to visceral involvement, particularly pulmonary hypertension."", ""supports"": ""SUPPORT""}"
5230	5120	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	2	evidence	1	PMID:37497727	SUPPORT		Pooled prevalence of PAH in MCTD patients was 12.53% [95% CI 8.30-18.48%]	This systematic review and meta-analysis of 983 MCTD patients establishes pulmonary arterial hypertension as a significant vascular complication, occurring in approximately 12.5% of patients, with mortality rates reaching up to 81.8% in affected individuals.	"{""explanation"": ""This systematic review and meta-analysis of 983 MCTD patients establishes pulmonary arterial hypertension as a significant vascular complication, occurring in approximately 12.5% of patients, with mortality rates reaching up to 81.8% in affected individuals."", ""reference"": ""PMID:37497727"", ""snippet"": ""Pooled prevalence of PAH in MCTD patients was 12.53% [95% CI 8.30-18.48%]"", ""supports"": ""SUPPORT""}"
5231	5121	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	3	evidence	0	PMID:39876825	SUPPORT		In biopsied muscle specimens, common findings were mild myogenic change, increased necrotic and regenerating fibers, and inflammatory infiltrates predominating in the perivascular region.	This 2025 case series of nine MCTD myositis patients demonstrates the characteristic inflammatory myopathy with perivascular lymphocytic infiltration, muscle fiber necrosis and regeneration, and atypical weakness patterns affecting proximal and axial muscles, reflecting the heterogeneity of MCTD-associated muscle involvement.	"{""explanation"": ""This 2025 case series of nine MCTD myositis patients demonstrates the characteristic inflammatory myopathy with perivascular lymphocytic infiltration, muscle fiber necrosis and regeneration, and atypical weakness patterns affecting proximal and axial muscles, reflecting the heterogeneity of MCTD-associated muscle involvement."", ""reference"": ""PMID:39876825"", ""snippet"": ""In biopsied muscle specimens, common findings were mild myogenic change, increased necrotic and regenerating fibers, and inflammatory infiltrates predominating in the perivascular region."", ""supports"": ""SUPPORT""}"
5232	5122	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	pathophysiology	4	evidence	0	PMID:31440254	SUPPORT		We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication.	The first epigenome-wide association study in MCTD revealed widespread DNA hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) with evidence that genetic variants at IRF7 and IFI44 may exert disease risk through DNA methylation changes, establishing type I interferon pathway activation as a central molecular mechanism shared with SLE and Sjogren syndrome.	"{""explanation"": ""The first epigenome-wide association study in MCTD revealed widespread DNA hypomethylation at interferon-related genes (MX1, PARP9, DDX60, IFI44L) with evidence that genetic variants at IRF7 and IFI44 may exert disease risk through DNA methylation changes, establishing type I interferon pathway activation as a central molecular mechanism shared with SLE and Sjogren syndrome."", ""reference"": ""PMID:31440254"", ""snippet"": ""We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication."", ""supports"": ""SUPPORT""}"
5258	5149	216	Monkeypox	Monkeypox.yaml	pathophysiology	2	evidence	0	PMID:37026012	SUPPORT		Once inoculated, the viruses multiply rapidly and spread into the bloodstream to cause viremia, which then affect multiple organs.	This snippet confirms that monkeypox virus multiplies at the site of entry and spreads into the bloodstream.	"{""explanation"": ""This snippet confirms that monkeypox virus multiplies at the site of entry and spreads into the bloodstream."", ""reference"": ""PMID:37026012"", ""snippet"": ""Once inoculated, the viruses multiply rapidly and spread into the bloodstream to cause viremia, which then affect multiple organs."", ""supports"": ""SUPPORT""}"
5259	5153	216	Monkeypox	Monkeypox.yaml	pathophysiology	6	evidence	0	PMID:36253513	SUPPORT		We detected MPXV in interstitial cells and seminiferous tubules of testes as well as epididymal lumina, which are the sites of sperm production and maturation.	This reference mentions that the virus is found in specific tissues after initial replication, which supports the idea that it spreads systemically.	"{""explanation"": ""This reference mentions that the virus is found in specific tissues after initial replication, which supports the idea that it spreads systemically."", ""reference"": ""PMID:36253513"", ""snippet"": ""We detected MPXV in interstitial cells and seminiferous tubules of testes as well as epididymal lumina, which are the sites of sperm production and maturation."", ""supports"": ""SUPPORT""}"
5311	5183	217	Muenke Syndrome	Muenke_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:10696568	SUPPORT	HUMAN_CLINICAL	Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active.	This review explains that FGFR3 mutations cause varying degrees of constitutive receptor activation, which underlies the pathophysiology of Muenke syndrome and related FGFR3 disorders.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review explains that FGFR3 mutations cause varying degrees of constitutive receptor activation, which underlies the pathophysiology of Muenke syndrome and related FGFR3 disorders."", ""reference"": ""PMID:10696568"", ""snippet"": ""Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active."", ""supports"": ""SUPPORT""}"
5356	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:40636815	SUPPORT		Multiple sclerosis (MS) is a complex immune-mediated disease that leads to neurological disability	This 2024 review explicitly states the causal relationship between the immune-mediated (autoimmune) nature of MS and neurological disability.	"{""explanation"": ""This 2024 review explicitly states the causal relationship between the immune-mediated (autoimmune) nature of MS and neurological disability."", ""reference"": ""PMID:40636815"", ""snippet"": ""Multiple sclerosis (MS) is a complex immune-mediated disease that leads to neurological disability"", ""supports"": ""SUPPORT""}"
5357	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	0	PMID:24507511	SUPPORT		Multiple sclerosis (MS) is considered a prototype inflammatory autoimmune disorder of the central nervous system (CNS)... These autoreactive lymphocytes can migrate to the CNS where they become reactivated upon encountering their target antigen, initiating an autoimmune inflammatory attack. This ultimately leads to demyelination and axonal damage.	The literature supports that MS involves the immune system attacking myelin in the CNS, leading to demyelination. It specifically mentions the role of autoreactive lymphocytes, which include T and B lymphocytes.	"{""explanation"": ""The literature supports that MS involves the immune system attacking myelin in the CNS, leading to demyelination. It specifically mentions the role of autoreactive lymphocytes, which include T and B lymphocytes."", ""reference"": ""PMID:24507511"", ""snippet"": ""Multiple sclerosis (MS) is considered a prototype inflammatory autoimmune disorder of the central nervous system (CNS)... These autoreactive lymphocytes can migrate to the CNS where they become reactivated upon encountering their target antigen, initiating an autoimmune inflammatory attack. This ultimately leads to demyelination and axonal damage."", ""supports"": ""SUPPORT""}"
5358	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	1	PMID:19847447	SUPPORT		Oligodendrocytes are the myelinating cells of the central nervous system (CNS)... we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases...	The literature supports the involvement of oligodendrocytes in myelination and their loss in CNS diseases like MS, which leads to demyelination.	"{""explanation"": ""The literature supports the involvement of oligodendrocytes in myelination and their loss in CNS diseases like MS, which leads to demyelination."", ""reference"": ""PMID:19847447"", ""snippet"": ""Oligodendrocytes are the myelinating cells of the central nervous system (CNS)... we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases..."", ""supports"": ""SUPPORT""}"
5359	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	2	PMID:36889543	SUPPORT		Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating disease... CNS myelin is normally produced by oligodendroglial cells.	The literature supports that MS is a demyelinating disease affecting the CNS, with oligodendrocytes being the cells responsible for myelin production.	"{""explanation"": ""The literature supports that MS is a demyelinating disease affecting the CNS, with oligodendrocytes being the cells responsible for myelin production."", ""reference"": ""PMID:36889543"", ""snippet"": ""Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating disease... CNS myelin is normally produced by oligodendroglial cells."", ""supports"": ""SUPPORT""}"
5360	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	3	PMID:37629092	SUPPORT		Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system (CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a vital role in maintaining the integrity of myelin... However, in MS, oligodendrocytes become dysfunctional, leading to myelin damage and axonal degeneration.	The literature supports that MS involves demyelination and neurodegeneration in the CNS, with oligodendrocytes playing a crucial role in this process.	"{""explanation"": ""The literature supports that MS involves demyelination and neurodegeneration in the CNS, with oligodendrocytes playing a crucial role in this process."", ""reference"": ""PMID:37629092"", ""snippet"": ""Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system (CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a vital role in maintaining the integrity of myelin... However, in MS, oligodendrocytes become dysfunctional, leading to myelin damage and axonal degeneration."", ""supports"": ""SUPPORT""}"
5361	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	4	PMID:15727225	SUPPORT		Multiple sclerosis (MS) is characterized by multiple demyelinated inflammatory lesions disseminated in the central nervous system (CNS)... different mechanisms of demyelination, such as T-cell/macrophage-mediated demyelination, antibody/complement-mediated demyelination, and primary damage of the oligodendrocyte have been observed in individual MS patients.	The literature supports that MS involves demyelination in the CNS and mentions the role of T-cells and oligodendrocytes in this process.	"{""explanation"": ""The literature supports that MS involves demyelination in the CNS and mentions the role of T-cells and oligodendrocytes in this process."", ""reference"": ""PMID:15727225"", ""snippet"": ""Multiple sclerosis (MS) is characterized by multiple demyelinated inflammatory lesions disseminated in the central nervous system (CNS)... different mechanisms of demyelination, such as T-cell/macrophage-mediated demyelination, antibody/complement-mediated demyelination, and primary damage of the oligodendrocyte have been observed in individual MS patients."", ""supports"": ""SUPPORT""}"
5362	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	5	PMID:21425268	SUPPORT		Multiple sclerosis is an inflammatory demyelinating disease of the brain and spinal cord with a presumed autoimmune etiology... Approaches that directly protect myelin-producing oligodendrocytes and enhance remyelination may improve long-term outcomes...	The literature supports that MS is an autoimmune disease causing demyelination in the CNS, involving oligodendrocytes.	"{""explanation"": ""The literature supports that MS is an autoimmune disease causing demyelination in the CNS, involving oligodendrocytes."", ""reference"": ""PMID:21425268"", ""snippet"": ""Multiple sclerosis is an inflammatory demyelinating disease of the brain and spinal cord with a presumed autoimmune etiology... Approaches that directly protect myelin-producing oligodendrocytes and enhance remyelination may improve long-term outcomes..."", ""supports"": ""SUPPORT""}"
5363	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	6	PMID:28674983	SUPPORT		MS is a chronic inflammatory disease of the central nervous system caused by aberrant immune activation resulting in damage to myelin sheaths within the brain and spinal cord and axonal loss	The literature supports that MS involves immune activation leading to damage of myelin sheaths in the CNS.	"{""explanation"": ""The literature supports that MS involves immune activation leading to damage of myelin sheaths in the CNS."", ""reference"": ""PMID:28674983"", ""snippet"": ""MS is a chronic inflammatory disease of the central nervous system caused by aberrant immune activation resulting in damage to myelin sheaths within the brain and spinal cord and axonal loss"", ""supports"": ""SUPPORT""}"
5364	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	7	PMID:17548563	SUPPORT		Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS)... Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs)...	The literature supports that MS is an autoimmune disease involving the immune system's attack on myelin and oligodendrocytes in the CNS.	"{""explanation"": ""The literature supports that MS is an autoimmune disease involving the immune system's attack on myelin and oligodendrocytes in the CNS."", ""reference"": ""PMID:17548563"", ""snippet"": ""Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS)... Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs)..."", ""supports"": ""SUPPORT""}"
5365	5225	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	0	evidence	8	PMID:24507514	SUPPORT		This review, focused on demyelination in multiple sclerosis, is divided in two parts. The first part addresses the many and not exclusive mechanisms leading to demyelination in the central nervous system... the influence of a primary immune response against myelin antigen(s), with a diversity of potential targets.	The literature supports that MS involves immune responses against myelin antigens leading to demyelination in the CNS.	"{""explanation"": ""The literature supports that MS involves immune responses against myelin antigens leading to demyelination in the CNS."", ""reference"": ""PMID:24507514"", ""snippet"": ""This review, focused on demyelination in multiple sclerosis, is divided in two parts. The first part addresses the many and not exclusive mechanisms leading to demyelination in the central nervous system... the influence of a primary immune response against myelin antigen(s), with a diversity of potential targets."", ""supports"": ""SUPPORT""}"
5366	5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	evidence	0	PMID:21425267	SUPPORT		Here, we review distinct, but not mutually exclusive, mechanisms of pathogenesis of axonal damage in multiple sclerosis patients that are either consequent to long-term demyelination or independent from it.	The article discusses axonal damage as a significant factor in the pathogenesis of multiple sclerosis, supporting the statement that axonal damage contributes to permanent neurological deficits.	"{""explanation"": ""The article discusses axonal damage as a significant factor in the pathogenesis of multiple sclerosis, supporting the statement that axonal damage contributes to permanent neurological deficits."", ""reference"": ""PMID:21425267"", ""snippet"": ""Here, we review distinct, but not mutually exclusive, mechanisms of pathogenesis of axonal damage in multiple sclerosis patients that are either consequent to long-term demyelination or independent from it."", ""supports"": ""SUPPORT""}"
5367	5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	evidence	1	PMID:17115075	SUPPORT		Recent studies have implicated specific sodium channel isoforms as having an important role in several aspects of the pathophysiology of MS, including the restoration of impulse conduction after demyelination, axonal degeneration and the mistuning of Purkinje neurons that leads to cerebellar dysfunction.	The article mentions axonal degeneration as part of the pathophysiology of MS, supporting the statement that axonal damage contributes to permanent neurological deficits.	"{""explanation"": ""The article mentions axonal degeneration as part of the pathophysiology of MS, supporting the statement that axonal damage contributes to permanent neurological deficits."", ""reference"": ""PMID:17115075"", ""snippet"": ""Recent studies have implicated specific sodium channel isoforms as having an important role in several aspects of the pathophysiology of MS, including the restoration of impulse conduction after demyelination, axonal degeneration and the mistuning of Purkinje neurons that leads to cerebellar dysfunction."", ""supports"": ""SUPPORT""}"
5368	5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	evidence	2	PMID:25159125	SUPPORT		Axonal degeneration is a major determinant of permanent neurological impairment during multiple sclerosis (MS).	The article directly states that axonal degeneration is a major determinant of permanent neurological impairment in MS, which supports the statement.	"{""explanation"": ""The article directly states that axonal degeneration is a major determinant of permanent neurological impairment in MS, which supports the statement."", ""reference"": ""PMID:25159125"", ""snippet"": ""Axonal degeneration is a major determinant of permanent neurological impairment during multiple sclerosis (MS)."", ""supports"": ""SUPPORT""}"
5369	5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	evidence	3	PMID:31760649	SUPPORT		Demyelination and axonal damage are responsible for neurological deficits in demyelinating diseases including multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system.	The article explicitly mentions that both demyelination and axonal damage are responsible for neurological deficits in MS, supporting the statement.	"{""explanation"": ""The article explicitly mentions that both demyelination and axonal damage are responsible for neurological deficits in MS, supporting the statement."", ""reference"": ""PMID:31760649"", ""snippet"": ""Demyelination and axonal damage are responsible for neurological deficits in demyelinating diseases including multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system."", ""supports"": ""SUPPORT""}"
5370	5226	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	1	evidence	4	PMID:17884680	SUPPORT		Although neuroaxonal degeneration seems to underlie PPMS, the pathogenesis and the extent to which immune-mediated mechanisms operate is unclear.	The article discusses neuroaxonal degeneration as underlying primary-progressive multiple sclerosis (PPMS), which supports the statement.	"{""explanation"": ""The article discusses neuroaxonal degeneration as underlying primary-progressive multiple sclerosis (PPMS), which supports the statement."", ""reference"": ""PMID:17884680"", ""snippet"": ""Although neuroaxonal degeneration seems to underlie PPMS, the pathogenesis and the extent to which immune-mediated mechanisms operate is unclear."", ""supports"": ""SUPPORT""}"
5371	5227	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	2	evidence	0	PMID:21550344	SUPPORT		Leukocyte entry into the CNS is nonetheless an early event in multiple sclerosis (MS), an inflammatory disorder of the CNS... Immune cells of MS subjects express inflammatory cytokines, reactive oxygen species (ROS) and enzymes that can facilitate their migration to the CNS by influencing BBB function, either directly or indirectly.	This reference supports the statement that immune cells cross the blood-brain barrier and create inflammation in the central nervous system.	"{""explanation"": ""This reference supports the statement that immune cells cross the blood-brain barrier and create inflammation in the central nervous system."", ""reference"": ""PMID:21550344"", ""snippet"": ""Leukocyte entry into the CNS is nonetheless an early event in multiple sclerosis (MS), an inflammatory disorder of the CNS... Immune cells of MS subjects express inflammatory cytokines, reactive oxygen species (ROS) and enzymes that can facilitate their migration to the CNS by influencing BBB function, either directly or indirectly."", ""supports"": ""SUPPORT""}"
5372	5227	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	2	evidence	1	PMID:34440810	SUPPORT		During this early stage of the disease, leukocytes cross the blood-brain barrier to drive the formation of focal demyelinating plaques.	This reference directly supports the statement by mentioning that leukocytes cross the blood-brain barrier and drive the formation of focal demyelinating plaques, which are inflammatory lesions.	"{""explanation"": ""This reference directly supports the statement by mentioning that leukocytes cross the blood-brain barrier and drive the formation of focal demyelinating plaques, which are inflammatory lesions."", ""reference"": ""PMID:34440810"", ""snippet"": ""During this early stage of the disease, leukocytes cross the blood-brain barrier to drive the formation of focal demyelinating plaques."", ""supports"": ""SUPPORT""}"
5373	5227	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	2	evidence	2	PMID:30407467	SUPPORT		Neuroinflammation is triggered when peripheral leukocytes migrate to the central nervous system and release cytokines such as interleukins 1 and 6 (IL-1 and 6) and tumor necrosis factor (TNF), which act on dwelling cells.	This reference supports the statement by explaining that peripheral leukocytes migrate to the CNS and trigger neuroinflammation.	"{""explanation"": ""This reference supports the statement by explaining that peripheral leukocytes migrate to the CNS and trigger neuroinflammation."", ""reference"": ""PMID:30407467"", ""snippet"": ""Neuroinflammation is triggered when peripheral leukocytes migrate to the central nervous system and release cytokines such as interleukins 1 and 6 (IL-1 and 6) and tumor necrosis factor (TNF), which act on dwelling cells."", ""supports"": ""SUPPORT""}"
5374	5227	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	pathophysiology	2	evidence	3	PMID:29515568	SUPPORT		Astrocytes are now recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system.	This reference supports the statement by mentioning the role of astrocytes in providing access for peripheral immune cells to the CNS, contributing to lesion formation.	"{""explanation"": ""This reference supports the statement by mentioning the role of astrocytes in providing access for peripheral immune cells to the CNS, contributing to lesion formation."", ""reference"": ""PMID:29515568"", ""snippet"": ""Astrocytes are now recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system."", ""supports"": ""SUPPORT""}"
5465	5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	evidence	0	PMID:36881797	SUPPORT		Believed to be a postinfection hyperinflammatory response, the clinical manifestation of this viral sequelae can vary significantly in severity and symptomatic presentation.	The literature describes MIS-C as a postinfection hyperinflammatory response, supporting the statement.	"{""explanation"": ""The literature describes MIS-C as a postinfection hyperinflammatory response, supporting the statement."", ""reference"": ""PMID:36881797"", ""snippet"": ""Believed to be a postinfection hyperinflammatory response, the clinical manifestation of this viral sequelae can vary significantly in severity and symptomatic presentation."", ""supports"": ""SUPPORT""}"
5466	5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	evidence	1	PMID:33341814	SUPPORT		The inflammatory response generated after infection by increased proinflammatory cytokines and chemokines, and complement proteins activation may likely contribute to disease severity.	The literature indicates an abnormally heightened immune response following COVID-19 infection, which aligns with the statement.	"{""explanation"": ""The literature indicates an abnormally heightened immune response following COVID-19 infection, which aligns with the statement."", ""reference"": ""PMID:33341814"", ""snippet"": ""The inflammatory response generated after infection by increased proinflammatory cytokines and chemokines, and complement proteins activation may likely contribute to disease severity."", ""supports"": ""SUPPORT""}"
5467	5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	evidence	2	PMID:36879079	SUPPORT		On the other hand, the presence of a wide range of inflammatory manifestations, including multisystem inflammatory syndrome in children (MIS-C), in the period after infection suggests a particular susceptibility of some children toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	The literature supports that MIS-C is a post-infection condition characterized by an inflammatory response.	"{""explanation"": ""The literature supports that MIS-C is a post-infection condition characterized by an inflammatory response."", ""reference"": ""PMID:36879079"", ""snippet"": ""On the other hand, the presence of a wide range of inflammatory manifestations, including multisystem inflammatory syndrome in children (MIS-C), in the period after infection suggests a particular susceptibility of some children toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."", ""supports"": ""SUPPORT""}"
5468	5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	evidence	3	PMID:35183528	SUPPORT		Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock.	The literature describes MIS-C as associated with a hyperinflammatory state post-COVID-19 infection, supporting the statement.	"{""explanation"": ""The literature describes MIS-C as associated with a hyperinflammatory state post-COVID-19 infection, supporting the statement."", ""reference"": ""PMID:35183528"", ""snippet"": ""Since the COVID-19 pandemic began, a cohort of Multisystem inflammatory syndrome in children (MIS-C) patients has been described. Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock."", ""supports"": ""SUPPORT""}"
5469	5270	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	0	evidence	4	PMID:38864099	SUPPORT		PIMS-TS is a rare hyperinflammatory immune response syndrome, usually occurring two to six weeks after SARS-CoV-2 infection, which mainly affects schoolchildren and is often associated with the need for intensive care.	The literature describes PIMS-TS (another term for MIS-C) as a hyperinflammatory response following COVID-19 infection, supporting the statement.	"{""explanation"": ""The literature describes PIMS-TS (another term for MIS-C) as a hyperinflammatory response following COVID-19 infection, supporting the statement."", ""reference"": ""PMID:38864099"", ""snippet"": ""PIMS-TS is a rare hyperinflammatory immune response syndrome, usually occurring two to six weeks after SARS-CoV-2 infection, which mainly affects schoolchildren and is often associated with the need for intensive care."", ""supports"": ""SUPPORT""}"
5470	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	evidence	0	PMID:34463724	SUPPORT		MIS-C has unique inflammatory signatures involving both adaptive and innate systems. Certain cytokines, inflammatory markers, and cardiac markers assist in the differentiation of MIS-C from other hyperinflammatory conditions.	The abstract indicates that MIS-C is characterized by unique inflammatory signatures involving cytokines, which supports the description of excessive production of pro-inflammatory cytokines leading to widespread inflammation.	"{""explanation"": ""The abstract indicates that MIS-C is characterized by unique inflammatory signatures involving cytokines, which supports the description of excessive production of pro-inflammatory cytokines leading to widespread inflammation."", ""reference"": ""PMID:34463724"", ""snippet"": ""MIS-C has unique inflammatory signatures involving both adaptive and innate systems. Certain cytokines, inflammatory markers, and cardiac markers assist in the differentiation of MIS-C from other hyperinflammatory conditions."", ""supports"": ""SUPPORT""}"
5471	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	evidence	1	PMID:32961074	SUPPORT		The COVID-19 disease pathology is plausibly linked to the hyperinflammatory response of the body characterized by pathological cytokine levels. The term 'cytokine storm syndrome' is perhaps one of the critical hallmarks of COVID-19 disease severity.	The abstract describes the hyperinflammatory response and cytokine storm syndrome associated with COVID-19, which is related to MIS-C, supporting the statement about excessive production of pro-inflammatory cytokines.	"{""explanation"": ""The abstract describes the hyperinflammatory response and cytokine storm syndrome associated with COVID-19, which is related to MIS-C, supporting the statement about excessive production of pro-inflammatory cytokines."", ""reference"": ""PMID:32961074"", ""snippet"": ""The COVID-19 disease pathology is plausibly linked to the hyperinflammatory response of the body characterized by pathological cytokine levels. The term 'cytokine storm syndrome' is perhaps one of the critical hallmarks of COVID-19 disease severity."", ""supports"": ""SUPPORT""}"
5472	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	evidence	2	PMID:33023287	SUPPORT		These symptoms include malaise, myalgias, chest tightness, brain fog and other neuropsychiatric symptoms that were originally reported in children and named Multisystem Inflammatory Syndrome (MIS-C).	The abstract links MIS-C to a range of inflammatory symptoms, supporting the idea of widespread inflammation due to excessive cytokine production.	"{""explanation"": ""The abstract links MIS-C to a range of inflammatory symptoms, supporting the idea of widespread inflammation due to excessive cytokine production."", ""reference"": ""PMID:33023287"", ""snippet"": ""These symptoms include malaise, myalgias, chest tightness, brain fog and other neuropsychiatric symptoms that were originally reported in children and named Multisystem Inflammatory Syndrome (MIS-C)."", ""supports"": ""SUPPORT""}"
5473	5271	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	pathophysiology	1	evidence	3	PMID:35275051	SUPPORT		Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory state that occurs after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.	The abstract describes MIS-C as a hyperinflammatory state, which aligns with the statement about excessive production of pro-inflammatory cytokines leading to widespread inflammation.	"{""explanation"": ""The abstract describes MIS-C as a hyperinflammatory state, which aligns with the statement about excessive production of pro-inflammatory cytokines leading to widespread inflammation."", ""reference"": ""PMID:35275051"", ""snippet"": ""Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory state that occurs after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection."", ""supports"": ""SUPPORT""}"
5541	5301	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:37226227	SUPPORT		several studies validated the involvement of immune dysfunction in the pathology of ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of illness	The BMC Medicine systematic review identifies immune dysfunction as the most reproducible finding in ME/CFS.	"{""explanation"": ""The BMC Medicine systematic review identifies immune dysfunction as the most reproducible finding in ME/CFS."", ""reference"": ""PMID:37226227"", ""snippet"": ""several studies validated the involvement of immune dysfunction in the pathology of ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of illness"", ""supports"": ""SUPPORT""}"
5542	5302	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:31727160	SUPPORT		Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications	Systematic review of 17 studies confirms NK cell dysfunction as the most reproducible immunological finding in ME/CFS.	"{""explanation"": ""Systematic review of 17 studies confirms NK cell dysfunction as the most reproducible immunological finding in ME/CFS."", ""reference"": ""PMID:31727160"", ""snippet"": ""Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications"", ""supports"": ""SUPPORT""}"
5543	5302	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:27245705	SUPPORT		There was a significant reduction of TRPM3 surface expression on CD19(+) B cells (1.56 ± 0.191) and CD56(bright) NK cells (17.37 % ± 5.34) in CFS/ME compared with healthy controls	This study demonstrates reduced TRPM3 expression on NK cells in ME/CFS.	"{""explanation"": ""This study demonstrates reduced TRPM3 expression on NK cells in ME/CFS."", ""reference"": ""PMID:27245705"", ""snippet"": ""There was a significant reduction of TRPM3 surface expression on CD19(+) B cells (1.56 ± 0.191) and CD56(bright) NK cells (17.37 % ± 5.34) in CFS/ME compared with healthy controls"", ""supports"": ""SUPPORT""}"
5544	5303	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:37226227	SUPPORT		Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological (29.7%), metabolomics/mitochondrial/microbiome (14.85%)	Systematic review documents diverse biomarker categories including immune and metabolic dysfunction in ME/CFS.	"{""explanation"": ""Systematic review documents diverse biomarker categories including immune and metabolic dysfunction in ME/CFS."", ""reference"": ""PMID:37226227"", ""snippet"": ""Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological (29.7%), metabolomics/mitochondrial/microbiome (14.85%)"", ""supports"": ""SUPPORT""}"
5545	5304	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:36730360	SUPPORT		ME/CFS patients had markedly reduced FMD compared to healthy controls at baseline (5.1% vs. 8.2%)	Clinical study demonstrates impaired flow-mediated dilation indicating vascular dysfunction in ME/CFS.	"{""explanation"": ""Clinical study demonstrates impaired flow-mediated dilation indicating vascular dysfunction in ME/CFS."", ""reference"": ""PMID:36730360"", ""snippet"": ""ME/CFS patients had markedly reduced FMD compared to healthy controls at baseline (5.1% vs. 8.2%)"", ""supports"": ""SUPPORT""}"
5546	5305	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:31736966	SUPPORT		TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated from ME/CFS patients after incubation for 24 h with NTX	Research demonstrates impaired TRPM3 function in ME/CFS NK cells and potential for pharmacological restoration.	"{""explanation"": ""Research demonstrates impaired TRPM3 function in ME/CFS NK cells and potential for pharmacological restoration."", ""reference"": ""PMID:31736966"", ""snippet"": ""TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated from ME/CFS patients after incubation for 24 h with NTX"", ""supports"": ""SUPPORT""}"
5547	5306	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:32873297	SUPPORT		Additional brain area recruitment for cognitive tasks and abnormalities in the brain stem are frequent observations	Systematic review of 63 neuroimaging studies supports CNS involvement in ME/CFS.	"{""explanation"": ""Systematic review of 63 neuroimaging studies supports CNS involvement in ME/CFS."", ""reference"": ""PMID:32873297"", ""snippet"": ""Additional brain area recruitment for cognitive tasks and abnormalities in the brain stem are frequent observations"", ""supports"": ""SUPPORT""}"
5548	5307	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	pathophysiology	6	evidence	0	PMID:22837795	SUPPORT		all patients tested have measureable mitochondrial dysfunction which correlates with the severity of the illness	ATP Profile testing demonstrates mitochondrial dysfunction in ME/CFS patients correlating with disease severity.	"{""explanation"": ""ATP Profile testing demonstrates mitochondrial dysfunction in ME/CFS patients correlating with disease severity."", ""reference"": ""PMID:22837795"", ""snippet"": ""all patients tested have measureable mitochondrial dysfunction which correlates with the severity of the illness"", ""supports"": ""SUPPORT""}"
5564	5336	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	0	evidence	0	PMID:37869140	SUPPORT		Myasthenia gravis is a prototypic neuroimmune disorder with autoantibodies targeting the acetylcholine receptor complex at the neuromuscular junction.	Confirms that autoantibodies targeting the AChR complex at the NMJ are central to myasthenia gravis pathophysiology.	"{""explanation"": ""Confirms that autoantibodies targeting the AChR complex at the NMJ are central to myasthenia gravis pathophysiology."", ""reference"": ""PMID:37869140"", ""snippet"": ""Myasthenia gravis is a prototypic neuroimmune disorder with autoantibodies targeting the acetylcholine receptor complex at the neuromuscular junction."", ""supports"": ""SUPPORT""}"
5565	5336	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	0	evidence	1	PMID:29266249	SUPPORT		Approximately 74-88% of patients with gMG have acetylcholine receptor (AChR) autoantibodies.	Documents the prevalence of AChR autoantibodies in generalized myasthenia gravis.	"{""explanation"": ""Documents the prevalence of AChR autoantibodies in generalized myasthenia gravis."", ""reference"": ""PMID:29266249"", ""snippet"": ""Approximately 74-88% of patients with gMG have acetylcholine receptor (AChR) autoantibodies."", ""supports"": ""SUPPORT""}"
5566	5337	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	1	evidence	0	PMID:29266249	SUPPORT		activation and amplification of complement results in the formation of membrane attack complexes (MACs), lipophilic proteins that damage cell membranes.	Describes how complement activation leads to MAC formation and subsequent membrane damage.	"{""explanation"": ""Describes how complement activation leads to MAC formation and subsequent membrane damage."", ""reference"": ""PMID:29266249"", ""snippet"": ""activation and amplification of complement results in the formation of membrane attack complexes (MACs), lipophilic proteins that damage cell membranes."", ""supports"": ""SUPPORT""}"
5567	5337	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	1	evidence	1	PMID:29266249	SUPPORT		Studies in animals lacking specific complement proteins have confirmed that MAC formation is required to induce experimental autoimmune MG (EAMG) and NMJ damage.	Animal studies demonstrate that MAC formation is essential for NMJ damage in myasthenia gravis.	"{""explanation"": ""Animal studies demonstrate that MAC formation is essential for NMJ damage in myasthenia gravis."", ""reference"": ""PMID:29266249"", ""snippet"": ""Studies in animals lacking specific complement proteins have confirmed that MAC formation is required to induce experimental autoimmune MG (EAMG) and NMJ damage."", ""supports"": ""SUPPORT""}"
5568	5337	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	1	evidence	2	PMID:37869140	SUPPORT		Acetylcholine receptor antibodies are present in the majority of patients and are of IgG1 and IgG3 subtypes which can activate the complement system. The complement involvement plays a major role in the neuromuscular junction damage.	Confirms that AChR antibodies (IgG1 and IgG3) activate complement, contributing to NMJ damage.	"{""explanation"": ""Confirms that AChR antibodies (IgG1 and IgG3) activate complement, contributing to NMJ damage."", ""reference"": ""PMID:37869140"", ""snippet"": ""Acetylcholine receptor antibodies are present in the majority of patients and are of IgG1 and IgG3 subtypes which can activate the complement system. The complement involvement plays a major role in the neuromuscular junction damage."", ""supports"": ""SUPPORT""}"
5569	5338	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	2	evidence	0	PMID:21922466	SUPPORT		The thymus plays a major role in the pathogenesis of MG with anti-AChR antibodies: it shows marked pathologic alterations (hyperplastic or tumoral) in most AChR-positive patients and contains the elements required to initiate and sustain an autoimmune reaction (AChR autoantigen, AChR-specific T cells, and autoantibody-secreting plasma cells).	Demonstrates that the thymus shows pathologic changes in most AChR-positive MG patients and contains all elements needed to initiate and sustain autoimmunity.	"{""explanation"": ""Demonstrates that the thymus shows pathologic changes in most AChR-positive MG patients and contains all elements needed to initiate and sustain autoimmunity."", ""reference"": ""PMID:21922466"", ""snippet"": ""The thymus plays a major role in the pathogenesis of MG with anti-AChR antibodies: it shows marked pathologic alterations (hyperplastic or tumoral) in most AChR-positive patients and contains the elements required to initiate and sustain an autoimmune reaction (AChR autoantigen, AChR-specific T cells, and autoantibody-secreting plasma cells)."", ""supports"": ""SUPPORT""}"
5570	5338	222	Myasthenia Gravis	Myasthenia_Gravis.yaml	pathophysiology	2	evidence	1	PMID:21922466	SUPPORT		Myasthenia gravis (MG) is an autoimmune disorder caused, in most cases, by autoantibodies against components of the neuromuscular junction, frequently the acetylcholine receptor (AChR), and less often the muscle-specific kinase receptor.	Confirms the autoimmune nature of myasthenia gravis with autoantibodies targeting NMJ components.	"{""explanation"": ""Confirms the autoimmune nature of myasthenia gravis with autoantibodies targeting NMJ components."", ""reference"": ""PMID:21922466"", ""snippet"": ""Myasthenia gravis (MG) is an autoimmune disorder caused, in most cases, by autoantibodies against components of the neuromuscular junction, frequently the acetylcholine receptor (AChR), and less often the muscle-specific kinase receptor."", ""supports"": ""SUPPORT""}"
5578	5355	223	Mycetoma	Mycetoma.yaml	pathophysiology	0	evidence	0	PMID:35887499	SUPPORT		Mycetoma describes a heterogeneous group of cutaneous and subcutaneous infections caused by either fungi (eumycetomas) or bacteria (actinomycetomas).	The abstract defines mycetoma as fungal or bacterial cutaneous/subcutaneous infection.	"{""explanation"": ""The abstract defines mycetoma as fungal or bacterial cutaneous/subcutaneous infection."", ""reference"": ""PMID:35887499"", ""snippet"": ""Mycetoma describes a heterogeneous group of cutaneous and subcutaneous infections caused by either fungi (eumycetomas) or bacteria (actinomycetomas)."", ""supports"": ""SUPPORT""}"
5581	5361	224	Acute Myeloid Leukemia, NPM1-Mutated	NPM1_Mutant_AML.yaml	pathophysiology	0	evidence	0	PMID:40647396	SUPPORT		The aberrant localization of the mutated nucleophosmin (NPM1) protein in the cytoplasm is the hallmark of the development of acute myeloid leukemia (AML)	This abstract identifies cytoplasmic NPM1 as a hallmark of NPM1-mutated AML, supporting the mislocalization mechanism.	"{""explanation"": ""This abstract identifies cytoplasmic NPM1 as a hallmark of NPM1-mutated AML, supporting the mislocalization mechanism."", ""reference"": ""PMID:40647396"", ""snippet"": ""The aberrant localization of the mutated nucleophosmin (NPM1) protein in the cytoplasm is the hallmark of the development of acute myeloid leukemia (AML)"", ""supports"": ""SUPPORT""}"
5583	5379	225	NRAS Mutant Melanoma	NRAS_Mutant_Melanoma.yaml	pathophysiology	0	evidence	0	PMID:40023845	SUPPORT		Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively.	This abstract reports hotspot NRAS mutations in a substantial fraction of cutaneous melanomas, supporting the NRAS-mutant subtype.	"{""explanation"": ""This abstract reports hotspot NRAS mutations in a substantial fraction of cutaneous melanomas, supporting the NRAS-mutant subtype."", ""reference"": ""PMID:40023845"", ""snippet"": ""Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively."", ""supports"": ""SUPPORT""}"
5588	5396	226	NTRK Fusion-Positive Cancer	NTRK_Fusion_Positive_Cancer.yaml	pathophysiology	0	evidence	0	PMID:39988443	SUPPORT		Fusion variations of neurotrophic receptor tyrosine kinase (NTRK) are oncogenic drivers in various solid tumors such as breast cancer, salivary gland carcinoma, infant fibrosarcoma, etc.	Supports NTRK fusions as oncogenic drivers across solid tumors.	"{""explanation"": ""Supports NTRK fusions as oncogenic drivers across solid tumors."", ""reference"": ""PMID:39988443"", ""snippet"": ""Fusion variations of neurotrophic receptor tyrosine kinase (NTRK) are oncogenic drivers in various solid tumors such as breast cancer, salivary gland carcinoma, infant fibrosarcoma, etc."", ""supports"": ""SUPPORT""}"
5594	5413	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	0	evidence	0	PMID:25728441	SUPPORT		Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus.	Landmark review establishes hypocretin neuron loss as the cause of narcolepsy with cataplexy.	"{""explanation"": ""Landmark review establishes hypocretin neuron loss as the cause of narcolepsy with cataplexy."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."", ""supports"": ""SUPPORT""}"
5595	5414	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	1	evidence	0	PMID:25728441	SUPPORT		The hypothesis that a targeted immune-mediated or autoimmune attack causes the specific degeneration of hypocretin neurons arose mainly through the discovery of genetic associations, first with the HLA-DQB1*06:02 allele and then with the T-cell receptor α locus.	Genetic associations with HLA and TCR loci strongly support autoimmune etiology.	"{""explanation"": ""Genetic associations with HLA and TCR loci strongly support autoimmune etiology."", ""reference"": ""PMID:25728441"", ""snippet"": ""The hypothesis that a targeted immune-mediated or autoimmune attack causes the specific degeneration of hypocretin neurons arose mainly through the discovery of genetic associations, first with the HLA-DQB1*06:02 allele and then with the T-cell receptor α locus."", ""supports"": ""SUPPORT""}"
5596	5414	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	1	evidence	1	PMID:32227223	SUPPORT		Narcolepsy type 1 is hypothesized to be an autoimmune disease targeting the hypocretin/orexin neurons in the hypothalamus. Ample genetic and epidemiological evidence points in the direction of a pathogenesis involving the immune system	Recent review summarizing that genetic and epidemiological evidence supports autoimmune pathogenesis.	"{""explanation"": ""Recent review summarizing that genetic and epidemiological evidence supports autoimmune pathogenesis."", ""reference"": ""PMID:32227223"", ""snippet"": ""Narcolepsy type 1 is hypothesized to be an autoimmune disease targeting the hypocretin/orexin neurons in the hypothalamus. Ample genetic and epidemiological evidence points in the direction of a pathogenesis involving the immune system"", ""supports"": ""SUPPORT""}"
5597	5414	227	Narcolepsy	Narcolepsy.yaml	pathophysiology	1	evidence	2	PMID:38077397	SUPPORT		NT1 is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons. The mechanisms involved in the destruction of orexin neurons are not yet elucidated but the association of narcolepsy with environmental triggers and genetic susceptibility (strong association with the HLA, TCRs and other immunologically-relevant loci) implicates an immuno-pathological process.	Transcriptomic study confirms the immunological basis and T-cell involvement in narcolepsy pathogenesis.	"{""explanation"": ""Transcriptomic study confirms the immunological basis and T-cell involvement in narcolepsy pathogenesis."", ""reference"": ""PMID:38077397"", ""snippet"": ""NT1 is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons. The mechanisms involved in the destruction of orexin neurons are not yet elucidated but the association of narcolepsy with environmental triggers and genetic susceptibility (strong association with the HLA, TCRs and other immunologically-relevant loci) implicates an immuno-pathological process."", ""supports"": ""SUPPORT""}"
5639	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	evidence	0	PMID:19118152	SUPPORT		Nephronophthisis (NPHP), a recessive cystic kidney disease... Mutations in NPHP genes cause defects in signaling mechanisms that involve the noncanonical Wnt signaling pathway and the sonic hedgehog signaling pathway, resulting in defects of planar cell polarity and tissue maintenance.	The provided snippet indicates that mutations in NPHP genes affect mechanisms that disrupt cellular functions related to cilia, supporting the statement that these mutations lead to impaired cilia.	"{""explanation"": ""The provided snippet indicates that mutations in NPHP genes affect mechanisms that disrupt cellular functions related to cilia, supporting the statement that these mutations lead to impaired cilia."", ""reference"": ""PMID:19118152"", ""snippet"": ""Nephronophthisis (NPHP), a recessive cystic kidney disease... Mutations in NPHP genes cause defects in signaling mechanisms that involve the noncanonical Wnt signaling pathway and the sonic hedgehog signaling pathway, resulting in defects of planar cell polarity and tissue maintenance."", ""supports"": ""SUPPORT""}"
5640	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	evidence	1	PMID:34183231	SUPPORT		Mutations in genes encoding centriolar or ciliary proteins cause diseases collectively known as 'ciliopathies'.	This statement refers to how ciliary protein gene mutations cause related ciliopathies, aligning with impaired cilia as seen in Nephronophthisis.	"{""explanation"": ""This statement refers to how ciliary protein gene mutations cause related ciliopathies, aligning with impaired cilia as seen in Nephronophthisis."", ""reference"": ""PMID:34183231"", ""snippet"": ""Mutations in genes encoding centriolar or ciliary proteins cause diseases collectively known as 'ciliopathies'."", ""supports"": ""SUPPORT""}"
5641	5465	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	0	evidence	2	PMID:21113628	SUPPORT		Ciliary dysfunction has emerged as a common factor underlying the pathogenesis of both syndromic and isolated kidney cystic disease, an observation that has contributed to the unification of human genetic disorders of the cilium, the ciliopathies.	The excerpt affirms that ciliary dysfunction is fundamental to the development of various cystic kidney diseases, including Nephronophthisis, caused by mutations affecting cilia.	"{""explanation"": ""The excerpt affirms that ciliary dysfunction is fundamental to the development of various cystic kidney diseases, including Nephronophthisis, caused by mutations affecting cilia."", ""reference"": ""PMID:21113628"", ""snippet"": ""Ciliary dysfunction has emerged as a common factor underlying the pathogenesis of both syndromic and isolated kidney cystic disease, an observation that has contributed to the unification of human genetic disorders of the cilium, the ciliopathies."", ""supports"": ""SUPPORT""}"
5642	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	evidence	0	PMID:19186246	PARTIAL		Their importance for key developmental pathways such as Sonic Hedgehog (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example, is vital for breaking early embryonic symmetry, Shh signaling is important for tissue morphogenesis and successful Wnt signaling for organ growth and differentiation. When ciliary function is perturbed...brains form improperly.	This reference supports the idea that disrupted cilia function affects the Wnt and Hedgehog pathways, but it does not specify nephronophthisis directly.	"{""explanation"": ""This reference supports the idea that disrupted cilia function affects the Wnt and Hedgehog pathways, but it does not specify nephronophthisis directly."", ""reference"": ""PMID:19186246"", ""snippet"": ""Their importance for key developmental pathways such as Sonic Hedgehog (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example, is vital for breaking early embryonic symmetry, Shh signaling is important for tissue morphogenesis and successful Wnt signaling for organ growth and differentiation. When ciliary function is perturbed...brains form improperly."", ""supports"": ""PARTIAL""}"
5643	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	evidence	1	PMID:22206729	SUPPORT		Mutations of the ankyrin-repeat protein Inversin, a member of a diverse family of more than 12 proteins, cause nephronophthisis (NPH)...Most NPH gene products (NPHPs) localize to the cilium, and appear to control the transport of cargo protein to the cilium by forming functional networks.	This reference directly links nephronophthisis to defective cilia and mentions involvement in pathways like Wnt signaling.	"{""explanation"": ""This reference directly links nephronophthisis to defective cilia and mentions involvement in pathways like Wnt signaling."", ""reference"": ""PMID:22206729"", ""snippet"": ""Mutations of the ankyrin-repeat protein Inversin, a member of a diverse family of more than 12 proteins, cause nephronophthisis (NPH)...Most NPH gene products (NPHPs) localize to the cilium, and appear to control the transport of cargo protein to the cilium by forming functional networks."", ""supports"": ""SUPPORT""}"
5644	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	evidence	2	PMID:24162855	PARTIAL		The primary cilium, a microtubule-based organelle that can serve as a signaling antenna, has been demonstrated to have a significant role in ensuring correct kidney development and function...one of the signaling pathways that requires the cilium for normal development is Wnt signaling.	This reference supports the involvement of the primary cilium in Wnt signaling but does not explicitly connect it to nephronophthisis.	"{""explanation"": ""This reference supports the involvement of the primary cilium in Wnt signaling but does not explicitly connect it to nephronophthisis."", ""reference"": ""PMID:24162855"", ""snippet"": ""The primary cilium, a microtubule-based organelle that can serve as a signaling antenna, has been demonstrated to have a significant role in ensuring correct kidney development and function...one of the signaling pathways that requires the cilium for normal development is Wnt signaling."", ""supports"": ""PARTIAL""}"
5645	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	evidence	3	PMID:20544799	PARTIAL		mutation of proteins required for function of cilia often leads to impaired Shh signaling and to disruption of neural tube closure.	This reference supports the idea that ciliary dysfunction affects Hedgehog signaling but focuses on neural tube defects rather than nephronophthisis.	"{""explanation"": ""This reference supports the idea that ciliary dysfunction affects Hedgehog signaling but focuses on neural tube defects rather than nephronophthisis."", ""reference"": ""PMID:20544799"", ""snippet"": ""mutation of proteins required for function of cilia often leads to impaired Shh signaling and to disruption of neural tube closure."", ""supports"": ""PARTIAL""}"
5646	5466	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	1	evidence	4	PMID:35655331	SUPPORT		Ciliary dysfunction causes many human conditions termed ciliopathies...ciliopathy spectrum could be the poster child for advances and challenges in Mendelian human genetics over the past half century...illustrates many core concepts of human genetics.	This reference supports the concept that defects in the primary cilia affect key signaling pathways, including the ones mentioned, in the context of nephronophthisis.	"{""explanation"": ""This reference supports the concept that defects in the primary cilia affect key signaling pathways, including the ones mentioned, in the context of nephronophthisis."", ""reference"": ""PMID:35655331"", ""snippet"": ""Ciliary dysfunction causes many human conditions termed ciliopathies...ciliopathy spectrum could be the poster child for advances and challenges in Mendelian human genetics over the past half century...illustrates many core concepts of human genetics."", ""supports"": ""SUPPORT""}"
5647	5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	evidence	0	PMID:21071979	PARTIAL		Nephronophthisis is a recessive disorder of the kidney that is the leading cause of end-stage renal failure in children. Through positional cloning, many of the causative mutations have been mapped to genes involved in centrosome and cilia function.	The literature supports that nephronophthisis is related to ciliary dysfunction, but it does not explicitly mention polyuria and polydipsia as part of its pathophysiology.	"{""explanation"": ""The literature supports that nephronophthisis is related to ciliary dysfunction, but it does not explicitly mention polyuria and polydipsia as part of its pathophysiology."", ""reference"": ""PMID:21071979"", ""snippet"": ""Nephronophthisis is a recessive disorder of the kidney that is the leading cause of end-stage renal failure in children. Through positional cloning, many of the causative mutations have been mapped to genes involved in centrosome and cilia function."", ""supports"": ""PARTIAL""}"
5648	5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	evidence	1	PMID:16186680	PARTIAL		Renal tubular disorders may affect multiple (e.g., Fanconi syndrome) or specific (e.g., nephrogenic diabetes insipidus, renal glucosuria) tubular functions. Most conditions are primary and monogenic but occasionally are secondary to other disorders.	The reference discusses renal tubular disorders, which can result in polyuria and electrolyte imbalance, but it does not explicitly link these to ciliary dysfunction in nephronophthisis.	"{""explanation"": ""The reference discusses renal tubular disorders, which can result in polyuria and electrolyte imbalance, but it does not explicitly link these to ciliary dysfunction in nephronophthisis."", ""reference"": ""PMID:16186680"", ""snippet"": ""Renal tubular disorders may affect multiple (e.g., Fanconi syndrome) or specific (e.g., nephrogenic diabetes insipidus, renal glucosuria) tubular functions. Most conditions are primary and monogenic but occasionally are secondary to other disorders."", ""supports"": ""PARTIAL""}"
5649	5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	evidence	2	PMID:9790573	PARTIAL		Cysts originate within the glomeruli and all tubular structures, and their growth is the result of proliferation of incompletely differentiated epithelial cells and the accumulation of fluid within the cysts.	While the reference discusses fluid accumulation and cyst formation in polycystic kidney disease, it does not directly link these to nephronophthisis or explicitly mention polyuria.	"{""explanation"": ""While the reference discusses fluid accumulation and cyst formation in polycystic kidney disease, it does not directly link these to nephronophthisis or explicitly mention polyuria."", ""reference"": ""PMID:9790573"", ""snippet"": ""Cysts originate within the glomeruli and all tubular structures, and their growth is the result of proliferation of incompletely differentiated epithelial cells and the accumulation of fluid within the cysts."", ""supports"": ""PARTIAL""}"
5650	5467	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	2	evidence	3	PMID:18312782	PARTIAL		Overlapping clinical entities including situs inversus, certain infertility disorders, as well as chronic respiratory infections have their roots in abnormal ciliary function.	This reference supports the involvement of ciliary dysfunction in various disorders but does not provide specific details on nephronophthisis and its pathophysiology related to polyuria and polydipsia.	"{""explanation"": ""This reference supports the involvement of ciliary dysfunction in various disorders but does not provide specific details on nephronophthisis and its pathophysiology related to polyuria and polydipsia."", ""reference"": ""PMID:18312782"", ""snippet"": ""Overlapping clinical entities including situs inversus, certain infertility disorders, as well as chronic respiratory infections have their roots in abnormal ciliary function."", ""supports"": ""PARTIAL""}"
5651	5468	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	3	evidence	0	PMID:35533128	SUPPORT		Diagnosis is made by a positive genetic test, or a kidney biopsy demonstrating chronic tubulointerstitial changes with thickening of the tubular basement membranes.	The diagnosis of nephronophthisis includes tubulointerstitial changes, which aligns with chronic tubular dysfunction and inflammation leading to interstitial fibrosis.	"{""explanation"": ""The diagnosis of nephronophthisis includes tubulointerstitial changes, which aligns with chronic tubular dysfunction and inflammation leading to interstitial fibrosis."", ""reference"": ""PMID:35533128"", ""snippet"": ""Diagnosis is made by a positive genetic test, or a kidney biopsy demonstrating chronic tubulointerstitial changes with thickening of the tubular basement membranes."", ""supports"": ""SUPPORT""}"
5652	5468	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	3	evidence	1	PMID:31399984	PARTIAL		Renal interstitial lymphangiogenesis is found in patients with chronic kidney disease (CKD) and a series of animal models of renal fibrosis.	While the study focuses on lymphangiogenesis, it mentions renal interstitial fibrosis related to chronic kidney disease, of which nephronophthisis is a type.	"{""explanation"": ""While the study focuses on lymphangiogenesis, it mentions renal interstitial fibrosis related to chronic kidney disease, of which nephronophthisis is a type."", ""reference"": ""PMID:31399984"", ""snippet"": ""Renal interstitial lymphangiogenesis is found in patients with chronic kidney disease (CKD) and a series of animal models of renal fibrosis."", ""supports"": ""PARTIAL""}"
5653	5469	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	4	evidence	0	PMID:16966065	WRONG_STATEMENT		Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure.	The statement claims that abnormal cell proliferation and differentiation result in cyst formation in nephronophthisis, but the literature describes nephronophthisis as a chronic tubulo-interstitial nephritis without indicating cyst formation due to abnormal cell proliferation and differentiation as a characteristic pathophysiological mechanism. Instead, it mentions cortical microcysts in infantile forms but emphasizes interstitial fibrosis and tubular basement membrane changes.	"{""explanation"": ""The statement claims that abnormal cell proliferation and differentiation result in cyst formation in nephronophthisis, but the literature describes nephronophthisis as a chronic tubulo-interstitial nephritis without indicating cyst formation due to abnormal cell proliferation and differentiation as a characteristic pathophysiological mechanism. Instead, it mentions cortical microcysts in infantile forms but emphasizes interstitial fibrosis and tubular basement membrane changes."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."", ""supports"": ""WRONG_STATEMENT""}"
5654	5469	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	4	evidence	1	PMID:25575298	NO_EVIDENCE		Almost all of proteins associated with a broad spectrum of human cystic kidney diseases have been localized to the region in or around the cilia.	While this reference discusses abnormal cilia structure and function in cystic kidney diseases, it does not specifically address nephronophthisis or the mechanism of abnormal cell proliferation and differentiation leading to renal cyst formation in nephronophthisis.	"{""explanation"": ""While this reference discusses abnormal cilia structure and function in cystic kidney diseases, it does not specifically address nephronophthisis or the mechanism of abnormal cell proliferation and differentiation leading to renal cyst formation in nephronophthisis."", ""reference"": ""PMID:25575298"", ""snippet"": ""Almost all of proteins associated with a broad spectrum of human cystic kidney diseases have been localized to the region in or around the cilia."", ""supports"": ""NO_EVIDENCE""}"
5655	5470	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	5	evidence	0	PMID:16966065	SUPPORT		Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure... Histologic lesions concern tubular basement membranes which are thickened and multilayered or thinned. There is an associated interstitial fibrosis.	The provided excerpt mentions chronic tubulo-interstitial nephritis (tubular dysfunction and interstitial fibrosis) and progression to terminal renal failure, supporting the statement that these factors contribute to ESRD.	"{""explanation"": ""The provided excerpt mentions chronic tubulo-interstitial nephritis (tubular dysfunction and interstitial fibrosis) and progression to terminal renal failure, supporting the statement that these factors contribute to ESRD."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure... Histologic lesions concern tubular basement membranes which are thickened and multilayered or thinned. There is an associated interstitial fibrosis."", ""supports"": ""SUPPORT""}"
5656	5470	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	5	evidence	1	PMID:10352410	PARTIAL		Progressive renal disease poses an increasing problem for the medical community. Though the causes of end-stage renal failure are multiple, the histologic pictures of chronic renal disease are remarkably similar being characterized by interstitial infiltration, fibrosis, tubular atrophy and dilatation.	This literature indicates the role of interstitial infiltration, fibrosis, and tubular atrophy leading to ESRD, which partially overlaps with the factors mentioned in the statement. However, cyst formation specific to nephronophthisis was not explicitly mentioned.	"{""explanation"": ""This literature indicates the role of interstitial infiltration, fibrosis, and tubular atrophy leading to ESRD, which partially overlaps with the factors mentioned in the statement. However, cyst formation specific to nephronophthisis was not explicitly mentioned."", ""reference"": ""PMID:10352410"", ""snippet"": ""Progressive renal disease poses an increasing problem for the medical community. Though the causes of end-stage renal failure are multiple, the histologic pictures of chronic renal disease are remarkably similar being characterized by interstitial infiltration, fibrosis, tubular atrophy and dilatation."", ""supports"": ""PARTIAL""}"
5657	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	evidence	0	PMID:35533128	PARTIAL		Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis.	The literature supports the involvement of the liver and retina in nephronophthisis but does not mention the brain specifically in this context.	"{""explanation"": ""The literature supports the involvement of the liver and retina in nephronophthisis but does not mention the brain specifically in this context."", ""reference"": ""PMID:35533128"", ""snippet"": ""Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."", ""supports"": ""PARTIAL""}"
5658	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	evidence	1	PMID:32432520	PARTIAL		Senior-Løken syndrome (SLS) is a rare autosomal recessive disease characterised by nephronophthisis and retinal degeneration, and belongs to a group of genetically heterogeneous disorders known as the ciliopathies.	The literature supports the involvement of the retina in Senior-Loken syndrome but does not mention the liver or brain specifically in this context.	"{""explanation"": ""The literature supports the involvement of the retina in Senior-Loken syndrome but does not mention the liver or brain specifically in this context."", ""reference"": ""PMID:32432520"", ""snippet"": ""Senior-Løken syndrome (SLS) is a rare autosomal recessive disease characterised by nephronophthisis and retinal degeneration, and belongs to a group of genetically heterogeneous disorders known as the ciliopathies."", ""supports"": ""PARTIAL""}"
5659	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	evidence	2	PMID:33306870	SUPPORT		Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis and retinal degeneration, leading to end-stage renal disease and progressive blindness.	The literature supports the involvement of the retina in Senior-Loken syndrome, which is a form of nephronophthisis.	"{""explanation"": ""The literature supports the involvement of the retina in Senior-Loken syndrome, which is a form of nephronophthisis."", ""reference"": ""PMID:33306870"", ""snippet"": ""Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis and retinal degeneration, leading to end-stage renal disease and progressive blindness."", ""supports"": ""SUPPORT""}"
5660	5471	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	6	evidence	3	PMID:35655331	NO_EVIDENCE		The JS phenotype alone is caused by pathogenic variants in more than 40 genes; remarkably, all of the associated proteins function in and around the primary cilium.	This reference discusses the involvement of primary cilia in a broader sense but does not specify the extrarenal manifestations like those in Senior-Loken syndrome.	"{""explanation"": ""This reference discusses the involvement of primary cilia in a broader sense but does not specify the extrarenal manifestations like those in Senior-Loken syndrome."", ""reference"": ""PMID:35655331"", ""snippet"": ""The JS phenotype alone is caused by pathogenic variants in more than 40 genes; remarkably, all of the associated proteins function in and around the primary cilium."", ""supports"": ""NO_EVIDENCE""}"
5661	5472	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	7	evidence	0	PMID:34828368	SUPPORT		NPHP gene types present with some common pathophysiological features alongside a diverse range of extra-renal phenotypes associated with specific syndromic presentations.	The reference states that there is diversity in pathophysiological features and extra-renal phenotypes among different NPHP gene types, which supports the statement that the age of onset and rate of progression vary.	"{""explanation"": ""The reference states that there is diversity in pathophysiological features and extra-renal phenotypes among different NPHP gene types, which supports the statement that the age of onset and rate of progression vary."", ""reference"": ""PMID:34828368"", ""snippet"": ""NPHP gene types present with some common pathophysiological features alongside a diverse range of extra-renal phenotypes associated with specific syndromic presentations."", ""supports"": ""SUPPORT""}"
5662	5472	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	7	evidence	1	PMID:35570616	SUPPORT		Nephronophthisis is the most common genetic cause of kidney failure in childhood....Treatment for nephronophthisis is symptomatic, and kidney transplant is a good treatment option when kidney failure has developed.	While this reference highlights the general management of nephronophthisis, it implies variability in progression and severity since not all individuals progress to kidney failure at the same rate.	"{""explanation"": ""While this reference highlights the general management of nephronophthisis, it implies variability in progression and severity since not all individuals progress to kidney failure at the same rate."", ""reference"": ""PMID:35570616"", ""snippet"": ""Nephronophthisis is the most common genetic cause of kidney failure in childhood....Treatment for nephronophthisis is symptomatic, and kidney transplant is a good treatment option when kidney failure has developed."", ""supports"": ""SUPPORT""}"
5663	5472	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	7	evidence	2	PMID:35922195	SUPPORT		All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset.	The reference indicates variability in the progression to end-stage renal disease, supporting the statement regarding variable progression rates depending on the specific NPHP gene mutations.	"{""explanation"": ""The reference indicates variability in the progression to end-stage renal disease, supporting the statement regarding variable progression rates depending on the specific NPHP gene mutations."", ""reference"": ""PMID:35922195"", ""snippet"": ""All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset."", ""supports"": ""SUPPORT""}"
5664	5472	229	Nephronophthisis	Nephronophthisis.yaml	pathophysiology	7	evidence	3	PMID:16966065	SUPPORT		There are three main clinical forms of nephronophtisis which have been associated with five gene defects. Juvenile nephronophtisis, the most frequent, progress to end stage renal failure before age 15.	This reference identifies different clinical forms of nephronophthisis, which progress at different rates, thus supporting the statement on variability in age of onset and progression.	"{""explanation"": ""This reference identifies different clinical forms of nephronophthisis, which progress at different rates, thus supporting the statement on variability in age of onset and progression."", ""reference"": ""PMID:16966065"", ""snippet"": ""There are three main clinical forms of nephronophtisis which have been associated with five gene defects. Juvenile nephronophtisis, the most frequent, progress to end stage renal failure before age 15."", ""supports"": ""SUPPORT""}"
5691	5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	evidence	0	PMID:41560679	SUPPORT		Neuroblastoma (NB) is a pediatric solid tumor originating from neural crest cells (NCCs), which are precursors of the sympathetic nervous system.	This abstract states neuroblastoma originates from neural crest cells, supporting the developmental origin described.	"{""explanation"": ""This abstract states neuroblastoma originates from neural crest cells, supporting the developmental origin described."", ""reference"": ""PMID:41560679"", ""snippet"": ""Neuroblastoma (NB) is a pediatric solid tumor originating from neural crest cells (NCCs), which are precursors of the sympathetic nervous system."", ""supports"": ""SUPPORT""}"
5692	5501	230	Neuroblastoma	Neuroblastoma.yaml	pathophysiology	0	evidence	1	PMID:32296467	SUPPORT		Neuroblastoma is a clinically heterogenous pediatric cancer of the sympathetic nervous system that originates from neural crest cells.	Supports neural crest origin and clinical heterogeneity of neuroblastoma.	"{""explanation"": ""Supports neural crest origin and clinical heterogeneity of neuroblastoma."", ""reference"": ""PMID:32296467"", ""snippet"": ""Neuroblastoma is a clinically heterogenous pediatric cancer of the sympathetic nervous system that originates from neural crest cells."", ""supports"": ""SUPPORT""}"
5697	5536	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	0	evidence	0	PMID:35454180	SUPPORT		In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner.	The abstract describes AQP4-IgG binding and complement-mediated astrocyte disruption.	"{""explanation"": ""The abstract describes AQP4-IgG binding and complement-mediated astrocyte disruption."", ""reference"": ""PMID:35454180"", ""snippet"": ""In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner."", ""supports"": ""SUPPORT""}"
5698	5537	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	pathophysiology	1	evidence	0	PMID:35454180	SUPPORT		Recent studies have also demonstrated complement-independent cytotoxic effects of NMO-IgG. Antibody-induced endocytosis of AQP4 has been suggested to be involved in this mechanism.	The abstract notes complement-independent cytotoxicity and AQP4 endocytosis in NMOSD.	"{""explanation"": ""The abstract notes complement-independent cytotoxicity and AQP4 endocytosis in NMOSD."", ""reference"": ""PMID:35454180"", ""snippet"": ""Recent studies have also demonstrated complement-independent cytotoxic effects of NMO-IgG. Antibody-induced endocytosis of AQP4 has been suggested to be involved in this mechanism."", ""supports"": ""SUPPORT""}"
5707	5548	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	0	evidence	0	PMID:35454180	SUPPORT		In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner.	This review confirms that NMO-IgG binds AQP4 on astrocyte end-feet and causes complement-dependent astrocyte destruction.	"{""explanation"": ""This review confirms that NMO-IgG binds AQP4 on astrocyte end-feet and causes complement-dependent astrocyte destruction."", ""reference"": ""PMID:35454180"", ""snippet"": ""In NMOSD, the autoantibody (NMO-IgG) binds to the extracellular loops of AQP4 as expressed in perivascular astrocytic end-feet and disrupts astrocytes in a complement-dependent manner."", ""supports"": ""SUPPORT""}"
5708	5549	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	pathophysiology	1	evidence	0	PMID:31050279	SUPPORT		At least two thirds of cases are associated with aquaporin-4 antibodies (AQP4-IgG) and complement-mediated damage to the central nervous system.	The PREVENT trial confirms that NMOSD involves complement-mediated CNS damage.	"{""explanation"": ""The PREVENT trial confirms that NMOSD involves complement-mediated CNS damage."", ""reference"": ""PMID:31050279"", ""snippet"": ""At least two thirds of cases are associated with aquaporin-4 antibodies (AQP4-IgG) and complement-mediated damage to the central nervous system."", ""supports"": ""SUPPORT""}"
5717	5563	234	Noma	Noma.yaml	pathophysiology	0	evidence	0	PMID:26437752	SUPPORT		The characteristic tissue necrosis is produced by a polymicrobial infection.	The abstract attributes tissue necrosis to polymicrobial infection.	"{""explanation"": ""The abstract attributes tissue necrosis to polymicrobial infection."", ""reference"": ""PMID:26437752"", ""snippet"": ""The characteristic tissue necrosis is produced by a polymicrobial infection."", ""supports"": ""SUPPORT""}"
5760	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	0	PMID:22987962	SUPPORT		Mutations in EGFR best illustrate the therapeutic relevance of molecular classification. This article reviews the scope of presently known driving molecular alterations, including ROS1, BRAF, KRAS, HER2 and PIK3CA, with a special emphasis on aLK rearrangements, and outlines their potential therapeutic applications.	This reference confirms that mutations in genes such as EGFR, ALK, ROS1, and BRAF are recognized as driving molecular alterations that underpin the malignant phenotype of non-small cell lung cancer.	"{""explanation"": ""This reference confirms that mutations in genes such as EGFR, ALK, ROS1, and BRAF are recognized as driving molecular alterations that underpin the malignant phenotype of non-small cell lung cancer."", ""reference"": ""PMID:22987962"", ""snippet"": ""Mutations in EGFR best illustrate the therapeutic relevance of molecular classification. This article reviews the scope of presently known driving molecular alterations, including ROS1, BRAF, KRAS, HER2 and PIK3CA, with a special emphasis on aLK rearrangements, and outlines their potential therapeutic applications."", ""supports"": ""SUPPORT""}"
5761	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	1	PMID:29989448	SUPPORT		Activating mutations in the EGFR and rearrangements in the anaplastic lymphoma kinase (ALK) or ROS proto-oncogene 1 receptor tyrosine kinase (ROS1) genes have been identified as oncogenic drivers in non-small-cell lung cancer.	The reference supports that mutations in EGFR, ALK, and ROS1 genes serve as oncogenic drivers in non-small cell lung cancer, contributing to uncontrolled cell growth and survival.	"{""explanation"": ""The reference supports that mutations in EGFR, ALK, and ROS1 genes serve as oncogenic drivers in non-small cell lung cancer, contributing to uncontrolled cell growth and survival."", ""reference"": ""PMID:29989448"", ""snippet"": ""Activating mutations in the EGFR and rearrangements in the anaplastic lymphoma kinase (ALK) or ROS proto-oncogene 1 receptor tyrosine kinase (ROS1) genes have been identified as oncogenic drivers in non-small-cell lung cancer."", ""supports"": ""SUPPORT""}"
5762	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	2	PMID:35709927	SUPPORT		The aim of the current study is to extract meaningful information from the online somatic mutation data (retrieved from cBioPortal) of 16 most significantly mutated oncogenes in non-small-cell lung cancer (NSCLC), namely EGFR, NRAS, KRAS, HER2 (ERBB2), RET, MET, ROS1, FGFR1, BRAF ... for improving our understanding of the pathobiology of the lung cancer.	This reference further lists EGFR, ALK, ROS1, and BRAF among the significantly mutated oncogenes in non-small cell lung cancer, thus supporting the statement.	"{""explanation"": ""This reference further lists EGFR, ALK, ROS1, and BRAF among the significantly mutated oncogenes in non-small cell lung cancer, thus supporting the statement."", ""reference"": ""PMID:35709927"", ""snippet"": ""The aim of the current study is to extract meaningful information from the online somatic mutation data (retrieved from cBioPortal) of 16 most significantly mutated oncogenes in non-small-cell lung cancer (NSCLC), namely EGFR, NRAS, KRAS, HER2 (ERBB2), RET, MET, ROS1, FGFR1, BRAF ... for improving our understanding of the pathobiology of the lung cancer."", ""supports"": ""SUPPORT""}"
5763	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	3	PMID:31627700	SUPPORT		Epidermal growth factor receptor (EGFR) mutations play an important role in the pathogenesis of non-small cell lung cancer. ... In patients with EGFR mutations, a significant improvement in therapeutic outcomes was achieved with the administration of targeted therapy using tyrosine kinase inhibitors.	This reference confirms the crucial role of EGFR mutations in NSCLC pathogenesis, indicating their role in driving tumor growth and survival.	"{""explanation"": ""This reference confirms the crucial role of EGFR mutations in NSCLC pathogenesis, indicating their role in driving tumor growth and survival."", ""reference"": ""PMID:31627700"", ""snippet"": ""Epidermal growth factor receptor (EGFR) mutations play an important role in the pathogenesis of non-small cell lung cancer. ... In patients with EGFR mutations, a significant improvement in therapeutic outcomes was achieved with the administration of targeted therapy using tyrosine kinase inhibitors."", ""supports"": ""SUPPORT""}"
5764	5583	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	4	PMID:33435440	SUPPORT		Testing the presence of driver mutations in specific genes in lung tumors has thus radically changed the clinical management and outcomes of the disease. ... namely EGFR, KRAS, BRAF, MET, and HER2 mutations or amplification, as well as ALK and ROS1 fusions.	This reference supports that identifying driver mutations in genes like EGFR, ALK, ROS1, and BRAF is crucial in the clinical management of NSCLC, implying their role in uncontrolled cell growth and survival.	"{""explanation"": ""This reference supports that identifying driver mutations in genes like EGFR, ALK, ROS1, and BRAF is crucial in the clinical management of NSCLC, implying their role in uncontrolled cell growth and survival."", ""reference"": ""PMID:33435440"", ""snippet"": ""Testing the presence of driver mutations in specific genes in lung tumors has thus radically changed the clinical management and outcomes of the disease. ... namely EGFR, KRAS, BRAF, MET, and HER2 mutations or amplification, as well as ALK and ROS1 fusions."", ""supports"": ""SUPPORT""}"
5765	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	0	PMID:27416962	SUPPORT		We are also beginning to understand the methods of immune evasion employed by NSCLC which likely contribute to the 20% response rate to immunotherapy.	The study indicates that non-small cell lung cancer (NSCLC) employs methods of immune evasion, which aligns with the statement.	"{""explanation"": ""The study indicates that non-small cell lung cancer (NSCLC) employs methods of immune evasion, which aligns with the statement."", ""reference"": ""PMID:27416962"", ""snippet"": ""We are also beginning to understand the methods of immune evasion employed by NSCLC which likely contribute to the 20% response rate to immunotherapy."", ""supports"": ""SUPPORT""}"
5766	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	1	PMID:29107330	SUPPORT		Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. ... Using LOHHLA, we find that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity.	The study describes immune evasion mechanisms such as HLA loss in NSCLC, supporting the statement.	"{""explanation"": ""The study describes immune evasion mechanisms such as HLA loss in NSCLC, supporting the statement."", ""reference"": ""PMID:29107330"", ""snippet"": ""Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. ... Using LOHHLA, we find that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity."", ""supports"": ""SUPPORT""}"
5767	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	2	PMID:37130455	SUPPORT		Since MHC-I antigen presentation is not essential for cell growth or survival, many cancers inactivate this pathway, and thereby escape control by CD8 T cells. Such immune evasion allows cancers to progress and also become resistant to CD8 T-cell-based immunotherapies, such as checkpoint blockade.	The study discusses how NSCLC cells evade the immune system by inactivating MHC-I antigen presentation, supporting the statement.	"{""explanation"": ""The study discusses how NSCLC cells evade the immune system by inactivating MHC-I antigen presentation, supporting the statement."", ""reference"": ""PMID:37130455"", ""snippet"": ""Since MHC-I antigen presentation is not essential for cell growth or survival, many cancers inactivate this pathway, and thereby escape control by CD8 T cells. Such immune evasion allows cancers to progress and also become resistant to CD8 T-cell-based immunotherapies, such as checkpoint blockade."", ""supports"": ""SUPPORT""}"
5768	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	3	PMID:34484217	SUPPORT		These data raise the possibility that proteins with mechanical barrier function in NSCLC may be used by cancer cells to protect them from immune cell infiltration and immune-mediated destruction, which can otherwise be targeted effectively with immunotherapy or collagen therapy.	The study mentions mechanisms employed by NSCLC cells to evade immune destruction, supporting the statement.	"{""explanation"": ""The study mentions mechanisms employed by NSCLC cells to evade immune destruction, supporting the statement."", ""reference"": ""PMID:34484217"", ""snippet"": ""These data raise the possibility that proteins with mechanical barrier function in NSCLC may be used by cancer cells to protect them from immune cell infiltration and immune-mediated destruction, which can otherwise be targeted effectively with immunotherapy or collagen therapy."", ""supports"": ""SUPPORT""}"
5769	5584	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	4	PMID:37086716	SUPPORT		These data demonstrate that enhanced TRM-like activity prior to tumor development shapes the evolution of tumor immunogenicity and can impact immunotherapy outcomes.	The study outlines mechanisms of immune evasion in NSCLC, such as the loss of MHC class I protein expression, supporting the statement.	"{""explanation"": ""The study outlines mechanisms of immune evasion in NSCLC, such as the loss of MHC class I protein expression, supporting the statement."", ""reference"": ""PMID:37086716"", ""snippet"": ""These data demonstrate that enhanced TRM-like activity prior to tumor development shapes the evolution of tumor immunogenicity and can impact immunotherapy outcomes."", ""supports"": ""SUPPORT""}"
5770	5585	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	2	evidence	0	PMID:12824870	SUPPORT		Angiogenesis, neovascularization from pre-existing vasculature, is necessary to supply oxygen and nutrition for tumor growth in both primary and distant organs.	This reference discusses the requirement of angiogenesis in the growth and metastasis of non-small cell lung cancer (NSCLC).	"{""explanation"": ""This reference discusses the requirement of angiogenesis in the growth and metastasis of non-small cell lung cancer (NSCLC)."", ""reference"": ""PMID:12824870"", ""snippet"": ""Angiogenesis, neovascularization from pre-existing vasculature, is necessary to supply oxygen and nutrition for tumor growth in both primary and distant organs."", ""supports"": ""SUPPORT""}"
5771	5585	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	2	evidence	1	PMID:36269457	PARTIAL		Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions... Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations.	While the primary focus is not on angiogenesis, it mentions mechanisms of tumor growth and resistance, which can be linked to angiogenesis indirectly.	"{""explanation"": ""While the primary focus is not on angiogenesis, it mentions mechanisms of tumor growth and resistance, which can be linked to angiogenesis indirectly."", ""reference"": ""PMID:36269457"", ""snippet"": ""Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions... Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations."", ""supports"": ""PARTIAL""}"
5772	5585	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	2	evidence	2	PMID:26222080	PARTIAL		Many patients with lung cancer, breast cancer, and melanoma develop brain metastases that are resistant to conventional therapy. The median survival for untreated patients is 1 to 2 months, which may be extended to 6 months with surgery, radiotherapy, and chemotherapy.	This reference indirectly supports the statement by talking about brain metastasis and tumor progression but does not specifically focus on angiogenesis.	"{""explanation"": ""This reference indirectly supports the statement by talking about brain metastasis and tumor progression but does not specifically focus on angiogenesis."", ""reference"": ""PMID:26222080"", ""snippet"": ""Many patients with lung cancer, breast cancer, and melanoma develop brain metastases that are resistant to conventional therapy. The median survival for untreated patients is 1 to 2 months, which may be extended to 6 months with surgery, radiotherapy, and chemotherapy."", ""supports"": ""PARTIAL""}"
5773	5585	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	2	evidence	3	PMID:22550239	NO_EVIDENCE		Lung cancer, of which non-small cell lung cancer (NSCLC) composes the majority, is the leading cause of cancer-related deaths in the United States and worldwide... field cancerization phenomenon...	The reference discusses field cancerization and the complexities of NSCLC but does not provide specific evidence related to angiogenesis.	"{""explanation"": ""The reference discusses field cancerization and the complexities of NSCLC but does not provide specific evidence related to angiogenesis."", ""reference"": ""PMID:22550239"", ""snippet"": ""Lung cancer, of which non-small cell lung cancer (NSCLC) composes the majority, is the leading cause of cancer-related deaths in the United States and worldwide... field cancerization phenomenon..."", ""supports"": ""NO_EVIDENCE""}"
5774	5588	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	5	evidence	0	PMID:33533174	SUPPORT		Our results are suggestive for particular site- and sequence-specific metastasis patterns in human SCLC. SCLC bone metastases tend to appear together with liver metastases, while brain metastases occur together with adrenal gland metastases.	While this article primarily deals with small cell lung cancer (SCLC), it does mention metastasis pattern to common sites such as liver and adrenal glands, indicating support for the general concept of lung cancer metastasizing to these distant organs.	"{""explanation"": ""While this article primarily deals with small cell lung cancer (SCLC), it does mention metastasis pattern to common sites such as liver and adrenal glands, indicating support for the general concept of lung cancer metastasizing to these distant organs."", ""reference"": ""PMID:33533174"", ""snippet"": ""Our results are suggestive for particular site- and sequence-specific metastasis patterns in human SCLC. SCLC bone metastases tend to appear together with liver metastases, while brain metastases occur together with adrenal gland metastases."", ""supports"": ""SUPPORT""}"
5775	5588	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	5	evidence	1	PMID:31151683	SUPPORT		Nearly 75% of patients have a disseminated carcinoma at diagnosis. Up to 50% of patients with a localized disease will develop metastasis. Nevertheless, the current scientific evidence has demonstrated that when the metastatic disease is limited, particularly in specific locations such as the brain and the adrenal glands, a multidisciplinary approach with radical intent could achieve a longer survival.	This article supports the statement as it mentions that NSCLC can metastasize to the brain and adrenal glands.	"{""explanation"": ""This article supports the statement as it mentions that NSCLC can metastasize to the brain and adrenal glands."", ""reference"": ""PMID:31151683"", ""snippet"": ""Nearly 75% of patients have a disseminated carcinoma at diagnosis. Up to 50% of patients with a localized disease will develop metastasis. Nevertheless, the current scientific evidence has demonstrated that when the metastatic disease is limited, particularly in specific locations such as the brain and the adrenal glands, a multidisciplinary approach with radical intent could achieve a longer survival."", ""supports"": ""SUPPORT""}"
5776	5588	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	5	evidence	2	PMID:23322021	SUPPORT		At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain.	This article further supports the statement by specifying the brain as a common site for metastasis of lung cancer.	"{""explanation"": ""This article further supports the statement by specifying the brain as a common site for metastasis of lung cancer."", ""reference"": ""PMID:23322021"", ""snippet"": ""At least one third of the people with lung cancer develop brain metastases at some point during their disease, even often before the diagnosis of lung cancer is made. The high rate of brain metastasis makes lung cancer the most common type of tumor to spread to the brain."", ""supports"": ""SUPPORT""}"
5777	5588	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	pathophysiology	5	evidence	3	PMID:36269457	SUPPORT		Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions. Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations.	Although primarily focused on MET-driven tumors, this article aligns with the statement by addressing the mechanisms of how NSCLC can become metastatic.	"{""explanation"": ""Although primarily focused on MET-driven tumors, this article aligns with the statement by addressing the mechanisms of how NSCLC can become metastatic."", ""reference"": ""PMID:36269457"", ""snippet"": ""Pathologic activation of MET can be achieved with increased number of gene copies overexpression, or decreased protein degradation through several mechanisms, including mutations, amplifications, or fusions. Besides its role as primary driver, MET activation might also mediate resistance to kinase inhibitors in NSCLC with various other actionable alterations."", ""supports"": ""SUPPORT""}"
5840	5613	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains	PTPN11 mutations cluster at the N-SH2/PTP interface, disrupting autoinhibition.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""PTPN11 mutations cluster at the N-SH2/PTP interface, disrupting autoinhibition."", ""reference"": ""PMID:11992261"", ""snippet"": ""All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains"", ""supports"": ""SUPPORT""}"
5841	5614	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:17143285	SUPPORT	HUMAN_CLINICAL	Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation.	SOS1 mutations are gain-of-function, enhancing RAS-GTP loading.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""SOS1 mutations are gain-of-function, enhancing RAS-GTP loading."", ""reference"": ""PMID:17143285"", ""snippet"": ""Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation."", ""supports"": ""SUPPORT""}"
5842	5615	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:17603483	SUPPORT	HUMAN_CLINICAL	Most mutations altered a motif flanking Ser259, a residue critical for autoinhibition of RAF1 through 14-3-3 binding.	RAF1 mutations disrupt autoinhibitory 14-3-3 binding.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RAF1 mutations disrupt autoinhibitory 14-3-3 binding."", ""reference"": ""PMID:17603483"", ""snippet"": ""Most mutations altered a motif flanking Ser259, a residue critical for autoinhibition of RAF1 through 14-3-3 binding."", ""supports"": ""SUPPORT""}"
5843	5616	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:23791108	SUPPORT	HUMAN_CLINICAL	These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.	RIT1 gain-of-function mutations drive aberrant MAPK signaling.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 gain-of-function mutations drive aberrant MAPK signaling."", ""reference"": ""PMID:23791108"", ""snippet"": ""These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes."", ""supports"": ""SUPPORT""}"
5844	5619	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	6	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01)	Demonstrates that pulmonary valve stenosis is highly associated with PTPN11 mutations in Noonan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that pulmonary valve stenosis is highly associated with PTPN11 mutations in Noonan syndrome."", ""reference"": ""PMID:11992261"", ""snippet"": ""pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01)"", ""supports"": ""SUPPORT""}"
5845	5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	evidence	0	PMID:17603483	SUPPORT	HUMAN_CLINICAL	Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general.	Demonstrates strong association between RAF1 mutations and HCM, implicating the kinase pathway in cardiac hypertrophy.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates strong association between RAF1 mutations and HCM, implicating the kinase pathway in cardiac hypertrophy."", ""reference"": ""PMID:17603483"", ""snippet"": ""Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general."", ""supports"": ""SUPPORT""}"
5846	5620	236	Noonan Syndrome	Noonan_Syndrome.yaml	pathophysiology	7	evidence	1	PMID:23791108	SUPPORT	HUMAN_CLINICAL	Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome.	RIT1 mutations are strongly associated with hypertrophic cardiomyopathy.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 mutations are strongly associated with hypertrophic cardiomyopathy."", ""reference"": ""PMID:23791108"", ""snippet"": ""Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome."", ""supports"": ""SUPPORT""}"
5854	5661	237	Obesity	Obesity.yaml	pathophysiology	0	evidence	0	PMID:17212793	SUPPORT		Leptin is a mediator of long-term regulation of energy balance, suppressing food intake and thereby inducing weight loss. Ghrelin on the other hand is a fast-acting hormone, seemingly playing a role in meal initiation.	Describes the role of leptin and ghrelin as key hormones regulating energy balance in obesity.	"{""explanation"": ""Describes the role of leptin and ghrelin as key hormones regulating energy balance in obesity."", ""reference"": ""PMID:17212793"", ""snippet"": ""Leptin is a mediator of long-term regulation of energy balance, suppressing food intake and thereby inducing weight loss. Ghrelin on the other hand is a fast-acting hormone, seemingly playing a role in meal initiation."", ""supports"": ""SUPPORT""}"
5855	5661	237	Obesity	Obesity.yaml	pathophysiology	0	evidence	1	PMID:17212793	SUPPORT		In obese subjects the circulating level of the anorexigenic hormone leptin is increased, whereas surprisingly, the level of the orexigenic hormone ghrelin is decreased. It is now established that obese patients are leptin-resistant.	Explains the paradox of elevated leptin levels in obesity with concurrent leptin resistance, contributing to failed energy balance restoration.	"{""explanation"": ""Explains the paradox of elevated leptin levels in obesity with concurrent leptin resistance, contributing to failed energy balance restoration."", ""reference"": ""PMID:17212793"", ""snippet"": ""In obese subjects the circulating level of the anorexigenic hormone leptin is increased, whereas surprisingly, the level of the orexigenic hormone ghrelin is decreased. It is now established that obese patients are leptin-resistant."", ""supports"": ""SUPPORT""}"
5856	5662	237	Obesity	Obesity.yaml	pathophysiology	1	evidence	0	PMID:39456156	SUPPORT		"Under various physiological or pathological conditions, adipose tissue shifts cellular composition, lipid storage, and organelle dynamics to respond to the stress; this remodeling is called ""adipose tissue plasticity""."	Describes the dynamic remodeling of adipose tissue in response to obesity, including changes in cellular composition and metabolic function.	"{""explanation"": ""Describes the dynamic remodeling of adipose tissue in response to obesity, including changes in cellular composition and metabolic function."", ""reference"": ""PMID:39456156"", ""snippet"": ""Under various physiological or pathological conditions, adipose tissue shifts cellular composition, lipid storage, and organelle dynamics to respond to the stress; this remodeling is called \""adipose tissue plasticity\""."", ""supports"": ""SUPPORT""}"
5857	5662	237	Obesity	Obesity.yaml	pathophysiology	1	evidence	1	PMID:14679177	SUPPORT		Histologically, there is evidence of significant infiltration of macrophages, but not neutrophils and lymphocytes, into WAT of obese mice, with signs of adipocyte lipolysis and formation of multinucleate giant cells.	Provides histological evidence of macrophage infiltration into dysfunctional adipose tissue in obesity.	"{""explanation"": ""Provides histological evidence of macrophage infiltration into dysfunctional adipose tissue in obesity."", ""reference"": ""PMID:14679177"", ""snippet"": ""Histologically, there is evidence of significant infiltration of macrophages, but not neutrophils and lymphocytes, into WAT of obese mice, with signs of adipocyte lipolysis and formation of multinucleate giant cells."", ""supports"": ""SUPPORT""}"
5858	5662	237	Obesity	Obesity.yaml	pathophysiology	1	evidence	2	PMID:14679177	SUPPORT		These data suggest that macrophages in WAT play an active role in morbid obesity and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance.	Establishes the causal role of adipose tissue macrophages in obesity-related metabolic dysfunction.	"{""explanation"": ""Establishes the causal role of adipose tissue macrophages in obesity-related metabolic dysfunction."", ""reference"": ""PMID:14679177"", ""snippet"": ""These data suggest that macrophages in WAT play an active role in morbid obesity and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance."", ""supports"": ""SUPPORT""}"
5859	5663	237	Obesity	Obesity.yaml	pathophysiology	2	evidence	0	PMID:14679177	SUPPORT		Increasing evidence from human population studies and animal research has established correlative as well as causative links between chronic inflammation and insulin resistance.	Establishes both correlative and causative links between chronic inflammation and insulin resistance in obesity.	"{""explanation"": ""Establishes both correlative and causative links between chronic inflammation and insulin resistance in obesity."", ""reference"": ""PMID:14679177"", ""snippet"": ""Increasing evidence from human population studies and animal research has established correlative as well as causative links between chronic inflammation and insulin resistance."", ""supports"": ""SUPPORT""}"
5860	5663	237	Obesity	Obesity.yaml	pathophysiology	2	evidence	1	PMID:14679177	SUPPORT		We propose that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue.	Proposes that obesity-induced insulin resistance represents a chronic inflammatory disease originating in adipose tissue.	"{""explanation"": ""Proposes that obesity-induced insulin resistance represents a chronic inflammatory disease originating in adipose tissue."", ""reference"": ""PMID:14679177"", ""snippet"": ""We propose that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue."", ""supports"": ""SUPPORT""}"
5861	5663	237	Obesity	Obesity.yaml	pathophysiology	2	evidence	2	PMID:27503945	SUPPORT		Particularly chronic inflammation in adipose tissue seems to play an important role in the development of obesity-related insulin resistance.	Highlights the central role of chronic adipose tissue inflammation in obesity-related insulin resistance.	"{""explanation"": ""Highlights the central role of chronic adipose tissue inflammation in obesity-related insulin resistance."", ""reference"": ""PMID:27503945"", ""snippet"": ""Particularly chronic inflammation in adipose tissue seems to play an important role in the development of obesity-related insulin resistance."", ""supports"": ""SUPPORT""}"
5862	5664	237	Obesity	Obesity.yaml	pathophysiology	3	evidence	0	PMID:38490517	SUPPORT		Leptin acts through its receptor LepRb, expressed mainly in the hypothalamus, and induces a negative energy balance by potent inhibition of feeding and activation of energy expenditure.	Describes the central hypothalamic mechanism by which leptin normally regulates energy balance.	"{""explanation"": ""Describes the central hypothalamic mechanism by which leptin normally regulates energy balance."", ""reference"": ""PMID:38490517"", ""snippet"": ""Leptin acts through its receptor LepRb, expressed mainly in the hypothalamus, and induces a negative energy balance by potent inhibition of feeding and activation of energy expenditure."", ""supports"": ""SUPPORT""}"
5863	5664	237	Obesity	Obesity.yaml	pathophysiology	3	evidence	1	PMID:38490517	SUPPORT		However, the majority of patients with obesity presents elevated leptin production, suggesting that in this setting leptin is ineffective in the regulation of energy balance.	Explains leptin resistance in obesity where elevated leptin fails to regulate energy balance through hypothalamic circuits.	"{""explanation"": ""Explains leptin resistance in obesity where elevated leptin fails to regulate energy balance through hypothalamic circuits."", ""reference"": ""PMID:38490517"", ""snippet"": ""However, the majority of patients with obesity presents elevated leptin production, suggesting that in this setting leptin is ineffective in the regulation of energy balance."", ""supports"": ""SUPPORT""}"
5864	5665	237	Obesity	Obesity.yaml	pathophysiology	4	evidence	0	PMID:38286821	SUPPORT		Here we show that high-fat diet (HFD) feeding causes mitochondrial fragmentation in inguinal white adipocytes from male mice, leading to reduced oxidative capacity by a process dependent on the small GTPase RalA.	Demonstrates that obesity causes mitochondrial fragmentation through RalA in white adipocytes.	"{""explanation"": ""Demonstrates that obesity causes mitochondrial fragmentation through RalA in white adipocytes."", ""reference"": ""PMID:38286821"", ""snippet"": ""Here we show that high-fat diet (HFD) feeding causes mitochondrial fragmentation in inguinal white adipocytes from male mice, leading to reduced oxidative capacity by a process dependent on the small GTPase RalA."", ""supports"": ""SUPPORT""}"
5865	5665	237	Obesity	Obesity.yaml	pathophysiology	4	evidence	1	PMID:38286821	SUPPORT		Mechanistically, RalA increases fission in adipocytes by reversing the inhibitory Ser637 phosphorylation of the fission protein Drp1, leading to more mitochondrial fragmentation.	Describes the molecular mechanism by which RalA promotes mitochondrial fission through DRP1 dephosphorylation.	"{""explanation"": ""Describes the molecular mechanism by which RalA promotes mitochondrial fission through DRP1 dephosphorylation."", ""reference"": ""PMID:38286821"", ""snippet"": ""Mechanistically, RalA increases fission in adipocytes by reversing the inhibitory Ser637 phosphorylation of the fission protein Drp1, leading to more mitochondrial fragmentation."", ""supports"": ""SUPPORT""}"
5866	5665	237	Obesity	Obesity.yaml	pathophysiology	4	evidence	2	PMID:38286821	SUPPORT		Adipose tissue expression of the human homolog of Drp1, DNM1L, is positively correlated with obesity and insulin resistance.	Provides human evidence linking DNM1L expression to obesity and insulin resistance.	"{""explanation"": ""Provides human evidence linking DNM1L expression to obesity and insulin resistance."", ""reference"": ""PMID:38286821"", ""snippet"": ""Adipose tissue expression of the human homolog of Drp1, DNM1L, is positively correlated with obesity and insulin resistance."", ""supports"": ""SUPPORT""}"
5869	5689	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	0	evidence	0	PMID:38672697	SUPPORT		BACKGROUND: Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture.	Defines the fundamental pathophysiological mechanism of OSA as recurrent airway obstruction during sleep.	"{""explanation"": ""Defines the fundamental pathophysiological mechanism of OSA as recurrent airway obstruction during sleep."", ""reference"": ""PMID:38672697"", ""snippet"": ""BACKGROUND: Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture."", ""supports"": ""SUPPORT""}"
5870	5689	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	0	evidence	1	PMID:36982552	SUPPORT		Obstructive sleep apnea syndrome (OSAS) is characterized by intermittent hypoxia (IH) during sleep due to recurrent upper airway obstruction.	Confirms that intermittent hypoxia results from recurrent upper airway obstruction, the primary mechanical defect in OSA.	"{""explanation"": ""Confirms that intermittent hypoxia results from recurrent upper airway obstruction, the primary mechanical defect in OSA."", ""reference"": ""PMID:36982552"", ""snippet"": ""Obstructive sleep apnea syndrome (OSAS) is characterized by intermittent hypoxia (IH) during sleep due to recurrent upper airway obstruction."", ""supports"": ""SUPPORT""}"
5871	5690	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	1	evidence	0	PMID:38672697	SUPPORT		The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage.	Directly confirms that intermittent hypoxia in OSA triggers oxidative stress and cellular damage.	"{""explanation"": ""Directly confirms that intermittent hypoxia in OSA triggers oxidative stress and cellular damage."", ""reference"": ""PMID:38672697"", ""snippet"": ""The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage."", ""supports"": ""SUPPORT""}"
5872	5690	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	1	evidence	1	PMID:36982552	SUPPORT		IH increases oxygen free radicals (ROS) and reduces antioxidant capacities.	Demonstrates the molecular mechanism by which intermittent hypoxia produces oxidative stress through increased ROS and decreased antioxidant defenses.	"{""explanation"": ""Demonstrates the molecular mechanism by which intermittent hypoxia produces oxidative stress through increased ROS and decreased antioxidant defenses."", ""reference"": ""PMID:36982552"", ""snippet"": ""IH increases oxygen free radicals (ROS) and reduces antioxidant capacities."", ""supports"": ""SUPPORT""}"
5873	5690	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	1	evidence	2	PMID:39694586	SUPPORT		IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-α, NF-κB and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3.	Meta-analysis of rodent models confirming that intermittent hypoxia induces oxidative stress, inflammation, and apoptosis in the brain, establishing causal mechanisms.	"{""explanation"": ""Meta-analysis of rodent models confirming that intermittent hypoxia induces oxidative stress, inflammation, and apoptosis in the brain, establishing causal mechanisms."", ""reference"": ""PMID:39694586"", ""snippet"": ""IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-α, NF-κB and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3."", ""supports"": ""SUPPORT""}"
5874	5691	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	2	evidence	0	PMID:38672697	SUPPORT		Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture.	Confirms that disrupted sleep architecture is a fundamental consequence of recurrent airway obstruction in OSA.	"{""explanation"": ""Confirms that disrupted sleep architecture is a fundamental consequence of recurrent airway obstruction in OSA."", ""reference"": ""PMID:38672697"", ""snippet"": ""Obstructive sleep apnea syndrome (OSAS), affecting approximately 1 billion adults globally, is characterized by recurrent airway obstruction during sleep, leading to oxygen desaturation, elevated carbon dioxide levels, and disrupted sleep architecture."", ""supports"": ""SUPPORT""}"
5875	5692	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	3	evidence	0	PMID:38672697	SUPPORT		The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage.	Intermittent hypoxia triggers cellular stress that contributes to sympathetic activation and cardiovascular complications.	"{""explanation"": ""Intermittent hypoxia triggers cellular stress that contributes to sympathetic activation and cardiovascular complications."", ""reference"": ""PMID:38672697"", ""snippet"": ""The cyclic pattern of intermittent hypoxia in OSAS triggers oxidative stress, contributing to cellular damage."", ""supports"": ""SUPPORT""}"
5876	5692	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	3	evidence	1	PMID:39595069	SUPPORT		These agents, originally developed for T2D management, have demonstrated pleiotropic effects, including significant weight loss, blood pressure reduction, and amelioration of endothelial dysfunction and arterial stiffness, along with anti-inflammatory benefits, which may be particularly beneficial in OSA.	Indicates that OSA is associated with blood pressure elevation, endothelial dysfunction, and arterial stiffness, consistent with sympathetic overactivation.	"{""explanation"": ""Indicates that OSA is associated with blood pressure elevation, endothelial dysfunction, and arterial stiffness, consistent with sympathetic overactivation."", ""reference"": ""PMID:39595069"", ""snippet"": ""These agents, originally developed for T2D management, have demonstrated pleiotropic effects, including significant weight loss, blood pressure reduction, and amelioration of endothelial dysfunction and arterial stiffness, along with anti-inflammatory benefits, which may be particularly beneficial in OSA."", ""supports"": ""SUPPORT""}"
5877	5693	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	4	evidence	0	PMID:38672697	SUPPORT		The review delineates the imbalance between pro-inflammatory and anti-inflammatory factors in OSAS, leading to heightened oxidative stress.	Confirms that OSA is characterized by an imbalance favoring pro-inflammatory factors, resulting in heightened inflammation.	"{""explanation"": ""Confirms that OSA is characterized by an imbalance favoring pro-inflammatory factors, resulting in heightened inflammation."", ""reference"": ""PMID:38672697"", ""snippet"": ""The review delineates the imbalance between pro-inflammatory and anti-inflammatory factors in OSAS, leading to heightened oxidative stress."", ""supports"": ""SUPPORT""}"
5878	5693	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	4	evidence	1	PMID:36982552	SUPPORT		OS and metabolic alterations lead OSAS patients to undergo endothelial dysfunction, osteoporosis, systemic inflammation, increased cardiovascular risk, pulmonary remodeling, and neurological alterations.	Demonstrates that systemic inflammation is a key pathophysiological feature of OSA contributing to multiple complications.	"{""explanation"": ""Demonstrates that systemic inflammation is a key pathophysiological feature of OSA contributing to multiple complications."", ""reference"": ""PMID:36982552"", ""snippet"": ""OS and metabolic alterations lead OSAS patients to undergo endothelial dysfunction, osteoporosis, systemic inflammation, increased cardiovascular risk, pulmonary remodeling, and neurological alterations."", ""supports"": ""SUPPORT""}"
5879	5693	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	pathophysiology	4	evidence	2	PMID:39694586	SUPPORT		IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-α, NF-κB and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3.	Meta-analysis evidence showing that intermittent hypoxia induces inflammation through TNF-α and NF-κB activation.	"{""explanation"": ""Meta-analysis evidence showing that intermittent hypoxia induces inflammation through TNF-α and NF-κB activation."", ""reference"": ""PMID:39694586"", ""snippet"": ""IH-induced oxidative stress (increased malondialdehyde (MDA) and NADPH oxidase (NOX) and decreased superoxide dismutase), increased inflammation (tumour necrosis factor-α, NF-κB and inducible nitric oxide synthase), HIF-1 and apoptosis evaluated by terminal deoxynucleotidyl transferase dUTP nick-end labelling and cleaved caspase-3."", ""supports"": ""SUPPORT""}"
5893	5725	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	0	evidence	0	PMID:36737426	SUPPORT		In this review, we first summarize the epidemiology of OA, including its prevalence, incidence and burdens, and OA risk factors. We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/β-catenin, NF-κB, focal adhesion, HIFs, TGFβ/ΒΜP and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA. In addition, the roles of factors associated with OA, including MMPs, ADAMTS/ADAMs, and PRG4, are discussed in detail.	This review confirms that MMPs and ADAMTS enzymes are key factors in OA pathogenesis, supporting the role of matrix metalloproteinases and aggrecanases in cartilage degradation.	"{""explanation"": ""This review confirms that MMPs and ADAMTS enzymes are key factors in OA pathogenesis, supporting the role of matrix metalloproteinases and aggrecanases in cartilage degradation."", ""reference"": ""PMID:36737426"", ""snippet"": ""In this review, we first summarize the epidemiology of OA, including its prevalence, incidence and burdens, and OA risk factors. We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/β-catenin, NF-κB, focal adhesion, HIFs, TGFβ/ΒΜP and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA. In addition, the roles of factors associated with OA, including MMPs, ADAMTS/ADAMs, and PRG4, are discussed in detail."", ""supports"": ""SUPPORT""}"
5894	5725	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	0	evidence	1	PMID:38348279	SUPPORT		The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis.	MMP13 is specifically identified as a catabolic enzyme released during pyroptosis in OA, directly supporting the role of matrix metalloproteinases in cartilage component degradation.	"{""explanation"": ""MMP13 is specifically identified as a catabolic enzyme released during pyroptosis in OA, directly supporting the role of matrix metalloproteinases in cartilage component degradation."", ""reference"": ""PMID:38348279"", ""snippet"": ""The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis."", ""supports"": ""SUPPORT""}"
5895	5726	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	1	evidence	0	PMID:38348279	SUPPORT		The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA.	This evidence confirms that subchondral osteoblasts undergo pathological processes (pyroptosis) contributing to OA development, supporting the role of bone cell dysfunction in disease progression.	"{""explanation"": ""This evidence confirms that subchondral osteoblasts undergo pathological processes (pyroptosis) contributing to OA development, supporting the role of bone cell dysfunction in disease progression."", ""reference"": ""PMID:38348279"", ""snippet"": ""The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA."", ""supports"": ""SUPPORT""}"
5896	5726	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	1	evidence	1	PMID:36737426	SUPPORT		Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects more than 500 million population worldwide. OA was believed to be caused by the wearing and tearing of articular cartilage, but it is now more commonly referred to as a chronic whole-joint disorder that is initiated with biochemical and cellular alterations in the synovial joint tissues, which leads to the histological and structural changes of the joint and ends up with the whole tissue dysfunction.	This review confirms the modern understanding of OA as a whole-joint disorder involving structural changes across all joint tissues, including subchondral bone, rather than just cartilage wear.	"{""explanation"": ""This review confirms the modern understanding of OA as a whole-joint disorder involving structural changes across all joint tissues, including subchondral bone, rather than just cartilage wear."", ""reference"": ""PMID:36737426"", ""snippet"": ""Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects more than 500 million population worldwide. OA was believed to be caused by the wearing and tearing of articular cartilage, but it is now more commonly referred to as a chronic whole-joint disorder that is initiated with biochemical and cellular alterations in the synovial joint tissues, which leads to the histological and structural changes of the joint and ends up with the whole tissue dysfunction."", ""supports"": ""SUPPORT""}"
5897	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	evidence	0	PMID:38348279	SUPPORT		Pyroptosis is a complex process that involves three pathways culminating in the assembly of Gasdermin-D (GSDMD)-N-terminal (GSDMD-NT) into pores through aggregation on the plasma membrane. The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis.	This evidence demonstrates the specific mechanism by which synovial cells release inflammatory mediators (IL-1β, IL-18) through pyroptosis, directly supporting the description of inflammatory mediator release in synovitis.	"{""explanation"": ""This evidence demonstrates the specific mechanism by which synovial cells release inflammatory mediators (IL-1β, IL-18) through pyroptosis, directly supporting the description of inflammatory mediator release in synovitis."", ""reference"": ""PMID:38348279"", ""snippet"": ""Pyroptosis is a complex process that involves three pathways culminating in the assembly of Gasdermin-D (GSDMD)-N-terminal (GSDMD-NT) into pores through aggregation on the plasma membrane. The aggregation of GSDMD-NT proteins stimulates the release of inflammatory mediators, such as Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and Matrix Metallopeptidase 13 (MMP13), ultimately leading to cellular lysis."", ""supports"": ""SUPPORT""}"
5898	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	evidence	1	PMID:38348279	SUPPORT		The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA.	This confirms that both synovial macrophages and fibroblast-like synoviocytes undergo pyroptosis in OA, supporting the role of macrophage infiltration and synoviocyte dysfunction in disease pathogenesis.	"{""explanation"": ""This confirms that both synovial macrophages and fibroblast-like synoviocytes undergo pyroptosis in OA, supporting the role of macrophage infiltration and synoviocyte dysfunction in disease pathogenesis."", ""reference"": ""PMID:38348279"", ""snippet"": ""The pyroptosis process in specific cells, including synovial macrophages, fibroblast-like synoviocytes (FLS), chondrocytes, and subchondral osteoblasts, contributs factor to the development of OA."", ""supports"": ""SUPPORT""}"
5899	5727	240	Osteoarthritis	Osteoarthritis.yaml	pathophysiology	2	evidence	2	PMID:36737426	SUPPORT		We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/β-catenin, NF-κB, focal adhesion, HIFs, TGFβ/ΒΜP and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA.	The NF-κB signaling pathway mentioned here is a key regulator of inflammatory responses, supporting the inflammatory nature of synovial pathology in OA.	"{""explanation"": ""The NF-κB signaling pathway mentioned here is a key regulator of inflammatory responses, supporting the inflammatory nature of synovial pathology in OA."", ""reference"": ""PMID:36737426"", ""snippet"": ""We then focus on the roles and regulation of the pathological signaling pathways, such as Wnt/β-catenin, NF-κB, focal adhesion, HIFs, TGFβ/ΒΜP and FGF signaling pathways, and key regulators AMPK, mTOR, and RUNX2 in the onset and development of OA."", ""supports"": ""SUPPORT""}"
5909	5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	evidence	0	PMID:1353940	SUPPORT	HUMAN_CLINICAL	Dermal fibroblasts from most individuals with osteogenesis imperfecta (OI) type I produce about half the normal amount of type I procollagen, as a result of decreased synthesis of one of its constituent chains, pro alpha 1 (I).	Landmark paper demonstrating that OI type I results from 50% reduced type I procollagen synthesis due to diminished pro alpha 1(I) chain production.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark paper demonstrating that OI type I results from 50% reduced type I procollagen synthesis due to diminished pro alpha 1(I) chain production."", ""reference"": ""PMID:1353940"", ""snippet"": ""Dermal fibroblasts from most individuals with osteogenesis imperfecta (OI) type I produce about half the normal amount of type I procollagen, as a result of decreased synthesis of one of its constituent chains, pro alpha 1 (I)."", ""supports"": ""SUPPORT""}"
5910	5742	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	pathophysiology	0	evidence	1	PMID:23529829	SUPPORT	HUMAN_CLINICAL	COL1A1 haploinsufficiency mutations lead to the mildest form of osteogenesis imperfecta (OI), OI type I.	Large clinical study (86 patients) confirming that COL1A1 haploinsufficiency specifically causes the mild type I phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large clinical study (86 patients) confirming that COL1A1 haploinsufficiency specifically causes the mild type I phenotype."", ""reference"": ""PMID:23529829"", ""snippet"": ""COL1A1 haploinsufficiency mutations lead to the mildest form of osteogenesis imperfecta (OI), OI type I."", ""supports"": ""SUPPORT""}"
5915	5754	242	Osteogenesis Imperfecta Type II	Osteogenesis_Imperfecta_Type_II.yaml	pathophysiology	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	The mutations act in a dominant negative manner as the mutant pro alpha chains are incorporated into type I procollagen molecules that also contain normal pro alpha chains. The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix.	Authoritative review establishing the dominant-negative mechanism of glycine substitutions in perinatal lethal OI.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Authoritative review establishing the dominant-negative mechanism of glycine substitutions in perinatal lethal OI."", ""reference"": ""PMID:7643358"", ""snippet"": ""The mutations act in a dominant negative manner as the mutant pro alpha chains are incorporated into type I procollagen molecules that also contain normal pro alpha chains. The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix."", ""supports"": ""SUPPORT""}"
5917	5765	243	Osteogenesis Imperfecta Type III	Osteogenesis_Imperfecta_Type_III.yaml	pathophysiology	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	Point mutations resulting in the substitution of Gly residues in Gly-X-Y amino acid triplets of the triple helical domain of the alpha 1(I) or alpha 2(I) chains are the most frequent mutations. They interrupt the repetitive Gly-X-Y structure that is mandatory for the formation of a stable triple helix.	Establishes glycine substitutions as the predominant mutation mechanism in OI with structural collagen defects, applicable to types II-IV.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes glycine substitutions as the predominant mutation mechanism in OI with structural collagen defects, applicable to types II-IV."", ""reference"": ""PMID:7643358"", ""snippet"": ""Point mutations resulting in the substitution of Gly residues in Gly-X-Y amino acid triplets of the triple helical domain of the alpha 1(I) or alpha 2(I) chains are the most frequent mutations. They interrupt the repetitive Gly-X-Y structure that is mandatory for the formation of a stable triple helix."", ""supports"": ""SUPPORT""}"
5919	5780	244	Osteogenesis Imperfecta Type IV	Osteogenesis_Imperfecta_Type_IV.yaml	pathophysiology	0	evidence	0	PMID:7643358	SUPPORT	HUMAN_CLINICAL	The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix. The collagen fibres are abnormally organised and mineralisation is impaired.	Describes the molecular consequences of collagen structural mutations that affect bone matrix formation, applicable across the OI severity spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Describes the molecular consequences of collagen structural mutations that affect bone matrix formation, applicable across the OI severity spectrum."", ""reference"": ""PMID:7643358"", ""snippet"": ""The abnormal molecules are poorly secreted, more susceptible to degradation, and impair the formation of the extracellular matrix. The collagen fibres are abnormally organised and mineralisation is impaired."", ""supports"": ""SUPPORT""}"
5921	5792	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	pathophysiology	0	evidence	0	PMID:22863190	SUPPORT	HUMAN_CLINICAL	Transfection of wild-type and mutant IFITM5 constructs revealed that the mutation added five amino acids (Met-Ala-Leu-Glu-Pro) to the N terminus of IFITM5. Given that IFITM5 expression and protein localization is restricted to the skeletal tissue and IFITM5 involvement in bone formation, we conclude that this recurrent mutation would have a specific effect on IFITM5 function.	Demonstrates the mutation produces an extended N-terminal protein and establishes IFITM5 as a bone-specific protein involved in bone formation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates the mutation produces an extended N-terminal protein and establishes IFITM5 as a bone-specific protein involved in bone formation."", ""reference"": ""PMID:22863190"", ""snippet"": ""Transfection of wild-type and mutant IFITM5 constructs revealed that the mutation added five amino acids (Met-Ala-Leu-Glu-Pro) to the N terminus of IFITM5. Given that IFITM5 expression and protein localization is restricted to the skeletal tissue and IFITM5 involvement in bone formation, we conclude that this recurrent mutation would have a specific effect on IFITM5 function."", ""supports"": ""SUPPORT""}"
5924	5805	246	Osteogenesis Imperfecta Type VII	Osteogenesis_Imperfecta_Type_VII.yaml	pathophysiology	0	evidence	0	PMID:17055431	SUPPORT	HUMAN_CLINICAL	CRTAP can form a complex with P3H1 and cyclophilin B (CYPB), and Crtap-/- bone and cartilage collagens show decreased prolyl 3-hydroxylation. Moreover, mutant collagen shows evidence of overmodification, and collagen fibrils in mutant skin have increased diameter consistent with altered fibrillogenesis.	Landmark Cell paper establishing CRTAP as essential for prolyl 3-hydroxylation and showing that loss leads to collagen overmodification and abnormal fibrils.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Landmark Cell paper establishing CRTAP as essential for prolyl 3-hydroxylation and showing that loss leads to collagen overmodification and abnormal fibrils."", ""reference"": ""PMID:17055431"", ""snippet"": ""CRTAP can form a complex with P3H1 and cyclophilin B (CYPB), and Crtap-/- bone and cartilage collagens show decreased prolyl 3-hydroxylation. Moreover, mutant collagen shows evidence of overmodification, and collagen fibrils in mutant skin have increased diameter consistent with altered fibrillogenesis."", ""supports"": ""SUPPORT""}"
5929	5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	evidence	0	PMID:21874760	SUPPORT		aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals.	Demonstrates that estrogen, produced by aromatase, is essential for normal bone remodeling and that deficiency leads to bone loss	"{""explanation"": ""Demonstrates that estrogen, produced by aromatase, is essential for normal bone remodeling and that deficiency leads to bone loss"", ""reference"": ""PMID:21874760"", ""snippet"": ""aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals."", ""supports"": ""SUPPORT""}"
5930	5831	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	0	evidence	1	PMID:23748068	SUPPORT		Estrogen deficiency can induce delayed epiphyseal closure, eunuchoid body habitus, osteopenia, and osteoporosis in both genders.	Clinical evidence showing that estrogen deficiency directly causes osteoporosis through impaired bone remodeling	"{""explanation"": ""Clinical evidence showing that estrogen deficiency directly causes osteoporosis through impaired bone remodeling"", ""reference"": ""PMID:23748068"", ""snippet"": ""Estrogen deficiency can induce delayed epiphyseal closure, eunuchoid body habitus, osteopenia, and osteoporosis in both genders."", ""supports"": ""SUPPORT""}"
5931	5832	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	1	evidence	0	PMID:33692806	SUPPORT		The differentiation of osteoclasts is induced significantly in the presence of IL-17 either directly (207), or indirectly, through upregulation of RANKL.	Demonstrates that RANKL upregulation is a key mechanism for osteoclast differentiation and bone resorption	"{""explanation"": ""Demonstrates that RANKL upregulation is a key mechanism for osteoclast differentiation and bone resorption"", ""reference"": ""PMID:33692806"", ""snippet"": ""The differentiation of osteoclasts is induced significantly in the presence of IL-17 either directly (207), or indirectly, through upregulation of RANKL."", ""supports"": ""SUPPORT""}"
5932	5832	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	1	evidence	1	PMID:21874760	SUPPORT		with aging, individual differences in aromatase activity and thus in estrogen levels may significantly affect bone loss and fracture risk in both genders.	Shows that age-related decline in estrogen production affects bone metabolism, linking to RANKL/OPG dysregulation	"{""explanation"": ""Shows that age-related decline in estrogen production affects bone metabolism, linking to RANKL/OPG dysregulation"", ""reference"": ""PMID:21874760"", ""snippet"": ""with aging, individual differences in aromatase activity and thus in estrogen levels may significantly affect bone loss and fracture risk in both genders."", ""supports"": ""SUPPORT""}"
5933	5833	247	Osteoporosis	Osteoporosis.yaml	pathophysiology	2	evidence	0	PMID:23748068	SUPPORT		recurrent bone fractures associated with minimal trauma starting in puberty	Clinical case demonstrating that estrogen deficiency leads to fragility fractures due to compromised bone microarchitecture	"{""explanation"": ""Clinical case demonstrating that estrogen deficiency leads to fragility fractures due to compromised bone microarchitecture"", ""reference"": ""PMID:23748068"", ""snippet"": ""recurrent bone fractures associated with minimal trauma starting in puberty"", ""supports"": ""SUPPORT""}"
5938	5847	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	0	evidence	0	PMID:41154810	SUPPORT		Osteosarcoma (OS) is the most common primary malignant bone tumor, predominantly affecting adolescents and young adults.	The abstract defines osteosarcoma as the most common primary malignant bone tumor.	"{""explanation"": ""The abstract defines osteosarcoma as the most common primary malignant bone tumor."", ""reference"": ""PMID:41154810"", ""snippet"": ""Osteosarcoma (OS) is the most common primary malignant bone tumor, predominantly affecting adolescents and young adults."", ""supports"": ""SUPPORT""}"
5939	5848	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	1	evidence	0	PMID:41154810	SUPPORT		We discuss classic morphologic and radiographic features alongside recent insights into the tumor microenvironment, including the role of tumor-infiltrating lymphocytes, tumor-associated macrophages, and immune checkpoint expression.	The abstract highlights immune microenvironment components in osteosarcoma.	"{""explanation"": ""The abstract highlights immune microenvironment components in osteosarcoma."", ""reference"": ""PMID:41154810"", ""snippet"": ""We discuss classic morphologic and radiographic features alongside recent insights into the tumor microenvironment, including the role of tumor-infiltrating lymphocytes, tumor-associated macrophages, and immune checkpoint expression."", ""supports"": ""SUPPORT""}"
5940	5849	248	Osteosarcoma	Osteosarcoma.yaml	pathophysiology	2	evidence	0	PMID:25704303	SUPPORT		An increasing body of evidence has shown that this pathway is frequently hyperactivated in OS and contributes to disease initiation and development, including tumorigenesis, proliferation, invasion, cell cycle progression, inhibition of apoptosis, angiogenesis, metastasis and chemoresistance.	The abstract describes PI3K/Akt hyperactivation contributing to osteosarcoma progression.	"{""explanation"": ""The abstract describes PI3K/Akt hyperactivation contributing to osteosarcoma progression."", ""reference"": ""PMID:25704303"", ""snippet"": ""An increasing body of evidence has shown that this pathway is frequently hyperactivated in OS and contributes to disease initiation and development, including tumorigenesis, proliferation, invasion, cell cycle progression, inhibition of apoptosis, angiogenesis, metastasis and chemoresistance."", ""supports"": ""SUPPORT""}"
5965	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:37048085	SUPPORT		Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein α-synuclein are the pathological characterizations.	This links tremor with dopaminergic neuronal loss as part of PD hallmark pathology, supporting the downstream relationship.	"{""explanation"": ""This links tremor with dopaminergic neuronal loss as part of PD hallmark pathology, supporting the downstream relationship."", ""reference"": ""PMID:37048085"", ""snippet"": ""Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein α-synuclein are the pathological characterizations."", ""supports"": ""SUPPORT""}"
5966	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	downstream[1].evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This establishes bradykinesia as a cardinal parkinsonian sign downstream of dopaminergic degeneration.	"{""explanation"": ""This establishes bradykinesia as a cardinal parkinsonian sign downstream of dopaminergic degeneration."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
5967	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	downstream[2].evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This identifies rigidity as a cardinal sign of parkinsonism consistent with dopaminergic neuron loss in PD.	"{""explanation"": ""This identifies rigidity as a cardinal sign of parkinsonism consistent with dopaminergic neuron loss in PD."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
5968	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	downstream[3].evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This supports impaired postural reflexes as a cardinal parkinsonian sign downstream of dopaminergic dysfunction.	"{""explanation"": ""This supports impaired postural reflexes as a cardinal parkinsonian sign downstream of dopaminergic dysfunction."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
5969	5885	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	0	evidence	0	PMID:37048085	SUPPORT		Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein α-synuclein are the pathological characterizations.	This review confirms that dopaminergic neuronal loss in the substantia nigra pars compacta is a pathological hallmark of Parkinson's disease, supporting the core mechanism of dopaminergic neuron degeneration.	"{""explanation"": ""This review confirms that dopaminergic neuronal loss in the substantia nigra pars compacta is a pathological hallmark of Parkinson's disease, supporting the core mechanism of dopaminergic neuron degeneration."", ""reference"": ""PMID:37048085"", ""snippet"": ""Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and aggregation of intracellular protein α-synuclein are the pathological characterizations."", ""supports"": ""SUPPORT""}"
5970	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:38245249	SUPPORT		Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease.	This indicates that α-synuclein aggregation drives disease development and progression, supporting downstream dopaminergic neuron loss.	"{""explanation"": ""This indicates that α-synuclein aggregation drives disease development and progression, supporting downstream dopaminergic neuron loss."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}"
5971	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	downstream[1].evidence	0	PMID:36598534	SUPPORT		α-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia.	This links α-synuclein accumulation to microglial activation, supporting neuroinflammation as a downstream effect.	"{""explanation"": ""This links α-synuclein accumulation to microglial activation, supporting neuroinflammation as a downstream effect."", ""reference"": ""PMID:36598534"", ""snippet"": ""α-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia."", ""supports"": ""SUPPORT""}"
5972	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	evidence	0	PMID:38245249	SUPPORT		Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein.	This authoritative Lancet review establishes that aggregated α-synuclein deposition is a defining feature of Parkinson's disease pathogenesis.	"{""explanation"": ""This authoritative Lancet review establishes that aggregated α-synuclein deposition is a defining feature of Parkinson's disease pathogenesis."", ""reference"": ""PMID:38245249"", ""snippet"": ""Parkinson's disease is a progressive neurodegenerative condition associated with the deposition of aggregated α-synuclein."", ""supports"": ""SUPPORT""}"
5973	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	evidence	1	PMID:38245249	SUPPORT		Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease.	This provides direct evidence for the prion-like spreading mechanism of α-synuclein pathology across neural networks, supporting the mechanism of trans-neuronal propagation.	"{""explanation"": ""This provides direct evidence for the prion-like spreading mechanism of α-synuclein pathology across neural networks, supporting the mechanism of trans-neuronal propagation."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}"
5974	5886	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	1	evidence	2	PMID:36598534	SUPPORT		Parkinson's disease (PD) is the second most common neurodegenerative disease, and is characterized by accumulation of α-synuclein (α-syn).	Confirms that α-synuclein accumulation is a key pathological characterization of PD, reinforcing the central role of protein aggregation in disease pathology.	"{""explanation"": ""Confirms that α-synuclein accumulation is a key pathological characterization of PD, reinforcing the central role of protein aggregation in disease pathology."", ""reference"": ""PMID:36598534"", ""snippet"": ""Parkinson's disease (PD) is the second most common neurodegenerative disease, and is characterized by accumulation of α-synuclein (α-syn)."", ""supports"": ""SUPPORT""}"
5975	5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	downstream[0].evidence	0	PMID:27911343	SUPPORT		For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease.	This supports mitochondrial dysfunction as a central driver of neurodegeneration in PD, consistent with dopaminergic neuron loss.	"{""explanation"": ""This supports mitochondrial dysfunction as a central driver of neurodegeneration in PD, consistent with dopaminergic neuron loss."", ""reference"": ""PMID:27911343"", ""snippet"": ""For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease."", ""supports"": ""SUPPORT""}"
5976	5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	evidence	0	PMID:38245249	SUPPORT		At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches.	This establishes that mitochondrial dysfunction is a common cellular feature across both genetic and sporadic forms of PD, supporting its central role in disease pathogenesis.	"{""explanation"": ""This establishes that mitochondrial dysfunction is a common cellular feature across both genetic and sporadic forms of PD, supporting its central role in disease pathogenesis."", ""reference"": ""PMID:38245249"", ""snippet"": ""At a cellular level, abnormal mitochondrial, lysosomal, and endosomal function can be identified in both monogenic and sporadic Parkinson's disease, suggesting multiple potential treatment approaches."", ""supports"": ""SUPPORT""}"
5977	5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	evidence	1	PMID:25611507	SUPPORT		Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease.	This directly supports the role of PINK1 and Parkin genes in mitochondrial quality control and confirms that mitochondrial damage is involved in PD pathogenesis.	"{""explanation"": ""This directly supports the role of PINK1 and Parkin genes in mitochondrial quality control and confirms that mitochondrial damage is involved in PD pathogenesis."", ""reference"": ""PMID:25611507"", ""snippet"": ""Biochemical and genetic studies reveal that the products of two genes that are mutated in autosomal recessive parkinsonism, PINK1 and Parkin, normally work together in the same pathway to govern mitochondrial quality control, bolstering previous evidence that mitochondrial damage is involved in Parkinson's disease."", ""supports"": ""SUPPORT""}"
5978	5887	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	2	evidence	2	PMID:27911343	SUPPORT		For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease. The identifications of mutations in genes encoding PINK1 (PTEN-induced kinase 1) and Parkin (E3 ubiquitin ligase) in familial PD and their functional association with mitochondrial quality control provided further support to this hypothesis.	This review confirms the long-standing central role of mitochondrial dysfunction in PD and validates the connection between PINK1/Parkin mutations and mitochondrial quality control defects.	"{""explanation"": ""This review confirms the long-standing central role of mitochondrial dysfunction in PD and validates the connection between PINK1/Parkin mutations and mitochondrial quality control defects."", ""reference"": ""PMID:27911343"", ""snippet"": ""For the past 30 years, mitochondrial dysfunction has been hypothesized to play a central role in the pathobiology of this devastating neurodegenerative disease. The identifications of mutations in genes encoding PINK1 (PTEN-induced kinase 1) and Parkin (E3 ubiquitin ligase) in familial PD and their functional association with mitochondrial quality control provided further support to this hypothesis."", ""supports"": ""SUPPORT""}"
5979	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	downstream[0].evidence	0	PMID:37048085	SUPPORT		Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD.	This indicates neuroinflammation contributes to PD progression, supporting dopaminergic neuron loss downstream.	"{""explanation"": ""This indicates neuroinflammation contributes to PD progression, supporting dopaminergic neuron loss downstream."", ""reference"": ""PMID:37048085"", ""snippet"": ""Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD."", ""supports"": ""SUPPORT""}"
5980	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	evidence	0	PMID:38245249	SUPPORT		Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease.	This establishes that maladaptive immune and inflammatory responses play an active role in accelerating PD pathogenesis, supporting the neuroinflammation mechanism.	"{""explanation"": ""This establishes that maladaptive immune and inflammatory responses play an active role in accelerating PD pathogenesis, supporting the neuroinflammation mechanism."", ""reference"": ""PMID:38245249"", ""snippet"": ""Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease."", ""supports"": ""SUPPORT""}"
5981	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	evidence	1	PMID:37048085	SUPPORT		Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD. It is a complex network of interactions comprising immune and non-immune cells in addition to mediators of the immune response. Microglia, the resident macrophages in the CNS, take on the leading role in regulating neuroinflammation and maintaining homeostasis.	This directly supports the role of microglia-mediated neuroinflammation in PD initiation and progression, confirming the importance of microglial activation in disease pathology.	"{""explanation"": ""This directly supports the role of microglia-mediated neuroinflammation in PD initiation and progression, confirming the importance of microglial activation in disease pathology."", ""reference"": ""PMID:37048085"", ""snippet"": ""Neuroinflammation has emerged as an involving mechanism at the initiation and development of PD. It is a complex network of interactions comprising immune and non-immune cells in addition to mediators of the immune response. Microglia, the resident macrophages in the CNS, take on the leading role in regulating neuroinflammation and maintaining homeostasis."", ""supports"": ""SUPPORT""}"
5982	5888	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	3	evidence	2	PMID:36598534	SUPPORT		Neuroinflammation driven by microglia is an important pathological manifestation of PD. α-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia.	This links α-synuclein accumulation to microglial activation and pro-inflammatory M1 phenotype polarization, supporting the mechanism by which neuroinflammation contributes to neurodegeneration in PD.	"{""explanation"": ""This links α-synuclein accumulation to microglial activation and pro-inflammatory M1 phenotype polarization, supporting the mechanism by which neuroinflammation contributes to neurodegeneration in PD."", ""reference"": ""PMID:36598534"", ""snippet"": ""Neuroinflammation driven by microglia is an important pathological manifestation of PD. α-Syn is a crucial marker of PD, and its accumulation leads to microglia M1-like phenotype polarization, activation of NLRP3 inflammasomes, and impaired autophagy and phagocytosis in microglia."", ""supports"": ""SUPPORT""}"
5983	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	downstream[0].evidence	0	PMID:31761667	SUPPORT		α-synuclein, encoded by the SNCA gene, is degraded mainly by the ALP, and mutations/multiplications in SNCA may lead to impairment of chaperone mediated autophagy or other ALP functions.	This shows that autophagy-lysosome pathway dysfunction impairs α-synuclein clearance, supporting aggregation downstream.	"{""explanation"": ""This shows that autophagy-lysosome pathway dysfunction impairs α-synuclein clearance, supporting aggregation downstream."", ""reference"": ""PMID:31761667"", ""snippet"": ""α-synuclein, encoded by the SNCA gene, is degraded mainly by the ALP, and mutations/multiplications in SNCA may lead to impairment of chaperone mediated autophagy or other ALP functions."", ""supports"": ""SUPPORT""}"
5984	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	downstream[1].evidence	0	PMID:31761667	SUPPORT		In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD).	This supports ALP dysfunction as a key PD mechanism contributing to neuronal degeneration.	"{""explanation"": ""This supports ALP dysfunction as a key PD mechanism contributing to neuronal degeneration."", ""reference"": ""PMID:31761667"", ""snippet"": ""In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD)."", ""supports"": ""SUPPORT""}"
5985	5889	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	4	evidence	0	PMID:31761667	SUPPORT		In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD). Genes such as GBA and LRRK2, which harbor some of the most common mutations associated with PD, have essential roles in the ALP.	This review establishes the genetic basis for autophagy-lysosome dysfunction in PD, identifying key genes and their mechanistic roles.	"{""explanation"": ""This review establishes the genetic basis for autophagy-lysosome dysfunction in PD, identifying key genes and their mechanistic roles."", ""reference"": ""PMID:31761667"", ""snippet"": ""In recent years, multiple lines of evidence from human genetic and molecular studies have highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's disease (PD). Genes such as GBA and LRRK2, which harbor some of the most common mutations associated with PD, have essential roles in the ALP."", ""supports"": ""SUPPORT""}"
5986	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	downstream[0].evidence	0	PMID:38245249	SUPPORT		Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease.	This links gut-to-brain spread with α-synuclein aggregation, supporting this downstream effect.	"{""explanation"": ""This links gut-to-brain spread with α-synuclein aggregation, supporting this downstream effect."", ""reference"": ""PMID:38245249"", ""snippet"": ""Biochemical studies, investigation of transplanted neurons in patients with Parkinson's disease, and cell and animal model studies suggest that abnormal aggregation of α-synuclein and spreading of pathology between the gut, brainstem, and higher brain regions probably underlie the development and progression of Parkinson's disease."", ""supports"": ""SUPPORT""}"
5987	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	downstream[1].evidence	0	PMID:38245249	SUPPORT		Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease.	This supports gut-triggered immune responses as a driver of neuroinflammation in PD.	"{""explanation"": ""This supports gut-triggered immune responses as a driver of neuroinflammation in PD."", ""reference"": ""PMID:38245249"", ""snippet"": ""Recent work has also highlighted maladaptive immune and inflammatory responses, possibly triggered in the gut, that accelerate the pathogenesis of Parkinson's disease."", ""supports"": ""SUPPORT""}"
5988	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	downstream[2].evidence	0	PMID:38098067	SUPPORT		The typical symptomatology of PD includes motor symptoms; however, a range of nonmotor symptoms, such as intestinal issues, usually occur before the motor symptoms.	This supports constipation and other intestinal symptoms as early gut-related manifestations in PD.	"{""explanation"": ""This supports constipation and other intestinal symptoms as early gut-related manifestations in PD."", ""reference"": ""PMID:38098067"", ""snippet"": ""The typical symptomatology of PD includes motor symptoms; however, a range of nonmotor symptoms, such as intestinal issues, usually occur before the motor symptoms."", ""supports"": ""SUPPORT""}"
5989	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	evidence	0	PMID:38098067	SUPPORT		Various microorganisms inhabiting the gastrointestinal tract can profoundly influence the physiopathology of the central nervous system through neurological, endocrine, and immune system pathways involved in the microbiota-gut-brain axis.	This review establishes the gut microbiota-brain connection in PD pathophysiology.	"{""explanation"": ""This review establishes the gut microbiota-brain connection in PD pathophysiology."", ""reference"": ""PMID:38098067"", ""snippet"": ""Various microorganisms inhabiting the gastrointestinal tract can profoundly influence the physiopathology of the central nervous system through neurological, endocrine, and immune system pathways involved in the microbiota-gut-brain axis."", ""supports"": ""SUPPORT""}"
5990	5890	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	5	evidence	1	PMID:37449597	SUPPORT		The vagus nerve, the main component of the parasympathetic nervous system, is involved in the regulation of immune response, digestion, heart rate, and control of mood.	Establishes the vagus nerve as the key anatomical connection mediating gut-brain communication in PD.	"{""explanation"": ""Establishes the vagus nerve as the key anatomical connection mediating gut-brain communication in PD."", ""reference"": ""PMID:37449597"", ""snippet"": ""The vagus nerve, the main component of the parasympathetic nervous system, is involved in the regulation of immune response, digestion, heart rate, and control of mood."", ""supports"": ""SUPPORT""}"
5991	5891	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	6	evidence	0	PMID:37303175	SUPPORT		Reactive oxygen species (ROS)-induced oxidative stress triggers the vicious cycle leading to the degeneration of dopaminergic neurons in the nigra pars compacta.	This review directly describes the mechanism by which oxidative stress drives dopaminergic neurodegeneration.	"{""explanation"": ""This review directly describes the mechanism by which oxidative stress drives dopaminergic neurodegeneration."", ""reference"": ""PMID:37303175"", ""snippet"": ""Reactive oxygen species (ROS)-induced oxidative stress triggers the vicious cycle leading to the degeneration of dopaminergic neurons in the nigra pars compacta."", ""supports"": ""SUPPORT""}"
5992	5892	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	7	evidence	0	PMID:35339179	SUPPORT		Calcium (Ca2+) plays a central role in regulating many cellular processes and influences cell survival.	This review establishes the fundamental role of calcium channel dysregulation in PD pathogenesis.	"{""explanation"": ""This review establishes the fundamental role of calcium channel dysregulation in PD pathogenesis."", ""reference"": ""PMID:35339179"", ""snippet"": ""Calcium (Ca2+) plays a central role in regulating many cellular processes and influences cell survival."", ""supports"": ""SUPPORT""}"
5993	5893	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	8	evidence	0	PMID:38026955	SUPPORT		Accumulating evidence shows that endoplasmic reticulum (ER) stress occurring in the SNpc DA neurons is an early event in the development of PD.	This review establishes ER stress as an early and central event in PD pathogenesis.	"{""explanation"": ""This review establishes ER stress as an early and central event in PD pathogenesis."", ""reference"": ""PMID:38026955"", ""snippet"": ""Accumulating evidence shows that endoplasmic reticulum (ER) stress occurring in the SNpc DA neurons is an early event in the development of PD."", ""supports"": ""SUPPORT""}"
5994	5894	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	9	evidence	0	PMID:38595283	SUPPORT		Notably, several of these genes are linked to the synaptic vesicle recycling process, particularly the clathrin-mediated endocytosis pathway. This suggests that impaired synaptic vesicle recycling might represent an early feature of Parkinson's disease	Establishes synaptic vesicle endocytosis dysfunction as an early feature of PD.	"{""explanation"": ""Establishes synaptic vesicle endocytosis dysfunction as an early feature of PD."", ""reference"": ""PMID:38595283"", ""snippet"": ""Notably, several of these genes are linked to the synaptic vesicle recycling process, particularly the clathrin-mediated endocytosis pathway. This suggests that impaired synaptic vesicle recycling might represent an early feature of Parkinson's disease"", ""supports"": ""SUPPORT""}"
5995	5895	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	10	evidence	0	PMID:39218077	SUPPORT		Parkinson's disease (PD) is a prevalent and advancing age-related neurodegenerative disorder, distinguished by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Iron regional deposit in SNpc is a significant pathological characteristic of PD.	This review establishes iron accumulation as a significant pathological characteristic and mechanistic driver of PD.	"{""explanation"": ""This review establishes iron accumulation as a significant pathological characteristic and mechanistic driver of PD."", ""reference"": ""PMID:39218077"", ""snippet"": ""Parkinson's disease (PD) is a prevalent and advancing age-related neurodegenerative disorder, distinguished by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Iron regional deposit in SNpc is a significant pathological characteristic of PD."", ""supports"": ""SUPPORT""}"
5996	5896	250	Parkinson's Disease	Parkinsons_Disease.yaml	pathophysiology	11	evidence	0	PMID:39075566	SUPPORT		There is increasing evidence for blood-brain barrier (BBB) alterations in Parkinson's disease (PD), the second most common neurodegenerative disorder with rapidly rising prevalence.	This comprehensive 2024 review establishes BBB dysfunction as an emerging mechanism in PD pathogenesis.	"{""explanation"": ""This comprehensive 2024 review establishes BBB dysfunction as an emerging mechanism in PD pathogenesis."", ""reference"": ""PMID:39075566"", ""snippet"": ""There is increasing evidence for blood-brain barrier (BBB) alterations in Parkinson's disease (PD), the second most common neurodegenerative disorder with rapidly rising prevalence."", ""supports"": ""SUPPORT""}"
6029	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	evidence	0	PMID:26438050	SUPPORT		Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations.	Shows T-cell predominance in ocular infiltrates supporting autoimmune pathogenesis.	"{""explanation"": ""Shows T-cell predominance in ocular infiltrates supporting autoimmune pathogenesis."", ""reference"": ""PMID:26438050"", ""snippet"": ""Clinical and histopathological findings suggest an autoimmune etiology, most likely as a reaction to endogenous antigen of unknown source, with T cells predominant in both vitreous and pars plana infiltrations."", ""supports"": ""SUPPORT""}"
6030	5927	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	0	evidence	1	PMID:37976519	SUPPORT		It is thought to be a T-cell mediated disease with a genetic predisposition.	Confirms T-cell mediated immunopathogenesis and genetic susceptibility in pars planitis.	"{""explanation"": ""Confirms T-cell mediated immunopathogenesis and genetic susceptibility in pars planitis."", ""reference"": ""PMID:37976519"", ""snippet"": ""It is thought to be a T-cell mediated disease with a genetic predisposition."", ""supports"": ""SUPPORT""}"
6031	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:27051493	SUPPORT		The most common presenting symptoms are floaters and blurred vision.	Early visual symptoms arise from inflammatory cells and haze in the vitreous cavity.	"{""explanation"": ""Early visual symptoms arise from inflammatory cells and haze in the vitreous cavity."", ""reference"": ""PMID:27051493"", ""snippet"": ""The most common presenting symptoms are floaters and blurred vision."", ""supports"": ""SUPPORT""}"
6032	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	evidence	0	PMID:27051493	SUPPORT		Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis.	Documents vitreous cell infiltration and haze as defining inflammatory findings.	"{""explanation"": ""Documents vitreous cell infiltration and haze as defining inflammatory findings."", ""reference"": ""PMID:27051493"", ""snippet"": ""Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis."", ""supports"": ""SUPPORT""}"
6033	5928	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	1	evidence	1	PMID:28389773	SUPPORT		Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations.	Confirms high prevalence of vitreous inflammation and snowballs in clinical cohorts.	"{""explanation"": ""Confirms high prevalence of vitreous inflammation and snowballs in clinical cohorts."", ""reference"": ""PMID:28389773"", ""snippet"": ""Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations."", ""supports"": ""SUPPORT""}"
6034	5929	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	2	evidence	0	PMID:28389773	SUPPORT		Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations.	Shows snowbanks as a frequent structural manifestation of pars planitis at the pars plana.	"{""explanation"": ""Shows snowbanks as a frequent structural manifestation of pars planitis at the pars plana."", ""reference"": ""PMID:28389773"", ""snippet"": ""Vitreous inflammation (100%), vitreous haze (92.6%), snowballs (74.1%), snowbanks (66.7%)...were the most common presentations."", ""supports"": ""SUPPORT""}"
6035	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	downstream[0].evidence	0	PMID:27188332	SUPPORT		Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001).	Demonstrates that increased retinal thickness from leakage correlates with worse visual acuity in intermediate uveitis.	"{""explanation"": ""Demonstrates that increased retinal thickness from leakage correlates with worse visual acuity in intermediate uveitis."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}"
6036	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	evidence	0	PMID:27051493	SUPPORT		Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings.	Notes peripheral retinal vasculitis as a recognized manifestation in pars planitis.	"{""explanation"": ""Notes peripheral retinal vasculitis as a recognized manifestation in pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."", ""supports"": ""SUPPORT""}"
6037	5930	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	3	evidence	1	PMID:28389773	SUPPORT		...peripheral retinal vascular sheathing (48.1%) were the most common presentations.	Confirms high frequency of peripheral vascular sheathing in clinical series.	"{""explanation"": ""Confirms high frequency of peripheral vascular sheathing in clinical series."", ""reference"": ""PMID:28389773"", ""snippet"": ""...peripheral retinal vascular sheathing (48.1%) were the most common presentations."", ""supports"": ""SUPPORT""}"
6038	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	downstream[0].evidence	0	PMID:27188332	SUPPORT		Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001).	Links macular thickening to loss of visual acuity.	"{""explanation"": ""Links macular thickening to loss of visual acuity."", ""reference"": ""PMID:27188332"", ""snippet"": ""Correlation between LogMAR visual acuity and central retinal thickness at baseline was strong (r = 0.7436, p < 0.0001)."", ""supports"": ""SUPPORT""}"
6039	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	evidence	0	PMID:27188332	SUPPORT		The cut-off value of CFT for initiating systemic treatment was determined at 215.5 μm in a post hoc analysis (sensitivity 62.5 %, specificity 96.4 %).	Shows that macular thickening beyond a threshold prompts treatment due to risk of vision loss in intermediate uveitis.	"{""explanation"": ""Shows that macular thickening beyond a threshold prompts treatment due to risk of vision loss in intermediate uveitis."", ""reference"": ""PMID:27188332"", ""snippet"": ""The cut-off value of CFT for initiating systemic treatment was determined at 215.5 μm in a post hoc analysis (sensitivity 62.5 %, specificity 96.4 %)."", ""supports"": ""SUPPORT""}"
6040	5931	251	Pars Planitis	Pars_Planitis.yaml	pathophysiology	4	evidence	1	PMID:33559832	SUPPORT		According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination.	OCT-defined diffuse macular edema and foveal contour loss predict worse visual acuity, underscoring the impact of macular thickening.	"{""explanation"": ""OCT-defined diffuse macular edema and foveal contour loss predict worse visual acuity, underscoring the impact of macular thickening."", ""reference"": ""PMID:33559832"", ""snippet"": ""According to multivariate linear regression analysis, the presence of DME, and loss of normal foveal contour appearance at baseline were the independent factors associated with BCVA at the final examination."", ""supports"": ""SUPPORT""}"
6085	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	0	PMID:9372060	SUPPORT		Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells.	The abstract clearly states that Parvovirus B19 has a strong preference for infecting human erythroid progenitor cells.	"{""explanation"": ""The abstract clearly states that Parvovirus B19 has a strong preference for infecting human erythroid progenitor cells."", ""reference"": ""PMID:9372060"", ""snippet"": ""Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells."", ""supports"": ""SUPPORT""}"
6086	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	1	PMID:26845771	SUPPORT		The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs)...	The study describes the infection dynamics of Parvovirus B19 in erythroid progenitor cells, supporting the statement that the virus primarily targets these cells.	"{""explanation"": ""The study describes the infection dynamics of Parvovirus B19 in erythroid progenitor cells, supporting the statement that the virus primarily targets these cells."", ""reference"": ""PMID:26845771"", ""snippet"": ""The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs)..."", ""supports"": ""SUPPORT""}"
6087	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	2	PMID:37175911	SUPPORT		Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow erythroid progenitor cells, leading to transient or persistent anemia.	The abstract mentions that Parvovirus B19 infects erythroid progenitor cells in the bone marrow, aligning with the statement.	"{""explanation"": ""The abstract mentions that Parvovirus B19 infects erythroid progenitor cells in the bone marrow, aligning with the statement."", ""reference"": ""PMID:37175911"", ""snippet"": ""Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow erythroid progenitor cells, leading to transient or persistent anemia."", ""supports"": ""SUPPORT""}"
6088	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	3	PMID:21680529	SUPPORT		Human parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells of the human bone marrow.	The abstract confirms the restriction of Parvovirus B19 infection to erythroid progenitor cells in the bone marrow.	"{""explanation"": ""The abstract confirms the restriction of Parvovirus B19 infection to erythroid progenitor cells in the bone marrow."", ""reference"": ""PMID:21680529"", ""snippet"": ""Human parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells of the human bone marrow."", ""supports"": ""SUPPORT""}"
6089	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	4	PMID:28377277	SUPPORT		Parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells (EPCs) of the human bone marrow, leading to transient arrest of erythropoiesis...	The study indicates that Parvovirus B19 infection is limited to erythroid progenitor cells and disrupts red blood cell production.	"{""explanation"": ""The study indicates that Parvovirus B19 infection is limited to erythroid progenitor cells and disrupts red blood cell production."", ""reference"": ""PMID:28377277"", ""snippet"": ""Parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells (EPCs) of the human bone marrow, leading to transient arrest of erythropoiesis..."", ""supports"": ""SUPPORT""}"
6090	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	5	PMID:35062288	SUPPORT		Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance, characterized by a selective tropism for erythroid progenitor cells in bone marrow.	The abstract highlights the selective tropism of Parvovirus B19 for erythroid progenitor cells in the bone marrow.	"{""explanation"": ""The abstract highlights the selective tropism of Parvovirus B19 for erythroid progenitor cells in the bone marrow."", ""reference"": ""PMID:35062288"", ""snippet"": ""Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance, characterized by a selective tropism for erythroid progenitor cells in bone marrow."", ""supports"": ""SUPPORT""}"
6091	5950	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	0	evidence	6	PMID:12116854	SUPPORT		Parvovirus B19 is a human erythrovirus, i.e. which induces the death of erythroid progenitors.	The abstract states that Parvovirus B19 induces the death of erythroid progenitors, supporting the statement.	"{""explanation"": ""The abstract states that Parvovirus B19 induces the death of erythroid progenitors, supporting the statement."", ""reference"": ""PMID:12116854"", ""snippet"": ""Parvovirus B19 is a human erythrovirus, i.e. which induces the death of erythroid progenitors."", ""supports"": ""SUPPORT""}"
6092	5951	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	1	evidence	0	PMID:37434352	SUPPORT		Notably, adult patients with B19V infection frequently experience joint pain and cutaneous eruptions, which are ostensibly immune responses to the infection and necessitate careful differentiation from autoimmunity.	The reference describes joint pain and skin rash as immune responses to Parvovirus B19 infection, supporting the statement.	"{""explanation"": ""The reference describes joint pain and skin rash as immune responses to Parvovirus B19 infection, supporting the statement."", ""reference"": ""PMID:37434352"", ""snippet"": ""Notably, adult patients with B19V infection frequently experience joint pain and cutaneous eruptions, which are ostensibly immune responses to the infection and necessitate careful differentiation from autoimmunity."", ""supports"": ""SUPPORT""}"
6093	5951	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	pathophysiology	1	evidence	1	PMID:9595838	SUPPORT		Infections caused by human parvovirus B19 result in a variety of clinical manifestations, the severity of which depends on the immune and hematologic status of the host. Arthropathy is known to occur in children and adults with acute parvovirus B19 infection.	The reference mentions that arthropathy (joint symptoms) occurs in individuals with Parvovirus B19 infection, supporting the statement.	"{""explanation"": ""The reference mentions that arthropathy (joint symptoms) occurs in individuals with Parvovirus B19 infection, supporting the statement."", ""reference"": ""PMID:9595838"", ""snippet"": ""Infections caused by human parvovirus B19 result in a variety of clinical manifestations, the severity of which depends on the immune and hematologic status of the host. Arthropathy is known to occur in children and adults with acute parvovirus B19 infection."", ""supports"": ""SUPPORT""}"
6141	5971	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	0	evidence	0	PMID:10878487	SUPPORT		Auto-Ab against the desmosomal adhesion molecule, desmoglein 3 (Dsg3), are critical in the pathogenesis of this disease, since the transfer of serum IgG Ab reactive with Dsg3 into newborn mice induces a bullous skin disease resembling PV.	Passive transfer experiments demonstrate that anti-Dsg3 IgG autoantibodies are directly pathogenic and sufficient to cause pemphigus-like disease.	"{""explanation"": ""Passive transfer experiments demonstrate that anti-Dsg3 IgG autoantibodies are directly pathogenic and sufficient to cause pemphigus-like disease."", ""reference"": ""PMID:10878487"", ""snippet"": ""Auto-Ab against the desmosomal adhesion molecule, desmoglein 3 (Dsg3), are critical in the pathogenesis of this disease, since the transfer of serum IgG Ab reactive with Dsg3 into newborn mice induces a bullous skin disease resembling PV."", ""supports"": ""SUPPORT""}"
6142	5971	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	0	evidence	1	PMID:39075718	SUPPORT		The most notable biomarkers trends include elevations in IL-4, IL-6, IL-17A, anti-Dsg1/3 autoantibodies, and a reduction in Treg cells and FOXP3.	Systematic review of 66 studies confirms that anti-Dsg1 and anti-Dsg3 autoantibodies are the most consistent biomarkers in pemphigus vulgaris.	"{""explanation"": ""Systematic review of 66 studies confirms that anti-Dsg1 and anti-Dsg3 autoantibodies are the most consistent biomarkers in pemphigus vulgaris."", ""reference"": ""PMID:39075718"", ""snippet"": ""The most notable biomarkers trends include elevations in IL-4, IL-6, IL-17A, anti-Dsg1/3 autoantibodies, and a reduction in Treg cells and FOXP3."", ""supports"": ""SUPPORT""}"
6143	5972	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	1	evidence	0	PMID:10878487	SUPPORT		Antibody (Ab) binding interferes with the adhesive function of these molecules, leading to detachment and subsequently blister formation.	Autoantibody binding directly interferes with the adhesive function of desmogleins, resulting in keratinocyte detachment and blister formation.	"{""explanation"": ""Autoantibody binding directly interferes with the adhesive function of desmogleins, resulting in keratinocyte detachment and blister formation."", ""reference"": ""PMID:10878487"", ""snippet"": ""Antibody (Ab) binding interferes with the adhesive function of these molecules, leading to detachment and subsequently blister formation."", ""supports"": ""SUPPORT""}"
6144	5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	evidence	0	PMID:19811408	SUPPORT		All patients with PV and PF showed significantly (p < 0.000) elevated levels of T(H)2 cytokines (IL-10 and IL-4) as compared with healthy controls. However, the mean concentration of T(H)1 cytokines (IL-2 and IFN-gamma) was significantly decreased in patients as compared to healthy individuals.	Cytokine profiling demonstrates a clear Th2 cytokine dominance in PV patients with elevated IL-4 and IL-10, supporting the role of Th2-mediated immune responses in disease pathogenesis.	"{""explanation"": ""Cytokine profiling demonstrates a clear Th2 cytokine dominance in PV patients with elevated IL-4 and IL-10, supporting the role of Th2-mediated immune responses in disease pathogenesis."", ""reference"": ""PMID:19811408"", ""snippet"": ""All patients with PV and PF showed significantly (p < 0.000) elevated levels of T(H)2 cytokines (IL-10 and IL-4) as compared with healthy controls. However, the mean concentration of T(H)1 cytokines (IL-2 and IFN-gamma) was significantly decreased in patients as compared to healthy individuals."", ""supports"": ""SUPPORT""}"
6145	5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	evidence	1	PMID:17377382	SUPPORT		The proportion of Treg cells in all PV patients was severely reduced, approximately ten times less than controls. These observations were further confirmed by both diminished gene and protein expression of Foxp3 in the CD4(+)CD25(+) T cell population in PV patients.	Severe reduction in regulatory T cells may contribute to loss of tolerance and failure to suppress autoreactive B and T cells in pemphigus vulgaris.	"{""explanation"": ""Severe reduction in regulatory T cells may contribute to loss of tolerance and failure to suppress autoreactive B and T cells in pemphigus vulgaris."", ""reference"": ""PMID:17377382"", ""snippet"": ""The proportion of Treg cells in all PV patients was severely reduced, approximately ten times less than controls. These observations were further confirmed by both diminished gene and protein expression of Foxp3 in the CD4(+)CD25(+) T cell population in PV patients."", ""supports"": ""SUPPORT""}"
6146	5974	253	Pemphigus Vulgaris	Pemphigus_Vulgaris.yaml	pathophysiology	3	evidence	2	PMID:39075718	SUPPORT		The results of this review support current theories of PV pathogenesis, with increased Th2 activity, increased Th17 activity, decreased Treg activity, and production of anti-Dsg1/3 autoantibodies being observed.	Systematic review synthesizing 66 studies confirms the Th2/Th17 skewing and Treg deficiency as core immunological features of pemphigus vulgaris.	"{""explanation"": ""Systematic review synthesizing 66 studies confirms the Th2/Th17 skewing and Treg deficiency as core immunological features of pemphigus vulgaris."", ""reference"": ""PMID:39075718"", ""snippet"": ""The results of this review support current theories of PV pathogenesis, with increased Th2 activity, increased Th17 activity, decreased Treg activity, and production of anti-Dsg1/3 autoantibodies being observed."", ""supports"": ""SUPPORT""}"
6147	5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	evidence	0	PMID:38003290	SUPPORT		Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms.	Confirms atherosclerosis as the primary pathophysiological mechanism underlying PAD.	"{""explanation"": ""Confirms atherosclerosis as the primary pathophysiological mechanism underlying PAD."", ""reference"": ""PMID:38003290"", ""snippet"": ""Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms."", ""supports"": ""SUPPORT""}"
6148	5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	evidence	1	PMID:37452714	SUPPORT		Atherosclerosis is a lipid-driven chronic inflammatory disease characterized by the accumulation and transformation of inflammatory cells, and smooth muscle cells in the intimal space.	Describes the characteristic lipid accumulation and cellular transformation in atherosclerotic plaques.	"{""explanation"": ""Describes the characteristic lipid accumulation and cellular transformation in atherosclerotic plaques."", ""reference"": ""PMID:37452714"", ""snippet"": ""Atherosclerosis is a lipid-driven chronic inflammatory disease characterized by the accumulation and transformation of inflammatory cells, and smooth muscle cells in the intimal space."", ""supports"": ""SUPPORT""}"
6149	5995	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	0	evidence	2	PMID:38401035	SUPPORT		Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis.	Links neutrophil activity to atherosclerotic plaque progression and severity in peripheral arteries.	"{""explanation"": ""Links neutrophil activity to atherosclerotic plaque progression and severity in peripheral arteries."", ""reference"": ""PMID:38401035"", ""snippet"": ""Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis."", ""supports"": ""SUPPORT""}"
6150	5996	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	1	evidence	0	PMID:38961103	SUPPORT		It was observed that serum IL-6, IL-8, ICAM and VCAM levels in type II diabetes mellitus (T2DM) with PAD patients were increased significantly (85.93, 597.08, 94.80 and 80.66) as compared to T2DM patients (59.52, 231.34, 56.88 and 50.19) and healthy individuals (4.81, 16.93, 5.55 and 5.16).	Demonstrates marked elevation of endothelial activation markers (ICAM, VCAM) in PAD patients, indicating severe endothelial dysfunction.	"{""explanation"": ""Demonstrates marked elevation of endothelial activation markers (ICAM, VCAM) in PAD patients, indicating severe endothelial dysfunction."", ""reference"": ""PMID:38961103"", ""snippet"": ""It was observed that serum IL-6, IL-8, ICAM and VCAM levels in type II diabetes mellitus (T2DM) with PAD patients were increased significantly (85.93, 597.08, 94.80 and 80.66) as compared to T2DM patients (59.52, 231.34, 56.88 and 50.19) and healthy individuals (4.81, 16.93, 5.55 and 5.16)."", ""supports"": ""SUPPORT""}"
6151	5996	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	1	evidence	1	PMID:38182796	SUPPORT		We have previously shown that VEGF165b, an alternatively spliced anti-angiogenic VEGF-A isoform, inhibits the VEGFR-STAT3 pathway in ischemic endothelial cells (ECs) to decrease their angiogenic capacity.	Describes impaired angiogenic signaling in ischemic endothelial cells in PAD, contributing to endothelial dysfunction and inadequate collateral formation.	"{""explanation"": ""Describes impaired angiogenic signaling in ischemic endothelial cells in PAD, contributing to endothelial dysfunction and inadequate collateral formation."", ""reference"": ""PMID:38182796"", ""snippet"": ""We have previously shown that VEGF165b, an alternatively spliced anti-angiogenic VEGF-A isoform, inhibits the VEGFR-STAT3 pathway in ischemic endothelial cells (ECs) to decrease their angiogenic capacity."", ""supports"": ""SUPPORT""}"
6152	5997	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	2	evidence	0	PMID:38401035	SUPPORT		Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC).	Demonstrates that neutrophil extracellular traps promote platelet activation and thrombosis in atherosclerotic vessels.	"{""explanation"": ""Demonstrates that neutrophil extracellular traps promote platelet activation and thrombosis in atherosclerotic vessels."", ""reference"": ""PMID:38401035"", ""snippet"": ""Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC)."", ""supports"": ""SUPPORT""}"
6153	5997	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	2	evidence	1	PMID:37452714	SUPPORT		NETs not only capture pathogens in innate immunity but also respond to sterile inflammatory stimuli in atherosclerosis, such as lipoproteins and inflammatory cytokines.	Shows how NETs respond to atherosclerotic stimuli and contribute to prothrombotic conditions in PAD.	"{""explanation"": ""Shows how NETs respond to atherosclerotic stimuli and contribute to prothrombotic conditions in PAD."", ""reference"": ""PMID:37452714"", ""snippet"": ""NETs not only capture pathogens in innate immunity but also respond to sterile inflammatory stimuli in atherosclerosis, such as lipoproteins and inflammatory cytokines."", ""supports"": ""SUPPORT""}"
6154	5998	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	3	evidence	0	PMID:38003290	SUPPORT		Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms.	Establishes inflammation as a core mechanism underlying PAD pathophysiology.	"{""explanation"": ""Establishes inflammation as a core mechanism underlying PAD pathophysiology."", ""reference"": ""PMID:38003290"", ""snippet"": ""Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying mechanisms."", ""supports"": ""SUPPORT""}"
6155	5998	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	3	evidence	1	PMID:37452714	SUPPORT		Neutrophil extracellular traps (NETs) are network-like structures of chromatin filaments decorated by histones, granules, and cytoplasmic-derived proteins expelled by activated neutrophils under multiple pathogenic conditions.	Describes neutrophil-driven inflammatory mechanisms involving NET formation in atherosclerosis.	"{""explanation"": ""Describes neutrophil-driven inflammatory mechanisms involving NET formation in atherosclerosis."", ""reference"": ""PMID:37452714"", ""snippet"": ""Neutrophil extracellular traps (NETs) are network-like structures of chromatin filaments decorated by histones, granules, and cytoplasmic-derived proteins expelled by activated neutrophils under multiple pathogenic conditions."", ""supports"": ""SUPPORT""}"
6156	5998	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	pathophysiology	3	evidence	2	PMID:38401035	SUPPORT		Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC).	Demonstrates how neutrophil-mediated inflammation causes vascular cell damage in atherosclerotic disease.	"{""explanation"": ""Demonstrates how neutrophil-mediated inflammation causes vascular cell damage in atherosclerotic disease."", ""reference"": ""PMID:38401035"", ""snippet"": ""Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC)."", ""supports"": ""SUPPORT""}"
6186	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	0	PMID:33417206	SUPPORT		Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs).	This reference highlights that mutations affecting peroxisome biogenesis lead to dysfunction of peroxisomes and consequently to metabolic impairments.	"{""explanation"": ""This reference highlights that mutations affecting peroxisome biogenesis lead to dysfunction of peroxisomes and consequently to metabolic impairments."", ""reference"": ""PMID:33417206"", ""snippet"": ""Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs)."", ""supports"": ""SUPPORT""}"
6187	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	1	PMID:28409474	SUPPORT		More than a dozen complementation groups of animal somatic mutant cells defective in peroxisome biogenesis have been successfully isolated in Chinese hamster ovary (CHO) cells and used as a model system reflecting fatal human severe genetic disorders named peroxisome biogenesis disorders (PBD).	Defective peroxisome biogenesis due to mutations in PEX genes supports the statement about peroxisomal disorders and impaired metabolic processes.	"{""explanation"": ""Defective peroxisome biogenesis due to mutations in PEX genes supports the statement about peroxisomal disorders and impaired metabolic processes."", ""reference"": ""PMID:28409474"", ""snippet"": ""More than a dozen complementation groups of animal somatic mutant cells defective in peroxisome biogenesis have been successfully isolated in Chinese hamster ovary (CHO) cells and used as a model system reflecting fatal human severe genetic disorders named peroxisome biogenesis disorders (PBD)."", ""supports"": ""SUPPORT""}"
6188	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	2	PMID:28320181	SUPPORT		Peroxisome biogenesis factor 10 (PEX10) is involved in the import of peroxisomal matrix proteins, and the mutation of this gene causes 3 subtypes of peroxisome biogenesis disorders...	The reference details how mutations in PEX10 affect peroxisomal import, aligning with the statement's assertion about disrupted peroxisome function.	"{""explanation"": ""The reference details how mutations in PEX10 affect peroxisomal import, aligning with the statement's assertion about disrupted peroxisome function."", ""reference"": ""PMID:28320181"", ""snippet"": ""Peroxisome biogenesis factor 10 (PEX10) is involved in the import of peroxisomal matrix proteins, and the mutation of this gene causes 3 subtypes of peroxisome biogenesis disorders..."", ""supports"": ""SUPPORT""}"
6189	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	3	PMID:36249295	SUPPORT		Peroxisomal biogenesis disorders (PBDs) represent a spectrum of conditions that result in vision loss, sensorineural hearing loss, neurologic dysfunction, and other abnormalities resulting from aberrant peroxisomal function caused by mutations in PEX genes.	The study confirms that mutations in PEX genes disrupt peroxisomal functions, leading to various metabolic and physiological impairments.	"{""explanation"": ""The study confirms that mutations in PEX genes disrupt peroxisomal functions, leading to various metabolic and physiological impairments."", ""reference"": ""PMID:36249295"", ""snippet"": ""Peroxisomal biogenesis disorders (PBDs) represent a spectrum of conditions that result in vision loss, sensorineural hearing loss, neurologic dysfunction, and other abnormalities resulting from aberrant peroxisomal function caused by mutations in PEX genes."", ""supports"": ""SUPPORT""}"
6190	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	4	PMID:34804114	SUPPORT		Pathogenic variants in the PEX26 gene lead to peroxisomal disorders of the full Zellweger spectrum continuum.	PEX26 mutations, which lead to peroxisomal biogenesis disorders, confirm the link between PEX gene defects and impaired peroxisomal function.	"{""explanation"": ""PEX26 mutations, which lead to peroxisomal biogenesis disorders, confirm the link between PEX gene defects and impaired peroxisomal function."", ""reference"": ""PMID:34804114"", ""snippet"": ""Pathogenic variants in the PEX26 gene lead to peroxisomal disorders of the full Zellweger spectrum continuum."", ""supports"": ""SUPPORT""}"
6191	6025	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	0	evidence	5	PMID:9458170	SUPPORT		Neurological dysfunction is a prominent feature of most peroxisomal disorders. Enormous progress in defining their gene defects has been achieved. The genes and gene products, peroxins (PEX), in five of the complementation groups have been defined.	This reference illustrates the role of PEX genes in peroxisomal disorders, supporting the claim of their involvement in cellular and metabolic disruption.	"{""explanation"": ""This reference illustrates the role of PEX genes in peroxisomal disorders, supporting the claim of their involvement in cellular and metabolic disruption."", ""reference"": ""PMID:9458170"", ""snippet"": ""Neurological dysfunction is a prominent feature of most peroxisomal disorders. Enormous progress in defining their gene defects has been achieved. The genes and gene products, peroxins (PEX), in five of the complementation groups have been defined."", ""supports"": ""SUPPORT""}"
6192	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	evidence	0	PMID:19933170	PARTIAL		Peroxisomes are vital eukaryotic organelles that participate in lipid metabolism, in particular the metabolism of very-long-chain fatty acids (VLCFA)... including impaired peroxisomal protein import, elevated VLCFA levels and growth retardation.	The reference supports the accumulation of VLCFAs as part of the pathophysiology of Peroxisome Biogenesis Disorders but does not mention bile acid intermediates or phytanic acid.	"{""explanation"": ""The reference supports the accumulation of VLCFAs as part of the pathophysiology of Peroxisome Biogenesis Disorders but does not mention bile acid intermediates or phytanic acid."", ""reference"": ""PMID:19933170"", ""snippet"": ""Peroxisomes are vital eukaryotic organelles that participate in lipid metabolism, in particular the metabolism of very-long-chain fatty acids (VLCFA)... including impaired peroxisomal protein import, elevated VLCFA levels and growth retardation."", ""supports"": ""PARTIAL""}"
6193	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	evidence	1	PMID:3119940	PARTIAL		In patients with cerebro-hepato-renal (Zellweger) syndrome, the absence of peroxisomes results in an impairment of metabolic processes... These include the catabolism of very long chain (greater than C22) fatty acids... the catabolism of phytanic acid and the catabolism of pipecolic acid.	This reference supports the accumulation of VLCFAs and phytanic acid in peroxisomal disorders but does not mention bile acid intermediates.	"{""explanation"": ""This reference supports the accumulation of VLCFAs and phytanic acid in peroxisomal disorders but does not mention bile acid intermediates."", ""reference"": ""PMID:3119940"", ""snippet"": ""In patients with cerebro-hepato-renal (Zellweger) syndrome, the absence of peroxisomes results in an impairment of metabolic processes... These include the catabolism of very long chain (greater than C22) fatty acids... the catabolism of phytanic acid and the catabolism of pipecolic acid."", ""supports"": ""PARTIAL""}"
6194	6026	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	1	evidence	2	PMID:22978395	PARTIAL		By comparing the different peroxisomal disorders, we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA).	This reference supports the accumulation of bile acid intermediates in peroxisomal disorders but does not mention VLCFAs or phytanic acid.	"{""explanation"": ""This reference supports the accumulation of bile acid intermediates in peroxisomal disorders but does not mention VLCFAs or phytanic acid."", ""reference"": ""PMID:22978395"", ""snippet"": ""By comparing the different peroxisomal disorders, we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""PARTIAL""}"
6195	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	evidence	0	PMID:36720320	SUPPORT		The absence of plasmalogens in several organs of patients with deficiency in peroxisome biogenesis suggests that de novo synthesis of plasmalogens contributes significantly to plasmalogen homeostasis in humans.	The literature indicates that plasmalogen biosynthesis is significantly affected in patients with peroxisome biogenesis disorders, which supports the statement regarding impaired synthesis of plasmalogens disrupting normal cellular functions.	"{""explanation"": ""The literature indicates that plasmalogen biosynthesis is significantly affected in patients with peroxisome biogenesis disorders, which supports the statement regarding impaired synthesis of plasmalogens disrupting normal cellular functions."", ""reference"": ""PMID:36720320"", ""snippet"": ""The absence of plasmalogens in several organs of patients with deficiency in peroxisome biogenesis suggests that de novo synthesis of plasmalogens contributes significantly to plasmalogen homeostasis in humans."", ""supports"": ""SUPPORT""}"
6196	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	evidence	1	PMID:32165495	SUPPORT		The peroxisome is a subcellular organelle that functions in essential metabolic pathways, including biosynthesis of plasmalogens, fatty acid beta-oxidation of very-long-chain fatty acids, and degradation of hydrogen peroxide. Peroxisome biogenesis disorders (PBDs) manifest as severe dysfunction in multiple organs, including the central nervous system (CNS), but the pathogenic mechanisms in PBDs are largely unknown.	This study reinforces that impaired peroxisome function, including the biosynthesis of plasmalogens, leads to a broad spectrum of cellular dysfunctions.	"{""explanation"": ""This study reinforces that impaired peroxisome function, including the biosynthesis of plasmalogens, leads to a broad spectrum of cellular dysfunctions."", ""reference"": ""PMID:32165495"", ""snippet"": ""The peroxisome is a subcellular organelle that functions in essential metabolic pathways, including biosynthesis of plasmalogens, fatty acid beta-oxidation of very-long-chain fatty acids, and degradation of hydrogen peroxide. Peroxisome biogenesis disorders (PBDs) manifest as severe dysfunction in multiple organs, including the central nervous system (CNS), but the pathogenic mechanisms in PBDs are largely unknown."", ""supports"": ""SUPPORT""}"
6197	6027	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	2	evidence	2	PMID:33417206	SUPPORT		Peroxisomes are presented in all eukaryotic cells and play essential roles in many of lipid metabolic pathways, including beta-oxidation of fatty acids and synthesis of ether-linked glycerophospholipids, such as plasmalogens.	The abstract confirms that peroxisomes are crucial for the synthesis of plasmalogens and that their dysfunction could disrupt normal cellular functions.	"{""explanation"": ""The abstract confirms that peroxisomes are crucial for the synthesis of plasmalogens and that their dysfunction could disrupt normal cellular functions."", ""reference"": ""PMID:33417206"", ""snippet"": ""Peroxisomes are presented in all eukaryotic cells and play essential roles in many of lipid metabolic pathways, including beta-oxidation of fatty acids and synthesis of ether-linked glycerophospholipids, such as plasmalogens."", ""supports"": ""SUPPORT""}"
6198	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	evidence	0	PMID:15868469	SUPPORT		Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes.	The reference specifies that a lack of functional peroxisomes leads to severe neurological dysfunction, including demyelination and defects in neuronal migration, which aligns with the statement's content.	"{""explanation"": ""The reference specifies that a lack of functional peroxisomes leads to severe neurological dysfunction, including demyelination and defects in neuronal migration, which aligns with the statement's content."", ""reference"": ""PMID:15868469"", ""snippet"": ""Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes."", ""supports"": ""SUPPORT""}"
6199	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	evidence	1	PMID:33417206	SUPPORT		Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs).	This reference describes PBDs leading to significant neurodegeneration and psychomotor dysfunction, consistent with the statement on neurological dysfunction due to the disorder.	"{""explanation"": ""This reference describes PBDs leading to significant neurodegeneration and psychomotor dysfunction, consistent with the statement on neurological dysfunction due to the disorder."", ""reference"": ""PMID:33417206"", ""snippet"": ""Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs)."", ""supports"": ""SUPPORT""}"
6200	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	evidence	2	PMID:22978395	PARTIAL		Liver pathology is a frequent finding in patients affected by a peroxisomal disorder. ... we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA).	While this reference supports the role of toxic metabolites, it focuses on liver pathology rather than CNS-specific features like demyelination and neuronal migration defects.	"{""explanation"": ""While this reference supports the role of toxic metabolites, it focuses on liver pathology rather than CNS-specific features like demyelination and neuronal migration defects."", ""reference"": ""PMID:22978395"", ""snippet"": ""Liver pathology is a frequent finding in patients affected by a peroxisomal disorder. ... we provide evidence suggesting that the main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""PARTIAL""}"
6201	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	evidence	3	PMID:7685145	SUPPORT		Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction.	The reference acknowledges the impact on the nervous system and describes psychomotor dysfunction, supporting the idea of neurological dysfunction.	"{""explanation"": ""The reference acknowledges the impact on the nervous system and describes psychomotor dysfunction, supporting the idea of neurological dysfunction."", ""reference"": ""PMID:7685145"", ""snippet"": ""Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction."", ""supports"": ""SUPPORT""}"
6202	6028	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	3	evidence	4	PMID:30739266	PARTIAL		The importance of functional peroxisomes for cellular metabolism is demonstrated by the marked brain and systemic organ abnormalities occuring in peroxisome biogenesis disorders and peroxisomal enzyme deficiencies	This reference highlights general brain abnormalities due to peroxisomal dysfunction but does not specifically describe demyelination and neuronal migration defects. Partial support is given as it indicates a broad CNS impact.	"{""explanation"": ""This reference highlights general brain abnormalities due to peroxisomal dysfunction but does not specifically describe demyelination and neuronal migration defects. Partial support is given as it indicates a broad CNS impact."", ""reference"": ""PMID:30739266"", ""snippet"": ""The importance of functional peroxisomes for cellular metabolism is demonstrated by the marked brain and systemic organ abnormalities occuring in peroxisome biogenesis disorders and peroxisomal enzyme deficiencies"", ""supports"": ""PARTIAL""}"
6203	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	0	PMID:12473763	SUPPORT		Common to these three disorders are liver disease, variable neurodevelopmental delay, retinopathy, and perceptive deafness.	The study mentions liver disease as a common symptom of peroxisome biogenesis disorder (PBD), supporting hepatic dysfunction.	"{""explanation"": ""The study mentions liver disease as a common symptom of peroxisome biogenesis disorder (PBD), supporting hepatic dysfunction."", ""reference"": ""PMID:12473763"", ""snippet"": ""Common to these three disorders are liver disease, variable neurodevelopmental delay, retinopathy, and perceptive deafness."", ""supports"": ""SUPPORT""}"
6204	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	1	PMID:22978395	SUPPORT		The main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA).	This reference supports the accumulation of bile acid intermediates causing liver pathology in PBDs.	"{""explanation"": ""This reference supports the accumulation of bile acid intermediates causing liver pathology in PBDs."", ""reference"": ""PMID:22978395"", ""snippet"": ""The main hepatotoxic metabolites responsible for the liver pathology found in patients, are the bile acid synthesis intermediates di- and trihydroxycholestanoic acid (DHCA and THCA)."", ""supports"": ""SUPPORT""}"
6205	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	2	PMID:29282281	SUPPORT		They are caused by mutations of peroxisomal biogenesis factors encoded by Pex genes, and result in childhood lethality	This reference indirectly supports the statement by discussing the lethal and severe impact of PBDs, including liver dysfunction.	"{""explanation"": ""This reference indirectly supports the statement by discussing the lethal and severe impact of PBDs, including liver dysfunction."", ""reference"": ""PMID:29282281"", ""snippet"": ""They are caused by mutations of peroxisomal biogenesis factors encoded by Pex genes, and result in childhood lethality"", ""supports"": ""SUPPORT""}"
6206	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	3	PMID:8184191	SUPPORT		Zellweger disease or cerebro-hepato-renal syndrome is characterized clinically by... liver damage leading to cirrhosis.	This confirms hepatic dysfunction including fibrosis in PBDs.	"{""explanation"": ""This confirms hepatic dysfunction including fibrosis in PBDs."", ""reference"": ""PMID:8184191"", ""snippet"": ""Zellweger disease or cerebro-hepato-renal syndrome is characterized clinically by... liver damage leading to cirrhosis."", ""supports"": ""SUPPORT""}"
6207	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	4	PMID:8729109	SUPPORT		Abnormally high levels of very long-chain fatty acids (VLCFA) are a feature in...peroxisomal disorders.	Supports the accumulation of VLCFAs as part of the pathophysiology.	"{""explanation"": ""Supports the accumulation of VLCFAs as part of the pathophysiology."", ""reference"": ""PMID:8729109"", ""snippet"": ""Abnormally high levels of very long-chain fatty acids (VLCFA) are a feature in...peroxisomal disorders."", ""supports"": ""SUPPORT""}"
6208	6029	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	4	evidence	5	PMID:17682975	SUPPORT		Nine recognized inborn errors of bile acid metabolism have been identified that lead to enzyme deficiencies and impaired bile acid synthesis in infants, children, and adults.	This reference supports the accumulation of bile acid intermediates, contributing to hepatic dysfunction.	"{""explanation"": ""This reference supports the accumulation of bile acid intermediates, contributing to hepatic dysfunction."", ""reference"": ""PMID:17682975"", ""snippet"": ""Nine recognized inborn errors of bile acid metabolism have been identified that lead to enzyme deficiencies and impaired bile acid synthesis in infants, children, and adults."", ""supports"": ""SUPPORT""}"
6209	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	evidence	0	PMID:10904262	SUPPORT		Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders characterized by loss of multiple peroxisomal metabolic functions.	The context indicates that rhizomelic chondrodysplasia punctata (a type of peroxisome biogenesis disorder) results from peroxisomal dysfunction, supporting the connection between plasmalogen deficiency and skeletal abnormalities, including rhizomelic shortening of limbs and chondrodysplasia punctata.	"{""explanation"": ""The context indicates that rhizomelic chondrodysplasia punctata (a type of peroxisome biogenesis disorder) results from peroxisomal dysfunction, supporting the connection between plasmalogen deficiency and skeletal abnormalities, including rhizomelic shortening of limbs and chondrodysplasia punctata."", ""reference"": ""PMID:10904262"", ""snippet"": ""Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders characterized by loss of multiple peroxisomal metabolic functions."", ""supports"": ""SUPPORT""}"
6210	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	evidence	1	PMID:10972423	SUPPORT		The case of a Yemeni girl with isolated peroxisomal acyl-CoA:dihydroxyacetonephosphate acyltransferase (DHAPAT) deficiency is reported. She had rhizomelic chondrodysplasia punctata, microcephaly, failure to thrive, delayed motor and mental development, and spastic quadriplegia.	The document discusses a case where plasmalogen biosynthesis deficiency leads to rhizomelic chondrodysplasia punctata, supporting the statement.	"{""explanation"": ""The document discusses a case where plasmalogen biosynthesis deficiency leads to rhizomelic chondrodysplasia punctata, supporting the statement."", ""reference"": ""PMID:10972423"", ""snippet"": ""The case of a Yemeni girl with isolated peroxisomal acyl-CoA:dihydroxyacetonephosphate acyltransferase (DHAPAT) deficiency is reported. She had rhizomelic chondrodysplasia punctata, microcephaly, failure to thrive, delayed motor and mental development, and spastic quadriplegia."", ""supports"": ""SUPPORT""}"
6211	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	evidence	2	PMID:8507680	SUPPORT		The results have clearly shown an indispensable role for peroxisomes in the total process of ether lipid synthesis as evidenced by a description of the cellular topography of this process.	The paper supports the importance of peroxisomes in lipid synthesis, including plasmalogens, which are associated with diseases like rhizomelic chondrodysplasia punctata that impact bone and cartilage formation.	"{""explanation"": ""The paper supports the importance of peroxisomes in lipid synthesis, including plasmalogens, which are associated with diseases like rhizomelic chondrodysplasia punctata that impact bone and cartilage formation."", ""reference"": ""PMID:8507680"", ""snippet"": ""The results have clearly shown an indispensable role for peroxisomes in the total process of ether lipid synthesis as evidenced by a description of the cellular topography of this process."", ""supports"": ""SUPPORT""}"
6212	6030	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	5	evidence	3	PMID:24172221	SUPPORT		Rhizomelic chondrodysplasia punctata (RCDP); a peroxisomal disorder clinically characterized by skeletal abnormalities, congenital cataracts, severe growth and developmental impairments and immobility of joints. Defective plasmalogen biosynthesis is the main biochemical feature.	This clearly supports the notion that defective plasmalogen biosynthesis leads to skeletal abnormalities characteristic of rhizomelic chondrodysplasia punctata, including rhizomelic shortening of limbs and chondrodysplasia punctata.	"{""explanation"": ""This clearly supports the notion that defective plasmalogen biosynthesis leads to skeletal abnormalities characteristic of rhizomelic chondrodysplasia punctata, including rhizomelic shortening of limbs and chondrodysplasia punctata."", ""reference"": ""PMID:24172221"", ""snippet"": ""Rhizomelic chondrodysplasia punctata (RCDP); a peroxisomal disorder clinically characterized by skeletal abnormalities, congenital cataracts, severe growth and developmental impairments and immobility of joints. Defective plasmalogen biosynthesis is the main biochemical feature."", ""supports"": ""SUPPORT""}"
6213	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	0	PMID:14527301	SUPPORT		The multisystem clinical phenotype varies widely in severity and results from disturbances in both development and metabolic homeostasis.	This statement supports the pervasive nature of peroxisomal dysfunction affecting multiple organ systems, leading to a range of clinical manifestations.	"{""explanation"": ""This statement supports the pervasive nature of peroxisomal dysfunction affecting multiple organ systems, leading to a range of clinical manifestations."", ""reference"": ""PMID:14527301"", ""snippet"": ""The multisystem clinical phenotype varies widely in severity and results from disturbances in both development and metabolic homeostasis."", ""supports"": ""SUPPORT""}"
6214	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	1	PMID:33417210	SUPPORT		Peroxisomopathies are rare diseases due to dysfunctions of the peroxisome in which this organelle is either absent or with impaired activities. These diseases... affect the central and peripheral nervous system.	This statement aligns with the notion that peroxisomal dysfunction affects multiple organ systems.	"{""explanation"": ""This statement aligns with the notion that peroxisomal dysfunction affects multiple organ systems."", ""reference"": ""PMID:33417210"", ""snippet"": ""Peroxisomopathies are rare diseases due to dysfunctions of the peroxisome in which this organelle is either absent or with impaired activities. These diseases... affect the central and peripheral nervous system."", ""supports"": ""SUPPORT""}"
6215	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	2	PMID:26453805	SUPPORT		The peroxisomal compartment in hepatocytes hosts several essential metabolic conversions. These are defective in peroxisomal disorders... including mitochondria and the ER.	This reference details the involvement of multiple cellular compartments and metabolic pathways, illustrating multisystem impact.	"{""explanation"": ""This reference details the involvement of multiple cellular compartments and metabolic pathways, illustrating multisystem impact."", ""reference"": ""PMID:26453805"", ""snippet"": ""The peroxisomal compartment in hepatocytes hosts several essential metabolic conversions. These are defective in peroxisomal disorders... including mitochondria and the ER."", ""supports"": ""SUPPORT""}"
6216	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	3	PMID:1710072	SUPPORT		Several childhood multisystem disorders with prominent ophthalmological manifestations have been ascribed to the malfunction of the peroxisome, a subcellular organelle.	It categorizes peroxisomal disorders as multisystem with significant implications in different organ systems, particularly the eyes.	"{""explanation"": ""It categorizes peroxisomal disorders as multisystem with significant implications in different organ systems, particularly the eyes."", ""reference"": ""PMID:1710072"", ""snippet"": ""Several childhood multisystem disorders with prominent ophthalmological manifestations have been ascribed to the malfunction of the peroxisome, a subcellular organelle."", ""supports"": ""SUPPORT""}"
6217	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	4	PMID:15868469	SUPPORT		Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes.	This echoes the impact on multiple organ systems but emphasizes the neurological dysfunctions.	"{""explanation"": ""This echoes the impact on multiple organ systems but emphasizes the neurological dysfunctions."", ""reference"": ""PMID:15868469"", ""snippet"": ""Peroxisome biogenesis disorders, of which Zellweger syndrome is the most severe, result in severe neurological dysfunction associated with abnormal CNS neuronal migrations due to the lack of functional peroxisomes."", ""supports"": ""SUPPORT""}"
6218	6031	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	pathophysiology	6	evidence	5	PMID:21397417	SUPPORT		Peroxisomal disorders (PDs) are heterogeneous groups of diseases and affect many organs with varying degrees of involvement.	This source supports the statement by highlighting the multi-organ involvement in peroxisomal disorders.	"{""explanation"": ""This source supports the statement by highlighting the multi-organ involvement in peroxisomal disorders."", ""reference"": ""PMID:21397417"", ""snippet"": ""Peroxisomal disorders (PDs) are heterogeneous groups of diseases and affect many organs with varying degrees of involvement."", ""supports"": ""SUPPORT""}"
6270	6064	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	0	evidence	0	PMID:37054692	SUPPORT		Peutz-Jeghers syndrome (PJS) is a rare disease characterized by the presence of hamartomatous polyposis throughout the gastrointestinal tract, except for the esophagus, along with characteristic mucocutaneous pigmentation. It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance	Establishes STK11 germline variants as the driver of hamartomatous polyposis in PJS.	"{""explanation"": ""Establishes STK11 germline variants as the driver of hamartomatous polyposis in PJS."", ""reference"": ""PMID:37054692"", ""snippet"": ""Peutz-Jeghers syndrome (PJS) is a rare disease characterized by the presence of hamartomatous polyposis throughout the gastrointestinal tract, except for the esophagus, along with characteristic mucocutaneous pigmentation. It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance"", ""supports"": ""SUPPORT""}"
6271	6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	evidence	0	PMID:19541609	SUPPORT		Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice.	Demonstrates mTORC1 pathway hyperactivation in LKB1-deficient PJS models.	"{""explanation"": ""Demonstrates mTORC1 pathway hyperactivation in LKB1-deficient PJS models."", ""reference"": ""PMID:19541609"", ""snippet"": ""Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice."", ""supports"": ""SUPPORT""}"
6272	6065	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	1	evidence	1	PMID:19541609	SUPPORT		Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1alpha, and GLUT1 levels.	Confirms mTORC1 signaling is upregulated in human PJS polyps.	"{""explanation"": ""Confirms mTORC1 signaling is upregulated in human PJS polyps."", ""reference"": ""PMID:19541609"", ""snippet"": ""Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1alpha, and GLUT1 levels."", ""supports"": ""SUPPORT""}"
6273	6066	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	pathophysiology	2	evidence	0	PMID:36998347	SUPPORT		The resected specimen showed a branching bundle of smooth muscle fibers covered by hyperplastic mucosa, consistent with a hamartomatous polyp	Histologic description supports the arborizing smooth muscle core in PJS polyps.	"{""explanation"": ""Histologic description supports the arborizing smooth muscle core in PJS polyps."", ""reference"": ""PMID:36998347"", ""snippet"": ""The resected specimen showed a branching bundle of smooth muscle fibers covered by hyperplastic mucosa, consistent with a hamartomatous polyp"", ""supports"": ""SUPPORT""}"
6288	6078	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:7874169	SUPPORT	HUMAN_CLINICAL	A C to G transversion in exon 5, predicting a proline to arginine substitution in the putative extracellular domain, was identified in all affected members of five unrelated PS families but not in any unaffected individuals.	Demonstrates that the FGFR1 P252R mutation causes familial Pfeiffer syndrome through a gain-of-function mechanism in the extracellular domain.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that the FGFR1 P252R mutation causes familial Pfeiffer syndrome through a gain-of-function mechanism in the extracellular domain."", ""reference"": ""PMID:7874169"", ""snippet"": ""A C to G transversion in exon 5, predicting a proline to arginine substitution in the putative extracellular domain, was identified in all affected members of five unrelated PS families but not in any unaffected individuals."", ""supports"": ""SUPPORT""}"
6298	6093	258	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Ph_Positive_ALL.yaml	pathophysiology	0	evidence	0	PMID:41251904	SUPPORT		Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is characterized by the BCR::ABL1 fusion gene resulting from the translocation t(9;22).	This abstract directly links Ph+ ALL to the BCR::ABL1 fusion from t(9;22), matching the described mechanism.	"{""explanation"": ""This abstract directly links Ph+ ALL to the BCR::ABL1 fusion from t(9;22), matching the described mechanism."", ""reference"": ""PMID:41251904"", ""snippet"": ""Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is characterized by the BCR::ABL1 fusion gene resulting from the translocation t(9;22)."", ""supports"": ""SUPPORT""}"
6299	6122	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	0	evidence	0	PMID:29025426	SUPPORT		Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine.	European guidelines confirm PAH deficiency as the core enzymatic defect in PKU.	"{""explanation"": ""European guidelines confirm PAH deficiency as the core enzymatic defect in PKU."", ""reference"": ""PMID:29025426"", ""snippet"": ""Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine."", ""supports"": ""SUPPORT""}"
6300	6123	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	1	evidence	0	PMID:34017006	SUPPORT		Phenylketonuria (PKU; also known as phenylalanine hydroxylase (PAH) deficiency) is an autosomal recessive disorder of phenylalanine metabolism, in which especially high phenylalanine concentrations cause brain dysfunction.	The Nature Reviews Primer identifies high phenylalanine as the direct cause of brain dysfunction.	"{""explanation"": ""The Nature Reviews Primer identifies high phenylalanine as the direct cause of brain dysfunction."", ""reference"": ""PMID:34017006"", ""snippet"": ""Phenylketonuria (PKU; also known as phenylalanine hydroxylase (PAH) deficiency) is an autosomal recessive disorder of phenylalanine metabolism, in which especially high phenylalanine concentrations cause brain dysfunction."", ""supports"": ""SUPPORT""}"
6301	6123	259	Phenylketonuria	Phenylketonuria.yaml	pathophysiology	1	evidence	1	PMID:37265600	SUPPORT		In conclusion, our findings demonstrate that white matter alterations in early-treated phenylketonuria persist into adulthood, are most prominent in the posterior white matter and are likely to be driven by axonal damage.	DTI study demonstrates white matter damage persists even in early-treated adults.	"{""explanation"": ""DTI study demonstrates white matter damage persists even in early-treated adults."", ""reference"": ""PMID:37265600"", ""snippet"": ""In conclusion, our findings demonstrate that white matter alterations in early-treated phenylketonuria persist into adulthood, are most prominent in the posterior white matter and are likely to be driven by axonal damage."", ""supports"": ""SUPPORT""}"
6309	6148	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	0	evidence	0	PMID:33112834	SUPPORT		SDHx mutations lead to the accumulation of succinate, which acts as an oncometabolite by inhibiting iron(II) and alpha-ketoglutarate-dependent dioxygenases thereby regulating the cell's hypoxic response and epigenetic processes.	This abstract connects SDHx mutations to succinate accumulation and dioxygenase inhibition, matching the described mechanism.	"{""explanation"": ""This abstract connects SDHx mutations to succinate accumulation and dioxygenase inhibition, matching the described mechanism."", ""reference"": ""PMID:33112834"", ""snippet"": ""SDHx mutations lead to the accumulation of succinate, which acts as an oncometabolite by inhibiting iron(II) and alpha-ketoglutarate-dependent dioxygenases thereby regulating the cell's hypoxic response and epigenetic processes."", ""supports"": ""SUPPORT""}"
6310	6151	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	pathophysiology	3	evidence	0	PMID:32617052	SUPPORT		The majority of PCC and sympathetic PGL are endocrine active tumors causing clinical symptoms by secreting excess catecholamines (norepinephrine, epinephrine, dopamine) and their metabolites.	Abstract notes catecholamine-secreting tumors causing clinical symptoms.	"{""explanation"": ""Abstract notes catecholamine-secreting tumors causing clinical symptoms."", ""reference"": ""PMID:32617052"", ""snippet"": ""The majority of PCC and sympathetic PGL are endocrine active tumors causing clinical symptoms by secreting excess catecholamines (norepinephrine, epinephrine, dopamine) and their metabolites."", ""supports"": ""SUPPORT""}"
6327	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:15365985	SUPPORT		Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration.	This review establishes that abnormal tau protein aggregation is a defining pathological characteristic of Pick Disease, which is classified as a subtype of frontotemporal dementia.	"{""explanation"": ""This review establishes that abnormal tau protein aggregation is a defining pathological characteristic of Pick Disease, which is classified as a subtype of frontotemporal dementia."", ""reference"": ""PMID:15365985"", ""snippet"": ""Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative diseases, including frontotemporal dementia, Pick Disease, Alzheimer disease, argyrophilic grain disease, progressive supranuclear palsy, and corticobasal degeneration."", ""supports"": ""SUPPORT""}"
6328	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	evidence	0	PMID:20487487	SUPPORT		Pick's disease is a rare and incurable type of dementia that is associated with atrophy of the frontal and temporal lobes of the brain over time as a result of accumulation of tau protein fibres known as Pick's bodies.	The accumulation of tau proteins in the brain is mentioned as a central feature of Pick's disease, supporting the statement.	"{""explanation"": ""The accumulation of tau proteins in the brain is mentioned as a central feature of Pick's disease, supporting the statement."", ""reference"": ""PMID:20487487"", ""snippet"": ""Pick's disease is a rare and incurable type of dementia that is associated with atrophy of the frontal and temporal lobes of the brain over time as a result of accumulation of tau protein fibres known as Pick's bodies."", ""supports"": ""SUPPORT""}"
6329	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	evidence	1	PMID:26583316	SUPPORT		Pick disease tau neuropathology may originate in limbic/paralimbic cortices. The patterns of tau pathology observed here provide novel insights into the natural history and biology of tau-mediated neurodegeneration.	This study outlines how tau pathology progresses and leads to neuron damage, supporting the statement's claim about the mechanism.	"{""explanation"": ""This study outlines how tau pathology progresses and leads to neuron damage, supporting the statement's claim about the mechanism."", ""reference"": ""PMID:26583316"", ""snippet"": ""Pick disease tau neuropathology may originate in limbic/paralimbic cortices. The patterns of tau pathology observed here provide novel insights into the natural history and biology of tau-mediated neurodegeneration."", ""supports"": ""SUPPORT""}"
6330	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	evidence	2	PMID:30158706	SUPPORT		Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau... Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia.	The mechanistic understanding of tau filaments in Pick's disease supports the idea that tau protein accumulation leads to neuron damage and brain dysfunction.	"{""explanation"": ""The mechanistic understanding of tau filaments in Pick's disease supports the idea that tau protein accumulation leads to neuron damage and brain dysfunction."", ""reference"": ""PMID:30158706"", ""snippet"": ""Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau... Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia."", ""supports"": ""SUPPORT""}"
6331	6169	261	Pick Disease	Pick_Disease.yaml	pathophysiology	0	evidence	3	PMID:37351604	SUPPORT		Two siblings with deletion mutation ∆K281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus.	Genetic mutation leading to the accumulation of tau proteins and subsequent neuron damage supports the statement.	"{""explanation"": ""Genetic mutation leading to the accumulation of tau proteins and subsequent neuron damage supports the statement."", ""reference"": ""PMID:37351604"", ""snippet"": ""Two siblings with deletion mutation ∆K281 in MAPT developed frontotemporal dementia. At autopsy, numerous inclusions of hyperphosphorylated 3R Tau were present in neurons and glial cells of neocortex and some subcortical regions, including hippocampus, caudate/putamen and globus pallidus."", ""supports"": ""SUPPORT""}"
6332	6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	evidence	0	PMID:27025090	SUPPORT		Pick's disease is a type of frontotemporal lobar degeneration (FTLD) with circumscribed atrophy in the frontotemporal lobe.	The literature states that Pick's disease involves atrophy in the frontotemporal lobe, which aligns with neuronal loss in the frontal and temporal lobes as described.	"{""explanation"": ""The literature states that Pick's disease involves atrophy in the frontotemporal lobe, which aligns with neuronal loss in the frontal and temporal lobes as described."", ""reference"": ""PMID:27025090"", ""snippet"": ""Pick's disease is a type of frontotemporal lobar degeneration (FTLD) with circumscribed atrophy in the frontotemporal lobe."", ""supports"": ""SUPPORT""}"
6333	6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	evidence	1	PMID:38521060	SUPPORT		Here, we report a high-resolution, comparative single-cell molecular atlas of the human primary motor and dorsolateral prefrontal cortices and their transcriptional alterations in sporadic and familial ALS and FTLD.	While discussing FTLD, which includes Pick Disease, literature supports degeneration in the frontal areas of the brain.	"{""explanation"": ""While discussing FTLD, which includes Pick Disease, literature supports degeneration in the frontal areas of the brain."", ""reference"": ""PMID:38521060"", ""snippet"": ""Here, we report a high-resolution, comparative single-cell molecular atlas of the human primary motor and dorsolateral prefrontal cortices and their transcriptional alterations in sporadic and familial ALS and FTLD."", ""supports"": ""SUPPORT""}"
6334	6171	261	Pick Disease	Pick_Disease.yaml	pathophysiology	2	evidence	2	PMID:11809165	SUPPORT		The area of the substantia nigra was significantly reduced in PiD with PB... The pigmented and nonpigmented neuron counts in PiD with PB were not statistically different from those in controls.	Although the literature specifies a reduction in neuron size rather than number, it aligns with the idea of neuronal degradation in PiD.	"{""explanation"": ""Although the literature specifies a reduction in neuron size rather than number, it aligns with the idea of neuronal degradation in PiD."", ""reference"": ""PMID:11809165"", ""snippet"": ""The area of the substantia nigra was significantly reduced in PiD with PB... The pigmented and nonpigmented neuron counts in PiD with PB were not statistically different from those in controls."", ""supports"": ""SUPPORT""}"
6372	6200	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	0	evidence	0	PMID:33553405	SUPPORT		Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst.	The CT finding localizes the polycystic hydatid lesion to hepatic parenchyma, consistent with metacestode implantation.	"{""explanation"": ""The CT finding localizes the polycystic hydatid lesion to hepatic parenchyma, consistent with metacestode implantation."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}"
6373	6201	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	1	evidence	0	PMID:33553405	SUPPORT		Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst.	The multilocular hepatic mass on imaging reflects proliferating daughter cysts and associated matrix remodeling.	"{""explanation"": ""The multilocular hepatic mass on imaging reflects proliferating daughter cysts and associated matrix remodeling."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}"
6374	6202	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	pathophysiology	2	evidence	0	PMID:33553405	SUPPORT		Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst.	The large polycystic hepatic lesion demonstrates mass effect consistent with local compression and invasive growth.	"{""explanation"": ""The large polycystic hepatic lesion demonstrates mass effect consistent with local compression and invasive growth."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}"
6394	6223	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	0	evidence	0	PMID:29105594	SUPPORT		the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume	Tolvaptan’s effect on kidney volume underscores vasopressin/cAMP signaling as a key driver of cyst expansion.	"{""explanation"": ""Tolvaptan’s effect on kidney volume underscores vasopressin/cAMP signaling as a key driver of cyst expansion."", ""reference"": ""PMID:29105594"", ""snippet"": ""the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"", ""supports"": ""SUPPORT""}"
6395	6224	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	1	evidence	0	PMID:29105594	SUPPORT		slowed the growth in total kidney volume and the decline in the estimated glomerular filtration rate	Dampening kidney volume growth parallels slower GFR loss, linking cyst epithelial proliferation to functional decline.	"{""explanation"": ""Dampening kidney volume growth parallels slower GFR loss, linking cyst epithelial proliferation to functional decline."", ""reference"": ""PMID:29105594"", ""snippet"": ""slowed the growth in total kidney volume and the decline in the estimated glomerular filtration rate"", ""supports"": ""SUPPORT""}"
6396	6225	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	2	evidence	0	PMID:29105594	SUPPORT		the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume	Reduction of cyst growth via V2 receptor blockade underscores cAMP-mediated ciliary signaling as a driver of cystogenesis.	"{""explanation"": ""Reduction of cyst growth via V2 receptor blockade underscores cAMP-mediated ciliary signaling as a driver of cystogenesis."", ""reference"": ""PMID:29105594"", ""snippet"": ""the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"", ""supports"": ""SUPPORT""}"
6397	6226	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	pathophysiology	3	evidence	0	PMID:40126492	SUPPORT		ADPKD accounts for 5% to 10% of kidney failure in the US and Europe	High kidney failure burden reflects cumulative nephron loss from cyst-driven injury and interstitial fibrosis.	"{""explanation"": ""High kidney failure burden reflects cumulative nephron loss from cyst-driven injury and interstitial fibrosis."", ""reference"": ""PMID:40126492"", ""snippet"": ""ADPKD accounts for 5% to 10% of kidney failure in the US and Europe"", ""supports"": ""SUPPORT""}"
6418	6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:38152131	SUPPORT		Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition.	This review establishes hyperandrogenism as potentially causative rather than merely symptomatic in PCOS pathophysiology.	"{""explanation"": ""This review establishes hyperandrogenism as potentially causative rather than merely symptomatic in PCOS pathophysiology."", ""reference"": ""PMID:38152131"", ""snippet"": ""Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition."", ""supports"": ""SUPPORT""}"
6419	6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:24014605	SUPPORT		LHCGR and 17α-hydroxylase/17-20-lyase (CYP17A1) protein levels are increased in polycystic ovaries (PCOs).	Direct evidence of increased androgen biosynthetic machinery (CYP17A1) in PCOS ovaries, supporting intrinsic theca cell abnormality.	"{""explanation"": ""Direct evidence of increased androgen biosynthetic machinery (CYP17A1) in PCOS ovaries, supporting intrinsic theca cell abnormality."", ""reference"": ""PMID:24014605"", ""snippet"": ""LHCGR and 17α-hydroxylase/17-20-lyase (CYP17A1) protein levels are increased in polycystic ovaries (PCOs)."", ""supports"": ""SUPPORT""}"
6420	6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:24014605	SUPPORT		A significant increase in the intensity of immunostaining for CYP17A1 was identified in antral follicles in sections of PCO compared with ovaries from normal women (P = 0.04).	Quantitative demonstration of elevated CYP17A1 protein in polycystic ovaries compared to controls.	"{""explanation"": ""Quantitative demonstration of elevated CYP17A1 protein in polycystic ovaries compared to controls."", ""reference"": ""PMID:24014605"", ""snippet"": ""A significant increase in the intensity of immunostaining for CYP17A1 was identified in antral follicles in sections of PCO compared with ovaries from normal women (P = 0.04)."", ""supports"": ""SUPPORT""}"
6421	6249	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:24014605	SUPPORT		A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01).	Increased LH receptor expression in theca cells explains heightened LH-driven androgen production in PCOS.	"{""explanation"": ""Increased LH receptor expression in theca cells explains heightened LH-driven androgen production in PCOS."", ""reference"": ""PMID:24014605"", ""snippet"": ""A higher proportion of theca cells from anovulatory PCO expressed LHCGR protein when compared with control ovaries (P = 0.01)."", ""supports"": ""SUPPORT""}"
6422	6250	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:40013621	SUPPORT		Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens.	Demonstrates the direct mechanistic link between hyperinsulinemia and worsening of reproductive and androgenic features in PCOS.	"{""explanation"": ""Demonstrates the direct mechanistic link between hyperinsulinemia and worsening of reproductive and androgenic features in PCOS."", ""reference"": ""PMID:40013621"", ""snippet"": ""Hyperinsulinemia (i.e., elevated insulin without hypoglycemia) is a common metabolic feature of PCOS that worsens its reproductive symptoms by exacerbating pituitary hormone imbalances and increasing levels of bioactive androgens."", ""supports"": ""SUPPORT""}"
6423	6250	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:40013621	SUPPORT		However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance.	Challenges traditional causality and suggests hyperinsulinemia may be primary rather than compensatory in some PCOS cases.	"{""explanation"": ""Challenges traditional causality and suggests hyperinsulinemia may be primary rather than compensatory in some PCOS cases."", ""reference"": ""PMID:40013621"", ""snippet"": ""However, it is challenging to define the sequential relationship between insulin sensitivity and insulin secretion, as they are tightly interlinked, and evidence suggests that hyperinsulinemia can alternatively precede insulin resistance."", ""supports"": ""SUPPORT""}"
6424	6250	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:40013621	SUPPORT		Notably, other drivers of hyperinsulinemia (outside of insulin resistance) may be highly relevant in the context of PCOS. For instance, high androgen levels can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating cycle of reproductive and metabolic dysfunction.	Describes the vicious cycle where androgens exacerbate both hyperinsulinemia and insulin resistance in PCOS.	"{""explanation"": ""Describes the vicious cycle where androgens exacerbate both hyperinsulinemia and insulin resistance in PCOS."", ""reference"": ""PMID:40013621"", ""snippet"": ""Notably, other drivers of hyperinsulinemia (outside of insulin resistance) may be highly relevant in the context of PCOS. For instance, high androgen levels can augment both hyperinsulinemia and insulin resistance, generating a self-perpetuating cycle of reproductive and metabolic dysfunction."", ""supports"": ""SUPPORT""}"
6425	6251	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:14671196	SUPPORT		Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS.	Documents the 2-3 fold increase in small growing follicle number characteristic of PCOS polycystic morphology.	"{""explanation"": ""Documents the 2-3 fold increase in small growing follicle number characteristic of PCOS polycystic morphology."", ""reference"": ""PMID:14671196"", ""snippet"": ""Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS."", ""supports"": ""SUPPORT""}"
6426	6251	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:14671196	SUPPORT		Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively).	Shows parallel elevation of AMH levels and small antral follicle count in PCOS, implicating AMH in follicular arrest.	"{""explanation"": ""Shows parallel elevation of AMH levels and small antral follicle count in PCOS, implicating AMH in follicular arrest."", ""reference"": ""PMID:14671196"", ""snippet"": ""Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively)."", ""supports"": ""SUPPORT""}"
6427	6251	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	2	evidence	2	PMID:14671196	SUPPORT		We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.	Proposes mechanism by which elevated AMH interferes with FSH action to prevent dominant follicle selection in PCOS.	"{""explanation"": ""Proposes mechanism by which elevated AMH interferes with FSH action to prevent dominant follicle selection in PCOS."", ""reference"": ""PMID:14671196"", ""snippet"": ""We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection."", ""supports"": ""SUPPORT""}"
6428	6252	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:39036884	SUPPORT		Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory conditions generated by Endoplasmic reticulum (ER) stress.	Establishes the link between ER stress, inflammation, and apoptotic pathways in PCOS pathophysiology.	"{""explanation"": ""Establishes the link between ER stress, inflammation, and apoptotic pathways in PCOS pathophysiology."", ""reference"": ""PMID:39036884"", ""snippet"": ""Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory conditions generated by Endoplasmic reticulum (ER) stress."", ""supports"": ""SUPPORT""}"
6429	6252	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:39036884	SUPPORT		The levels of TNF-α (p = 0.009), IL-18 (p = 0.003), IL-6 (p = 0.013) and active caspase-3 (p = 0.012) were also statistically significant lower in the therapy group.	Clinical trial evidence demonstrating elevated TNF-α, IL-18, and IL-6 levels in PCOS patients at baseline, confirming chronic inflammatory state.	"{""explanation"": ""Clinical trial evidence demonstrating elevated TNF-α, IL-18, and IL-6 levels in PCOS patients at baseline, confirming chronic inflammatory state."", ""reference"": ""PMID:39036884"", ""snippet"": ""The levels of TNF-α (p = 0.009), IL-18 (p = 0.003), IL-6 (p = 0.013) and active caspase-3 (p = 0.012) were also statistically significant lower in the therapy group."", ""supports"": ""SUPPORT""}"
6434	6272	266	Polycythemia Vera	Polycythemia_Vera.yaml	pathophysiology	3	evidence	0	PMID:41580684	SUPPORT		Polycythemia vera (PV) is a myeloproliferative neoplasm, characterized by trilineage hypercellularity, which increases the risk of thrombosis.	This abstract states that PV is an MPN with increased thrombosis risk, supporting the thrombotic mechanism described.	"{""explanation"": ""This abstract states that PV is an MPN with increased thrombosis risk, supporting the thrombotic mechanism described."", ""reference"": ""PMID:41580684"", ""snippet"": ""Polycythemia vera (PV) is a myeloproliferative neoplasm, characterized by trilineage hypercellularity, which increases the risk of thrombosis."", ""supports"": ""SUPPORT""}"
6435	6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	evidence	0	PMID:31257434	SUPPORT		The hallmark histopathology of PM is the presence of CD8+ T cells in the non-necrotic muscle cells.	Demonstrates that CD8+ T cell invasion into muscle fibers is the defining pathological feature of polymyositis.	"{""explanation"": ""Demonstrates that CD8+ T cell invasion into muscle fibers is the defining pathological feature of polymyositis."", ""reference"": ""PMID:31257434"", ""snippet"": ""The hallmark histopathology of PM is the presence of CD8+ T cells in the non-necrotic muscle cells."", ""supports"": ""SUPPORT""}"
6436	6290	267	Polymyositis	Polymyositis.yaml	pathophysiology	0	evidence	1	PMID:31257434	SUPPORT		CD8+ T cells invade into muscle cells and contribute to muscle injury in PM.	Confirms the direct cytotoxic role of CD8+ T cells in causing muscle fiber damage through invasion and attack.	"{""explanation"": ""Confirms the direct cytotoxic role of CD8+ T cells in causing muscle fiber damage through invasion and attack."", ""reference"": ""PMID:31257434"", ""snippet"": ""CD8+ T cells invade into muscle cells and contribute to muscle injury in PM."", ""supports"": ""SUPPORT""}"
6437	6291	267	Polymyositis	Polymyositis.yaml	pathophysiology	1	evidence	0	PMID:15934115	SUPPORT		Up-regulation of class I MHC in skeletal muscle fibers was an early and consistent feature of human inflammatory myopathies.	Demonstrates that MHC class I upregulation is a hallmark feature of polymyositis pathogenesis.	"{""explanation"": ""Demonstrates that MHC class I upregulation is a hallmark feature of polymyositis pathogenesis."", ""reference"": ""PMID:15934115"", ""snippet"": ""Up-regulation of class I MHC in skeletal muscle fibers was an early and consistent feature of human inflammatory myopathies."", ""supports"": ""SUPPORT""}"
6438	6291	267	Polymyositis	Polymyositis.yaml	pathophysiology	1	evidence	1	PMID:15934115	SUPPORT		Class I MHC staining in muscle fibers of myositis patients showed both cell surface and a reticular pattern of internal reactivity.	Shows that aberrant MHC I expression occurs both on the sarcolemma and within the endoplasmic reticulum of muscle fibers.	"{""explanation"": ""Shows that aberrant MHC I expression occurs both on the sarcolemma and within the endoplasmic reticulum of muscle fibers."", ""reference"": ""PMID:15934115"", ""snippet"": ""Class I MHC staining in muscle fibers of myositis patients showed both cell surface and a reticular pattern of internal reactivity."", ""supports"": ""SUPPORT""}"
6439	6294	267	Polymyositis	Polymyositis.yaml	pathophysiology	4	evidence	0	PMID:15934115	SUPPORT		The pathways of endoplasmic reticulum (ER) stress response, the unfolded protein response (glucose-regulated protein 78 pathway), and the ER overload response (NF-kappaB pathway) were significantly activated in muscle tissue of human myositis patients and in the mouse model.	Demonstrates that ER stress pathways are activated in polymyositis muscle tissue as a consequence of MHC I overexpression.	"{""explanation"": ""Demonstrates that ER stress pathways are activated in polymyositis muscle tissue as a consequence of MHC I overexpression."", ""reference"": ""PMID:15934115"", ""snippet"": ""The pathways of endoplasmic reticulum (ER) stress response, the unfolded protein response (glucose-regulated protein 78 pathway), and the ER overload response (NF-kappaB pathway) were significantly activated in muscle tissue of human myositis patients and in the mouse model."", ""supports"": ""SUPPORT""}"
6440	6294	267	Polymyositis	Polymyositis.yaml	pathophysiology	4	evidence	1	PMID:15934115	SUPPORT		These results indicate that the ER stress response may be a major nonimmune mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositis.	Identifies ER stress as a non-immune mechanism contributing to muscle pathology, explaining why inflammation doesn't always correlate with disease severity.	"{""explanation"": ""Identifies ER stress as a non-immune mechanism contributing to muscle pathology, explaining why inflammation doesn't always correlate with disease severity."", ""reference"": ""PMID:15934115"", ""snippet"": ""These results indicate that the ER stress response may be a major nonimmune mechanism responsible for skeletal muscle damage and dysfunction in autoimmune myositis."", ""supports"": ""SUPPORT""}"
6441	6295	267	Polymyositis	Polymyositis.yaml	pathophysiology	5	evidence	0	PMID:37483632	SUPPORT		Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs).	Establishes necroptosis as a key mechanism of muscle fiber death in polymyositis that perpetuates inflammation.	"{""explanation"": ""Establishes necroptosis as a key mechanism of muscle fiber death in polymyositis that perpetuates inflammation."", ""reference"": ""PMID:37483632"", ""snippet"": ""Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs)."", ""supports"": ""SUPPORT""}"
6442	6295	267	Polymyositis	Polymyositis.yaml	pathophysiology	5	evidence	1	PMID:37483632	SUPPORT		The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness.	Demonstrates that blocking necroptosis or DAMP signaling improves both inflammation and muscle function, highlighting therapeutic potential.	"{""explanation"": ""Demonstrates that blocking necroptosis or DAMP signaling improves both inflammation and muscle function, highlighting therapeutic potential."", ""reference"": ""PMID:37483632"", ""snippet"": ""The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness."", ""supports"": ""SUPPORT""}"
6443	6296	267	Polymyositis	Polymyositis.yaml	pathophysiology	6	evidence	0	PMID:32936839	SUPPORT		Apoptotic myonuclei were found in muscle with partial invasion, but not in the invaded fibres. Fibres with TUNEL positive nuclei were surrounded by CD8+ T-cells, granzyme B+ cells and macrophages, but lacked FAS receptor expression.	Shows that apoptosis occurs in polymyositis muscle fibers adjacent to those with CD8+ T cell invasion, mediated by cytotoxic mechanisms.	"{""explanation"": ""Shows that apoptosis occurs in polymyositis muscle fibers adjacent to those with CD8+ T cell invasion, mediated by cytotoxic mechanisms."", ""reference"": ""PMID:32936839"", ""snippet"": ""Apoptotic myonuclei were found in muscle with partial invasion, but not in the invaded fibres. Fibres with TUNEL positive nuclei were surrounded by CD8+ T-cells, granzyme B+ cells and macrophages, but lacked FAS receptor expression."", ""supports"": ""SUPPORT""}"
6444	6296	267	Polymyositis	Polymyositis.yaml	pathophysiology	6	evidence	1	PMID:32936839	SUPPORT		The findings confirm that apoptosis occurs in idiopathic inflammatory myopathies and support that it is mediated by CD8+ cytotoxic T- cells, acting in parallel to the process of partial invasion.	Establishes that CD8+ T cell-mediated apoptosis is a distinct pathway of muscle damage occurring alongside direct fiber invasion.	"{""explanation"": ""Establishes that CD8+ T cell-mediated apoptosis is a distinct pathway of muscle damage occurring alongside direct fiber invasion."", ""reference"": ""PMID:32936839"", ""snippet"": ""The findings confirm that apoptosis occurs in idiopathic inflammatory myopathies and support that it is mediated by CD8+ cytotoxic T- cells, acting in parallel to the process of partial invasion."", ""supports"": ""SUPPORT""}"
6446	6308	268	Pouchitis	Pouchitis.yaml	pathophysiology	0	evidence	0	PMID:20845425	SUPPORT		"UCP samples exhibited significantly more TRFLP peaks matching Clostridium and Eubacterium genera compared to HUC and FAP pouches and fewer peaks matching Lactobacillus and Streptococcus genera compared to FAP.
"	"Demonstrates distinct microbiome alterations in UC-associated pouchitis with increased Clostridium/Eubacterium and decreased Lactobacillus/Streptococcus, supporting the dysbiosis mechanism.
"	"{""explanation"": ""Demonstrates distinct microbiome alterations in UC-associated pouchitis with increased Clostridium/Eubacterium and decreased Lactobacillus/Streptococcus, supporting the dysbiosis mechanism.\n"", ""reference"": ""PMID:20845425"", ""snippet"": ""UCP samples exhibited significantly more TRFLP peaks matching Clostridium and Eubacterium genera compared to HUC and FAP pouches and fewer peaks matching Lactobacillus and Streptococcus genera compared to FAP.\n"", ""supports"": ""SUPPORT""}"
6447	6308	268	Pouchitis	Pouchitis.yaml	pathophysiology	0	evidence	1	PMID:25110406	SUPPORT		"there is evidence that a dysbiosis characterized by decreased gut microbiota diversity in UC-IPAA patients may, in genetically predisposed subjects, lead to aberrant mucosal immune regulation triggering an inflammatory process.
"	"Review confirming that microbiome dysbiosis with decreased diversity is central to pouchitis pathogenesis, leading to aberrant immune regulation and inflammation.
"	"{""explanation"": ""Review confirming that microbiome dysbiosis with decreased diversity is central to pouchitis pathogenesis, leading to aberrant immune regulation and inflammation.\n"", ""reference"": ""PMID:25110406"", ""snippet"": ""there is evidence that a dysbiosis characterized by decreased gut microbiota diversity in UC-IPAA patients may, in genetically predisposed subjects, lead to aberrant mucosal immune regulation triggering an inflammatory process.\n"", ""supports"": ""SUPPORT""}"
6448	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	evidence	0	PMID:40240062	SUPPORT		"we outline the putative mechanisms of pouchitis, including genetic predisposition, microbiome alterations, dysfunction of the intestinal barrier and the immune system
"	"Comprehensive review establishing that immune system dysfunction is a core pathogenic mechanism in pouchitis alongside barrier and microbiome alterations.
"	"{""explanation"": ""Comprehensive review establishing that immune system dysfunction is a core pathogenic mechanism in pouchitis alongside barrier and microbiome alterations.\n"", ""reference"": ""PMID:40240062"", ""snippet"": ""we outline the putative mechanisms of pouchitis, including genetic predisposition, microbiome alterations, dysfunction of the intestinal barrier and the immune system\n"", ""supports"": ""SUPPORT""}"
6449	6309	268	Pouchitis	Pouchitis.yaml	pathophysiology	1	evidence	1	PMID:7634977	SUPPORT		"Cytokine production in pouchitis is similar to that in ulcerative colitis.
"	"Demonstrates that the cytokine profile in pouchitis resembles that of ulcerative colitis, supporting shared inflammatory mechanisms between these conditions.
"	"{""explanation"": ""Demonstrates that the cytokine profile in pouchitis resembles that of ulcerative colitis, supporting shared inflammatory mechanisms between these conditions.\n"", ""reference"": ""PMID:7634977"", ""snippet"": ""Cytokine production in pouchitis is similar to that in ulcerative colitis.\n"", ""supports"": ""SUPPORT""}"
6450	6310	268	Pouchitis	Pouchitis.yaml	pathophysiology	2	evidence	0	PMID:25222658	SUPPORT		"In patients with UC with pouchitis, epithelial expression of ZO-1 and claudin 1 were reduced
"	"Demonstrates reduced expression of barrier-forming tight junction proteins (ZO-1 and claudin-1) in pouchitis, directly supporting epithelial barrier dysfunction as a pathogenic mechanism.
"	"{""explanation"": ""Demonstrates reduced expression of barrier-forming tight junction proteins (ZO-1 and claudin-1) in pouchitis, directly supporting epithelial barrier dysfunction as a pathogenic mechanism.\n"", ""reference"": ""PMID:25222658"", ""snippet"": ""In patients with UC with pouchitis, epithelial expression of ZO-1 and claudin 1 were reduced\n"", ""supports"": ""SUPPORT""}"
6451	6310	268	Pouchitis	Pouchitis.yaml	pathophysiology	2	evidence	1	PMID:25222658	SUPPORT		"Increased epithelial expression of the ""pore-forming"" TJP claudin 2, and DC expression of gut-homing markers CCR 9 and integrin β7, occurred early after ileostomy closure.
"	"Shows early upregulation of claudin-2, a pore-forming protein that increases permeability, indicating that barrier dysfunction may be an initiating event in pouchitis development.
"	"{""explanation"": ""Shows early upregulation of claudin-2, a pore-forming protein that increases permeability, indicating that barrier dysfunction may be an initiating event in pouchitis development.\n"", ""reference"": ""PMID:25222658"", ""snippet"": ""Increased epithelial expression of the \""pore-forming\"" TJP claudin 2, and DC expression of gut-homing markers CCR 9 and integrin β7, occurred early after ileostomy closure.\n"", ""supports"": ""SUPPORT""}"
6452	6311	268	Pouchitis	Pouchitis.yaml	pathophysiology	3	evidence	0	PMID:22879519	SUPPORT		"The NOD2insC (rs2066847) risk variant was the single nucleotide polymorphism (SNP) most significantly associated with pouch outcome (p=7.4×10(-5)). Specifically, it was associated with both CP and CDL in comparison with NCP (OR=3.2 and 4.3, respectively).
"	"Landmark multicenter study demonstrating that NOD2insC polymorphism is the strongest genetic risk factor for chronic pouchitis (OR=3.2) and Crohn's-like disease of the pouch (OR=4.3).
"	"{""explanation"": ""Landmark multicenter study demonstrating that NOD2insC polymorphism is the strongest genetic risk factor for chronic pouchitis (OR=3.2) and Crohn's-like disease of the pouch (OR=4.3).\n"", ""reference"": ""PMID:22879519"", ""snippet"": ""The NOD2insC (rs2066847) risk variant was the single nucleotide polymorphism (SNP) most significantly associated with pouch outcome (p=7.4×10(-5)). Specifically, it was associated with both CP and CDL in comparison with NCP (OR=3.2 and 4.3, respectively).\n"", ""supports"": ""SUPPORT""}"
6456	6328	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	0	evidence	0	PMID:26953925	SUPPORT		Primary biliary cholangitis (PBC) is an autoimmune hepatobiliary disease characterized by immune mediated destruction of the intrahepatic small bile ducts and the presence of antimitochondrial antibodies (AMAs). The mitochondrial autoantigens have been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complex, including the E2 subunits of pyruvate dehydrogenase, branched-chain 2-oxo acid dehydrogenase complex, oxoglutarate dehydrogenase complex, E3 binding protein and PDC E1 alpha subunit.	This paper confirms that AMAs targeting PDC-E2 and related E2 subunits are characteristic of PBC and are associated with immune-mediated bile duct destruction.	"{""explanation"": ""This paper confirms that AMAs targeting PDC-E2 and related E2 subunits are characteristic of PBC and are associated with immune-mediated bile duct destruction."", ""reference"": ""PMID:26953925"", ""snippet"": ""Primary biliary cholangitis (PBC) is an autoimmune hepatobiliary disease characterized by immune mediated destruction of the intrahepatic small bile ducts and the presence of antimitochondrial antibodies (AMAs). The mitochondrial autoantigens have been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complex, including the E2 subunits of pyruvate dehydrogenase, branched-chain 2-oxo acid dehydrogenase complex, oxoglutarate dehydrogenase complex, E3 binding protein and PDC E1 alpha subunit."", ""supports"": ""SUPPORT""}"
6457	6328	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	0	evidence	1	PMID:39329760	SUPPORT		Although the pathogenesis of the disease is multifactorial, there is a consensus that individuals with a genetic predisposition develop the disease in the presence of specific environmental triggers. A dysbiosis of intestinal microbiota is increasingly considered among the potential pathogenic factors.	This review highlights the multifactorial pathogenesis of PBC, including genetic predisposition and environmental triggers that lead to AMA production and disease development.	"{""explanation"": ""This review highlights the multifactorial pathogenesis of PBC, including genetic predisposition and environmental triggers that lead to AMA production and disease development."", ""reference"": ""PMID:39329760"", ""snippet"": ""Although the pathogenesis of the disease is multifactorial, there is a consensus that individuals with a genetic predisposition develop the disease in the presence of specific environmental triggers. A dysbiosis of intestinal microbiota is increasingly considered among the potential pathogenic factors."", ""supports"": ""SUPPORT""}"
6458	6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	evidence	0	PMID:24556277	SUPPORT		In vitro cholangiocyte cytotoxicity assays demonstrated significantly increased numbers of cytotoxic hepatic dnTGFβRII KLRG1(+) CD8 cells compared to B6. Protection from disease by B6 Tregs was associated with elimination of hepatic dnTGFβRII CD8 mediated cholangiocyte cytotoxicity. These results emphasize that autoimmune cholangitis requires defects in both the T effector and regulatory compartments.	This study demonstrates that cytotoxic CD8+ T cells directly target and destroy cholangiocytes in experimental PBC, supporting the role of T cell- mediated cytotoxicity in bile duct epithelial cell destruction.	"{""explanation"": ""This study demonstrates that cytotoxic CD8+ T cells directly target and destroy cholangiocytes in experimental PBC, supporting the role of T cell- mediated cytotoxicity in bile duct epithelial cell destruction."", ""reference"": ""PMID:24556277"", ""snippet"": ""In vitro cholangiocyte cytotoxicity assays demonstrated significantly increased numbers of cytotoxic hepatic dnTGFβRII KLRG1(+) CD8 cells compared to B6. Protection from disease by B6 Tregs was associated with elimination of hepatic dnTGFβRII CD8 mediated cholangiocyte cytotoxicity. These results emphasize that autoimmune cholangitis requires defects in both the T effector and regulatory compartments."", ""supports"": ""SUPPORT""}"
6459	6329	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	1	evidence	1	PMID:39329760	SUPPORT		Cholangiocytes, the epithelial cells lining the bile ducts, are the main target of a dysregulated immune response, and cholangiocytes senescence has been recognized as a driving mechanism, leading to impaired bile duct function, in disease progression.	This review confirms that cholangiocytes are the primary cellular targets of immune attack in PBC, with senescent cholangiocytes driving disease progression through impaired bile duct function.	"{""explanation"": ""This review confirms that cholangiocytes are the primary cellular targets of immune attack in PBC, with senescent cholangiocytes driving disease progression through impaired bile duct function."", ""reference"": ""PMID:39329760"", ""snippet"": ""Cholangiocytes, the epithelial cells lining the bile ducts, are the main target of a dysregulated immune response, and cholangiocytes senescence has been recognized as a driving mechanism, leading to impaired bile duct function, in disease progression."", ""supports"": ""SUPPORT""}"
6460	6330	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	2	evidence	0	PMID:37047635	SUPPORT		In recent years, several studies have shown that, in case of a change in gut bacterial homeostasis or impairment of intestinal barrier functions, cholangiocytes, which are the epithelial cells lining the bile ducts, activate innate immune responses against gut-derived microorganisms or bacterial products that reach the liver via enterohepatic circulation. Intestinal dysbiosis or impaired intestinal barrier functions cause cholangiocytes to be exposed to an increasing amount of microorganisms that can reactivate inflammatory responses, thus inducing the onset of liver fibrosis.	This review demonstrates that cholangiocyte injury and bile duct destruction in PBC are promoted by gut-derived bacterial products reaching the liver, which trigger inflammatory responses that induce liver fibrosis and progressive disease.	"{""explanation"": ""This review demonstrates that cholangiocyte injury and bile duct destruction in PBC are promoted by gut-derived bacterial products reaching the liver, which trigger inflammatory responses that induce liver fibrosis and progressive disease."", ""reference"": ""PMID:37047635"", ""snippet"": ""In recent years, several studies have shown that, in case of a change in gut bacterial homeostasis or impairment of intestinal barrier functions, cholangiocytes, which are the epithelial cells lining the bile ducts, activate innate immune responses against gut-derived microorganisms or bacterial products that reach the liver via enterohepatic circulation. Intestinal dysbiosis or impaired intestinal barrier functions cause cholangiocytes to be exposed to an increasing amount of microorganisms that can reactivate inflammatory responses, thus inducing the onset of liver fibrosis."", ""supports"": ""SUPPORT""}"
6461	6330	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	pathophysiology	2	evidence	1	PMID:39329760	SUPPORT		Bile acids are also recognized as playing an important role, both in disease development and therapy. Thus, while bile acid-based therapies, specifically ursodeoxycholic acid and obeticholic acid, have been the cornerstone of therapy in PBC, novel therapeutic approaches have been developed in recent years.	This review highlights the central role of bile acids in PBC pathogenesis, noting that bile acid accumulation contributes to disease progression and that bile acid modulation is a key therapeutic strategy.	"{""explanation"": ""This review highlights the central role of bile acids in PBC pathogenesis, noting that bile acid accumulation contributes to disease progression and that bile acid modulation is a key therapeutic strategy."", ""reference"": ""PMID:39329760"", ""snippet"": ""Bile acids are also recognized as playing an important role, both in disease development and therapy. Thus, while bile acid-based therapies, specifically ursodeoxycholic acid and obeticholic acid, have been the cornerstone of therapy in PBC, novel therapeutic approaches have been developed in recent years."", ""supports"": ""SUPPORT""}"
6489	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	evidence	0	PMID:19818430	SUPPORT		Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth.	The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement.	"{""explanation"": ""The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement."", ""reference"": ""PMID:19818430"", ""snippet"": ""Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth."", ""supports"": ""SUPPORT""}"
6490	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	evidence	1	PMID:20525503	SUPPORT		Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination.	This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance.	"{""explanation"": ""This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance."", ""reference"": ""PMID:20525503"", ""snippet"": ""Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination."", ""supports"": ""SUPPORT""}"
6491	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	evidence	2	PMID:17059358	SUPPORT		The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility.	The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance.	"{""explanation"": ""The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance."", ""reference"": ""PMID:17059358"", ""snippet"": ""The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility."", ""supports"": ""SUPPORT""}"
6492	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	evidence	3	PMID:15750039	SUPPORT		Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by recurrent infections of the airways and situs inversus in half of the affected offspring. The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.	This reference supports the statement by listing DNAH5 and DNAI1 as genes involved in PCD, which is characterized by defects in motile cilia leading to impaired mucociliary clearance.	"{""explanation"": ""This reference supports the statement by listing DNAH5 and DNAI1 as genes involved in PCD, which is characterized by defects in motile cilia leading to impaired mucociliary clearance."", ""reference"": ""PMID:15750039"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by recurrent infections of the airways and situs inversus in half of the affected offspring. The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components."", ""supports"": ""SUPPORT""}"
6493	6356	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	0	evidence	4	PMID:32185794	SUPPORT		Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by defects in the function or structure of motitle cilia	The reference supports the statement by confirming that PCD involves defects in the structure and function of motile cilia, which impair mucociliary clearance.	"{""explanation"": ""The reference supports the statement by confirming that PCD involves defects in the structure and function of motile cilia, which impair mucociliary clearance."", ""reference"": ""PMID:32185794"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by defects in the function or structure of motitle cilia"", ""supports"": ""SUPPORT""}"
6494	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	evidence	0	PMID:11376511	SUPPORT		Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis.	The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media.	"{""explanation"": ""The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media."", ""reference"": ""PMID:11376511"", ""snippet"": ""Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis."", ""supports"": ""SUPPORT""}"
6495	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	evidence	1	PMID:17142159	SUPPORT		Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.	The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media.	"{""explanation"": ""The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media."", ""reference"": ""PMID:17142159"", ""snippet"": ""Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses."", ""supports"": ""SUPPORT""}"
6496	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	evidence	2	PMID:15917207	SUPPORT		Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis.	The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis.	"{""explanation"": ""The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis."", ""reference"": ""PMID:15917207"", ""snippet"": ""Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis."", ""supports"": ""SUPPORT""}"
6497	6357	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	1	evidence	3	PMID:29490941	SUPPORT		We hypothesised that olfactory function could be impaired in primary ciliary dyskinesia (PCD). Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan). PCD and non-PCD patients had similar severity of sinus disease.	The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and associated conditions such as sinusitis.	"{""explanation"": ""The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and associated conditions such as sinusitis."", ""reference"": ""PMID:29490941"", ""snippet"": ""We hypothesised that olfactory function could be impaired in primary ciliary dyskinesia (PCD). Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan). PCD and non-PCD patients had similar severity of sinus disease."", ""supports"": ""SUPPORT""}"
6498	6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	evidence	0	PMID:16036877	PARTIAL		The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen's) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.	The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase 'abnormal placement of internal organs' is more general and could include other forms of laterality defects, not just situs inversus.	"{""explanation"": ""The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase 'abnormal placement of internal organs' is more general and could include other forms of laterality defects, not just situs inversus."", ""reference"": ""PMID:16036877"", ""snippet"": ""The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen's) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus."", ""supports"": ""PARTIAL""}"
6499	6358	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	pathophysiology	2	evidence	1	PMID:36342963	PARTIAL		Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)	The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement.	"{""explanation"": ""The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement."", ""reference"": ""PMID:36342963"", ""snippet"": ""Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)"", ""supports"": ""PARTIAL""}"
6557	6379	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	pathophysiology	0	evidence	0	PMID:26515619	SUPPORT		Primary lateral sclerosis is characterized by insidious onset of progressive upper motor neuron dysfunction in the absence of clinical signs of lower motor neuron involvement.	The abstract defines PLS by progressive upper motor neuron dysfunction.	"{""explanation"": ""The abstract defines PLS by progressive upper motor neuron dysfunction."", ""reference"": ""PMID:26515619"", ""snippet"": ""Primary lateral sclerosis is characterized by insidious onset of progressive upper motor neuron dysfunction in the absence of clinical signs of lower motor neuron involvement."", ""supports"": ""SUPPORT""}"
6558	6380	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	pathophysiology	1	evidence	0	PMID:33602010	SUPPORT		Degeneration of the primary motor cortex and corticospinal tracts with preservation of lower motor neurons (LMN) has been reported in most cases.	The abstract describes cortical and corticospinal degeneration with LMN preservation.	"{""explanation"": ""The abstract describes cortical and corticospinal degeneration with LMN preservation."", ""reference"": ""PMID:33602010"", ""snippet"": ""Degeneration of the primary motor cortex and corticospinal tracts with preservation of lower motor neurons (LMN) has been reported in most cases."", ""supports"": ""SUPPORT""}"
6564	6394	272	Primary Myelofibrosis	Primary_Myelofibrosis.yaml	pathophysiology	2	evidence	0	PMID:41514563	SUPPORT		Primary myelofibrosis (PMF) is a Philadelphia chromosome (Ph)-negative myeloproliferative neoplasm (MPN) that features clonal proliferation of atypical megakaryocytes and myeloid cells, fibrosis of the bone marrow, extramedullary hematopoiesis, and increased risk of leukemic transformation to acute myeloid leukemia (AML).	This abstract highlights bone marrow fibrosis and atypical megakaryocyte proliferation, supporting the fibrosis mechanism described.	"{""explanation"": ""This abstract highlights bone marrow fibrosis and atypical megakaryocyte proliferation, supporting the fibrosis mechanism described."", ""reference"": ""PMID:41514563"", ""snippet"": ""Primary myelofibrosis (PMF) is a Philadelphia chromosome (Ph)-negative myeloproliferative neoplasm (MPN) that features clonal proliferation of atypical megakaryocytes and myeloid cells, fibrosis of the bone marrow, extramedullary hematopoiesis, and increased risk of leukemic transformation to acute myeloid leukemia (AML)."", ""supports"": ""SUPPORT""}"
6570	6414	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	pathophysiology	0	evidence	0	PMID:19300609	SUPPORT		Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains.	The abstract describes progressive, isolated language loss as the core neurodegenerative process.	"{""explanation"": ""The abstract describes progressive, isolated language loss as the core neurodegenerative process."", ""reference"": ""PMID:19300609"", ""snippet"": ""Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains."", ""supports"": ""SUPPORT""}"
6576	6425	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	0	evidence	0	PMID:39250501	SUPPORT		Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela.	Demonstrates that PSC involves progressive fibrosis as a core pathological feature of biliary tract disorders.	"{""explanation"": ""Demonstrates that PSC involves progressive fibrosis as a core pathological feature of biliary tract disorders."", ""reference"": ""PMID:39250501"", ""snippet"": ""Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela."", ""supports"": ""SUPPORT""}"
6577	6425	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	0	evidence	1	PMID:39250501	SUPPORT		Herein, we review the pivotal role of cholangiocytes in cholestatic fibrogenesis, focusing on the crosstalk between cholangiocytes and portal fibroblasts and HSCs.	Confirms the central role of fibroblast-cholangiocyte crosstalk in driving periductal fibrosis in PSC.	"{""explanation"": ""Confirms the central role of fibroblast-cholangiocyte crosstalk in driving periductal fibrosis in PSC."", ""reference"": ""PMID:39250501"", ""snippet"": ""Herein, we review the pivotal role of cholangiocytes in cholestatic fibrogenesis, focusing on the crosstalk between cholangiocytes and portal fibroblasts and HSCs."", ""supports"": ""SUPPORT""}"
6578	6426	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	1	evidence	0	PMID:39250501	SUPPORT		The crosstalk between cholangiocytes and cells of the innate (neutrophils and macrophages) and adaptive (T cells and B cells) immune systems is also examined in detail.	Confirms the role of adaptive immune cells, particularly T cells, in the pathogenesis of cholestatic liver diseases including PSC.	"{""explanation"": ""Confirms the role of adaptive immune cells, particularly T cells, in the pathogenesis of cholestatic liver diseases including PSC."", ""reference"": ""PMID:39250501"", ""snippet"": ""The crosstalk between cholangiocytes and cells of the innate (neutrophils and macrophages) and adaptive (T cells and B cells) immune systems is also examined in detail."", ""supports"": ""SUPPORT""}"
6579	6427	274	Primary Sclerosing Cholangitis	Primary_Sclerosing_Cholangitis.yaml	pathophysiology	2	evidence	0	PMID:39250501	SUPPORT		The proclivity of these cells to undergo a senescence-associated secretory phenotype, which is proinflammatory and profibrogenic, and the intrinsic intracellular activation pathways resulting in the secretion of cytokines and chemokines are reviewed.	Directly supports that cholangiocytes undergo senescence-associated secretory phenotype that drives inflammation and fibrosis in cholestatic diseases.	"{""explanation"": ""Directly supports that cholangiocytes undergo senescence-associated secretory phenotype that drives inflammation and fibrosis in cholestatic diseases."", ""reference"": ""PMID:39250501"", ""snippet"": ""The proclivity of these cells to undergo a senescence-associated secretory phenotype, which is proinflammatory and profibrogenic, and the intrinsic intracellular activation pathways resulting in the secretion of cytokines and chemokines are reviewed."", ""supports"": ""SUPPORT""}"
6667	6482	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	0	evidence	0	DOI:10.1038/srep17162	SUPPORT		A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome.	This establishes mosaic, somatic AKT1 p.E17K activation in Proteus syndrome.	"{""explanation"": ""This establishes mosaic, somatic AKT1 p.E17K activation in Proteus syndrome."", ""reference"": ""DOI:10.1038/srep17162"", ""snippet"": ""A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."", ""supports"": ""SUPPORT""}"
6668	6483	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	1	evidence	0	DOI:10.1038/srep17162	SUPPORT		A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome.	This directly links AKT1 activation to elevated AKT signaling in mutation-positive cells.	"{""explanation"": ""This directly links AKT1 activation to elevated AKT signaling in mutation-positive cells."", ""reference"": ""DOI:10.1038/srep17162"", ""snippet"": ""A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."", ""supports"": ""SUPPORT""}"
6669	6484	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	2	evidence	0	DOI:10.1093/hmg/ddz116	SUPPORT		Identification of variant-positive cells by green fluorescent protein (GFP) staining in chimeric Proteus syndrome mice showed that in some lesions, hyperplastic cells were predominantly GFP/Akt1E17K-positive and showed increased pAKT signal compared to GFP-negative cells.	This demonstrates increased pAKT signaling in mutant clones within lesions.	"{""explanation"": ""This demonstrates increased pAKT signaling in mutant clones within lesions."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""Identification of variant-positive cells by green fluorescent protein (GFP) staining in chimeric Proteus syndrome mice showed that in some lesions, hyperplastic cells were predominantly GFP/Akt1E17K-positive and showed increased pAKT signal compared to GFP-negative cells."", ""supports"": ""SUPPORT""}"
6670	6485	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	3	evidence	0	DOI:10.1093/hmg/ddz116	SUPPORT		However, hyperplastic mammary epithelium was a mixture of GFP/Akt1E17K-positive and negative cells with some GFP/Akt1E17K-negative cells also having increased pAKT signal suggesting that the variant-positive cells can induce lesion formation in a non-cell autonomous manner.	This provides evidence for non-cell-autonomous effects in lesion formation.	"{""explanation"": ""This provides evidence for non-cell-autonomous effects in lesion formation."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""However, hyperplastic mammary epithelium was a mixture of GFP/Akt1E17K-positive and negative cells with some GFP/Akt1E17K-negative cells also having increased pAKT signal suggesting that the variant-positive cells can induce lesion formation in a non-cell autonomous manner."", ""supports"": ""SUPPORT""}"
6671	6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	evidence	0	DOI:10.1101/2024.01.26.577324	SUPPORT		Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections.	AKT overactivation increases vascular connectivity in organoid vasculature.	"{""explanation"": ""AKT overactivation increases vascular connectivity in organoid vasculature."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."", ""supports"": ""SUPPORT""}"
6672	6486	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	4	evidence	1	DOI:10.1101/2024.01.26.577324	SUPPORT		This could be due to the significant vasculogenesis induced by AKT overactivation.	The study explicitly links AKT overactivation to increased vasculogenesis.	"{""explanation"": ""The study explicitly links AKT overactivation to increased vasculogenesis."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""This could be due to the significant vasculogenesis induced by AKT overactivation."", ""supports"": ""SUPPORT""}"
6673	6487	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	5	evidence	0	DOI:10.1101/2024.01.26.577324	SUPPORT		Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections.	AKT overactivation is linked to unstable vascular connections.	"{""explanation"": ""AKT overactivation is linked to unstable vascular connections."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."", ""supports"": ""SUPPORT""}"
6674	6487	276	Proteus syndrome	Proteus_syndrome.yaml	pathophysiology	5	evidence	1	DOI:10.1101/2024.01.26.577324	SUPPORT		Additionally, a notable increase in dysfunctional PDGFRβ + mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids.	This supports mural cell dysfunction as part of the vascular phenotype.	"{""explanation"": ""This supports mural cell dysfunction as part of the vascular phenotype."", ""reference"": ""DOI:10.1101/2024.01.26.577324"", ""snippet"": ""Additionally, a notable increase in dysfunctional PDGFRβ + mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids."", ""supports"": ""SUPPORT""}"
6713	6514	277	Prurigo Nodularis	Prurigo_Nodularis.yaml	pathophysiology	0	evidence	0	PMID:38345154	SUPPORT		associated with immune and neural dysregulation, mediated by inflammatory	The review describes immune and neural dysregulation with cytokines and neuropeptides in PN.	"{""explanation"": ""The review describes immune and neural dysregulation with cytokines and neuropeptides in PN."", ""reference"": ""PMID:38345154"", ""snippet"": ""associated with immune and neural dysregulation, mediated by inflammatory"", ""supports"": ""SUPPORT""}"
6718	6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	evidence	0	PMID:38686385	SUPPORT		Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease.	IL-23 drives Th17 cell differentiation and maintenance, which is central to T cell-mediated inflammation in psoriasis.	"{""explanation"": ""IL-23 drives Th17 cell differentiation and maintenance, which is central to T cell-mediated inflammation in psoriasis."", ""reference"": ""PMID:38686385"", ""snippet"": ""Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease."", ""supports"": ""SUPPORT""}"
6719	6534	278	Psoriasis	Psoriasis.yaml	pathophysiology	0	evidence	1	PMID:39337637	SUPPORT		Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk).	This describes the complex inflammatory response involving multiple cellular processes, consistent with T cell-mediated inflammation involving transcriptional regulation and immune cell crosstalk.	"{""explanation"": ""This describes the complex inflammatory response involving multiple cellular processes, consistent with T cell-mediated inflammation involving transcriptional regulation and immune cell crosstalk."", ""reference"": ""PMID:39337637"", ""snippet"": ""Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk)."", ""supports"": ""SUPPORT""}"
6720	6535	278	Psoriasis	Psoriasis.yaml	pathophysiology	1	evidence	0	PMID:39337637	SUPPORT		Many skin diseases begin with inflammatory changes on a molecular level.	Inflammatory changes at the molecular level drive keratinocyte hyperproliferation in psoriasis, linking inflammation to cellular proliferation.	"{""explanation"": ""Inflammatory changes at the molecular level drive keratinocyte hyperproliferation in psoriasis, linking inflammation to cellular proliferation."", ""reference"": ""PMID:39337637"", ""snippet"": ""Many skin diseases begin with inflammatory changes on a molecular level."", ""supports"": ""SUPPORT""}"
6721	6535	278	Psoriasis	Psoriasis.yaml	pathophysiology	1	evidence	1	PMID:39576422	SUPPORT		Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types.	The chronic autoimmune nature of psoriasis results in persistent inflammatory signaling that drives sustained keratinocyte hyperproliferation, manifesting as the characteristic plaque types.	"{""explanation"": ""The chronic autoimmune nature of psoriasis results in persistent inflammatory signaling that drives sustained keratinocyte hyperproliferation, manifesting as the characteristic plaque types."", ""reference"": ""PMID:39576422"", ""snippet"": ""Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types."", ""supports"": ""SUPPORT""}"
6722	6536	278	Psoriasis	Psoriasis.yaml	pathophysiology	2	evidence	0	PMID:38686385	SUPPORT		We review IL-23 biology, IL-23 signaling in IMIDs, and the effect of IL-23 inhibition in treating these diseases.	Dendritic cells are the primary producers of IL-23, which is central to psoriasis pathophysiology. This evidence supports the critical role of dendritic cell activation in initiating the inflammatory cascade through IL-23 production.	"{""explanation"": ""Dendritic cells are the primary producers of IL-23, which is central to psoriasis pathophysiology. This evidence supports the critical role of dendritic cell activation in initiating the inflammatory cascade through IL-23 production."", ""reference"": ""PMID:38686385"", ""snippet"": ""We review IL-23 biology, IL-23 signaling in IMIDs, and the effect of IL-23 inhibition in treating these diseases."", ""supports"": ""SUPPORT""}"
6723	6536	278	Psoriasis	Psoriasis.yaml	pathophysiology	2	evidence	1	PMID:39337637	SUPPORT		Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk).	Dendritic cells act as innate immunity sensors and initiate the inflammatory response through antigen presentation and cytokine production, representing the dysregulation of innate immunity sensors described here.	"{""explanation"": ""Dendritic cells act as innate immunity sensors and initiate the inflammatory response through antigen presentation and cytokine production, representing the dysregulation of innate immunity sensors described here."", ""reference"": ""PMID:39337637"", ""snippet"": ""Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk)."", ""supports"": ""SUPPORT""}"
6724	6537	278	Psoriasis	Psoriasis.yaml	pathophysiology	3	evidence	0	PMID:38686385	SUPPORT		Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease.	This confirms IL-23 as the hierarchically dominant regulatory cytokine in psoriasis, supporting its central role in the IL-23/IL-17 axis and why it is the major therapeutic target.	"{""explanation"": ""This confirms IL-23 as the hierarchically dominant regulatory cytokine in psoriasis, supporting its central role in the IL-23/IL-17 axis and why it is the major therapeutic target."", ""reference"": ""PMID:38686385"", ""snippet"": ""Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis, psoriatic arthritis, and inflammatory bowel disease."", ""supports"": ""SUPPORT""}"
6725	6537	278	Psoriasis	Psoriasis.yaml	pathophysiology	3	evidence	1	PMID:39337637	SUPPORT		Many skin diseases begin with inflammatory changes on a molecular level.	This establishes that inflammatory molecular mechanisms are fundamental to skin disease pathogenesis, consistent with the IL-23/IL-17 inflammatory axis driving psoriasis.	"{""explanation"": ""This establishes that inflammatory molecular mechanisms are fundamental to skin disease pathogenesis, consistent with the IL-23/IL-17 inflammatory axis driving psoriasis."", ""reference"": ""PMID:39337637"", ""snippet"": ""Many skin diseases begin with inflammatory changes on a molecular level."", ""supports"": ""SUPPORT""}"
6729	6552	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	0	evidence	0	PMID:36902329	SUPPORT		The pathogenesis of PsA is complex and multifaceted, with an interplay of genetic predisposition, triggering environmental factors, and activation of the innate and adaptive immune system, although autoinflammation has also been implicated.	The review summarizes immune-mediated pathogenesis with genetic and environmental drivers.	"{""explanation"": ""The review summarizes immune-mediated pathogenesis with genetic and environmental drivers."", ""reference"": ""PMID:36902329"", ""snippet"": ""The pathogenesis of PsA is complex and multifaceted, with an interplay of genetic predisposition, triggering environmental factors, and activation of the innate and adaptive immune system, although autoinflammation has also been implicated."", ""supports"": ""SUPPORT""}"
6730	6553	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	1	evidence	0	PMID:36902329	SUPPORT		Research has identified several immune-inflammatory pathways defined by cytokines (IL-23/IL-17, TNF), leading to the development of efficacious therapeutic targets.	The abstract highlights cytokine pathways as central inflammatory drivers in PsA.	"{""explanation"": ""The abstract highlights cytokine pathways as central inflammatory drivers in PsA."", ""reference"": ""PMID:36902329"", ""snippet"": ""Research has identified several immune-inflammatory pathways defined by cytokines (IL-23/IL-17, TNF), leading to the development of efficacious therapeutic targets."", ""supports"": ""SUPPORT""}"
6731	6554	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	2	evidence	0	PMID:32159793	SUPPORT		Enthesitis is a key manifestation of PsA and current knowledge supports the concept that it may be among the primary events in the development of this disease, as well as other forms of SpA.	The abstract describes enthesitis as a key manifestation and potential primary event in PsA.	"{""explanation"": ""The abstract describes enthesitis as a key manifestation and potential primary event in PsA."", ""reference"": ""PMID:32159793"", ""snippet"": ""Enthesitis is a key manifestation of PsA and current knowledge supports the concept that it may be among the primary events in the development of this disease, as well as other forms of SpA."", ""supports"": ""SUPPORT""}"
6732	6554	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	pathophysiology	2	evidence	1	PMID:32159793	SUPPORT		Activation of pro-inflammatory mediators such as IL-17 and TNF-α as well as the influx of innate immune cells are key events in the development of enthesitis in PsA.	The abstract notes IL-17 and TNF-α as key mediators of PsA enthesitis.	"{""explanation"": ""The abstract notes IL-17 and TNF-α as key mediators of PsA enthesitis."", ""reference"": ""PMID:32159793"", ""snippet"": ""Activation of pro-inflammatory mediators such as IL-17 and TNF-α as well as the influx of innate immune cells are key events in the development of enthesitis in PsA."", ""supports"": ""SUPPORT""}"
6738	6581	280	Pulmonary_hypertension	Pulmonary_hypertension.yaml	pathophysiology	6	downstream[0].evidence	0	PMID:39581144	SUPPORT		Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by elevated pulmonary vascular resistance, progressive increases in pulmonary artery pressures, ultimately leading to right-sided heart failure	This 2024 paper establishes that progressive vascular remodeling in PAH leads to increased resistance and right ventricular failure.	"{""explanation"": ""This 2024 paper establishes that progressive vascular remodeling in PAH leads to increased resistance and right ventricular failure."", ""reference"": ""PMID:39581144"", ""snippet"": ""Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by elevated pulmonary vascular resistance, progressive increases in pulmonary artery pressures, ultimately leading to right-sided heart failure"", ""supports"": ""SUPPORT""}"
6743	6622	282	RET-Rearranged Non-Small Cell Lung Cancer	RET_Rearranged_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:38110308	SUPPORT		Nearly 1% to 2% of NSCLCs harbor RET fusions, and this patient population may not respond well to traditional treatments like chemotherapy or radiation therapy.	Supports the presence of RET fusions in a subset of NSCLC.	"{""explanation"": ""Supports the presence of RET fusions in a subset of NSCLC."", ""reference"": ""PMID:38110308"", ""snippet"": ""Nearly 1% to 2% of NSCLCs harbor RET fusions, and this patient population may not respond well to traditional treatments like chemotherapy or radiation therapy."", ""supports"": ""SUPPORT""}"
6746	6642	283	ROS1-Rearranged Non-Small Cell Lung Cancer	ROS1_Rearranged_NSCLC.yaml	pathophysiology	0	evidence	0	PMID:31720561	SUPPORT		ROS1 gene fusions account for approximately 1-2% of all cases of non-small cell lung cancer (NSCLC).	This abstract establishes that ROS1 fusions define a small NSCLC subset, supporting the ROS1 gene rearrangement mechanism.	"{""explanation"": ""This abstract establishes that ROS1 fusions define a small NSCLC subset, supporting the ROS1 gene rearrangement mechanism."", ""reference"": ""PMID:31720561"", ""snippet"": ""ROS1 gene fusions account for approximately 1-2% of all cases of non-small cell lung cancer (NSCLC)."", ""supports"": ""SUPPORT""}"
6748	6656	284	Rabies	Rabies.yaml	pathophysiology	0	evidence	0	PMID:12144896	SUPPORT		Rabies is an acute, progressive, incurable viral encephalitis.	The abstract defines rabies as viral encephalitis.	"{""explanation"": ""The abstract defines rabies as viral encephalitis."", ""reference"": ""PMID:12144896"", ""snippet"": ""Rabies is an acute, progressive, incurable viral encephalitis."", ""supports"": ""SUPPORT""}"
6749	6657	284	Rabies	Rabies.yaml	pathophysiology	1	evidence	0	PMID:12144896	SUPPORT		once the virus is deposited in peripheral wounds, centripetal passage occurs towards the central nervous system.	The abstract describes centripetal spread to the CNS.	"{""explanation"": ""The abstract describes centripetal spread to the CNS."", ""reference"": ""PMID:12144896"", ""snippet"": ""once the virus is deposited in peripheral wounds, centripetal passage occurs towards the central nervous system."", ""supports"": ""SUPPORT""}"
6768	6676	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	The typical patient who experiences RFS has been malnourished for days to weeks	This describes the malnourished state that precedes refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This describes the malnourished state that precedes refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""The typical patient who experiences RFS has been malnourished for days to weeks"", ""supports"": ""SUPPORT""}"
6769	6677	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:19931071	SUPPORT	HUMAN_CLINICAL	Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient	This identifies aggressive refeeding in malnourished patients as the precipitating step.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies aggressive refeeding in malnourished patients as the precipitating step."", ""reference"": ""PMID:19931071"", ""snippet"": ""Refeeding syndrome (RFS) is the result of aggressive enteral or parenteral feeding in a malnourished patient"", ""supports"": ""SUPPORT""}"
6770	6678	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:19931071	SUPPORT	HUMAN_CLINICAL	with hypophosphatemia being the hallmark of this phenomenon.	This explicitly labels hypophosphatemia as the hallmark feature of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This explicitly labels hypophosphatemia as the hallmark feature of refeeding syndrome."", ""reference"": ""PMID:19931071"", ""snippet"": ""with hypophosphatemia being the hallmark of this phenomenon."", ""supports"": ""SUPPORT""}"
6771	6679	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:36936877	SUPPORT	MODEL_ORGANISM	Hypophosphatemia inevitably is observed at the onset of refeeding syndrome and therefore is monitored during refeeding	This notes that hypophosphatemia appears at onset and is monitored during refeeding.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""This notes that hypophosphatemia appears at onset and is monitored during refeeding."", ""reference"": ""PMID:36936877"", ""snippet"": ""Hypophosphatemia inevitably is observed at the onset of refeeding syndrome and therefore is monitored during refeeding"", ""supports"": ""SUPPORT""}"
6772	6680	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	acute intracellular shift in electrolytes, increased phosphate demand during tissue anabolism, and formation of high-energy phosphate bonds.	This directly describes the intracellular electrolyte shift and increased phosphate demand that drive refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This directly describes the intracellular electrolyte shift and increased phosphate demand that drive refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""acute intracellular shift in electrolytes, increased phosphate demand during tissue anabolism, and formation of high-energy phosphate bonds."", ""supports"": ""SUPPORT""}"
6773	6681	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:40738722	SUPPORT	HUMAN_CLINICAL	Phosphate levels showed the most significant decline post-PN initiation (43%), followed by potassium (19%) and magnesium (17%)	This quantifies the rapid decline in phosphate compared with potassium and magnesium after PN initiation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This quantifies the rapid decline in phosphate compared with potassium and magnesium after PN initiation."", ""reference"": ""PMID:40738722"", ""snippet"": ""Phosphate levels showed the most significant decline post-PN initiation (43%), followed by potassium (19%) and magnesium (17%)"", ""supports"": ""SUPPORT""}"
6774	6682	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	6	evidence	0	PMID:19931071	SUPPORT	HUMAN_CLINICAL	along with sodium and fluid retention.	This identifies sodium and fluid retention as a common concurrent change.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies sodium and fluid retention as a common concurrent change."", ""reference"": ""PMID:19931071"", ""snippet"": ""along with sodium and fluid retention."", ""supports"": ""SUPPORT""}"
6775	6683	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	7	evidence	0	PMID:29448987	SUPPORT	HUMAN_CLINICAL	thiamine deficiency and disorder of sodium and fluid balance are common.	This identifies thiamine deficiency as a common accompanying feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This identifies thiamine deficiency as a common accompanying feature."", ""reference"": ""PMID:29448987"", ""snippet"": ""thiamine deficiency and disorder of sodium and fluid balance are common."", ""supports"": ""SUPPORT""}"
6776	6684	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	8	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency	This lists the severe cardiorespiratory complications of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This lists the severe cardiorespiratory complications of refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency"", ""supports"": ""SUPPORT""}"
6777	6685	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	9	evidence	0	PMID:41246683	SUPPORT	HUMAN_CLINICAL	Refeeding syndrome potentially causes death from refeeding-induced central nervous system disorders, such as hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy.	This case report highlights CNS complications associated with refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report highlights CNS complications associated with refeeding syndrome."", ""reference"": ""PMID:41246683"", ""snippet"": ""Refeeding syndrome potentially causes death from refeeding-induced central nervous system disorders, such as hypoglycemic encephalopathy, Wernicke encephalopathy, and hypophosphatemic encephalopathy."", ""supports"": ""SUPPORT""}"
6778	6686	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	pathophysiology	10	evidence	0	PMID:39310593	SUPPORT	HUMAN_CLINICAL	The abnormal metabolism of fatty acids was the presumed cause of cardiac dysfunction.	This cardiohistological case links abnormal fatty acid metabolism to cardiac dysfunction in refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This cardiohistological case links abnormal fatty acid metabolism to cardiac dysfunction in refeeding syndrome."", ""reference"": ""PMID:39310593"", ""snippet"": ""The abnormal metabolism of fatty acids was the presumed cause of cardiac dysfunction."", ""supports"": ""SUPPORT""}"
6799	6704	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	pathophysiology	0	evidence	0	PMID:28898679	SUPPORT		The most common form of kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC).	The abstract identifies RCC as arising from renal epithelium.	"{""explanation"": ""The abstract identifies RCC as arising from renal epithelium."", ""reference"": ""PMID:28898679"", ""snippet"": ""The most common form of kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC)."", ""supports"": ""SUPPORT""}"
6800	6705	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	pathophysiology	1	evidence	0	PMID:28898679	SUPPORT		This entity comprises different histological and molecular subtypes.	The abstract notes RCC heterogeneity across histologic and molecular subtypes.	"{""explanation"": ""The abstract notes RCC heterogeneity across histologic and molecular subtypes."", ""reference"": ""PMID:28898679"", ""snippet"": ""This entity comprises different histological and molecular subtypes."", ""supports"": ""SUPPORT""}"
6809	6718	287	Retinoblastoma	Retinoblastoma.yaml	pathophysiology	2	evidence	0	PMID:5279523	SUPPORT		retinoblastoma is a cancer caused by two mutational events. In the dominantly inherited form, one mutation is inherited via the germinal cells and the second occurs in somatic cells. In the nonhereditary form, both mutations occur in somatic cells.	This is the foundational Knudson paper establishing the two-hit hypothesis based on statistical analysis of retinoblastoma cases.	"{""explanation"": ""This is the foundational Knudson paper establishing the two-hit hypothesis based on statistical analysis of retinoblastoma cases."", ""reference"": ""PMID:5279523"", ""snippet"": ""retinoblastoma is a cancer caused by two mutational events. In the dominantly inherited form, one mutation is inherited via the germinal cells and the second occurs in somatic cells. In the nonhereditary form, both mutations occur in somatic cells."", ""supports"": ""SUPPORT""}"
6814	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	evidence	0	PMID:35122356	SUPPORT		prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention	The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism.	"{""explanation"": ""The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism."", ""reference"": ""PMID:35122356"", ""snippet"": ""prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"", ""supports"": ""SUPPORT""}"
6815	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	evidence	1	PMID:38587015	SUPPORT		RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility.	The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients.	"{""explanation"": ""The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients."", ""reference"": ""PMID:38587015"", ""snippet"": ""RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."", ""supports"": ""SUPPORT""}"
6816	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	evidence	2	PMID:41506952	SUPPORT		high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching.	The Dealino 2026 cases document absent UES relaxation during attempted belching.	"{""explanation"": ""The Dealino 2026 cases document absent UES relaxation during attempted belching."", ""reference"": ""PMID:41506952"", ""snippet"": ""high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."", ""supports"": ""SUPPORT""}"
6817	6730	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	0	evidence	3	PMID:38767031	SUPPORT		We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch.	The Jiménez-Castillo 2025 case series shows failure of UES relaxation during retrograde distension.	"{""explanation"": ""The Jiménez-Castillo 2025 case series shows failure of UES relaxation during retrograde distension."", ""reference"": ""PMID:38767031"", ""snippet"": ""We performed HRM with a belch provocation test for which the patient drank 500 ml of carbonated water. The study revealed increased esophageal pressure, an absence of UES relaxation and secondary peristalsis once the patient mentioned the need to belch."", ""supports"": ""SUPPORT""}"
6818	6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	evidence	0	PMID:38587015	SUPPORT		The RCPD cohort, compared to the asymptomatic cohort, exhibited significantly greater upper esophageal sphincter (UES) length [4.5 (SD: 0.7) vs 3.7 (0.9) cm	The case-control study quantified higher UES basal pressures in R-CPD patients relative to controls.	"{""explanation"": ""The case-control study quantified higher UES basal pressures in R-CPD patients relative to controls."", ""reference"": ""PMID:38587015"", ""snippet"": ""The RCPD cohort, compared to the asymptomatic cohort, exhibited significantly greater upper esophageal sphincter (UES) length [4.5 (SD: 0.7) vs 3.7 (0.9) cm"", ""supports"": ""SUPPORT""}"
6819	6731	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	pathophysiology	1	evidence	1	PMID:41506952	SUPPORT		high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching.	Elevated resting UES pressure was observed in both cases in the 2026 report.	"{""explanation"": ""Elevated resting UES pressure was observed in both cases in the 2026 report."", ""reference"": ""PMID:41506952"", ""snippet"": ""high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."", ""supports"": ""SUPPORT""}"
6842	6742	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:10508514	SUPPORT		MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A	Original discovery paper confirms MeCP2 functions as a transcriptional regulator through DNA methylation binding.	"{""explanation"": ""Original discovery paper confirms MeCP2 functions as a transcriptional regulator through DNA methylation binding."", ""reference"": ""PMID:10508514"", ""snippet"": ""MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A"", ""supports"": ""SUPPORT""}"
6843	6743	289	Rett Syndrome	Rett_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:24615633	SUPPORT		Rett syndrome (RTT) is a severe and progressive neurological disorder, which mainly affects young females. Mutations of the methyl-CpG binding protein 2 (MECP2) gene are the most prevalent cause of classical RTT cases.	Review confirms MECP2 mutations cause the neurological dysfunction in Rett syndrome.	"{""explanation"": ""Review confirms MECP2 mutations cause the neurological dysfunction in Rett syndrome."", ""reference"": ""PMID:24615633"", ""snippet"": ""Rett syndrome (RTT) is a severe and progressive neurological disorder, which mainly affects young females. Mutations of the methyl-CpG binding protein 2 (MECP2) gene are the most prevalent cause of classical RTT cases."", ""supports"": ""SUPPORT""}"
6903	6775	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	0	evidence	0	PMID:22608255	SUPPORT		Rheumatoid arthritis (RA) is an autoimmune disease, characterized by chronic inflammation and synovial hyperplasia in the joints that ultimately lead to cartilage and bone destruction. A wealth of research has shown that CD4(+) T cells, especially IL-17 producing helper T (Th17) cells, play an important role in RA development.	This reference supports the statement that Th17 cells are involved in the autoimmune response in RA, particularly affecting the joints.	"{""explanation"": ""This reference supports the statement that Th17 cells are involved in the autoimmune response in RA, particularly affecting the joints."", ""reference"": ""PMID:22608255"", ""snippet"": ""Rheumatoid arthritis (RA) is an autoimmune disease, characterized by chronic inflammation and synovial hyperplasia in the joints that ultimately lead to cartilage and bone destruction. A wealth of research has shown that CD4(+) T cells, especially IL-17 producing helper T (Th17) cells, play an important role in RA development."", ""supports"": ""SUPPORT""}"
6904	6775	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	0	evidence	1	PMID:30572135	SUPPORT		These pro-inflammatory T-cells are also key players in autoimmunity and a pathogenic role has been demonstrated in several diseases such as rheumatoid arthritis or psoriasis.	The cited literature indicates that Th17 cells play a significant role in the autoimmune response and inflammation characteristic of RA.	"{""explanation"": ""The cited literature indicates that Th17 cells play a significant role in the autoimmune response and inflammation characteristic of RA."", ""reference"": ""PMID:30572135"", ""snippet"": ""These pro-inflammatory T-cells are also key players in autoimmunity and a pathogenic role has been demonstrated in several diseases such as rheumatoid arthritis or psoriasis."", ""supports"": ""SUPPORT""}"
6905	6775	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	0	evidence	2	PMID:31895885	SUPPORT		Rheumatoid arthritis (RA) is a prototypic autoimmune disease manifesting as chronic inflammation of the synovium and leading to acceleration of cardiovascular disease and shortening of life expectancy.	This reference corroborates that RA is an autoimmune disease affecting the synovium, aligning with the statement.	"{""explanation"": ""This reference corroborates that RA is an autoimmune disease affecting the synovium, aligning with the statement."", ""reference"": ""PMID:31895885"", ""snippet"": ""Rheumatoid arthritis (RA) is a prototypic autoimmune disease manifesting as chronic inflammation of the synovium and leading to acceleration of cardiovascular disease and shortening of life expectancy."", ""supports"": ""SUPPORT""}"
6906	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	evidence	0	PMID:9836373	SUPPORT		Rheumatoid arthritis (RA) is well known to be a chronic autoimmune/inflammatory disease which leads to progressive joint damage and destruction.	The abstract explicitly states that RA leads to progressive joint damage and inflammation, which aligns with the statement that overproduction of inflammatory cytokines leads to joint inflammation and damage.	"{""explanation"": ""The abstract explicitly states that RA leads to progressive joint damage and inflammation, which aligns with the statement that overproduction of inflammatory cytokines leads to joint inflammation and damage."", ""reference"": ""PMID:9836373"", ""snippet"": ""Rheumatoid arthritis (RA) is well known to be a chronic autoimmune/inflammatory disease which leads to progressive joint damage and destruction."", ""supports"": ""SUPPORT""}"
6907	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	evidence	1	PMID:34688020	SUPPORT		This pleiotropic cytokine [IL-6] is a key factor in the pathogenesis of rheumatoid arthritis (RA) and is involved in many extra-articular manifestations that accompany the disease.	IL-6 is mentioned as a key factor in the pathogenesis of RA, supporting the notion that overproduction of inflammatory cytokines like IL-6 contributes to RA.	"{""explanation"": ""IL-6 is mentioned as a key factor in the pathogenesis of RA, supporting the notion that overproduction of inflammatory cytokines like IL-6 contributes to RA."", ""reference"": ""PMID:34688020"", ""snippet"": ""This pleiotropic cytokine [IL-6] is a key factor in the pathogenesis of rheumatoid arthritis (RA) and is involved in many extra-articular manifestations that accompany the disease."", ""supports"": ""SUPPORT""}"
6908	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	evidence	2	PMID:32830085	SUPPORT		The pro-inflammatory mediators released via interaction of intracellular kinases direct the development of Rheumatoid arthritis.	The abstract clearly states that pro-inflammatory mediators direct the development of RA, which supports the statement about the role of cytokines like TNF-α, IL-1, and IL-6 in joint inflammation and damage.	"{""explanation"": ""The abstract clearly states that pro-inflammatory mediators direct the development of RA, which supports the statement about the role of cytokines like TNF-α, IL-1, and IL-6 in joint inflammation and damage."", ""reference"": ""PMID:32830085"", ""snippet"": ""The pro-inflammatory mediators released via interaction of intracellular kinases direct the development of Rheumatoid arthritis."", ""supports"": ""SUPPORT""}"
6909	6776	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	1	evidence	3	PMID:33692806	SUPPORT		IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as ... Rheumatoid Arthritis.	Although focusing on IL-23/IL-17, the review also discusses other inflammatory cytokines such as IL-6 and TNF-α and their role in RA, which supports the statement.	"{""explanation"": ""Although focusing on IL-23/IL-17, the review also discusses other inflammatory cytokines such as IL-6 and TNF-α and their role in RA, which supports the statement."", ""reference"": ""PMID:33692806"", ""snippet"": ""IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as ... Rheumatoid Arthritis."", ""supports"": ""SUPPORT""}"
6910	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	downstream[0].evidence	0	PMID:32071294	SUPPORT		Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction.	This paper establishes that synovial hyperplasia leads to pannus formation which directly causes cartilage and bone destruction in RA.	"{""explanation"": ""This paper establishes that synovial hyperplasia leads to pannus formation which directly causes cartilage and bone destruction in RA."", ""reference"": ""PMID:32071294"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia, pannus formation, and cartilage and bone destruction."", ""supports"": ""SUPPORT""}"
6911	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	evidence	0	PMID:15353290	SUPPORT		Rheumatoid arthritis (RA) is a chronic inflammatory disease with progressive articular damage. Activated cells of the synovium produce pro-inflammatory and matrix-degrading effector molecules, which maintain the inflammation and lead to the destruction of the involved joints. In addition to macrophages and T- and B-cells, fibroblast-like synoviocytes must be considered key cells in driving the pathological processes. They can be distinguished by their transformed-appearing phenotype and their invasion into adjacent cartilage and bone.	The literature describes that fibroblast-like synoviocytes and macrophages play a key role in the inflammation and invasion of cartilage and bone in RA, supporting the statement.	"{""explanation"": ""The literature describes that fibroblast-like synoviocytes and macrophages play a key role in the inflammation and invasion of cartilage and bone in RA, supporting the statement."", ""reference"": ""PMID:15353290"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic inflammatory disease with progressive articular damage. Activated cells of the synovium produce pro-inflammatory and matrix-degrading effector molecules, which maintain the inflammation and lead to the destruction of the involved joints. In addition to macrophages and T- and B-cells, fibroblast-like synoviocytes must be considered key cells in driving the pathological processes. They can be distinguished by their transformed-appearing phenotype and their invasion into adjacent cartilage and bone."", ""supports"": ""SUPPORT""}"
6912	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	evidence	1	PMID:35958604	SUPPORT		Synovial hyperplasia often presents when joints become inflamed due to immune cell infiltration. Synovial membrane... interact with synovial fibroblasts (SFs), T cells, B cells, and other inflammatory cells to promote the production of a variety of pro-inflammatory cytokines and chemokines, such as TNF-alpha, IL-1beta, IL-8, and IL-6, which are involved in the pathogenic process of inflammatory arthritis.	This source confirms the role of synovial fibroblasts and macrophages in the inflammatory process associated with synovial hyperplasia in RA.	"{""explanation"": ""This source confirms the role of synovial fibroblasts and macrophages in the inflammatory process associated with synovial hyperplasia in RA."", ""reference"": ""PMID:35958604"", ""snippet"": ""Synovial hyperplasia often presents when joints become inflamed due to immune cell infiltration. Synovial membrane... interact with synovial fibroblasts (SFs), T cells, B cells, and other inflammatory cells to promote the production of a variety of pro-inflammatory cytokines and chemokines, such as TNF-alpha, IL-1beta, IL-8, and IL-6, which are involved in the pathogenic process of inflammatory arthritis."", ""supports"": ""SUPPORT""}"
6913	6777	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	2	evidence	2	PMID:29287304	SUPPORT		Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by destructive hyperplasia of the synovium. Fibroblast-like synoviocytes (FLS) are a major component of synovial pannus and actively participate in the pathologic progression of RA.	The source supports the role of fibroblast-like synoviocytes in the hyperplasia of the synovium and formation of pannus tissue in RA.	"{""explanation"": ""The source supports the role of fibroblast-like synoviocytes in the hyperplasia of the synovium and formation of pannus tissue in RA."", ""reference"": ""PMID:29287304"", ""snippet"": ""Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by destructive hyperplasia of the synovium. Fibroblast-like synoviocytes (FLS) are a major component of synovial pannus and actively participate in the pathologic progression of RA."", ""supports"": ""SUPPORT""}"
6914	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	evidence	0	PMID:28597065	SUPPORT		Structural damage of cartilage and bone tissue is a hallmark of rheumatoid arthritis (RA). The resulting joint destruction constitutes one of the major disease consequences for patients... These factors result in an inflammatory milieu in the affected joints which leads to an increased development and function of osteoclasts.		"{""reference"": ""PMID:28597065"", ""snippet"": ""Structural damage of cartilage and bone tissue is a hallmark of rheumatoid arthritis (RA). The resulting joint destruction constitutes one of the major disease consequences for patients... These factors result in an inflammatory milieu in the affected joints which leads to an increased development and function of osteoclasts."", ""supports"": ""SUPPORT""}"
6915	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	evidence	1	PMID:17634141	SUPPORT		Chronic inflammatory arthritis not only leads to inflammatory bone loss but it also involves local erosion of articular bone. This osteo-destructive feature of chronic inflammatory arthritis is a major cause of disability in patients with rheumatoid arthritis.		"{""reference"": ""PMID:17634141"", ""snippet"": ""Chronic inflammatory arthritis not only leads to inflammatory bone loss but it also involves local erosion of articular bone. This osteo-destructive feature of chronic inflammatory arthritis is a major cause of disability in patients with rheumatoid arthritis."", ""supports"": ""SUPPORT""}"
6916	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	evidence	2	PMID:24217093	SUPPORT		Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability.		"{""reference"": ""PMID:24217093"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability."", ""supports"": ""SUPPORT""}"
6917	6778	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	3	evidence	3	PMID:35273387	SUPPORT		Rheumatoid arthritis can involve localized, periarticular bone erosion...The RANK-RANKL-osteoprotegerin axis and the Wnt-beta-catenin signalling pathway...have been implicated in inflammatory bone loss.		"{""reference"": ""PMID:35273387"", ""snippet"": ""Rheumatoid arthritis can involve localized, periarticular bone erosion...The RANK-RANKL-osteoprotegerin axis and the Wnt-beta-catenin signalling pathway...have been implicated in inflammatory bone loss."", ""supports"": ""SUPPORT""}"
6918	6779	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	pathophysiology	4	evidence	0	PMID:35367240	SUPPORT		the JAK-STAT pathway has been majorly implicated in RA disease progression upon IL-6 stimulation	This review demonstrates that JAK-STAT signaling is central to IL-6 mediated pathogenesis in rheumatoid arthritis, and that JAK inhibitors are clinically effective in treating RA by abrogating this signaling pathway.	"{""explanation"": ""This review demonstrates that JAK-STAT signaling is central to IL-6 mediated pathogenesis in rheumatoid arthritis, and that JAK inhibitors are clinically effective in treating RA by abrogating this signaling pathway."", ""reference"": ""PMID:35367240"", ""snippet"": ""the JAK-STAT pathway has been majorly implicated in RA disease progression upon IL-6 stimulation"", ""supports"": ""SUPPORT""}"
6991	6811	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	0	evidence	0	PMID:26522830	SUPPORT		Roifman Syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency. Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal compound heterozygous rare variants that disrupt highly conserved positions of the RNU4ATAC small nuclear RNA gene, a minor spliceosome component that is essential for minor intron splicing.	The study confirms that mutations in the RNU4ATAC gene disrupt the minor spliceosome, leading to defective minor intron splicing, which aligns with the statement.	"{""explanation"": ""The study confirms that mutations in the RNU4ATAC gene disrupt the minor spliceosome, leading to defective minor intron splicing, which aligns with the statement."", ""reference"": ""PMID:26522830"", ""snippet"": ""Roifman Syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency. Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal compound heterozygous rare variants that disrupt highly conserved positions of the RNU4ATAC small nuclear RNA gene, a minor spliceosome component that is essential for minor intron splicing."", ""supports"": ""SUPPORT""}"
6992	6811	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	0	evidence	1	PMID:36802443	SUPPORT		Its noncoding gene, RNU4ATAC, has been found mutated in Taybi-Linder (TALS/microcephalic osteodysplastic primordial dwarfism type 1), Roifman (RFMN), and Lowry-Wood (LWS) syndromes. These rare developmental disorders, whose physiopathological mechanisms remain unsolved, associate ante- and post-natal growth retardation, microcephaly, skeletal dysplasia, intellectual disability, retinal dystrophy, and immunodeficiency.	The literature confirms that mutations in the RNU4ATAC gene are associated with Roifman syndrome and disrupt the minor spliceosome, affecting cellular processes.	"{""explanation"": ""The literature confirms that mutations in the RNU4ATAC gene are associated with Roifman syndrome and disrupt the minor spliceosome, affecting cellular processes."", ""reference"": ""PMID:36802443"", ""snippet"": ""Its noncoding gene, RNU4ATAC, has been found mutated in Taybi-Linder (TALS/microcephalic osteodysplastic primordial dwarfism type 1), Roifman (RFMN), and Lowry-Wood (LWS) syndromes. These rare developmental disorders, whose physiopathological mechanisms remain unsolved, associate ante- and post-natal growth retardation, microcephaly, skeletal dysplasia, intellectual disability, retinal dystrophy, and immunodeficiency."", ""supports"": ""SUPPORT""}"
6993	6812	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	1	evidence	0	PMID:35063500	SUPPORT		We sought to determine whether disease-associated mutations in TOP2B impact NK-cell development and function. ... Mature NK cells were reduced in the periphery of TOP2B knockin mice consistent with patient reports, with reduced cytotoxicity toward target cell lines.	The study indicates that mutations associated with Hoffman syndrome, which is another syndromic immunodeficiency, result in decreased NK cell function. This supports the statement about Roifman syndrome having decreased NK cell function due to the similarity in the impact on NK cells.	"{""explanation"": ""The study indicates that mutations associated with Hoffman syndrome, which is another syndromic immunodeficiency, result in decreased NK cell function. This supports the statement about Roifman syndrome having decreased NK cell function due to the similarity in the impact on NK cells."", ""reference"": ""PMID:35063500"", ""snippet"": ""We sought to determine whether disease-associated mutations in TOP2B impact NK-cell development and function. ... Mature NK cells were reduced in the periphery of TOP2B knockin mice consistent with patient reports, with reduced cytotoxicity toward target cell lines."", ""supports"": ""SUPPORT""}"
6994	6813	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	2	evidence	0	PMID:29391254	PARTIAL		The patients exhibited a dramatic reduction in B-cell numbers, with differentiation halted at the transitional B-cell stage.	The study confirms a dramatic reduction in total B-cell numbers in Roifman syndrome patients but does not specifically mention memory B cells.	"{""explanation"": ""The study confirms a dramatic reduction in total B-cell numbers in Roifman syndrome patients but does not specifically mention memory B cells."", ""reference"": ""PMID:29391254"", ""snippet"": ""The patients exhibited a dramatic reduction in B-cell numbers, with differentiation halted at the transitional B-cell stage."", ""supports"": ""PARTIAL""}"
6995	6814	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	3	evidence	0	PMID:35450878	SUPPORT		Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.	The abstract mentions that Roifman syndrome is an immunodeficiency, which implies hypogammaglobulinemia.	"{""explanation"": ""The abstract mentions that Roifman syndrome is an immunodeficiency, which implies hypogammaglobulinemia."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."", ""supports"": ""SUPPORT""}"
6996	6814	291	Roifman-syndrome	Roifman-syndrome.yaml	pathophysiology	3	evidence	1	PMID:32017208	SUPPORT		Primary B-cell immunodeficiency is the most frequent immune defect in infancy.	Roifman syndrome is a type of primary immunodeficiency, which is often associated with hypogammaglobulinemia.	"{""explanation"": ""Roifman syndrome is a type of primary immunodeficiency, which is often associated with hypogammaglobulinemia."", ""reference"": ""PMID:32017208"", ""snippet"": ""Primary B-cell immunodeficiency is the most frequent immune defect in infancy."", ""supports"": ""SUPPORT""}"
7018	6829	292	SADDAN	SADDAN.yaml	pathophysiology	0	evidence	0	PMID:24352917	SUPPORT		The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3).	The abstract states SADDAN is caused by the FGFR3 p.Lys650Met mutation.	"{""explanation"": ""The abstract states SADDAN is caused by the FGFR3 p.Lys650Met mutation."", ""reference"": ""PMID:24352917"", ""snippet"": ""The disorder is the result of a single missense mutation at codon 650 (p.Lys650Met) in the fibroblast growth factor receptor 3 gene (FGFR3)."", ""supports"": ""SUPPORT""}"
7019	6830	292	SADDAN	SADDAN.yaml	pathophysiology	1	evidence	0	PMID:10053006	SUPPORT		Transient transfection studies with FGFR3 mutant constructs show that the Lys650Met mutation causes a dramatic increase in constitutive receptor kinase activity, approximately three times greater than that observed with the Lys650Glu mutation.	Functional studies show Lys650Met increases constitutive FGFR3 kinase activity.	"{""explanation"": ""Functional studies show Lys650Met increases constitutive FGFR3 kinase activity."", ""reference"": ""PMID:10053006"", ""snippet"": ""Transient transfection studies with FGFR3 mutant constructs show that the Lys650Met mutation causes a dramatic increase in constitutive receptor kinase activity, approximately three times greater than that observed with the Lys650Glu mutation."", ""supports"": ""SUPPORT""}"
7020	6831	292	SADDAN	SADDAN.yaml	pathophysiology	2	evidence	0	PMID:10377013	SUPPORT		The FGFR3 Lys650Met mutation results in severe disturbances in endochondral bone growth that approach and overlap those observed in thanatophoric dysplasia, type I.	The abstract links Lys650Met to severe disturbances in endochondral bone growth.	"{""explanation"": ""The abstract links Lys650Met to severe disturbances in endochondral bone growth."", ""reference"": ""PMID:10377013"", ""snippet"": ""The FGFR3 Lys650Met mutation results in severe disturbances in endochondral bone growth that approach and overlap those observed in thanatophoric dysplasia, type I."", ""supports"": ""SUPPORT""}"
7044	6851	293	Salla Disease	Salla_Disease.yaml	pathophysiology	0	evidence	0	PMID:37727271	SUPPORT	IN_VITRO	Here, we evaluated the efficacy of CRISPR-Cas9-mediated homology directed repair (HDR) and adenine base editing (ABE) targeting the founder variant, SLC17A5 c.115C>T (p.Arg39Cys)	Study of patient-derived cells confirms c.115C>T as founder variant and demonstrates pathogenicity through CRISPR approaches.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""Study of patient-derived cells confirms c.115C>T as founder variant and demonstrates pathogenicity through CRISPR approaches."", ""reference"": ""PMID:37727271"", ""snippet"": ""Here, we evaluated the efficacy of CRISPR-Cas9-mediated homology directed repair (HDR) and adenine base editing (ABE) targeting the founder variant, SLC17A5 c.115C>T (p.Arg39Cys)"", ""supports"": ""SUPPORT""}"
7045	6852	293	Salla Disease	Salla_Disease.yaml	pathophysiology	1	evidence	0	DOI:10.1126/sciadv.ade8346	SUPPORT	IN_VITRO	Our analysis reveals two unique features in Sialin: (i) The H+ coupling/sensing requires two highly conserved Glu residues (E171 and E175) instead of one	2023 Science Advances cryo-EM structure and functional assays demonstrate molecular mechanism of sialin transport and mutation effects.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""2023 Science Advances cryo-EM structure and functional assays demonstrate molecular mechanism of sialin transport and mutation effects."", ""reference"": ""DOI:10.1126/sciadv.ade8346"", ""snippet"": ""Our analysis reveals two unique features in Sialin: (i) The H+ coupling/sensing requires two highly conserved Glu residues (E171 and E175) instead of one"", ""supports"": ""SUPPORT""}"
7046	6852	293	Salla Disease	Salla_Disease.yaml	pathophysiology	1	evidence	1	PMID:39742826	SUPPORT	IN_VITRO	Functional studies, including SLC17A5 knockout cells and transient transfections of mutated SLC17A5 demonstrated pathogenicity of the identified variants.	2025 study demonstrates pathogenicity of SLC17A5 variants including tissue-specific mosaic mutations causing atypical FSASD presentations.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""2025 study demonstrates pathogenicity of SLC17A5 variants including tissue-specific mosaic mutations causing atypical FSASD presentations."", ""reference"": ""PMID:39742826"", ""snippet"": ""Functional studies, including SLC17A5 knockout cells and transient transfections of mutated SLC17A5 demonstrated pathogenicity of the identified variants."", ""supports"": ""SUPPORT""}"
7047	6853	293	Salla Disease	Salla_Disease.yaml	pathophysiology	2	evidence	0	PMID:40529477	SUPPORT	HUMAN_CLINICAL	Individuals with FSASD exhibited significantly higher levels of free Neu5Ac compared to their unaffected biological parents (36-fold), LSD-negative subjects (22-fold), and individuals with other LSDs (49-fold).	Diagnostic study demonstrates profound accumulation of free sialic acid in FSASD patients, confirming primary biochemical defect.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Diagnostic study demonstrates profound accumulation of free sialic acid in FSASD patients, confirming primary biochemical defect."", ""reference"": ""PMID:40529477"", ""snippet"": ""Individuals with FSASD exhibited significantly higher levels of free Neu5Ac compared to their unaffected biological parents (36-fold), LSD-negative subjects (22-fold), and individuals with other LSDs (49-fold)."", ""supports"": ""SUPPORT""}"
7048	6853	293	Salla Disease	Salla_Disease.yaml	pathophysiology	2	evidence	1	PMID:39257666	SUPPORT	IN_VITRO	Both cell lines were also cultured with N-acetyl-d-mannosamine monohydrate (ManNAc) to see if it increased SA concentration in the cells. The STXM technique was chosen to simultaneously observe the morphological and chemical changes in cells. It was observed that free SA did not remain in the lysosomes during the sample processing, leaving empty vacuoles to the fibroblasts.	2024 soft X-ray spectromicroscopy study demonstrates cellular vacuolation and lysosomal dysfunction in Salla disease fibroblasts.	"{""evidence_source"": ""IN_VITRO"", ""explanation"": ""2024 soft X-ray spectromicroscopy study demonstrates cellular vacuolation and lysosomal dysfunction in Salla disease fibroblasts."", ""reference"": ""PMID:39257666"", ""snippet"": ""Both cell lines were also cultured with N-acetyl-d-mannosamine monohydrate (ManNAc) to see if it increased SA concentration in the cells. The STXM technique was chosen to simultaneously observe the morphological and chemical changes in cells. It was observed that free SA did not remain in the lysosomes during the sample processing, leaving empty vacuoles to the fibroblasts."", ""supports"": ""SUPPORT""}"
7049	6854	293	Salla Disease	Salla_Disease.yaml	pathophysiology	3	evidence	0	PMID:39991440	SUPPORT	HUMAN_CLINICAL	In CSF, total GSLs, GM1a, GM3, GD3, GD1a, and GD1b were significantly elevated compared to comparison samples. These results reveal dysregulated GSL metabolism and suggest the potential of gangliosides as biomarkers.	Study of CSF and plasma in FSASD patients demonstrates dysregulated GSL metabolism with elevated gangliosides, supporting alterations in pathogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of CSF and plasma in FSASD patients demonstrates dysregulated GSL metabolism with elevated gangliosides, supporting alterations in pathogenesis."", ""reference"": ""PMID:39991440"", ""snippet"": ""In CSF, total GSLs, GM1a, GM3, GD3, GD1a, and GD1b were significantly elevated compared to comparison samples. These results reveal dysregulated GSL metabolism and suggest the potential of gangliosides as biomarkers."", ""supports"": ""SUPPORT""}"
7050	6855	293	Salla Disease	Salla_Disease.yaml	pathophysiology	4	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT	HUMAN_CLINICAL	Oligodendroglia in FSASD pathogenesis is established, the roles of other neural cell types remain elusive.	iPSC disease modeling confirms oligodendroglial involvement and differential cell-type vulnerability in FSASD.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""iPSC disease modeling confirms oligodendroglial involvement and differential cell-type vulnerability in FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Oligodendroglia in FSASD pathogenesis is established, the roles of other neural cell types remain elusive."", ""supports"": ""SUPPORT""}"
7051	6856	293	Salla Disease	Salla_Disease.yaml	pathophysiology	5	evidence	0	PMID:37713976	SUPPORT	HUMAN_CLINICAL	Disease onset occurred within the first six months of life in both patients. Early childhood development was delayed with achievement of some milestones followed by a developmental plateau in late childhood. After this, both patients began a slow and progressive neurological regression in adolescence.	Longitudinal study documents progressive neurodegeneration from infancy through adolescence in intermediate-severe Salla disease.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Longitudinal study documents progressive neurodegeneration from infancy through adolescence in intermediate-severe Salla disease."", ""reference"": ""PMID:37713976"", ""snippet"": ""Disease onset occurred within the first six months of life in both patients. Early childhood development was delayed with achievement of some milestones followed by a developmental plateau in late childhood. After this, both patients began a slow and progressive neurological regression in adolescence."", ""supports"": ""SUPPORT""}"
7070	6885	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	0	evidence	0	PMID:35011621	SUPPORT		Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas	This review confirms the characteristic non-caseating granuloma formation in sarcoidosis.	"{""explanation"": ""This review confirms the characteristic non-caseating granuloma formation in sarcoidosis."", ""reference"": ""PMID:35011621"", ""snippet"": ""Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas"", ""supports"": ""SUPPORT""}"
7071	6886	294	Sarcoidosis	Sarcoidosis.yaml	pathophysiology	1	evidence	0	PMID:35011621	SUPPORT		Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease.	Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs.	"{""explanation"": ""Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs."", ""reference"": ""PMID:35011621"", ""snippet"": ""Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease."", ""supports"": ""SUPPORT""}"
7073	6898	295	Scabies	Scabies.yaml	pathophysiology	0	evidence	0	PMID:30755943	SUPPORT		Scabies is an infestation of the skin by the mite Sarcoptes scabiei.	The abstract describes scabies as a skin infestation by S. scabiei.	"{""explanation"": ""The abstract describes scabies as a skin infestation by S. scabiei."", ""reference"": ""PMID:30755943"", ""snippet"": ""Scabies is an infestation of the skin by the mite Sarcoptes scabiei."", ""supports"": ""SUPPORT""}"
7079	6904	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	0	evidence	0	PMID:30093684	SUPPORT		Mature adult worms reside in the mesenteric (Schistosoma mansoni and Schistosoma japonicum) or pelvic (Schistosoma haematobium) veins	The abstract localizes adult worms to mesenteric or pelvic venous beds.	"{""explanation"": ""The abstract localizes adult worms to mesenteric or pelvic venous beds."", ""reference"": ""PMID:30093684"", ""snippet"": ""Mature adult worms reside in the mesenteric (Schistosoma mansoni and Schistosoma japonicum) or pelvic (Schistosoma haematobium) veins"", ""supports"": ""SUPPORT""}"
7080	6905	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	1	evidence	0	PMID:30093684	SUPPORT		Eggs trapped in the surrounding tissues and organs, such as the liver and bladder, cause inflammatory immune responses (including granulomas)	Trapped eggs drive inflammatory granulomas in liver and bladder tissue.	"{""explanation"": ""Trapped eggs drive inflammatory granulomas in liver and bladder tissue."", ""reference"": ""PMID:30093684"", ""snippet"": ""Eggs trapped in the surrounding tissues and organs, such as the liver and bladder, cause inflammatory immune responses (including granulomas)"", ""supports"": ""SUPPORT""}"
7081	6906	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	2	evidence	0	PMID:24698483	SUPPORT		periportal fibrosis with portal hypertension	The review links egg-induced pathology to periportal fibrosis and portal hypertension.	"{""explanation"": ""The review links egg-induced pathology to periportal fibrosis and portal hypertension."", ""reference"": ""PMID:24698483"", ""snippet"": ""periportal fibrosis with portal hypertension"", ""supports"": ""SUPPORT""}"
7082	6907	296	Schistosomiasis	Schistosomiasis.yaml	pathophysiology	3	evidence	0	PMID:24698483	SUPPORT		urogenital inflammation and scarring	The abstract lists urogenital inflammation and scarring as organ-specific effects.	"{""explanation"": ""The abstract lists urogenital inflammation and scarring as organ-specific effects."", ""reference"": ""PMID:24698483"", ""snippet"": ""urogenital inflammation and scarring"", ""supports"": ""SUPPORT""}"
7118	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:35390609	SUPPORT		Striatal dopamine dysregulation follows, causing abnormal salience and resultant psychotic symptoms.	This 2022 review describes how dopamine dysregulation in the striatum creates abnormal salience attribution which directly results in the psychotic symptoms characteristic of schizophrenia.	"{""explanation"": ""This 2022 review describes how dopamine dysregulation in the striatum creates abnormal salience attribution which directly results in the psychotic symptoms characteristic of schizophrenia."", ""reference"": ""PMID:35390609"", ""snippet"": ""Striatal dopamine dysregulation follows, causing abnormal salience and resultant psychotic symptoms."", ""supports"": ""SUPPORT""}"
7119	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	evidence	0	PMID:27206569	PARTIAL		Findings have converged to suggest early dysregulation in the striatum, especially in the rostral caudate, manifesting as excess synthesis and release. Recent data showed deficit extending to most cortical regions and even to other extrastriatal subcortical regions not previously considered to be 'hypodopaminergic' in schizophrenia.	While the literature supports dopamine dysregulation in various brain regions, it does not specifically emphasize the mesolimbic and mesocortical pathways alone.	"{""explanation"": ""While the literature supports dopamine dysregulation in various brain regions, it does not specifically emphasize the mesolimbic and mesocortical pathways alone."", ""reference"": ""PMID:27206569"", ""snippet"": ""Findings have converged to suggest early dysregulation in the striatum, especially in the rostral caudate, manifesting as excess synthesis and release. Recent data showed deficit extending to most cortical regions and even to other extrastriatal subcortical regions not previously considered to be 'hypodopaminergic' in schizophrenia."", ""supports"": ""PARTIAL""}"
7120	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	evidence	1	PMID:24986384	NO_EVIDENCE		A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic).	The abstract does not provide specific information supporting the imbalance of dopamine transmission specifically in the mesolimbic and mesocortical pathways as described in the statement.	"{""explanation"": ""The abstract does not provide specific information supporting the imbalance of dopamine transmission specifically in the mesolimbic and mesocortical pathways as described in the statement."", ""reference"": ""PMID:24986384"", ""snippet"": ""A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)."", ""supports"": ""NO_EVIDENCE""}"
7121	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	evidence	2	PMID:1981107	NO_EVIDENCE		This article discusses the possibility that a deficient activity within the cortico-striatal glutamatergic pathway is an important pathophysiological component in some cases of schizophrenia and that glutamatergic agonists may prove beneficial in this disorder.	The study focuses on glutamate dysregulation rather than dopamine transmission dysregulation in mesolimbic and mesocortical pathways.	"{""explanation"": ""The study focuses on glutamate dysregulation rather than dopamine transmission dysregulation in mesolimbic and mesocortical pathways."", ""reference"": ""PMID:1981107"", ""snippet"": ""This article discusses the possibility that a deficient activity within the cortico-striatal glutamatergic pathway is an important pathophysiological component in some cases of schizophrenia and that glutamatergic agonists may prove beneficial in this disorder."", ""supports"": ""NO_EVIDENCE""}"
7122	6927	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	0	evidence	3	PMID:24128684	PARTIAL		This clinical picture is generally associated with supersensitivity to dopamine, and activates dopamine neurotransmission that is usually alleviated or blocked by drugs that block dopamine D2 receptors.	There is an implication of dopamine dysregulation, but the specifics of mesolimbic and mesocortical pathways are not confirmed.	"{""explanation"": ""There is an implication of dopamine dysregulation, but the specifics of mesolimbic and mesocortical pathways are not confirmed."", ""reference"": ""PMID:24128684"", ""snippet"": ""This clinical picture is generally associated with supersensitivity to dopamine, and activates dopamine neurotransmission that is usually alleviated or blocked by drugs that block dopamine D2 receptors."", ""supports"": ""PARTIAL""}"
7123	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	evidence	0	PMID:11532718	SUPPORT		Research has implicated dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia.	The literature specifically states that glutamatergic neurotransmission dysfunction is associated with the pathophysiology of schizophrenia, supporting the provided statement.	"{""explanation"": ""The literature specifically states that glutamatergic neurotransmission dysfunction is associated with the pathophysiology of schizophrenia, supporting the provided statement."", ""reference"": ""PMID:11532718"", ""snippet"": ""Research has implicated dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia."", ""supports"": ""SUPPORT""}"
7124	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	evidence	1	PMID:28754595	SUPPORT		Accumulating evidence suggests that synaptic plasticity is impaired in schizophrenia. Given the role of synaptic plasticity in learning, memory, and neural circuit maturation, impaired plasticity may underlie many features of the schizophrenia syndrome.	The literature discusses the impairment of synaptic plasticity in schizophrenia and its interaction with brain maturation, aligning with the statement.	"{""explanation"": ""The literature discusses the impairment of synaptic plasticity in schizophrenia and its interaction with brain maturation, aligning with the statement."", ""reference"": ""PMID:28754595"", ""snippet"": ""Accumulating evidence suggests that synaptic plasticity is impaired in schizophrenia. Given the role of synaptic plasticity in learning, memory, and neural circuit maturation, impaired plasticity may underlie many features of the schizophrenia syndrome."", ""supports"": ""SUPPORT""}"
7125	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	evidence	2	PMID:29954475	SUPPORT		Psychosis is now widely hypothesized to involve neural networks beyond the classical dopaminergic mesolimbic pathway, including serotonin and glutamate systems as well.	This reference supports the involvement of glutamatergic systems in schizophrenia, reinforcing the statement.	"{""explanation"": ""This reference supports the involvement of glutamatergic systems in schizophrenia, reinforcing the statement."", ""reference"": ""PMID:29954475"", ""snippet"": ""Psychosis is now widely hypothesized to involve neural networks beyond the classical dopaminergic mesolimbic pathway, including serotonin and glutamate systems as well."", ""supports"": ""SUPPORT""}"
7126	6928	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	1	evidence	3	PMID:22351070	SUPPORT		Schizophrenia is believed to result from problems during neural development that lead to improper function of synaptic transmission and plasticity, and in agreement, many of the susceptibility genes encode proteins critical for neural development.	The literature supports the idea that schizophrenia impacts synaptic transmission and plasticity, specifically implicating glutamatergic, GABAergic, dopaminergic, and cholinergic synapses.	"{""explanation"": ""The literature supports the idea that schizophrenia impacts synaptic transmission and plasticity, specifically implicating glutamatergic, GABAergic, dopaminergic, and cholinergic synapses."", ""reference"": ""PMID:22351070"", ""snippet"": ""Schizophrenia is believed to result from problems during neural development that lead to improper function of synaptic transmission and plasticity, and in agreement, many of the susceptibility genes encode proteins critical for neural development."", ""supports"": ""SUPPORT""}"
7127	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	evidence	0	PMID:10372507	SUPPORT		At the cellular level, gamma-aminobutyric acid (GABA)-ergic interneurons are a common feature in psychotic states... and are themselves synchronised by the ascending dopamine and serotonin innervations.	The literature highlights that GABAergic interneurons play a significant role in the cellular characteristics found in psychotic states, including schizophrenia.	"{""explanation"": ""The literature highlights that GABAergic interneurons play a significant role in the cellular characteristics found in psychotic states, including schizophrenia."", ""reference"": ""PMID:10372507"", ""snippet"": ""At the cellular level, gamma-aminobutyric acid (GABA)-ergic interneurons are a common feature in psychotic states... and are themselves synchronised by the ascending dopamine and serotonin innervations."", ""supports"": ""SUPPORT""}"
7128	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	evidence	1	PMID:22308256	SUPPORT		Disturbances in glutamate and GABAergic neurotransmission may underlie the pathophysiology of schizophrenia.	This reference directly states that disturbances in GABAergic neurotransmission may underlie the pathophysiology of schizophrenia.	"{""explanation"": ""This reference directly states that disturbances in GABAergic neurotransmission may underlie the pathophysiology of schizophrenia."", ""reference"": ""PMID:22308256"", ""snippet"": ""Disturbances in glutamate and GABAergic neurotransmission may underlie the pathophysiology of schizophrenia."", ""supports"": ""SUPPORT""}"
7129	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	evidence	2	PMID:34584230	SUPPORT		Reduced GABA levels indicate that the disruption of excitatory/inhibitory balance may be related to the pathophysiology of schizophrenia-spectrum disorders.	This meta-analysis supports the idea that reduced GABA levels and thus GABAergic dysfunction are related to the pathophysiology of schizophrenia.	"{""explanation"": ""This meta-analysis supports the idea that reduced GABA levels and thus GABAergic dysfunction are related to the pathophysiology of schizophrenia."", ""reference"": ""PMID:34584230"", ""snippet"": ""Reduced GABA levels indicate that the disruption of excitatory/inhibitory balance may be related to the pathophysiology of schizophrenia-spectrum disorders."", ""supports"": ""SUPPORT""}"
7130	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	evidence	3	PMID:25432637	SUPPORT		Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. GABAergic receptor abnormalities have been documented in several major psychiatric disorders including schizophrenia.	The abnormalities in GABAergic receptors in schizophrenia support the idea of GABAergic signaling abnormalities being part of the disorder’s pathophysiology.	"{""explanation"": ""The abnormalities in GABAergic receptors in schizophrenia support the idea of GABAergic signaling abnormalities being part of the disorder’s pathophysiology."", ""reference"": ""PMID:25432637"", ""snippet"": ""Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. GABAergic receptor abnormalities have been documented in several major psychiatric disorders including schizophrenia."", ""supports"": ""SUPPORT""}"
7131	6929	297	Schizophrenia	Schizophrenia.yaml	pathophysiology	2	evidence	4	PMID:22351070	SUPPORT		Here, we will review evidence for altered neurotransmission at ... GABAergic ... synapses in schizophrenia...	This article reviews evidence for altered GABAergic neurotransmission in schizophrenia, supporting the stated claim.	"{""explanation"": ""This article reviews evidence for altered GABAergic neurotransmission in schizophrenia, supporting the stated claim."", ""reference"": ""PMID:22351070"", ""snippet"": ""Here, we will review evidence for altered neurotransmission at ... GABAergic ... synapses in schizophrenia..."", ""supports"": ""SUPPORT""}"
7214	6962	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:16638549	SUPPORT	HUMAN_CLINICAL	In this article, we review the historical aspects, presentation, and pathophysiology of Scimitar syndrome and discuss available treatment strategies.	Review covering the developmental pathophysiology underlying scimitar syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review covering the developmental pathophysiology underlying scimitar syndrome."", ""reference"": ""PMID:16638549"", ""snippet"": ""In this article, we review the historical aspects, presentation, and pathophysiology of Scimitar syndrome and discuss available treatment strategies."", ""supports"": ""SUPPORT""}"
7215	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:16638549	SUPPORT	HUMAN_CLINICAL	Scimitar syndrome is a rare congenital anomaly consisting in part of right pulmonary venous return to the inferior vena cava.	Review establishing the core anatomic defect of anomalous right pulmonary venous drainage to the IVC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review establishing the core anatomic defect of anomalous right pulmonary venous drainage to the IVC."", ""reference"": ""PMID:16638549"", ""snippet"": ""Scimitar syndrome is a rare congenital anomaly consisting in part of right pulmonary venous return to the inferior vena cava."", ""supports"": ""SUPPORT""}"
7216	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:38634941	SUPPORT	HUMAN_CLINICAL	Scimitar Syndrome is part of a complex spectrum of congenital cardiovascular anomalies related to anomalous pulmonary venous return.	Colombian tertiary-center series confirming scimitar syndrome as a complex spectrum of anomalous pulmonary venous return anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Colombian tertiary-center series confirming scimitar syndrome as a complex spectrum of anomalous pulmonary venous return anomalies."", ""reference"": ""PMID:38634941"", ""snippet"": ""Scimitar Syndrome is part of a complex spectrum of congenital cardiovascular anomalies related to anomalous pulmonary venous return."", ""supports"": ""SUPPORT""}"
7217	6963	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:40110298	SUPPORT	HUMAN_CLINICAL	a unique vessel, identified as the Scimitar vein, was found draining into the left portal vein.	Rare variant with scimitar vein draining into the portal vein rather than the IVC, causing portal hypertension and esophageal varices in a child.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Rare variant with scimitar vein draining into the portal vein rather than the IVC, causing portal hypertension and esophageal varices in a child."", ""reference"": ""PMID:40110298"", ""snippet"": ""a unique vessel, identified as the Scimitar vein, was found draining into the left portal vein."", ""supports"": ""SUPPORT""}"
7218	6964	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:34396590	SUPPORT	HUMAN_CLINICAL	Associated cardiac and extracardiac defects, particularly hypoplasia of the right lung, are present in up to three-quarters of cases.	Review of 92 published investigations confirming right lung hypoplasia is present in up to 75% of scimitar syndrome cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review of 92 published investigations confirming right lung hypoplasia is present in up to 75% of scimitar syndrome cases."", ""reference"": ""PMID:34396590"", ""snippet"": ""Associated cardiac and extracardiac defects, particularly hypoplasia of the right lung, are present in up to three-quarters of cases."", ""supports"": ""SUPPORT""}"
7219	6964	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:38634941	SUPPORT	HUMAN_CLINICAL	six (54.55%) cardiac dextroposition, six (54.55%) pulmonary hypoplasia, five (45.45%) right pulmonary artery hypoplasia	Tertiary center series quantifying the frequency of pulmonary hypoplasia (55%), dextroposition (55%), and right pulmonary artery hypoplasia (45%) in scimitar syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series quantifying the frequency of pulmonary hypoplasia (55%), dextroposition (55%), and right pulmonary artery hypoplasia (45%) in scimitar syndrome."", ""reference"": ""PMID:38634941"", ""snippet"": ""six (54.55%) cardiac dextroposition, six (54.55%) pulmonary hypoplasia, five (45.45%) right pulmonary artery hypoplasia"", ""supports"": ""SUPPORT""}"
7220	6965	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:38634941	SUPPORT	HUMAN_CLINICAL	three (27.27%) had aortopulmonary collaterals. Four (36.36%) patients had horseshoe lungs, and four (36.36%) had bronchopulmonary sequestration.	Tertiary center series documenting the frequency of aortopulmonary collaterals (27%) and bronchopulmonary sequestration (36%) as associated anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting the frequency of aortopulmonary collaterals (27%) and bronchopulmonary sequestration (36%) as associated anomalies."", ""reference"": ""PMID:38634941"", ""snippet"": ""three (27.27%) had aortopulmonary collaterals. Four (36.36%) patients had horseshoe lungs, and four (36.36%) had bronchopulmonary sequestration."", ""supports"": ""SUPPORT""}"
7221	6965	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:29054305	SUPPORT	HUMAN_CLINICAL	Noninfants exhibited lower incidences of right pulmonary artery hypoplasia (p < 0.001), aortopulmonary collaterals (p = 0.004)	Large cohort showing aortopulmonary collaterals are significantly more common in infantile than non-infantile forms.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large cohort showing aortopulmonary collaterals are significantly more common in infantile than non-infantile forms."", ""reference"": ""PMID:29054305"", ""snippet"": ""Noninfants exhibited lower incidences of right pulmonary artery hypoplasia (p < 0.001), aortopulmonary collaterals (p = 0.004)"", ""supports"": ""SUPPORT""}"
7222	6966	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	4	evidence	0	PMID:35804238	SUPPORT	HUMAN_CLINICAL	PH, CHD, neonatal SS diagnosis, ECMO support, and markedly elevated scimitar vein pressure are associated with mortality.	Three-decade single-center study of 84 patients identifying pulmonary hypertension as a major mortality risk factor.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Three-decade single-center study of 84 patients identifying pulmonary hypertension as a major mortality risk factor."", ""reference"": ""PMID:35804238"", ""snippet"": ""PH, CHD, neonatal SS diagnosis, ECMO support, and markedly elevated scimitar vein pressure are associated with mortality."", ""supports"": ""SUPPORT""}"
7223	6966	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	4	evidence	1	PMID:36093138	SUPPORT	HUMAN_CLINICAL	High-risk factors of death included age at diagnosis (p = 0.000), PH (p = 0.007) and PVS (p = 0.014).	Retrospective analysis of 34 patients confirming pulmonary hypertension and pulmonary vein stenosis as independent risk factors for mortality.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Retrospective analysis of 34 patients confirming pulmonary hypertension and pulmonary vein stenosis as independent risk factors for mortality."", ""reference"": ""PMID:36093138"", ""snippet"": ""High-risk factors of death included age at diagnosis (p = 0.000), PH (p = 0.007) and PVS (p = 0.014)."", ""supports"": ""SUPPORT""}"
7224	6967	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	5	evidence	0	PMID:38634941	SUPPORT	HUMAN_CLINICAL	two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot.	Tertiary center series documenting ASD in 18% of scimitar syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting ASD in 18% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}"
7225	6967	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	5	evidence	1	PMID:29054305	SUPPORT	HUMAN_CLINICAL	Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)	Columbia cohort showing 43% of patients had significant associated cardiac defects, with ASD being among the most common.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Columbia cohort showing 43% of patients had significant associated cardiac defects, with ASD being among the most common."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}"
7226	6968	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	6	evidence	0	PMID:38634941	SUPPORT	HUMAN_CLINICAL	two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot.	Tertiary center series documenting VSD in 27% of scimitar syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting VSD in 27% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}"
7227	6969	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	7	evidence	0	PMID:29054305	SUPPORT	HUMAN_CLINICAL	Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)	Columbia cohort documenting the spectrum of associated cardiac defects including great vessel anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Columbia cohort documenting the spectrum of associated cardiac defects including great vessel anomalies."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}"
7228	6970	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	8	evidence	0	PMID:29054305	SUPPORT	HUMAN_CLINICAL	Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)	Cohort showing 15% of scimitar syndrome patients had single ventricle physiology, the most severe end of associated cardiac anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort showing 15% of scimitar syndrome patients had single ventricle physiology, the most severe end of associated cardiac anomalies."", ""reference"": ""PMID:29054305"", ""snippet"": ""Forty-seven patients were identified, including 20 infants with significant associated congenital heart defects (42.6%, including 7 with single ventricle physiology)"", ""supports"": ""SUPPORT""}"
7229	6970	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	8	evidence	1	PMID:38634941	SUPPORT	HUMAN_CLINICAL	two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot.	Tertiary center series documenting Tetralogy of Fallot in 9% of scimitar syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting Tetralogy of Fallot in 9% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""two (18.18%) patients were found to have an atrial septal defect, three (27.27%) ventricular septal defect, and one (9%) had Tetralogy of Fallot."", ""supports"": ""SUPPORT""}"
7230	6970	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	pathophysiology	8	evidence	2	PMID:41625720	SUPPORT	HUMAN_CLINICAL	The cardiac anomalies included right atrial isomerism, persistent left superior vena cava, unbalanced complete atrioventricular (AV) atrial septal defect with atresia of the left component of the AV valve and a hypoplastic left ventricle, double outlet right ventricle, malposition of the great arteries, and anomalous origin of left pulmonary artery (AOLPA) from the perihilar portion of the right pulmonary artery.	First reported case of left-sided scimitar with horseshoe lung and complex CHD including heterotaxy, single ventricle, and DORV, demonstrating the extreme end of the spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""First reported case of left-sided scimitar with horseshoe lung and complex CHD including heterotaxy, single ventricle, and DORV, demonstrating the extreme end of the spectrum."", ""reference"": ""PMID:41625720"", ""snippet"": ""The cardiac anomalies included right atrial isomerism, persistent left superior vena cava, unbalanced complete atrioventricular (AV) atrial septal defect with atresia of the left component of the AV valve and a hypoplastic left ventricle, double outlet right ventricle, malposition of the great arteries, and anomalous origin of left pulmonary artery (AOLPA) from the perihilar portion of the right pulmonary artery."", ""supports"": ""SUPPORT""}"
7254	6984	299	Scurvy	Scurvy.yaml	pathophysiology	0	evidence	0	PMID:37366866	SUPPORT		It leads to a varied presentation, affecting multiple organ systems due to its role in the biochemical reactions of connective tissue synthesis.	This abstract confirms scurvy affects multiple organ systems through its role in connective tissue synthesis, supporting the collagen synthesis impairment mechanism.	"{""explanation"": ""This abstract confirms scurvy affects multiple organ systems through its role in connective tissue synthesis, supporting the collagen synthesis impairment mechanism."", ""reference"": ""PMID:37366866"", ""snippet"": ""It leads to a varied presentation, affecting multiple organ systems due to its role in the biochemical reactions of connective tissue synthesis."", ""supports"": ""SUPPORT""}"
7255	6985	299	Scurvy	Scurvy.yaml	pathophysiology	1	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	The manifestations of gingival bleeding, perifollicular hemorrhage, and ecchymoses are direct consequences of vascular fragility from defective collagen.	"{""explanation"": ""The manifestations of gingival bleeding, perifollicular hemorrhage, and ecchymoses are direct consequences of vascular fragility from defective collagen."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7266	6994	300	Secondary Hypertension	Secondary_Hypertension.yaml	pathophysiology	0	evidence	0	PMID:37115960	SUPPORT		A common theme across several contributors to SH are coactivation of the sympathetic drive and hormonal changes, independent of hormonal axis activation.	This review highlights sympathetic and hormonal coactivation as shared mechanisms.	"{""explanation"": ""This review highlights sympathetic and hormonal coactivation as shared mechanisms."", ""reference"": ""PMID:37115960"", ""snippet"": ""A common theme across several contributors to SH are coactivation of the sympathetic drive and hormonal changes, independent of hormonal axis activation."", ""supports"": ""SUPPORT""}"
7268	6996	301	Semantic Dementia	Semantic_Dementia.yaml	pathophysiology	0	evidence	0	PMID:41089414	SUPPORT		Semantic dementia (SD) is a progressive neurodegenerative disorder primarily characterized by core linguistic deficits, notably impaired confrontation naming and single-word comprehension.	The abstract identifies progressive neurodegeneration with semantic language deficits.	"{""explanation"": ""The abstract identifies progressive neurodegeneration with semantic language deficits."", ""reference"": ""PMID:41089414"", ""snippet"": ""Semantic dementia (SD) is a progressive neurodegenerative disorder primarily characterized by core linguistic deficits, notably impaired confrontation naming and single-word comprehension."", ""supports"": ""SUPPORT""}"
7269	6997	301	Semantic Dementia	Semantic_Dementia.yaml	pathophysiology	1	evidence	0	PMID:11287367	SUPPORT		Semantic dementia is a recently documented syndrome associated with non-Alzheimer degenerative pathology of the polar and inferolateral temporal neocortex, with relative sparing (at least in the early stages) of the hippocampal complex.	The abstract specifies the temporal neocortical pathology and relative hippocampal sparing.	"{""explanation"": ""The abstract specifies the temporal neocortical pathology and relative hippocampal sparing."", ""reference"": ""PMID:11287367"", ""snippet"": ""Semantic dementia is a recently documented syndrome associated with non-Alzheimer degenerative pathology of the polar and inferolateral temporal neocortex, with relative sparing (at least in the early stages) of the hippocampal complex."", ""supports"": ""SUPPORT""}"
7279	7006	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:22312921	SUPPORT		Histopathologic examination of the right ear showed a 1.4 x 0.6-mm dehiscence of bone covering the superior canal. Dura was in direct contact with the endosteum and the membranous duct at the level of the dehiscence.	Histopathological examination confirmed the anatomical basis of the dehiscence with direct dura-to-membranous duct contact at the bony defect.	"{""explanation"": ""Histopathological examination confirmed the anatomical basis of the dehiscence with direct dura-to-membranous duct contact at the bony defect."", ""reference"": ""PMID:22312921"", ""snippet"": ""Histopathologic examination of the right ear showed a 1.4 x 0.6-mm dehiscence of bone covering the superior canal. Dura was in direct contact with the endosteum and the membranous duct at the level of the dehiscence."", ""supports"": ""SUPPORT""}"
7280	7007	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:32982922	SUPPORT		If sufficiently large, a third window will introduce a low mechanical impedance, thus shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window.	This biomechanical review explains how the dehiscence creates abnormal fluid dynamics by introducing a low-impedance pathway.	"{""explanation"": ""This biomechanical review explains how the dehiscence creates abnormal fluid dynamics by introducing a low-impedance pathway."", ""reference"": ""PMID:32982922"", ""snippet"": ""If sufficiently large, a third window will introduce a low mechanical impedance, thus shunting part of the inner ear fluid pressure and fluid volume flow at the site of the window."", ""supports"": ""SUPPORT""}"
7281	7007	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:18223508	SUPPORT		A number of disparate disorders affecting the labyrinth can produce CHL by acting as a pathologic third window in the inner ear. The common denominator is that these conditions result in a mobile window on the scala vestibuli side of the cochlear partition.	This landmark paper establishes the third window mechanism as the cause of the conductive hearing loss pattern seen in SCDS.	"{""explanation"": ""This landmark paper establishes the third window mechanism as the cause of the conductive hearing loss pattern seen in SCDS."", ""reference"": ""PMID:18223508"", ""snippet"": ""A number of disparate disorders affecting the labyrinth can produce CHL by acting as a pathologic third window in the inner ear. The common denominator is that these conditions result in a mobile window on the scala vestibuli side of the cochlear partition."", ""supports"": ""SUPPORT""}"
7282	7008	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:32982922	SUPPORT		Third window syndrome describes a set of vestibular and auditory symptoms that arise when a pathological third mobile window is present in the bony labyrinth of the inner ear.	The biomechanics review explains how the third window allows sound and pressure to inappropriately stimulate vestibular structures.	"{""explanation"": ""The biomechanics review explains how the third window allows sound and pressure to inappropriately stimulate vestibular structures."", ""reference"": ""PMID:32982922"", ""snippet"": ""Third window syndrome describes a set of vestibular and auditory symptoms that arise when a pathological third mobile window is present in the bony labyrinth of the inner ear."", ""supports"": ""SUPPORT""}"
7283	7008	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:16222184	SUPPORT		For the 60 patients with vestibular manifestations, symptoms induced by loud sounds were noted in 54 patients and pressure-induced symptoms (coughing, sneezing, straining) were present in 44.	Clinical data from the original case series demonstrates the high frequency of sound- and pressure-induced symptoms in SCDS patients.	"{""explanation"": ""Clinical data from the original case series demonstrates the high frequency of sound- and pressure-induced symptoms in SCDS patients."", ""reference"": ""PMID:16222184"", ""snippet"": ""For the 60 patients with vestibular manifestations, symptoms induced by loud sounds were noted in 54 patients and pressure-induced symptoms (coughing, sneezing, straining) were present in 44."", ""supports"": ""SUPPORT""}"
7284	7009	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:22312921	SUPPORT		No osteoclastic process was evident within the otic capsule bone surrounding the dehiscence.	Histopathological examination showed absence of active bone resorption, supporting developmental thin-bone predisposition rather than active resorption.	"{""explanation"": ""Histopathological examination showed absence of active bone resorption, supporting developmental thin-bone predisposition rather than active resorption."", ""reference"": ""PMID:22312921"", ""snippet"": ""No osteoclastic process was evident within the otic capsule bone surrounding the dehiscence."", ""supports"": ""SUPPORT""}"
7312	7030	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	0	evidence	0	DOI:10.3390/ijms222413484	SUPPORT		AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins.	This establishes AGK's role in lipid signaling that is lost with AGK deficiency.	"{""explanation"": ""This establishes AGK's role in lipid signaling that is lost with AGK deficiency."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins."", ""supports"": ""SUPPORT""}"
7313	7031	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	1	evidence	0	DOI:10.3390/ijms222413484	SUPPORT		AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins.	This supports a TIM22 assembly defect at the mitochondrial inner membrane in AGK deficiency.	"{""explanation"": ""This supports a TIM22 assembly defect at the mitochondrial inner membrane in AGK deficiency."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins."", ""supports"": ""SUPPORT""}"
7314	7032	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	2	evidence	0	DOI:10.1091/mbc.e20-06-0390	SUPPORT		Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors.	This supports reduced import/abundance of inner-membrane carriers and sideroflexins in AGK deficiency.	"{""explanation"": ""This supports reduced import/abundance of inner-membrane carriers and sideroflexins in AGK deficiency."", ""reference"": ""DOI:10.1091/mbc.e20-06-0390"", ""snippet"": ""Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors."", ""supports"": ""SUPPORT""}"
7315	7033	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	3	evidence	0	DOI:10.1091/mbc.e20-06-0390	SUPPORT		Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors.	This links AGK/TIM22 dysfunction to loss of carrier and sideroflexin import with effects on one-carbon metabolism.	"{""explanation"": ""This links AGK/TIM22 dysfunction to loss of carrier and sideroflexin import with effects on one-carbon metabolism."", ""reference"": ""DOI:10.1091/mbc.e20-06-0390"", ""snippet"": ""Proteomic profiling of Sengers patient fibroblasts and AGK knockout models identifies remodeling of the mitochondrial proteome, including mitochondrial one-carbon metabolism enzymes, inner membrane serine transporters, sideroflexins, and Complex I subunits and assembly factors."", ""supports"": ""SUPPORT""}"
7316	7034	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	4	evidence	0	DOI:10.3390/ijms222413484	SUPPORT		AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome.	This statement links AGK mutations to altered phospholipid metabolism in Sengers syndrome.	"{""explanation"": ""This statement links AGK mutations to altered phospholipid metabolism in Sengers syndrome."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome."", ""supports"": ""SUPPORT""}"
7317	7035	303	Sengers syndrome	Sengers_syndrome.yaml	pathophysiology	5	evidence	0	DOI:10.3390/ijms222413484	SUPPORT		Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patient’s fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V.	This provides direct evidence of impaired oxidative phosphorylation and reduced complex I and V activity.	"{""explanation"": ""This provides direct evidence of impaired oxidative phosphorylation and reduced complex I and V activity."", ""reference"": ""DOI:10.3390/ijms222413484"", ""snippet"": ""Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patient’s fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V."", ""supports"": ""SUPPORT""}"
7364	7069	304	Shigellosis	Shigellosis.yaml	pathophysiology	0	evidence	0	PMID:40915309	SUPPORT		Humans are the only natural reservoir and an inoculum of only 10-100 organisms is required for infection	Highlights the extraordinary efficiency of Shigella invasion, demonstrating that the T3SS-mediated invasion mechanism is highly optimized for intracellular entry	"{""explanation"": ""Highlights the extraordinary efficiency of Shigella invasion, demonstrating that the T3SS-mediated invasion mechanism is highly optimized for intracellular entry"", ""reference"": ""PMID:40915309"", ""snippet"": ""Humans are the only natural reservoir and an inoculum of only 10-100 organisms is required for infection"", ""supports"": ""SUPPORT""}"
7365	7070	304	Shigellosis	Shigellosis.yaml	pathophysiology	1	evidence	0	PMID:37952487	SUPPORT		destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain	Describes the characteristic tissue damage phenotype resulting from Shigella's actin-based cell-to-cell spread and mucosal invasion	"{""explanation"": ""Describes the characteristic tissue damage phenotype resulting from Shigella's actin-based cell-to-cell spread and mucosal invasion"", ""reference"": ""PMID:37952487"", ""snippet"": ""destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain"", ""supports"": ""SUPPORT""}"
7366	7071	304	Shigellosis	Shigellosis.yaml	pathophysiology	2	evidence	0	PMID:29493962	SUPPORT		In the colon, they secrete virulence factors that cause severe inflammation and mediate enterotoxic effects, enabling colonization and invasion of the colonic epithelium	Establishes inflammasome-mediated pyroptosis and cytokine release as central to Shigella pathogenesis	"{""explanation"": ""Establishes inflammasome-mediated pyroptosis and cytokine release as central to Shigella pathogenesis"", ""reference"": ""PMID:29493962"", ""snippet"": ""In the colon, they secrete virulence factors that cause severe inflammation and mediate enterotoxic effects, enabling colonization and invasion of the colonic epithelium"", ""supports"": ""SUPPORT""}"
7367	7072	304	Shigellosis	Shigellosis.yaml	pathophysiology	3	evidence	0	PMID:29493962	SUPPORT		Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms	Enterotoxins and Shiga toxins are key virulence factors causing epithelial damage and systemic complications	"{""explanation"": ""Enterotoxins and Shiga toxins are key virulence factors causing epithelial damage and systemic complications"", ""reference"": ""PMID:29493962"", ""snippet"": ""Shigella produces 3 enterotoxins that cause watery or bloody diarrhea and infection-associated symptoms"", ""supports"": ""SUPPORT""}"
7368	7073	304	Shigellosis	Shigellosis.yaml	pathophysiology	4	evidence	0	PMID:37952487	SUPPORT		a severe enteric disease characterized by destruction and inflammation of the colonic epithelium	Epithelial destruction is the hallmark of Shigella pathogenesis, directly causing barrier dysfunction	"{""explanation"": ""Epithelial destruction is the hallmark of Shigella pathogenesis, directly causing barrier dysfunction"", ""reference"": ""PMID:37952487"", ""snippet"": ""a severe enteric disease characterized by destruction and inflammation of the colonic epithelium"", ""supports"": ""SUPPORT""}"
7385	7095	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	0	evidence	0	PMID:29614632	SUPPORT		Due to the unique dependence of Hb S polymerization on cellular Hb S concentration, cell dehydration promotes polymerization and sickling.	HbS polymerization is concentration-dependent and leads to sickling.	"{""explanation"": ""HbS polymerization is concentration-dependent and leads to sickling."", ""reference"": ""PMID:29614632"", ""snippet"": ""Due to the unique dependence of Hb S polymerization on cellular Hb S concentration, cell dehydration promotes polymerization and sickling."", ""supports"": ""SUPPORT""}"
7386	7095	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	0	evidence	1	PMID:3965046	SUPPORT		Our results support the hypothesis that the intracellular polymerization of HbS is the primary determinant of the severity of both anemia and clinical symptomatology in the sickle hemoglobinopathies.	Establishes HbS polymerization as the primary determinant of clinical severity in sickling syndromes.	"{""explanation"": ""Establishes HbS polymerization as the primary determinant of clinical severity in sickling syndromes."", ""reference"": ""PMID:3965046"", ""snippet"": ""Our results support the hypothesis that the intracellular polymerization of HbS is the primary determinant of the severity of both anemia and clinical symptomatology in the sickle hemoglobinopathies."", ""supports"": ""SUPPORT""}"
7387	7096	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	1	evidence	0	PMID:29614632	SUPPORT		In double heterozygosis for Hb S and C (SC disease) dehydration is the determining factor in disease pathophysiology.	Cell dehydration promotes sickling and fragility of red blood cells.	"{""explanation"": ""Cell dehydration promotes sickling and fragility of red blood cells."", ""reference"": ""PMID:29614632"", ""snippet"": ""In double heterozygosis for Hb S and C (SC disease) dehydration is the determining factor in disease pathophysiology."", ""supports"": ""SUPPORT""}"
7388	7097	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	2	evidence	0	PMID:24277079	SUPPORT		intravascular hemolysis in SCD releases heme that activates endothelial TLR4 signaling leading to WPB degranulation, NF-κB activation, and vaso-occlusion.	Heme released from hemolysis triggers TLR4 signaling on endothelial cells, leading to Weibel-Palade body degranulation and release of P-selectin and von Willebrand factor, which promote adhesion and vaso-occlusion.	"{""explanation"": ""Heme released from hemolysis triggers TLR4 signaling on endothelial cells, leading to Weibel-Palade body degranulation and release of P-selectin and von Willebrand factor, which promote adhesion and vaso-occlusion."", ""reference"": ""PMID:24277079"", ""snippet"": ""intravascular hemolysis in SCD releases heme that activates endothelial TLR4 signaling leading to WPB degranulation, NF-κB activation, and vaso-occlusion."", ""supports"": ""SUPPORT""}"
7389	7098	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	3	evidence	0	PMID:15998894	SUPPORT		hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide.	Hemolysis releases both arginase (which depletes L-arginine, the substrate for nitric oxide synthesis) and free hemoglobin (which directly scavenges nitric oxide), leading to endothelial dysfunction and pulmonary hypertension.	"{""explanation"": ""Hemolysis releases both arginase (which depletes L-arginine, the substrate for nitric oxide synthesis) and free hemoglobin (which directly scavenges nitric oxide), leading to endothelial dysfunction and pulmonary hypertension."", ""reference"": ""PMID:15998894"", ""snippet"": ""hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide."", ""supports"": ""SUPPORT""}"
7390	7098	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	pathophysiology	3	evidence	1	PMID:15998894	SUPPORT		The ratios of arginine to ornithine and arginine to ornithine plus citrulline are independently associated with pulmonary hypertension and increased mortality in patients with sickle cell disease.	Low arginine bioavailability due to increased arginase activity is directly associated with pulmonary hypertension severity and mortality risk in SCD patients.	"{""explanation"": ""Low arginine bioavailability due to increased arginase activity is directly associated with pulmonary hypertension severity and mortality risk in SCD patients."", ""reference"": ""PMID:15998894"", ""snippet"": ""The ratios of arginine to ornithine and arginine to ornithine plus citrulline are independently associated with pulmonary hypertension and increased mortality in patients with sickle cell disease."", ""supports"": ""SUPPORT""}"
7400	7119	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:23946747	SUPPORT		Obstruction of the maxillary ostium appears to play a critical role in the development of SSS.	The reference explicitly states that ostium obstruction plays a critical role in SSS development.	"{""explanation"": ""The reference explicitly states that ostium obstruction plays a critical role in SSS development."", ""reference"": ""PMID:23946747"", ""snippet"": ""Obstruction of the maxillary ostium appears to play a critical role in the development of SSS."", ""supports"": ""SUPPORT""}"
7401	7120	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:23946747	SUPPORT		The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos, which is the result of chronic maxillary sinus atelectasis.	This reference directly states that SSS is the result of chronic maxillary sinus atelectasis, confirming the pathophysiological mechanism.	"{""explanation"": ""This reference directly states that SSS is the result of chronic maxillary sinus atelectasis, confirming the pathophysiological mechanism."", ""reference"": ""PMID:23946747"", ""snippet"": ""The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos, which is the result of chronic maxillary sinus atelectasis."", ""supports"": ""SUPPORT""}"
7402	7120	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:11404606	SUPPORT		progressive enophthalmos secondary to maxillary collapse resulting from maxillary sinus hypoventilation	This reference describes the progressive collapse mechanism due to sinus hypoventilation.	"{""explanation"": ""This reference describes the progressive collapse mechanism due to sinus hypoventilation."", ""reference"": ""PMID:11404606"", ""snippet"": ""progressive enophthalmos secondary to maxillary collapse resulting from maxillary sinus hypoventilation"", ""supports"": ""SUPPORT""}"
7403	7121	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:8152774	SUPPORT		characterized by bone resorption and remodeling of the orbital floor due to otherwise asymptomatic maxillary sinus disease	The original description of SSS confirms bone resorption and remodeling of the orbital floor as a key mechanism.	"{""explanation"": ""The original description of SSS confirms bone resorption and remodeling of the orbital floor as a key mechanism."", ""reference"": ""PMID:8152774"", ""snippet"": ""characterized by bone resorption and remodeling of the orbital floor due to otherwise asymptomatic maxillary sinus disease"", ""supports"": ""SUPPORT""}"
7404	7121	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:11404606	SUPPORT		opacified, partially collapsed maxillary sinuses with osteopenia of the sinus walls and orbital floor displacement resulting in enophthalmos	This case series confirms osteopenia and orbital floor displacement secondary to maxillary sinus collapse.	"{""explanation"": ""This case series confirms osteopenia and orbital floor displacement secondary to maxillary sinus collapse."", ""reference"": ""PMID:11404606"", ""snippet"": ""opacified, partially collapsed maxillary sinuses with osteopenia of the sinus walls and orbital floor displacement resulting in enophthalmos"", ""supports"": ""SUPPORT""}"
7414	7138	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:33911236	SUPPORT		The ductal cells of the salivary gland in pSS are characteristically surrounded by a CD4+ T cell-rich and B cell-rich infiltrate, implying a degree of communication between epithelial cells and immune cells.	Demonstrates the characteristic lymphocytic infiltration pattern in salivary glands with both CD4+ T cells and B cells surrounding ductal epithelium.	"{""explanation"": ""Demonstrates the characteristic lymphocytic infiltration pattern in salivary glands with both CD4+ T cells and B cells surrounding ductal epithelium."", ""reference"": ""PMID:33911236"", ""snippet"": ""The ductal cells of the salivary gland in pSS are characteristically surrounded by a CD4+ T cell-rich and B cell-rich infiltrate, implying a degree of communication between epithelial cells and immune cells."", ""supports"": ""SUPPORT""}"
7415	7139	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:38542233	SUPPORT		Primary Sjögren's disease is primarily driven by B-cell activation and is associated with a high risk of developing non-Hodgkin's lymphoma (NHL).	Highlights the central role of B-cell activation in primary Sjögren's disease, which drives autoantibody production including anti-Ro/SSA and anti-La/SSB antibodies.	"{""explanation"": ""Highlights the central role of B-cell activation in primary Sjögren's disease, which drives autoantibody production including anti-Ro/SSA and anti-La/SSB antibodies."", ""reference"": ""PMID:38542233"", ""snippet"": ""Primary Sjögren's disease is primarily driven by B-cell activation and is associated with a high risk of developing non-Hodgkin's lymphoma (NHL)."", ""supports"": ""SUPPORT""}"
7416	7140	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:33911236	SUPPORT		Multiple innate immune pathways are likely dysregulated in the salivary gland epithelium in pSS, including the nuclear factor-κB pathway, the inflammasome and interferon signalling.	Confirms that interferon signaling is a key dysregulated pathway in the salivary gland epithelium, contributing to the type I interferon signature observed in Sjögren's syndrome.	"{""explanation"": ""Confirms that interferon signaling is a key dysregulated pathway in the salivary gland epithelium, contributing to the type I interferon signature observed in Sjögren's syndrome."", ""reference"": ""PMID:33911236"", ""snippet"": ""Multiple innate immune pathways are likely dysregulated in the salivary gland epithelium in pSS, including the nuclear factor-κB pathway, the inflammasome and interferon signalling."", ""supports"": ""SUPPORT""}"
7417	7140	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:38982205	SUPPORT		Several randomized controlled trials have just been completed or are poised to commence evaluating the effectiveness of novel drugs targeting both innate and adaptive immune pathways, including pro-inflammatory cytokines, the type I interferon system, B cell activation, B cell and T cell co-stimulation pathway, and ectopic germinal centre formation.	Highlights type I interferon system as a major therapeutic target in Sjögren's syndrome, underscoring its central pathogenic role.	"{""explanation"": ""Highlights type I interferon system as a major therapeutic target in Sjögren's syndrome, underscoring its central pathogenic role."", ""reference"": ""PMID:38982205"", ""snippet"": ""Several randomized controlled trials have just been completed or are poised to commence evaluating the effectiveness of novel drugs targeting both innate and adaptive immune pathways, including pro-inflammatory cytokines, the type I interferon system, B cell activation, B cell and T cell co-stimulation pathway, and ectopic germinal centre formation."", ""supports"": ""SUPPORT""}"
7418	7141	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	3	evidence	0	PMID:33911236	SUPPORT		B cell infiltrates within the ducts can initiate the development of lymphoepithelial lesions, including basal ductal cell hyperplasia. Vice versa, the epithelium provides chronic activation signals to the glandular B cell fraction.	Demonstrates that epithelial cells actively participate in disease pathogenesis by providing chronic activation signals to immune cells, not merely serving as passive targets.	"{""explanation"": ""Demonstrates that epithelial cells actively participate in disease pathogenesis by providing chronic activation signals to immune cells, not merely serving as passive targets."", ""reference"": ""PMID:33911236"", ""snippet"": ""B cell infiltrates within the ducts can initiate the development of lymphoepithelial lesions, including basal ductal cell hyperplasia. Vice versa, the epithelium provides chronic activation signals to the glandular B cell fraction."", ""supports"": ""SUPPORT""}"
7419	7141	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	pathophysiology	3	evidence	1	PMID:38982205	SUPPORT		Sjögren syndrome or Sjögren disease is a chronic form of autoimmune epithelitis characterized by lymphocytic infiltration of the exocrine glands, particularly the salivary and lacrimal glands, leading to progressive glandular dysfunction and subsequent xerostomia and xerophthalmia.	Defines the disease as an autoimmune epithelitis, emphasizing the central role of epithelial cell dysfunction in disease pathology and clinical manifestations.	"{""explanation"": ""Defines the disease as an autoimmune epithelitis, emphasizing the central role of epithelial cell dysfunction in disease pathology and clinical manifestations."", ""reference"": ""PMID:38982205"", ""snippet"": ""Sjögren syndrome or Sjögren disease is a chronic form of autoimmune epithelitis characterized by lymphocytic infiltration of the exocrine glands, particularly the salivary and lacrimal glands, leading to progressive glandular dysfunction and subsequent xerostomia and xerophthalmia."", ""supports"": ""SUPPORT""}"
7425	7163	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	0	evidence	0	PMID:36399634	SUPPORT		"The canonical model of ""small cell lung cancer"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."	Abstract states the canonical model involves TP53 and RB1 inactivation.	"{""explanation"": ""Abstract states the canonical model involves TP53 and RB1 inactivation."", ""reference"": ""PMID:36399634"", ""snippet"": ""The canonical model of \""small cell lung cancer\"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."", ""supports"": ""SUPPORT""}"
7426	7164	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	1	evidence	0	PMID:36399634	SUPPORT		"The canonical model of ""small cell lung cancer"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."	Abstract states the canonical model involves TP53 and RB1 inactivation.	"{""explanation"": ""Abstract states the canonical model involves TP53 and RB1 inactivation."", ""reference"": ""PMID:36399634"", ""snippet"": ""The canonical model of \""small cell lung cancer\"" (SCLC) depicts tumors arising from dual inactivation of TP53 and RB1."", ""supports"": ""SUPPORT""}"
7427	7168	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	5	evidence	0	PMID:40931078	SUPPORT		Here we show that SCLC cells can form functional synapses and receive synaptic transmission.	Abstract reports functional synapses and synaptic transmission between neurons and SCLC cells.	"{""explanation"": ""Abstract reports functional synapses and synaptic transmission between neurons and SCLC cells."", ""reference"": ""PMID:40931078"", ""snippet"": ""Here we show that SCLC cells can form functional synapses and receive synaptic transmission."", ""supports"": ""SUPPORT""}"
7428	7169	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	6	evidence	0	PMID:40931078	SUPPORT		we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons.	Abstract reports neuron co-culture provides a proliferation advantage to SCLC cells.	"{""explanation"": ""Abstract reports neuron co-culture provides a proliferation advantage to SCLC cells."", ""reference"": ""PMID:40931078"", ""snippet"": ""we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons."", ""supports"": ""SUPPORT""}"
7429	7170	308	Small Cell Lung Cancer	Small_Cell_Lung_Cancer.yaml	pathophysiology	7	evidence	0	PMID:40931078	SUPPORT		Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC.	Abstract reports therapeutic efficacy of glutamate signaling inhibition in an SCLC mouse model.	"{""explanation"": ""Abstract reports therapeutic efficacy of glutamate signaling inhibition in an SCLC mouse model."", ""reference"": ""PMID:40931078"", ""snippet"": ""Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC."", ""supports"": ""SUPPORT""}"
7430	7182	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	pathophysiology	0	evidence	0	PMID:38798120	SUPPORT		Small intestinal bacterial overgrowth (SIBO) has been recognized for over a century in patients with predisposing conditions causing intestinal stasis, such as surgical alteration of the small bowel or chronic diseases	ESNM/ANMS practice update confirms SIBO is well-established in stasis conditions.	"{""explanation"": ""ESNM/ANMS practice update confirms SIBO is well-established in stasis conditions."", ""reference"": ""PMID:38798120"", ""snippet"": ""Small intestinal bacterial overgrowth (SIBO) has been recognized for over a century in patients with predisposing conditions causing intestinal stasis, such as surgical alteration of the small bowel or chronic diseases"", ""supports"": ""SUPPORT""}"
7432	7191	310	Snakebite envenoming	Snakebite_Envenoming.yaml	pathophysiology	0	evidence	0	PMID:28905944	SUPPORT		Snake venoms are complex mixtures of proteins that exert a wide range of toxic actions.	The abstract summarizes the toxic nature of snake venoms.	"{""explanation"": ""The abstract summarizes the toxic nature of snake venoms."", ""reference"": ""PMID:28905944"", ""snippet"": ""Snake venoms are complex mixtures of proteins that exert a wide range of toxic actions."", ""supports"": ""SUPPORT""}"
7433	7192	310	Snakebite envenoming	Snakebite_Envenoming.yaml	pathophysiology	1	evidence	0	PMID:28905944	SUPPORT		The high variability in snake venom composition is responsible for the various clinical manifestations in envenomings, ranging from local tissue damage to potentially life-threatening systemic effects.	The abstract links venom variability to local and systemic effects.	"{""explanation"": ""The abstract links venom variability to local and systemic effects."", ""reference"": ""PMID:28905944"", ""snippet"": ""The high variability in snake venom composition is responsible for the various clinical manifestations in envenomings, ranging from local tissue damage to potentially life-threatening systemic effects."", ""supports"": ""SUPPORT""}"
7444	7203	311	Soil-transmitted helminthiases	Soil_Transmitted_Helminthiases.yaml	pathophysiology	0	evidence	0	PMID:27929101	SUPPORT		Adult worms feed on the blood of a host and can cause iron deficiency anaemia	Hookworm blood feeding causes iron deficiency anemia.	"{""explanation"": ""Hookworm blood feeding causes iron deficiency anemia."", ""reference"": ""PMID:27929101"", ""snippet"": ""Adult worms feed on the blood of a host and can cause iron deficiency anaemia"", ""supports"": ""SUPPORT""}"
7449	7215	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	0	evidence	0	PMID:16364894	SUPPORT		SMA is caused by mutations in a single gene, the Survival of Motor Neuron 1 (SMN1) gene.	Review confirms SMN1 gene mutations cause SMA.	"{""explanation"": ""Review confirms SMN1 gene mutations cause SMA."", ""reference"": ""PMID:16364894"", ""snippet"": ""SMA is caused by mutations in a single gene, the Survival of Motor Neuron 1 (SMN1) gene."", ""supports"": ""SUPPORT""}"
7450	7215	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	0	evidence	1	PMID:18572081	SUPPORT		Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation.	Lancet review confirms SMN1 gene disruption causes SMA with motor neuron degeneration.	"{""explanation"": ""Lancet review confirms SMN1 gene disruption causes SMA with motor neuron degeneration."", ""reference"": ""PMID:18572081"", ""snippet"": ""Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation."", ""supports"": ""SUPPORT""}"
7451	7216	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	pathophysiology	1	evidence	0	PMID:16364894	SUPPORT		The disease results in motor neuron loss and skeletal muscle atrophy.	Review confirms motor neuron loss as the pathological basis of SMA.	"{""explanation"": ""Review confirms motor neuron loss as the pathological basis of SMA."", ""reference"": ""PMID:16364894"", ""snippet"": ""The disease results in motor neuron loss and skeletal muscle atrophy."", ""supports"": ""SUPPORT""}"
7463	7229	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	pathophysiology	0	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen.	This paper established that individuals with COL2A1 mutations affecting type II collagen-containing tissues exhibit growth plate abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This paper established that individuals with COL2A1 mutations affecting type II collagen-containing tissues exhibit growth plate abnormalities."", ""reference"": ""PMID:7550321"", ""snippet"": ""Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen."", ""supports"": ""SUPPORT""}"
7474	7247	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	pathophysiology	1	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen.	This study documents that vitreous humor abnormalities are a feature of COL2A1-related chondrodysplasias including SEDC, due to type II collagen being a major component of the vitreous.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents that vitreous humor abnormalities are a feature of COL2A1-related chondrodysplasias including SEDC, due to type II collagen being a major component of the vitreous."", ""reference"": ""PMID:7550321"", ""snippet"": ""Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen."", ""supports"": ""SUPPORT""}"
7479	7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	evidence	0	PMID:20179744	SUPPORT	HUMAN_CLINICAL	"Stickler syndrome type 1 is predominantly caused by loss-of-function mutations in the COL2A1 gene as >90% of the mutations were predicted to result in nonsense-mediated decay.
"	"Large-scale genotype-phenotype study of 100 STL1 patients confirms that the majority of COL2A1 mutations cause haploinsufficiency through NMD.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large-scale genotype-phenotype study of 100 STL1 patients confirms that the majority of COL2A1 mutations cause haploinsufficiency through NMD.\n"", ""reference"": ""PMID:20179744"", ""snippet"": ""Stickler syndrome type 1 is predominantly caused by loss-of-function mutations in the COL2A1 gene as >90% of the mutations were predicted to result in nonsense-mediated decay.\n"", ""supports"": ""SUPPORT""}"
7480	7264	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	0	evidence	1	PMID:11007540	SUPPORT	HUMAN_CLINICAL	"Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding.
"	"Study examining vitreous phenotypes confirms that premature termination codons causing haploinsufficiency are the predominant mutation type in STL1.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study examining vitreous phenotypes confirms that premature termination codons causing haploinsufficiency are the predominant mutation type in STL1.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding.\n"", ""supports"": ""SUPPORT""}"
7481	7265	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	1	evidence	0	PMID:11007540	SUPPORT	HUMAN_CLINICAL	"Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding. These produce a characteristic congenital ""membranous"" anomaly of the vitreous of all affected individuals.
"	"Demonstrates that COL2A1 haploinsufficiency produces the characteristic membranous vitreous phenotype that is pathognomonic for STL1.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates that COL2A1 haploinsufficiency produces the characteristic membranous vitreous phenotype that is pathognomonic for STL1.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding. These produce a characteristic congenital \""membranous\"" anomaly of the vitreous of all affected individuals.\n"", ""supports"": ""SUPPORT""}"
7482	7265	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	pathophysiology	1	evidence	1	PMID:11007540	SUPPORT	HUMAN_CLINICAL	"Experience has shown that vitreous slit-lamp biomicroscopy can distinguish between patients with COL2A1 mutations and those with dominant negative mutations in COL11A1, who produce a different ""beaded"" vitreous phenotype.
"	"The membranous vitreous phenotype can be used to distinguish STL1 (COL2A1) from STL2 (COL11A1), supporting its diagnostic utility.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The membranous vitreous phenotype can be used to distinguish STL1 (COL2A1) from STL2 (COL11A1), supporting its diagnostic utility.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Experience has shown that vitreous slit-lamp biomicroscopy can distinguish between patients with COL2A1 mutations and those with dominant negative mutations in COL11A1, who produce a different \""beaded\"" vitreous phenotype.\n"", ""supports"": ""SUPPORT""}"
7501	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	downstream[0].evidence	0	PMID:35084720	SUPPORT		the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms	The mechanism explicitly describes how reciprocal inhibition failure leads to the characteristic muscle co-contraction.	"{""explanation"": ""The mechanism explicitly describes how reciprocal inhibition failure leads to the characteristic muscle co-contraction."", ""reference"": ""PMID:35084720"", ""snippet"": ""the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms"", ""supports"": ""SUPPORT""}"
7502	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:3281011	SUPPORT		A band comigrating with glutamic acid decarboxylase in sodium dodecyl sulfate-polyacrylamide gels appeared to be the only nervous-tissue antigen recognized by cerebrospinal fluid antibodies	This landmark paper identified GAD as the target antigen in stiff person syndrome, establishing the autoimmune basis.	"{""explanation"": ""This landmark paper identified GAD as the target antigen in stiff person syndrome, establishing the autoimmune basis."", ""reference"": ""PMID:3281011"", ""snippet"": ""A band comigrating with glutamic acid decarboxylase in sodium dodecyl sulfate-polyacrylamide gels appeared to be the only nervous-tissue antigen recognized by cerebrospinal fluid antibodies"", ""supports"": ""SUPPORT""}"
7503	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:35084720	SUPPORT		Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level	High GAD antibody titers correlate with reduced GABA levels, supporting the pathophysiological mechanism.	"{""explanation"": ""High GAD antibody titers correlate with reduced GABA levels, supporting the pathophysiological mechanism."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level"", ""supports"": ""SUPPORT""}"
7504	7286	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:37059468	SUPPORT		caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis	The 2023 review confirms that intrathecal GAD antibody synthesis and impaired GABAergic neurotransmission are central to pathogenesis.	"{""explanation"": ""The 2023 review confirms that intrathecal GAD antibody synthesis and impaired GABAergic neurotransmission are central to pathogenesis."", ""reference"": ""PMID:37059468"", ""snippet"": ""caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis"", ""supports"": ""SUPPORT""}"
7505	7287	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:35084720	SUPPORT		the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms	Directly describes the loss of reciprocal inhibition mechanism.	"{""explanation"": ""Directly describes the loss of reciprocal inhibition mechanism."", ""reference"": ""PMID:35084720"", ""snippet"": ""the phenomenon of reciprocal inhibition as the fundamental mechanism of the patients' muscle stiffness and spasms"", ""supports"": ""SUPPORT""}"
7506	7288	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	2	evidence	0	PMID:35084720	SUPPORT		Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level and increased anti-GAD-specific IgG intrathecal synthesis denoting stimulation of B-cell clones in the CNS	Describes the intrathecal B-cell activation and antibody synthesis characteristic of SPS.	"{""explanation"": ""Describes the intrathecal B-cell activation and antibody synthesis characteristic of SPS."", ""reference"": ""PMID:35084720"", ""snippet"": ""Very high serum anti-GAD antibody titers are a key diagnostic feature for all GAD-SD, commonly associated with the presence of GAD antibodies in the CSF, a reduced CSF GABA level and increased anti-GAD-specific IgG intrathecal synthesis denoting stimulation of B-cell clones in the CNS"", ""supports"": ""SUPPORT""}"
7507	7288	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	pathophysiology	2	evidence	1	PMID:37059468	SUPPORT		caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis	Confirms that intrathecal GAD antibody synthesis is central to the autoimmune pathogenesis.	"{""explanation"": ""Confirms that intrathecal GAD antibody synthesis is central to the autoimmune pathogenesis."", ""reference"": ""PMID:37059468"", ""snippet"": ""caused by impaired GABAergic inhibitory neurotransmission and autoimmunity characterized by very high titers of GAD antibodies and increased GAD-IgG intrathecal synthesis"", ""supports"": ""SUPPORT""}"
7526	7307	317	Synovial Sarcoma	Synovial_Sarcoma.yaml	pathophysiology	0	evidence	0	PMID:32092619	SUPPORT		SS18 (SYT) break-apart by FISH or SS18-SSX (SYT-SSX) fusion by reverse transcription-polymerase chain reaction is recommended as a sensitive and specific test to differentiate patients with synovial sarcoma from other sarcomas.	Supports the presence of SS18-SSX fusions as a defining feature of synovial sarcoma.	"{""explanation"": ""Supports the presence of SS18-SSX fusions as a defining feature of synovial sarcoma."", ""reference"": ""PMID:32092619"", ""snippet"": ""SS18 (SYT) break-apart by FISH or SS18-SSX (SYT-SSX) fusion by reverse transcription-polymerase chain reaction is recommended as a sensitive and specific test to differentiate patients with synovial sarcoma from other sarcomas."", ""supports"": ""SUPPORT""}"
7577	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	evidence	0	PMID:27709413	PARTIAL		Here, we review what is known on the altered metabolic patterns of CD4(+) T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis.	The reference discusses the altered metabolic patterns of B cells, CD4(+) T cells, and myeloid cells (which include macrophages) and their contribution to lupus, which indirectly supports the involvement of these cell types in lupus mechanisms, but it does not specifically address immune complex formation directly.	"{""explanation"": ""The reference discusses the altered metabolic patterns of B cells, CD4(+) T cells, and myeloid cells (which include macrophages) and their contribution to lupus, which indirectly supports the involvement of these cell types in lupus mechanisms, but it does not specifically address immune complex formation directly."", ""reference"": ""PMID:27709413"", ""snippet"": ""Here, we review what is known on the altered metabolic patterns of CD4(+) T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis."", ""supports"": ""PARTIAL""}"
7578	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	evidence	1	PMID:29925508	PARTIAL		TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus.	This reference demonstrates the role of specific plasma cells in the development of lupus nephritis, implying their role in immune complex-related pathology, but does not detail the direct involvement of B cells or macrophages in immune complex formation.	"{""explanation"": ""This reference demonstrates the role of specific plasma cells in the development of lupus nephritis, implying their role in immune complex-related pathology, but does not detail the direct involvement of B cells or macrophages in immune complex formation."", ""reference"": ""PMID:29925508"", ""snippet"": ""TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus."", ""supports"": ""PARTIAL""}"
7579	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	evidence	2	PMID:34402453	PARTIAL		B-lymphocytes are crucial in the pathogenesis of systemic lupus erythematosus (SLE), including autoantibody production, antigen presentation, co-stimulation, and cytokine secretion.	The reference highlights the crucial role of B cells in the pathogenesis of SLE through mechanisms such as autoantibody production, which is critical for immune complex formation. However, it does not explicitly discuss the role of plasma cells or macrophages in the context given.	"{""explanation"": ""The reference highlights the crucial role of B cells in the pathogenesis of SLE through mechanisms such as autoantibody production, which is critical for immune complex formation. However, it does not explicitly discuss the role of plasma cells or macrophages in the context given."", ""reference"": ""PMID:34402453"", ""snippet"": ""B-lymphocytes are crucial in the pathogenesis of systemic lupus erythematosus (SLE), including autoantibody production, antigen presentation, co-stimulation, and cytokine secretion."", ""supports"": ""PARTIAL""}"
7580	7340	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	0	evidence	3	PMID:22999705	PARTIAL		C1q opsonized apoptotic cells also exert an immunosuppressive effect through cytokine regulation and the stimulation of additional opsonins by macrophages.	This suggests that macrophages have a role in immune complex-mediated processes through cytokine regulation and opsonin stimulation, contributing to the immune system’s activity in lupus but does not detail the involvement of B cells or plasma cells in immune complex formation.	"{""explanation"": ""This suggests that macrophages have a role in immune complex-mediated processes through cytokine regulation and opsonin stimulation, contributing to the immune system’s activity in lupus but does not detail the involvement of B cells or plasma cells in immune complex formation."", ""reference"": ""PMID:22999705"", ""snippet"": ""C1q opsonized apoptotic cells also exert an immunosuppressive effect through cytokine regulation and the stimulation of additional opsonins by macrophages."", ""supports"": ""PARTIAL""}"
7581	7341	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	1	evidence	0	PMID:33841392	SUPPORT		Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges. Deposition of immune complexes in kidneys glomeruli are associated with lupus nephritis, determining SLE diagnosis.	The literature supports the deposition of immune complexes in kidney glomeruli but does not cover skeletal joints, skin, heart, or lung in this context.	"{""explanation"": ""The literature supports the deposition of immune complexes in kidney glomeruli but does not cover skeletal joints, skin, heart, or lung in this context."", ""reference"": ""PMID:33841392"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges. Deposition of immune complexes in kidneys glomeruli are associated with lupus nephritis, determining SLE diagnosis."", ""supports"": ""SUPPORT""}"
7582	7341	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	1	evidence	1	PMID:30009962	SUPPORT		LN is characterized by glomerular kidney injury, essentially due to deposition of immune complexes involving autoantibodies against cellular components and circulating proteins.	This confirms immune complex deposition in kidneys.	"{""explanation"": ""This confirms immune complex deposition in kidneys."", ""reference"": ""PMID:30009962"", ""snippet"": ""LN is characterized by glomerular kidney injury, essentially due to deposition of immune complexes involving autoantibodies against cellular components and circulating proteins."", ""supports"": ""SUPPORT""}"
7583	7342	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	2	evidence	0	PMID:35872103	SUPPORT		The autoantibodies, especially anti-dsDNA and anti-Sm autoantibodies are highly specific to SLE, and participate in the immune complex formation and inflammatory damage on multiple end-organs such as kidney, skin, and central nervous system (CNS).	This paper directly establishes that autoantibodies form immune complexes which cause inflammatory damage to multiple organs in SLE.	"{""explanation"": ""This paper directly establishes that autoantibodies form immune complexes which cause inflammatory damage to multiple organs in SLE."", ""reference"": ""PMID:35872103"", ""snippet"": ""The autoantibodies, especially anti-dsDNA and anti-Sm autoantibodies are highly specific to SLE, and participate in the immune complex formation and inflammatory damage on multiple end-organs such as kidney, skin, and central nervous system (CNS)."", ""supports"": ""SUPPORT""}"
7584	7342	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	2	evidence	1	PMID:16572034	SUPPORT		Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues.	The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context.	"{""explanation"": ""The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues."", ""supports"": ""SUPPORT""}"
7585	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	evidence	0	PMID:16572034	SUPPORT		Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues.	The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context.	"{""explanation"": ""The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues."", ""supports"": ""SUPPORT""}"
7586	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	evidence	1	PMID:2860699	SUPPORT		Evidence is now slowly accumulating that substantiates that immune complex deposition, complement activation and subsequent inflammatory reaction is responsible for the majority of the cardiovascular manifestations of SLE, for example, pericarditis, myocarditis, endocarditis, coronary arteritis, coronary atherosclerosis, and systemic and pulmonary vasculitis.	This confirms immune complex deposition in the heart.	"{""explanation"": ""This confirms immune complex deposition in the heart."", ""reference"": ""PMID:2860699"", ""snippet"": ""Evidence is now slowly accumulating that substantiates that immune complex deposition, complement activation and subsequent inflammatory reaction is responsible for the majority of the cardiovascular manifestations of SLE, for example, pericarditis, myocarditis, endocarditis, coronary arteritis, coronary atherosclerosis, and systemic and pulmonary vasculitis."", ""supports"": ""SUPPORT""}"
7587	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	evidence	2	PMID:28900675	WRONG_STATEMENT		Recent studies demonstrated an increased incidence of osteoporosis and peripheral and vertebral fractures in patients with SLE	This reference does not mention the deposition of immune complexes in skeletal joints.	"{""explanation"": ""This reference does not mention the deposition of immune complexes in skeletal joints."", ""reference"": ""PMID:28900675"", ""snippet"": ""Recent studies demonstrated an increased incidence of osteoporosis and peripheral and vertebral fractures in patients with SLE"", ""supports"": ""WRONG_STATEMENT""}"
7588	7343	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	3	evidence	3	PMID:158982	SUPPORT		Abundant evidence currently exists to suggest that immune complexes play an important role in inflammatory diseases of the lung. ... systemic lupus erythematosus have been shown to be associated with the presence of immune complexes both in lung and in the serum.	This confirms immune complex deposition in the lung.	"{""explanation"": ""This confirms immune complex deposition in the lung."", ""reference"": ""PMID:158982"", ""snippet"": ""Abundant evidence currently exists to suggest that immune complexes play an important role in inflammatory diseases of the lung. ... systemic lupus erythematosus have been shown to be associated with the presence of immune complexes both in lung and in the serum."", ""supports"": ""SUPPORT""}"
7589	7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	evidence	0	PMID:22192660	SUPPORT		Systemic lupus erythematosus is a prototypic autoimmune disease characterized by autoantibody production and immune complex formation/deposition in target organs such as the kidney. Resultant local inflammation then leads to organ damage.	The article describes inflammation and immune complex deposition as mechanisms leading to tissue damage in SLE.	"{""explanation"": ""The article describes inflammation and immune complex deposition as mechanisms leading to tissue damage in SLE."", ""reference"": ""PMID:22192660"", ""snippet"": ""Systemic lupus erythematosus is a prototypic autoimmune disease characterized by autoantibody production and immune complex formation/deposition in target organs such as the kidney. Resultant local inflammation then leads to organ damage."", ""supports"": ""SUPPORT""}"
7590	7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	evidence	1	PMID:36555640	SUPPORT		The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues.	The literature explains that inflammation and tissue damage are core mechanisms in the pathology of SLE due to immune system disturbances.	"{""explanation"": ""The literature explains that inflammation and tissue damage are core mechanisms in the pathology of SLE due to immune system disturbances."", ""reference"": ""PMID:36555640"", ""snippet"": ""The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues."", ""supports"": ""SUPPORT""}"
7591	7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	evidence	2	PMID:28623084	SUPPORT		Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. A complex interaction of genetics, environment, and hormones leads to immune dysregulation and breakdown of tolerance to self-antigens, resulting in autoantibody production, inflammation, and destruction of end-organs.	This article outlines inflammation as part of the immune dysregulation in SLE, leading to tissue damage in multiple organs.	"{""explanation"": ""This article outlines inflammation as part of the immune dysregulation in SLE, leading to tissue damage in multiple organs."", ""reference"": ""PMID:28623084"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. A complex interaction of genetics, environment, and hormones leads to immune dysregulation and breakdown of tolerance to self-antigens, resulting in autoantibody production, inflammation, and destruction of end-organs."", ""supports"": ""SUPPORT""}"
7592	7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	evidence	3	PMID:33841392	SUPPORT		Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges.	The study identifies widespread inflammation and tissue damage as defining characteristics of SLE.	"{""explanation"": ""The study identifies widespread inflammation and tissue damage as defining characteristics of SLE."", ""reference"": ""PMID:33841392"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges."", ""supports"": ""SUPPORT""}"
7593	7344	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	4	evidence	4	PMID:37712757	SUPPORT		In the current review, we focus on the commonly affected organs (skin, kidney, and nervous system) in SLE to summarize the emerging biomarkers that show promise in disease diagnosis, monitoring and treatment response assessment.	The review supports that inflammation and tissue damage are significant mechanisms in SLE affecting organs such as the skin, kidneys, and nervous system.	"{""explanation"": ""The review supports that inflammation and tissue damage are significant mechanisms in SLE affecting organs such as the skin, kidneys, and nervous system."", ""reference"": ""PMID:37712757"", ""snippet"": ""In the current review, we focus on the commonly affected organs (skin, kidney, and nervous system) in SLE to summarize the emerging biomarkers that show promise in disease diagnosis, monitoring and treatment response assessment."", ""supports"": ""SUPPORT""}"
7594	7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	evidence	0	PMID:16572034	SUPPORT		Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues...	The abstract confirms that inflammation is a key aspect of systemic lupus erythematosus pathogenesis.	"{""explanation"": ""The abstract confirms that inflammation is a key aspect of systemic lupus erythematosus pathogenesis."", ""reference"": ""PMID:16572034"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues..."", ""supports"": ""SUPPORT""}"
7595	7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	evidence	1	PMID:26330673	SUPPORT		Systemic lupus erythematosus, the prototype systemic autoimmune disease, is characterized by extensive self-reactivity, inflammation, and organ system damage.	The abstract clearly mentions inflammation as a characteristic feature of SLE.	"{""explanation"": ""The abstract clearly mentions inflammation as a characteristic feature of SLE."", ""reference"": ""PMID:26330673"", ""snippet"": ""Systemic lupus erythematosus, the prototype systemic autoimmune disease, is characterized by extensive self-reactivity, inflammation, and organ system damage."", ""supports"": ""SUPPORT""}"
7596	7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	evidence	2	PMID:32237942	SUPPORT		Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is potentially life-threatening and can affect any organ.	The literature describes SLE as a chronic autoimmune disease affecting various organs, implying sustained inflammation over time.	"{""explanation"": ""The literature describes SLE as a chronic autoimmune disease affecting various organs, implying sustained inflammation over time."", ""reference"": ""PMID:32237942"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is potentially life-threatening and can affect any organ."", ""supports"": ""SUPPORT""}"
7597	7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	evidence	3	PMID:24992143	SUPPORT		Recent evidence suggests that the inflammasome machinery is dysregulated in SLE, plays an important role in promotion of organ damage, and may mediate cross-talk between environmental triggers and the development of lupus.	The abstract discusses the role of inflammasome and inflammation in organ damage associated with SLE, supporting the chronic inflammation mechanism.	"{""explanation"": ""The abstract discusses the role of inflammasome and inflammation in organ damage associated with SLE, supporting the chronic inflammation mechanism."", ""reference"": ""PMID:24992143"", ""snippet"": ""Recent evidence suggests that the inflammasome machinery is dysregulated in SLE, plays an important role in promotion of organ damage, and may mediate cross-talk between environmental triggers and the development of lupus."", ""supports"": ""SUPPORT""}"
7598	7345	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	5	evidence	4	PMID:36555640	SUPPORT		The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues.	The literature describes inflammation and tissue damage due to immune complexes, which supports chronic inflammation as a mechanism of SLE.	"{""explanation"": ""The literature describes inflammation and tissue damage due to immune complexes, which supports chronic inflammation as a mechanism of SLE."", ""reference"": ""PMID:36555640"", ""snippet"": ""The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues."", ""supports"": ""SUPPORT""}"
7599	7346	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	6	evidence	0	PMID:26951252	SUPPORT		These include exposure to UV light, infections, certain hormones, and drugs which may activate the innate and adaptive immune system, resulting in inflammation, cytotoxic effects, and clinical symptoms.	This reference mentions the potential triggers for lupus flares, which include UV light (sunlight) and infections.	"{""explanation"": ""This reference mentions the potential triggers for lupus flares, which include UV light (sunlight) and infections."", ""reference"": ""PMID:26951252"", ""snippet"": ""These include exposure to UV light, infections, certain hormones, and drugs which may activate the innate and adaptive immune system, resulting in inflammation, cytotoxic effects, and clinical symptoms."", ""supports"": ""SUPPORT""}"
7600	7346	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	6	evidence	1	PMID:26494589	SUPPORT		Some triggers for these exacerbations have been identified, including infections, vaccines, pregnancy, environmental factors such as weather, stress and drugs.	This reference specifically states that stress and infections can trigger lupus flares.	"{""explanation"": ""This reference specifically states that stress and infections can trigger lupus flares."", ""reference"": ""PMID:26494589"", ""snippet"": ""Some triggers for these exacerbations have been identified, including infections, vaccines, pregnancy, environmental factors such as weather, stress and drugs."", ""supports"": ""SUPPORT""}"
7601	7346	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	6	evidence	2	PMID:22385883	SUPPORT		Exposure to sunlight is one of the environmental factors involved in the pathogenesis of systemic lupus erythematosus.	This reference confirms that sunlight exposure can trigger lupus flares.	"{""explanation"": ""This reference confirms that sunlight exposure can trigger lupus flares."", ""reference"": ""PMID:22385883"", ""snippet"": ""Exposure to sunlight is one of the environmental factors involved in the pathogenesis of systemic lupus erythematosus."", ""supports"": ""SUPPORT""}"
7602	7346	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	6	evidence	3	PMID:30488801	SUPPORT		The cutaneous manifestations that were present included malar rash 37.69%, photosensitivity 35.10%, discoid lupus 17.63%, and hair loss 39.29%.	This reference discusses photosensitivity (sunlight) as a significant factor, aligning with the statement's mention of sunlight as a trigger.	"{""explanation"": ""This reference discusses photosensitivity (sunlight) as a significant factor, aligning with the statement's mention of sunlight as a trigger."", ""reference"": ""PMID:30488801"", ""snippet"": ""The cutaneous manifestations that were present included malar rash 37.69%, photosensitivity 35.10%, discoid lupus 17.63%, and hair loss 39.29%."", ""supports"": ""SUPPORT""}"
7603	7347	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	pathophysiology	7	evidence	0	PMID:24834763	SUPPORT		An increased expression of type I IFN-regulated genes, termed IFN signature, has been reported in patients with SLE.	This review describes the type I interferon gene signature in SLE, supporting chronic activation of the type I interferon pathway.	"{""explanation"": ""This review describes the type I interferon gene signature in SLE, supporting chronic activation of the type I interferon pathway."", ""reference"": ""PMID:24834763"", ""snippet"": ""An increased expression of type I IFN-regulated genes, termed IFN signature, has been reported in patients with SLE."", ""supports"": ""SUPPORT""}"
7651	7378	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	0	evidence	0	PMID:38927538	SUPPORT		In systemic sclerosis (SSc, or scleroderma), defective angiogenesis, clinically manifesting with abnormal capillary architecture and severe capillary reduction, represents a hallmark of early-stage disease, usually preceding the onset of tissue fibrosis, and is caused by several cellular and molecular mechanisms affecting microvascular endothelial cells with different outcomes.	This evidence supports the early vascular injury mechanism by demonstrating that defective angiogenesis and capillary abnormalities precede fibrosis in SSc.	"{""explanation"": ""This evidence supports the early vascular injury mechanism by demonstrating that defective angiogenesis and capillary abnormalities precede fibrosis in SSc."", ""reference"": ""PMID:38927538"", ""snippet"": ""In systemic sclerosis (SSc, or scleroderma), defective angiogenesis, clinically manifesting with abnormal capillary architecture and severe capillary reduction, represents a hallmark of early-stage disease, usually preceding the onset of tissue fibrosis, and is caused by several cellular and molecular mechanisms affecting microvascular endothelial cells with different outcomes."", ""supports"": ""SUPPORT""}"
7652	7378	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	0	evidence	1	PMID:38927538	SUPPORT		Indeed, once damaged, endothelial cells can be dysfunctionally activated, thus becoming unable to undergo angiogenesis and promoting perivascular inflammation. They can also undergo apoptosis, transdifferentiate into profibrotic myofibroblasts, or acquire a senescence-associated secretory phenotype characterized by the release of exosomes and several profibrotic and proinflammatory mediators.	This describes multiple mechanisms of endothelial dysfunction in SSc, including impaired angiogenesis, endothelial-to-mesenchymal transition, and inflammatory mediator release that contribute to vascular pathology.	"{""explanation"": ""This describes multiple mechanisms of endothelial dysfunction in SSc, including impaired angiogenesis, endothelial-to-mesenchymal transition, and inflammatory mediator release that contribute to vascular pathology."", ""reference"": ""PMID:38927538"", ""snippet"": ""Indeed, once damaged, endothelial cells can be dysfunctionally activated, thus becoming unable to undergo angiogenesis and promoting perivascular inflammation. They can also undergo apoptosis, transdifferentiate into profibrotic myofibroblasts, or acquire a senescence-associated secretory phenotype characterized by the release of exosomes and several profibrotic and proinflammatory mediators."", ""supports"": ""SUPPORT""}"
7653	7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	evidence	0	PMID:38296975	SUPPORT		Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls. The lead SNP is in the FCGR/FCRL region, which shows a penetrating association in the Asian population, while a complete linkage disequilibrium SNP, rs10917688, is found in a cis-regulatory element for IRF8.	This genetic evidence implicates B cell and Fc receptor biology in SSc susceptibility, with IRF8 being a key regulator of immune cell development and interferon responses that contribute to immune dysregulation.	"{""explanation"": ""This genetic evidence implicates B cell and Fc receptor biology in SSc susceptibility, with IRF8 being a key regulator of immune cell development and interferon responses that contribute to immune dysregulation."", ""reference"": ""PMID:38296975"", ""snippet"": ""Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls. The lead SNP is in the FCGR/FCRL region, which shows a penetrating association in the Asian population, while a complete linkage disequilibrium SNP, rs10917688, is found in a cis-regulatory element for IRF8."", ""supports"": ""SUPPORT""}"
7654	7379	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	1	evidence	1	PMID:38296975	SUPPORT		Prioritizing the top 5% of SNPs of IRF8 binding sites in B cells improves the fitting of the polygenic risk scores, underscoring the roles of B cells and IRF8 in the development of systemic sclerosis.	This supports the role of B cell biology and autoantibody production in SSc pathogenesis, demonstrating that B cell-specific genetic variants contribute to disease risk.	"{""explanation"": ""This supports the role of B cell biology and autoantibody production in SSc pathogenesis, demonstrating that B cell-specific genetic variants contribute to disease risk."", ""reference"": ""PMID:38296975"", ""snippet"": ""Prioritizing the top 5% of SNPs of IRF8 binding sites in B cells improves the fitting of the polygenic risk scores, underscoring the roles of B cells and IRF8 in the development of systemic sclerosis."", ""supports"": ""SUPPORT""}"
7655	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	evidence	0	PMID:38147960	SUPPORT		SSc skin demonstrated an increased abundance of COMP+, COL11A1+, MYOC+, CCL19+, SFRP4/SFRP2+, and PRSS23/SFRP2+ fibroblasts signatures and decreased proportions of CXCL12+ and PI16+ fibroblast signatures in the Prospective Registry of Early Systemic Sclerosis and Genetics versus Environment in Scleroderma Outcome Study cohorts.	This demonstrates the heterogeneity of fibroblast populations in SSc, with increased profibrotic fibroblast subpopulations and decreased normal fibroblast signatures contributing to excessive ECM deposition.	"{""explanation"": ""This demonstrates the heterogeneity of fibroblast populations in SSc, with increased profibrotic fibroblast subpopulations and decreased normal fibroblast signatures contributing to excessive ECM deposition."", ""reference"": ""PMID:38147960"", ""snippet"": ""SSc skin demonstrated an increased abundance of COMP+, COL11A1+, MYOC+, CCL19+, SFRP4/SFRP2+, and PRSS23/SFRP2+ fibroblasts signatures and decreased proportions of CXCL12+ and PI16+ fibroblast signatures in the Prospective Registry of Early Systemic Sclerosis and Genetics versus Environment in Scleroderma Outcome Study cohorts."", ""supports"": ""SUPPORT""}"
7656	7380	319	Systemic Sclerosis	Systemic_Sclerosis.yaml	pathophysiology	2	evidence	1	PMID:38147960	SUPPORT		The proportions of profibrotic COMP+, COL11A1+, SFRP4/SFRP2+, and PRSS23/SFRP2+ and proinflammatory CCL19+ fibroblast signatures were positively correlated with clinical and histopathological parameters of skin fibrosis, whereas signatures of CXCL12+ and PI16+ fibroblasts were inversely correlated.	This provides direct evidence linking specific fibroblast subpopulations to clinical severity of skin fibrosis, supporting the role of fibroblast activation in SSc pathogenesis and disease progression.	"{""explanation"": ""This provides direct evidence linking specific fibroblast subpopulations to clinical severity of skin fibrosis, supporting the role of fibroblast activation in SSc pathogenesis and disease progression."", ""reference"": ""PMID:38147960"", ""snippet"": ""The proportions of profibrotic COMP+, COL11A1+, SFRP4/SFRP2+, and PRSS23/SFRP2+ and proinflammatory CCL19+ fibroblast signatures were positively correlated with clinical and histopathological parameters of skin fibrosis, whereas signatures of CXCL12+ and PI16+ fibroblasts were inversely correlated."", ""supports"": ""SUPPORT""}"
7659	7395	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	0	evidence	0	PMID:36944446	SUPPORT		TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the RBM10 gene	Lane et al. 2023 establishes RBM10 as the causative gene for TARP syndrome with loss-of-function splice mutations.	"{""explanation"": ""Lane et al. 2023 establishes RBM10 as the causative gene for TARP syndrome with loss-of-function splice mutations."", ""reference"": ""PMID:36944446"", ""snippet"": ""TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the RBM10 gene"", ""supports"": ""SUPPORT""}"
7660	7396	320	TARP syndrome	TARP_syndrome.yaml	pathophysiology	1	evidence	0	PMID:39080280	SUPPORT		RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability	Machour et al. 2024 demonstrates the splicing-independent role of RBM10 in maintaining DNA replication fork stability through HDAC1 recruitment.	"{""explanation"": ""Machour et al. 2024 demonstrates the splicing-independent role of RBM10 in maintaining DNA replication fork stability through HDAC1 recruitment."", ""reference"": ""PMID:39080280"", ""snippet"": ""RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability"", ""supports"": ""SUPPORT""}"
7679	7415	321	Taeniasis/cysticercosis	Taeniasis_Cysticercosis.yaml	pathophysiology	0	evidence	0	PMID:12932389	SUPPORT		The larval stage of the pork tapeworm (Taenia solium) infects the human nervous system, causing neurocysticercosis.	The abstract links larval infection to neurocysticercosis.	"{""explanation"": ""The abstract links larval infection to neurocysticercosis."", ""reference"": ""PMID:12932389"", ""snippet"": ""The larval stage of the pork tapeworm (Taenia solium) infects the human nervous system, causing neurocysticercosis."", ""supports"": ""SUPPORT""}"
7683	7425	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	0	evidence	0	PMID:40710901	SUPPORT		Mechanistically, TSD is caused by mutations in the HEXA gene, which encodes the alpha subunit of hexosaminidase A.	Review states Tay-Sachs disease is caused by HEXA mutations affecting hexosaminidase A.	"{""explanation"": ""Review states Tay-Sachs disease is caused by HEXA mutations affecting hexosaminidase A."", ""reference"": ""PMID:40710901"", ""snippet"": ""Mechanistically, TSD is caused by mutations in the HEXA gene, which encodes the alpha subunit of hexosaminidase A."", ""supports"": ""SUPPORT""}"
7684	7426	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	1	evidence	0	PMID:19820796	SUPPORT		Tay-Sachs disease is an autosomal recessive disorder of sphingolipid metabolism, caused by enzyme hexosaminidase A deficiency that leads to an accumulation of GM2 in neurocytes which results in progressive loss of neurological function.	Supports hexosaminidase A deficiency as a core defect in Tay-Sachs disease.	"{""explanation"": ""Supports hexosaminidase A deficiency as a core defect in Tay-Sachs disease."", ""reference"": ""PMID:19820796"", ""snippet"": ""Tay-Sachs disease is an autosomal recessive disorder of sphingolipid metabolism, caused by enzyme hexosaminidase A deficiency that leads to an accumulation of GM2 in neurocytes which results in progressive loss of neurological function."", ""supports"": ""SUPPORT""}"
7685	7427	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	2	evidence	0	PMID:22025593	SUPPORT		G(M2) gangliosidoses are caused by an inherited deficiency of lysosomal β-hexosaminidase and result in ganglioside accumulation in the brain.	GM2 gangliosidosis (includes Tay-Sachs) shows ganglioside accumulation in brain.	"{""explanation"": ""GM2 gangliosidosis (includes Tay-Sachs) shows ganglioside accumulation in brain."", ""reference"": ""PMID:22025593"", ""snippet"": ""G(M2) gangliosidoses are caused by an inherited deficiency of lysosomal β-hexosaminidase and result in ganglioside accumulation in the brain."", ""supports"": ""SUPPORT""}"
7686	7428	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	pathophysiology	3	evidence	0	PMID:29618308	SUPPORT		Inherited as a classical autosomal recessive disorder, this global disease of the nervous system induces developmental arrest with regression of attained milestones; neurodegeneration progresses rapidly to cause premature death in young children.	Review describes rapid neurodegeneration in infantile GM2 gangliosidosis, consistent with neuronal loss.	"{""explanation"": ""Review describes rapid neurodegeneration in infantile GM2 gangliosidosis, consistent with neuronal loss."", ""reference"": ""PMID:29618308"", ""snippet"": ""Inherited as a classical autosomal recessive disorder, this global disease of the nervous system induces developmental arrest with regression of attained milestones; neurodegeneration progresses rapidly to cause premature death in young children."", ""supports"": ""SUPPORT""}"
7705	7445	323	Tetanus	Tetanus.yaml	pathophysiology	0	evidence	0	PMID:35333944	SUPPORT		Tetanus and botulinum neurotoxins cause the neuroparalytic syndromes of tetanus and botulism, respectively, by delivering inside different types of neurons, metalloproteases specifically cleaving the SNARE proteins that are essential for the release of neurotransmitters.	This review confirms the mechanism of tetanus toxin action through metalloprotease cleavage of SNARE proteins, blocking neurotransmitter release.	"{""explanation"": ""This review confirms the mechanism of tetanus toxin action through metalloprotease cleavage of SNARE proteins, blocking neurotransmitter release."", ""reference"": ""PMID:35333944"", ""snippet"": ""Tetanus and botulinum neurotoxins cause the neuroparalytic syndromes of tetanus and botulism, respectively, by delivering inside different types of neurons, metalloproteases specifically cleaving the SNARE proteins that are essential for the release of neurotransmitters."", ""supports"": ""SUPPORT""}"
7706	7446	323	Tetanus	Tetanus.yaml	pathophysiology	1	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Links tetanospasmin to dysautonomia underlying cardiovascular instability.	"{""explanation"": ""Links tetanospasmin to dysautonomia underlying cardiovascular instability."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7707	7447	323	Tetanus	Tetanus.yaml	pathophysiology	2	evidence	0	PMID:40543524	SUPPORT		Tetanus results from infections with spore-forming Clostridium tetani bacteria, usually acquired via contaminated wounds and burns.	Confirms wound contamination as the typical entry and toxin production site.	"{""explanation"": ""Confirms wound contamination as the typical entry and toxin production site."", ""reference"": ""PMID:40543524"", ""snippet"": ""Tetanus results from infections with spore-forming Clostridium tetani bacteria, usually acquired via contaminated wounds and burns."", ""supports"": ""SUPPORT""}"
7721	7487	326	Trachoma	Trachoma.yaml	pathophysiology	0	evidence	0	PMID:35618795	SUPPORT		Trachoma is a disease complex composed of two linked chronic processes: a recurrent, generally subclinical infectious-inflammatory disease that mostly affects children, and a non-communicable, cicatricial and, owing to trichiasis, eventually blinding disease	The abstract describes chronic infection progressing to cicatricial disease with trichiasis.	"{""explanation"": ""The abstract describes chronic infection progressing to cicatricial disease with trichiasis."", ""reference"": ""PMID:35618795"", ""snippet"": ""Trachoma is a disease complex composed of two linked chronic processes: a recurrent, generally subclinical infectious-inflammatory disease that mostly affects children, and a non-communicable, cicatricial and, owing to trichiasis, eventually blinding disease"", ""supports"": ""SUPPORT""}"
7727	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	evidence	0	PMID:21146802	REFUTE		Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.	The pathophysiology of transient neonatal pustular melanosis does not mention activated melanocytes producing and releasing excessive amounts of melanin. The etiology is still unknown.	"{""explanation"": ""The pathophysiology of transient neonatal pustular melanosis does not mention activated melanocytes producing and releasing excessive amounts of melanin. The etiology is still unknown."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""REFUTE""}"
7728	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	evidence	1	PMID:32092380	REFUTE		The well-characterized MSH/MC1R-cAMP-MITF pathway regulates UV-induced melanization. Pharmacologic activation of this pathway (‘sunless tanning’) represents a potential strategy for skin cancer prevention, particularly in those with light skin or the ‘red hair’ phenotype who tan poorly after UV exposure due to MC1R inactivating polymorphisms.	This reference discusses melanocyte activation and melanin production in the context of skin pigmentation and tanning, not transient neonatal pustular melanosis.	"{""explanation"": ""This reference discusses melanocyte activation and melanin production in the context of skin pigmentation and tanning, not transient neonatal pustular melanosis."", ""reference"": ""PMID:32092380"", ""snippet"": ""The well-characterized MSH/MC1R-cAMP-MITF pathway regulates UV-induced melanization. Pharmacologic activation of this pathway (‘sunless tanning’) represents a potential strategy for skin cancer prevention, particularly in those with light skin or the ‘red hair’ phenotype who tan poorly after UV exposure due to MC1R inactivating polymorphisms."", ""supports"": ""REFUTE""}"
7729	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	evidence	2	PMID:18633434	NO_EVIDENCE		Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a protective response. We have studied the melanocyte proliferative response after a single UVR exposure to neonatal mice.	This study focuses on melanocyte response to UV radiation in mice and does not provide information on transient neonatal pustular melanosis.	"{""explanation"": ""This study focuses on melanocyte response to UV radiation in mice and does not provide information on transient neonatal pustular melanosis."", ""reference"": ""PMID:18633434"", ""snippet"": ""Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a protective response. We have studied the melanocyte proliferative response after a single UVR exposure to neonatal mice."", ""supports"": ""NO_EVIDENCE""}"
7730	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	evidence	3	PMID:15953139	NO_EVIDENCE		We discuss this transition and then branch out to touch on issues of premature infant as well as neonatal skin care. Disruption of the barrier function due to toxins and development errors are expounded upon.	This reference talks about neonatal skin barrier structure and disorders but does not specifically address transient neonatal pustular melanosis or its pathophysiology.	"{""explanation"": ""This reference talks about neonatal skin barrier structure and disorders but does not specifically address transient neonatal pustular melanosis or its pathophysiology."", ""reference"": ""PMID:15953139"", ""snippet"": ""We discuss this transition and then branch out to touch on issues of premature infant as well as neonatal skin care. Disruption of the barrier function due to toxins and development errors are expounded upon."", ""supports"": ""NO_EVIDENCE""}"
7731	7495	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	1	evidence	4	PMID:36048560	NO_EVIDENCE		Solar lentigo (SL) is a hyperpigmented macule that occurs in sun-exposed areas and is characterized by the accumulation of melanin pigment in the epidermis.	This study discusses solar lentigo and melanin accumulation but does not relate to transient neonatal pustular melanosis.	"{""explanation"": ""This study discusses solar lentigo and melanin accumulation but does not relate to transient neonatal pustular melanosis."", ""reference"": ""PMID:36048560"", ""snippet"": ""Solar lentigo (SL) is a hyperpigmented macule that occurs in sun-exposed areas and is characterized by the accumulation of melanin pigment in the epidermis."", ""supports"": ""NO_EVIDENCE""}"
7732	7496	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	2	evidence	0	PMID:21146802	REFUTE		Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.	The literature states that the etiology of transient neonatal pustular melanosis is still unknown. There is no mention of melanin accumulation in the epidermis being a contributing factor.	"{""explanation"": ""The literature states that the etiology of transient neonatal pustular melanosis is still unknown. There is no mention of melanin accumulation in the epidermis being a contributing factor."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""REFUTE""}"
7733	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	evidence	0	PMID:1271148	SUPPORT		The lesions often present as, or evolve into, a pigmented macule and persist from three weeks to three months.	The reference indicates that the vesicopustular lesions associated with Transient Neonatal Pustular Melanosis can evolve into pigmented macules, which aligns with areas of hyper pigmentation or dark spots on the skin, consistent with melanin accumulation.	"{""explanation"": ""The reference indicates that the vesicopustular lesions associated with Transient Neonatal Pustular Melanosis can evolve into pigmented macules, which aligns with areas of hyper pigmentation or dark spots on the skin, consistent with melanin accumulation."", ""reference"": ""PMID:1271148"", ""snippet"": ""The lesions often present as, or evolve into, a pigmented macule and persist from three weeks to three months."", ""supports"": ""SUPPORT""}"
7734	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	evidence	1	PMID:33397568	SUPPORT		Diagnosis of Transient Neonatal Pustular Melanosis.	Although the reference title confirms the focus on Transient Neonatal Pustular Melanosis, it does not provide a detailed enough snippet to fully confirm details about the resultant hyperpigmentation. However, it does support the occurrence of the condition.	"{""explanation"": ""Although the reference title confirms the focus on Transient Neonatal Pustular Melanosis, it does not provide a detailed enough snippet to fully confirm details about the resultant hyperpigmentation. However, it does support the occurrence of the condition."", ""reference"": ""PMID:33397568"", ""snippet"": ""Diagnosis of Transient Neonatal Pustular Melanosis."", ""supports"": ""SUPPORT""}"
7735	7497	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	3	evidence	2	PMID:15095913	PARTIAL		The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils.	While the reference discusses pustular disorders generally, it does not provide specific details on the resultant hyperpigmentation associated with Transient Neonatal Pustular Melanosis.	"{""explanation"": ""While the reference discusses pustular disorders generally, it does not provide specific details on the resultant hyperpigmentation associated with Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:15095913"", ""snippet"": ""The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils."", ""supports"": ""PARTIAL""}"
7736	7498	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	4	evidence	0	PMID:15095913	PARTIAL		The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils with prominent accompanying intercellular edema or a canthelysis involving various levels of the epithelium.	While this reference explains the general characteristics of pustular disorders, it doesn't clearly support or refute the specific statement regarding desquamation following the resolution of pustules in Transient Neonatal Pustular Melanosis.	"{""explanation"": ""While this reference explains the general characteristics of pustular disorders, it doesn't clearly support or refute the specific statement regarding desquamation following the resolution of pustules in Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:15095913"", ""snippet"": ""The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils with prominent accompanying intercellular edema or a canthelysis involving various levels of the epithelium."", ""supports"": ""PARTIAL""}"
7737	7498	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	4	evidence	1	PMID:21793881	NO_EVIDENCE		There is paucity of literature on the incidence and clinical associations of transient benign dermatological conditions in twin neonates.	This study mentions several dermatological conditions commonly seen in neonates, including erythema toxicum neonatorum and physiological skin desquamation, but does not provide specific information about desquamation in the context of Transient Neonatal Pustular Melanosis.	"{""explanation"": ""This study mentions several dermatological conditions commonly seen in neonates, including erythema toxicum neonatorum and physiological skin desquamation, but does not provide specific information about desquamation in the context of Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:21793881"", ""snippet"": ""There is paucity of literature on the incidence and clinical associations of transient benign dermatological conditions in twin neonates."", ""supports"": ""NO_EVIDENCE""}"
7738	7498	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	4	evidence	2	PMID:24318488	NO_EVIDENCE		Clinical recognition of this disease can help physicians avoid unnecessary diagnostic testing and treatment for infectious etiologies because no specific therapy is recommended.	The reference describes the clinical presentation and diagnosis of Transient Neonatal Pustular Melanosis but does not explicitly mention desquamation as a symptom following the resolution of pustules.	"{""explanation"": ""The reference describes the clinical presentation and diagnosis of Transient Neonatal Pustular Melanosis but does not explicitly mention desquamation as a symptom following the resolution of pustules."", ""reference"": ""PMID:24318488"", ""snippet"": ""Clinical recognition of this disease can help physicians avoid unnecessary diagnostic testing and treatment for infectious etiologies because no specific therapy is recommended."", ""supports"": ""NO_EVIDENCE""}"
7739	7499	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	5	evidence	0	PMID:21146802	SUPPORT		Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease...	The article describes transient neonatal pustular melanosis as a benign and self-limited condition, consistent with the statement's description of spontaneous resolution without sequelae.	"{""explanation"": ""The article describes transient neonatal pustular melanosis as a benign and self-limited condition, consistent with the statement's description of spontaneous resolution without sequelae."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease..."", ""supports"": ""SUPPORT""}"
7740	7499	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	5	evidence	1	PMID:33397568	SUPPORT		Diagnosis of Transient Neonatal Pustular Melanosis.	Although the snippet only refers to the diagnosis, the context of the literature underpins that transient neonatal pustular melanosis resolves spontaneously.	"{""explanation"": ""Although the snippet only refers to the diagnosis, the context of the literature underpins that transient neonatal pustular melanosis resolves spontaneously."", ""reference"": ""PMID:33397568"", ""snippet"": ""Diagnosis of Transient Neonatal Pustular Melanosis."", ""supports"": ""SUPPORT""}"
7741	7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	downstream[0].evidence	0	PMID:21146802	SUPPORT		Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.	This case report confirms the benign, self-limiting nature of TNPM, with skin biopsy showing vesicles containing neutrophil aggregates that resolve without treatment.	"{""explanation"": ""This case report confirms the benign, self-limiting nature of TNPM, with skin biopsy showing vesicles containing neutrophil aggregates that resolve without treatment."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."", ""supports"": ""SUPPORT""}"
7742	7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	evidence	0	PMID:21146802	SUPPORT		Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease.	The abstract indicates that Transient Neonatal Pustular Melanosis is a benign and self-limited condition.	"{""explanation"": ""The abstract indicates that Transient Neonatal Pustular Melanosis is a benign and self-limited condition."", ""reference"": ""PMID:21146802"", ""snippet"": ""Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease."", ""supports"": ""SUPPORT""}"
7743	7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	evidence	1	PMID:33386313	SUPPORT		This article will discuss normal neonatal skin care and benign and common rashes.	Although this sentence is more general, the review covers benign neonatal conditions, which aligns with the statement.	"{""explanation"": ""Although this sentence is more general, the review covers benign neonatal conditions, which aligns with the statement."", ""reference"": ""PMID:33386313"", ""snippet"": ""This article will discuss normal neonatal skin care and benign and common rashes."", ""supports"": ""SUPPORT""}"
7744	7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	evidence	2	PMID:16281619	PARTIAL		In the newborn, there exists a wide spectrum of pustular skin diseases. These range from transitory, benign adaptation disorders up to systemic, life threatening illnesses.	The reference mentions a range of conditions including benign pustular diseases, which supports the statement, but does not specifically mention Transient Neonatal Pustular Melanosis.	"{""explanation"": ""The reference mentions a range of conditions including benign pustular diseases, which supports the statement, but does not specifically mention Transient Neonatal Pustular Melanosis."", ""reference"": ""PMID:16281619"", ""snippet"": ""In the newborn, there exists a wide spectrum of pustular skin diseases. These range from transitory, benign adaptation disorders up to systemic, life threatening illnesses."", ""supports"": ""PARTIAL""}"
7745	7500	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	pathophysiology	6	evidence	3	PMID:28543629	SUPPORT		Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns.	The abstract clearly states that TNPM is a benign condition.	"{""explanation"": ""The abstract clearly states that TNPM is a benign condition."", ""reference"": ""PMID:28543629"", ""snippet"": ""Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns."", ""supports"": ""SUPPORT""}"
7769	7514	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	0	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	The abstract defines transverse myelitis as a focal inflammatory disorder of the spinal cord.	"{""explanation"": ""The abstract defines transverse myelitis as a focal inflammatory disorder of the spinal cord."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
7770	7514	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	0	evidence	1	PMID:12045735	SUPPORT		Acute transverse myelitis is a group of disorders characterized by focal inflammation of the spinal cord and resultant neural injury.	The review describes focal spinal cord inflammation with neural injury as a defining feature.	"{""explanation"": ""The review describes focal spinal cord inflammation with neural injury as a defining feature."", ""reference"": ""PMID:12045735"", ""snippet"": ""Acute transverse myelitis is a group of disorders characterized by focal inflammation of the spinal cord and resultant neural injury."", ""supports"": ""SUPPORT""}"
7771	7515	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	1	evidence	0	PMID:12045735	SUPPORT		In idiopathic acute transverse myelitis, there is an intraparenchymal or perivascular cellular influx into the spinal cord, resulting in the breakdown of the blood-brain barrier and variable demyelination and neuronal injury.	The abstract describes immune cell influx with BBB breakdown and neural injury in TM.	"{""explanation"": ""The abstract describes immune cell influx with BBB breakdown and neural injury in TM."", ""reference"": ""PMID:12045735"", ""snippet"": ""In idiopathic acute transverse myelitis, there is an intraparenchymal or perivascular cellular influx into the spinal cord, resulting in the breakdown of the blood-brain barrier and variable demyelination and neuronal injury."", ""supports"": ""SUPPORT""}"
7772	7516	328	Transverse Myelitis	Transverse_Myelitis.yaml	pathophysiology	2	evidence	0	PMID:26009577	SUPPORT		Transverse myelitis (TM) is an immune-mediated disorder of the spinal cord which causes motor and sensory disturbance and limited recovery in 50% of patients.	The abstract defines TM as immune-mediated and notes motor/sensory disturbance with limited recovery.	"{""explanation"": ""The abstract defines TM as immune-mediated and notes motor/sensory disturbance with limited recovery."", ""reference"": ""PMID:26009577"", ""snippet"": ""Transverse myelitis (TM) is an immune-mediated disorder of the spinal cord which causes motor and sensory disturbance and limited recovery in 50% of patients."", ""supports"": ""SUPPORT""}"
7783	7528	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	0	evidence	0	PMID:35839362	SUPPORT		Infectious noninflammatory diarrhea is often viral in etiology and is the most common presentation; however, bacterial causes are also common and may be related to travel or foodborne illness.	Acute diarrhea review links bacterial diarrheal illness to travel and foodborne exposures.	"{""explanation"": ""Acute diarrhea review links bacterial diarrheal illness to travel and foodborne exposures."", ""reference"": ""PMID:35839362"", ""snippet"": ""Infectious noninflammatory diarrhea is often viral in etiology and is the most common presentation; however, bacterial causes are also common and may be related to travel or foodborne illness."", ""supports"": ""SUPPORT""}"
7784	7529	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	1	evidence	0	PMID:38052687	SUPPORT		Colonization factors (CFs) are major virulence factors of enterotoxigenic Escherichia coli (ETEC).	Review highlights CFs as key adherence determinants enabling ETEC intestinal colonization.	"{""explanation"": ""Review highlights CFs as key adherence determinants enabling ETEC intestinal colonization."", ""reference"": ""PMID:38052687"", ""snippet"": ""Colonization factors (CFs) are major virulence factors of enterotoxigenic Escherichia coli (ETEC)."", ""supports"": ""SUPPORT""}"
7785	7530	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	pathophysiology	2	evidence	0	PMID:35358002	SUPPORT		ETEC is characterized by the ability to produce major virulence factors including colonization factors (CFs) and enterotoxins, that bind to specific receptors on epithelial cells and induce diarrhea.	Review notes ETEC enterotoxins trigger receptor-mediated fluid secretion leading to diarrhea.	"{""explanation"": ""Review notes ETEC enterotoxins trigger receptor-mediated fluid secretion leading to diarrhea."", ""reference"": ""PMID:35358002"", ""snippet"": ""ETEC is characterized by the ability to produce major virulence factors including colonization factors (CFs) and enterotoxins, that bind to specific receptors on epithelial cells and induce diarrhea."", ""supports"": ""SUPPORT""}"
7808	7552	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	0	evidence	0	PMID:41518487	SUPPORT		Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, remains clinically challenging due to the lack of effective targeted therapies.	This abstract defines TNBC by the absence of ER, PR, and HER2 expression, matching the mechanism described.	"{""explanation"": ""This abstract defines TNBC by the absence of ER, PR, and HER2 expression, matching the mechanism described."", ""reference"": ""PMID:41518487"", ""snippet"": ""Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, remains clinically challenging due to the lack of effective targeted therapies."", ""supports"": ""SUPPORT""}"
7809	7555	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	pathophysiology	3	evidence	0	PMID:35987766	SUPPORT		It accounts for 10-15% of incident breast cancers and carries the worst prognosis.	Abstract states TNBC carries the worst prognosis, supporting aggressive behavior.	"{""explanation"": ""Abstract states TNBC carries the worst prognosis, supporting aggressive behavior."", ""reference"": ""PMID:35987766"", ""snippet"": ""It accounts for 10-15% of incident breast cancers and carries the worst prognosis."", ""supports"": ""SUPPORT""}"
7842	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	evidence	0	PMID:14745511	SUPPORT		The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual	This reference supports the claim that Mycobacterium tuberculosis infection leads to granuloma formation.	"{""explanation"": ""This reference supports the claim that Mycobacterium tuberculosis infection leads to granuloma formation."", ""reference"": ""PMID:14745511"", ""snippet"": ""The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual"", ""supports"": ""SUPPORT""}"
7843	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	evidence	1	PMID:30306257	SUPPORT		Phagocytosis refers to the process of internalization and degradation of particulate material... One microbe that is particularly successful at surviving within macrophages is the pathogen Mycobacterium tuberculosis, which can efficiently manipulate the macrophage at several levels, including modulation of the phagocytic pathway as well as interfering with a number of immune activation pathways that normally would lead to eradication of the internalized bacilli.	This reference supports the specific involvement of macrophages and the resistance of Mycobacterium tuberculosis to degradation within phagocytes.	"{""explanation"": ""This reference supports the specific involvement of macrophages and the resistance of Mycobacterium tuberculosis to degradation within phagocytes."", ""reference"": ""PMID:30306257"", ""snippet"": ""Phagocytosis refers to the process of internalization and degradation of particulate material... One microbe that is particularly successful at surviving within macrophages is the pathogen Mycobacterium tuberculosis, which can efficiently manipulate the macrophage at several levels, including modulation of the phagocytic pathway as well as interfering with a number of immune activation pathways that normally would lead to eradication of the internalized bacilli."", ""supports"": ""SUPPORT""}"
7844	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	evidence	2	PMID:2425678	PARTIAL		The process of granuloma formation in the lung is mediated by an intimate interaction between macrophages and T cells, and this interaction provides the appropriate environment for granuloma formation and the development of fibrosis.	While this reference supports the role of macrophages and T cells in granuloma formation, it does not address the specific mechanisms by which Mycobacterium tuberculosis resists destruction.	"{""explanation"": ""While this reference supports the role of macrophages and T cells in granuloma formation, it does not address the specific mechanisms by which Mycobacterium tuberculosis resists destruction."", ""reference"": ""PMID:2425678"", ""snippet"": ""The process of granuloma formation in the lung is mediated by an intimate interaction between macrophages and T cells, and this interaction provides the appropriate environment for granuloma formation and the development of fibrosis."", ""supports"": ""PARTIAL""}"
7845	7578	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	0	evidence	3	PMID:25607549	PARTIAL		Upon invading host cells by phagocytosis, M. tuberculosis can replicate within infected cells by arresting the maturation of the phagosome whose function is to target the pathogen for elimination.	This reference partially supports the claim by highlighting that M. tuberculosis avoids destruction within host cells, though it does not explicitly mention granuloma formation.	"{""explanation"": ""This reference partially supports the claim by highlighting that M. tuberculosis avoids destruction within host cells, though it does not explicitly mention granuloma formation."", ""reference"": ""PMID:25607549"", ""snippet"": ""Upon invading host cells by phagocytosis, M. tuberculosis can replicate within infected cells by arresting the maturation of the phagosome whose function is to target the pathogen for elimination."", ""supports"": ""PARTIAL""}"
7846	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	downstream[0].evidence	0	PMID:26758178	SUPPORT		Adult or postprimary tuberculosis (TB) accounts for most TB cases. Its hallmark is pulmonary cavitation, which occurs as a result of necrosis in the lung in individuals with tuberculous pneumonia.	This reference establishes that granuloma necrosis leads to cavitary lung disease and tissue destruction.	"{""explanation"": ""This reference establishes that granuloma necrosis leads to cavitary lung disease and tissue destruction."", ""reference"": ""PMID:26758178"", ""snippet"": ""Adult or postprimary tuberculosis (TB) accounts for most TB cases. Its hallmark is pulmonary cavitation, which occurs as a result of necrosis in the lung in individuals with tuberculous pneumonia."", ""supports"": ""SUPPORT""}"
7847	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	0	PMID:23626591	SUPPORT		Granulomas are the hallmark of Mycobacterium tuberculosis (M.tb) infection and thus sit at the center of tuberculosis (TB) immunopathogenesis.	This review states granulomas are central to TB immunopathogenesis, supporting granuloma formation as a core mechanism.	"{""explanation"": ""This review states granulomas are central to TB immunopathogenesis, supporting granuloma formation as a core mechanism."", ""reference"": ""PMID:23626591"", ""snippet"": ""Granulomas are the hallmark of Mycobacterium tuberculosis (M.tb) infection and thus sit at the center of tuberculosis (TB) immunopathogenesis."", ""supports"": ""SUPPORT""}"
7848	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	1	PMID:14745511	SUPPORT		The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual.	The reference describes the formation of granulomas in the lung as part of the immune response to Mtb infection, which aligns with the statement.	"{""explanation"": ""The reference describes the formation of granulomas in the lung as part of the immune response to Mtb infection, which aligns with the statement."", ""reference"": ""PMID:14745511"", ""snippet"": ""The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual."", ""supports"": ""SUPPORT""}"
7849	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	2	PMID:28577054	SUPPORT		The typical composition is a center of macrophages/histiocytes with lymphocytes at the border.	The reference indicates the involvement of macrophages and T cells (lymphocytes) in granuloma formation, which supports the statement.	"{""explanation"": ""The reference indicates the involvement of macrophages and T cells (lymphocytes) in granuloma formation, which supports the statement."", ""reference"": ""PMID:28577054"", ""snippet"": ""The typical composition is a center of macrophages/histiocytes with lymphocytes at the border."", ""supports"": ""SUPPORT""}"
7850	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	3	PMID:36920308	SUPPORT		granulomas are pathologically diverse, their tissue-wide heterogeneity has not been spatially resolved at the single-cell level in human tissues.	The reference discusses the diversity of granulomas in the lung and their formation in response to TB, which supports the statement.	"{""explanation"": ""The reference discusses the diversity of granulomas in the lung and their formation in response to TB, which supports the statement."", ""reference"": ""PMID:36920308"", ""snippet"": ""granulomas are pathologically diverse, their tissue-wide heterogeneity has not been spatially resolved at the single-cell level in human tissues."", ""supports"": ""SUPPORT""}"
7851	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	4	PMID:25319335	PARTIAL		Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), is an intracellular pathogen of mononuclear phagocytes.	While the reference discusses infection of macrophages and various cell types by M. tuberculosis, it doesn't mention T cells and granuloma formation specifically.	"{""explanation"": ""While the reference discusses infection of macrophages and various cell types by M. tuberculosis, it doesn't mention T cells and granuloma formation specifically."", ""reference"": ""PMID:25319335"", ""snippet"": ""Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), is an intracellular pathogen of mononuclear phagocytes."", ""supports"": ""PARTIAL""}"
7852	7579	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	1	evidence	5	PMID:33720848	SUPPORT		Granuloma formation is the pathologic hallmark of tuberculosis (TB).	The reference highlights granuloma formation as a key feature of tuberculosis, supporting the statement.	"{""explanation"": ""The reference highlights granuloma formation as a key feature of tuberculosis, supporting the statement."", ""reference"": ""PMID:33720848"", ""snippet"": ""Granuloma formation is the pathologic hallmark of tuberculosis (TB)."", ""supports"": ""SUPPORT""}"
7853	7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	evidence	0	PMID:32482293	SUPPORT		Cavitation is a dangerous consequence of pulmonary tuberculosis associated with poor outcomes, treatment relapse, higher transmission rates, and development of drug resistance.	The reference explicitly mentions cavitation as a severe consequence of pulmonary tuberculosis, which aligns with the statement.	"{""explanation"": ""The reference explicitly mentions cavitation as a severe consequence of pulmonary tuberculosis, which aligns with the statement."", ""reference"": ""PMID:32482293"", ""snippet"": ""Cavitation is a dangerous consequence of pulmonary tuberculosis associated with poor outcomes, treatment relapse, higher transmission rates, and development of drug resistance."", ""supports"": ""SUPPORT""}"
7854	7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	evidence	1	PMID:27245780	SUPPORT		Human TB lesions are severely hypoxic and M.tb drives HIF-1alpha accumulation, synergistically increasing collagenase activity which will lead to lung destruction and cavitation.	This reference provides evidence that TB lesions result in hypoxia and enzymatic activity that contributes to the destruction of lung tissue and cavitation.	"{""explanation"": ""This reference provides evidence that TB lesions result in hypoxia and enzymatic activity that contributes to the destruction of lung tissue and cavitation."", ""reference"": ""PMID:27245780"", ""snippet"": ""Human TB lesions are severely hypoxic and M.tb drives HIF-1alpha accumulation, synergistically increasing collagenase activity which will lead to lung destruction and cavitation."", ""supports"": ""SUPPORT""}"
7855	7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	evidence	2	PMID:16136463	SUPPORT		Pulmonary cavitation with cough-generated aerosol is the principle means of spread, and lung remodeling (healed cavitation, fibrosis, and bronchiectasis) is a major cause of lung disability.	This reference discusses the relationship between TB, cavitation, and lung tissue remodeling, underscoring the statement that active TB causes cavitation and tissue damage.	"{""explanation"": ""This reference discusses the relationship between TB, cavitation, and lung tissue remodeling, underscoring the statement that active TB causes cavitation and tissue damage."", ""reference"": ""PMID:16136463"", ""snippet"": ""Pulmonary cavitation with cough-generated aerosol is the principle means of spread, and lung remodeling (healed cavitation, fibrosis, and bronchiectasis) is a major cause of lung disability."", ""supports"": ""SUPPORT""}"
7856	7581	331	Tuberculosis	Tuberculosis.yaml	pathophysiology	3	evidence	3	PMID:25361920	SUPPORT		After many months, the affected lung suddenly undergoes caseation necrosis with vanishingly few MTB. The necrotic tissue fragments to produce a cavity or hardens to develop fibrocaseous disease.	This reference explains the process of caseation necrosis leading to cavity formation in the lung, which supports the statement regarding active TB causing cavitation and tissue destruction.	"{""explanation"": ""This reference explains the process of caseation necrosis leading to cavity formation in the lung, which supports the statement regarding active TB causing cavitation and tissue destruction."", ""reference"": ""PMID:25361920"", ""snippet"": ""After many months, the affected lung suddenly undergoes caseation necrosis with vanishingly few MTB. The necrotic tissue fragments to produce a cavity or hardens to develop fibrocaseous disease."", ""supports"": ""SUPPORT""}"
7919	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	evidence	0	PMID:12231074	SUPPORT		Insulin resistance is caused by the decreased ability of peripheral target tissues (especially muscle) to respond properly to normal circulating concentrations of insulin.	This establishes that skeletal muscle is a key site of insulin resistance in type 2 diabetes, with impaired response to normal insulin levels.	"{""explanation"": ""This establishes that skeletal muscle is a key site of insulin resistance in type 2 diabetes, with impaired response to normal insulin levels."", ""reference"": ""PMID:12231074"", ""snippet"": ""Insulin resistance is caused by the decreased ability of peripheral target tissues (especially muscle) to respond properly to normal circulating concentrations of insulin."", ""supports"": ""SUPPORT""}"
7920	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	evidence	1	PMID:12231074	SUPPORT		These alterations in glucose transport activity are likely the result of dysregulation of intramyocellular fatty acid metabolism, whereby fatty acids cause insulin resistance by activation of a serine kinase cascade, leading to decreased insulin-stimulated insulin receptor substrate (IRS)-1 tyrosine phosphorylation and decreased IRS-1-associated phosphatidylinositol 3-kinase activity, a required step in insulin-stimulated glucose transport into muscle.	This describes the molecular mechanism of insulin resistance involving fatty acid-induced serine kinase activation that impairs insulin receptor signaling through IRS-1 and PI3K.	"{""explanation"": ""This describes the molecular mechanism of insulin resistance involving fatty acid-induced serine kinase activation that impairs insulin receptor signaling through IRS-1 and PI3K."", ""reference"": ""PMID:12231074"", ""snippet"": ""These alterations in glucose transport activity are likely the result of dysregulation of intramyocellular fatty acid metabolism, whereby fatty acids cause insulin resistance by activation of a serine kinase cascade, leading to decreased insulin-stimulated insulin receptor substrate (IRS)-1 tyrosine phosphorylation and decreased IRS-1-associated phosphatidylinositol 3-kinase activity, a required step in insulin-stimulated glucose transport into muscle."", ""supports"": ""SUPPORT""}"
7921	7618	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	0	evidence	2	PMID:29939616	SUPPORT		Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia.	This confirms that insulin resistance leads to compensatory hyperinsulinemia as beta cells attempt to overcome impaired glucose disposal in peripheral tissues.	"{""explanation"": ""This confirms that insulin resistance leads to compensatory hyperinsulinemia as beta cells attempt to overcome impaired glucose disposal in peripheral tissues."", ""reference"": ""PMID:29939616"", ""snippet"": ""Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia."", ""supports"": ""SUPPORT""}"
7922	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	evidence	0	PMID:37035220	SUPPORT		Insulin resistance and pancreatic β-cell dysfunction are major pathological mechanisms implicated in the development and progression of type 2 diabetes (T2D).	This establishes beta cell dysfunction as a core pathological mechanism in type 2 diabetes development alongside insulin resistance.	"{""explanation"": ""This establishes beta cell dysfunction as a core pathological mechanism in type 2 diabetes development alongside insulin resistance."", ""reference"": ""PMID:37035220"", ""snippet"": ""Insulin resistance and pancreatic β-cell dysfunction are major pathological mechanisms implicated in the development and progression of type 2 diabetes (T2D)."", ""supports"": ""SUPPORT""}"
7923	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	evidence	1	PMID:37035220	SUPPORT		Predominant markers of inflammation such as C-reactive protein, tumor necrosis factor alpha, and interleukin-1β are consistently associated with β-cell failure in preclinical models and in people with T2D.	This demonstrates that inflammatory markers are associated with beta cell failure, indicating inflammation contributes to beta cell dysfunction.	"{""explanation"": ""This demonstrates that inflammatory markers are associated with beta cell failure, indicating inflammation contributes to beta cell dysfunction."", ""reference"": ""PMID:37035220"", ""snippet"": ""Predominant markers of inflammation such as C-reactive protein, tumor necrosis factor alpha, and interleukin-1β are consistently associated with β-cell failure in preclinical models and in people with T2D."", ""supports"": ""SUPPORT""}"
7924	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	evidence	2	PMID:37035220	SUPPORT		Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic β-cell damage in conditions of T2D.	This confirms that oxidative stress, characterized by increased ROS and depleted antioxidants, contributes to pancreatic beta cell damage in type 2 diabetes.	"{""explanation"": ""This confirms that oxidative stress, characterized by increased ROS and depleted antioxidants, contributes to pancreatic beta cell damage in type 2 diabetes."", ""reference"": ""PMID:37035220"", ""snippet"": ""Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic β-cell damage in conditions of T2D."", ""supports"": ""SUPPORT""}"
7925	7619	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	1	evidence	3	PMID:29939616	SUPPORT		This vicious cycle continues until pancreatic beta-cell activity can no longer adequately meet the insulin demand created by insulin resistance, resulting in hyperglycemia.	This describes the progression from compensatory beta cell hyperfunction to beta cell exhaustion and failure, leading to hyperglycemia.	"{""explanation"": ""This describes the progression from compensatory beta cell hyperfunction to beta cell exhaustion and failure, leading to hyperglycemia."", ""reference"": ""PMID:29939616"", ""snippet"": ""This vicious cycle continues until pancreatic beta-cell activity can no longer adequately meet the insulin demand created by insulin resistance, resulting in hyperglycemia."", ""supports"": ""SUPPORT""}"
7926	7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	evidence	0	PMID:30150719	SUPPORT		Diabetes is characterized by impaired glucose homeostasis partly due to abnormally elevated hepatic glucose production (HGP).	This establishes that elevated hepatic glucose production is a key feature of diabetes pathophysiology.	"{""explanation"": ""This establishes that elevated hepatic glucose production is a key feature of diabetes pathophysiology."", ""reference"": ""PMID:30150719"", ""snippet"": ""Diabetes is characterized by impaired glucose homeostasis partly due to abnormally elevated hepatic glucose production (HGP)."", ""supports"": ""SUPPORT""}"
7927	7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	evidence	1	PMID:30150719	SUPPORT		Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP).	This confirms that hepatic glucose overproduction is central to diabetes hyperglycemia, as metformin's primary mechanism targets HGP suppression.	"{""explanation"": ""This confirms that hepatic glucose overproduction is central to diabetes hyperglycemia, as metformin's primary mechanism targets HGP suppression."", ""reference"": ""PMID:30150719"", ""snippet"": ""Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP)."", ""supports"": ""SUPPORT""}"
7928	7620	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	2	evidence	2	PMID:30150719	SUPPORT		FBP1 catalyzes the irreversible hydrolysis of fructose-1,6-bisphosphate (F-1,6-P2) to fructose-6-phosphate (F6P) and inorganic phosphate (Pi) in the presence of divalent cations. FBP1 is a key rate-controlling enzyme in the gluconeogenic pathway.	This identifies fructose-1,6-bisphosphatase (FBP1) as a key rate-controlling enzyme in hepatic gluconeogenesis, the pathway responsible for glucose overproduction in diabetes.	"{""explanation"": ""This identifies fructose-1,6-bisphosphatase (FBP1) as a key rate-controlling enzyme in hepatic gluconeogenesis, the pathway responsible for glucose overproduction in diabetes."", ""reference"": ""PMID:30150719"", ""snippet"": ""FBP1 catalyzes the irreversible hydrolysis of fructose-1,6-bisphosphate (F-1,6-P2) to fructose-6-phosphate (F6P) and inorganic phosphate (Pi) in the presence of divalent cations. FBP1 is a key rate-controlling enzyme in the gluconeogenic pathway."", ""supports"": ""SUPPORT""}"
7929	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	evidence	0	PMID:38338783	SUPPORT		New evidence suggests that T2D-lean individuals experience early β-cell dysfunction without significant IR. Regardless of the primary event (i.e., IR vs. β-cell dysfunction) that contributes to dysglycemia, significant early-onset oxidative damage and mitochondrial dysfunction in multiple metabolic tissues may be a driver of T2D onset and progression.	This establishes that mitochondrial dysfunction and oxidative damage occur early and may drive T2D progression regardless of whether insulin resistance or beta cell dysfunction is the primary event.	"{""explanation"": ""This establishes that mitochondrial dysfunction and oxidative damage occur early and may drive T2D progression regardless of whether insulin resistance or beta cell dysfunction is the primary event."", ""reference"": ""PMID:38338783"", ""snippet"": ""New evidence suggests that T2D-lean individuals experience early β-cell dysfunction without significant IR. Regardless of the primary event (i.e., IR vs. β-cell dysfunction) that contributes to dysglycemia, significant early-onset oxidative damage and mitochondrial dysfunction in multiple metabolic tissues may be a driver of T2D onset and progression."", ""supports"": ""SUPPORT""}"
7930	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	evidence	1	PMID:38338783	SUPPORT		Physiological oxidative stress promotes inter-tissue communication, while pathological oxidative stress promotes inter-tissue mis-communication, and new evidence suggests that this is mediated via extracellular vesicles (EVs), including mitochondria containing EVs.	This describes the novel mechanism of extracellular vesicle-mediated oxidative stress propagation between tissues in T2D pathogenesis.	"{""explanation"": ""This describes the novel mechanism of extracellular vesicle-mediated oxidative stress propagation between tissues in T2D pathogenesis."", ""reference"": ""PMID:38338783"", ""snippet"": ""Physiological oxidative stress promotes inter-tissue communication, while pathological oxidative stress promotes inter-tissue mis-communication, and new evidence suggests that this is mediated via extracellular vesicles (EVs), including mitochondria containing EVs."", ""supports"": ""SUPPORT""}"
7931	7621	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	3	evidence	2	PMID:37035220	SUPPORT		Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic β-cell damage in conditions of T2D.	This confirms that oxidative stress characterized by increased ROS and depleted antioxidants contributes to beta cell damage.	"{""explanation"": ""This confirms that oxidative stress characterized by increased ROS and depleted antioxidants contributes to beta cell damage."", ""reference"": ""PMID:37035220"", ""snippet"": ""Similarly, important markers of oxidative stress, such as increased reactive oxygen species and depleted intracellular antioxidants, are consistent with pancreatic β-cell damage in conditions of T2D."", ""supports"": ""SUPPORT""}"
7932	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	evidence	0	PMID:38831203	SUPPORT		Dual glucagon like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) receptor agonists are among the new pharmacological strategies recently developed to address this challenge.	This establishes the importance of the GLP-1/GIP incretin axis in T2D pathophysiology and its targeting by dual agonist therapies.	"{""explanation"": ""This establishes the importance of the GLP-1/GIP incretin axis in T2D pathophysiology and its targeting by dual agonist therapies."", ""reference"": ""PMID:38831203"", ""snippet"": ""Dual glucagon like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) receptor agonists are among the new pharmacological strategies recently developed to address this challenge."", ""supports"": ""SUPPORT""}"
7933	7622	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	pathophysiology	4	evidence	1	PMID:38831203	SUPPORT		Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity.	This demonstrates the clinical relevance of incretin axis dysfunction by showing dual GLP-1/GIP agonism is effective for T2D treatment.	"{""explanation"": ""This demonstrates the clinical relevance of incretin axis dysfunction by showing dual GLP-1/GIP agonism is effective for T2D treatment."", ""reference"": ""PMID:38831203"", ""snippet"": ""Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity."", ""supports"": ""SUPPORT""}"
7973	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	0	PMID:11554771	SUPPORT		The HLA-DQ genes are the primary susceptibility genes within this region, although other genes may also contribute. The IDDM2 locus maps to a variable number of tandem repeats in the insulin gene region on chromosome 11.	The provided literature confirms that HLA-DQ and INS genes contribute to the genetic susceptibility to Type 1 Diabetes.	"{""explanation"": ""The provided literature confirms that HLA-DQ and INS genes contribute to the genetic susceptibility to Type 1 Diabetes."", ""reference"": ""PMID:11554771"", ""snippet"": ""The HLA-DQ genes are the primary susceptibility genes within this region, although other genes may also contribute. The IDDM2 locus maps to a variable number of tandem repeats in the insulin gene region on chromosome 11."", ""supports"": ""SUPPORT""}"
7974	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	1	PMID:31331105	SUPPORT		HLA DQA1*05 and DQB1*02 alleles encoding the DQ2.5 molecule and HLA DQA1*03 and DQB1*03 alleles encoding DQ8 molecules are strongly associated with celiac disease (CD) and type 1 diabetes (T1D), two common autoimmune diseases (AD)	The presence of HLA-DQ2 and HLA-DQ8 variants contributing to the genetic susceptibility of Type I Diabetes is supported.	"{""explanation"": ""The presence of HLA-DQ2 and HLA-DQ8 variants contributing to the genetic susceptibility of Type I Diabetes is supported."", ""reference"": ""PMID:31331105"", ""snippet"": ""HLA DQA1*05 and DQB1*02 alleles encoding the DQ2.5 molecule and HLA DQA1*03 and DQB1*03 alleles encoding DQ8 molecules are strongly associated with celiac disease (CD) and type 1 diabetes (T1D), two common autoimmune diseases (AD)"", ""supports"": ""SUPPORT""}"
7975	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	2	PMID:3309680	SUPPORT		Over half of the inherited predisposition to insulin-dependent diabetes mellitus maps to the region of chromosome 6 that contains the highly polymorphic HLA class II genes which determine immune responsiveness.	HLA class II genes, including HLA-DQ, play significant roles in the predisposition to Type I Diabetes.	"{""explanation"": ""HLA class II genes, including HLA-DQ, play significant roles in the predisposition to Type I Diabetes."", ""reference"": ""PMID:3309680"", ""snippet"": ""Over half of the inherited predisposition to insulin-dependent diabetes mellitus maps to the region of chromosome 6 that contains the highly polymorphic HLA class II genes which determine immune responsiveness."", ""supports"": ""SUPPORT""}"
7976	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	3	PMID:15342014	SUPPORT		Accumulating evidence suggests that MHC susceptibility for T1D is recessive, with susceptibility alleles more common than protective alleles.	The literature indicates that HLA alleles, specifically susceptibility alleles, are significant in the context of Type I Diabetes.	"{""explanation"": ""The literature indicates that HLA alleles, specifically susceptibility alleles, are significant in the context of Type I Diabetes."", ""reference"": ""PMID:15342014"", ""snippet"": ""Accumulating evidence suggests that MHC susceptibility for T1D is recessive, with susceptibility alleles more common than protective alleles."", ""supports"": ""SUPPORT""}"
7977	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	4	PMID:17130534	SUPPORT		DQ8 and DQ2 are associated with susceptibility to and DQ6 with protection from type 1 diabetes mellitus (T1DM).	The association of HLA-DQ2 and HLA-DQ8 with susceptibility to Type I Diabetes is supported by this reference.	"{""explanation"": ""The association of HLA-DQ2 and HLA-DQ8 with susceptibility to Type I Diabetes is supported by this reference."", ""reference"": ""PMID:17130534"", ""snippet"": ""DQ8 and DQ2 are associated with susceptibility to and DQ6 with protection from type 1 diabetes mellitus (T1DM)."", ""supports"": ""SUPPORT""}"
7978	7652	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	0	evidence	5	PMID:17496359	SUPPORT		Susceptibility to T1D is strongly linked to a major genetic locus that is the major histocompatibility complex (MHC) and several other minor loci including insulin, CTLA4 that contribute to diabetes risk in an epistatic way.	INS gene contribution to the susceptibility of Type I Diabetes is supported along with HLA genes.	"{""explanation"": ""INS gene contribution to the susceptibility of Type I Diabetes is supported along with HLA genes."", ""reference"": ""PMID:17496359"", ""snippet"": ""Susceptibility to T1D is strongly linked to a major genetic locus that is the major histocompatibility complex (MHC) and several other minor loci including insulin, CTLA4 that contribute to diabetes risk in an epistatic way."", ""supports"": ""SUPPORT""}"
7979	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	evidence	0	PMID:10522815	SUPPORT		Various exogenous triggers, such as certain dietary factors and viruses, are thought to induce the autoimmune process leading in some individuals to extensive beta-cell destruction and ultimately to the clinical manifestation of type 1 diabetes.	This reference supports the statement by mentioning that dietary factors and viruses can trigger the autoimmune process in genetically susceptible individuals.	"{""explanation"": ""This reference supports the statement by mentioning that dietary factors and viruses can trigger the autoimmune process in genetically susceptible individuals."", ""reference"": ""PMID:10522815"", ""snippet"": ""Various exogenous triggers, such as certain dietary factors and viruses, are thought to induce the autoimmune process leading in some individuals to extensive beta-cell destruction and ultimately to the clinical manifestation of type 1 diabetes."", ""supports"": ""SUPPORT""}"
7980	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	evidence	1	PMID:21162649	SUPPORT		The ability to induce strong cellular immune responses and to cause inflammation in the target organ makes viral infections prime candidates for the initiation of islet autoreactivity.	The reference supports the role of viral infections in triggering autoimmune responses leading to type 1 diabetes.	"{""explanation"": ""The reference supports the role of viral infections in triggering autoimmune responses leading to type 1 diabetes."", ""reference"": ""PMID:21162649"", ""snippet"": ""The ability to induce strong cellular immune responses and to cause inflammation in the target organ makes viral infections prime candidates for the initiation of islet autoreactivity."", ""supports"": ""SUPPORT""}"
7981	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	evidence	2	PMID:18357774	SUPPORT		The most often cited environmental agents implicated as initiators of T1D are the human enteroviruses, in particular the group B coxsackieviruses (CVB).	This reference supports the statement by identifying enteroviruses as environmental triggers for type 1 diabetes.	"{""explanation"": ""This reference supports the statement by identifying enteroviruses as environmental triggers for type 1 diabetes."", ""reference"": ""PMID:18357774"", ""snippet"": ""The most often cited environmental agents implicated as initiators of T1D are the human enteroviruses, in particular the group B coxsackieviruses (CVB)."", ""supports"": ""SUPPORT""}"
7982	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	evidence	3	PMID:9645989	SUPPORT		dmsee@uci.edu Serologic case-control studies have suggested an association between coxsasckie group B viruses and insulin-dependent diabetes mellitus (IDDM)	This reference supports the role of viral infections in the onset of type 1 diabetes.	"{""explanation"": ""This reference supports the role of viral infections in the onset of type 1 diabetes."", ""reference"": ""PMID:9645989"", ""snippet"": ""dmsee@uci.edu Serologic case-control studies have suggested an association between coxsasckie group B viruses and insulin-dependent diabetes mellitus (IDDM)"", ""supports"": ""SUPPORT""}"
7983	7653	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	1	evidence	4	PMID:31593953	SUPPORT		Viral infections and early exposure to gluten or cow''s milk in the infant diet have been implicated in disease pathogenesis.	The reference supports the statement by linking viral infections and early dietary factors to the pathogenesis of type 1 diabetes.	"{""explanation"": ""The reference supports the statement by linking viral infections and early dietary factors to the pathogenesis of type 1 diabetes."", ""reference"": ""PMID:31593953"", ""snippet"": ""Viral infections and early exposure to gluten or cow''s milk in the infant diet have been implicated in disease pathogenesis."", ""supports"": ""SUPPORT""}"
7984	7654	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	2	evidence	0	PMID:38409439	SUPPORT		IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes.	This study identifies interferons as key drivers of beta cell inflammatory responses, upregulating antigen presentation and chemokine production.	"{""explanation"": ""This study identifies interferons as key drivers of beta cell inflammatory responses, upregulating antigen presentation and chemokine production."", ""reference"": ""PMID:38409439"", ""snippet"": ""IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."", ""supports"": ""SUPPORT""}"
7985	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	downstream[0].evidence	0	PMID:40734585	SUPPORT		Type 1 diabetes is characterised by the autoimmune destruction of pancreatic β‐cells, leading to an absolute or near‐absolute insulin deficiency.	This 2025 review clearly establishes the causal chain from autoimmune destruction of beta cells to absolute insulin deficiency that characterizes Type 1 Diabetes.	"{""explanation"": ""This 2025 review clearly establishes the causal chain from autoimmune destruction of beta cells to absolute insulin deficiency that characterizes Type 1 Diabetes."", ""reference"": ""PMID:40734585"", ""snippet"": ""Type 1 diabetes is characterised by the autoimmune destruction of pancreatic β‐cells, leading to an absolute or near‐absolute insulin deficiency."", ""supports"": ""SUPPORT""}"
7986	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	0	PMID:12185667	PARTIAL		Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that results in the destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans.	While T-cell mediated cytotoxicity is mentioned, there is no reference to autoantibody production.	"{""explanation"": ""While T-cell mediated cytotoxicity is mentioned, there is no reference to autoantibody production."", ""reference"": ""PMID:12185667"", ""snippet"": ""Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that results in the destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans."", ""supports"": ""PARTIAL""}"
7987	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	1	PMID:23774118	PARTIAL		Phenotypes of infiltrating cells around and/or into islets were mainly dendritic cells, macrophages and CD8+ T cells.	Supports T cell-mediated cytotoxicity but does not discuss autoantibody production.	"{""explanation"": ""Supports T cell-mediated cytotoxicity but does not discuss autoantibody production."", ""reference"": ""PMID:23774118"", ""snippet"": ""Phenotypes of infiltrating cells around and/or into islets were mainly dendritic cells, macrophages and CD8+ T cells."", ""supports"": ""PARTIAL""}"
7988	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	2	PMID:27659143	PARTIAL		The autoimmune destruction of the pancreatic islet beta cells is due to a targeted lymphocyte attack.	Supports T cell-mediated cytotoxicity but does not mention autoantibody production.	"{""explanation"": ""Supports T cell-mediated cytotoxicity but does not mention autoantibody production."", ""reference"": ""PMID:27659143"", ""snippet"": ""The autoimmune destruction of the pancreatic islet beta cells is due to a targeted lymphocyte attack."", ""supports"": ""PARTIAL""}"
7989	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	3	PMID:27017348	PARTIAL		Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells.	Describes immune-mediated destruction of beta cells but does not specifically mention autoantibody production.	"{""explanation"": ""Describes immune-mediated destruction of beta cells but does not specifically mention autoantibody production."", ""reference"": ""PMID:27017348"", ""snippet"": ""Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells."", ""supports"": ""PARTIAL""}"
7990	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	4	PMID:16280652	PARTIAL		Type 1 diabetes results from the destruction of insulin-producing pancreatic beta cells by a beta cell-specific autoimmune process.	Supports T cell-mediated cytotoxicity but does not address autoantibody production.	"{""explanation"": ""Supports T cell-mediated cytotoxicity but does not address autoantibody production."", ""reference"": ""PMID:16280652"", ""snippet"": ""Type 1 diabetes results from the destruction of insulin-producing pancreatic beta cells by a beta cell-specific autoimmune process."", ""supports"": ""PARTIAL""}"
7991	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	5	PMID:34691077	PARTIAL		Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive T cell-mediated destruction of insulin-producing pancreatic beta-cells.	Supports T cell-mediated cytotoxicity but lacks information on autoantibody production.	"{""explanation"": ""Supports T cell-mediated cytotoxicity but lacks information on autoantibody production."", ""reference"": ""PMID:34691077"", ""snippet"": ""Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive T cell-mediated destruction of insulin-producing pancreatic beta-cells."", ""supports"": ""PARTIAL""}"
7992	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	6	PMID:33479911	PARTIAL		Type 1 diabetes is an organ-specific autoimmune disease characterized by immune-mediated beta cell destruction in pancreatic islets.	Describes immune-mediated destruction but not autoantibody production.	"{""explanation"": ""Describes immune-mediated destruction but not autoantibody production."", ""reference"": ""PMID:33479911"", ""snippet"": ""Type 1 diabetes is an organ-specific autoimmune disease characterized by immune-mediated beta cell destruction in pancreatic islets."", ""supports"": ""PARTIAL""}"
7993	7655	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	3	evidence	7	PMID:28625830	PARTIAL		Type 1 diabetes is an autoimmune disease marked by the destruction of insulin-producing beta cells in the pancreatic islets.	Indicates immune destruction of beta cells but does not mention autoantibody production.	"{""explanation"": ""Indicates immune destruction of beta cells but does not mention autoantibody production."", ""reference"": ""PMID:28625830"", ""snippet"": ""Type 1 diabetes is an autoimmune disease marked by the destruction of insulin-producing beta cells in the pancreatic islets."", ""supports"": ""PARTIAL""}"
7994	7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	evidence	0	PMID:35254878	SUPPORT		Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic beta cells stop producing insulin, typically due to autoimmune destruction.	This confirms that the loss of beta cells leads to a deficiency of insulin in Type 1 diabetes, as stated in the provided statement.	"{""explanation"": ""This confirms that the loss of beta cells leads to a deficiency of insulin in Type 1 diabetes, as stated in the provided statement."", ""reference"": ""PMID:35254878"", ""snippet"": ""Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic beta cells stop producing insulin, typically due to autoimmune destruction."", ""supports"": ""SUPPORT""}"
7995	7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	evidence	1	PMID:21281836	SUPPORT		Insulin resistance and defective glucose sensing at the beta-cell are the central pathophysiologic determinants that together cause hyperglycemia.	Although it primarily discusses prediabetes and Type 2 diabetes, the excerpt supports the idea that beta-cell issues lead to hyperglycemia.	"{""explanation"": ""Although it primarily discusses prediabetes and Type 2 diabetes, the excerpt supports the idea that beta-cell issues lead to hyperglycemia."", ""reference"": ""PMID:21281836"", ""snippet"": ""Insulin resistance and defective glucose sensing at the beta-cell are the central pathophysiologic determinants that together cause hyperglycemia."", ""supports"": ""SUPPORT""}"
7996	7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	evidence	2	PMID:2006409	SUPPORT		Glucose uptake into pancreatic beta cells by means of the glucose transporter GLUT-2, which has a high Michaelis constant, is essential for the normal insulin secretory response to hyperglycemia.	This indicates the importance of beta cells in glucose regulation and the resulting hyperglycemia when their function is impaired.	"{""explanation"": ""This indicates the importance of beta cells in glucose regulation and the resulting hyperglycemia when their function is impaired."", ""reference"": ""PMID:2006409"", ""snippet"": ""Glucose uptake into pancreatic beta cells by means of the glucose transporter GLUT-2, which has a high Michaelis constant, is essential for the normal insulin secretory response to hyperglycemia."", ""supports"": ""SUPPORT""}"
7997	7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	evidence	3	PMID:11822099	SUPPORT		Peripheral insulin-resistance and impairment of the hepatocellular function are two major possible causes of diabetes mellitus in liver cirrhosis.	This reference is more about liver cirrhosis but supports the general mechanism where insulin deficiency, due to impaired beta-cell function, leads to diabetes.	"{""explanation"": ""This reference is more about liver cirrhosis but supports the general mechanism where insulin deficiency, due to impaired beta-cell function, leads to diabetes."", ""reference"": ""PMID:11822099"", ""snippet"": ""Peripheral insulin-resistance and impairment of the hepatocellular function are two major possible causes of diabetes mellitus in liver cirrhosis."", ""supports"": ""SUPPORT""}"
7998	7656	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	4	evidence	4	PMID:11508279	SUPPORT		Loss of blood glucose control might result from failure of the beta cells to secrete insulin, resistance of the tissues to its action, or a combination of both.	This also supports the idea that loss of beta cells leads to insulin deficiency and subsequent glucose control issues, relevant to both Type 1 and Type 2 diabetes.	"{""explanation"": ""This also supports the idea that loss of beta cells leads to insulin deficiency and subsequent glucose control issues, relevant to both Type 1 and Type 2 diabetes."", ""reference"": ""PMID:11508279"", ""snippet"": ""Loss of blood glucose control might result from failure of the beta cells to secrete insulin, resistance of the tissues to its action, or a combination of both."", ""supports"": ""SUPPORT""}"
7999	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	evidence	0	PMID:33970586	SUPPORT		Type 1 diabetes is defined as a state of hyperglycemia due to insulin deficiency caused by autoimmune pancreatic beta-cell destruction.	The abstract from PMID:33970586 confirms that type 1 diabetes is characterized by hyperglycemia due to insulin deficiency, which supports the statement regarding elevated blood glucose and related downstream effects.	"{""explanation"": ""The abstract from PMID:33970586 confirms that type 1 diabetes is characterized by hyperglycemia due to insulin deficiency, which supports the statement regarding elevated blood glucose and related downstream effects."", ""reference"": ""PMID:33970586"", ""snippet"": ""Type 1 diabetes is defined as a state of hyperglycemia due to insulin deficiency caused by autoimmune pancreatic beta-cell destruction."", ""supports"": ""SUPPORT""}"
8000	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	evidence	1	PMID:37921158	PARTIAL		HbA1c offers a trustworthy indicator of chronic hyperglycemia and strongly correlates with the likelihood of long-term consequences from diabetes.	Although this reference supports the relationship between elevated HbA1c and hyperglycemia, it does not specifically address all the downstream effects such as Glucosuria, Polyuria, Polydipsia, and Diabetic Ketoacidosis (DKA).	"{""explanation"": ""Although this reference supports the relationship between elevated HbA1c and hyperglycemia, it does not specifically address all the downstream effects such as Glucosuria, Polyuria, Polydipsia, and Diabetic Ketoacidosis (DKA)."", ""reference"": ""PMID:37921158"", ""snippet"": ""HbA1c offers a trustworthy indicator of chronic hyperglycemia and strongly correlates with the likelihood of long-term consequences from diabetes."", ""supports"": ""PARTIAL""}"
8001	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	evidence	2	PMID:21281836	NO_EVIDENCE		The phenotype of prediabetes includes dyslipidemia and higher arterial blood pressure.	This study does not specifically address the pathophysiology of type 1 diabetes or the particular assays and downstream effects mentioned in the statement.	"{""explanation"": ""This study does not specifically address the pathophysiology of type 1 diabetes or the particular assays and downstream effects mentioned in the statement."", ""reference"": ""PMID:21281836"", ""snippet"": ""The phenotype of prediabetes includes dyslipidemia and higher arterial blood pressure."", ""supports"": ""NO_EVIDENCE""}"
8002	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	evidence	3	PMID:11921414	NO_EVIDENCE		Lack of insulin production or abnormalities affecting insulin secretion are key to the development of almost all forms of diabetes.	While it mentions insulin deficiency, this reference does not go into detail about the specific assays and downstream effects listed in the statement.	"{""explanation"": ""While it mentions insulin deficiency, this reference does not go into detail about the specific assays and downstream effects listed in the statement."", ""reference"": ""PMID:11921414"", ""snippet"": ""Lack of insulin production or abnormalities affecting insulin secretion are key to the development of almost all forms of diabetes."", ""supports"": ""NO_EVIDENCE""}"
8003	7657	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	5	evidence	4	PMID:15137354	NO_EVIDENCE		The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis.	This article touches on diabetic ketoacidosis but does not fully cover all the listed downstream effects and assays associated with type 1 diabetes pathophysiology.	"{""explanation"": ""This article touches on diabetic ketoacidosis but does not fully cover all the listed downstream effects and assays associated with type 1 diabetes pathophysiology."", ""reference"": ""PMID:15137354"", ""snippet"": ""The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis."", ""supports"": ""NO_EVIDENCE""}"
8004	7658	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	6	evidence	0	PMID:12477252	SUPPORT		Type 1 or insulin-dependent diabetes mellitus is caused by autoimmune attack and selective destruction of the pancreatic beta cells.	The lack of insulin in type 1 diabetes mellitus leads to impaired glucose utilization as described in the statement.	"{""explanation"": ""The lack of insulin in type 1 diabetes mellitus leads to impaired glucose utilization as described in the statement."", ""reference"": ""PMID:12477252"", ""snippet"": ""Type 1 or insulin-dependent diabetes mellitus is caused by autoimmune attack and selective destruction of the pancreatic beta cells."", ""supports"": ""SUPPORT""}"
8005	7658	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	6	evidence	1	PMID:15137354	SUPPORT		The following article reviews the basic pathophysiology of both type 1 diabetes mellitus and type 2 diabetes mellitus as we understand it today.	This article explains that in diabetes, particularly type 1, the lack of insulin results in impaired glucose utilization, leading to characteristic symptoms like weight loss and fatigue.	"{""explanation"": ""This article explains that in diabetes, particularly type 1, the lack of insulin results in impaired glucose utilization, leading to characteristic symptoms like weight loss and fatigue."", ""reference"": ""PMID:15137354"", ""snippet"": ""The following article reviews the basic pathophysiology of both type 1 diabetes mellitus and type 2 diabetes mellitus as we understand it today."", ""supports"": ""SUPPORT""}"
8006	7659	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	7	evidence	0	PMID:38409439	SUPPORT		IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes.	This study shows interferons drive beta cell stress responses including ER stress pathways that contribute to beta cell dysfunction and death.	"{""explanation"": ""This study shows interferons drive beta cell stress responses including ER stress pathways that contribute to beta cell dysfunction and death."", ""reference"": ""PMID:38409439"", ""snippet"": ""IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes."", ""supports"": ""SUPPORT""}"
8007	7660	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	8	evidence	0	PMID:6409465	SUPPORT		Insulin deficiency results in increased rates of lipolysis and provides increased substrate (free fatty acids) for ketogenesis.	The article explains that insulin deficiency leads to increased lipolysis, which eventually results in the production of ketone bodies. This supports the statement's claim about the pathophysiology involving lipolysis and ketone production in Type I Diabetes.	"{""explanation"": ""The article explains that insulin deficiency leads to increased lipolysis, which eventually results in the production of ketone bodies. This supports the statement's claim about the pathophysiology involving lipolysis and ketone production in Type I Diabetes."", ""reference"": ""PMID:6409465"", ""snippet"": ""Insulin deficiency results in increased rates of lipolysis and provides increased substrate (free fatty acids) for ketogenesis."", ""supports"": ""SUPPORT""}"
8008	7660	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	8	evidence	1	PMID:15137354	SUPPORT		The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis.	The article suggests that DKA is a critical concern in Type I Diabetes due to insufficient insulin, which is aligned with the statement indicating the downstream effect of heightened lipolysis and ketone production.	"{""explanation"": ""The article suggests that DKA is a critical concern in Type I Diabetes due to insufficient insulin, which is aligned with the statement indicating the downstream effect of heightened lipolysis and ketone production."", ""reference"": ""PMID:15137354"", ""snippet"": ""The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis."", ""supports"": ""SUPPORT""}"
8009	7660	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	8	evidence	2	PMID:34922394	PARTIAL		the involvement of B:9-23rPep-specific IFN-gamma-related immunoreactivity in the pathophysiology of some unprovoked A-beta+ KPD.	Although the study highlights immune responses related to ketosis-prone Type 2 Diabetes, it indirectly supports the notion that immune-mediated processes can contribute to ketosis and DKA.	"{""explanation"": ""Although the study highlights immune responses related to ketosis-prone Type 2 Diabetes, it indirectly supports the notion that immune-mediated processes can contribute to ketosis and DKA."", ""reference"": ""PMID:34922394"", ""snippet"": ""the involvement of B:9-23rPep-specific IFN-gamma-related immunoreactivity in the pathophysiology of some unprovoked A-beta+ KPD."", ""supports"": ""PARTIAL""}"
8010	7661	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	9	evidence	0	PMID:31346658	SUPPORT		Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy.	The literature indicates that hyperglycemia is a significant factor in the pathophysiology of diabetic complications including kidney disease (nephropathy), retinopathy, and neuropathy, thereby supporting the claim.	"{""explanation"": ""The literature indicates that hyperglycemia is a significant factor in the pathophysiology of diabetic complications including kidney disease (nephropathy), retinopathy, and neuropathy, thereby supporting the claim."", ""reference"": ""PMID:31346658"", ""snippet"": ""Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy."", ""supports"": ""SUPPORT""}"
8011	7661	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	9	evidence	1	PMID:34407376	SUPPORT		Hyperglycemia is the common denominator for most of the chronic diabetic vascular complications, which represent the main cause of life reduction in T1D patients.	This reference indicates that hyperglycemia underlies various chronic vascular complications in type 1 diabetes, thus supporting the statement.	"{""explanation"": ""This reference indicates that hyperglycemia underlies various chronic vascular complications in type 1 diabetes, thus supporting the statement."", ""reference"": ""PMID:34407376"", ""snippet"": ""Hyperglycemia is the common denominator for most of the chronic diabetic vascular complications, which represent the main cause of life reduction in T1D patients."", ""supports"": ""SUPPORT""}"
8012	7661	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	9	evidence	2	PMID:3528691	SUPPORT		The remaining 15 to 20% of patients have insulin-dependent diabetes mellitus, a disorder caused by the destruction of insulin-producing endocrine cells within the pancreas and currently considered to be the result of an autoimmune process. During the course of both types of diabetes mellitus, the so-called long-term complications of diabetes invariably occur to some extent in all patients. These complications include retinopathy, nephropathy, neuropathy, and premature atherosclerosis.	The study confirms that type 1 diabetes, which involves insulin-dependent diabetes mellitus, results in long-term complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease.	"{""explanation"": ""The study confirms that type 1 diabetes, which involves insulin-dependent diabetes mellitus, results in long-term complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease."", ""reference"": ""PMID:3528691"", ""snippet"": ""The remaining 15 to 20% of patients have insulin-dependent diabetes mellitus, a disorder caused by the destruction of insulin-producing endocrine cells within the pancreas and currently considered to be the result of an autoimmune process. During the course of both types of diabetes mellitus, the so-called long-term complications of diabetes invariably occur to some extent in all patients. These complications include retinopathy, nephropathy, neuropathy, and premature atherosclerosis."", ""supports"": ""SUPPORT""}"
8013	7661	333	Type I Diabetes	Type_I_Diabetes.yaml	pathophysiology	9	evidence	3	PMID:35456511	SUPPORT		The prevention of hyperglycemia is very important to avoid or at least postpone the development of micro- and macrovascular complications, also known as late complications. These include diabetic retinopathy, chronic renal failure, diabetic neuropathy, and cardiovascular diseases.	The literature points out that hyperglycemia leads to microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular diseases) complications, supporting the statement.	"{""explanation"": ""The literature points out that hyperglycemia leads to microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular diseases) complications, supporting the statement."", ""reference"": ""PMID:35456511"", ""snippet"": ""The prevention of hyperglycemia is very important to avoid or at least postpone the development of micro- and macrovascular complications, also known as late complications. These include diabetic retinopathy, chronic renal failure, diabetic neuropathy, and cardiovascular diseases."", ""supports"": ""SUPPORT""}"
8072	7703	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	0	evidence	0	PMID:38314135	SUPPORT		Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1β, IL-18, NLRP3).	Pyroptosis-associated inflammatory cytokines IL-1β and IL-18 are produced in UC mucosa, contributing to the characteristic mucosal inflammation.	"{""explanation"": ""Pyroptosis-associated inflammatory cytokines IL-1β and IL-18 are produced in UC mucosa, contributing to the characteristic mucosal inflammation."", ""reference"": ""PMID:38314135"", ""snippet"": ""Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1β, IL-18, NLRP3)."", ""supports"": ""SUPPORT""}"
8073	7703	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	0	evidence	1	PMID:39438660	SUPPORT		We generated ~1 million single-cell transcriptomes, organised into 109 cell states, from 216 gut biopsies (41 subjects), revealing disease-specific differences.	Single-cell analysis of UC gut biopsies reveals disease-specific inflammatory cell states in the colonic mucosa.	"{""explanation"": ""Single-cell analysis of UC gut biopsies reveals disease-specific inflammatory cell states in the colonic mucosa."", ""reference"": ""PMID:39438660"", ""snippet"": ""We generated ~1 million single-cell transcriptomes, organised into 109 cell states, from 216 gut biopsies (41 subjects), revealing disease-specific differences."", ""supports"": ""SUPPORT""}"
8074	7704	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	1	evidence	0	PMID:39438660	SUPPORT		A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC.	Single-cell analysis demonstrates interferon-response signatures localize to T cell aggregates and epithelial damage in UC, revealing a key immune dysregulation mechanism.	"{""explanation"": ""Single-cell analysis demonstrates interferon-response signatures localize to T cell aggregates and epithelial damage in UC, revealing a key immune dysregulation mechanism."", ""reference"": ""PMID:39438660"", ""snippet"": ""A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC."", ""supports"": ""SUPPORT""}"
8075	7704	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	1	evidence	1	PMID:39438660	SUPPORT		Longitudinal comparisons demonstrated disease progression in nonremission: myeloid and T cell perturbations in CD and increased multi-cellular IFN signalling in UC.	Increased multi-cellular interferon signaling is associated with disease progression and non-remission in UC, indicating this is a critical pathway in dysregulated immune response.	"{""explanation"": ""Increased multi-cellular interferon signaling is associated with disease progression and non-remission in UC, indicating this is a critical pathway in dysregulated immune response."", ""reference"": ""PMID:39438660"", ""snippet"": ""Longitudinal comparisons demonstrated disease progression in nonremission: myeloid and T cell perturbations in CD and increased multi-cellular IFN signalling in UC."", ""supports"": ""SUPPORT""}"
8076	7704	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	1	evidence	2	PMID:39461795	SUPPORT		Addressing an upstream pathological mechanism shared between these disorders, this drug class has high efficacy rates and a durable response that extends dosing intervals up to 3 months.	IL-23 inhibitors target an upstream pathological mechanism in UC with high efficacy (up to 50% in IBD), supporting the role of aberrant immune signaling in disease pathogenesis.	"{""explanation"": ""IL-23 inhibitors target an upstream pathological mechanism in UC with high efficacy (up to 50% in IBD), supporting the role of aberrant immune signaling in disease pathogenesis."", ""reference"": ""PMID:39461795"", ""snippet"": ""Addressing an upstream pathological mechanism shared between these disorders, this drug class has high efficacy rates and a durable response that extends dosing intervals up to 3 months."", ""supports"": ""SUPPORT""}"
8077	7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	evidence	0	PMID:39438660	SUPPORT		A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC.	Interferon-response signatures are spatially localized to epithelial damage sites in UC, directly linking immune responses to barrier disruption.	"{""explanation"": ""Interferon-response signatures are spatially localized to epithelial damage sites in UC, directly linking immune responses to barrier disruption."", ""reference"": ""PMID:39438660"", ""snippet"": ""A systems biology-spatial analysis identified granuloma signatures in CD and interferon (IFN)-response signatures localising to T cell aggregates and epithelial damage in CD and UC."", ""supports"": ""SUPPORT""}"
8078	7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	evidence	1	PMID:38724705	SUPPORT		Luminal epithelial cells in patients with irColitis expressed PCSK9, PD-L1 and interferon-induced signatures associated with apoptosis, increased cell turnover and malabsorption.	Epithelial cells express interferon-induced signatures associated with apoptosis and increased cell turnover, demonstrating the mechanism of barrier dysfunction in inflammatory colitis.	"{""explanation"": ""Epithelial cells express interferon-induced signatures associated with apoptosis and increased cell turnover, demonstrating the mechanism of barrier dysfunction in inflammatory colitis."", ""reference"": ""PMID:38724705"", ""snippet"": ""Luminal epithelial cells in patients with irColitis expressed PCSK9, PD-L1 and interferon-induced signatures associated with apoptosis, increased cell turnover and malabsorption."", ""supports"": ""SUPPORT""}"
8079	7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	evidence	2	PMID:38724705	SUPPORT		Together, these data suggest roles for circulating T cells and epithelial-immune crosstalk critical to PD-1/CTLA-4-dependent tolerance and barrier function and identify potential therapeutic targets for irColitis.	Epithelial-immune crosstalk is critical to barrier function, confirming that disruption of this interaction underlies epithelial barrier dysfunction in colitis.	"{""explanation"": ""Epithelial-immune crosstalk is critical to barrier function, confirming that disruption of this interaction underlies epithelial barrier dysfunction in colitis."", ""reference"": ""PMID:38724705"", ""snippet"": ""Together, these data suggest roles for circulating T cells and epithelial-immune crosstalk critical to PD-1/CTLA-4-dependent tolerance and barrier function and identify potential therapeutic targets for irColitis."", ""supports"": ""SUPPORT""}"
8080	7705	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	2	evidence	3	PMID:39438660	SUPPORT		Pretreatment differences in epithelial and myeloid compartments were associated with remission outcomes in both diseases.	Epithelial compartment differences predict treatment outcomes, emphasizing the central role of epithelial dysfunction in UC pathogenesis.	"{""explanation"": ""Epithelial compartment differences predict treatment outcomes, emphasizing the central role of epithelial dysfunction in UC pathogenesis."", ""reference"": ""PMID:39438660"", ""snippet"": ""Pretreatment differences in epithelial and myeloid compartments were associated with remission outcomes in both diseases."", ""supports"": ""SUPPORT""}"
8081	7706	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	3	evidence	0	PMID:25307765	SUPPORT		IBD has a consistent signature across studies and allows high classification accuracy of IBD from non-IBD subjects.	Meta-analysis confirms IBD has consistent microbiota signatures distinguishing patients from healthy controls.	"{""explanation"": ""Meta-analysis confirms IBD has consistent microbiota signatures distinguishing patients from healthy controls."", ""reference"": ""PMID:25307765"", ""snippet"": ""IBD has a consistent signature across studies and allows high classification accuracy of IBD from non-IBD subjects."", ""supports"": ""SUPPORT""}"
8082	7707	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	4	evidence	0	PMID:18936492	SUPPORT		A decrease in the abundance and biodiversity of intestinal bacteria within the dominant phylum Firmicutes has been observed repeatedly in Crohn disease (CD) patients.	Sokol et al. demonstrated F. prausnitzii depletion is consistently observed in IBD.	"{""explanation"": ""Sokol et al. demonstrated F. prausnitzii depletion is consistently observed in IBD."", ""reference"": ""PMID:18936492"", ""snippet"": ""A decrease in the abundance and biodiversity of intestinal bacteria within the dominant phylum Firmicutes has been observed repeatedly in Crohn disease (CD) patients."", ""supports"": ""SUPPORT""}"
8083	7707	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	4	evidence	1	PMID:18936492	SUPPORT		F. prausnitzii exhibits anti-inflammatory effects on cellular and TNBS colitis models, partly due to secreted metabolites able to block NF-kappaB activation and IL-8 production.	F. prausnitzii has direct anti-inflammatory properties beyond its role as butyrate producer.	"{""explanation"": ""F. prausnitzii has direct anti-inflammatory properties beyond its role as butyrate producer."", ""reference"": ""PMID:18936492"", ""snippet"": ""F. prausnitzii exhibits anti-inflammatory effects on cellular and TNBS colitis models, partly due to secreted metabolites able to block NF-kappaB activation and IL-8 production."", ""supports"": ""SUPPORT""}"
8084	7708	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	5	evidence	0	PMID:26185088	SUPPORT		This is often characterized by an increased relative abundance of facultative anaerobic bacteria (e.g., Enterobacteriaeceae, Bacilli) and, at the same time, depletion of obligate anaerobic bacteria of the classes Bacteroidia and Clostridia.	Dysbiosis in IBD involves expansion of Enterobacteriaceae pathobionts alongside depletion of beneficial obligate anaerobes.	"{""explanation"": ""Dysbiosis in IBD involves expansion of Enterobacteriaceae pathobionts alongside depletion of beneficial obligate anaerobes."", ""reference"": ""PMID:26185088"", ""snippet"": ""This is often characterized by an increased relative abundance of facultative anaerobic bacteria (e.g., Enterobacteriaeceae, Bacilli) and, at the same time, depletion of obligate anaerobic bacteria of the classes Bacteroidia and Clostridia."", ""supports"": ""SUPPORT""}"
8085	7709	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	6	evidence	0	PMID:23023125	SUPPORT		Patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens.	While this study focused on T2D, it demonstrates the general principle that dysbiosis involves loss of butyrate producers - a pattern also seen in IBD.	"{""explanation"": ""While this study focused on T2D, it demonstrates the general principle that dysbiosis involves loss of butyrate producers - a pattern also seen in IBD."", ""reference"": ""PMID:23023125"", ""snippet"": ""Patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens."", ""supports"": ""SUPPORT""}"
8086	7711	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	8	evidence	0	PMID:28836573	SUPPORT		The result is an 'Anna Karenina principle' for animal microbiomes, in which dysbiotic individuals vary more in microbial community composition than healthy individuals-paralleling Leo Tolstoy's dictum that 'all happy families look alike; each unhappy family is unhappy in its own way'.	Zaneveld et al. demonstrated the Anna Karenina principle applies to disease-associated microbiomes.	"{""explanation"": ""Zaneveld et al. demonstrated the Anna Karenina principle applies to disease-associated microbiomes."", ""reference"": ""PMID:28836573"", ""snippet"": ""The result is an 'Anna Karenina principle' for animal microbiomes, in which dysbiotic individuals vary more in microbial community composition than healthy individuals-paralleling Leo Tolstoy's dictum that 'all happy families look alike; each unhappy family is unhappy in its own way'."", ""supports"": ""SUPPORT""}"
8087	7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	evidence	0	PMID:38314135	SUPPORT		SLC6A14 was increased and correlated with NLRP3 in UC tissues.	SLC6A14 expression is elevated and correlates with NLRP3 in UC tissues, establishing a molecular link between this transporter and inflammasome activation.	"{""explanation"": ""SLC6A14 expression is elevated and correlates with NLRP3 in UC tissues, establishing a molecular link between this transporter and inflammasome activation."", ""reference"": ""PMID:38314135"", ""snippet"": ""SLC6A14 was increased and correlated with NLRP3 in UC tissues."", ""supports"": ""SUPPORT""}"
8088	7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	evidence	1	PMID:38314135	SUPPORT		Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1β, IL-18, NLRP3).	Experimental reduction of SLC6A14 decreases pyroptosis-associated proteins including NLRP3, IL-1β, and IL-18, demonstrating the causal role of this pathway in UC.	"{""explanation"": ""Experimental reduction of SLC6A14 decreases pyroptosis-associated proteins including NLRP3, IL-1β, and IL-18, demonstrating the causal role of this pathway in UC."", ""reference"": ""PMID:38314135"", ""snippet"": ""Reducing SLC6A14 decreased pyroptosis-associated proteins (ASC, IL-1β, IL-18, NLRP3)."", ""supports"": ""SUPPORT""}"
8089	7712	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	pathophysiology	9	evidence	2	PMID:38314135	SUPPORT		SLC6A14 promotes UC pyroptosis by regulating NLRP3, suggesting the therapeutic potential of modulating the SLC6A14/NLRP3 axis.	SLC6A14 promotes UC progression through NLRP3-mediated pyroptosis, identifying this as a key pathophysiological mechanism and potential therapeutic target.	"{""explanation"": ""SLC6A14 promotes UC progression through NLRP3-mediated pyroptosis, identifying this as a key pathophysiological mechanism and potential therapeutic target."", ""reference"": ""PMID:38314135"", ""snippet"": ""SLC6A14 promotes UC pyroptosis by regulating NLRP3, suggesting the therapeutic potential of modulating the SLC6A14/NLRP3 axis."", ""supports"": ""SUPPORT""}"
8091	7728	335	Urticaria	Urticaria.yaml	pathophysiology	0	evidence	0	PMID:40845419	SUPPORT		The central role of mast cells is being reinforced, but multiple cells, pathways, and mediators are involved in a complex interrelationship.	The review emphasizes mast cells as central effectors in urticaria pathogenesis.	"{""explanation"": ""The review emphasizes mast cells as central effectors in urticaria pathogenesis."", ""reference"": ""PMID:40845419"", ""snippet"": ""The central role of mast cells is being reinforced, but multiple cells, pathways, and mediators are involved in a complex interrelationship."", ""supports"": ""SUPPORT""}"
8093	7739	336	Uveal Melanoma	Uveal_Melanoma.yaml	pathophysiology	0	evidence	0	PMID:23877823	SUPPORT		Recently, major key genes involved in uveal melanoma development, GNAQ, GNA11, BAP1, SF3B1 and EIF1AX, have been identified.	Supports GNAQ and GNA11 as key genes in uveal melanoma development.	"{""explanation"": ""Supports GNAQ and GNA11 as key genes in uveal melanoma development."", ""reference"": ""PMID:23877823"", ""snippet"": ""Recently, major key genes involved in uveal melanoma development, GNAQ, GNA11, BAP1, SF3B1 and EIF1AX, have been identified."", ""supports"": ""SUPPORT""}"
8100	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:38465699	SUPPORT		Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions and investigated glutamatergic and serotoninergic neurotransmission.	Recent studies confirm cortical hyperresponsivity and connectivity alterations in VSS.	"{""explanation"": ""Recent studies confirm cortical hyperresponsivity and connectivity alterations in VSS."", ""reference"": ""PMID:38465699"", ""snippet"": ""Electrophysiological studies have revealed cortical hyperresponsivity in visual brain areas, imaging studies demonstrated microstructural and functional connectivity alterations in multiple cortical and thalamic regions and investigated glutamatergic and serotoninergic neurotransmission."", ""supports"": ""SUPPORT""}"
8101	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:24816400	SUPPORT		"The hypermetabolic lingual gyrus confirms a brain dysfunction in patients with ""visual snow."""	PET imaging demonstrates hypermetabolism in the lingual gyrus in visual snow patients.	"{""explanation"": ""PET imaging demonstrates hypermetabolism in the lingual gyrus in visual snow patients."", ""reference"": ""PMID:24816400"", ""snippet"": ""The hypermetabolic lingual gyrus confirms a brain dysfunction in patients with \""visual snow.\"""", ""supports"": ""SUPPORT""}"
8102	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	evidence	2	PMID:34570907	SUPPORT		Imaging and electrophysiological findings indicate a hyperexcitability of the primary and secondary visual areas of the brain possibly due to an impairment of inhibitory feedback mechanisms.	Review article confirms hyperexcitability in visual cortical areas with impaired inhibitory feedback.	"{""explanation"": ""Review article confirms hyperexcitability in visual cortical areas with impaired inhibitory feedback."", ""reference"": ""PMID:34570907"", ""snippet"": ""Imaging and electrophysiological findings indicate a hyperexcitability of the primary and secondary visual areas of the brain possibly due to an impairment of inhibitory feedback mechanisms."", ""supports"": ""SUPPORT""}"
8103	7752	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	0	evidence	3	PMID:33008511	SUPPORT		Regarding pathophysiology, hyperexcitability of the visual cortex and a processing problem of higher order visual function are assumed, but the location is still in discussion.	Systematic review confirms visual cortex hyperexcitability as leading hypothesis for VSS pathophysiology.	"{""explanation"": ""Systematic review confirms visual cortex hyperexcitability as leading hypothesis for VSS pathophysiology."", ""reference"": ""PMID:33008511"", ""snippet"": ""Regarding pathophysiology, hyperexcitability of the visual cortex and a processing problem of higher order visual function are assumed, but the location is still in discussion."", ""supports"": ""SUPPORT""}"
8104	7753	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	1	evidence	0	PMID:38465699	SUPPORT		These findings suggest that VSS might be a network disorder.	Recent research suggests VSS is a network disorder affecting multiple brain regions.	"{""explanation"": ""Recent research suggests VSS is a network disorder affecting multiple brain regions."", ""reference"": ""PMID:38465699"", ""snippet"": ""These findings suggest that VSS might be a network disorder."", ""supports"": ""SUPPORT""}"
8105	7753	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	1	evidence	1	PMID:34570907	SUPPORT		Imaging and electrophysiological findings hint toward network disorders involving the sensory networks and other large-scale networks involved in the management of attention and emotional processing.	Evidence points to network-level dysfunction involving sensory processing and attention networks.	"{""explanation"": ""Evidence points to network-level dysfunction involving sensory processing and attention networks."", ""reference"": ""PMID:34570907"", ""snippet"": ""Imaging and electrophysiological findings hint toward network disorders involving the sensory networks and other large-scale networks involved in the management of attention and emotional processing."", ""supports"": ""SUPPORT""}"
8106	7753	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	pathophysiology	1	evidence	2	PMID:33008511	SUPPORT		In particular, it is unclear if the primary visual cortex, the visual association cortex or the thalamocortical pathway is involved.	The thalamocortical pathway is one of the candidate structures involved in VSS pathophysiology.	"{""explanation"": ""The thalamocortical pathway is one of the candidate structures involved in VSS pathophysiology."", ""reference"": ""PMID:33008511"", ""snippet"": ""In particular, it is unclear if the primary visual cortex, the visual association cortex or the thalamocortical pathway is involved."", ""supports"": ""SUPPORT""}"
8177	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	evidence	0	PMID:33200838	SUPPORT	HUMAN_CLINICAL	Vitiligo is an autoimmune depigment disease results from extensive melanocytes destruction...self-responsive immune function directly contributes to the bulk of melanocyte deaths in vitiligo...CD8(+) cytotoxic T lymphocytes finally execute the killing of melanocytes.	The literature describes the autoimmune-mediated destruction of melanocytes involving CD8+ T lymphocytes, consistent with the provided statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature describes the autoimmune-mediated destruction of melanocytes involving CD8+ T lymphocytes, consistent with the provided statement."", ""reference"": ""PMID:33200838"", ""snippet"": ""Vitiligo is an autoimmune depigment disease results from extensive melanocytes destruction...self-responsive immune function directly contributes to the bulk of melanocyte deaths in vitiligo...CD8(+) cytotoxic T lymphocytes finally execute the killing of melanocytes."", ""supports"": ""SUPPORT""}"
8178	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	evidence	1	PMID:31209143	SUPPORT	HUMAN_CLINICAL	Vitiligo is an autoimmune skin disease mediated by autoreactive CD8(+) T cells that destroy the pigment-producing cells of the epidermis, melanocytes, leading to areas of depigmentation.	The reference confirms the autoimmune-mediated destruction mechanism, mentioning both CD8+ T lymphocytes and melanocytes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference confirms the autoimmune-mediated destruction mechanism, mentioning both CD8+ T lymphocytes and melanocytes."", ""reference"": ""PMID:31209143"", ""snippet"": ""Vitiligo is an autoimmune skin disease mediated by autoreactive CD8(+) T cells that destroy the pigment-producing cells of the epidermis, melanocytes, leading to areas of depigmentation."", ""supports"": ""SUPPORT""}"
8179	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	evidence	2	PMID:25184918	SUPPORT	HUMAN_CLINICAL	The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes.	The literature supports the involvement of CD8+ T lymphocytes and the destruction of melanocytes in vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature supports the involvement of CD8+ T lymphocytes and the destruction of melanocytes in vitiligo."", ""reference"": ""PMID:25184918"", ""snippet"": ""The main histopathological finding in vitiligo is the total absence of functioning melanocytes in the lesions, while the inflammatory cells most commonly found on the edges of the lesions are CD4+ and CD8+ T lymphocytes."", ""supports"": ""SUPPORT""}"
8180	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	evidence	3	PMID:35653192	SUPPORT	HUMAN_CLINICAL	Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreactive CD8+ T cells.	This source directly mentions the destruction of melanocytes by CD8+ T cells.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This source directly mentions the destruction of melanocytes by CD8+ T cells."", ""reference"": ""PMID:35653192"", ""snippet"": ""Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreactive CD8+ T cells."", ""supports"": ""SUPPORT""}"
8181	7785	338	Vitiligo	Vitiligo.yaml	pathophysiology	0	evidence	4	PMID:18460889	SUPPORT	HUMAN_CLINICAL	Vitiligo is characterized by progressive skin depigmentation resulting from an autoimmune response targeting epidermal melanocytes...Type I cytokine-mediated immunity to melanocytes in vitiligo involves T cells reactive with melanosomal antigens...	The source elaborates on the autoimmune nature of vitiligo, involving T cells and targeting melanocytes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The source elaborates on the autoimmune nature of vitiligo, involving T cells and targeting melanocytes."", ""reference"": ""PMID:18460889"", ""snippet"": ""Vitiligo is characterized by progressive skin depigmentation resulting from an autoimmune response targeting epidermal melanocytes...Type I cytokine-mediated immunity to melanocytes in vitiligo involves T cells reactive with melanosomal antigens..."", ""supports"": ""SUPPORT""}"
8182	7786	338	Vitiligo	Vitiligo.yaml	pathophysiology	1	evidence	0	PMID:28317533	SUPPORT	HUMAN_CLINICAL	Vitiligo reflects simultaneous contributions of multiple genetic risk factors and environmental triggers. Genomewide association studies have discovered approximately 50 genetic loci contributing to vitiligo risk.	The literature clearly states that multiple genetic risk factors contribute to vitiligo, aligning with the statement's claim of a complex interplay of genes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature clearly states that multiple genetic risk factors contribute to vitiligo, aligning with the statement's claim of a complex interplay of genes."", ""reference"": ""PMID:28317533"", ""snippet"": ""Vitiligo reflects simultaneous contributions of multiple genetic risk factors and environmental triggers. Genomewide association studies have discovered approximately 50 genetic loci contributing to vitiligo risk."", ""supports"": ""SUPPORT""}"
8183	7786	338	Vitiligo	Vitiligo.yaml	pathophysiology	1	evidence	1	PMID:28206724	SUPPORT	HUMAN_CLINICAL	Contrary to the Northern part of Europe but likewise to the Mediterranean area, the frequency of the CAT genotypes in Sicily is equally distributed. Out of all CAT genotypes, only CAT-89 T/T frequency was found to be significantly higher amongst vitiligo patients than controls.	The study mentions the association of specific gene polymorphisms with vitiligo, supporting the notion of a genetic predisposition.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study mentions the association of specific gene polymorphisms with vitiligo, supporting the notion of a genetic predisposition."", ""reference"": ""PMID:28206724"", ""snippet"": ""Contrary to the Northern part of Europe but likewise to the Mediterranean area, the frequency of the CAT genotypes in Sicily is equally distributed. Out of all CAT genotypes, only CAT-89 T/T frequency was found to be significantly higher amongst vitiligo patients than controls."", ""supports"": ""SUPPORT""}"
8184	7786	338	Vitiligo	Vitiligo.yaml	pathophysiology	1	evidence	2	PMID:29704874	SUPPORT	HUMAN_CLINICAL	The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time.	The convergence theory supports the idea that multiple genetic and environmental factors contribute to vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The convergence theory supports the idea that multiple genetic and environmental factors contribute to vitiligo."", ""reference"": ""PMID:29704874"", ""snippet"": ""The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time."", ""supports"": ""SUPPORT""}"
8185	7786	338	Vitiligo	Vitiligo.yaml	pathophysiology	1	evidence	3	PMID:33278065	SUPPORT	HUMAN_CLINICAL	The complex interplay between non-immunological and immunological factors in vitiligo is key for the development of the disease.	This underscores the multifactorial nature of vitiligo, consistent with the statement's emphasis on a complex genetic interplay.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This underscores the multifactorial nature of vitiligo, consistent with the statement's emphasis on a complex genetic interplay."", ""reference"": ""PMID:33278065"", ""snippet"": ""The complex interplay between non-immunological and immunological factors in vitiligo is key for the development of the disease."", ""supports"": ""SUPPORT""}"
8186	7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	evidence	0	PMID:25838868	SUPPORT	HUMAN_CLINICAL	Vitiligo is an acquired dermatological disease frequently associated with autoimmune thyroid disorders...Currently, the autocytotoxic and the autoimmune theories are the most accredited hypothesis	The article indicates a strong association between vitiligo and autoimmune thyroid disorders, supporting a common autoimmune etiology.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The article indicates a strong association between vitiligo and autoimmune thyroid disorders, supporting a common autoimmune etiology."", ""reference"": ""PMID:25838868"", ""snippet"": ""Vitiligo is an acquired dermatological disease frequently associated with autoimmune thyroid disorders...Currently, the autocytotoxic and the autoimmune theories are the most accredited hypothesis"", ""supports"": ""SUPPORT""}"
8187	7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	evidence	1	PMID:26769615	SUPPORT	HUMAN_CLINICAL	Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo... The most commonly associated autoimmune disease is thyroiditis.	The reference confirms a frequent coexistence of vitiligo and autoimmune thyroid disorders, supporting the common autoimmune etiology theory.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference confirms a frequent coexistence of vitiligo and autoimmune thyroid disorders, supporting the common autoimmune etiology theory."", ""reference"": ""PMID:26769615"", ""snippet"": ""Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo... The most commonly associated autoimmune disease is thyroiditis."", ""supports"": ""SUPPORT""}"
8188	7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	evidence	2	PMID:26724277	SUPPORT	HUMAN_CLINICAL	Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi.	This reference indicates the association of vitiligo with multiple autoimmune diseases, further supporting the shared autoimmune etiology.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference indicates the association of vitiligo with multiple autoimmune diseases, further supporting the shared autoimmune etiology."", ""reference"": ""PMID:26724277"", ""snippet"": ""Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi."", ""supports"": ""SUPPORT""}"
8189	7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	evidence	3	PMID:20578892	SUPPORT	HUMAN_CLINICAL	Generalized vitiligo is an autoimmune disease of skin pigmentation that is associated with increased prevalence of other autoimmune diseases, particularly autoimmune thyroid disease.	The increased prevalence of autoimmune thyroid disease among vitiligo patients supports the notion of a shared autoimmune mechanism.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The increased prevalence of autoimmune thyroid disease among vitiligo patients supports the notion of a shared autoimmune mechanism."", ""reference"": ""PMID:20578892"", ""snippet"": ""Generalized vitiligo is an autoimmune disease of skin pigmentation that is associated with increased prevalence of other autoimmune diseases, particularly autoimmune thyroid disease."", ""supports"": ""SUPPORT""}"
8190	7787	338	Vitiligo	Vitiligo.yaml	pathophysiology	2	evidence	4	PMID:11681494	SUPPORT	HUMAN_CLINICAL	In brief, the disease is frequently associated with other disorders which have an autoimmune origin such as autoimmune thyroiditis and insulin-dependent diabetes mellitus.	The frequent association of vitiligo with other autoimmune disorders aligns with the concept of a common autoimmune etiology.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The frequent association of vitiligo with other autoimmune disorders aligns with the concept of a common autoimmune etiology."", ""reference"": ""PMID:11681494"", ""snippet"": ""In brief, the disease is frequently associated with other disorders which have an autoimmune origin such as autoimmune thyroiditis and insulin-dependent diabetes mellitus."", ""supports"": ""SUPPORT""}"
8191	7788	338	Vitiligo	Vitiligo.yaml	pathophysiology	3	evidence	0	PMID:36980277	SUPPORT	HUMAN_CLINICAL	Oxidative stress is considered to play a crucial role in activating consequent autoimmune responses related to vitiligo.	The literature supports the statement that increased oxidative stress in the skin contributes to melanocyte vulnerability and destruction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature supports the statement that increased oxidative stress in the skin contributes to melanocyte vulnerability and destruction."", ""reference"": ""PMID:36980277"", ""snippet"": ""Oxidative stress is considered to play a crucial role in activating consequent autoimmune responses related to vitiligo."", ""supports"": ""SUPPORT""}"
8192	7788	338	Vitiligo	Vitiligo.yaml	pathophysiology	3	evidence	1	PMID:33098225	SUPPORT	HUMAN_CLINICAL	Hydrogen peroxide (H2 O2 ) and malondialdehyde (MDA) were significantly higher in patients than controls (p-value < .001, <.001, respectively); on the other hand, total antioxidant capacity (TAC) was significantly lower in patients than controls (p-value = .001)	This study supports the idea that oxidative stress biomarkers are elevated in vitiligo patients, contributing to melanocyte vulnerability.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study supports the idea that oxidative stress biomarkers are elevated in vitiligo patients, contributing to melanocyte vulnerability."", ""reference"": ""PMID:33098225"", ""snippet"": ""Hydrogen peroxide (H2 O2 ) and malondialdehyde (MDA) were significantly higher in patients than controls (p-value < .001, <.001, respectively); on the other hand, total antioxidant capacity (TAC) was significantly lower in patients than controls (p-value = .001)"", ""supports"": ""SUPPORT""}"
8193	7788	338	Vitiligo	Vitiligo.yaml	pathophysiology	3	evidence	2	PMID:33346939	SUPPORT	HUMAN_CLINICAL	Apoptosis is most widely studied cell death pathways in vitiligo...new types of regulated cell death including necroptosis, pyroptosis, and ferroptosis may also participate in the pathogenesis of vitiligo.	This supports the involvement of oxidative stress-induced mechanisms in melanocyte death.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports the involvement of oxidative stress-induced mechanisms in melanocyte death."", ""reference"": ""PMID:33346939"", ""snippet"": ""Apoptosis is most widely studied cell death pathways in vitiligo...new types of regulated cell death including necroptosis, pyroptosis, and ferroptosis may also participate in the pathogenesis of vitiligo."", ""supports"": ""SUPPORT""}"
8194	7788	338	Vitiligo	Vitiligo.yaml	pathophysiology	3	evidence	3	PMID:37230937	SUPPORT	HUMAN_CLINICAL	We found that the expression levels of collagen-related genes and anti-oxidative enzymes were upregulated in vitiligo-derived fibroblasts.	The study highlights the role of oxidative stress and its impact on melanocyte vulnerability, contributing to their destruction in vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study highlights the role of oxidative stress and its impact on melanocyte vulnerability, contributing to their destruction in vitiligo."", ""reference"": ""PMID:37230937"", ""snippet"": ""We found that the expression levels of collagen-related genes and anti-oxidative enzymes were upregulated in vitiligo-derived fibroblasts."", ""supports"": ""SUPPORT""}"
8232	7811	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	0	evidence	0	PMID:37980175	SUPPORT		von Hippel-Lindau (VHL) disease is characterized by biallelic inactivation of the VHL gene leading to abnormal or absent VHL protein function, and constitutive activation of hypoxia-inducible factors (HIF) that leads to pro-tumorigenic signaling.	Confirms that biallelic VHL inactivation (consistent with two-hit hypothesis) leads to constitutive HIF activation and pro-tumorigenic signaling.	"{""explanation"": ""Confirms that biallelic VHL inactivation (consistent with two-hit hypothesis) leads to constitutive HIF activation and pro-tumorigenic signaling."", ""reference"": ""PMID:37980175"", ""snippet"": ""von Hippel-Lindau (VHL) disease is characterized by biallelic inactivation of the VHL gene leading to abnormal or absent VHL protein function, and constitutive activation of hypoxia-inducible factors (HIF) that leads to pro-tumorigenic signaling."", ""supports"": ""SUPPORT""}"
8233	7812	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	1	evidence	0	PMID:19671042	SUPPORT		The von-Hippel Lindau tumor suppressor (pVHL) is the substrate recognition component of an E3 ubiquitin ligase and functions as a master regulator of HIF activity by targeting the hydroxylated HIF-alpha subunit for ubiquitylation and rapid proteasomal degradation under normoxic conditions.	Defines pVHL as the substrate recognition component of an E3 ubiquitin ligase that targets hydroxylated HIF-alpha for proteasomal degradation.	"{""explanation"": ""Defines pVHL as the substrate recognition component of an E3 ubiquitin ligase that targets hydroxylated HIF-alpha for proteasomal degradation."", ""reference"": ""PMID:19671042"", ""snippet"": ""The von-Hippel Lindau tumor suppressor (pVHL) is the substrate recognition component of an E3 ubiquitin ligase and functions as a master regulator of HIF activity by targeting the hydroxylated HIF-alpha subunit for ubiquitylation and rapid proteasomal degradation under normoxic conditions."", ""supports"": ""SUPPORT""}"
8234	7812	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	1	evidence	1	PMID:15162797	SUPPORT		VHL tumor suppressor is a specific substrate-recognition component of the E3 ubiquitin complex, which regulates proteasomal degradation of the subunit of the hypoxia inducible transcription factor (HIF). Impaired VHL complex function leads to accumulation of HIF, overexpression of various HIF-induced gene products and formation of highly vascular neoplasia.	Confirms that impaired VHL function leads to HIF accumulation due to loss of proteasomal degradation.	"{""explanation"": ""Confirms that impaired VHL function leads to HIF accumulation due to loss of proteasomal degradation."", ""reference"": ""PMID:15162797"", ""snippet"": ""VHL tumor suppressor is a specific substrate-recognition component of the E3 ubiquitin complex, which regulates proteasomal degradation of the subunit of the hypoxia inducible transcription factor (HIF). Impaired VHL complex function leads to accumulation of HIF, overexpression of various HIF-induced gene products and formation of highly vascular neoplasia."", ""supports"": ""SUPPORT""}"
8235	7813	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	2	evidence	0	PMID:11114720	SUPPORT		in VHL deficient cell lines, both HIF-alpha subunits are constitutively expressed, whereas re-introduction of a functional VHL gene restores the instability of HIF-1alpha and HIF-2alpha proteins under normoxic conditions.	Demonstrates that VHL deficiency leads to constitutive HIF-alpha expression even under normoxic conditions, and that VHL restoration can reverse this effect.	"{""explanation"": ""Demonstrates that VHL deficiency leads to constitutive HIF-alpha expression even under normoxic conditions, and that VHL restoration can reverse this effect."", ""reference"": ""PMID:11114720"", ""snippet"": ""in VHL deficient cell lines, both HIF-alpha subunits are constitutively expressed, whereas re-introduction of a functional VHL gene restores the instability of HIF-1alpha and HIF-2alpha proteins under normoxic conditions."", ""supports"": ""SUPPORT""}"
8236	7814	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	3	evidence	0	PMID:11114720	SUPPORT		In a previous study of hemangioblastomas, the most frequent manifestation of hereditary von Hippel-Lindau disease (VHL), we found elevated levels of vascular endothelial growth factor and HIF-2alpha mRNA in stromal cells of the tumors.	Demonstrates elevated VEGF levels in VHL-associated hemangioblastomas, linking HIF activation to VEGF overexpression.	"{""explanation"": ""Demonstrates elevated VEGF levels in VHL-associated hemangioblastomas, linking HIF activation to VEGF overexpression."", ""reference"": ""PMID:11114720"", ""snippet"": ""In a previous study of hemangioblastomas, the most frequent manifestation of hereditary von Hippel-Lindau disease (VHL), we found elevated levels of vascular endothelial growth factor and HIF-2alpha mRNA in stromal cells of the tumors."", ""supports"": ""SUPPORT""}"
8237	7814	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	3	evidence	1	PMID:11114720	SUPPORT		The data presented here provide evidence for a role of the VHL protein in regulation of angiogenesis and erythropoiesis mediated by the HIF-1alpha and HIF-2alpha proteins.	Confirms VHL protein regulates angiogenesis through HIF-mediated mechanisms.	"{""explanation"": ""Confirms VHL protein regulates angiogenesis through HIF-mediated mechanisms."", ""reference"": ""PMID:11114720"", ""snippet"": ""The data presented here provide evidence for a role of the VHL protein in regulation of angiogenesis and erythropoiesis mediated by the HIF-1alpha and HIF-2alpha proteins."", ""supports"": ""SUPPORT""}"
8238	7815	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	4	evidence	0	PMID:37980175	SUPPORT		immunohistochemical studies for markers such as paired box 8 (PAX-8), carbonic anhydrase 9 (CA9), and glucose transporter 1 (GLUT-1) have an important role in routine clinical practice and represent cost-effective diagnostic tools.	The use of GLUT-1 as a diagnostic marker for VHL-associated tumors reflects HIF-induced metabolic reprogramming with increased glucose uptake.	"{""explanation"": ""The use of GLUT-1 as a diagnostic marker for VHL-associated tumors reflects HIF-induced metabolic reprogramming with increased glucose uptake."", ""reference"": ""PMID:37980175"", ""snippet"": ""immunohistochemical studies for markers such as paired box 8 (PAX-8), carbonic anhydrase 9 (CA9), and glucose transporter 1 (GLUT-1) have an important role in routine clinical practice and represent cost-effective diagnostic tools."", ""supports"": ""SUPPORT""}"
8239	7816	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	5	evidence	0	PMID:19671042	SUPPORT		Mutations in pVHL can be found in familial and sporadic hemangioblastomas, clear cell carcinomas of the kidney, pheochromocytomas and inherited forms of erythrocytosis, illustrating the importance of disrupted molecular oxygen sensing in the pathogenesis of these diseases.	Documents the characteristic tumor spectrum of VHL disease and links it to disrupted oxygen sensing.	"{""explanation"": ""Documents the characteristic tumor spectrum of VHL disease and links it to disrupted oxygen sensing."", ""reference"": ""PMID:19671042"", ""snippet"": ""Mutations in pVHL can be found in familial and sporadic hemangioblastomas, clear cell carcinomas of the kidney, pheochromocytomas and inherited forms of erythrocytosis, illustrating the importance of disrupted molecular oxygen sensing in the pathogenesis of these diseases."", ""supports"": ""SUPPORT""}"
8240	7816	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	pathophysiology	5	evidence	1	PMID:15162797	SUPPORT		Loss of von Hippel-Lindau (VHL) protein function results in an autosomal-dominant cancer syndrome known as VHL disease, which manifests as angiomas of the retina, hemangioblastomas of the central nervous system, renal clear-cell carcinomas and pheochromocytomas.	Confirms the characteristic tumor spectrum associated with VHL protein loss.	"{""explanation"": ""Confirms the characteristic tumor spectrum associated with VHL protein loss."", ""reference"": ""PMID:15162797"", ""snippet"": ""Loss of von Hippel-Lindau (VHL) protein function results in an autosomal-dominant cancer syndrome known as VHL disease, which manifests as angiomas of the retina, hemangioblastomas of the central nervous system, renal clear-cell carcinomas and pheochromocytomas."", ""supports"": ""SUPPORT""}"
8252	7835	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	0	evidence	0	PMID:26288590	SUPPORT		The disease is a chronic infection of the intestinal mucosa with the bacterium Tropheryma whipplei, which leads to a lymphostasis with an impaired absorption of the nutrition.	Review describes lymphatic obstruction and malabsorption from chronic infection.	"{""explanation"": ""Review describes lymphatic obstruction and malabsorption from chronic infection."", ""reference"": ""PMID:26288590"", ""snippet"": ""The disease is a chronic infection of the intestinal mucosa with the bacterium Tropheryma whipplei, which leads to a lymphostasis with an impaired absorption of the nutrition."", ""supports"": ""SUPPORT""}"
8253	7835	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	0	evidence	1	PMID:26288590	SUPPORT		Recent studies suggest that a host-specific dysfunction of the intestinal macrophages is responsible for the chronic infection with T. whipplei.	Highlights macrophage functional defect underlying persistent infection.	"{""explanation"": ""Highlights macrophage functional defect underlying persistent infection."", ""reference"": ""PMID:26288590"", ""snippet"": ""Recent studies suggest that a host-specific dysfunction of the intestinal macrophages is responsible for the chronic infection with T. whipplei."", ""supports"": ""SUPPORT""}"
8254	7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	evidence	0	PMID:40062480	SUPPORT		Half the world's population is exposed to T. whipplei, but only one in a million develop WD. This suggests that acquired or inborn errors of immunity (IEI) may underlie WD.	Genetic review links rare immune defects to disease susceptibility.	"{""explanation"": ""Genetic review links rare immune defects to disease susceptibility."", ""reference"": ""PMID:40062480"", ""snippet"": ""Half the world's population is exposed to T. whipplei, but only one in a million develop WD. This suggests that acquired or inborn errors of immunity (IEI) may underlie WD."", ""supports"": ""SUPPORT""}"
8255	7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	evidence	1	PMID:40062480	SUPPORT		Anti-TNF treatment is a well established risk factor for flare-ups of WD.	Notes iatrogenic immune suppression as a trigger for disease activation.	"{""explanation"": ""Notes iatrogenic immune suppression as a trigger for disease activation."", ""reference"": ""PMID:40062480"", ""snippet"": ""Anti-TNF treatment is a well established risk factor for flare-ups of WD."", ""supports"": ""SUPPORT""}"
8256	7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	evidence	2	PMID:32896657	SUPPORT		About 60% were immunosuppressed. The most frequent clinical presentations were joint pain (16/22), weight loss (15/22) and/or digestive tract disorder (15/22).	Cohort shows high immunosuppression rate among confirmed Whipple disease cases.	"{""explanation"": ""Cohort shows high immunosuppression rate among confirmed Whipple disease cases."", ""reference"": ""PMID:32896657"", ""snippet"": ""About 60% were immunosuppressed. The most frequent clinical presentations were joint pain (16/22), weight loss (15/22) and/or digestive tract disorder (15/22)."", ""supports"": ""SUPPORT""}"
8257	7836	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	1	evidence	3	PMID:37727483	SUPPORT		The patient was admitted to the hospital due to recurrent diarrhea for 1 mo, shortness of breath, and 1 wk of fever, after 3 years of renal transplantation.	Post-transplant case illustrates Whipple disease emerging under chronic immunosuppression.	"{""explanation"": ""Post-transplant case illustrates Whipple disease emerging under chronic immunosuppression."", ""reference"": ""PMID:37727483"", ""snippet"": ""The patient was admitted to the hospital due to recurrent diarrhea for 1 mo, shortness of breath, and 1 wk of fever, after 3 years of renal transplantation."", ""supports"": ""SUPPORT""}"
8258	7837	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	2	evidence	0	PMID:34093562	SUPPORT		Etanercept, adalimumab or certolizumab treatment of monocyte-derived macrophages from healthy subjects significantly increased bacterial replication in vitro without affecting uptake.	Demonstrates TNF inhibitors increase T. whipplei replication within macrophages.	"{""explanation"": ""Demonstrates TNF inhibitors increase T. whipplei replication within macrophages."", ""reference"": ""PMID:34093562"", ""snippet"": ""Etanercept, adalimumab or certolizumab treatment of monocyte-derived macrophages from healthy subjects significantly increased bacterial replication in vitro without affecting uptake."", ""supports"": ""SUPPORT""}"
8259	7837	340	Whipple Disease	Whipple_Disease.yaml	pathophysiology	2	evidence	1	PMID:34093562	SUPPORT		TNFI aggravate/exacerbate latent or subclinical undiagnosed Whipple's disease by promoting a strong inflammatory response and apoptosis.	Study links TNF blockade to apoptosis-driven exacerbation of Whipple disease.	"{""explanation"": ""Study links TNF blockade to apoptosis-driven exacerbation of Whipple disease."", ""reference"": ""PMID:34093562"", ""snippet"": ""TNFI aggravate/exacerbate latent or subclinical undiagnosed Whipple's disease by promoting a strong inflammatory response and apoptosis."", ""supports"": ""SUPPORT""}"
8276	7859	341	Wilms Tumor	Wilms_Tumor.yaml	pathophysiology	0	evidence	0	PMID:20021811	SUPPORT		The WT1 gene located at 11p13 was identified in 1990 as a tumor suppressor gene important in the development in WT.	Supports the role of WT1 in Wilms tumor development.	"{""explanation"": ""Supports the role of WT1 in Wilms tumor development."", ""reference"": ""PMID:20021811"", ""snippet"": ""The WT1 gene located at 11p13 was identified in 1990 as a tumor suppressor gene important in the development in WT."", ""supports"": ""SUPPORT""}"
8284	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	0	PMID:37741465	SUPPORT		Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder	Establishes that ATP7B mutations are the causative defect in Wilson's disease.	"{""explanation"": ""Establishes that ATP7B mutations are the causative defect in Wilson's disease."", ""reference"": ""PMID:37741465"", ""snippet"": ""Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder"", ""supports"": ""SUPPORT""}"
8285	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	1	PMID:38731973	SUPPORT		Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein.	Confirms that impaired biliary copper excretion leads to hepatic copper accumulation.	"{""explanation"": ""Confirms that impaired biliary copper excretion leads to hepatic copper accumulation."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein."", ""supports"": ""SUPPORT""}"
8286	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	2	PMID:16382340	SUPPORT		Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism, resulting in pathological accumulation of copper in many organs and tissues.	Supports multi-organ copper accumulation in Wilson disease.	"{""explanation"": ""Supports multi-organ copper accumulation in Wilson disease."", ""reference"": ""PMID:16382340"", ""snippet"": ""Wilson disease (WD) is an autosomal recessive inherited disorder of copper metabolism, resulting in pathological accumulation of copper in many organs and tissues."", ""supports"": ""SUPPORT""}"
8287	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	3	PMID:16382340	SUPPORT		ATP7B is the gene product of the WD gene located on chromosome 13 and resides in hepatocytes in the trans-Golgi network, transporting copper into the secretory pathway for incorporation into apoceruloplasmin and excretion into the bile.	Supports ATP7B localization to the trans-Golgi network and copper loading into apoceruloplasmin with biliary excretion.	"{""explanation"": ""Supports ATP7B localization to the trans-Golgi network and copper loading into apoceruloplasmin with biliary excretion."", ""reference"": ""PMID:16382340"", ""snippet"": ""ATP7B is the gene product of the WD gene located on chromosome 13 and resides in hepatocytes in the trans-Golgi network, transporting copper into the secretory pathway for incorporation into apoceruloplasmin and excretion into the bile."", ""supports"": ""SUPPORT""}"
8288	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	4	PMID:18395099	SUPPORT		Copper excess provokes a massive download of the ATP7B retained in the trans-Golgi network into the bile canalicular membrane.	Demonstrates copper-stimulated ATP7B trafficking to the canalicular membrane.	"{""explanation"": ""Demonstrates copper-stimulated ATP7B trafficking to the canalicular membrane."", ""reference"": ""PMID:18395099"", ""snippet"": ""Copper excess provokes a massive download of the ATP7B retained in the trans-Golgi network into the bile canalicular membrane."", ""supports"": ""SUPPORT""}"
8289	7879	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	0	evidence	5	PMID:25002079	SUPPORT		Free copper in Wilson disease (WD) is toxic and may reduce antioxidant, increase oxidative stress marker and thereby cytokine release and excitotoxic injury, but there is paucity of studies in humans.	Supports toxic effects of free copper and oxidative stress in Wilson disease.	"{""explanation"": ""Supports toxic effects of free copper and oxidative stress in Wilson disease."", ""reference"": ""PMID:25002079"", ""snippet"": ""Free copper in Wilson disease (WD) is toxic and may reduce antioxidant, increase oxidative stress marker and thereby cytokine release and excitotoxic injury, but there is paucity of studies in humans."", ""supports"": ""SUPPORT""}"
8290	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	evidence	0	PMID:38731973	SUPPORT		Excess Cu2+ primarily leads to the generation of reactive oxygen species (ROS), as evidenced by early experimental studies exemplified with the detection of hydroxyl radical formation	Demonstrates that excess copper generates ROS leading to oxidative stress and cellular injury.	"{""explanation"": ""Demonstrates that excess copper generates ROS leading to oxidative stress and cellular injury."", ""reference"": ""PMID:38731973"", ""snippet"": ""Excess Cu2+ primarily leads to the generation of reactive oxygen species (ROS), as evidenced by early experimental studies exemplified with the detection of hydroxyl radical formation"", ""supports"": ""SUPPORT""}"
8291	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	evidence	1	PMID:24517326	SUPPORT		On the contrary, however, when copper is massively deposited in mitochondria, severe structural and respiratory impairments are observed upon disease progression. This provokes reactive oxygen species and consequently causes the mitochondrial membranes to disintegrate, which triggers hepatocyte death.	Supports mitochondrial dysfunction, ROS generation, and hepatocyte death with copper overload.	"{""explanation"": ""Supports mitochondrial dysfunction, ROS generation, and hepatocyte death with copper overload."", ""reference"": ""PMID:24517326"", ""snippet"": ""On the contrary, however, when copper is massively deposited in mitochondria, severe structural and respiratory impairments are observed upon disease progression. This provokes reactive oxygen species and consequently causes the mitochondrial membranes to disintegrate, which triggers hepatocyte death."", ""supports"": ""SUPPORT""}"
8292	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	evidence	2	PMID:28433112	SUPPORT		Most liver biopsy specimens show moderate to severe steatosis, variable degree of portal and/or lobular inflammation, and fibrosis eventually progressing to cirrhosis.	Supports progression from hepatic injury to fibrosis and cirrhosis.	"{""explanation"": ""Supports progression from hepatic injury to fibrosis and cirrhosis."", ""reference"": ""PMID:28433112"", ""snippet"": ""Most liver biopsy specimens show moderate to severe steatosis, variable degree of portal and/or lobular inflammation, and fibrosis eventually progressing to cirrhosis."", ""supports"": ""SUPPORT""}"
8293	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	evidence	3	PMID:30452922	SUPPORT		Hepatocytes in liver tissues from patients with WD and from Atp7b-/- mice and rats (but not controls) had multiple autophagosomes.	Demonstrates activation of autophagy in Wilson disease hepatocytes under copper overload.	"{""explanation"": ""Demonstrates activation of autophagy in Wilson disease hepatocytes under copper overload."", ""reference"": ""PMID:30452922"", ""snippet"": ""Hepatocytes in liver tissues from patients with WD and from Atp7b-/- mice and rats (but not controls) had multiple autophagosomes."", ""supports"": ""SUPPORT""}"
8294	7880	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	1	evidence	4	PMID:33360697	SUPPORT	MODEL_ORGANISM	In general, the results reveal that Cu exposure can cause mitophagy through the PINK1/Parkin pathway in chicken livers, and that mitophagy might attenuate Cu-induced mitochondrial apoptosis.	Shows copper-induced mitophagy in a liver model, supporting mitochondrial quality control responses.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Shows copper-induced mitophagy in a liver model, supporting mitochondrial quality control responses."", ""reference"": ""PMID:33360697"", ""snippet"": ""In general, the results reveal that Cu exposure can cause mitophagy through the PINK1/Parkin pathway in chicken livers, and that mitophagy might attenuate Cu-induced mitochondrial apoptosis."", ""supports"": ""SUPPORT""}"
8295	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	evidence	0	PMID:38731973	SUPPORT		Released from the liver cells due to limited storage capacity, the toxic copper enters the circulation and arrives at other organs, causing local accumulation and cell injury. This explains why copper injures not only the liver, but also the brain	Explains the pathophysiology of copper-induced brain injury in Wilson's disease.	"{""explanation"": ""Explains the pathophysiology of copper-induced brain injury in Wilson's disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Released from the liver cells due to limited storage capacity, the toxic copper enters the circulation and arrives at other organs, causing local accumulation and cell injury. This explains why copper injures not only the liver, but also the brain"", ""supports"": ""SUPPORT""}"
8296	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	evidence	1	PMID:28433113	SUPPORT		In Wilson disease (WD), brain cellular damage is thought to be due to copper deposition. Striatal lesions are the most characteristic lesions found in the brain of patients with neurologic symptoms, as emphasized in the initial reports of S.A.K. Wilson.	Supports copper deposition driving brain damage with characteristic striatal lesions.	"{""explanation"": ""Supports copper deposition driving brain damage with characteristic striatal lesions."", ""reference"": ""PMID:28433113"", ""snippet"": ""In Wilson disease (WD), brain cellular damage is thought to be due to copper deposition. Striatal lesions are the most characteristic lesions found in the brain of patients with neurologic symptoms, as emphasized in the initial reports of S.A.K. Wilson."", ""supports"": ""SUPPORT""}"
8297	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	evidence	2	PMID:31179301	SUPPORT		Most severe neuropathologic abnormalities, including tissue rarefaction, reactive astrogliosis, myelin palor, and presence of iron-laden macrophages, are typically present in the putamen while other basal ganglia, thalami, and brainstem are usually less affected.	Supports reactive astrogliosis and basal ganglia/putamen involvement.	"{""explanation"": ""Supports reactive astrogliosis and basal ganglia/putamen involvement."", ""reference"": ""PMID:31179301"", ""snippet"": ""Most severe neuropathologic abnormalities, including tissue rarefaction, reactive astrogliosis, myelin palor, and presence of iron-laden macrophages, are typically present in the putamen while other basal ganglia, thalami, and brainstem are usually less affected."", ""supports"": ""SUPPORT""}"
8298	7881	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	2	evidence	3	PMID:39334421	SUPPORT	MODEL_ORGANISM	At 3-5 months of age, these mice started to display neurological deficits in motor coordination and cognitive dysfunction, accompanied by increased expression of inflammatory cytokines in the central nervous system. Microglia in the striatum and cortex exhibit significant activation, shorter processes, and decreased branch points.	Demonstrates CNS inflammatory cytokines and microglial activation in a Wilson disease mouse model.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Demonstrates CNS inflammatory cytokines and microglial activation in a Wilson disease mouse model."", ""reference"": ""PMID:39334421"", ""snippet"": ""At 3-5 months of age, these mice started to display neurological deficits in motor coordination and cognitive dysfunction, accompanied by increased expression of inflammatory cytokines in the central nervous system. Microglia in the striatum and cortex exhibit significant activation, shorter processes, and decreased branch points."", ""supports"": ""SUPPORT""}"
8299	7882	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	3	evidence	0	PMID:38731973	SUPPORT		Many interesting disease details were published on the mechanistic steps, such as the generation of reactive oxygen species (ROS) and cuproptosis causing a copper dependent cell death	Establishes cuproptosis as a copper-dependent cell death mechanism in Wilson disease.	"{""explanation"": ""Establishes cuproptosis as a copper-dependent cell death mechanism in Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Many interesting disease details were published on the mechanistic steps, such as the generation of reactive oxygen species (ROS) and cuproptosis causing a copper dependent cell death"", ""supports"": ""SUPPORT""}"
8300	7882	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	3	evidence	1	PMID:41006805	SUPPORT		"Moreover, abnormal lipoylation of the copper-dependent proteins metal-binding domain of ferredoxin 1 and dihydrolipoamide transacetylase causes mitochondrial protein oligomer buildup and tricarboxylic acid cycle dysfunction, reinforcing an ""oxidative damage-inflammation-fibrosis"" vicious cycle."	Supports lipoylation-related mitochondrial proteotoxic stress and TCA cycle dysfunction consistent with cuproptosis.	"{""explanation"": ""Supports lipoylation-related mitochondrial proteotoxic stress and TCA cycle dysfunction consistent with cuproptosis."", ""reference"": ""PMID:41006805"", ""snippet"": ""Moreover, abnormal lipoylation of the copper-dependent proteins metal-binding domain of ferredoxin 1 and dihydrolipoamide transacetylase causes mitochondrial protein oligomer buildup and tricarboxylic acid cycle dysfunction, reinforcing an \""oxidative damage-inflammation-fibrosis\"" vicious cycle."", ""supports"": ""SUPPORT""}"
8301	7883	342	Wilson Disease	Wilsons_Disease.yaml	pathophysiology	4	evidence	0	PMID:38731973	SUPPORT		In the liver of patients with Wilson disease, also, increased iron deposits were found that may lead to iron-related ferroptosis responsible for phospholipid peroxidation within membranes of subcellular organelles	Demonstrates that ferroptosis may contribute to liver injury in Wilson disease due to iron accumulation.	"{""explanation"": ""Demonstrates that ferroptosis may contribute to liver injury in Wilson disease due to iron accumulation."", ""reference"": ""PMID:38731973"", ""snippet"": ""In the liver of patients with Wilson disease, also, increased iron deposits were found that may lead to iron-related ferroptosis responsible for phospholipid peroxidation within membranes of subcellular organelles"", ""supports"": ""SUPPORT""}"
8352	7929	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:32914558	SUPPORT		The syndrome is caused by deletion of a critical region (Wolf-Hirschhorn Syndrome Critical region-WHSCR) on chromosome 4p16.3.	This establishes the genetic basis of Wolf-Hirschhorn syndrome as a deletion of the critical region on 4p16.3.	"{""explanation"": ""This establishes the genetic basis of Wolf-Hirschhorn syndrome as a deletion of the critical region on 4p16.3."", ""reference"": ""PMID:32914558"", ""snippet"": ""The syndrome is caused by deletion of a critical region (Wolf-Hirschhorn Syndrome Critical region-WHSCR) on chromosome 4p16.3."", ""supports"": ""SUPPORT""}"
8353	7929	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	pathophysiology	0	evidence	1	PMID:18474167	SUPPORT		We report a case of a rare chromosomal disorder, Wolf-Hirschhorn syndrome, caused by deletion of short arm of chromosome 4.	This confirms that Wolf-Hirschhorn syndrome results from deletion of the short arm of chromosome 4.	"{""explanation"": ""This confirms that Wolf-Hirschhorn syndrome results from deletion of the short arm of chromosome 4."", ""reference"": ""PMID:18474167"", ""snippet"": ""We report a case of a rare chromosomal disorder, Wolf-Hirschhorn syndrome, caused by deletion of short arm of chromosome 4."", ""supports"": ""SUPPORT""}"
8394	7956	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	pathophysiology	0	evidence	0	PMID:33444416	SUPPORT		the human counterpart of CLK-2/TEL2, TELO2, has been also implicated in the NMD, suggesting a conserved role of CLK-2/TEL2 proteins in mRNA surveillance	Demonstrates that TELO2 plays a conserved role in nonsense-mediated mRNA decay, linking the genetic defect to cellular dysfunction.	"{""explanation"": ""Demonstrates that TELO2 plays a conserved role in nonsense-mediated mRNA decay, linking the genetic defect to cellular dysfunction."", ""reference"": ""PMID:33444416"", ""snippet"": ""the human counterpart of CLK-2/TEL2, TELO2, has been also implicated in the NMD, suggesting a conserved role of CLK-2/TEL2 proteins in mRNA surveillance"", ""supports"": ""SUPPORT""}"
